Cover
Cover - shares | 9 Months Ended | |
Jun. 30, 2023 | Aug. 01, 2023 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Annual Report | true | |
Document Period End Date | Jun. 30, 2023 | |
Document Transition Report | false | |
Securities Act File Number | 1-33901 | |
Entity Registrant Name | Oaktree Specialty Lending Corporation | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 26-1219283 | |
Entity Address, Address Line One | 333 South Grand Avenue | |
Entity Address, Address Line Two | 28th Floor | |
Entity Address, City or Town | Los Angeles | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 90071 | |
City Area Code | 213 | |
Local Phone Number | 830-6300 | |
Title of 12(b) Security | Common Stock, par value $0.01 per share | |
Trading Symbol | OCSL | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 77,079,811 | |
Entity Central Index Key | 0001414932 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q3 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --09-30 |
Consolidated Statements of Asse
Consolidated Statements of Assets and Liabilities - USD ($) $ in Thousands | Jun. 30, 2023 | Sep. 30, 2022 | |||
Assets [Abstract] | |||||
Investments at fair value | $ 3,135,619 | $ 2,494,111 | |||
Cash and cash equivalents | 59,704 | 23,528 | |||
Restricted cash | 12,956 | 2,836 | |||
Interest, dividends and fees receivable | 29,457 | 35,598 | |||
Due from portfolio companies | 2,080 | 22,495 | |||
Receivables from unsettled transactions | 39,261 | 4,692 | |||
Due from broker | 39,990 | 45,530 | |||
Deferred financing costs | 13,284 | 7,350 | |||
Deferred offering costs | 186 | 32 | |||
Deferred tax asset, net | 2,695 | 1,687 | |||
Derivative assets at fair value | 49 | 6,789 | |||
Other assets | 693 | 1,665 | |||
Total assets | 3,335,974 | 2,646,313 | |||
Liabilities [Abstract] | |||||
Accounts payable, accrued expenses and other liabilities | 3,412 | 3,701 | |||
Base management fee and incentive fee payable | 20,072 | 15,940 | |||
Due to affiliate | 7,724 | 3,180 | |||
Interest payable | 12,907 | 7,936 | |||
Payables from unsettled transactions | 2,785 | 26,981 | |||
Derivative liability at fair value | 39,567 | 41,969 | |||
Credit facilities payable | 1,135,000 | 700,000 | |||
Unsecured notes payable (net of $3,909 and $5,020 of unamortized financing costs as of June 30, 2023 and September 30, 2022, respectively) | 605,066 | 601,043 | |||
Total liabilities | 1,826,533 | 1,400,750 | |||
Commitments and contingencies (Note 13) | |||||
Net Assets [Abstract] | |||||
Common stock, $0.01 par value per share, 250,000 shares authorized; 77,080 and 61,125 shares issued and outstanding as of June 30, 2023 and September 30, 2022, respectively (1) | [1] | 771 | 611 | ||
Additional paid-in-capital | 2,163,528 | 1,827,721 | |||
Accumulated overdistributed earnings | (654,858) | (582,769) | |||
Total net assets (equivalent to $19.58 and $20.38 per common share as of June 30, 2023 and September 30, 2022, respectively) (Note 11) (1) | [1] | 1,509,441 | 1,245,563 | ||
Total liabilities and net assets | 3,335,974 | 2,646,313 | |||
Control Investments | |||||
Assets [Abstract] | |||||
Investments at fair value | 238,196 | [2],[3] | 214,165 | [4],[5] | |
Control & Affiliate Investments | |||||
Assets [Abstract] | |||||
Investments at fair value | 23,911 | 26,196 | |||
Non-control/Non-affiliate | |||||
Assets [Abstract] | |||||
Investments at fair value | $ 2,873,512 | [6] | $ 2,253,750 | [7] | |
[1](1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The issued and outstanding shares and net asset value per share reflect the reverse stock split on a retroactive basis.[2]As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the nine months ended June 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.[3]Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.[4]As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2022 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.[5]Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.[6]Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.[7]Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments. |
Consolidated Statements of As_2
Consolidated Statements of Assets and Liabilities (Parenthetical) $ in Thousands | Jun. 30, 2023 USD ($) $ / shares shares | Sep. 30, 2022 USD ($) $ / shares shares | ||
Investment, cost | $ 3,296,285 | $ 2,617,754 | ||
Unamortized financing costs | $ 3,909 | $ 5,020 | ||
Common stock, par value, (in dollars per share) | $ / shares | $ 0.01 | $ 0.01 | ||
Common stock, shares authorized (in shares) | shares | 250,000,000 | 250,000,000 | ||
Common stock, shares issued (in shares) | shares | 77,080,000 | 61,125,000 | ||
Common stock, shares outstanding (in shares) | shares | 77,080,000 | [1] | 61,125,000 | |
Net asset value per common share (dollars per share) | $ / shares | $ 19.58 | [1] | $ 20.38 | |
Control Investments | ||||
Investment, cost | $ 285,236 | [2],[3] | $ 260,305 | [4],[5] |
Affiliate Investments | ||||
Investment, cost | 25,370 | [6] | 27,353 | [7] |
Non-control/Non-affiliate | ||||
Investment, cost | $ 2,985,679 | [8] | $ 2,330,096 | [9] |
[1](1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.[2]As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the nine months ended June 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.[3]Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.[4]As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2022 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.[5]Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.[6]Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.[7]Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.[8]Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.[9]Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments. |
Consolidated Statements of Oper
Consolidated Statements of Operations $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Jun. 30, 2023 USD ($) $ / shares shares | Jun. 30, 2022 USD ($) $ / shares shares | Jun. 30, 2023 USD ($) $ / shares shares | Jun. 30, 2022 USD ($) $ / shares shares | ||
Revenues [Abstract] | |||||
Interest on cash and cash equivalents | $ 992 | $ 151 | $ 2,221 | $ 157 | |
Total interest income | 95,310 | 54,728 | 254,033 | 167,197 | |
Interest income, PIK | 3,967 | 5,178 | 14,220 | 14,515 | |
Fee income | 1,573 | 2,275 | 5,974 | 5,092 | |
Dividend income | 1,050 | 956 | 3,154 | 5,572 | |
Total investment income | 101,900 | 63,137 | 277,381 | 192,376 | |
Operating Expenses [Abstract] | |||||
Base management fee | 11,983 | 9,819 | 33,383 | 29,853 | |
Part I incentive fee | 9,590 | 6,497 | 26,300 | 19,658 | |
Part II incentive fee | 0 | (6,796) | 0 | (8,791) | |
Professional fees | 1,387 | 885 | 4,962 | 3,029 | |
Directors fees | 160 | 160 | 480 | 443 | |
Interest expense | 30,793 | 11,870 | 79,316 | 31,178 | |
Administrator expense | 322 | 271 | 935 | 968 | |
General and administrative expenses | 752 | 811 | 2,753 | 2,217 | |
Total expenses | 54,987 | 23,517 | 148,129 | 78,555 | |
Fees waived | (1,500) | (750) | (4,025) | (2,250) | |
Net expenses | 53,487 | 22,767 | 144,104 | 76,305 | |
Net investment income before taxes | 48,413 | 40,370 | 133,277 | 116,071 | |
(Provision) benefit for taxes on net investment income | 0 | 0 | 0 | (3,308) | |
Excise tax | 0 | 0 | (78) | 0 | |
Net investment income | 48,413 | 40,370 | 133,199 | 112,763 | |
Unrealized appreciation (depreciation): | |||||
Foreign currency forward contracts | 4,575 | (1,630) | (4,802) | (778) | |
Net unrealized appreciation (depreciation) | (1,039) | (86,755) | (42,300) | (118,379) | |
Realized gains (losses): | |||||
Foreign currency forward contracts | (6,309) | 8,796 | (5,513) | 12,179 | |
Net realized gains (losses) | (10,603) | 9,212 | (19,917) | 19,935 | |
(Provision) benefit for taxes on realized and unrealized gains (losses) | (86) | (661) | 397 | 1,696 | |
Net realized and unrealized gains (losses), net of taxes | (11,728) | (78,204) | (61,820) | (96,748) | |
Net increase (decrease) in net assets resulting from operations | $ 36,685 | $ (37,834) | $ 71,379 | $ 16,015 | |
Net investment income per common share - basic and diluted (dollars per share) | $ / shares | [1] | $ 0.63 | $ 0.66 | $ 1.89 | $ 1.86 |
Earnings (loss) per common share - basic (dollars per share) | $ / shares | [1] | 0.48 | (0.62) | 1.01 | 0.26 |
Earnings (loss) per common share - diluted (dollars per share) | $ / shares | [1] | $ 0.48 | $ (0.62) | $ 1.01 | $ 0.26 |
Weighted average common shares outstanding - basic (shares) | shares | [1] | 77,080,000 | 61,123,000 | 70,431,000 | 60,593,000 |
Weighted average common shares outstanding - diluted (shares) | shares | [1] | 77,080,000 | 61,123,000 | 70,431,000 | 60,593,000 |
Control Investments | |||||
Revenues [Abstract] | |||||
Interest income | $ 5,568 | $ 3,400 | $ 15,326 | $ 10,214 | |
Fee income | 13 | 12 | 38 | 38 | |
Dividend income | 1,050 | 875 | 3,150 | 5,491 | |
Unrealized appreciation (depreciation): | |||||
Net unrealized appreciation (depreciation) | 734 | (16,991) | (900) | (26,552) | |
Realized gains (losses): | |||||
Realized gain (loss) | 0 | 0 | 0 | 1,868 | |
Control & Affiliate Investments | |||||
Revenues [Abstract] | |||||
Interest income | 681 | 470 | 1,970 | 1,170 | |
Fee income | 5 | 5 | 15 | 15 | |
Unrealized appreciation (depreciation): | |||||
Net unrealized appreciation (depreciation) | 149 | (328) | (302) | (716) | |
Non-control/Non-affiliate | |||||
Revenues [Abstract] | |||||
Interest income | 88,069 | 50,707 | 234,516 | 155,656 | |
Interest income, PIK | 3,967 | 5,178 | 14,220 | 14,515 | |
Fee income | 1,555 | 2,258 | 5,921 | 5,039 | |
Dividend income | 0 | 81 | 4 | 81 | |
Unrealized appreciation (depreciation): | |||||
Net unrealized appreciation (depreciation) | (6,497) | (67,806) | (36,296) | (90,333) | |
Realized gains (losses): | |||||
Realized gain (loss) | $ (4,294) | $ 416 | $ (14,404) | $ 5,888 | |
[1](1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis. |
Consolidated Statements of Chan
Consolidated Statements of Changes in Net Assets $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||||||||||||||
Jan. 20, 2023 | Jun. 30, 2022 USD ($) $ / shares shares | Mar. 31, 2022 USD ($) $ / shares shares | Dec. 31, 2021 USD ($) | Jun. 30, 2023 USD ($) $ / shares shares | Mar. 31, 2023 USD ($) $ / shares shares | Dec. 31, 2022 USD ($) | Jun. 30, 2022 USD ($) $ / shares shares | Mar. 31, 2022 USD ($) $ / shares shares | Dec. 31, 2021 USD ($) | Jun. 30, 2023 USD ($) $ / shares shares | Jun. 30, 2022 USD ($) $ / shares shares | Sep. 30, 2022 USD ($) $ / shares shares | Sep. 30, 2021 USD ($) $ / shares shares | |||||||
Net increase (decrease) in net assets resulting from operations | ||||||||||||||||||||
Net investment income | $ 48,413 | $ 45,978 | $ 38,808 | $ 40,370 | $ 40,098 | $ 32,295 | $ 133,199 | $ 112,763 | ||||||||||||
Net unrealized appreciation (depreciation) | (1,039) | (86,755) | (42,300) | (118,379) | ||||||||||||||||
Net realized gains (losses) | (10,603) | 9,212 | (19,917) | 19,935 | ||||||||||||||||
(Provision) benefit for taxes on realized and unrealized gains (losses) | (86) | (66) | 549 | (661) | (21) | 2,378 | 397 | 1,696 | ||||||||||||
Net increase (decrease) in net assets resulting from operations | 36,685 | (37,834) | 71,379 | 16,015 | ||||||||||||||||
Stockholder transactions: | ||||||||||||||||||||
Net increase (decrease) in net assets from stockholder transactions | (42,394) | (42,395) | (58,679) | (30,256) | (29,271) | (27,956) | (143,468) | (87,483) | ||||||||||||
Capital share transactions: | ||||||||||||||||||||
Issuance of common stock in connection with the OSI2 Merger | 0 | 334,034 | 0 | 334,034 | 0 | |||||||||||||||
Issuance of common stock under dividend reinvestment plan | $ 900 | $ 800 | $ 800 | 1,123 | 1,295 | 1,933 | 874 | 766 | 786 | 4,351 | 2,426 | |||||||||
Repurchase of common stock under dividend reinvestment plan | (1,123) | (1,295) | (874) | (2,418) | (874) | |||||||||||||||
Issuance of common stock in connection with the "at the market" offering | 0 | 1,243 | 19,379 | 0 | 20,622 | |||||||||||||||
Net increase (decrease) in net assets from capital share transactions | 0 | 1,243 | 335,967 | 22,174 | ||||||||||||||||
Total increase (decrease) in net assets | (5,709) | (66,847) | 263,878 | (49,294) | ||||||||||||||||
Net assets | $ 1,263,529 | $ 1,330,376 | $ 1,325,061 | $ 1,509,441 | [1] | $ 1,515,150 | $ 1,201,989 | $ 1,263,529 | $ 1,330,376 | $ 1,325,061 | $ 1,509,441 | [1] | $ 1,263,529 | $ 1,245,563 | [1] | $ 1,312,823 | ||||
Net asset value per common share (dollars per share) | $ / shares | $ 20.67 | [2] | $ 21.79 | $ 19.58 | [2] | $ 19.66 | $ 20.67 | [2] | $ 21.79 | $ 19.58 | [2] | $ 20.67 | [2] | $ 20.38 | $ 21.84 | |||||
Common shares outstanding at end of period (shares) | shares | 61,125,000 | [2] | 61,068,000 | 77,080,000 | [2] | 77,080,000 | 61,125,000 | [2] | 61,068,000 | 77,080,000 | [2] | 61,125,000 | [2] | 61,125,000 | 60,120,000 | |||||
Stock split, conversion ratio | 0.0033 | |||||||||||||||||||
[1](1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The issued and outstanding shares and net asset value per share reflect the reverse stock split on a retroactive basis.[2](1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis. |
Consolidated Statement of Cash
Consolidated Statement of Cash Flows - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |
Jun. 30, 2023 | Jun. 30, 2023 | Jun. 30, 2022 | |
Operating activities: | |||
Net increase (decrease) in net assets resulting from operations | $ 36,685 | $ 71,379 | $ 16,015 |
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities: | |||
Net unrealized (appreciation) depreciation | 1,039 | 42,300 | 118,379 |
Net realized (gains) losses | 10,603 | 19,917 | (19,935) |
PIK interest income | (3,967) | (14,220) | (14,515) |
Accretion of original issue discount on investments | (15,554) | (22,707) | |
Accretion of original issue discount on unsecured notes payable | 509 | 509 | |
Amortization of deferred financing costs | 3,407 | 2,801 | |
Deferred taxes | (900) | (1,030) | (984) |
Purchases of investments | (597,662) | (620,843) | |
Proceeds from the sales and repayments of investments | 521,163 | 554,933 | |
Cash received in the OSI2 Merger | 22,317 | 0 | |
Changes in operating assets and liabilities: | |||
(Increase) decrease in interest, dividends and fees receivable | 12,866 | (9,456) | |
(Increase) decrease in due from portfolio companies | 20,520 | (4,891) | |
(Increase) decrease in receivables from unsettled transactions | (34,562) | 4,876 | |
(Increase) decrease in due from broker | 5,540 | (34,700) | |
(Increase) decrease in other assets | (548) | 1,017 | |
Increase (decrease) in accounts payable, accrued expenses and other liabilities | (52,290) | (700) | |
Increase (decrease) in base management fee and incentive fee payable | 37 | (17,086) | |
Increase (decrease) in due to affiliate | 3,823 | (817) | |
Increase (decrease) in interest payable | 1,278 | 3,759 | |
Increase (decrease) in payables from unsettled transactions | (24,196) | 470 | |
Increase (decrease) in director fees payable | (9) | 38 | |
Net cash provided by (used in) operating activities | (15,015) | (43,837) | |
Financing activities: | |||
Distributions paid in cash | (139,117) | (85,057) | |
Borrowings under credit facilities | 572,000 | 290,000 | |
Repayments of borrowings under credit facilities | (362,000) | (175,000) | |
Shares issued under the "at the market" offering | 0 | 20,839 | |
Repurchase of common stock under dividend reinvestment plan | (2,418) | (874) | |
Deferred financing costs paid | (7,314) | (334) | |
Offering costs paid | (186) | (215) | |
Net cash provided by (used in) financing activities | 60,965 | 49,359 | |
Effect of exchange rate changes on foreign currency | 346 | (842) | |
Net increase (decrease) in cash and cash equivalents and restricted cash | 46,296 | 4,680 | |
Cash and cash equivalents and restricted cash, beginning of period | 26,364 | 31,635 | |
Cash and cash equivalents and restricted cash, end of period | 72,660 | 72,660 | 36,315 |
Supplemental information: | |||
Cash paid for interest | 70,429 | 24,109 | |
Non-cash financing activities: | |||
Issuance of common stock under dividend reinvestment plan | 1,933 | 2,426 | |
Deferred Financing costs | 125 | 0 | |
Issuance of common stock in connection with the OSI2 Merger | 334,034 | $ 0 | |
Reconciliation to the Consolidated Statements of Assets and Liabilities [Abstract] | |||
Cash and cash equivalents | 59,704 | 59,704 | |
Restricted cash | 12,956 | 12,956 | |
Total cash and cash equivalents and restricted cash | $ 72,660 | $ 72,660 |
Consolidated Schedule of Invest
Consolidated Schedule of Investments € in Thousands, £ in Thousands, $ in Thousands | Jun. 30, 2023 USD ($) shares | Jun. 30, 2023 EUR (€) shares | Jun. 30, 2023 GBP (£) shares | Sep. 30, 2022 USD ($) shares | Sep. 30, 2022 EUR (€) shares | Sep. 30, 2022 GBP (£) shares | Jun. 30, 2022 USD ($) shares | Sep. 30, 2021 USD ($) | |||||||
Investment, cost | $ 3,296,285 | $ 2,617,754 | |||||||||||||
Investments at fair value | $ 3,135,619 | $ 2,494,111 | |||||||||||||
Investment owned, percent of net assets | 207.73% | 207.73% | 207.73% | 200.24% | 200.24% | 200.24% | |||||||||
Money market funds, at carrying value | $ 72,660 | $ 26,364 | |||||||||||||
Money market funds, percent of net assets | 4.80% | 4.80% | 4.80% | 2.10% | 2.10% | 2.10% | |||||||||
Investment owned and money market funds, percent of net assets | 212.50% | 212.50% | 212.50% | 202.40% | 202.40% | 202.40% | |||||||||
Total investment owned, at cost and money market funds, at carrying value | $ 3,368,945 | $ 2,644,118 | |||||||||||||
Total investment owned, at fair value and money market funds, at carrying value | 3,208,279 | 2,520,475 | |||||||||||||
Control Investments | |||||||||||||||
Investment, principal | 188,591 | $ 172,598 | |||||||||||||
Investment, cost | 285,236 | [1],[2] | 260,305 | [3],[4] | |||||||||||
Investments at fair value | $ 238,196 | [1],[2] | $ 214,165 | [3],[4] | $ 222,858 | $ 270,765 | |||||||||
Investment owned, ownership percentage | [3],[4] | 17.20% | 17.20% | 17.20% | |||||||||||
Investment owned, percent of net assets | 15.80% | [1],[2] | 15.80% | [1],[2] | 15.80% | [1],[2] | 17.60% | ||||||||
Affiliate Investments | |||||||||||||||
Investment, interest rate | [5] | 2.10% | 2.10% | 2.10% | |||||||||||
Investment, principal | $ 22,304 | $ 21,754 | |||||||||||||
Investment, cost | 25,370 | [6] | $ 27,353 | [5] | |||||||||||
Investments at fair value | $ 23,911 | [6] | 26,196 | [5] | $ 23,427 | 18,289 | |||||||||
Investment owned, percent of net assets | 1.60% | [6] | 1.60% | [6] | 1.60% | [6] | 1.90% | ||||||||
Non-control/Non-affiliate | |||||||||||||||
Investment, cost | $ 2,985,679 | [7] | 2,330,096 | [8] | |||||||||||
Investments at fair value | $ 2,873,512 | [7] | $ 2,253,750 | [8] | |||||||||||
Investment owned, percent of net assets | 190.40% | [7] | 190.40% | [7] | 190.40% | [7] | 180.90% | [8] | 180.90% | [8] | 180.90% | [8] | |||
Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan | |||||||||||||||
Investment, interest rate | [7],[9],[10],[11],[12],[13] | 12.50% | 12.50% | 12.50% | |||||||||||
Investment, principal | [7],[9],[11],[13],[14] | $ 1,174 | |||||||||||||
Investment, cost | [7],[9],[11],[13] | 1,133 | |||||||||||||
Investments at fair value | [7],[9],[11],[13] | $ 1,112 | |||||||||||||
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver | |||||||||||||||
Investment, interest rate | [7],[9],[10],[11],[12] | 11% | 11% | 11% | |||||||||||
Investment, principal | [7],[9],[11],[14] | $ 14,916 | |||||||||||||
Investment, cost | [7],[9],[11] | 14,770 | |||||||||||||
Investments at fair value | [7],[9],[11] | $ 14,489 | |||||||||||||
Investment, Identifier [Axis]: 109 Montgomery Owner LLC, Real Estate Operating Companies, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 9.80% | 9.80% | 9.80% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 389 | |||||||||||||
Investment, cost | [8],[15],[16] | 387 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 727 | |||||||||||||
Investment, Identifier [Axis]: 109 Montgomery Owner LLC, Real Estate Operating Companies, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16],[19] | 7% | 7% | 7% | |||||||||||
Investment, principal | [8],[15],[16],[18],[19] | $ 0 | |||||||||||||
Investment, cost | [8],[15],[16],[19] | (31) | |||||||||||||
Investments at fair value | [8],[15],[16],[19] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan | |||||||||||||||
Investment, interest rate | [7],[9],[10],[11],[12],[13] | 12% | 12% | 12% | |||||||||||
Investment, principal | [7],[9],[11],[13],[14] | $ 3,710 | |||||||||||||
Investment, cost | [7],[9],[11],[13] | 3,664 | |||||||||||||
Investments at fair value | [7],[9],[11],[13] | $ 3,645 | |||||||||||||
Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan | |||||||||||||||
Investment, interest rate | [7],[9],[10],[12],[20],[21] | 14.25% | 14.25% | 14.25% | |||||||||||
Investment, principal | [7],[9],[14],[20],[21] | $ 21,434 | |||||||||||||
Investment, cost | [7],[9],[20],[21] | 21,620 | |||||||||||||
Investments at fair value | [7],[9],[20],[21] | $ 21,434 | |||||||||||||
Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan | |||||||||||||||
Investment, interest rate, paid in kind | 20% | [7],[9],[20] | 20% | [7],[9],[20] | 20% | [7],[9],[20] | 10.50% | [8],[15],[22] | 10.50% | [8],[15],[22] | 10.50% | [8],[15],[22] | |||
Investment, principal | $ 5,576 | [7],[9],[14],[20] | $ 33,997 | [8],[15],[18],[22] | |||||||||||
Investment, cost | 5,561 | [7],[9],[20] | 33,960 | [8],[15],[22] | |||||||||||
Investments at fair value | $ 5,464 | [7],[9],[20] | $ 34,891 | [8],[15],[22] | |||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 6.25% | 6.25% | 6.25% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 9.80% | 9.80% | 9.80% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 14,685 | |||||||||||||
Investment, cost | [8],[15],[16] | 14,217 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 14,431 | |||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12% | 12% | 12% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 3,520 | |||||||||||||
Investment, cost | [7],[9],[12] | 3,480 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 3,455 | |||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12% | 12% | 12% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 18,271 | |||||||||||||
Investment, cost | [7],[9],[12] | 18,091 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 17,935 | |||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 11.66% | 11.66% | 11.66% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 1,000 | |||||||||||||
Investment, cost | [7],[9],[12] | 983 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 982 | |||||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[9],[20] | 7.50% | [7],[9],[20] | 7.50% | [7],[9],[20] | 7.50% | [8],[15],[16],[22] | 7.50% | [8],[15],[16],[22] | 7.50% | [8],[15],[16],[22] | |||
Investment, interest rate | 12.89% | [7],[9],[10],[12],[20] | 12.89% | [7],[9],[10],[12],[20] | 12.89% | [7],[9],[10],[12],[20] | 11.20% | [8],[15],[16],[17],[22] | 11.20% | [8],[15],[16],[17],[22] | 11.20% | [8],[15],[16],[17],[22] | |||
Investment, principal | $ 6,589 | [7],[9],[12],[14],[20] | $ 6,589 | [8],[15],[16],[18],[22] | |||||||||||
Investment, cost | 6,292 | [7],[9],[12],[20] | 6,256 | [8],[15],[16],[22] | |||||||||||
Investments at fair value | $ 6,267 | [7],[9],[12],[20] | $ 6,262 | [8],[15],[16],[22] | |||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[9],[11],[20] | 7.50% | [7],[9],[11],[20] | 7.50% | [7],[9],[11],[20] | 7.50% | [8],[15],[16],[19],[22] | 7.50% | [8],[15],[16],[19],[22] | 7.50% | [8],[15],[16],[19],[22] | |||
Investment, principal | $ 0 | [7],[9],[11],[12],[14],[20] | $ 0 | [8],[15],[16],[18],[19],[22] | |||||||||||
Investment, cost | (38) | [7],[9],[11],[12],[20] | (38) | [8],[15],[16],[19],[22] | |||||||||||
Investments at fair value | $ (38) | [7],[9],[11],[12],[20] | $ (37) | [8],[15],[16],[19],[22] | |||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 28,948 | [7],[9],[20] | 28,948 | [7],[9],[20] | 28,948 | [7],[9],[20] | 28,948 | [8],[15],[22] | 28,948 | [8],[15],[22] | 28,948 | [8],[15],[22] | |||
Investment, cost | $ 174 | [7],[9],[20] | $ 174 | [8],[15],[22] | |||||||||||
Investments at fair value | $ 18 | [7],[9],[20] | $ 73 | [8],[15],[22] | |||||||||||
Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[9],[12],[20] | 7.25% | [7],[9],[12],[20] | 7.25% | [7],[9],[12],[20] | 7.25% | [8],[15],[16],[22] | 7.25% | [8],[15],[16],[22] | 7.25% | [8],[15],[16],[22] | |||
Investment, interest rate | 10.67% | [7],[9],[10],[12],[20] | 10.67% | [7],[9],[10],[12],[20] | 10.67% | [7],[9],[10],[12],[20] | 7.94% | [8],[15],[16],[17],[22] | 7.94% | [8],[15],[16],[17],[22] | 7.94% | [8],[15],[16],[17],[22] | |||
Investment, principal | € | € 29,985 | [7],[9],[12],[14],[20] | € 24,838 | [8],[15],[16],[18],[22] | |||||||||||
Investment, cost | $ 33,119 | [7],[9],[12],[20] | $ 27,752 | [8],[15],[16],[22] | |||||||||||
Investments at fair value | $ 32,128 | [7],[9],[12],[20] | $ 22,143 | [8],[15],[16],[22] | |||||||||||
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 17,870 | [7],[9] | 17,870 | [7],[9] | 17,870 | [7],[9] | 14,410 | [8],[15] | 14,410 | [8],[15] | 14,410 | [8],[15] | |||
Investment, cost | $ 1,733 | [7],[9] | $ 1,352 | [8],[15] | |||||||||||
Investments at fair value | $ 2,578 | [7],[9] | $ 1,291 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.75% | [7],[9],[12] | 7.75% | [7],[9],[12] | 7.75% | [7],[9],[12] | 7.75% | [8],[15],[16] | 7.75% | [8],[15],[16] | 7.75% | [8],[15],[16] | |||
Investment, interest rate | 12.95% | [7],[9],[10],[12] | 12.95% | [7],[9],[10],[12] | 12.95% | [7],[9],[10],[12] | 10.88% | [8],[15],[16],[17] | 10.88% | [8],[15],[16],[17] | 10.88% | [8],[15],[16],[17] | |||
Investment, principal | $ 17,873 | [7],[9],[12],[14] | $ 14,414 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 17,646 | [7],[9],[12] | 14,154 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 17,533 | [7],[9],[12] | $ 13,910 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: APX Group Inc., Electrical Components & Equipment, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [8],[16],[17],[22] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, principal | [8],[18],[22] | $ 2,075 | |||||||||||||
Investment, cost | [8],[22] | 1,733 | |||||||||||||
Investments at fair value | [8],[22] | $ 1,645 | |||||||||||||
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., Trading Companies & Distributors, Fixed Rate Bond 1 | |||||||||||||||
Investment, interest rate | [8],[16],[17] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, principal | [8],[18] | $ 5,500 | |||||||||||||
Investment, cost | [8] | 5,408 | |||||||||||||
Investments at fair value | [8] | $ 3,641 | |||||||||||||
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., Trading Companies & Distributors, Fixed Rate Bond 2 | |||||||||||||||
Investment, interest rate | [8],[16],[17] | 5.25% | 5.25% | 5.25% | |||||||||||
Investment, principal | [8],[18] | $ 2,500 | |||||||||||||
Investment, cost | [8] | 2,220 | |||||||||||||
Investments at fair value | [8] | $ 1,926 | |||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12],[20] | 6% | 6% | 6% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14],[20] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[12],[20] | (14) | |||||||||||||
Investments at fair value | [7],[9],[11],[12],[20] | $ (20) | |||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12],[20] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [7],[9],[10],[12],[20] | 11.31% | 11.31% | 11.31% | |||||||||||
Investment, principal | [7],[9],[12],[14],[20] | $ 3,284 | |||||||||||||
Investment, cost | [7],[9],[12],[20] | 3,276 | |||||||||||||
Investments at fair value | [7],[9],[12],[20] | 3,120 | |||||||||||||
Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan | |||||||||||||||
Investment, principal | [7],[9],[14],[20],[21] | 11,683 | |||||||||||||
Investment, cost | [7],[9],[20],[21] | 11,723 | |||||||||||||
Investments at fair value | [7],[9],[20],[21] | $ 11,274 | |||||||||||||
Investment, Identifier [Axis]: Access CIG, LLC, Diversified Support Services, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.75% | [7],[9] | 7.75% | [7],[9] | 7.75% | [7],[9] | 7.75% | [8],[16] | 7.75% | [8],[16] | 7.75% | [8],[16] | |||
Investment, interest rate | 12.94% | [7],[9],[10],[12] | 12.94% | [7],[9],[10],[12] | 12.94% | [7],[9],[10],[12] | 10.82% | [8],[16],[17] | 10.82% | [8],[16],[17] | 10.82% | [8],[16],[17] | |||
Investment, principal | $ 20,000 | [7],[9],[12],[14] | $ 20,000 | [8],[16],[18] | |||||||||||
Investment, cost | 19,943 | [7],[9],[12] | 19,927 | [8],[16] | |||||||||||
Investments at fair value | $ 18,883 | [7],[9],[12] | $ 19,075 | [8],[16] | |||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[11],[12] | 10.86% | 10.86% | 10.86% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14] | $ 2,033 | |||||||||||||
Investment, cost | [7],[9],[11],[12] | 2,011 | |||||||||||||
Investments at fair value | [7],[9],[11],[12] | $ 2,027 | |||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 10.86% | 10.86% | 10.86% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 20,286 | |||||||||||||
Investment, cost | [7],[9],[12] | 20,193 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 20,246 | |||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[11],[12] | ||||||||||||||
Investment, principal | [7],[9],[11],[12],[14] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[12] | (2) | |||||||||||||
Investments at fair value | [7],[9],[11],[12] | $ (8) | |||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16],[19] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [8],[15],[16],[17],[19] | 9.14% | 9.14% | 9.14% | |||||||||||
Investment, principal | [8],[15],[16],[18],[19] | $ 500 | |||||||||||||
Investment, cost | [8],[15],[16],[19] | 462 | |||||||||||||
Investments at fair value | [8],[15],[16],[19] | $ 495 | |||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 9.12% | 9.12% | 9.12% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 15,976 | |||||||||||||
Investment, cost | [8],[15],[16] | 15,686 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 15,944 | |||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16],[19] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, principal | [8],[15],[16],[18],[19] | $ 0 | |||||||||||||
Investment, cost | [8],[15],[16],[19] | 0 | |||||||||||||
Investments at fair value | [8],[15],[16],[19] | $ (6) | |||||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[9],[11] | 7% | [7],[9],[11] | 7% | [7],[9],[11] | 7% | [8],[15],[16],[19] | 7% | [8],[15],[16],[19] | 7% | [8],[15],[16],[19] | |||
Investment, interest rate | 12.05% | [7],[9],[10],[11],[12] | 12.05% | [7],[9],[10],[11],[12] | 12.05% | [7],[9],[10],[11],[12] | 10.64% | [8],[15],[16],[17],[19] | 10.64% | [8],[15],[16],[17],[19] | 10.64% | [8],[15],[16],[17],[19] | |||
Investment, principal | $ 2,113 | [7],[9],[11],[12],[14] | $ 914 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | 2,101 | [7],[9],[11],[12] | 890 | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ 2,102 | [7],[9],[11],[12] | $ 898 | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 9.63% | 9.63% | 9.63% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 27,349 | |||||||||||||
Investment, cost | [8],[15],[16] | 27,038 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 27,158 | |||||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12.34% | 12.34% | 12.34% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 6,400 | |||||||||||||
Investment, cost | [7],[9],[12] | 6,327 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 6,374 | |||||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12.34% | 12.34% | 12.34% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 25,332 | |||||||||||||
Investment, cost | [7],[9],[12] | 25,283 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 25,230 | |||||||||||||
Investment, Identifier [Axis]: Aden & Anais Merger Sub, Inc., Apparel, Accessories & Luxury Goods, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[15] | 51,645 | 51,645 | 51,645 | |||||||||||
Investment, cost | [8],[15] | $ 5,165 | |||||||||||||
Investments at fair value | [8],[15] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: AirStrip Technologies, Inc., Application Software, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 5,715 | [7],[9] | 5,715 | [7],[9] | 5,715 | [7],[9] | 5,715 | [8],[15] | 5,715 | [8],[15] | 5,715 | [8],[15] | |||
Investment, cost | $ 90 | [7],[9] | $ 90 | [8],[15] | |||||||||||
Investments at fair value | $ 0 | [7],[9] | $ 0 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, interest rate, paid in kind | [8],[15],[16] | 11.64% | 11.64% | 11.64% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 23,338 | |||||||||||||
Investment, cost | [8],[15],[16] | 22,057 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 22,141 | |||||||||||||
Investment, Identifier [Axis]: All Web Leads, Inc., First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12],[23] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, principal | [7],[9],[12],[14],[23] | $ 23,562 | |||||||||||||
Investment, cost | [7],[9],[12],[23] | 22,795 | |||||||||||||
Investments at fair value | [7],[9],[12],[23] | $ 16,880 | |||||||||||||
Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | 5.50% | [7],[10],[12],[20] | 5.50% | [7],[10],[12],[20] | 5.50% | [7],[10],[12],[20] | 5.50% | [8],[16],[17],[22] | 5.50% | [8],[16],[17],[22] | 5.50% | [8],[16],[17],[22] | |||
Investment, principal | $ 4,050 | [7],[14],[20] | $ 4,050 | [8],[18],[22] | |||||||||||
Investment, cost | 3,561 | [7],[20] | 3,518 | [8],[22] | |||||||||||
Investments at fair value | $ 2,900 | [7],[20] | $ 3,057 | [8],[22] | |||||||||||
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 8% | 8% | 8% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 13.34% | 13.34% | 13.34% | |||||||||||
Investment, interest rate, paid in kind | [7],[9],[12] | 3.50% | 3.50% | 3.50% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 8,794 | |||||||||||||
Investment, cost | [7],[9],[12] | 8,132 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 8,011 | |||||||||||||
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | [7],[9] | 166,414 | 166,414 | 166,414 | |||||||||||
Investment, cost | [7],[9] | $ 642 | |||||||||||||
Investments at fair value | [7],[9] | $ 518 | |||||||||||||
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[9],[12] | 7.50% | [7],[9],[12] | 7.50% | [7],[9],[12] | 7.50% | [8],[15],[16] | 7.50% | [8],[15],[16] | 7.50% | [8],[15],[16] | |||
Investment, interest rate | 12.89% | [7],[9],[10],[12] | 12.89% | [7],[9],[10],[12] | 12.89% | [7],[9],[10],[12] | 11.20% | [8],[15],[16],[17] | 11.20% | [8],[15],[16],[17] | 11.20% | [8],[15],[16],[17] | |||
Investment, principal | $ 17,280 | [7],[9],[12],[14] | $ 13,134 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 17,197 | [7],[9],[12] | 12,847 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 16,503 | [7],[9],[12] | $ 13,068 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1 | |||||||||||||||
Investment, interest rate | [8],[15],[16],[17],[22] | 10% | 10% | 10% | |||||||||||
Investment, principal | [8],[15],[18],[22] | $ 24,043 | |||||||||||||
Investment, cost | [8],[15],[22] | 23,747 | |||||||||||||
Investments at fair value | [8],[15],[22] | $ 23,923 | |||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 1 | |||||||||||||||
Investment owned, balance (in shares) | shares | 824,197 | [7],[20] | 824,197 | [7],[20] | 824,197 | [7],[20] | 587,930 | [8],[22] | 587,930 | [8],[22] | 587,930 | [8],[22] | |||
Investment, cost | $ 2,426 | [7],[20] | $ 5,308 | [8],[22] | |||||||||||
Investments at fair value | $ 6,379 | [7],[20] | $ 3,974 | [8],[22] | |||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 2 | |||||||||||||||
Investment owned, balance (in shares) | shares | 141,640 | [7],[9],[20],[24] | 141,640 | [7],[9],[20],[24] | 141,640 | [7],[9],[20],[24] | 124,780 | [8],[15],[22],[25] | 124,780 | [8],[15],[22],[25] | 124,780 | [8],[15],[22],[25] | |||
Investment, cost | $ 566 | [7],[9],[20],[24] | $ 485 | [8],[15],[22],[25] | |||||||||||
Investments at fair value | $ 339 | [7],[9],[20],[24] | $ 212 | [8],[15],[22],[25] | |||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 1 | |||||||||||||||
Investment, interest rate | [7],[9],[10],[12],[20] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, interest rate, paid in kind | [7],[9],[20] | 3.50% | 3.50% | 3.50% | |||||||||||
Investment, principal | [7],[9],[14],[20] | $ 28,464 | |||||||||||||
Investment, cost | [7],[9],[20] | 28,363 | |||||||||||||
Investments at fair value | [7],[9],[20] | $ 27,682 | |||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 2 | |||||||||||||||
Investment, interest rate | [7],[9],[10],[12],[20] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, interest rate, paid in kind | [7],[9],[20] | 3.50% | 3.50% | 3.50% | |||||||||||
Investment, principal | [7],[9],[14],[20] | $ 2,121 | |||||||||||||
Investment, cost | [7],[9],[20] | 1,945 | |||||||||||||
Investments at fair value | [7],[9],[20] | $ 2,063 | |||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 3 | |||||||||||||||
Investment, interest rate | [7],[9],[10],[12],[20] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, interest rate, paid in kind | [7],[9],[20] | 3.50% | 3.50% | 3.50% | |||||||||||
Investment, principal | [7],[9],[14],[20] | $ 27,692 | |||||||||||||
Investment, cost | [7],[9],[20] | 27,612 | |||||||||||||
Investments at fair value | [7],[9],[20] | $ 26,930 | |||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 4 | |||||||||||||||
Investment, interest rate | [7],[9],[10],[12],[20] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, interest rate, paid in kind | [7],[9],[20] | 3.50% | 3.50% | 3.50% | |||||||||||
Investment, principal | [7],[9],[14],[20] | $ 2,064 | |||||||||||||
Investment, cost | [7],[9],[20] | 1,891 | |||||||||||||
Investments at fair value | [7],[9],[20] | $ 2,007 | |||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2 | |||||||||||||||
Investment, interest rate | [8],[15],[16],[17],[22] | 10% | 10% | 10% | |||||||||||
Investment, principal | [8],[15],[18],[22] | $ 23,522 | |||||||||||||
Investment, cost | [8],[15],[22] | 23,264 | |||||||||||||
Investments at fair value | [8],[15],[22] | $ 23,404 | |||||||||||||
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 8.75% | [7],[9],[12] | 8.75% | [7],[9],[12] | 8.75% | [7],[9],[12] | 8.75% | [8],[15],[16] | 8.75% | [8],[15],[16] | 8.75% | [8],[15],[16] | |||
Investment, interest rate | 13.99% | [7],[9],[10],[12] | 13.99% | [7],[9],[10],[12] | 13.99% | [7],[9],[10],[12] | 12.30% | [8],[15],[16],[17] | 12.30% | [8],[15],[16],[17] | 12.30% | [8],[15],[16],[17] | |||
Investment, principal | $ 17,048 | [7],[9],[12],[14] | $ 14,760 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 16,411 | [7],[9],[12] | 14,492 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 12,616 | [7],[9],[12] | $ 13,284 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | [7],[12] | 6.25% | [7],[12] | 6.25% | [7],[12] | 6.25% | [8],[16] | 6.25% | [8],[16] | 6.25% | [8],[16] | |||
Investment, interest rate | 11.49% | [7],[10],[12] | 11.49% | [7],[10],[12] | 11.49% | [7],[10],[12] | 9.03% | [8],[16],[17] | 9.03% | [8],[16],[17] | 9.03% | [8],[16],[17] | |||
Investment, principal | $ 19,163 | [7],[12],[14] | $ 9,895 | [8],[16],[18] | |||||||||||
Investment, cost | 18,289 | [7],[12] | 9,772 | [8],[16] | |||||||||||
Investments at fair value | $ 16,718 | [7],[12] | $ 9,293 | [8],[16] | |||||||||||
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16],[22] | 4.25% | 4.25% | 4.25% | |||||||||||
Investment, interest rate | [8],[15],[16],[17],[22] | 7.92% | 7.92% | 7.92% | |||||||||||
Investment, principal | [8],[15],[16],[18],[22] | $ 15,220 | |||||||||||||
Investment, cost | [8],[15],[16],[22] | 13,973 | |||||||||||||
Investments at fair value | [8],[15],[16],[22] | $ 14,687 | |||||||||||||
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[9],[12],[20] | 8% | [7],[9],[12],[20] | 8% | [7],[9],[12],[20] | 8% | [8],[15],[16],[22] | 8% | [8],[15],[16],[22] | 8% | [8],[15],[16],[22] | |||
Investment, interest rate | 13.39% | [7],[9],[10],[12],[20] | 13.39% | [7],[9],[10],[12],[20] | 13.39% | [7],[9],[10],[12],[20] | 11.67% | [8],[15],[16],[17],[22] | 11.67% | [8],[15],[16],[17],[22] | 11.67% | [8],[15],[16],[17],[22] | |||
Investment, principal | $ 12,500 | [7],[9],[12],[14],[20] | $ 12,500 | [8],[15],[16],[18],[22] | |||||||||||
Investment, cost | 12,188 | [7],[9],[12],[20] | 12,188 | [8],[15],[16],[22] | |||||||||||
Investments at fair value | $ 11,865 | [7],[9],[12],[20] | $ 11,958 | [8],[15],[16],[22] | |||||||||||
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[12] | 3.75% | 3.75% | 3.75% | |||||||||||
Investment, interest rate | [7],[10],[12] | 9.25% | 9.25% | 9.25% | |||||||||||
Investment, principal | [7],[12],[14] | $ 3,710 | |||||||||||||
Investment, cost | [7],[12] | 3,075 | |||||||||||||
Investments at fair value | [7],[12] | $ 2,863 | |||||||||||||
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Products, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[16] | 3.75% | 3.75% | 3.75% | |||||||||||
Investment, interest rate | [8],[16],[17] | 7.42% | 7.42% | 7.42% | |||||||||||
Investment, principal | [8],[16],[18] | $ 2,736 | |||||||||||||
Investment, cost | [8],[16] | 2,260 | |||||||||||||
Investments at fair value | [8],[16] | $ 2,189 | |||||||||||||
Investment, Identifier [Axis]: Ankura Consulting Group LLC, Research & Consulting Services, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 8% | 8% | 8% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 10.78% | 10.78% | 10.78% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 4,346 | |||||||||||||
Investment, cost | [8],[15],[16] | 4,281 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 3,813 | |||||||||||||
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 5% | [7],[9],[11],[12] | 5% | [7],[9],[11],[12] | 5% | [7],[9],[11],[12] | 6% | [8],[15],[16],[19] | 6% | [8],[15],[16],[19] | 6% | [8],[15],[16],[19] | |||
Investment, interest rate | 10.20% | [7],[9],[10],[11],[12] | 10.20% | [7],[9],[10],[11],[12] | 10.20% | [7],[9],[10],[11],[12] | 8.46% | [8],[15],[16],[17],[19] | 8.46% | [8],[15],[16],[17],[19] | 8.46% | [8],[15],[16],[17],[19] | |||
Investment, principal | $ 808 | [7],[9],[11],[12],[14] | $ 892 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | 792 | [7],[9],[11],[12] | 863 | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ 808 | [7],[9],[11],[12] | $ 846 | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 8.46% | 8.46% | 8.46% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 34,458 | |||||||||||||
Investment, cost | [8],[15],[16] | 33,737 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 33,738 | |||||||||||||
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 5% | 5% | 5% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 10.20% | 10.20% | 10.20% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 9,280 | |||||||||||||
Investment, cost | [7],[9],[12] | 9,189 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 9,280 | |||||||||||||
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 5% | 5% | 5% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 10.20% | 10.20% | 10.20% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 32,308 | |||||||||||||
Investment, cost | [7],[9],[12] | 31,999 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 32,308 | |||||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[9],[12],[20] | 7.25% | [7],[9],[12],[20] | 7.25% | [7],[9],[12],[20] | 7% | [8],[15],[16],[22] | 7% | [8],[15],[16],[22] | 7% | [8],[15],[16],[22] | |||
Investment, interest rate | 10.07% | [7],[9],[10],[12],[20] | 10.07% | [7],[9],[10],[12],[20] | 10.07% | [7],[9],[10],[12],[20] | 8% | [8],[15],[16],[17],[22] | 8% | [8],[15],[16],[17],[22] | 8% | [8],[15],[16],[17],[22] | |||
Investment, principal | € | € 3,017 | [7],[9],[12],[14],[20] | € 1,964 | [8],[15],[16],[18],[22] | |||||||||||
Investment, cost | $ 3,341 | [7],[9],[12],[20] | $ 2,176 | [8],[15],[16],[22] | |||||||||||
Investments at fair value | $ 3,321 | [7],[9],[12],[20] | $ 1,927 | [8],[15],[16],[22] | |||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[9],[12],[20] | 6% | [7],[9],[12],[20] | 6% | [7],[9],[12],[20] | 7% | [8],[15],[16],[22] | 7% | [8],[15],[16],[22] | 7% | [8],[15],[16],[22] | |||
Investment, interest rate | 11.25% | [7],[9],[10],[12],[20] | 11.25% | [7],[9],[10],[12],[20] | 11.25% | [7],[9],[10],[12],[20] | 9.19% | [8],[15],[16],[17],[22] | 9.19% | [8],[15],[16],[17],[22] | 9.19% | [8],[15],[16],[17],[22] | |||
Investment, principal | $ 10,519 | [7],[9],[12],[14],[20] | £ 18,636 | [8],[15],[16],[18],[22] | |||||||||||
Investment, cost | 10,389 | [7],[9],[12],[20] | $ 23,139 | [8],[15],[16],[22] | |||||||||||
Investments at fair value | $ 10,614 | [7],[9],[12],[20] | $ 20,826 | [8],[15],[16],[22] | |||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[9],[12],[20] | 7.25% | [7],[9],[12],[20] | 7.25% | [7],[9],[12],[20] | 5.75% | [8],[15],[16],[22] | 5.75% | [8],[15],[16],[22] | 5.75% | [8],[15],[16],[22] | |||
Investment, interest rate | 12.18% | [7],[9],[10],[12],[20] | 12.18% | [7],[9],[10],[12],[20] | 12.18% | [7],[9],[10],[12],[20] | 8.81% | [8],[15],[16],[17],[22] | 8.81% | [8],[15],[16],[17],[22] | 8.81% | [8],[15],[16],[17],[22] | |||
Investment, principal | £ 4,949 | [7],[9],[12],[14],[20] | $ 10,519 | [8],[15],[16],[18],[22] | |||||||||||
Investment, cost | $ 6,364 | [7],[9],[12],[20] | 10,357 | [8],[15],[16],[22] | |||||||||||
Investments at fair value | $ 6,348 | [7],[9],[12],[20] | $ 10,328 | [8],[15],[16],[22] | |||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4 | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[9],[12],[20] | 7.25% | [7],[9],[12],[20] | 7.25% | [7],[9],[12],[20] | 5.75% | [8],[15],[16],[19],[22] | 5.75% | [8],[15],[16],[19],[22] | 5.75% | [8],[15],[16],[19],[22] | |||
Investment, interest rate | [7],[9],[10],[12],[20] | 12.45% | 12.45% | 12.45% | |||||||||||
Investment, principal | £ | £ 23,675 | [7],[9],[12],[14],[20] | £ 0 | [8],[15],[16],[18],[19],[22] | |||||||||||
Investment, cost | $ 28,939 | [7],[9],[12],[20] | $ (44) | [8],[15],[16],[19],[22] | |||||||||||
Investments at fair value | $ 30,370 | [7],[9],[12],[20] | 0 | [8],[15],[16],[19],[22] | |||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12],[20] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, interest rate | [7],[9],[10],[12],[20] | 8.57% | 8.57% | 8.57% | |||||||||||
Investment, principal | € | [7],[9],[12],[14],[20] | € 3,649 | |||||||||||||
Investment, cost | [7],[9],[12],[20] | $ 3,927 | |||||||||||||
Investments at fair value | [7],[9],[12],[20] | $ 4,027 | |||||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,783,332 | 1,783,332 | 1,783,332 | 1,609,201 | |||||||||||
Investment, principal | $ 0 | $ 0 | |||||||||||||
Investments at fair value | $ 0 | 370 | $ 563 | 587 | |||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | 0% | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||
Investment, interest rate | 12.29% | 12.29% | 12.29% | 9% | |||||||||||
Investment, principal | $ 22,304 | $ 21,754 | |||||||||||||
Investments at fair value | $ 22,186 | 24,225 | $ 21,260 | 15,712 | |||||||||||
Investment owned, percent of net assets | 1.50% | 1.50% | 1.50% | 1.70% | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,129,453 | 1,129,453 | 1,129,453 | 1,019,169 | |||||||||||
Investment, principal | $ 0 | $ 0 | |||||||||||||
Investments at fair value | $ 1,412 | $ 1,223 | $ 1,203 | 1,152 | |||||||||||
Investment owned, percent of net assets | 0.10% | 0.10% | 0.10% | 0.10% | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,783,332 | [6],[9] | 1,783,332 | [6],[9] | 1,783,332 | [6],[9] | 1,609,201 | [5],[15] | 1,609,201 | [5],[15] | 1,609,201 | [5],[15] | |||
Investment, cost | $ 804 | [6],[9] | $ 764 | [5],[15] | |||||||||||
Investments at fair value | $ 0 | [6],[9] | $ 370 | [5],[15] | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [6],[9],[11],[12] | 6.75% | [6],[9],[11],[12] | 6.75% | [6],[9],[11],[12] | 6.75% | [5],[15],[16],[19] | 6.75% | [5],[15],[16],[19] | 6.75% | [5],[15],[16],[19] | |||
Investment, interest rate | 12.29% | [6],[9],[10],[11],[12] | 12.29% | [6],[9],[10],[11],[12] | 12.29% | [6],[9],[10],[11],[12] | 10.42% | [5],[15],[16],[17],[19] | 10.42% | [5],[15],[16],[17],[19] | 10.42% | [5],[15],[16],[17],[19] | |||
Investment, principal | $ 22,304 | [6],[9],[11],[12],[14] | $ 24,490 | [5],[15],[16],[18],[19] | |||||||||||
Investment, cost | 22,327 | [6],[9],[11],[12] | 24,490 | [5],[15],[16],[19] | |||||||||||
Investments at fair value | $ 22,186 | [6],[9],[11],[12] | $ 24,225 | [5],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,129,453 | [6],[9] | 1,129,453 | [6],[9] | 1,129,453 | [6],[9] | 1,019,169 | [5],[15] | 1,019,169 | [5],[15] | 1,019,169 | [5],[15] | |||
Investment, cost | $ 1,159 | [6],[9] | $ 1,019 | [5],[15] | |||||||||||
Investments at fair value | $ 1,412 | [6],[9] | $ 1,223 | [5],[15] | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 78,045 | [6],[9] | 78,045 | [6],[9] | 78,045 | [6],[9] | 70,425 | [5],[15] | 70,425 | [5],[15] | 70,425 | [5],[15] | |||
Investment, cost | $ 0 | [6],[9] | $ 0 | [5],[15] | |||||||||||
Investments at fair value | $ 0 | [6],[9] | 0 | [5],[15] | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 78,045 | 78,045 | 78,045 | 70,425 | |||||||||||
Investment, principal | $ 0 | $ 0 | |||||||||||||
Investments at fair value | $ 0 | $ 0 | $ 0 | 0 | |||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | 0% | |||||||||||
Investment, Identifier [Axis]: Associated Asphalt Partners, LLC, Construction Materials, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[16] | 5.25% | 5.25% | 5.25% | |||||||||||
Investment, interest rate | [8],[16],[17] | 8.06% | 8.06% | 8.06% | |||||||||||
Investment, principal | [8],[16],[18] | $ 2,501 | |||||||||||||
Investment, cost | [8],[16] | 2,331 | |||||||||||||
Investments at fair value | [8],[16] | $ 1,934 | |||||||||||||
Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | [7],[12] | 5.25% | [7],[12] | 5.25% | [7],[12] | 5.25% | [8],[16] | 5.25% | [8],[16] | 5.25% | [8],[16] | |||
Investment, interest rate | 10.44% | [7],[10],[12] | 10.44% | [7],[10],[12] | 10.44% | [7],[10],[12] | 8.37% | [8],[16],[17] | 8.37% | [8],[16],[17] | 8.37% | [8],[16],[17] | |||
Investment, principal | $ 8,490 | [7],[12],[14] | $ 5,640 | [8],[16],[18] | |||||||||||
Investment, cost | 8,153 | [7],[12] | 5,482 | [8],[16] | |||||||||||
Investments at fair value | $ 5,983 | [7],[12] | $ 4,822 | [8],[16] | |||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 1 | |||||||||||||||
Investment, interest rate | 11% | [7],[9],[10],[12],[20],[23] | 11% | [7],[9],[10],[12],[20],[23] | 11% | [7],[9],[10],[12],[20],[23] | 11% | [8],[15],[16],[17],[22] | 11% | [8],[15],[16],[17],[22] | 11% | [8],[15],[16],[17],[22] | |||
Investment, principal | $ 1,338 | [7],[9],[14],[20],[23] | $ 13,346 | [8],[15],[18],[22] | |||||||||||
Investment, cost | 1,257 | [7],[9],[20],[23] | 12,929 | [8],[15],[22] | |||||||||||
Investments at fair value | $ 1,257 | [7],[9],[20],[23] | 12,812 | [8],[15],[22] | |||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 2 | |||||||||||||||
Investment, interest rate | [7],[9],[10],[12],[20],[23] | 11% | 11% | 11% | |||||||||||
Investment, principal | $ 1,338 | [7],[9],[14],[20],[23] | 8,309 | [8],[15],[18],[22],[26] | |||||||||||
Investment, cost | 1,241 | [7],[9],[20],[23] | 8,264 | [8],[15],[22],[26] | |||||||||||
Investments at fair value | $ 1,257 | [7],[9],[20],[23] | $ 8,309 | [8],[15],[22],[26] | |||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 3 | |||||||||||||||
Investment, interest rate | [7],[9],[10],[12],[20],[23] | 11% | 11% | 11% | |||||||||||
Investment, principal | [7],[9],[14],[20],[23] | $ 5,350 | |||||||||||||
Investment, cost | [7],[9],[20],[23] | 4,951 | |||||||||||||
Investments at fair value | [7],[9],[20],[23] | $ 5,029 | |||||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[15],[22] | 328,149 | 328,149 | 328,149 | |||||||||||
Investment, cost | [8],[15],[22] | $ 973 | |||||||||||||
Investments at fair value | [8],[15],[22] | $ 16 | |||||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants 1 | |||||||||||||||
Investment owned, balance (in shares) | shares | 10,634 | 10,634 | 10,634 | ||||||||||||
Investment, principal | [7],[9],[14],[20] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[20] | 488 | |||||||||||||
Investments at fair value | [7],[9],[20] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants 2 | |||||||||||||||
Investment owned, balance (in shares) | shares | [7],[9],[20] | 10,634 | 10,634 | 10,634 | |||||||||||
Investment, cost | [7],[9],[20] | $ 488 | |||||||||||||
Investments at fair value | [7],[9],[20] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[9],[12],[20] | 6% | [7],[9],[12],[20] | 6% | [7],[9],[12],[20] | 6% | [8],[15],[16],[22] | 6% | [8],[15],[16],[22] | 6% | [8],[15],[16],[22] | |||
Investment, interest rate | 11.27% | [7],[9],[10],[12],[20] | 11.27% | [7],[9],[10],[12],[20] | 11.27% | [7],[9],[10],[12],[20] | 8.78% | [8],[15],[16],[17],[22] | 8.78% | [8],[15],[16],[17],[22] | 8.78% | [8],[15],[16],[17],[22] | |||
Investment, principal | $ 29,509 | [7],[9],[12],[14],[20] | $ 22,425 | [8],[15],[16],[18],[22] | |||||||||||
Investment, cost | 29,137 | [7],[9],[12],[20] | 22,086 | [8],[15],[16],[22] | |||||||||||
Investments at fair value | $ 28,299 | [7],[9],[12],[20] | $ 21,326 | [8],[15],[16],[22] | |||||||||||
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[12] | (113) | |||||||||||||
Investments at fair value | [7],[9],[11],[12] | $ (101) | |||||||||||||
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12.49% | 12.49% | 12.49% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 50,470 | |||||||||||||
Investment, cost | [7],[9],[12] | 49,639 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 49,461 | |||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16],[19] | 5% | 5% | 5% | |||||||||||
Investment, interest rate | [8],[15],[16],[17],[19] | 8.12% | 8.12% | 8.12% | |||||||||||
Investment, principal | [8],[15],[16],[18],[19] | $ 2,546 | |||||||||||||
Investment, cost | [8],[15],[16],[19] | 2,503 | |||||||||||||
Investments at fair value | [8],[15],[16],[19] | $ 2,395 | |||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 5% | 5% | 5% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 10.50% | 10.50% | 10.50% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 3,258 | |||||||||||||
Investment, cost | [7],[9],[12] | 3,227 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 3,173 | |||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 5% | 5% | 5% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 10.50% | 10.50% | 10.50% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 1,264 | |||||||||||||
Investment, cost | [7],[9],[12] | 1,273 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 1,232 | |||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[9],[12] | 8.50% | [7],[9],[12] | 8.50% | [7],[9],[12] | 8.50% | [8],[15],[16] | 8.50% | [8],[15],[16] | 8.50% | [8],[15],[16] | |||
Investment, interest rate | 14% | [7],[9],[10],[12] | 14% | [7],[9],[10],[12] | 14% | [7],[9],[10],[12] | 11.62% | [8],[15],[16],[17] | 11.62% | [8],[15],[16],[17] | 11.62% | [8],[15],[16],[17] | |||
Investment, principal | $ 8,920 | [7],[9],[12],[14] | $ 7,166 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 8,819 | [7],[9],[12] | 7,059 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 8,661 | [7],[9],[12] | $ 6,915 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[9],[12] | 8.50% | [7],[9],[12] | 8.50% | [7],[9],[12] | 8.50% | [8],[15],[16],[19] | 8.50% | [8],[15],[16],[19] | 8.50% | [8],[15],[16],[19] | |||
Investment, interest rate | 14% | [7],[9],[10],[12] | 14% | [7],[9],[10],[12] | 14% | [7],[9],[10],[12] | 11.62% | [8],[15],[16],[17],[19] | 11.62% | [8],[15],[16],[17],[19] | 11.62% | [8],[15],[16],[17],[19] | |||
Investment, principal | $ 2,091 | [7],[9],[12],[14] | $ 4,227 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | 2,067 | [7],[9],[12] | 4,070 | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ 2,030 | [7],[9],[12] | $ 3,839 | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 14% | 14% | 14% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 4,361 | |||||||||||||
Investment, cost | [7],[9],[12] | 4,296 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 4,235 | |||||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12] | 4.50% | 4.50% | 4.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[11],[12] | 12.50% | 12.50% | 12.50% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14] | $ 2,528 | |||||||||||||
Investment, cost | [7],[9],[11],[12] | 2,492 | |||||||||||||
Investments at fair value | [7],[9],[11],[12] | $ 2,482 | |||||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 10.70% | 10.70% | 10.70% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 40,764 | |||||||||||||
Investment, cost | [7],[9],[12] | 40,529 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 40,316 | |||||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16],[19] | 4.50% | 4.50% | 4.50% | |||||||||||
Investment, interest rate | [8],[15],[16],[17],[19] | 10.75% | 10.75% | 10.75% | |||||||||||
Investment, principal | [8],[15],[16],[18],[19] | $ 1,702 | |||||||||||||
Investment, cost | [8],[15],[16],[19] | 1,660 | |||||||||||||
Investments at fair value | [8],[15],[16],[19] | $ 1,617 | |||||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 8.31% | 8.31% | 8.31% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 33,078 | |||||||||||||
Investment, cost | [8],[15],[16] | 32,612 | |||||||||||||
Investments at fair value | [8],[15],[16] | 32,053 | |||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan | |||||||||||||||
Investment, principal | [8],[15],[18],[19],[22],[26] | 0 | |||||||||||||
Investment, cost | [8],[15],[19],[22],[26] | 0 | |||||||||||||
Investments at fair value | [8],[15],[19],[22],[26] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1 | |||||||||||||||
Investment, interest rate | 8% | [7],[9],[10],[12],[20] | 8% | [7],[9],[10],[12],[20] | 8% | [7],[9],[10],[12],[20] | 10.25% | [8],[15],[16],[17],[22] | 10.25% | [8],[15],[16],[17],[22] | 10.25% | [8],[15],[16],[17],[22] | |||
Investment, interest rate, paid in kind | [7],[9],[20] | 2.25% | 2.25% | 2.25% | |||||||||||
Investment, principal | $ 6,719 | [7],[9],[14],[20] | $ 5,322 | [8],[15],[18],[22] | |||||||||||
Investment, cost | 6,508 | [7],[9],[20] | 5,111 | [8],[15],[22] | |||||||||||
Investments at fair value | 6,282 | [7],[9],[20] | $ 5,114 | [8],[15],[22] | |||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2 | |||||||||||||||
Investment, interest rate | [8],[15],[16],[17],[19],[22] | 10.25% | 10.25% | 10.25% | |||||||||||
Investment, principal | 3,210 | [7],[9],[14],[20],[21] | $ 0 | [8],[15],[18],[19],[22] | |||||||||||
Investment, cost | 3,230 | [7],[9],[20],[21] | 0 | [8],[15],[19],[22] | |||||||||||
Investments at fair value | $ 3,130 | [7],[9],[20],[21] | 0 | [8],[15],[19],[22] | |||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3 | |||||||||||||||
Investment, interest rate | [7],[9],[10],[12],[20] | 8% | 8% | 8% | |||||||||||
Investment, interest rate, paid in kind | [7],[9],[20] | 2.25% | 2.25% | 2.25% | |||||||||||
Investment, principal | $ 0 | [7],[9],[11],[14],[20] | 2,353 | [8],[15],[18],[22],[26] | |||||||||||
Investment, cost | 0 | [7],[9],[11],[20] | 2,353 | [8],[15],[22],[26] | |||||||||||
Investments at fair value | $ 0 | [7],[9],[11],[20] | $ 2,353 | [8],[15],[22],[26] | |||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4 | |||||||||||||||
Investment, interest rate | [7],[9],[10],[12],[20] | 8% | 8% | 8% | |||||||||||
Investment, interest rate, paid in kind | [7],[9],[20] | 2.25% | 2.25% | 2.25% | |||||||||||
Investment, principal | [7],[9],[11],[14],[20] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[20] | 0 | |||||||||||||
Investments at fair value | [7],[9],[11],[20] | 0 | |||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5 | |||||||||||||||
Investment, principal | [7],[9],[11],[14],[20],[21] | 0 | |||||||||||||
Investment, cost | [7],[9],[11],[20],[21] | 0 | |||||||||||||
Investments at fair value | [7],[9],[11],[20],[21] | 0 | |||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6 | |||||||||||||||
Investment, principal | [7],[9],[11],[14],[20],[21] | 0 | |||||||||||||
Investment, cost | [7],[9],[11],[20],[21] | 0 | |||||||||||||
Investments at fair value | [7],[9],[11],[20],[21] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 26,131 | [7],[9],[20] | 26,131 | [7],[9],[20] | 26,131 | [7],[9],[20] | 21,177 | [8],[15],[22] | 21,177 | [8],[15],[22] | 21,177 | [8],[15],[22] | |||
Investment, cost | $ 225 | [7],[9],[20] | $ 125 | [8],[15],[22] | |||||||||||
Investments at fair value | $ 34 | [7],[9],[20] | $ 98 | [8],[15],[22] | |||||||||||
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[12] | 7% | [7],[12] | 7% | [7],[12] | 7% | [8],[16] | 7% | [8],[16] | 7% | [8],[16] | |||
Investment, interest rate | 12.25% | [7],[10],[12] | 12.25% | [7],[10],[12] | 12.25% | [7],[10],[12] | 9.50% | [8],[16],[17] | 9.50% | [8],[16],[17] | 9.50% | [8],[16],[17] | |||
Investment, principal | $ 30,625 | [7],[12],[14] | $ 30,625 | [8],[16],[18] | |||||||||||
Investment, cost | 30,346 | [7],[12] | 30,276 | [8],[16] | |||||||||||
Investments at fair value | $ 29,385 | [7],[12] | $ 29,017 | [8],[16] | |||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 394,297 | [7],[9] | 394,297 | [7],[9] | 394,297 | [7],[9] | 298,460 | [8],[15] | 298,460 | [8],[15] | 298,460 | [8],[15] | |||
Investment, cost | $ 424 | [7],[9] | $ 298 | [8],[15] | |||||||||||
Investments at fair value | $ 355 | [7],[9] | $ 349 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan | |||||||||||||||
Investment, interest rate | 9% | [7],[9],[10],[12] | 9% | [7],[9],[10],[12] | 9% | [7],[9],[10],[12] | 9% | [8],[15],[16],[17] | 9% | [8],[15],[16],[17] | 9% | [8],[15],[16],[17] | |||
Investment, principal | $ 4,994 | [7],[9],[14] | $ 3,979 | [8],[15],[18] | |||||||||||
Investment, cost | 5,006 | [7],[9] | 3,980 | [8],[15] | |||||||||||
Investments at fair value | $ 4,969 | [7],[9] | $ 3,960 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 1 | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,708,618 | [7],[9] | 1,708,618 | [7],[9] | 1,708,618 | [7],[9] | 1,293,324 | [8],[15] | 1,293,324 | [8],[15] | 1,293,324 | [8],[15] | |||
Investment, cost | $ 1,711 | [7],[9] | $ 1,293 | [8],[15] | |||||||||||
Investments at fair value | $ 2,085 | [7],[9] | $ 1,280 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 2 | |||||||||||||||
Investment owned, balance (in shares) | shares | 394,297 | [7],[9] | 394,297 | [7],[9] | 394,297 | [7],[9] | 298,460 | [8],[15] | 298,460 | [8],[15] | 298,460 | [8],[15] | |||
Investment, cost | $ 395 | [7],[9] | $ 298 | [8],[15] | |||||||||||
Investments at fair value | $ 481 | [7],[9] | $ 295 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 829 | ||||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investments at fair value | $ 0 | 0 | |||||||||||||
Investment owned, percent of net assets | 0% | ||||||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 829 | [1],[2],[9] | 829 | [1],[2],[9] | 829 | [1],[2],[9] | 829 | [3],[4],[15] | 829 | [3],[4],[15] | 829 | [3],[4],[15] | |||
Investment, principal | $ 0 | ||||||||||||||
Investment, cost | 0 | [1],[2],[9] | $ 0 | [3],[4],[15] | |||||||||||
Investments at fair value | $ 0 | [1],[2],[9] | $ 0 | [3],[4],[15] | |||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | ||||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | 34,984,460 | [1],[2],[9] | 34,984,460 | [1],[2],[9] | 34,984,460 | [1],[2],[9] | 34,984,460 | [3],[4],[15] | 34,984,460 | [3],[4],[15] | 34,984,460 | [3],[4],[15] | |||
Investment, principal | $ 0 | ||||||||||||||
Investment, cost | 34,984 | [1],[2],[9] | $ 34,984 | [3],[4],[15] | |||||||||||
Investments at fair value | $ 27,638 | [1],[2],[9] | $ 27,638 | [3],[4],[15] | |||||||||||
Investment owned, percent of net assets | 1.80% | 1.80% | 1.80% | ||||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | 34,984,460 | ||||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investments at fair value | $ 27,638 | 27,638 | |||||||||||||
Investment owned, percent of net assets | 2.20% | ||||||||||||||
Investment, Identifier [Axis]: CCO Holdings LLC, Cable & Satellite, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [8],[16],[17],[22] | 4.50% | 4.50% | 4.50% | |||||||||||
Investment, principal | [8],[18],[22] | $ 2,097 | |||||||||||||
Investment, cost | [8],[22] | 1,746 | |||||||||||||
Investments at fair value | [8],[22] | $ 1,603 | |||||||||||||
Investment, Identifier [Axis]: CITGO Holding, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [8],[16],[17] | 9.25% | 9.25% | 9.25% | |||||||||||
Investment, principal | [8],[18] | $ 7,857 | |||||||||||||
Investment, cost | [8] | 7,857 | |||||||||||||
Investments at fair value | [8] | $ 7,807 | |||||||||||||
Investment, Identifier [Axis]: CITGO Petroleum Corp., Oil & Gas Refining & Marketing, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[16] | 6.25% | 6.25% | 6.25% | |||||||||||
Investment, interest rate | [8],[16],[17] | 9.37% | 9.37% | 9.37% | |||||||||||
Investment, principal | [8],[16],[18] | $ 795 | |||||||||||||
Investment, cost | [8],[16] | 770 | |||||||||||||
Investments at fair value | [8],[16] | $ 797 | |||||||||||||
Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12],[23] | 7.75% | 7.75% | 7.75% | |||||||||||
Investment, principal | [7],[9],[12],[14],[23] | $ 727 | |||||||||||||
Investment, cost | [7],[9],[12],[23] | 462 | |||||||||||||
Investments at fair value | [7],[9],[12],[23] | $ 325 | |||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 9.31% | 9.31% | 9.31% | |||||||||||
Investment, interest rate, paid in kind | [8],[15],[16] | 2% | 2% | 2% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 14,294 | |||||||||||||
Investment, cost | [8],[15],[16] | 13,471 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 13,143 | |||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 11.91% | 11.91% | 11.91% | |||||||||||
Investment, interest rate, paid in kind | [7],[9],[12] | 2% | 2% | 2% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 13 | |||||||||||||
Investment, cost | [7],[9],[12] | 13 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 13 | |||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 11.91% | 11.91% | 11.91% | |||||||||||
Investment, interest rate, paid in kind | [7],[9],[12] | 2% | 2% | 2% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 3,031 | |||||||||||||
Investment, cost | [7],[9],[12] | 2,971 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 3,031 | |||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 11.91% | 11.91% | 11.91% | |||||||||||
Investment, interest rate, paid in kind | [7],[9],[12] | 2% | 2% | 2% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 1,557 | |||||||||||||
Investment, cost | [7],[9],[12] | 1,526 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 1,557 | |||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 11.91% | 11.91% | 11.91% | |||||||||||
Investment, interest rate, paid in kind | [7],[9],[12] | 2% | 2% | 2% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 1,024 | |||||||||||||
Investment, cost | [7],[9],[12] | 1,002 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 1,024 | |||||||||||||
Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,080,399 | [6],[9] | 1,080,399 | [6],[9] | 1,080,399 | [6],[9] | 1,080,399 | [5],[15] | 1,080,399 | [5],[15] | 1,080,399 | [5],[15] | |||
Investment, cost | $ 1,080 | [6],[9] | $ 1,080 | [5],[15] | |||||||||||
Investments at fair value | $ 313 | [6],[9] | 378 | [5],[15] | |||||||||||
Investment, Identifier [Axis]: Caregiver Services, Inc., Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,080,399 | 1,080,399 | 1,080,399 | 1,080,399 | |||||||||||
Investment, principal | $ 0 | $ 0 | |||||||||||||
Investments at fair value | $ 313 | $ 378 | $ 401 | 838 | |||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | 0% | |||||||||||
Investment, Identifier [Axis]: Carvana Co., Automotive Retail, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [8],[16],[17],[22] | 5.63% | 5.63% | 5.63% | |||||||||||
Investment, principal | [8],[18],[22] | $ 6,700 | |||||||||||||
Investment, cost | [8],[22] | 5,825 | |||||||||||||
Investments at fair value | [8],[22] | $ 4,724 | |||||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 8.62% | 8.62% | 8.62% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 10,692 | |||||||||||||
Investment, cost | [8],[15],[16] | 10,004 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 10,209 | |||||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 10.70% | 10.70% | 10.70% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 130 | |||||||||||||
Investment, cost | [7],[9],[12] | 130 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 130 | |||||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 10.70% | 10.70% | 10.70% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 129 | |||||||||||||
Investment, cost | [7],[9],[12] | 129 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 129 | |||||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 10.70% | 10.70% | 10.70% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 1,084 | |||||||||||||
Investment, cost | [7],[9],[12] | 1,103 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 1,084 | |||||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 4 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 10.70% | 10.70% | 10.70% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 9,002 | |||||||||||||
Investment, cost | [7],[9],[12] | 9,003 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 9,002 | |||||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1 | |||||||||||||||
Investment, interest rate | 7.50% | [7],[10],[12],[20] | 7.50% | [7],[10],[12],[20] | 7.50% | [7],[10],[12],[20] | 7.50% | [8],[16],[17],[22] | 7.50% | [8],[16],[17],[22] | 7.50% | [8],[16],[17],[22] | |||
Investment, principal | $ 2,632 | [7],[14],[20] | $ 4,311 | [8],[18],[22] | |||||||||||
Investment, cost | 2,632 | [7],[20] | 4,311 | [8],[22] | |||||||||||
Investments at fair value | $ 1,951 | [7],[20] | $ 3,132 | [8],[22] | |||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2 | |||||||||||||||
Investment, interest rate | 7.75% | [7],[10],[12],[20] | 7.75% | [7],[10],[12],[20] | 7.75% | [7],[10],[12],[20] | 5.13% | [8],[16],[17],[22] | 5.13% | [8],[16],[17],[22] | 5.13% | [8],[16],[17],[22] | |||
Investment, principal | $ 176 | [7],[14],[20] | $ 1,374 | [8],[18],[22] | |||||||||||
Investment, cost | 170 | [7],[20] | 1,229 | [8],[22] | |||||||||||
Investments at fair value | $ 138 | [7],[20] | $ 1,163 | [8],[22] | |||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 3 | |||||||||||||||
Investment, interest rate | [8],[16],[17],[22] | 7.75% | 7.75% | 7.75% | |||||||||||
Investment, principal | [8],[18],[22] | $ 676 | |||||||||||||
Investment, cost | [8],[22] | 648 | |||||||||||||
Investments at fair value | [8],[22] | $ 512 | |||||||||||||
Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | 7.38% | [7],[10],[12] | 7.38% | [7],[10],[12] | 7.38% | [7],[10],[12] | 7.38% | [8],[16],[17] | 7.38% | [8],[16],[17] | 7.38% | [8],[16],[17] | |||
Investment, principal | $ 8,420 | [7],[14] | $ 8,420 | [8],[18] | |||||||||||
Investment, cost | 8,257 | [7] | 8,243 | [8] | |||||||||||
Investments at fair value | $ 7,330 | [7] | $ 6,900 | [8] | |||||||||||
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[9],[12] | 8.50% | [7],[9],[12] | 8.50% | [7],[9],[12] | 8.50% | [8],[15],[16] | 8.50% | [8],[15],[16] | 8.50% | [8],[15],[16] | |||
Investment, interest rate | 13.69% | [7],[9],[10],[12] | 13.69% | [7],[9],[10],[12] | 13.69% | [7],[9],[10],[12] | 11.62% | [8],[15],[16],[17] | 11.62% | [8],[15],[16],[17] | 11.62% | [8],[15],[16],[17] | |||
Investment, principal | $ 24,350 | [7],[9],[12],[14] | $ 22,537 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 23,525 | [7],[9],[12] | 21,642 | [8],[15],[16] | |||||||||||
Investments at fair value | 21,506 | [7],[9],[12] | 20,396 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Warrants | |||||||||||||||
Investment, cost | 706 | [7],[9] | 648 | [8],[15] | |||||||||||
Investments at fair value | $ 154 | [7],[9] | $ 457 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: Convergeone Holdings, Inc., IT Consulting & Other Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5% | [7],[12] | 5% | [7],[12] | 5% | [7],[12] | 5% | [8],[16] | 5% | [8],[16] | 5% | [8],[16] | |||
Investment, interest rate | 10.37% | [7],[10],[12] | 10.37% | [7],[10],[12] | 10.37% | [7],[10],[12] | 8.12% | [8],[16],[17] | 8.12% | [8],[16],[17] | 8.12% | [8],[16],[17] | |||
Investment, principal | $ 17,506 | [7],[12],[14] | $ 11,913 | [8],[16],[18] | |||||||||||
Investment, cost | 15,434 | [7],[12] | 11,697 | [8],[16] | |||||||||||
Investments at fair value | $ 11,176 | [7],[12] | $ 8,596 | [8],[16] | |||||||||||
Investment, Identifier [Axis]: Conviva Inc., Application Software, Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | 417,851 | [7],[9] | 417,851 | [7],[9] | 417,851 | [7],[9] | 417,851 | [8],[15] | 417,851 | [8],[15] | 417,851 | [8],[15] | |||
Investment, cost | $ 605 | [7],[9] | $ 605 | [8],[15] | |||||||||||
Investments at fair value | $ 894 | [7],[9] | $ 894 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,500 | [7],[9] | 1,500 | [7],[9] | 1,500 | [7],[9] | 1,099 | [8],[15] | 1,099 | [8],[15] | 1,099 | [8],[15] | |||
Investment, cost | $ 1,574 | [7],[9] | $ 690 | [8],[15] | |||||||||||
Investments at fair value | $ 3,299 | [7],[9] | $ 2,340 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 5.75% | [7],[9],[11],[12] | 5.75% | [7],[9],[11],[12] | 5.75% | [7],[9],[11],[12] | 4.75% | [8],[15],[16],[19] | 4.75% | [8],[15],[16],[19] | 4.75% | [8],[15],[16],[19] | |||
Investment, interest rate | 14% | [7],[9],[10],[11],[12] | 14% | [7],[9],[10],[11],[12] | 14% | [7],[9],[10],[11],[12] | 11% | [8],[15],[16],[17],[19] | 11% | [8],[15],[16],[17],[19] | 11% | [8],[15],[16],[17],[19] | |||
Investment, principal | $ 1,250 | [7],[9],[11],[12],[14] | $ 916 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | 1,226 | [7],[9],[11],[12] | 898 | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ 1,202 | [7],[9],[11],[12] | $ 898 | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 8.88% | 8.88% | 8.88% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 13,712 | |||||||||||||
Investment, cost | [8],[15],[16] | 13,554 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 13,583 | |||||||||||||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 6.13% | 6.13% | 6.13% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 11.33% | 11.33% | 11.33% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 13,671 | |||||||||||||
Investment, cost | [7],[9],[12] | 13,633 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 13,408 | |||||||||||||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 6.13% | 6.13% | 6.13% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 11.33% | 11.33% | 11.33% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 4,903 | |||||||||||||
Investment, cost | [7],[9],[12] | 4,853 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 4,809 | |||||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[12] | (21) | |||||||||||||
Investments at fair value | [7],[9],[11],[12] | $ (21) | |||||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12.60% | 12.60% | 12.60% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 13,157 | |||||||||||||
Investment, cost | [7],[9],[12] | 12,843 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 12,852 | |||||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[12] | (15) | |||||||||||||
Investments at fair value | [7],[9],[11],[12] | $ (14) | |||||||||||||
Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5% | [7],[12] | 5% | [7],[12] | 5% | [7],[12] | 5% | [8],[16] | 5% | [8],[16] | 5% | [8],[16] | |||
Investment, interest rate | 10.24% | [7],[10],[12] | 10.24% | [7],[10],[12] | 10.24% | [7],[10],[12] | 7.65% | [8],[16],[17] | 7.65% | [8],[16],[17] | 7.65% | [8],[16],[17] | |||
Investment, principal | $ 14,787 | [7],[12],[14] | $ 10,336 | [8],[16],[18] | |||||||||||
Investment, cost | 14,186 | [7],[12] | 9,716 | [8],[16] | |||||||||||
Investments at fair value | $ 13,807 | [7],[12] | $ 9,681 | [8],[16] | |||||||||||
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[9],[11],[12] | 6% | [7],[9],[11],[12] | 6% | [7],[9],[11],[12] | 6% | [8],[15],[16],[19] | 6% | [8],[15],[16],[19] | 6% | [8],[15],[16],[19] | |||
Investment, interest rate | [10],[12] | 11.20% | 11.20% | 11.20% | |||||||||||
Investment, principal | $ 533 | [7],[9],[11],[12],[14] | $ 0 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | 520 | [7],[9],[11],[12] | (13) | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ 507 | [7],[9],[11],[12] | $ (26) | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[9],[12] | 6% | [7],[9],[12] | 6% | [7],[9],[12] | 6% | [8],[15],[16] | 6% | [8],[15],[16] | 6% | [8],[15],[16] | |||
Investment, interest rate | 11.10% | [7],[9],[10],[12] | 11.10% | [7],[9],[10],[12] | 11.10% | [7],[9],[10],[12] | 8.81% | [8],[15],[16],[17] | 8.81% | [8],[15],[16],[17] | 8.81% | [8],[15],[16],[17] | |||
Investment, principal | $ 18,060 | [7],[9],[12],[14] | $ 18,200 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 17,715 | [7],[9],[12] | 17,790 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 17,706 | [7],[9],[12] | $ 17,843 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | [7],[12] | 4.75% | [7],[12] | 4.75% | [7],[12] | 4.75% | [8],[16] | 4.75% | [8],[16] | 4.75% | [8],[16] | |||
Investment, interest rate | 9.80% | [7],[10],[12] | 9.80% | [7],[10],[12] | 9.80% | [7],[10],[12] | 7.33% | [8],[16],[17] | 7.33% | [8],[16],[17] | 7.33% | [8],[16],[17] | |||
Investment, principal | $ 4,963 | [7],[12],[14] | $ 5,000 | [8],[16],[18] | |||||||||||
Investment, cost | 4,879 | [7],[12] | 4,906 | [8],[16] | |||||||||||
Investments at fair value | $ 4,632 | [7],[12] | $ 4,760 | [8],[16] | |||||||||||
Investment, Identifier [Axis]: Delivery Hero FinCo LLC, Internet & Direct Marketing Retail, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[16],[22] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, interest rate | [8],[16],[17],[22] | 8.49% | 8.49% | 8.49% | |||||||||||
Investment, principal | [8],[16],[18],[22] | $ 4,988 | |||||||||||||
Investment, cost | [8],[16],[22] | 4,882 | |||||||||||||
Investments at fair value | [8],[16],[22] | $ 4,757 | |||||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 2 | [7],[9],[20] | 2 | [7],[9],[20] | 2 | [7],[9],[20] | 2 | [8],[15],[22] | 2 | [8],[15],[22] | 2 | [8],[15],[22] | |||
Investment, cost | $ 2 | [7],[9],[20] | $ 2 | [8],[15],[22] | |||||||||||
Investments at fair value | $ 2 | [7],[9],[20] | $ 2 | [8],[15],[22] | |||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | 419 | [7],[9],[20] | 419 | [7],[9],[20] | 419 | [7],[9],[20] | 419 | [8],[15],[22] | 419 | [8],[15],[22] | 419 | [8],[15],[22] | |||
Investment, cost | $ 419 | [7],[9],[20] | $ 419 | [8],[15],[22] | |||||||||||
Investments at fair value | $ 419 | [7],[9],[20] | $ 419 | [8],[15],[22] | |||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan | |||||||||||||||
Investment, interest rate | 3% | [7],[9],[10],[11],[12],[20] | 3% | [7],[9],[10],[11],[12],[20] | 3% | [7],[9],[10],[11],[12],[20] | 10% | [8],[15],[16],[17],[19],[22] | 10% | [8],[15],[16],[17],[19],[22] | 10% | [8],[15],[16],[17],[19],[22] | |||
Investment, interest rate, paid in kind | [7],[9],[11],[20] | 7% | 7% | 7% | |||||||||||
Investment, principal | $ 13,043 | [7],[9],[11],[14],[20] | $ 4,183 | [8],[15],[18],[19],[22] | |||||||||||
Investment, cost | 13,043 | [7],[9],[11],[20] | 4,183 | [8],[15],[19],[22] | |||||||||||
Investments at fair value | $ 13,043 | [7],[9],[11],[20] | $ 4,183 | [8],[15],[19],[22] | |||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 31 | [7],[9],[20] | 31 | [7],[9],[20] | 31 | [7],[9],[20] | 31 | [8],[15],[22] | 31 | [8],[15],[22] | 31 | [8],[15],[22] | |||
Investment, cost | $ 0 | [7],[9],[20] | $ 0 | [8],[15],[22] | |||||||||||
Investments at fair value | $ 0 | [7],[9],[20] | $ 0 | [8],[15],[22] | |||||||||||
Investment, Identifier [Axis]: Delta Topco, Inc., Systems Software, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[16] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [8],[16],[17] | 9.34% | 9.34% | 9.34% | |||||||||||
Investment, principal | [8],[16],[18] | $ 6,680 | |||||||||||||
Investment, cost | [8],[16] | 6,647 | |||||||||||||
Investments at fair value | [8],[16] | $ 5,934 | |||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 9% | 9% | 9% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 14.42% | 14.42% | 14.42% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 20,757 | |||||||||||||
Investment, cost | [7],[9],[12] | 20,092 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 20,705 | |||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 9% | 9% | 9% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 12.67% | 12.67% | 12.67% | |||||||||||
Investment, interest rate, paid in kind | [8],[15],[16] | 2% | 2% | 2% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 24,396 | |||||||||||||
Investment, cost | [8],[15],[16] | 23,083 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 22,993 | |||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16],[19] | 9% | 9% | 9% | |||||||||||
Investment, principal | [8],[15],[16],[18],[19] | $ 0 | |||||||||||||
Investment, cost | [8],[15],[16],[19] | (135) | |||||||||||||
Investments at fair value | [8],[15],[16],[19] | $ (129) | |||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan | |||||||||||||||
Investment, interest rate, paid in kind | [7],[9] | 8% | 8% | 8% | |||||||||||
Investment, principal | [7],[9],[14] | $ 641 | |||||||||||||
Investment, cost | [7],[9] | 640 | |||||||||||||
Investments at fair value | [7],[9] | $ 611 | |||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 6,397,254 | [7],[9] | 6,397,254 | [7],[9] | 6,397,254 | [7],[9] | 5,403,823 | [8],[15] | 5,403,823 | [8],[15] | 5,403,823 | [8],[15] | |||
Investment, cost | $ 1,642 | [7],[9] | $ 1,405 | [8],[15] | |||||||||||
Investments at fair value | $ 1,215 | [7],[9] | $ 1,297 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [7],[9],[11],[12] | 6.75% | [7],[9],[11],[12] | 6.75% | [7],[9],[11],[12] | 6.50% | [8],[15],[16],[19] | 6.50% | [8],[15],[16],[19] | 6.50% | [8],[15],[16],[19] | |||
Investment, interest rate | 12.09% | [7],[9],[10],[11],[12] | 12.09% | [7],[9],[10],[11],[12] | 12.09% | [7],[9],[10],[11],[12] | 9.41% | [8],[15],[16],[17],[19] | 9.41% | [8],[15],[16],[17],[19] | 9.41% | [8],[15],[16],[17],[19] | |||
Investment, principal | $ 204 | [7],[9],[11],[12],[14] | $ 251 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | 184 | [7],[9],[11],[12] | 228 | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ 172 | [7],[9],[11],[12] | $ 239 | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[9],[12] | 7% | [7],[9],[12] | 7% | [7],[9],[12] | 7% | [8],[15],[16] | 7% | [8],[15],[16] | 7% | [8],[15],[16] | |||
Investment, interest rate | 12.34% | [7],[9],[10],[12] | 12.34% | [7],[9],[10],[12] | 12.34% | [7],[9],[10],[12] | 9.91% | [8],[15],[16],[17] | 9.91% | [8],[15],[16],[17] | 9.91% | [8],[15],[16],[17] | |||
Investment, principal | $ 12,418 | [7],[9],[12],[14] | $ 9,902 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 12,226 | [7],[9],[12] | 9,599 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 12,120 | [7],[9],[12] | $ 9,793 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5% | [7],[12] | 5% | [7],[12] | 5% | [7],[12] | 5% | [8],[16] | 5% | [8],[16] | 5% | [8],[16] | |||
Investment, interest rate | 10.22% | [7],[10],[12] | 10.22% | [7],[10],[12] | 10.22% | [7],[10],[12] | 8.12% | [8],[16],[17] | 8.12% | [8],[16],[17] | 8.12% | [8],[16],[17] | |||
Investment, principal | $ 4,769 | [7],[12],[14] | $ 19,242 | [8],[16],[18] | |||||||||||
Investment, cost | 4,687 | [7],[12] | 18,970 | [8],[16] | |||||||||||
Investments at fair value | $ 4,672 | [7],[12] | $ 17,973 | [8],[16] | |||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 30,031 | ||||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investments at fair value | $ 9,267 | 18,065 | |||||||||||||
Investment owned, percent of net assets | 0.70% | ||||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 5% | ||||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investments at fair value | $ 0 | 0 | |||||||||||||
Investment owned, percent of net assets | 0% | ||||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5% | ||||||||||||||
Investment, interest rate | 7.26% | ||||||||||||||
Investment, principal | $ 16,074 | ||||||||||||||
Investments at fair value | $ 16,074 | 27,381 | |||||||||||||
Investment owned, percent of net assets | 1.30% | ||||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 30,031 | [1],[2],[9] | 30,031 | [1],[2],[9] | 30,031 | [1],[2],[9] | 30,031 | [3],[4],[15] | 30,031 | [3],[4],[15] | 30,031 | [3],[4],[15] | |||
Investment, principal | $ 0 | ||||||||||||||
Investment, cost | 15,222 | [1],[2],[9] | $ 15,222 | [3],[4],[15] | |||||||||||
Investments at fair value | $ 2,711 | [1],[2],[9] | $ 4,946 | [3],[4],[15] | |||||||||||
Investment owned, percent of net assets | 0.20% | 0.20% | 0.20% | ||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 5% | [1],[2],[9],[11],[12] | 5% | [1],[2],[9],[11],[12] | 5% | [1],[2],[9],[11],[12] | 5% | [3],[4],[15],[16],[19] | 5% | [3],[4],[15],[16],[19] | 5% | [3],[4],[15],[16],[19] | |||
Investment, interest rate | [1],[2],[9],[10],[11],[12] | 10.24% | 10.24% | 10.24% | |||||||||||
Investment, principal | $ 3,484 | [1],[2],[9],[11],[12],[14] | $ 0 | [3],[4],[15],[16],[18],[19] | |||||||||||
Investment, cost | 3,484 | [1],[2],[9],[11],[12] | 0 | [3],[4],[15],[16],[19] | |||||||||||
Investments at fair value | $ 3,484 | [1],[2],[9],[11],[12] | $ 0 | [3],[4],[15],[16],[19] | |||||||||||
Investment owned, percent of net assets | 0.20% | 0.20% | 0.20% | ||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [3],[4],[15],[16] | 5% | 5% | 5% | |||||||||||
Investment, interest rate | [3],[4],[15],[16],[17] | 8.68% | 8.68% | 8.68% | |||||||||||
Investment, principal | [3],[4],[15],[16],[18] | $ 14,333 | |||||||||||||
Investment, cost | [3],[4],[15],[16] | 14,333 | |||||||||||||
Investments at fair value | [3],[4],[15],[16] | 14,333 | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [1],[2],[9],[12] | 5% | 5% | 5% | |||||||||||
Investment, interest rate | [1],[2],[9],[10],[12] | 10.39% | 10.39% | 10.39% | |||||||||||
Investment, principal | [1],[2],[9],[12],[14] | $ 14,102 | |||||||||||||
Investment, cost | [1],[2],[9],[12] | 14,102 | |||||||||||||
Investments at fair value | $ 14,102 | [1],[2],[9],[12] | 14,333 | ||||||||||||
Investment owned, percent of net assets | 0.90% | 0.90% | 0.90% | ||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [1],[2],[9],[12] | 5% | 5% | 5% | |||||||||||
Investment, principal | [1],[2],[9],[11],[12],[14] | $ 0 | |||||||||||||
Investment, cost | [1],[2],[9],[11],[12] | 0 | |||||||||||||
Investments at fair value | $ 0 | [1],[2],[9],[11],[12] | $ 0 | ||||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | ||||||||||||
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 12,500 | [7],[9] | 12,500 | [7],[9] | 12,500 | [7],[9] | 12,500 | [8],[15] | 12,500 | [8],[15] | 12,500 | [8],[15] | |||
Investment, cost | $ 0 | [7],[9] | $ 0 | [8],[15] | |||||||||||
Investments at fair value | $ 0 | [7],[9] | $ 0 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | 488 | [7],[9] | 488 | [7],[9] | 488 | [7],[9] | 488 | [8],[15] | 488 | [8],[15] | 488 | [8],[15] | |||
Investment, cost | $ 488 | [7],[9] | $ 488 | [8],[15] | |||||||||||
Investments at fair value | $ 1,160 | [7],[9] | $ 966 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[9],[12] | 7.50% | [7],[9],[12] | 7.50% | [7],[9],[12] | 7.50% | [8],[15],[16] | 7.50% | [8],[15],[16] | 7.50% | [8],[15],[16] | |||
Investment, interest rate | 13.04% | [7],[9],[10],[12] | 13.04% | [7],[9],[10],[12] | 13.04% | [7],[9],[10],[12] | 11.17% | [8],[15],[16],[17] | 11.17% | [8],[15],[16],[17] | 11.17% | [8],[15],[16],[17] | |||
Investment, principal | $ 8,974 | [7],[9],[12],[14] | $ 8,974 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 8,884 | [7],[9],[12] | 8,884 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 7,359 | [7],[9],[12] | $ 8,503 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1 | |||||||||||||||
Investment, interest rate | 3% | [7],[9],[10],[12],[20] | 3% | [7],[9],[10],[12],[20] | 3% | [7],[9],[10],[12],[20] | 3% | [8],[15],[16],[17],[22] | 3% | [8],[15],[16],[17],[22] | 3% | [8],[15],[16],[17],[22] | |||
Investment, interest rate, paid in kind | 6% | [7],[9],[20] | 6% | [7],[9],[20] | 6% | [7],[9],[20] | 6% | [8],[15],[22] | 6% | [8],[15],[22] | 6% | [8],[15],[22] | |||
Investment, principal | $ 10,899 | [7],[9],[14],[20] | $ 10,418 | [8],[15],[18],[22] | |||||||||||
Investment, cost | 10,779 | [7],[9],[20] | 10,275 | [8],[15],[22] | |||||||||||
Investments at fair value | $ 10,463 | [7],[9],[20] | $ 10,231 | [8],[15],[22] | |||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2 | |||||||||||||||
Investment, interest rate | 3% | [7],[9],[10],[12],[20] | 3% | [7],[9],[10],[12],[20] | 3% | [7],[9],[10],[12],[20] | 3% | [8],[15],[16],[17],[19],[22] | 3% | [8],[15],[16],[17],[19],[22] | 3% | [8],[15],[16],[17],[19],[22] | |||
Investment, interest rate, paid in kind | [7],[9],[20] | 6% | 6% | 6% | |||||||||||
Investment, principal | $ 1,746 | [7],[9],[14],[20] | $ 0 | [8],[15],[18],[19],[22] | |||||||||||
Investment, cost | 1,720 | [7],[9],[20] | 3 | [8],[15],[19],[22] | |||||||||||
Investments at fair value | $ 1,676 | [7],[9],[20] | $ 0 | [8],[15],[19],[22] | |||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3 | |||||||||||||||
Investment, interest rate | [7],[9],[10],[11],[12],[20] | 3% | 3% | 3% | |||||||||||
Investment, interest rate, paid in kind | [7],[9],[11],[20] | 6% | 6% | 6% | |||||||||||
Investment, principal | [7],[9],[11],[14],[20] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[20] | 1 | |||||||||||||
Investments at fair value | [7],[9],[11],[20] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4 | |||||||||||||||
Investment, interest rate | [7],[9],[10],[11],[12],[20] | 3% | 3% | 3% | |||||||||||
Investment, interest rate, paid in kind | [7],[9],[11],[20] | 6% | 6% | 6% | |||||||||||
Investment, principal | [7],[9],[11],[14],[20] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[20] | 1 | |||||||||||||
Investments at fair value | [7],[9],[11],[20] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [7],[12] | 6.75% | [7],[12] | 6.75% | [7],[12] | 6.75% | [8],[16] | 6.75% | [8],[16] | 6.75% | [8],[16] | |||
Investment, interest rate | 11.94% | [7],[10],[12] | 11.94% | [7],[10],[12] | 11.94% | [7],[10],[12] | 9.87% | [8],[16],[17] | 9.87% | [8],[16],[17] | 9.87% | [8],[16],[17] | |||
Investment, principal | $ 31,074 | [7],[12],[14] | $ 25,061 | [8],[16],[18] | |||||||||||
Investment, cost | 29,063 | [7],[12] | 24,685 | [8],[16] | |||||||||||
Investments at fair value | $ 18,664 | [7],[12] | $ 21,646 | [8],[16] | |||||||||||
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan | |||||||||||||||
Investment, interest rate | 9% | [7],[9],[10],[11],[12] | 9% | [7],[9],[10],[11],[12] | 9% | [7],[9],[10],[11],[12] | 9% | [8],[15],[16],[17],[27] | 9% | [8],[15],[16],[17],[27] | 9% | [8],[15],[16],[17],[27] | |||
Investment, principal | $ 52,658 | [7],[9],[11],[14] | $ 27,850 | [8],[15],[18],[27] | |||||||||||
Investment, cost | 52,658 | [7],[9],[11] | 27,850 | [8],[15],[27] | |||||||||||
Investments at fair value | $ 52,658 | [7],[9],[11] | $ 27,850 | [8],[15],[27] | |||||||||||
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 2,500 | [7],[9],[20] | 2,500 | [7],[9],[20] | 2,500 | [7],[9],[20] | 2,500 | [8],[15],[22],[27] | 2,500 | [8],[15],[22],[27] | 2,500 | [8],[15],[22],[27] | |||
Investment, cost | $ 0 | [7],[9],[20] | $ 0 | [8],[15],[22],[27] | |||||||||||
Investments at fair value | $ 3 | [7],[9],[20] | $ 3 | [8],[15],[22],[27] | |||||||||||
Investment, Identifier [Axis]: First Star Speir Aviation Limited, First Lien Term Loan | |||||||||||||||
Investment, interest rate | 9% | ||||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investments at fair value | $ 0 | 7,500 | |||||||||||||
Investment owned, percent of net assets | 0% | ||||||||||||||
Investment, Identifier [Axis]: First Star Speir Aviation Limited, Membership Interest | |||||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investments at fair value | $ 0 | 698 | |||||||||||||
Investment owned, ownership percentage | 100% | ||||||||||||||
Investment owned, percent of net assets | 0% | ||||||||||||||
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan | |||||||||||||||
Investment, interest rate | 11% | [7],[9],[10],[12],[20] | 11% | [7],[9],[10],[12],[20] | 11% | [7],[9],[10],[12],[20] | 11% | [8],[15],[16],[17],[22] | 11% | [8],[15],[16],[17],[22] | 11% | [8],[15],[16],[17],[22] | |||
Investment, principal | $ 11,918 | [7],[9],[14],[20] | $ 9,466 | [8],[15],[18],[22] | |||||||||||
Investment, cost | 11,572 | [7],[9],[20] | 9,071 | [8],[15],[22] | |||||||||||
Investments at fair value | $ 11,173 | [7],[9],[20] | $ 9,008 | [8],[15],[22] | |||||||||||
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 417,011 | [7],[9],[20] | 417,011 | [7],[9],[20] | 417,011 | [7],[9],[20] | 331,200 | [8],[15],[22] | 331,200 | [8],[15],[22] | 331,200 | [8],[15],[22] | |||
Investment, cost | $ 427 | [7],[9],[20] | $ 405 | [8],[15],[22] | |||||||||||
Investments at fair value | $ 113 | [7],[9],[20] | $ 66 | [8],[15],[22] | |||||||||||
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | 6% | [7],[10],[12],[20] | 6% | [7],[10],[12],[20] | 6% | [7],[10],[12],[20] | 6% | [8],[16],[17],[22] | 6% | [8],[16],[17],[22] | 6% | [8],[16],[17],[22] | |||
Investment, principal | $ 4,881 | [7],[14],[20] | $ 4,881 | [8],[18],[22] | |||||||||||
Investment, cost | 4,456 | [7],[20] | 4,420 | [8],[22] | |||||||||||
Investments at fair value | $ 3,595 | [7],[20] | $ 3,845 | [8],[22] | |||||||||||
Investment, Identifier [Axis]: GKD Index Partners, LLC, Specialized Finance, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16],[19] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [8],[15],[16],[17],[19] | 10.60% | 10.60% | 10.60% | |||||||||||
Investment, principal | [8],[15],[16],[18],[19] | $ 1,280 | |||||||||||||
Investment, cost | [8],[15],[16],[19] | 1,268 | |||||||||||||
Investments at fair value | [8],[15],[16],[19] | $ 1,262 | |||||||||||||
Investment, Identifier [Axis]: GKD Index Partners, LLC, Specialized Finance, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 10.67% | 10.67% | 10.67% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 25,128 | |||||||||||||
Investment, cost | [8],[15],[16] | 24,915 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 24,851 | |||||||||||||
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [7],[9],[10],[11],[12] | 12.34% | 12.34% | 12.34% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14] | $ 1,638 | |||||||||||||
Investment, cost | [7],[9],[11],[12] | 1,530 | |||||||||||||
Investments at fair value | [7],[9],[11],[12] | $ 1,532 | |||||||||||||
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12.34% | 12.34% | 12.34% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 23,774 | |||||||||||||
Investment, cost | [7],[9],[12] | 23,080 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 23,094 | |||||||||||||
Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 5% | 5% | 5% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 10.25% | 10.25% | 10.25% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 2,463 | |||||||||||||
Investment, cost | [7],[9],[12] | 2,039 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 1,995 | |||||||||||||
Investment, Identifier [Axis]: Global Medical Response, Inc., Health Care Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[16] | 4.25% | 4.25% | 4.25% | |||||||||||
Investment, interest rate | [8],[16],[17] | 7.37% | 7.37% | 7.37% | |||||||||||
Investment, principal | [8],[16],[18] | $ 5,572 | |||||||||||||
Investment, cost | [8],[16] | 5,435 | |||||||||||||
Investments at fair value | [8],[16] | $ 4,848 | |||||||||||||
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes | |||||||||||||||
Investment, basis spread, variable rate | [7],[12],[20] | 2.85% | 2.85% | 2.85% | |||||||||||
Investment, interest rate | [7],[10],[12],[20] | 6.05% | 6.05% | 6.05% | |||||||||||
Investment, principal | € | [7],[12],[14],[20] | € 1,000 | |||||||||||||
Investment, cost | [7],[12],[20] | $ 872 | |||||||||||||
Investments at fair value | [7],[12],[20] | $ 970 | |||||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[9],[11],[12] | 8% | [7],[9],[11],[12] | 8% | [7],[9],[11],[12] | 8% | [8],[15],[16],[19] | 8% | [8],[15],[16],[19] | 8% | [8],[15],[16],[19] | |||
Investment, principal | $ 0 | [7],[9],[11],[12],[14] | $ 0 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | (29) | [7],[9],[11],[12] | (27) | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ (18) | [7],[9],[11],[12] | $ (25) | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[9],[12] | 8% | [7],[9],[12] | 8% | [7],[9],[12] | 8% | [8],[15],[16] | 8% | [8],[15],[16] | 8% | [8],[15],[16] | |||
Investment, interest rate | 13.39% | [7],[9],[10],[12] | 13.39% | [7],[9],[10],[12] | 13.39% | [7],[9],[10],[12] | 11.04% | [8],[15],[16],[17] | 11.04% | [8],[15],[16],[17] | 11.04% | [8],[15],[16],[17] | |||
Investment, principal | $ 17,488 | [7],[9],[12],[14] | $ 14,311 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 17,308 | [7],[9],[12] | 14,041 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 17,314 | [7],[9],[12] | $ 14,060 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[9],[11],[12] | 8% | [7],[9],[11],[12] | 8% | [7],[9],[11],[12] | 8% | [8],[15],[16],[19] | 8% | [8],[15],[16],[19] | 8% | [8],[15],[16],[19] | |||
Investment, principal | $ 0 | [7],[9],[11],[12],[14] | $ 0 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | (58) | [7],[9],[11],[12] | (54) | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ (35) | [7],[9],[11],[12] | $ (50) | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | [7],[12] | 5.25% | [7],[12] | 5.25% | [7],[12] | 5.25% | [8],[16] | 5.25% | [8],[16] | 5.25% | [8],[16] | |||
Investment, interest rate | 10.45% | [7],[10],[12] | 10.45% | [7],[10],[12] | 10.45% | [7],[10],[12] | 8.38% | [8],[16],[17] | 8.38% | [8],[16],[17] | 8.38% | [8],[16],[17] | |||
Investment, principal | $ 14,383 | [7],[12],[14] | $ 9,392 | [8],[16],[18] | |||||||||||
Investment, cost | 13,885 | [7],[12] | 9,080 | [8],[16] | |||||||||||
Investments at fair value | $ 12,352 | [7],[12] | $ 8,582 | [8],[16] | |||||||||||
Investment, Identifier [Axis]: Harrow Health, Inc., Pharmaceuticals, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12],[20] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12],[20] | 11.74% | 11.74% | 11.74% | |||||||||||
Investment, principal | [7],[9],[12],[14],[20] | $ 7,448 | |||||||||||||
Investment, cost | [7],[9],[12],[20] | 7,279 | |||||||||||||
Investments at fair value | [7],[9],[12],[20] | $ 7,295 | |||||||||||||
Investment, Identifier [Axis]: Harrow Health, Inc., Pharmaceuticals, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12],[20] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14],[20] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[12],[20] | (91) | |||||||||||||
Investments at fair value | [7],[9],[11],[12],[20] | $ (83) | |||||||||||||
Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes | |||||||||||||||
Investment, interest rate | [7],[10],[12],[20] | 4.46% | 4.46% | 4.46% | |||||||||||
Investment, principal | [7],[14],[20] | $ 6,932 | |||||||||||||
Investment, cost | [7],[20] | 5,577 | |||||||||||||
Investments at fair value | [7],[20] | $ 6,001 | |||||||||||||
Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12],[20] | 8.25% | 8.25% | 8.25% | |||||||||||
Investment, interest rate | [7],[9],[10],[12],[20] | 13.30% | 13.30% | 13.30% | |||||||||||
Investment, principal | [7],[9],[12],[14],[20] | $ 23,975 | |||||||||||||
Investment, cost | [7],[9],[12],[20] | 23,274 | |||||||||||||
Investments at fair value | [7],[9],[12],[20] | $ 23,292 | |||||||||||||
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 11.29% | 11.29% | 11.29% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 45,169 | |||||||||||||
Investment, cost | [7],[9],[12] | 43,394 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 35,834 | |||||||||||||
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Products, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 9.42% | 9.42% | 9.42% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 35,625 | |||||||||||||
Investment, cost | [8],[15],[16] | 34,806 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 31,528 | |||||||||||||
Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[9],[12] | 6.50% | [7],[9],[12] | 6.50% | [7],[9],[12] | 6.50% | [8],[15],[16] | 6.50% | [8],[15],[16] | 6.50% | [8],[15],[16] | |||
Investment, interest rate | 11.57% | [7],[9],[10],[12] | 11.57% | [7],[9],[10],[12] | 11.57% | [7],[9],[10],[12] | 9.44% | [8],[15],[16],[17] | 9.44% | [8],[15],[16],[17] | 9.44% | [8],[15],[16],[17] | |||
Investment, principal | $ 40,484 | [7],[9],[12],[14] | $ 34,357 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 39,779 | [7],[9],[12] | 33,612 | [8],[15],[16] | |||||||||||
Investments at fair value | 38,662 | [7],[9],[12] | $ 32,639 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Immucor, Inc., Health Care Supplies, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 9.42% | 9.42% | 9.42% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 8,569 | |||||||||||||
Investment, cost | [8],[15],[16] | 8,401 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 8,407 | |||||||||||||
Investment, Identifier [Axis]: Immucor, Inc., Health Care Supplies, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 8% | 8% | 8% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 11.67% | 11.67% | 11.67% | |||||||||||
Investment, interest rate, paid in kind | [8],[15],[16] | 3.50% | 3.50% | 3.50% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 22,619 | |||||||||||||
Investment, cost | [8],[15],[16] | 22,162 | |||||||||||||
Investments at fair value | [8],[15],[16] | 22,275 | |||||||||||||
Investment, Identifier [Axis]: Impel Neuropharma, Inc., Health Care Technology, First Lien Term Loan 1 | |||||||||||||||
Investment, principal | 15,302 | [7],[9],[14],[21] | 13,083 | [8],[15],[18],[26] | |||||||||||
Investment, cost | 15,341 | [7],[9],[21] | 13,083 | [8],[15],[26] | |||||||||||
Investments at fair value | $ 14,269 | [7],[9],[21] | $ 13,083 | [8],[15],[26] | |||||||||||
Investment, Identifier [Axis]: Impel Neuropharma, Inc., Health Care Technology, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 8.75% | [7],[9],[12] | 8.75% | [7],[9],[12] | 8.75% | [7],[9],[12] | 8.75% | [8],[15],[16] | 8.75% | [8],[15],[16] | 8.75% | [8],[15],[16] | |||
Investment, interest rate | 14.14% | [7],[9],[10],[12] | 14.14% | [7],[9],[10],[12] | 14.14% | [7],[9],[10],[12] | 12.45% | [8],[15],[16],[17] | 12.45% | [8],[15],[16],[17] | 12.45% | [8],[15],[16],[17] | |||
Investment, principal | $ 13,109 | [7],[9],[12],[14] | $ 12,161 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 12,939 | [7],[9],[12] | 11,944 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 12,617 | [7],[9],[12] | $ 11,942 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 1 | |||||||||||||||
Investment, interest rate | 11% | [7],[9],[10],[12],[20] | 11% | [7],[9],[10],[12],[20] | 11% | [7],[9],[10],[12],[20] | 11% | [8],[15],[16],[17],[22] | 11% | [8],[15],[16],[17],[22] | 11% | [8],[15],[16],[17],[22] | |||
Investment, principal | $ 8,452 | [7],[9],[14],[20] | $ 6,817 | [8],[15],[18],[22] | |||||||||||
Investment, cost | 8,185 | [7],[9],[20] | 6,553 | [8],[15],[22] | |||||||||||
Investments at fair value | $ 7,730 | [7],[9],[20] | $ 6,408 | [8],[15],[22] | |||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 2 | |||||||||||||||
Investment, interest rate | 11% | [7],[9],[10],[11],[12],[20] | 11% | [7],[9],[10],[11],[12],[20] | 11% | [7],[9],[10],[11],[12],[20] | 11% | [8],[15],[16],[17],[19],[22] | 11% | [8],[15],[16],[17],[19],[22] | 11% | [8],[15],[16],[17],[19],[22] | |||
Investment, principal | $ 0 | [7],[9],[11],[14],[20] | $ 0 | [8],[15],[18],[19],[22] | |||||||||||
Investment, cost | 0 | [7],[9],[11],[20] | 0 | [8],[15],[19],[22] | |||||||||||
Investments at fair value | $ 0 | [7],[9],[11],[20] | $ 0 | [8],[15],[19],[22] | |||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 3 | |||||||||||||||
Investment, interest rate | [7],[9],[10],[11],[12],[20] | 11% | 11% | 11% | |||||||||||
Investment, principal | [7],[9],[11],[14],[20] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[20] | 0 | |||||||||||||
Investments at fair value | [7],[9],[11],[20] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 112,990 | [7],[9],[20] | 112,990 | [7],[9],[20] | 112,990 | [7],[9],[20] | 56,999 | [8],[15],[22] | 56,999 | [8],[15],[22] | 56,999 | [8],[15],[22] | |||
Investment, cost | $ 300 | [7],[9],[20] | $ 135 | [8],[15],[22] | |||||||||||
Investments at fair value | $ 172 | [7],[9],[20] | $ 609 | [8],[15],[22] | |||||||||||
Investment, Identifier [Axis]: Integral Development Corporation, Diversified Financial Services, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | [7],[9] | 1,078,284 | 1,078,284 | 1,078,284 | |||||||||||
Investment, cost | [7],[9] | $ 113 | |||||||||||||
Investments at fair value | [7],[9] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Integral Development Corporation, Other Diversified Financial Services, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[15] | 1,078,284 | 1,078,284 | 1,078,284 | |||||||||||
Investment, cost | [8],[15] | $ 113 | |||||||||||||
Investments at fair value | [8],[15] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[12] | (114) | |||||||||||||
Investments at fair value | [7],[9],[11],[12] | $ (114) | |||||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[9],[12] | 7.50% | [7],[9],[12] | 7.50% | [7],[9],[12] | 5% | [8],[15],[16] | 5% | [8],[15],[16] | 5% | [8],[15],[16] | |||
Investment, interest rate | 12.72% | [7],[9],[10],[12] | 12.72% | [7],[9],[10],[12] | 12.72% | [7],[9],[10],[12] | 8.55% | [8],[15],[16],[17] | 8.55% | [8],[15],[16],[17] | 8.55% | [8],[15],[16],[17] | |||
Investment, principal | $ 33,498 | [7],[9],[12],[14] | $ 18,660 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 32,494 | [7],[9],[12] | 18,567 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 32,493 | [7],[9],[12] | $ 18,134 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 12.17% | 12.17% | 12.17% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 13,674 | |||||||||||||
Investment, cost | [8],[15],[16] | 13,514 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 13,154 | |||||||||||||
Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[12] | 7.25% | [7],[12] | 7.25% | [7],[12] | 7.25% | [8],[16] | 7.25% | [8],[16] | 7.25% | [8],[16] | |||
Investment, interest rate | 12.42% | [7],[10],[12] | 12.42% | [7],[10],[12] | 12.42% | [7],[10],[12] | 10.33% | [8],[16],[17] | 10.33% | [8],[16],[17] | 10.33% | [8],[16],[17] | |||
Investment, principal | $ 13,939 | [7],[12],[14] | $ 10,247 | [8],[16],[18] | |||||||||||
Investment, cost | 12,601 | [7],[12] | 10,196 | [8],[16] | |||||||||||
Investments at fair value | 9,252 | [7],[12] | 7,702 | [8],[16] | |||||||||||
Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund, Institutional Shares | |||||||||||||||
Investment, cost | 5,193 | ||||||||||||||
Investments at fair value | $ 5,193 | ||||||||||||||
Money market funds, at carrying value | $ 5,261 | ||||||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 10.62% | 10.62% | 10.62% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 36,234 | |||||||||||||
Investment, cost | [8],[15],[16] | 35,170 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 36,392 | |||||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12.70% | 12.70% | 12.70% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 17,069 | |||||||||||||
Investment, cost | [7],[9],[12] | 17,053 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 16,966 | |||||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12.70% | 12.70% | 12.70% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 27,360 | |||||||||||||
Investment, cost | [7],[9],[12] | 26,872 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 27,488 | |||||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 10.60% | 10.60% | 10.60% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 15,150 | |||||||||||||
Investment, cost | [7],[9],[12] | 14,331 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 14,924 | |||||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[12] | 8% | [7],[12] | 8% | [7],[12] | 8% | [8],[16] | 8% | [8],[16] | 8% | [8],[16] | |||
Investment, interest rate | 13.20% | [7],[10],[12] | 13.20% | [7],[10],[12] | 13.20% | [7],[10],[12] | 11.12% | [8],[16],[17] | 11.12% | [8],[16],[17] | 11.12% | [8],[16],[17] | |||
Investment, principal | $ 666 | [7],[12],[14] | $ 528 | [8],[16],[18] | |||||||||||
Investment, cost | 616 | [7],[12] | 478 | [8],[16] | |||||||||||
Investments at fair value | $ 652 | [7],[12] | $ 481 | [8],[16] | |||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[9],[11],[12] | 6.50% | [7],[9],[11],[12] | 6.50% | [7],[9],[11],[12] | 6.50% | [8],[15],[16],[19] | 6.50% | [8],[15],[16],[19] | 6.50% | [8],[15],[16],[19] | |||
Investment, interest rate | 11.84% | [7],[9],[10],[11],[12] | 11.84% | [7],[9],[10],[11],[12] | 11.84% | [7],[9],[10],[11],[12] | 10.17% | [8],[15],[16],[17],[19] | 10.17% | [8],[15],[16],[17],[19] | 10.17% | [8],[15],[16],[17],[19] | |||
Investment, principal | $ 545 | [7],[9],[11],[12],[14] | $ 329 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | 517 | [7],[9],[11],[12] | 311 | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ 510 | [7],[9],[11],[12] | $ 292 | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[9],[12] | 6.50% | [7],[9],[12] | 6.50% | [7],[9],[12] | 6.50% | [8],[15],[16] | 6.50% | [8],[15],[16] | 6.50% | [8],[15],[16] | |||
Investment, interest rate | 11.84% | [7],[9],[10],[12] | 11.84% | [7],[9],[10],[12] | 11.84% | [7],[9],[10],[12] | 10.17% | [8],[15],[16],[17] | 10.17% | [8],[15],[16],[17] | 10.17% | [8],[15],[16],[17] | |||
Investment, principal | $ 16,765 | [7],[9],[12],[14] | $ 13,623 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 16,636 | [7],[9],[12] | 13,487 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 16,511 | [7],[9],[12] | $ 13,351 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[9],[11],[12] | 6% | [7],[9],[11],[12] | 6% | [7],[9],[11],[12] | 6% | [8],[15],[16],[19] | 6% | [8],[15],[16],[19] | 6% | [8],[15],[16],[19] | |||
Investment, interest rate | [8],[15],[16],[17],[19] | 9.12% | 9.12% | 9.12% | |||||||||||
Investment, principal | $ 0 | [7],[9],[11],[12],[14] | $ 1,710 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | (44) | [7],[9],[11],[12] | 1,672 | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ (146) | [7],[9],[11],[12] | $ 1,651 | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 9.12% | 9.12% | 9.12% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 19,236 | |||||||||||||
Investment, cost | [8],[15],[16] | 18,894 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 18,707 | |||||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 11.20% | 11.20% | 11.20% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 2,742 | |||||||||||||
Investment, cost | [7],[9],[12] | 2,594 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 2,592 | |||||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 11.20% | 11.20% | 11.20% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 23,554 | |||||||||||||
Investment, cost | [7],[9],[12] | 23,166 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 22,258 | |||||||||||||
Investment, Identifier [Axis]: LTI Holdings, Inc., Electronic Components, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [7],[12] | 6.75% | [7],[12] | 6.75% | [7],[12] | 6.75% | [8],[16] | 6.75% | [8],[16] | 6.75% | [8],[16] | |||
Investment, interest rate | 11.97% | [7],[10],[12] | 11.97% | [7],[10],[12] | 11.97% | [7],[10],[12] | 9.87% | [8],[16],[17] | 9.87% | [8],[16],[17] | 9.87% | [8],[16],[17] | |||
Investment, principal | $ 2,140 | [7],[12],[14] | $ 2,140 | [8],[16],[18] | |||||||||||
Investment, cost | 2,101 | [7],[12] | 2,092 | [8],[16] | |||||||||||
Investments at fair value | $ 1,834 | [7],[12] | $ 1,890 | [8],[16] | |||||||||||
Investment, Identifier [Axis]: LaserShip, Inc., Air Freight & Logistics, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 10.38% | 10.38% | 10.38% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 2,394 | |||||||||||||
Investment, cost | [8],[15],[16] | 2,370 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 1,867 | |||||||||||||
Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[12],[20] | 9.50% | 9.50% | 9.50% | |||||||||||
Investment, interest rate | [7],[10],[12],[20] | 14.61% | 14.61% | 14.61% | |||||||||||
Investment, principal | [7],[12],[14],[20] | $ 26,489 | |||||||||||||
Investment, cost | [7],[12],[20] | 24,888 | |||||||||||||
Investments at fair value | [7],[12],[20] | $ 26,985 | |||||||||||||
Investment, Identifier [Axis]: Lift Brands Holdings, Inc., Leisure Facilities, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 2,000,000 | [7],[9] | 2,000,000 | [7],[9] | 2,000,000 | [7],[9] | 2,000,000 | [8],[15] | 2,000,000 | [8],[15] | 2,000,000 | [8],[15] | |||
Investment, cost | $ 1,399 | [7],[9] | $ 1,399 | [8],[15] | |||||||||||
Investments at fair value | $ 0 | [7],[9] | $ 0 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5% | [7],[9],[12] | 5% | [7],[9],[12] | 5% | [7],[9],[12] | 5% | [8],[15],[16] | 5% | [8],[15],[16] | 5% | [8],[15],[16] | |||
Investment, interest rate | 10.50% | [7],[9],[10],[12] | 10.50% | [7],[9],[10],[12] | 10.50% | [7],[9],[10],[12] | 8.67% | [8],[15],[16],[17] | 8.67% | [8],[15],[16],[17] | 8.67% | [8],[15],[16],[17] | |||
Investment, principal | $ 45,361 | [7],[9],[12],[14] | $ 41,008 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 44,783 | [7],[9],[12] | 40,243 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 44,227 | [7],[9],[12] | $ 39,573 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 559 | [7],[9] | 559 | [7],[9] | 559 | [7],[9] | 451 | [8],[15] | 451 | [8],[15] | 451 | [8],[15] | |||
Investment, principal | [7],[9],[14] | ||||||||||||||
Investment, cost | 563 | [7],[9] | $ 451 | [8],[15] | |||||||||||
Investments at fair value | $ 487 | [7],[9] | $ 451 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[9],[12] | 8.50% | [7],[9],[12] | 8.50% | [7],[9],[12] | 8.50% | [8],[15],[16] | 8.50% | [8],[15],[16] | 8.50% | [8],[15],[16] | |||
Investment, interest rate | 13.84% | [7],[9],[10],[12] | 13.84% | [7],[9],[10],[12] | 13.84% | [7],[9],[10],[12] | 11.38% | [8],[15],[16],[17] | 11.38% | [8],[15],[16],[17] | 11.38% | [8],[15],[16],[17] | |||
Investment, principal | $ 5,403 | [7],[9],[12],[14] | $ 4,357 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 5,344 | [7],[9],[12] | 4,285 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 5,173 | [7],[9],[12] | $ 4,226 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[9],[11],[12] | 8.50% | [7],[9],[11],[12] | 8.50% | [7],[9],[11],[12] | 8.50% | [8],[15],[16],[19] | 8.50% | [8],[15],[16],[19] | 8.50% | [8],[15],[16],[19] | |||
Investment, interest rate | 13.84% | [7],[9],[10],[11],[12] | 13.84% | [7],[9],[10],[11],[12] | 13.84% | [7],[9],[10],[11],[12] | 11.38% | [8],[15],[16],[17],[19] | 11.38% | [8],[15],[16],[17],[19] | 11.38% | [8],[15],[16],[17],[19] | |||
Investment, principal | $ 2,939 | [7],[9],[11],[12],[14] | $ 2,370 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | 2,883 | [7],[9],[11],[12] | 2,323 | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ 2,755 | [7],[9],[11],[12] | $ 2,265 | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[9],[11],[12] | 6% | [7],[9],[11],[12] | 6% | [7],[9],[11],[12] | 6% | [8],[15],[16],[19] | 6% | [8],[15],[16],[19] | 6% | [8],[15],[16],[19] | |||
Investment, interest rate | [7],[9],[10],[11],[12] | 11.25% | 11.25% | 11.25% | |||||||||||
Investment, principal | $ 250 | [7],[9],[11],[12],[14] | $ 0 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | 220 | [7],[9],[11],[12] | (23) | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ 203 | [7],[9],[11],[12] | $ (54) | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 9.50% | 9.50% | 9.50% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 18,390 | |||||||||||||
Investment, cost | [8],[15],[16] | 18,088 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 17,691 | |||||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 11.20% | 11.20% | 11.20% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 20,176 | |||||||||||||
Investment, cost | [7],[9],[12] | 19,949 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 19,648 | |||||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 11.20% | 11.20% | 11.20% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 2,637 | |||||||||||||
Investment, cost | [7],[9],[12] | 2,594 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 2,568 | |||||||||||||
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[11],[12] | 12.58% | 12.58% | 12.58% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14] | $ 2,118 | |||||||||||||
Investment, cost | [7],[9],[11],[12] | 1,853 | |||||||||||||
Investments at fair value | [7],[9],[11],[12] | $ 1,853 | |||||||||||||
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12.74% | 12.74% | 12.74% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 40,640 | |||||||||||||
Investment, cost | [7],[9],[12] | 39,937 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 39,937 | |||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | [7],[9],[11],[12] | 5.50% | [7],[9],[11],[12] | 5.50% | [7],[9],[11],[12] | 5.50% | [8],[15],[16],[19] | 5.50% | [8],[15],[16],[19] | 5.50% | [8],[15],[16],[19] | |||
Investment, principal | $ 0 | [7],[9],[11],[12],[14] | $ 0 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | (29) | [7],[9],[11],[12] | (13) | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ (62) | [7],[9],[11],[12] | $ (51) | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | [7],[9],[12] | 5.50% | [7],[9],[12] | 5.50% | [7],[9],[12] | 5.50% | [8],[15],[16] | 5.50% | [8],[15],[16] | 5.50% | [8],[15],[16] | |||
Investment, interest rate | 10.84% | [7],[9],[10],[12] | 10.84% | [7],[9],[10],[12] | 10.84% | [7],[9],[10],[12] | 9.17% | [8],[15],[16],[17] | 9.17% | [8],[15],[16],[17] | 9.17% | [8],[15],[16],[17] | |||
Investment, principal | $ 12,397 | [7],[9],[12],[14] | $ 29,565 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 12,357 | [7],[9],[12] | 29,128 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 12,056 | [7],[9],[12] | $ 28,734 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | [7],[9],[12] | 5.50% | [7],[9],[12] | 5.50% | [7],[9],[12] | 5.50% | [8],[15],[16],[19] | 5.50% | [8],[15],[16],[19] | 5.50% | [8],[15],[16],[19] | |||
Investment, interest rate | [7],[9],[10],[12] | 10.84% | 10.84% | 10.84% | |||||||||||
Investment, principal | $ 21,383 | [7],[9],[12],[14] | $ 0 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | 21,055 | [7],[9],[12] | (12) | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ 20,795 | [7],[9],[12] | $ (96) | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[11],[12] | 10.83% | 10.83% | 10.83% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14] | $ 570 | |||||||||||||
Investment, cost | [7],[9],[11],[12] | 559 | |||||||||||||
Investments at fair value | [7],[9],[11],[12] | $ 526 | |||||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1 | |||||||||||||||
Investment, interest rate | 11.50% | [7],[9],[10],[12],[20] | 11.50% | [7],[9],[10],[12],[20] | 11.50% | [7],[9],[10],[12],[20] | 11.50% | [8],[15],[16],[17],[22] | 11.50% | [8],[15],[16],[17],[22] | 11.50% | [8],[15],[16],[17],[22] | |||
Investment, principal | $ 8,568 | [7],[9],[14],[20] | $ 17,203 | [8],[15],[18],[22] | |||||||||||
Investment, cost | 8,488 | [7],[9],[20] | 16,954 | [8],[15],[22] | |||||||||||
Investments at fair value | $ 8,225 | [7],[9],[20] | $ 16,644 | [8],[15],[22] | |||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2 | |||||||||||||||
Investment, interest rate | 11.50% | [7],[9],[10],[12],[20] | 11.50% | [7],[9],[10],[12],[20] | 11.50% | [7],[9],[10],[12],[20] | 11.50% | [8],[15],[16],[17],[19],[22] | 11.50% | [8],[15],[16],[17],[19],[22] | 11.50% | [8],[15],[16],[17],[19],[22] | |||
Investment, principal | $ 4,284 | [7],[9],[14],[20] | $ 0 | [8],[15],[18],[19],[22] | |||||||||||
Investment, cost | 4,244 | [7],[9],[20] | 0 | [8],[15],[19],[22] | |||||||||||
Investments at fair value | $ 4,112 | [7],[9],[20] | $ 0 | [8],[15],[19],[22] | |||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3 | |||||||||||||||
Investment, interest rate | [7],[9],[10],[12],[20] | 11.50% | 11.50% | 11.50% | |||||||||||
Investment, principal | [7],[9],[14],[20] | $ 8,568 | |||||||||||||
Investment, cost | [7],[9],[20] | 8,488 | |||||||||||||
Investments at fair value | [7],[9],[20] | $ 8,225 | |||||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 4 | |||||||||||||||
Investment, interest rate | [7],[9],[10],[12],[20] | 11.50% | 11.50% | 11.50% | |||||||||||
Investment, principal | [7],[9],[11],[14],[20] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[20] | 0 | |||||||||||||
Investments at fair value | [7],[9],[11],[20] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 1 | |||||||||||||||
Investment, interest rate | 8% | [7],[9],[10],[12],[20] | 8% | [7],[9],[10],[12],[20] | 8% | [7],[9],[10],[12],[20] | 8% | [8],[15],[16],[17],[22] | 8% | [8],[15],[16],[17],[22] | 8% | [8],[15],[16],[17],[22] | |||
Investment, interest rate, paid in kind | 1.75% | [7],[9],[20] | 1.75% | [7],[9],[20] | 1.75% | [7],[9],[20] | 1.75% | [8],[15],[22] | 1.75% | [8],[15],[22] | 1.75% | [8],[15],[22] | |||
Investment, principal | $ 9,066 | [7],[9],[14],[20] | $ 7,215 | [8],[15],[18],[22] | |||||||||||
Investment, cost | 8,496 | [7],[9],[20] | 6,650 | [8],[15],[22] | |||||||||||
Investments at fair value | $ 8,114 | [7],[9],[20] | $ 6,440 | [8],[15],[22] | |||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 2 | |||||||||||||||
Investment, interest rate | 8% | [7],[9],[10],[12],[20] | 8% | [7],[9],[10],[12],[20] | 8% | [7],[9],[10],[12],[20] | 8% | [8],[15],[16],[17],[19],[22] | 8% | [8],[15],[16],[17],[19],[22] | 8% | [8],[15],[16],[17],[19],[22] | |||
Investment, interest rate, paid in kind | 1.75% | [7],[9],[20] | 1.75% | [7],[9],[20] | 1.75% | [7],[9],[20] | 1.75% | [8],[15],[19],[22] | 1.75% | [8],[15],[19],[22] | 1.75% | [8],[15],[19],[22] | |||
Investment, principal | $ 0 | [7],[9],[11],[14],[20] | $ 0 | [8],[15],[18],[19],[22] | |||||||||||
Investment, cost | 1 | [7],[9],[11],[20] | 1 | [8],[15],[19],[22] | |||||||||||
Investments at fair value | $ 0 | [7],[9],[11],[20] | $ 0 | [8],[15],[19],[22] | |||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 3 | |||||||||||||||
Investment, interest rate | [7],[9],[10],[12],[20] | 8% | 8% | 8% | |||||||||||
Investment, interest rate, paid in kind | [7],[9],[20] | 1.75% | 1.75% | 1.75% | |||||||||||
Investment, principal | [7],[9],[11],[14],[20] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[20] | 0 | |||||||||||||
Investments at fair value | [7],[9],[11],[20] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[15],[22] | 209,588 | 209,588 | 209,588 | |||||||||||
Investment, cost | [8],[15],[22] | $ 480 | |||||||||||||
Investments at fair value | [8],[15],[22] | $ 170 | |||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1 | |||||||||||||||
Investment owned, balance (in shares) | shares | [7],[9],[20] | 259,877 | 259,877 | 259,877 | |||||||||||
Investment, principal | [7],[9],[14],[20] | ||||||||||||||
Investment, cost | [7],[9],[20] | 545 | |||||||||||||
Investments at fair value | [7],[9],[20] | $ 437 | |||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2 | |||||||||||||||
Investment owned, balance (in shares) | shares | [7],[9],[20] | 66,817 | 66,817 | 66,817 | |||||||||||
Investment, principal | [7],[9],[14],[20] | ||||||||||||||
Investment, cost | [7],[9],[20] | 23 | |||||||||||||
Investments at fair value | [7],[9],[20] | $ 153 | |||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[9],[11],[12] | 7% | [7],[9],[11],[12] | 7% | [7],[9],[11],[12] | 8% | [8],[15],[16],[19] | 8% | [8],[15],[16],[19] | 8% | [8],[15],[16],[19] | |||
Investment, principal | $ 0 | [7],[9],[11],[12],[14] | $ 0 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | (51) | [7],[9],[11],[12] | (54) | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ (71) | [7],[9],[11],[12] | $ (100) | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 10.64% | 10.64% | 10.64% | |||||||||||
Investment, interest rate, paid in kind | [8],[15],[16] | 1.50% | 1.50% | 1.50% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 45,665 | |||||||||||||
Investment, cost | [8],[15],[16] | 44,689 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 44,523 | |||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12.19% | 12.19% | 12.19% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 7,464 | |||||||||||||
Investment, cost | [7],[9],[12] | 7,416 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 7,352 | |||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12.19% | 12.19% | 12.19% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 46,687 | |||||||||||||
Investment, cost | [7],[9],[12] | 46,157 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 45,987 | |||||||||||||
Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [7],[9],[12] | 6.75% | [7],[9],[12] | 6.75% | [7],[9],[12] | 6.75% | [8],[15],[16] | 6.75% | [8],[15],[16] | 6.75% | [8],[15],[16] | |||
Investment, interest rate | 11.97% | [7],[9],[10],[12] | 11.97% | [7],[9],[10],[12] | 11.97% | [7],[9],[10],[12] | 9.89% | [8],[15],[16],[17] | 9.89% | [8],[15],[16],[17] | 9.89% | [8],[15],[16],[17] | |||
Investment, principal | $ 55,297 | [7],[9],[12],[14] | $ 46,499 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 54,939 | [7],[9],[12] | 45,802 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 54,235 | [7],[9],[12] | $ 45,421 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [7],[10],[12] | 6.88% | 6.88% | 6.88% | |||||||||||
Investment, principal | [7],[14] | $ 10,191 | |||||||||||||
Investment, cost | [7] | 9,816 | |||||||||||||
Investments at fair value | [7] | $ 8,860 | |||||||||||||
Investment, Identifier [Axis]: NFP Corp., Other Diversified Financial Services, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [8],[16],[17] | 6.88% | 6.88% | 6.88% | |||||||||||
Investment, principal | [8],[18] | $ 10,191 | |||||||||||||
Investment, cost | [8] | 9,773 | |||||||||||||
Investments at fair value | [8] | $ 7,966 | |||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12],[20] | 6.88% | 6.88% | 6.88% | |||||||||||
Investment, interest rate | [7],[9],[10],[12],[20] | 12.08% | 12.08% | 12.08% | |||||||||||
Investment, interest rate, paid in kind | [7],[9],[12],[20] | 2% | 2% | 2% | |||||||||||
Investment, principal | [7],[9],[12],[14],[20] | $ 73,178 | |||||||||||||
Investment, cost | [7],[9],[12],[20] | 72,195 | |||||||||||||
Investments at fair value | [7],[9],[12],[20] | $ 69,885 | |||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1 | |||||||||||||||
Investment owned, balance (in shares) | shares | 487,870 | 487,870 | 487,870 | ||||||||||||
Investment, principal | € | [7],[9],[12],[14],[20] | € 0 | |||||||||||||
Investment, cost | [7],[9],[12],[20] | $ 0 | |||||||||||||
Investments at fair value | [7],[9],[12],[20] | $ 1,161 | |||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2 | |||||||||||||||
Investment owned, balance (in shares) | shares | 487,870 | 487,870 | 487,870 | ||||||||||||
Investment, principal | € | [7],[12],[14],[20] | € 0 | |||||||||||||
Investment, cost | [7],[12],[20] | $ 0 | |||||||||||||
Investments at fair value | [7],[12],[20] | $ 1,161 | |||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16],[22] | 6.88% | 6.88% | 6.88% | |||||||||||
Investment, interest rate | [8],[15],[16],[17],[22] | 9.99% | 9.99% | 9.99% | |||||||||||
Investment, principal | [8],[15],[16],[18],[22] | $ 58,713 | |||||||||||||
Investment, cost | [8],[15],[16],[22] | 57,655 | |||||||||||||
Investments at fair value | [8],[15],[16],[22] | $ 56,805 | |||||||||||||
Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[9],[12] | 8.50% | [7],[9],[12] | 8.50% | [7],[9],[12] | 8.50% | [8],[15],[16] | 8.50% | [8],[15],[16] | 8.50% | [8],[15],[16] | |||
Investment, interest rate | 14.04% | [7],[9],[10],[12] | 14.04% | [7],[9],[10],[12] | 14.04% | [7],[9],[10],[12] | 12.17% | [8],[15],[16],[17] | 12.17% | [8],[15],[16],[17] | 12.17% | [8],[15],[16],[17] | |||
Investment, principal | $ 30,339 | [7],[9],[12],[14] | $ 22,560 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 30,002 | [7],[9],[12] | 22,241 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 29,125 | [7],[9],[12] | $ 21,524 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 10.50% | [7],[9],[12] | 10.50% | [7],[9],[12] | 10.50% | [7],[9],[12] | 10.50% | [8],[15],[16] | 10.50% | [8],[15],[16] | 10.50% | [8],[15],[16] | |||
Investment, interest rate | 16.04% | [7],[9],[10],[12] | 16.04% | [7],[9],[10],[12] | 16.04% | [7],[9],[10],[12] | 14.17% | [8],[15],[16],[17] | 14.17% | [8],[15],[16],[17] | 14.17% | [8],[15],[16],[17] | |||
Investment, principal | $ 64,606 | [7],[9],[12],[14] | $ 50,459 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 64,750 | [7],[9],[12] | 49,301 | [8],[15],[16] | |||||||||||
Investments at fair value | 63,185 | [7],[9],[12] | $ 51,972 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Membership Interest | |||||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investments at fair value | $ 0 | 0 | |||||||||||||
Investment owned, ownership percentage | 87.50% | ||||||||||||||
Investment owned, percent of net assets | 0% | ||||||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest | |||||||||||||||
Investment owned, balance (in shares) | shares | [3],[4],[19],[22],[28],[29] | 0.875 | 0.875 | 0.875 | |||||||||||
Investment, principal | 0 | ||||||||||||||
Investment, cost | 0 | [1],[2],[11],[20],[30],[31] | $ 0 | [3],[4],[19],[22],[28],[29] | |||||||||||
Investments at fair value | $ 0 | [1],[2],[11],[20],[30],[31] | $ 0 | [3],[4],[19],[22],[28],[29] | |||||||||||
Investment owned, ownership percentage | [1],[2],[11],[20],[30],[31] | 87.50% | 87.50% | 87.50% | |||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | ||||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | [1],[2],[9],[11],[12],[20],[30] | 4.50% | [1],[2],[9],[11],[12],[20],[30] | 4.50% | [1],[2],[9],[11],[12],[20],[30] | 4.50% | [3],[4],[15],[16],[19],[22],[28] | 4.50% | [3],[4],[15],[16],[19],[22],[28] | 4.50% | [3],[4],[15],[16],[19],[22],[28] | |||
Investment, interest rate | 9.36% | [1],[2],[9],[10],[11],[12],[20],[30] | 9.36% | [1],[2],[9],[10],[11],[12],[20],[30] | 9.36% | [1],[2],[9],[10],[11],[12],[20],[30] | 6.30% | [3],[4],[15],[16],[17],[19],[22],[28] | 6.30% | [3],[4],[15],[16],[17],[19],[22],[28] | 6.30% | [3],[4],[15],[16],[17],[19],[22],[28] | |||
Investment, principal | $ 58,349 | [1],[2],[9],[11],[12],[14],[20],[30] | $ 59,662 | [3],[4],[15],[16],[18],[19],[22],[28] | |||||||||||
Investment, cost | 49,997 | [1],[2],[9],[11],[12],[20],[30] | 50,194 | [3],[4],[15],[16],[19],[22],[28] | |||||||||||
Investments at fair value | $ 49,632 | [1],[2],[9],[11],[12],[20],[30] | $ 50,283 | [3],[4],[15],[16],[19],[22],[28] | |||||||||||
Investment owned, percent of net assets | 3.30% | 3.30% | 3.30% | ||||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Subordinated Debt | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | ||||||||||||||
Investment, interest rate | 4.94% | ||||||||||||||
Investment, principal | $ 60,274 | ||||||||||||||
Investments at fair value | $ 50,606 | 55,582 | |||||||||||||
Investment owned, percent of net assets | 4% | ||||||||||||||
Investment, Identifier [Axis]: OEConnection LLC, Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[16] | 4% | 4% | 4% | |||||||||||
Investment, interest rate | [8],[16],[17] | 7.12% | 7.12% | 7.12% | |||||||||||
Investment, principal | [8],[16],[18] | $ 3,323 | |||||||||||||
Investment, cost | [8],[16] | 3,162 | |||||||||||||
Investments at fair value | [8],[16] | $ 3,207 | |||||||||||||
Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[9],[12] | 7% | [7],[9],[12] | 7% | [7],[9],[12] | 7% | [8],[15],[16] | 7% | [8],[15],[16] | 7% | [8],[15],[16] | |||
Investment, interest rate | 12.34% | [7],[9],[10],[12] | 12.34% | [7],[9],[10],[12] | 12.34% | [7],[9],[10],[12] | 10.05% | [8],[15],[16],[17] | 10.05% | [8],[15],[16],[17] | 10.05% | [8],[15],[16],[17] | |||
Investment, principal | $ 9,323 | [7],[9],[12],[14] | $ 7,519 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 9,203 | [7],[9],[12] | 7,389 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 9,090 | [7],[9],[12] | $ 7,237 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 10% | [7],[9],[12] | 10% | [7],[9],[12] | 10% | [7],[9],[12] | 2% | [8],[15],[16] | 2% | [8],[15],[16] | 2% | [8],[15],[16] | |||
Investment, interest rate | 15.50% | [7],[9],[10],[12] | 15.50% | [7],[9],[10],[12] | 15.50% | [7],[9],[10],[12] | 5.08% | [8],[15],[16],[17] | 5.08% | [8],[15],[16],[17] | 5.08% | [8],[15],[16],[17] | |||
Investment, interest rate, paid in kind | [8],[15],[16] | 8% | 8% | 8% | |||||||||||
Investment, principal | $ 25,712 | [7],[9],[12],[14] | $ 21,557 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 25,603 | [7],[9],[12] | 21,267 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 25,712 | [7],[9],[12] | $ 21,557 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 10% | [7],[9],[11],[12] | 10% | [7],[9],[11],[12] | 10% | [7],[9],[11],[12] | 2% | [8],[15],[16],[19] | 2% | [8],[15],[16],[19] | 2% | [8],[15],[16],[19] | |||
Investment, principal | $ 0 | [7],[9],[11],[12],[14] | $ 0 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | (13) | [7],[9],[11],[12] | (31) | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ 0 | [7],[9],[11],[12] | 0 | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12] | 10% | 10% | 10% | |||||||||||
Investment, interest rate | [7],[9],[10],[11],[12] | 15.39% | 15.39% | 15.39% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14] | $ 1,210 | |||||||||||||
Investment, cost | [7],[9],[11],[12] | 1,192 | |||||||||||||
Investments at fair value | [7],[9],[11],[12] | $ 1,210 | |||||||||||||
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12] | 7.75% | 7.75% | 7.75% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[12] | (44) | |||||||||||||
Investments at fair value | [7],[9],[11],[12] | $ (44) | |||||||||||||
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 7.75% | 7.75% | 7.75% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12.79% | 12.79% | 12.79% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 15,231 | |||||||||||||
Investment, cost | [7],[9],[12] | 14,876 | |||||||||||||
Investments at fair value | [7],[9],[12] | 14,882 | |||||||||||||
Investment, Identifier [Axis]: Other cash accounts | |||||||||||||||
Investment, cost | 67,467 | ||||||||||||||
Investments at fair value | $ 67,467 | ||||||||||||||
Money market funds, at carrying value | $ 21,103 | ||||||||||||||
Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | 7.75% | [7],[10],[12] | 7.75% | [7],[10],[12] | 7.75% | [7],[10],[12] | 7.75% | [8],[16],[17] | 7.75% | [8],[16],[17] | 7.75% | [8],[16],[17] | |||
Investment, principal | $ 7,480 | [7],[14] | $ 7,776 | [8],[18] | |||||||||||
Investment, cost | 7,514 | [7] | 7,820 | [8] | |||||||||||
Investments at fair value | $ 6,090 | [7] | $ 5,846 | [8] | |||||||||||
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16],[19] | 7% | 7% | 7% | |||||||||||
Investment, principal | [8],[15],[16],[18],[19] | $ 0 | |||||||||||||
Investment, cost | [8],[15],[16],[19] | (21) | |||||||||||||
Investments at fair value | [8],[15],[16],[19] | $ (13) | |||||||||||||
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 9.28% | 9.28% | 9.28% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 26,154 | |||||||||||||
Investment, cost | [8],[15],[16] | 25,712 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 25,893 | |||||||||||||
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16],[19] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [8],[15],[16],[17],[19] | 9.25% | 9.25% | 9.25% | |||||||||||
Investment, principal | [8],[15],[16],[18],[19] | $ 2,228 | |||||||||||||
Investment, cost | [8],[15],[16],[19] | 2,186 | |||||||||||||
Investments at fair value | [8],[15],[16],[19] | $ 2,203 | |||||||||||||
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12] | 7% | 7% | 7% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[12] | (55) | |||||||||||||
Investments at fair value | [7],[9],[11],[12] | $ (57) | |||||||||||||
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12.10% | 12.10% | 12.10% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 10,923 | |||||||||||||
Investment, cost | [7],[9],[12] | 10,513 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 10,497 | |||||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 100,000 | [7],[9] | 100,000 | [7],[9] | 100,000 | [7],[9] | 80,515 | [8],[15] | 80,515 | [8],[15] | 80,515 | [8],[15] | |||
Investment, cost | $ 109 | [7],[9] | $ 79 | [8],[15] | |||||||||||
Investments at fair value | $ 221 | [7],[9] | $ 89 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[9],[11],[12] | 6.50% | [7],[9],[11],[12] | 6.50% | [7],[9],[11],[12] | 6.75% | [8],[15],[16],[19] | 6.75% | [8],[15],[16],[19] | 6.75% | [8],[15],[16],[19] | |||
Investment, principal | $ 0 | [7],[9],[11],[12],[14] | $ 0 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | (37) | [7],[9],[11],[12] | (34) | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ (26) | [7],[9],[11],[12] | $ (49) | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[9],[12] | 6.50% | [7],[9],[12] | 6.50% | [7],[9],[12] | 6.75% | [8],[15],[16] | 6.75% | [8],[15],[16] | 6.75% | [8],[15],[16] | |||
Investment, interest rate | 11.73% | [7],[9],[10],[12] | 11.73% | [7],[9],[10],[12] | 11.73% | [7],[9],[10],[12] | 10.42% | [8],[15],[16],[17] | 10.42% | [8],[15],[16],[17] | 10.42% | [8],[15],[16],[17] | |||
Investment, principal | $ 38,521 | [7],[9],[12],[14] | $ 33,775 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 38,018 | [7],[9],[12] | 32,931 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 38,205 | [7],[9],[12] | $ 33,116 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5% | [7],[12] | 5% | [7],[12] | 5% | [7],[12] | 5% | [8],[16] | 5% | [8],[16] | 5% | [8],[16] | |||
Investment, interest rate | 10.20% | [7],[10],[12] | 10.20% | [7],[10],[12] | 10.20% | [7],[10],[12] | 8.13% | [8],[16],[17] | 8.13% | [8],[16],[17] | 8.13% | [8],[16],[17] | |||
Investment, principal | $ 9,701 | [7],[12],[14] | $ 9,850 | [8],[16],[18] | |||||||||||
Investment, cost | 9,535 | [7],[12] | 9,460 | [8],[16] | |||||||||||
Investments at fair value | $ 9,458 | [7],[12] | $ 9,374 | [8],[16] | |||||||||||
Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[9],[12] | 6% | [7],[9],[12] | 6% | [7],[9],[12] | 6% | [8],[15],[16] | 6% | [8],[15],[16] | 6% | [8],[15],[16] | |||
Investment, interest rate | 10.96% | [7],[9],[10],[12] | 10.96% | [7],[9],[10],[12] | 10.96% | [7],[9],[10],[12] | 8.88% | [8],[15],[16],[17] | 8.88% | [8],[15],[16],[17] | 8.88% | [8],[15],[16],[17] | |||
Investment, principal | $ 22,375 | [7],[9],[12],[14] | $ 17,976 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 22,177 | [7],[9],[12] | 17,690 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 21,829 | [7],[9],[12] | $ 17,537 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[9],[12] | 7.25% | [7],[9],[12] | 7.25% | [7],[9],[12] | 7.25% | [8],[15],[16] | 7.25% | [8],[15],[16] | 7.25% | [8],[15],[16] | |||
Investment, interest rate | 12.59% | [7],[9],[10],[12] | 12.59% | [7],[9],[10],[12] | 12.59% | [7],[9],[10],[12] | 10.92% | [8],[15],[16],[17] | 10.92% | [8],[15],[16],[17] | 10.92% | [8],[15],[16],[17] | |||
Investment, principal | $ 36,499 | [7],[9],[12],[14] | $ 28,627 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 35,427 | [7],[9],[12] | 28,198 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 32,606 | [7],[9],[12] | $ 27,482 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[9],[11],[12] | 8% | [7],[9],[11],[12] | 8% | [7],[9],[11],[12] | 8% | [8],[15],[16],[19] | 8% | [8],[15],[16],[19] | 8% | [8],[15],[16],[19] | |||
Investment, interest rate | [7],[9],[10],[11],[12] | 13.04% | 13.04% | 13.04% | |||||||||||
Investment, principal | $ 2,395 | [7],[9],[11],[12],[14] | $ 0 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | 2,312 | [7],[9],[11],[12] | (53) | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ 2,218 | [7],[9],[11],[12] | $ (111) | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[9],[12] | 8% | [7],[9],[12] | 8% | [7],[9],[12] | 8% | [8],[15],[16] | 8% | [8],[15],[16] | 8% | [8],[15],[16] | |||
Investment, interest rate | 13.04% | [7],[9],[10],[12] | 13.04% | [7],[9],[10],[12] | 13.04% | [7],[9],[10],[12] | 10.68% | [8],[15],[16],[17] | 10.68% | [8],[15],[16],[17] | 10.68% | [8],[15],[16],[17] | |||
Investment, principal | $ 67,244 | [7],[9],[12],[14] | $ 48,689 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 66,290 | [7],[9],[12] | 47,951 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 64,756 | [7],[9],[12] | $ 47,155 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12.42% | 12.42% | 12.42% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 24,537 | |||||||||||||
Investment, cost | [7],[9],[12] | 24,245 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 24,047 | |||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12.42% | 12.42% | 12.42% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 2,823 | |||||||||||||
Investment, cost | [7],[9],[12] | 2,797 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 2,767 | |||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 10.01% | 10.01% | 10.01% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 23,275 | |||||||||||||
Investment, cost | [8],[15],[16] | 22,722 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 22,810 | |||||||||||||
Investment, Identifier [Axis]: Project Boost Purchaser, LLC, Application Software, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[9],[12] | 8% | [7],[9],[12] | 8% | [7],[9],[12] | 8% | [8],[15],[16] | 8% | [8],[15],[16] | 8% | [8],[15],[16] | |||
Investment, interest rate | 13.22% | [7],[9],[10],[12] | 13.22% | [7],[9],[10],[12] | 13.22% | [7],[9],[10],[12] | 11.12% | [8],[15],[16],[17] | 11.12% | [8],[15],[16],[17] | 11.12% | [8],[15],[16],[17] | |||
Investment, principal | $ 6,750 | [7],[9],[12],[14] | $ 5,250 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 6,652 | [7],[9],[12] | 5,168 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 6,235 | [7],[9],[12] | $ 5,047 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5.68% | [7],[9],[12],[20] | 5.68% | [7],[9],[12],[20] | 5.68% | [7],[9],[12],[20] | 6% | [8],[15],[16],[22] | 6% | [8],[15],[16],[22] | 6% | [8],[15],[16],[22] | |||
Investment, interest rate | 10.88% | [7],[9],[10],[12],[20] | 10.88% | [7],[9],[10],[12],[20] | 10.88% | [7],[9],[10],[12],[20] | 8.39% | [8],[15],[16],[17],[22] | 8.39% | [8],[15],[16],[17],[22] | 8.39% | [8],[15],[16],[17],[22] | |||
Investment, principal | £ | £ 4,626 | [7],[9],[12],[14],[20] | £ 3,501 | [8],[15],[16],[18],[22] | |||||||||||
Investment, cost | $ 5,900 | [7],[9],[12],[20] | $ 4,646 | [8],[15],[16],[22] | |||||||||||
Investments at fair value | $ 5,296 | [7],[9],[12],[20] | $ 3,367 | [8],[15],[16],[22] | |||||||||||
Investment, Identifier [Axis]: QuorumLabs, Inc., Application Software, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 64,887,669 | [7],[9] | 64,887,669 | [7],[9] | 64,887,669 | [7],[9] | 64,887,669 | [8],[15] | 64,887,669 | [8],[15] | 64,887,669 | [8],[15] | |||
Investment, cost | $ 375 | [7],[9] | $ 375 | [8],[15] | |||||||||||
Investments at fair value | $ 0 | [7],[9] | $ 0 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: RP Escrow Issuer LLC, Health Care Distributors, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [8],[16],[17] | 5.25% | 5.25% | 5.25% | |||||||||||
Investment, principal | [8],[18] | $ 1,325 | |||||||||||||
Investment, cost | [8] | 1,218 | |||||||||||||
Investments at fair value | [8] | $ 1,097 | |||||||||||||
Investment, Identifier [Axis]: Radiology Partners, Inc., Health Care Distributors, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[16] | 4.25% | 4.25% | 4.25% | |||||||||||
Investment, interest rate | [8],[16],[17] | 7.33% | 7.33% | 7.33% | |||||||||||
Investment, principal | [8],[16],[18] | $ 3,400 | |||||||||||||
Investment, cost | [8],[16] | 3,202 | |||||||||||||
Investments at fair value | [8],[16] | $ 2,880 | |||||||||||||
Investment, Identifier [Axis]: Radiology Partners, Inc., Health Care Distributors, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [8],[16],[17] | 9.25% | 9.25% | 9.25% | |||||||||||
Investment, principal | [8],[18] | $ 4,755 | |||||||||||||
Investment, cost | [8] | 4,720 | |||||||||||||
Investments at fair value | [8] | $ 3,109 | |||||||||||||
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[9],[11],[12] | 6.50% | [7],[9],[11],[12] | 6.50% | [7],[9],[11],[12] | 6.50% | [8],[15],[16],[19] | 6.50% | [8],[15],[16],[19] | 6.50% | [8],[15],[16],[19] | |||
Investment, principal | $ 0 | [7],[9],[11],[12],[14] | $ 0 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | (46) | [7],[9],[11],[12] | (43) | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ (52) | [7],[9],[11],[12] | $ (64) | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[9],[12] | 7.50% | [7],[9],[12] | 7.50% | [7],[9],[12] | 7.50% | [8],[15],[16] | 7.50% | [8],[15],[16] | 7.50% | [8],[15],[16] | |||
Investment, interest rate | [7],[9],[10],[12] | 11.70% | 11.70% | 11.70% | |||||||||||
Investment, interest rate, paid in kind | [8],[15],[16] | 10.59% | 10.59% | 10.59% | |||||||||||
Investment, principal | $ 32,329 | [7],[9],[12],[14] | $ 24,692 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 32,052 | [7],[9],[12] | 24,265 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 31,715 | [7],[9],[12] | $ 24,101 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Renaissance Holding Corp., Diversified Banks, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[16] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [8],[16],[17] | 10.12% | 10.12% | 10.12% | |||||||||||
Investment, principal | [8],[16],[18] | $ 3,542 | |||||||||||||
Investment, cost | [8],[16] | 3,515 | |||||||||||||
Investments at fair value | [8],[16] | $ 3,402 | |||||||||||||
Investment, Identifier [Axis]: Renaissance Holding Corp., Education Services, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[12] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [7],[10],[12] | 12.19% | 12.19% | 12.19% | |||||||||||
Investment, principal | [7],[12],[14] | $ 1,789 | |||||||||||||
Investment, cost | [7],[12] | 1,775 | |||||||||||||
Investments at fair value | [7],[12] | $ 1,764 | |||||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 8.25% | [7],[9],[12],[20] | 8.25% | [7],[9],[12],[20] | 8.25% | [7],[9],[12],[20] | 8.25% | [8],[15],[16],[22] | 8.25% | [8],[15],[16],[22] | 8.25% | [8],[15],[16],[22] | |||
Investment, interest rate | 13.75% | [7],[9],[10],[12],[20] | 13.75% | [7],[9],[10],[12],[20] | 13.75% | [7],[9],[10],[12],[20] | 11.92% | [8],[15],[16],[17],[22] | 11.92% | [8],[15],[16],[17],[22] | 11.92% | [8],[15],[16],[17],[22] | |||
Investment, principal | $ 44,602 | [7],[9],[12],[14],[20] | $ 37,656 | [8],[15],[16],[18],[22] | |||||||||||
Investment, cost | 43,077 | [7],[9],[12],[20] | 35,775 | [8],[15],[16],[22] | |||||||||||
Investments at fair value | $ 41,815 | [7],[9],[12],[20] | $ 36,187 | [8],[15],[16],[22] | |||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 8.25% | [7],[9],[12],[20] | 8.25% | [7],[9],[12],[20] | 8.25% | [7],[9],[12],[20] | 8.25% | [8],[15],[16],[19],[22] | 8.25% | [8],[15],[16],[19],[22] | 8.25% | [8],[15],[16],[19],[22] | |||
Investment, interest rate | 13.75% | [7],[9],[10],[12],[20] | 13.75% | [7],[9],[10],[12],[20] | 13.75% | [7],[9],[10],[12],[20] | 11.92% | [8],[15],[16],[17],[19],[22] | 11.92% | [8],[15],[16],[17],[19],[22] | 11.92% | [8],[15],[16],[17],[19],[22] | |||
Investment, principal | $ 13,495 | [7],[9],[12],[14],[20] | $ 11,393 | [8],[15],[16],[18],[19],[22] | |||||||||||
Investment, cost | 13,010 | [7],[9],[12],[20] | 10,583 | [8],[15],[16],[19],[22] | |||||||||||
Investments at fair value | $ 12,651 | [7],[9],[12],[20] | $ 10,760 | [8],[15],[16],[19],[22] | |||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 204,454 | [7],[9],[20] | 204,454 | [7],[9],[20] | 204,454 | [7],[9],[20] | 164,660 | [8],[15],[22] | 164,660 | [8],[15],[22] | 164,660 | [8],[15],[22] | |||
Investment, cost | $ 1,202 | [7],[9],[20] | $ 1,202 | [8],[15],[22] | |||||||||||
Investments at fair value | $ 0 | [7],[9],[20] | $ 74 | [8],[15],[22] | |||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | [7],[9] | 1,037 | 1,037 | 1,037 | |||||||||||
Investment, cost | [7],[9] | $ 1,037 | |||||||||||||
Investments at fair value | [7],[9] | $ 1,024 | |||||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 8.75% | 8.75% | 8.75% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 14% | 14% | 14% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 8,010 | |||||||||||||
Investment, cost | [7],[9],[12] | 7,792 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 7,770 | |||||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12] | 8.75% | 8.75% | 8.75% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[12] | (35) | |||||||||||||
Investments at fair value | [7],[9],[11],[12] | $ (71) | |||||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal & Glass Containers, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[15] | 415 | 415 | 415 | |||||||||||
Investment, cost | [8],[15] | $ 681 | |||||||||||||
Investments at fair value | [8],[15] | $ 681 | |||||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | [7],[9] | 491 | 491 | 491 | |||||||||||
Investment, cost | [7],[9] | $ 727 | |||||||||||||
Investments at fair value | [7],[9] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 4.75% | 4.75% | 4.75% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 9.97% | 9.97% | 9.97% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 4,463 | |||||||||||||
Investment, cost | [7],[9],[12] | 3,780 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 4,139 | |||||||||||||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[9],[12] | 8% | [7],[9],[12] | 8% | [7],[9],[12] | 8% | [8],[15],[16] | 8% | [8],[15],[16] | 8% | [8],[15],[16] | |||
Investment, interest rate | 13.22% | [7],[9],[10],[12] | 13.22% | [7],[9],[10],[12] | 13.22% | [7],[9],[10],[12] | 10.74% | [8],[15],[16],[17] | 10.74% | [8],[15],[16],[17] | 10.74% | [8],[15],[16],[17] | |||
Investment, principal | $ 12,034 | [7],[9],[12],[14] | $ 9,109 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 11,220 | [7],[9],[12] | 8,972 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 9,387 | [7],[9],[12] | $ 8,289 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[16] | 4.50% | 4.50% | 4.50% | |||||||||||
Investment, interest rate | [8],[16],[17] | 7.63% | 7.63% | 7.63% | |||||||||||
Investment, principal | [8],[16],[18] | $ 1,500 | |||||||||||||
Investment, cost | [8],[16] | 1,410 | |||||||||||||
Investments at fair value | [8],[16] | $ 1,393 | |||||||||||||
Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [7],[9],[12] | 6.75% | [7],[9],[12] | 6.75% | [7],[9],[12] | 6.75% | [8],[15],[16] | 6.75% | [8],[15],[16] | 6.75% | [8],[15],[16] | |||
Investment, interest rate | 12.29% | [7],[9],[10],[12] | 12.29% | [7],[9],[10],[12] | 12.29% | [7],[9],[10],[12] | 10.42% | [8],[15],[16],[17] | 10.42% | [8],[15],[16],[17] | 10.42% | [8],[15],[16],[17] | |||
Investment, principal | $ 25,592 | [7],[9],[12],[14] | $ 20,766 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 23,832 | [7],[9],[12] | 19,550 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 19,514 | [7],[9],[12] | $ 18,188 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Sabert Corporation, Metal & Glass Containers, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[16] | 4.50% | 4.50% | 4.50% | |||||||||||
Investment, interest rate | [8],[16],[17] | 7.63% | 7.63% | 7.63% | |||||||||||
Investment, principal | [8],[16],[18] | $ 1,691 | |||||||||||||
Investment, cost | [8],[16] | 1,610 | |||||||||||||
Investments at fair value | [8],[16] | $ 1,623 | |||||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12] | 10% | 10% | 10% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[12] | (103) | |||||||||||||
Investments at fair value | [7],[9],[11],[12] | $ (93) | |||||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 10% | 10% | 10% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 15.24% | 15.24% | 15.24% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 25,558 | |||||||||||||
Investment, cost | [7],[9],[12] | 24,711 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 24,791 | |||||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | [7],[9] | 991,019 | 991,019 | 991,019 | |||||||||||
Investment, cost | [7],[9] | $ 327 | |||||||||||||
Investments at fair value | [7],[9] | $ 1,883 | |||||||||||||
Investment, Identifier [Axis]: Scilex Holding Co, Biotechnology, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | [7],[20] | 9,307 | 9,307 | 9,307 | |||||||||||
Investment, cost | [7],[20] | $ 78 | |||||||||||||
Investments at fair value | [7],[20] | 52 | |||||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Membership Interest | |||||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investments at fair value | $ 23,023 | 37,651 | |||||||||||||
Investment owned, ownership percentage | 87.50% | ||||||||||||||
Investment owned, percent of net assets | 1.80% | ||||||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest | |||||||||||||||
Investment owned, balance (in shares) | shares | [3],[4],[19],[22],[28],[29],[32] | 0.875 | 0.875 | 0.875 | |||||||||||
Investment, principal | 0 | ||||||||||||||
Investment, cost | 54,791 | [1],[2],[11],[20],[30],[31],[33] | $ 49,322 | [3],[4],[19],[22],[28],[29],[32] | |||||||||||
Investments at fair value | $ 27,973 | [1],[2],[11],[20],[30],[31],[33] | $ 20,715 | [3],[4],[19],[22],[28],[29],[32] | |||||||||||
Investment owned, ownership percentage | [1],[2],[11],[20],[30],[31],[33] | 87.50% | 87.50% | 87.50% | |||||||||||
Investment owned, percent of net assets | 1.90% | 1.90% | 1.90% | ||||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[2],[9],[11],[12],[20],[30] | 7% | [1],[2],[9],[11],[12],[20],[30] | 7% | [1],[2],[9],[11],[12],[20],[30] | 7% | [3],[4],[15],[16],[19],[22],[28] | 7% | [3],[4],[15],[16],[19],[22],[28] | 7% | [3],[4],[15],[16],[19],[22],[28] | |||
Investment, interest rate | 11.86% | [1],[2],[9],[10],[11],[12],[20],[30] | 11.86% | [1],[2],[9],[10],[11],[12],[20],[30] | 11.86% | [1],[2],[9],[10],[11],[12],[20],[30] | 8.80% | [3],[4],[15],[16],[17],[19],[22],[28] | 8.80% | [3],[4],[15],[16],[17],[19],[22],[28] | 8.80% | [3],[4],[15],[16],[17],[19],[22],[28] | |||
Investment, principal | $ 112,656 | [1],[2],[9],[11],[12],[14],[20],[30] | $ 96,250 | [3],[4],[15],[16],[18],[19],[22],[28] | |||||||||||
Investment, cost | 112,656 | [1],[2],[9],[11],[12],[20],[30] | 96,250 | [3],[4],[15],[16],[19],[22],[28] | |||||||||||
Investments at fair value | $ 112,656 | [1],[2],[9],[11],[12],[20],[30] | $ 96,250 | [3],[4],[15],[16],[19],[22],[28] | |||||||||||
Investment owned, percent of net assets | 7.50% | 7.50% | 7.50% | ||||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Subordinated Debt | |||||||||||||||
Investment, basis spread, variable rate | 7% | ||||||||||||||
Investment, interest rate | 8% | ||||||||||||||
Investment, principal | $ 96,250 | ||||||||||||||
Investments at fair value | $ 96,250 | $ 96,250 | |||||||||||||
Investment owned, percent of net assets | 7.60% | ||||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12],[20] | 7.88% | 7.88% | 7.88% | |||||||||||
Investment, interest rate | [7],[9],[12],[20] | 12.95% | 12.95% | 12.95% | |||||||||||
Investment, principal | [7],[9],[12],[14],[20] | $ 7,191 | |||||||||||||
Investment, cost | [7],[9],[12],[20] | 6,923 | |||||||||||||
Investments at fair value | [7],[9],[12],[20] | $ 6,931 | |||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12],[20] | 7.88% | 7.88% | 7.88% | |||||||||||
Investment, interest rate | [7],[9],[12],[20] | 12.88% | 12.88% | 12.88% | |||||||||||
Investment, principal | [7],[9],[12],[14],[20] | $ 2,697 | |||||||||||||
Investment, cost | [7],[9],[12],[20] | 2,596 | |||||||||||||
Investments at fair value | [7],[9],[12],[20] | $ 2,599 | |||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12],[20] | 7.88% | 7.88% | 7.88% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14],[20] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[12],[20] | 0 | |||||||||||||
Investments at fair value | [7],[9],[11],[12],[20] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12],[20] | 7.88% | 7.88% | 7.88% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14],[20] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[12],[20] | 0 | |||||||||||||
Investments at fair value | [7],[9],[11],[12],[20] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | [7],[9],[20] | 58,210 | 58,210 | 58,210 | |||||||||||
Investment, cost | [7],[9],[20] | $ 182 | |||||||||||||
Investments at fair value | [7],[9],[20] | $ 202 | |||||||||||||
Investment, Identifier [Axis]: ShareThis, Inc., Application Software, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 345,452 | [7],[9] | 345,452 | [7],[9] | 345,452 | [7],[9] | 345,452 | [8],[15] | 345,452 | [8],[15] | 345,452 | [8],[15] | |||
Investment, cost | $ 367 | [7],[9] | $ 367 | [8],[15] | |||||||||||
Investments at fair value | $ 0 | [7],[9] | $ 0 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal & Glass Containers, First Lien Term Loan | |||||||||||||||
Investment, interest rate | [8],[15],[16],[17] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate, paid in kind | [8],[15] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, principal | [8],[15],[18] | $ 46,121 | |||||||||||||
Investment, cost | [8],[15] | 45,413 | |||||||||||||
Investments at fair value | [8],[15] | $ 45,295 | |||||||||||||
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1 | |||||||||||||||
Investment, interest rate | [7],[9],[23] | 14% | 14% | 14% | |||||||||||
Investment, principal | [7],[9],[14],[23] | $ 54,730 | |||||||||||||
Investment, cost | [7],[9],[23] | 41,705 | |||||||||||||
Investments at fair value | [7],[9],[23] | $ 25,997 | |||||||||||||
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2 | |||||||||||||||
Investment, interest rate | [7],[9],[23] | 14% | 14% | 14% | |||||||||||
Investment, principal | [7],[9],[14],[23] | $ 14,993 | |||||||||||||
Investment, cost | [7],[9],[23] | 11,582 | |||||||||||||
Investments at fair value | [7],[9],[23] | $ 13,923 | |||||||||||||
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 3 | |||||||||||||||
Investment, interest rate | [7],[9],[10],[11],[12],[23] | 14% | 14% | 14% | |||||||||||
Investment, principal | [7],[9],[11],[14],[23] | $ 4,813 | |||||||||||||
Investment, cost | [7],[9],[11],[23] | 3,935 | |||||||||||||
Investments at fair value | [7],[9],[11],[23] | $ 4,034 | |||||||||||||
Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[9],[12] | 7.50% | [7],[9],[12] | 7.50% | [7],[9],[12] | 7.50% | [8],[15],[16] | 7.50% | [8],[15],[16] | 7.50% | [8],[15],[16] | |||
Investment, interest rate | 12.69% | [7],[9],[10],[12] | 12.69% | [7],[9],[10],[12] | 12.69% | [7],[9],[10],[12] | 10.48% | [8],[15],[16],[17] | 10.48% | [8],[15],[16],[17] | 10.48% | [8],[15],[16],[17] | |||
Investment, principal | $ 1,095 | [7],[9],[12],[14] | $ 3,195 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 1,084 | [7],[9],[12] | 3,163 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 1,024 | [7],[9],[12] | $ 2,997 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[12] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [7],[10],[12] | 10.69% | 10.69% | 10.69% | |||||||||||
Investment, principal | [7],[12],[14] | $ 1,054 | |||||||||||||
Investment, cost | [7],[12] | 1,053 | |||||||||||||
Investments at fair value | [7],[12] | $ 980 | |||||||||||||
Investment, Identifier [Axis]: Sorrento Therapeutics, Inc., Biotechnology, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 66,000 | [7],[20] | 66,000 | [7],[20] | 66,000 | [7],[20] | 50,000 | [8],[22] | 50,000 | [8],[22] | 50,000 | [8],[22] | |||
Investment, cost | $ 139 | [7],[20] | $ 197 | [8],[22] | |||||||||||
Investments at fair value | $ 24 | [7],[20] | $ 79 | [8],[22] | |||||||||||
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | [7],[9],[11],[12] | 5.25% | [7],[9],[11],[12] | 5.25% | [7],[9],[11],[12] | 5.25% | [8],[15],[16],[19] | 5.25% | [8],[15],[16],[19] | 5.25% | [8],[15],[16],[19] | |||
Investment, interest rate | 10.35% | [7],[9],[10],[11],[12] | 10.35% | [7],[9],[10],[11],[12] | 10.35% | [7],[9],[10],[11],[12] | 8.03% | [8],[15],[16],[17],[19] | 8.03% | [8],[15],[16],[17],[19] | 8.03% | [8],[15],[16],[17],[19] | |||
Investment, principal | $ 907 | [7],[9],[11],[12],[14] | $ 866 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | 862 | [7],[9],[11],[12] | 813 | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ 837 | [7],[9],[11],[12] | $ 796 | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | [7],[9],[12] | 5.50% | [7],[9],[12] | 5.50% | [7],[9],[12] | 5.25% | [8],[15],[16] | 5.25% | [8],[15],[16] | 5.25% | [8],[15],[16] | |||
Investment, interest rate | 10.70% | [7],[9],[10],[12] | 10.70% | [7],[9],[10],[12] | 10.70% | [7],[9],[10],[12] | 8.30% | [8],[15],[16],[17] | 8.30% | [8],[15],[16],[17] | 8.30% | [8],[15],[16],[17] | |||
Investment, principal | $ 4,500 | [7],[9],[12],[14] | $ 4,534 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 4,431 | [7],[9],[12] | 4,455 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 4,393 | [7],[9],[12] | $ 4,427 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12],[20] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12],[20] | 11.97% | 11.97% | 11.97% | |||||||||||
Investment, principal | € | [7],[9],[12],[14],[20] | € 23,731 | |||||||||||||
Investment, cost | [7],[9],[12],[20] | $ 26,829 | |||||||||||||
Investments at fair value | [7],[9],[12],[20] | $ 25,632 | |||||||||||||
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Other Diversified Financial Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16],[22] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, interest rate | [8],[15],[16],[17],[22] | 10% | 10% | 10% | |||||||||||
Investment, principal | £ | [8],[15],[16],[18],[22] | £ 16,911 | |||||||||||||
Investment, cost | [8],[15],[16],[22] | $ 19,414 | |||||||||||||
Investments at fair value | [8],[15],[16],[22] | $ 16,360 | |||||||||||||
Investment, Identifier [Axis]: Sunland Asphalt & Construction, LLC, Construction & Engineering, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 8.88% | 8.88% | 8.88% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 42,618 | |||||||||||||
Investment, cost | [8],[15],[16] | 41,654 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 41,723 | |||||||||||||
Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 7.75% | 7.75% | 7.75% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12.85% | 12.85% | 12.85% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 49,645 | |||||||||||||
Investment, cost | [7],[9],[12] | 48,611 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 49,128 | |||||||||||||
Investment, Identifier [Axis]: Supermoose Borrower, LLC, Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[16] | 3.75% | 3.75% | 3.75% | |||||||||||
Investment, interest rate | [8],[16],[17] | 7.42% | 7.42% | 7.42% | |||||||||||
Investment, principal | [8],[16],[18] | $ 3,466 | |||||||||||||
Investment, cost | [8],[16] | 3,141 | |||||||||||||
Investments at fair value | [8],[16] | $ 3,056 | |||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12],[34] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [7],[9],[10],[12],[34] | 12.18% | 12.18% | 12.18% | |||||||||||
Investment, principal | [7],[9],[12],[14],[34] | $ 1,552 | |||||||||||||
Investment, cost | [7],[9],[12],[34] | 1,539 | |||||||||||||
Investments at fair value | [7],[9],[12],[34] | $ 1,471 | |||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12],[34] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [7],[9],[10],[12],[34] | 12.18% | 12.18% | 12.18% | |||||||||||
Investment, principal | [7],[9],[12],[14],[34] | $ 32,185 | |||||||||||||
Investment, cost | [7],[9],[12],[34] | 31,923 | |||||||||||||
Investments at fair value | [7],[9],[12],[34] | $ 30,495 | |||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12],[34] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [7],[9],[10],[11],[12],[34] | 12.18% | 12.18% | 12.18% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14],[34] | $ 2,756 | |||||||||||||
Investment, cost | [7],[9],[11],[12],[34] | 2,728 | |||||||||||||
Investments at fair value | [7],[9],[11],[12],[34] | $ 2,593 | |||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12],[34] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [7],[9],[10],[11],[12],[34] | 12.18% | 12.18% | 12.18% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14],[34] | $ 1,099 | |||||||||||||
Investment, cost | [7],[9],[11],[12],[34] | 1,059 | |||||||||||||
Investments at fair value | [7],[9],[11],[12],[34] | $ 926 | |||||||||||||
Investment, Identifier [Axis]: Swordfish Merger Sub LLC, Auto Parts & Equipment, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [7],[9],[12] | 6.75% | [7],[9],[12] | 6.75% | [7],[9],[12] | 6.75% | [8],[15],[16] | 6.75% | [8],[15],[16] | 6.75% | [8],[15],[16] | |||
Investment, interest rate | 11.94% | [7],[9],[10],[12] | 11.94% | [7],[9],[10],[12] | 11.94% | [7],[9],[10],[12] | 9.81% | [8],[15],[16],[17] | 9.81% | [8],[15],[16],[17] | 9.81% | [8],[15],[16],[17] | |||
Investment, principal | $ 12,500 | [7],[9],[12],[14] | $ 12,500 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 12,480 | [7],[9],[12] | 12,474 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 11,681 | [7],[9],[12] | $ 11,469 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt | |||||||||||||||
Investment, interest rate | 11.50% | [7],[10],[12],[13],[20] | 11.50% | [7],[10],[12],[13],[20] | 11.50% | [7],[10],[12],[13],[20] | 11.50% | [8],[15],[16],[17],[22] | 11.50% | [8],[15],[16],[17],[22] | 11.50% | [8],[15],[16],[17],[22] | |||
Investment, principal | $ 4,984 | [7],[13],[14],[20] | $ 4,984 | [8],[15],[18],[22] | |||||||||||
Investment, cost | 4,887 | [7],[13],[20] | 4,866 | [8],[15],[22] | |||||||||||
Investments at fair value | $ 4,810 | [7],[13],[20] | $ 4,872 | [8],[15],[22] | |||||||||||
Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan | |||||||||||||||
Investment, interest rate | [7],[9],[10],[12],[20] | 13% | 13% | 13% | |||||||||||
Investment, principal | [7],[9],[14],[20] | $ 50,419 | |||||||||||||
Investment, cost | [7],[9],[20] | 49,787 | |||||||||||||
Investments at fair value | [7],[9],[20] | $ 49,809 | |||||||||||||
Investment, Identifier [Axis]: TIBCO Software Inc., Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | [7],[12] | 4.50% | [7],[12] | 4.50% | [7],[12] | 4.50% | [8],[16] | 4.50% | [8],[16] | 4.50% | [8],[16] | |||
Investment, interest rate | 9.84% | [7],[10],[12] | 9.84% | [7],[10],[12] | 9.84% | [7],[10],[12] | 8.15% | [8],[16],[17] | 8.15% | [8],[16],[17] | 8.15% | [8],[16],[17] | |||
Investment, principal | $ 17,213 | [7],[12],[14] | $ 12,032 | [8],[16],[18] | |||||||||||
Investment, cost | 15,952 | [7],[12] | 10,949 | [8],[16] | |||||||||||
Investments at fair value | $ 16,141 | [7],[12] | $ 10,827 | [8],[16] | |||||||||||
Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[12] | 7.50% | [7],[12] | 7.50% | [7],[12] | 7.50% | [8],[16] | 7.50% | [8],[16] | 7.50% | [8],[16] | |||
Investment, interest rate | 12.69% | [7],[10],[12] | 12.69% | [7],[10],[12] | 12.69% | [7],[10],[12] | 10.62% | [8],[16],[17] | 10.62% | [8],[16],[17] | 10.62% | [8],[16],[17] | |||
Investment, principal | $ 12,843 | [7],[12],[14] | $ 9,448 | [8],[16],[18] | |||||||||||
Investment, cost | 12,589 | [7],[12] | 9,338 | [8],[16] | |||||||||||
Investments at fair value | $ 12,168 | [7],[12] | $ 8,692 | [8],[16] | |||||||||||
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[9],[11],[12],[20] | 6% | [7],[9],[11],[12],[20] | 6% | [7],[9],[11],[12],[20] | 6% | [8],[15],[16],[19],[22] | 6% | [8],[15],[16],[19],[22] | 6% | [8],[15],[16],[19],[22] | |||
Investment, principal | $ 0 | [7],[9],[11],[12],[14],[20] | $ 0 | [8],[15],[16],[18],[19],[22] | |||||||||||
Investment, cost | (31) | [7],[9],[11],[12],[20] | (29) | [8],[15],[16],[19],[22] | |||||||||||
Investments at fair value | $ (24) | [7],[9],[11],[12],[20] | $ (28) | [8],[15],[16],[19],[22] | |||||||||||
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[9],[12],[20] | 6% | [7],[9],[12],[20] | 6% | [7],[9],[12],[20] | 6% | [8],[15],[16],[22] | 6% | [8],[15],[16],[22] | 6% | [8],[15],[16],[22] | |||
Investment, interest rate | 11.15% | [7],[9],[10],[12],[20] | 11.15% | [7],[9],[10],[12],[20] | 11.15% | [7],[9],[10],[12],[20] | 8.68% | [8],[15],[16],[17],[22] | 8.68% | [8],[15],[16],[17],[22] | 8.68% | [8],[15],[16],[17],[22] | |||
Investment, principal | $ 28,826 | [7],[9],[12],[14],[20] | $ 23,215 | [8],[15],[16],[18],[22] | |||||||||||
Investment, cost | 28,583 | [7],[9],[12],[20] | 22,815 | [8],[15],[16],[22] | |||||||||||
Investments at fair value | $ 28,537 | [7],[9],[12],[20] | $ 22,843 | [8],[15],[16],[22] | |||||||||||
Investment, Identifier [Axis]: Tecta America Corp., Construction & Engineering, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[9],[12] | 8.50% | [7],[9],[12] | 8.50% | [7],[9],[12] | 8.50% | [8],[15],[16] | 8.50% | [8],[15],[16] | 8.50% | [8],[15],[16] | |||
Investment, interest rate | 13.72% | [7],[9],[10],[12] | 13.72% | [7],[9],[10],[12] | 13.72% | [7],[9],[10],[12] | 11.62% | [8],[15],[16],[17] | 11.62% | [8],[15],[16],[17] | 11.62% | [8],[15],[16],[17] | |||
Investment, principal | $ 4,755 | [7],[9],[12],[14] | $ 5,203 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 4,677 | [7],[9],[12] | 5,125 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 4,529 | [7],[9],[12] | $ 5,034 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 9.75% | [7],[9],[11],[12] | 9.75% | [7],[9],[11],[12] | 9.75% | [7],[9],[11],[12] | 9.25% | [8],[15],[16],[19] | 9.25% | [8],[15],[16],[19] | 9.25% | [8],[15],[16],[19] | |||
Investment, interest rate | 14.93% | [7],[9],[10],[11],[12] | 14.93% | [7],[9],[10],[11],[12] | 14.93% | [7],[9],[10],[11],[12] | 12.20% | [8],[15],[16],[17],[19] | 12.20% | [8],[15],[16],[17],[19] | 12.20% | [8],[15],[16],[17],[19] | |||
Investment, principal | $ 1,590 | [7],[9],[11],[12],[14] | $ 1,231 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | 1,572 | [7],[9],[11],[12] | 1,210 | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ 1,535 | [7],[9],[11],[12] | $ 1,187 | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 9.75% | [7],[9],[12] | 9.75% | [7],[9],[12] | 9.75% | [7],[9],[12] | 9.25% | [8],[15],[16] | 9.25% | [8],[15],[16] | 9.25% | [8],[15],[16] | |||
Investment, interest rate | 14.99% | [7],[9],[10],[12] | 14.99% | [7],[9],[10],[12] | 14.99% | [7],[9],[10],[12] | 12.11% | [8],[15],[16],[17] | 12.11% | [8],[15],[16],[17] | 12.11% | [8],[15],[16],[17] | |||
Investment, principal | $ 23,483 | [7],[9],[12],[14] | $ 18,323 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 23,239 | [7],[9],[12] | 17,956 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 22,919 | [7],[9],[12] | $ 17,865 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 11.09% | 11.09% | 11.09% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 19,947 | |||||||||||||
Investment, cost | [7],[9],[12] | 18,963 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 19,000 | |||||||||||||
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Pharmaceuticals, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[15] | 668,879 | 668,879 | 668,879 | |||||||||||
Investment, principal | [8],[15],[18] | ||||||||||||||
Investment, cost | [8],[15] | 2,028 | |||||||||||||
Investments at fair value | [8],[15] | $ 4,077 | |||||||||||||
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Pharmaceuticals, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 9.50% | 9.50% | 9.50% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 13.17% | 13.17% | 13.17% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 29,663 | |||||||||||||
Investment, cost | [8],[15],[16] | 29,352 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 29,031 | |||||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.30% | [7],[9],[12],[23] | 7.30% | [7],[9],[12],[23] | 7.30% | [7],[9],[12],[23] | 7.30% | [8],[15],[16] | 7.30% | [8],[15],[16] | 7.30% | [8],[15],[16] | |||
Investment, interest rate | [8],[15],[16],[17] | 10.44% | 10.44% | 10.44% | |||||||||||
Investment, principal | $ 19,163 | [7],[9],[12],[14],[23] | $ 15,674 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 19,163 | [7],[9],[12],[23] | 15,605 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 18,286 | [7],[9],[12],[23] | $ 15,682 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 12.50% | [7],[9],[12],[23] | 12.50% | [7],[9],[12],[23] | 12.50% | [7],[9],[12],[23] | 12.50% | [8],[15],[16] | 12.50% | [8],[15],[16] | 12.50% | [8],[15],[16] | |||
Investment, interest rate | [8],[15],[16],[17] | 16.17% | 16.17% | 16.17% | |||||||||||
Investment, principal | $ 4,641 | [7],[9],[12],[14],[23] | $ 3,789 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 4,641 | [7],[9],[12],[23] | 3,774 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 4,164 | [7],[9],[12],[23] | $ 3,800 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12.50% | 12.50% | 12.50% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 46,832 | |||||||||||||
Investment, cost | [7],[9],[12] | 45,609 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 41,919 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 1 | |||||||||||||||
Investment owned, balance (in shares) | shares | [7],[9] | 10,616 | 10,616 | 10,616 | |||||||||||
Investment, cost | [7],[9] | $ 120 | |||||||||||||
Investments at fair value | [7],[9] | $ 55 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 2 | |||||||||||||||
Investment owned, balance (in shares) | shares | [7],[9] | 358,299 | 358,299 | 358,299 | |||||||||||
Investment, cost | [7],[9] | $ 2,912 | |||||||||||||
Investments at fair value | [7],[9] | $ 1,526 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 3 | |||||||||||||||
Investment owned, balance (in shares) | shares | [7],[9] | 60,862 | 60,862 | 60,862 | |||||||||||
Investment, cost | [7],[9] | $ 1,207 | |||||||||||||
Investments at fair value | [7],[9] | $ 795 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 4 | |||||||||||||||
Investment owned, balance (in shares) | shares | [7],[9] | 32,447 | 32,447 | 32,447 | |||||||||||
Investment, cost | [7],[9] | $ 33,353 | |||||||||||||
Investments at fair value | [7],[9] | $ 36,587 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 11.17% | 11.17% | 11.17% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 37,494 | |||||||||||||
Investment, cost | [8],[15],[16] | 36,569 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 35,807 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 1 | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[15] | 8,434 | 8,434 | 8,434 | |||||||||||
Investment, cost | [8],[15] | $ 101 | |||||||||||||
Investments at fair value | [8],[15] | $ 69 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 2 | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[15] | 284,650 | 284,650 | 284,650 | |||||||||||
Investment, cost | [8],[15] | $ 2,409 | |||||||||||||
Investments at fair value | [8],[15] | $ 2,320 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 3 | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[15] | 48,352 | 48,352 | 48,352 | |||||||||||
Investment, cost | [8],[15] | $ 979 | |||||||||||||
Investments at fair value | [8],[15] | $ 979 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 4 | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[15],[19] | 23,201 | 23,201 | 23,201 | |||||||||||
Investment, cost | [8],[15],[19] | $ 22,986 | |||||||||||||
Investments at fair value | [8],[15],[19] | $ 26,487 | |||||||||||||
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[9],[12] | 6% | [7],[9],[12] | 6% | [7],[9],[12] | 6% | [8],[15],[16] | 6% | [8],[15],[16] | 6% | [8],[15],[16] | |||
Investment, interest rate | 11.20% | [7],[9],[10],[12] | 11.20% | [7],[9],[10],[12] | 11.20% | [7],[9],[10],[12] | 9.12% | [8],[15],[16],[17] | 9.12% | [8],[15],[16],[17] | 9.12% | [8],[15],[16],[17] | |||
Investment, principal | $ 11,701 | [7],[9],[12],[14] | $ 6,016 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 11,675 | [7],[9],[12] | 5,908 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 11,408 | [7],[9],[12] | $ 5,895 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes | |||||||||||||||
Investment, basis spread, variable rate | [7],[12],[20] | 7.45% | 7.45% | 7.45% | |||||||||||
Investment, interest rate | [7],[10],[12],[20] | 12.72% | 12.72% | 12.72% | |||||||||||
Investment, principal | [7],[12],[14],[20] | $ 1,000 | |||||||||||||
Investment, cost | [7],[12],[20] | 814 | |||||||||||||
Investments at fair value | [7],[12],[20] | $ 929 | |||||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1 | |||||||||||||||
Investment, interest rate | [7],[10],[12],[20] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, principal | [7],[14],[20] | $ 4,500 | |||||||||||||
Investment, cost | [7],[20] | 4,101 | |||||||||||||
Investments at fair value | [7],[20] | $ 3,189 | |||||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2 | |||||||||||||||
Investment, interest rate | [7],[10],[12],[20] | 4.75% | 4.75% | 4.75% | |||||||||||
Investment, principal | [7],[14],[20] | $ 300 | |||||||||||||
Investment, cost | [7],[20] | 263 | |||||||||||||
Investments at fair value | [7],[20] | $ 249 | |||||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Specialized REITs, Fixed Rate Bond 1 | |||||||||||||||
Investment, interest rate | [8],[16],[17],[22] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, principal | [8],[18],[22] | $ 4,500 | |||||||||||||
Investment, cost | [8],[22] | 4,060 | |||||||||||||
Investments at fair value | [8],[22] | $ 3,026 | |||||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Specialized REITs, Fixed Rate Bond 2 | |||||||||||||||
Investment, interest rate | [8],[16],[17],[22] | 4.75% | 4.75% | 4.75% | |||||||||||
Investment, principal | [8],[18],[22] | $ 300 | |||||||||||||
Investment, cost | [8],[22] | 258 | |||||||||||||
Investments at fair value | [8],[22] | $ 238 | |||||||||||||
Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12.47% | 12.47% | 12.47% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 1,540 | |||||||||||||
Investment, cost | [7],[9],[12] | 1,239 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 1,279 | |||||||||||||
Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 15% | 15% | 15% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 21.22% | 21.22% | 21.22% | |||||||||||
Investment, principal | [7],[9],[12] | $ 1,323 | |||||||||||||
Investment, cost | [7],[9],[12] | 1,311 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 1,247 | |||||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | [7],[12] | 3.75% | [7],[12] | 3.75% | [7],[12] | 3.75% | [8],[16] | 3.75% | [8],[16] | 3.75% | [8],[16] | |||
Investment, interest rate | 9.03% | [7],[10],[12] | 9.03% | [7],[10],[12] | 9.03% | [7],[10],[12] | 6.56% | [8],[16],[17] | 6.56% | [8],[16],[17] | 6.56% | [8],[16],[17] | |||
Investment, principal | $ 11,822 | [7],[12] | $ 7,564 | [8],[16],[18] | |||||||||||
Investment, cost | 11,228 | [7],[12] | 6,989 | [8],[16] | |||||||||||
Investments at fair value | $ 10,743 | [7],[12] | $ 6,795 | [8],[16] | |||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 7.75% | 7.75% | 7.75% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 10.56% | 10.56% | 10.56% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 6,000 | |||||||||||||
Investment, cost | [8],[15],[16] | 5,855 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 5,070 | |||||||||||||
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | [8],[15],[16] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [8],[15],[16],[17] | 10.19% | 10.19% | 10.19% | |||||||||||
Investment, principal | [8],[15],[16],[18] | $ 40,536 | |||||||||||||
Investment, cost | [8],[15],[16] | 39,947 | |||||||||||||
Investments at fair value | [8],[15],[16] | $ 40,131 | |||||||||||||
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 11.38% | 11.38% | 11.38% | |||||||||||
Investment, principal | [7],[9],[12] | $ 35,853 | |||||||||||||
Investment, cost | [7],[9],[12] | 35,764 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 35,495 | |||||||||||||
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 12% | 12% | 12% | |||||||||||
Investment, principal | [7],[9],[12] | $ 19,306 | |||||||||||||
Investment, cost | [7],[9],[12] | 19,258 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 19,113 | |||||||||||||
Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[9],[12] | 7% | [7],[9],[12] | 7% | [7],[9],[12] | 7% | [8],[15],[16] | 7% | [8],[15],[16] | 7% | [8],[15],[16] | |||
Investment, interest rate | 12.50% | [7],[9],[10],[12] | 12.50% | [7],[9],[10],[12] | 12.50% | [7],[9],[10],[12] | 10.67% | [8],[15],[16],[17] | 10.67% | [8],[15],[16],[17] | 10.67% | [8],[15],[16],[17] | |||
Investment, principal | $ 5,000 | [7],[9],[12] | $ 5,000 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 4,925 | [7],[9],[12] | 4,925 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 4,025 | [7],[9],[12] | $ 4,538 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 15% | [7],[9],[12] | 15% | [7],[9],[12] | 15% | [7],[9],[12] | 15% | [8],[15],[16] | 15% | [8],[15],[16] | 15% | [8],[15],[16] | |||
Investment, interest rate | 21.22% | [7],[9],[10],[12] | 21.22% | [7],[9],[10],[12] | 21.22% | [7],[9],[10],[12] | 19.64% | [8],[15],[16],[17] | 19.64% | [8],[15],[16],[17] | 19.64% | [8],[15],[16],[17] | |||
Investment, principal | $ 1,565 | [7],[9],[12] | $ 2,316 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 1,551 | [7],[9],[12] | 2,293 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 1,475 | [7],[9],[12] | $ 2,264 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | 4,871 | [7],[9] | 4,871 | [7],[9] | 4,871 | [7],[9] | 3,621 | [8],[15] | 3,621 | [8],[15] | 3,621 | [8],[15] | |||
Investment, cost | $ 46 | [7],[9] | $ 0 | [8],[15] | |||||||||||
Investments at fair value | $ 136 | [7],[9] | $ 192 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Common Stock | |||||||||||||||
Investment owned, balance (in shares) | shares | 127,452 | [7],[9] | 127,452 | [7],[9] | 127,452 | [7],[9] | 18,032 | [8],[15] | 18,032 | [8],[15] | 18,032 | [8],[15] | |||
Investment, cost | $ 2,057 | [7],[9] | $ 216 | [8],[15] | |||||||||||
Investments at fair value | $ 1,565 | [7],[9] | $ 296 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | [7],[12] | 6.25% | [7],[12] | 6.25% | [7],[12] | 6.25% | [8],[16] | 6.25% | [8],[16] | 6.25% | [8],[16] | |||
Investment, interest rate | 11.45% | [7],[10],[12] | 11.45% | [7],[10],[12] | 11.45% | [7],[10],[12] | 9.37% | [8],[16],[17] | 9.37% | [8],[16],[17] | 9.37% | [8],[16],[17] | |||
Investment, principal | $ 24,419 | [7],[12] | $ 25,499 | [8],[16],[18] | |||||||||||
Investment, cost | 23,589 | [7],[12] | 24,632 | [8],[16] | |||||||||||
Investments at fair value | $ 22,862 | [7],[12] | $ 23,204 | [8],[16] | |||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[15] | 109,420 | 109,420 | 109,420 | |||||||||||
Investment, cost | [8],[15] | $ 1,842 | |||||||||||||
Investments at fair value | [8],[15] | $ 1,799 | |||||||||||||
Investment, Identifier [Axis]: Zayo Group Holdings, Inc., Alternative Carriers, Fixed Rate Bond | |||||||||||||||
Investment, interest rate | [8],[16],[17] | 4% | 4% | 4% | |||||||||||
Investment, principal | [8],[18] | $ 250 | |||||||||||||
Investment, cost | [8] | 212 | |||||||||||||
Investments at fair value | [8] | $ 201 | |||||||||||||
Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 8.25% | [7],[9],[12] | 8.25% | [7],[9],[12] | 8.25% | [7],[9],[12] | 8.25% | [8],[15],[16] | 8.25% | [8],[15],[16] | 8.25% | [8],[15],[16] | |||
Investment, interest rate | 13.79% | [7],[9],[10],[12] | 13.79% | [7],[9],[10],[12] | 13.79% | [7],[9],[10],[12] | 11.92% | [8],[15],[16],[17] | 11.92% | [8],[15],[16],[17] | 11.92% | [8],[15],[16],[17] | |||
Investment, principal | $ 19,578 | [7],[9],[12] | $ 19,578 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 19,551 | [7],[9],[12] | 19,542 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 13,693 | [7],[9],[12] | $ 16,152 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[9],[12],[20] | 7.50% | [7],[9],[12],[20] | 7.50% | [7],[9],[12],[20] | 7.50% | [8],[15],[16],[22] | 7.50% | [8],[15],[16],[22] | 7.50% | [8],[15],[16],[22] | |||
Investment, interest rate | 12.46% | [7],[9],[10],[12],[20] | 12.46% | [7],[9],[10],[12],[20] | 12.46% | [7],[9],[10],[12],[20] | 9.72% | [8],[15],[16],[17],[22] | 9.72% | [8],[15],[16],[17],[22] | 9.72% | [8],[15],[16],[17],[22] | |||
Investment, principal | £ | £ 20,000 | [7],[9],[12],[20] | £ 18,000 | [8],[15],[16],[18],[22] | |||||||||||
Investment, cost | $ 25,857 | [7],[9],[12],[20] | $ 23,804 | [8],[15],[16],[22] | |||||||||||
Investments at fair value | $ 23,270 | [7],[9],[12],[20] | $ 16,552 | [8],[15],[16],[22] | |||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Preferred Equity | |||||||||||||||
Investment owned, balance (in shares) | shares | 21,523 | [7],[9] | 21,523 | [7],[9] | 21,523 | [7],[9] | 18,635 | [8],[15] | 18,635 | [8],[15] | 18,635 | [8],[15] | |||
Investment, cost | $ 20,789 | [7],[9] | $ 18,264 | [8],[15] | |||||||||||
Investments at fair value | $ 18,821 | [7],[9] | $ 16,575 | [8],[15] | |||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [7],[9],[11],[12] | 6.75% | [7],[9],[11],[12] | 6.75% | [7],[9],[11],[12] | 6.75% | [8],[15],[16],[19] | 6.75% | [8],[15],[16],[19] | 6.75% | [8],[15],[16],[19] | |||
Investment, interest rate | [7],[9],[10],[11],[12] | 11.99% | 11.99% | 11.99% | |||||||||||
Investment, principal | $ 377 | [7],[9],[11],[12],[14] | $ 0 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | 331 | [7],[9],[11],[12] | (31) | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ 288 | [7],[9],[11],[12] | $ (32) | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[9],[12] | 7.25% | [7],[9],[12] | 7.25% | [7],[9],[12] | 6.75% | [8],[15],[16] | 6.75% | [8],[15],[16] | 6.75% | [8],[15],[16] | |||
Investment, interest rate | 8.50% | [7],[9],[10],[12] | 8.50% | [7],[9],[10],[12] | 8.50% | [7],[9],[10],[12] | 9.49% | [8],[15],[16],[17] | 9.49% | [8],[15],[16],[17] | 9.49% | [8],[15],[16],[17] | |||
Investment, interest rate, paid in kind | [7],[9] | 3.88% | 3.88% | 3.88% | |||||||||||
Investment, principal | $ 24,188 | [7],[9],[12],[14] | $ 19,203 | [8],[15],[16],[18] | |||||||||||
Investment, cost | 23,876 | [7],[9],[12] | 18,874 | [8],[15],[16] | |||||||||||
Investments at fair value | $ 23,235 | [7],[9],[12] | $ 18,867 | [8],[15],[16] | |||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[9],[12] | 7.25% | [7],[9],[12] | 7.25% | [7],[9],[12] | 6.75% | [8],[15],[16],[19] | 6.75% | [8],[15],[16],[19] | 6.75% | [8],[15],[16],[19] | |||
Investment, interest rate | [7],[9],[10],[12] | 12.38% | 12.38% | 12.38% | |||||||||||
Investment, principal | $ 3,636 | [7],[9],[12],[14] | $ 0 | [8],[15],[16],[18],[19] | |||||||||||
Investment, cost | 3,600 | [7],[9],[12] | 0 | [8],[15],[16],[19] | |||||||||||
Investments at fair value | $ 3,563 | [7],[9],[12] | $ 0 | [8],[15],[16],[19] | |||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[12] | 0 | |||||||||||||
Investments at fair value | [7],[9],[11],[12] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[12] | 8.75% | 8.75% | 8.75% | |||||||||||
Investment, interest rate | [7],[9],[10],[12] | 11.75% | 11.75% | 11.75% | |||||||||||
Investment, principal | [7],[9],[12],[14] | $ 5,212 | |||||||||||||
Investment, cost | [7],[9],[12] | 4,973 | |||||||||||||
Investments at fair value | [7],[9],[12] | $ 5,034 | |||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12] | 8.75% | 8.75% | 8.75% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[12] | 0 | |||||||||||||
Investments at fair value | [7],[9],[11],[12] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3 | |||||||||||||||
Investment, basis spread, variable rate | [7],[9],[11],[12] | 8.75% | 8.75% | 8.75% | |||||||||||
Investment, principal | [7],[9],[11],[12],[14] | $ 0 | |||||||||||||
Investment, cost | [7],[9],[11],[12] | 0 | |||||||||||||
Investments at fair value | [7],[9],[11],[12] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants | |||||||||||||||
Investment owned, balance (in shares) | shares | [7],[9] | 53,700 | 53,700 | 53,700 | |||||||||||
Investment, cost | [7],[9] | $ 175 | |||||||||||||
Investments at fair value | [7],[9] | $ 407 | |||||||||||||
[1]As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the nine months ended June 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.[2]Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.[3]As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2022 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.[4]Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.[5]Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.[6]Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.[7]Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.[8]Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.[9] As of June 30, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820"). ten twenty ten twenty ten twenty ten twenty |
Consolidated Schedule of Inve_2
Consolidated Schedule of Investments - Derivatives € in Thousands, £ in Thousands, $ in Thousands | Jun. 30, 2023 USD ($) | Jun. 30, 2023 EUR (€) | Jun. 30, 2023 GBP (£) | Sep. 30, 2022 USD ($) | Sep. 30, 2022 EUR (€) | Sep. 30, 2022 GBP (£) |
Schedule of Investments [Line Items] | ||||||
Derivative liability at fair value | $ (39,567) | $ (41,969) | ||||
Derivative asset at fair value | 49 | 6,789 | ||||
Interest rate swap | ||||||
Schedule of Investments [Line Items] | ||||||
Derivative liability at fair value | $ (39,567) | $ (41,969) | ||||
Interest rate | 2.70% | 2.70% | 2.70% | 2.70% | 2.70% | 2.70% |
Floating interest rate | 1.658% | 1.658% | 1.658% | 1.658% | 1.658% | 1.658% |
Notional amount | $ 350,000 | $ 350,000 | ||||
Foreign currency forward contract | ||||||
Schedule of Investments [Line Items] | ||||||
Derivative asset at fair value | 49 | 6,789 | ||||
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 10, 2022, 1 | ||||||
Schedule of Investments [Line Items] | ||||||
Notional Amount to be Purchased | 43,179 | |||||
Notional Amount to be Sold | € | € 41,444 | |||||
Derivative asset at fair value | 2,466 | |||||
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing August 10, 2023 | ||||||
Schedule of Investments [Line Items] | ||||||
Derivative liability at fair value | (482) | |||||
Derivative asset at fair value | 531 | |||||
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing May 11, 2023 | ||||||
Schedule of Investments [Line Items] | ||||||
Notional Amount to be Purchased | 78,866 | |||||
Notional Amount to be Sold | € | € 71,658 | |||||
Derivative asset at fair value | 531 | |||||
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 10, 2022 | ||||||
Schedule of Investments [Line Items] | ||||||
Notional Amount to be Purchased | 43,179 | |||||
Notional Amount to be Sold | € | € 41,444 | |||||
Derivative asset at fair value | 2,466 | |||||
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing May 11, 2023 | ||||||
Schedule of Investments [Line Items] | ||||||
Notional Amount to be Purchased | 71,438 | |||||
Notional Amount to be Sold | £ | £ 56,556 | |||||
Derivative liability at fair value | $ (482) | |||||
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 10, 2022 | ||||||
Schedule of Investments [Line Items] | ||||||
Notional Amount to be Purchased | 45,692 | |||||
Notional Amount to be Sold | £ | £ 37,033 | |||||
Derivative asset at fair value | 4,323 | |||||
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 19, 2022, 2 | ||||||
Schedule of Investments [Line Items] | ||||||
Notional Amount to be Purchased | 45,692 | |||||
Notional Amount to be Sold | £ | £ 37,033 | |||||
Derivative asset at fair value | $ 4,323 |
Consolidated Schedule of Inve_3
Consolidated Schedule of Investments (Parenthetical) - $ / shares | 6 Months Ended | 9 Months Ended | |
Mar. 31, 2023 | Jun. 30, 2023 | Sep. 30, 2022 | |
Schedule of Investments [Line Items] | |||
Percentage of total assets representing qualifying assets | 73.70% | 75.70% | |
Percentage of total assets representing non-qualifying assets | 26.30% | 24.30% | |
Share-Based Payment Arrangement, Tranche One | |||
Schedule of Investments [Line Items] | |||
Investment owned, balance, shares, VWAP threshold (in dollars per share) | $ 15 | $ 15 | |
Investment owned, balance, shares, VWAP number of trading days | 10 days | 10 days | |
Investment owned, balance, shares, VWAP, number of consecutive trading days | 20 days | 20 days | |
Share-Based Payment Arrangement, Tranche Two | |||
Schedule of Investments [Line Items] | |||
Investment owned, balance, shares, VWAP threshold (in dollars per share) | $ 20 | $ 20 | |
Investment owned, balance, shares, VWAP number of trading days | 10 days | 10 days | |
Investment owned, balance, shares, VWAP, number of consecutive trading days | 20 days | 20 days |
Organization
Organization | 9 Months Ended |
Jun. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization | Organization Oaktree Specialty Lending Corporation (together with its consolidated subsidiaries, the "Company") is a specialty finance company that looks to provide customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The Company was formed in late 2007 and operates as a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a Business Development Company under the Investment Company Act. The Company has qualified and elected to be treated as a regulated investment company ("RIC") under the Internal Revenue Code of 1986, as amended (the "Code"), for U.S. federal income tax purposes. The Company's investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. The Company may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. The Company is externally managed by Oaktree Fund Advisors, LLC ("Oaktree"), pursuant to an investment advisory agreement between the Company and Oaktree (as amended and restated, the "Investment Advisory Agreement"). Oaktree is an affiliate of Oaktree Capital Management, L.P. ("OCM"), the Company's external investment adviser from October 17, 2017 through May 3, 2020. Oaktree Fund Administration, LLC ("Oaktree Administrator"), a subsidiary of OCM, provides certain administrative and other services necessary for the Company to operate pursuant to an administration agreement between the Company and Oaktree Administrator (the "Administration Agreement"). See Note 10. In 2019, Brookfield Corporation (f/k/a Brookfield Asset Management Inc.) ("Brookfield") acquired a majority economic interest in Oaktree Capital Group, LLC. Oaktree and its affiliates operate as an independent business within Brookfield, with their own product offerings and investment, marketing and support teams. On March 19, 2021, the Company acquired Oaktree Strategic Income Corporation (“OCSI”), pursuant to that certain Agreement and Plan of Merger (the “OCSI Merger Agreement”), dated as of October 28, 2020, by and among OCSI, the Company, Lion Merger Sub, Inc., a wholly-owned subsidiary of the Company, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OCSI Merger Agreement, OCSI was merged with and into the Company in a two-step transaction, with the Company as the surviving company (the "OCSI Merger”). On January 23, 2023, the Company acquired Oaktree Strategic Income II, Inc. (“OSI2”) pursuant to that certain Agreement and Plan of Merger (the “OSI2 Merger Agreement”), dated as of September 14, 2022, by and among OSI2, the Company, Project Superior Merger Sub, Inc., a wholly-owned subsidiary of the Company, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OSI2 Merger Agreement, OSI2 was merged with and into the Company in a two-step transaction with the Company as the surviving company (the “OSI2 Merger”). For further information, see Note 14 "Merger with OSI2." |
Significant Accounting Policies
Significant Accounting Policies | 9 Months Ended |
Jun. 30, 2023 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | Significant Accounting Policies Basis of Presentation: The Consolidated Financial Statements of the Company have been prepared in accordance with GAAP and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the Consolidated Financial Statements have been made. All intercompany balances and transactions have been eliminated. The Company is an investment company following the accounting and reporting guidance in ASC Topic 946, Financial Services - Investment Companies ("ASC 946"). Certain prior period amounts have been reclassified to conform to the current period presentation. All per share amounts and common shares outstanding as of and for periods prior to March 31, 2023 reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. Use of Estimates: The preparation of the financial statements in conformity with accounting principles generally accepted in the United States ("GAAP") requires management to make certain estimates and assumptions affecting amounts reported in the financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition. Consolidation: The accompanying Consolidated Financial Statements include the accounts of Oaktree Specialty Lending Corporation and its consolidated subsidiaries. Each consolidated subsidiary is wholly-owned and, as such, consolidated into the Consolidated Financial Statements. Certain subsidiaries that hold investments are treated as pass through entities for U.S. federal income tax purposes. The assets of certain of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of Oaktree Specialty Lending Corporation or any of its other subsidiaries. As an investment company, portfolio investments held by the Company are not consolidated into the Consolidated Financial Statements but rather are included on the Statements of Assets and Liabilities as investments at fair value. Fair Value Measurements: The Company values its investments in accordance with ASC 820, which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity. Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows: • Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date. • Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities. • Level 3 — Unobservable inputs that reflect Oaktree's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. Oaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions. Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations. Oaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If Oaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within Oaktree's set threshold, Oaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, Oaktree does not adjust any of the prices received from these sources. If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, Oaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. Oaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and Oaktree considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, Oaktree depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable. Oaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates. Rule 2a-5 under the Investment Company Act permits boards of directors of registered investment companies and Business Development Companies to either (i) choose to determine fair value in good faith or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Directors has designated Oaktree to serve as its valuation designee effective September 8, 2022. Oaktree undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments: • The quarterly valuation process begins with each portfolio company or investment being initially valued by Oaktree's valuation team; • Preliminary valuations are then reviewed and discussed with management of Oaktree; • Separately, independent valuation firms prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to Oaktree; • Oaktree compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee; • The Audit Committee reviews the valuation report with Oaktree, and Oaktree responds and supplements the valuation report to reflect any discussions between Oaktree and the Audit Committee; and • Oaktree, as valuation designee, determines the fair value of each investment in the Company's portfolio. The fair value of the Company's investments as of June 30, 2023 and September 30, 2022 was determined by Oaktree, as the Company's valuation designee. The Company has and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of its portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material. With the exception of the line items entitled "deferred financing costs," "deferred offering costs," "other assets," "deferred tax asset, net," "credit facilities payable" and "unsecured notes payable," which are reported at amortized cost, all assets and liabilities approximate fair value on the Consolidated Statements of Assets and Liabilities. The carrying value of the line items titled "interest, dividends and fees receivable," "due from portfolio companies," "receivables from unsettled transactions," "due from broker," "accounts payable, accrued expenses and other liabilities," "base management fee and incentive fee payable," "due to affiliate," "interest payable" and "payables from unsettled transactions" approximate fair value due to their short maturities. Foreign Currency Translation: The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company. Derivative Instruments: Foreign Currency Forward Contracts The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded within derivative assets or derivative liabilities on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statements of Operations. Interest Rate Swaps The Company uses an interest rate swap to hedge some of the Company's fixed rate debt. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship, and therefore the periodic payments are recognized as components of interest expense in the Consolidated Statements of Operations. Depending on the nature of the balance at period end, the fair value of the interest rate swap is either included as a derivative asset or derivative liability on the Company's Consolidated Statements of Assets and Liabilities. The change in fair value of the interest rate swap is offset by a change in the carrying value of the fixed rate debt. Any amounts paid to the counterparty to cover collateral obligations under the terms of the interest rate swap agreement are included in due from broker on the Company's Consolidated Statements of Assets and Liabilities. Investment Income: Interest Income Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of June 30, 2023, there were five investments on non-accrual status that in aggregate represented 3.6% and 3.1% of total debt investments at cost and fair value, respectively. As of September 30, 2022, there were no investments on non-accrual status. In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan. PIK Interest Income The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost bases of these investments in the Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by the Company to Oaktree. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s stockholders, even though the Company has not yet collected the cash and may never do so. Fee Income Oaktree or its affiliates may provide financial advisory services to portfolio companies and, in return, the Company may receive fees for capital structuring services. These fees are generally non-recurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment, exit and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered. Dividend Income The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment. Cash and Cash Equivalents and Restricted Cash: Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less when acquired. The Company places its cash and cash equivalents and restricted cash with financial institutions and, at times, cash held in bank accounts exceeds the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets. As of September 30, 2022, included in restricted cash was $2.8 million that was held at Wells Fargo Bank, N.A. in connection with the Citibank Facility (as defined in Note 6. Borrowings). Pursuant to the terms of the Citibank Facility, the Company was restricted in terms of access to $2.8 million as of September 30, 2022, until t he occurrence of the periodic distribution dates and, in connection therewith, the Company’s submission of its required periodic reporting schedules and verifications of the Company’s compliance with the terms of the Citibank Facility. As of June 30, 2023, included in restricted cash was $13.0 million that was held at Deutsche Bank Trust Company Americas in connection with the Company’s OSI2 Citibank Facility (defined in Note 6. Borrowings). Pursuant to the terms of the OSI2 Citibank Facility, the Company was restricted in terms of access to the $13.0 million until the occurrence of the periodic distribution dates and, in connection therewith, the Company’s submission of its required periodic reporting schedules and verifications of the Company’s compliance with the terms of the OSI2 Citibank Facility. Due from Portfolio Companies: Due from portfolio companies consists of amounts payable to the Company from its portfolio companies, including proceeds from the sale of portfolio companies not yet received or being held in escrow and excluding those amounts attributable to interest, dividends or fees receivable. These amounts are recognized as they become payable to the Company ( e.g. , principal payments on the scheduled amortization payment date). Receivables/Payables from Unsettled Transactions: Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date. Deferred Financing Costs: Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities and debt offerings. Deferred financing costs in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Company's Consolidated Statements of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense. For extinguishments of the Company’s unsecured notes payable, any unamortized deferred financing costs are deducted from the carrying amount of the debt in determining the gain or loss from the extinguishment. Deferred Offering Costs: Legal fees and other costs incurred in connection with the Company’s shelf registration statement are capitalized as deferred offering costs in the Consolidated Statements of Assets and Liabilities. To the extent any such costs relate to equity offerings, these costs are charged as a reduction of capital upon utilization. To the extent any such costs relate to debt offerings, these costs are treated as deferred financing costs and are amortized over the term of the respective debt arrangement. Any deferred offering costs that remain at the expiration of the shelf registration statement or when it becomes probable that an offering will not be completed are expensed. Income Taxes: The Company has elected to be subject to tax as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to be subject to tax as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute dividends to its stockholders of an amount generally at least equal to 90% of investment company taxable income, as defined by the Code and determined without regard to any deduction for dividends paid, for each taxable year. As a RIC, the Company is not subject to U.S. federal income tax on the portion of its taxable income and gains distributed currently to stockholders as a dividend. Depending on the level of taxable income earned during a taxable year, the Company may choose to retain taxable income in excess of current year dividend distributions and would distribute such taxable income in the next taxable year. The Company would then incur a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income, determined on a calendar year basis, could exceed estimated current calendar year dividend distributions, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. The Company anticipates timely distribution of its taxable income within the tax rules under Subchapter M of the Code. The Company did not incur a U.S. federal excise tax for calendar year 2021. For the calendar year 2022, the Company incurred $0.1 million of excise tax. The Company does not expect to incur a U.S. federal excise tax for calendar year 2023. The Company holds certain portfolio investments through taxable subsidiaries. The purpose of the Company's taxable subsidiaries is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiaries are consolidated for financial reporting purposes, and portfolio investments held by them are included in the Company’s Consolidated Financial Statements as portfolio investments and recorded at fair value. The taxable subsidiaries are not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statements of Operations. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences. FASB ASC Topic 740, Accounting for Uncertainty in Income Taxes ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the Company's Consolidated Financial Statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Management's determinations regarding ASC 740 may be subject to review and adjustment at a later date based upon factors including an ongoing analysis of tax laws, regulations and interpretations thereof. The Company recognizes the tax benefits of uncertain tax positions only where the position is "more-likely-than-not" to be sustained assuming examination by tax authorities. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years 2020, 2021 and 2022. The Company identifies its major tax jurisdictions as U.S. Federal and California, and the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months. |
Portfolio Investments
Portfolio Investments | 9 Months Ended |
Jun. 30, 2023 | |
Schedule of Investments [Abstract] | |
Portfolio Investments | Portfolio Investments As of June 30, 2023, 207.7% of net assets at fair value, or $3.1 billion, was invested in 156 portfolio companies, including (i) $140.6 million in subordinated notes and limited liability company ("LLC") equity interests of Senior Loan Fund JV I, LLC ("SLF JV I"), a joint venture through which the Company and Trinity Universal Insurance Company, a subsidiary of Kemper Corporation ("Kemper"), co-invest in senior secured loans of middle-market companies and other corporate debt securities and (ii) $49.6 million in subordinated notes and LLC equity interests of OCSI Glick JV LLC ("Glick JV" and, together with SLF JV I, the "JVs"), a joint venture through which the Company and GF Equity Funding 2014 LLC ("GF Equity Funding") co-invest primarily in senior secured loans of middle-market companies. As of June 30, 2023, 4.8% of net assets at fair value, or $72.7 million, was invested in cash and cash equivalents (including $13.0 million of restricted cash). In comparison, as of September 30, 2022, 200.2% of net assets at fair value, or $2.5 billion, was invested in 149 portfolio investments, including (i) $117.0 million in subordinated notes and LLC equity interests of SLF JV I and (ii) $50.3 million in subordinated notes and LLC equity interests of Glick JV. As of September 30, 2022, 2.1% of net assets at fair value, or $26.4 million, was invested in cash and cash equivalents (including $2.8 million of restricted cash). As of June 30, 2023, 88.5% of the Company's portfolio at fair value consisted of senior secured debt investments and 6.8% consisted of subordinated debt investments, including the debt investments in the JVs. As of September 30, 2022, 86.9% of the Company's portfolio at fair value consisted of senior secured debt investments and 8.1% consisted of subordinated debt investments, including the debt investments in the JVs. The Company also held equity investments in certain of its portfolio companies consisting of common stock, preferred stock, warrants, limited partnership interests or LLC equity interests. These instruments generally do not produce a current return but are held for potential investment appreciation and capital gain. During the three and nine months ended June 30, 2023, the Company recorded net realized losses of $10.6 million and $19.9 million, respectively. During the three and nine months ended June 30, 2022, the Company recorded net realized gains of $9.2 million and $19.9 million, respectively. During the three and nine months ended June 30, 2023, the Company recorded net unrealized depreciation of $1.0 million and $42.3 million, respectively. During the three and nine months ended June 30, 2022, the Company recorded net unrealized depreciation of $86.8 million and $118.4 million, respectively. The composition of the Company's investments as of June 30, 2023 and September 30, 2022 at cost and fair value was as follows: June 30, 2023 September 30, 2022 Cost Fair Value Cost Fair Value Investments in debt securities $ 2,942,222 $ 2,826,369 $ 2,294,392 $ 2,223,329 Investments in equity securities 136,619 118,989 127,596 103,534 Debt investments in the JVs 162,653 162,288 146,444 146,533 Equity investments in the JVs 54,791 27,973 49,322 20,715 Total $ 3,296,285 $ 3,135,619 $ 2,617,754 $ 2,494,111 The following table presents the composition of the Company's debt investments as of June 30, 2023 and September 30, 2022 at fixed rates and floating rates: June 30, 2023 September 30, 2022 Fair Value % of Debt Fair Value % of Debt Floating rate debt securities, including the debt investments in the JVs $ 2,571,458 86.04 % $ 2,049,644 86.49 % Fixed rate debt securities 417,199 13.96 320,218 13.51 Total $ 2,988,657 100.00 % $ 2,369,862 100.00 % The following table presents the financial instruments carried at fair value as of June 30, 2023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820: Level 1 Level 2 Level 3 Measured at Net Asset Value (a) Total Investments in debt securities (senior secured) $ — $ 245,925 $ 2,528,448 $ — $ 2,774,373 Investments in debt securities (subordinated, including the debt investments in the JVs) — 29,368 184,916 — 214,284 Investments in equity securities (preferred) — — 92,186 — 92,186 Investments in equity securities (common and warrants, including LLC equity interests of the JVs) 6,455 — 20,348 27,973 54,776 Total investments at fair value 6,455 275,293 2,825,898 27,973 3,135,619 Cash equivalents 5,193 — — — 5,193 Derivative asset — 49 — — 49 Total assets at fair value $ 11,648 $ 275,342 $ 2,825,898 $ 27,973 $ 3,140,861 Derivative liability $ — $ 39,567 $ — $ — $ 39,567 Total liabilities at fair value $ — $ 39,567 $ — $ — $ 39,567 __________ (a) In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The following table presents the financial instruments carried at fair value as of September 30, 2022 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820: Level 1 Level 2 Level 3 Measured at Net Asset Value (a) Total Investments in debt securities (senior secured) $ — $ 255,803 $ 1,910,606 $ — $ 2,166,409 Investments in debt securities (subordinated, including the debt investments in the JVs) — 44,065 159,388 — 203,453 Investments in equity securities (preferred) — — 79,523 — 79,523 Investments in equity securities (common and warrants, including LLC equity interests of the JVs) 4,053 — 19,958 20,715 44,726 Total investments at fair value 4,053 299,868 2,169,475 20,715 2,494,111 Cash equivalents 5,261 — — — 5,261 Derivative assets — 6,789 — — 6,789 Total assets at fair value $ 9,314 $ 306,657 $ 2,169,475 $ 20,715 $ 2,506,161 Derivative liability $ — $ 41,969 $ — $ — $ 41,969 Total liabilities at fair value $ — $ 41,969 $ — $ — $ 41,969 __________ (a) In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. When a determination is made to classify a financial instrument within Level 3 of the valuation hierarchy, the determination is based upon the fact that the unobservable factors are significant to the overall fair value measurement. However, Level 3 financial instruments typically have both unobservable or Level 3 components and observable components (i.e. components that are actively quoted and can be validated by external sources). Accordingly, the appreciation (depreciation) in the tables below includes changes in fair value due in part to observable factors that are part of the valuation methodology. Transfers between levels are recognized at the beginning of the reporting period. The following table provides a roll-forward in the changes in fair value from March 31, 2023 to June 30, 2023 for all investments for which the Company determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of March 31, 2023 $ 2,493,622 $ 183,756 $ 91,447 $ 25,509 $ 2,794,334 Purchases 228,375 4,183 — 182 232,740 Sales and repayments (191,409) (350) — (7,320) (199,079) Transfers out (a) — (2,708) — — (2,708) Capitalized PIK interest income 3,610 358 — — 3,968 Accretion of OID 4,086 381 — — 4,467 Net unrealized appreciation (depreciation) (8,027) (704) 739 1,893 (6,099) Net realized gains (losses) (1,809) — — 84 (1,725) Fair value as of June 30, 2023 $ 2,528,448 $ 184,916 $ 92,186 $ 20,348 $ 2,825,898 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2023 $ (10,360) $ (704) $ 739 $ 1,095 $ (9,230) __________ (a) There were transfers out of Level 3 to Level 2 for certain investments during the three months ended June 30, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity. The following table provides a roll-forward in the changes in fair value from March 31, 2022 to June 30, 2022 for all investments for which the Company determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of March 31, 2022 $ 1,955,858 $ 160,727 $ 84,372 $ 33,588 $ 2,234,545 Purchases 60,692 29 — 125 60,846 Sales and repayments (91,730) (733) — (3,890) (96,353) Transfers in (a) 28,475 — — — 28,475 Transfers out (b) — — — (5,838) (5,838) Capitalized PIK interest income 5,537 — — — 5,537 Accretion of OID 5,100 430 — — 5,530 Net unrealized appreciation (depreciation) (33,208) (4,873) (2,756) (873) (41,710) Net realized gains (losses) (10) — — 393 383 Fair value as of June 30, 2022 $ 1,930,714 $ 155,580 $ 81,616 $ 23,505 $ 2,191,415 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2022 $ (33,199) $ (4,873) $ (2,756) $ (917) $ (41,745) __________ (a) There was a transfer into Level 3 from Level 2 for an investment during the three months ended June 30, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity. (b) This transfer out was the result of a transaction in which Level 3 common equity was exchanged for Level 1 common equity The following table provides a roll-forward in the changes in fair value from September 30, 2022 to June 30, 2023 for all investments for which the Company determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of September 30, 2022 $ 1,910,606 $ 159,388 $ 79,523 $ 19,958 $ 2,169,475 Purchases (a) 980,595 26,508 14,296 5,610 1,027,009 Sales and repayments (357,903) (1,396) — (8,295) (367,594) Transfers in (b) 19,075 — — — 19,075 Capitalized PIK interest income 12,549 376 — — 12,925 Accretion of OID 11,684 1,109 — — 12,793 Net unrealized appreciation (depreciation) (45,019) (1,069) (1,633) 2,804 (44,917) Net realized gains (losses) (3,139) — — 271 (2,868) Fair value as of June 30, 2023 $ 2,528,448 $ 184,916 $ 92,186 $ 20,348 $ 2,825,898 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the nine months ended June 30, 2023 $ (46,680) $ (1,069) $ (1,633) $ (355) $ (49,737) __________ (a) Includes Level 3 investments acquired in connection with the OSI2 Merger during the nine months ended June 30, 2023. (b) There was a transfer into Level 3 from Level 2 for an investment during the nine months ended June 30, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity. The following table provides a roll-forward in the changes in fair value from September 30, 2021 to June 30, 2022 for all investments for which the Company determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of September 30, 2021 $ 1,878,536 $ 176,317 $ 63,565 $ 43,163 $ 2,161,581 Purchases 437,922 3,777 19,243 2,180 463,122 Sales and repayments (391,959) (21,868) (163) (12,836) (426,826) Transfers in (a) 37,042 — — — 37,042 Transfers out (a)(b) (17,070) — — (5,838) (22,908) Capitalized PIK interest income 16,653 313 — — 16,966 Accretion of OID 19,048 1,628 — — 20,676 Net unrealized appreciation (depreciation) (57,909) (4,587) (517) (2,520) (65,533) Net realized gains (losses) 8,451 — (512) (644) 7,295 Fair value as of June 30, 2022 $ 1,930,714 $ 155,580 $ 81,616 $ 23,505 $ 2,191,415 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the nine months ended June 30, 2022 $ (45,187) $ (4,734) $ (752) $ (7,629) $ (58,302) __________ (a) There were transfers into/out of Level 3 from/to Level 2 for certain investments during the nine months ended June 30, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity. (b) This transfer out was the result of a transaction in which Level 3 common equity was exchanged for Level 1 common equity. Significant Unobservable Inputs for Level 3 Investments The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of June 30, 2023: Asset Fair Value Valuation Technique Unobservable Input Range Weighted Senior Secured Debt $ 2,058,831 Market Yield Market Yield (b) 9.0% - 38.0% 14.1% 43,954 Enterprise Value Revenue Multiple (c) 5.0x - 7.0x 6.0x 34,466 Enterprise Value EBITDA Multiple (c) 3.4x - 5.4x 5.2x 32,379 Transaction Precedent Transaction Price (d) N/A - N/A N/A 358,818 Broker quotations Broker Quoted Price (e) N/A - N/A N/A Subordinated Debt 18,464 Market Yield Market Yield (b) 10.0% - 22.0% 11.4% 4,164 Broker Quotations Broker Quoted Price (e) N/A - N/A N/A Debt Investments in the JVs 162,288 Enterprise Value N/A (f) N/A - N/A N/A Preferred & Common Equity 70,852 Enterprise Value Revenue Multiple (c) 0.4x - 6.0x 1.4x 37,322 Enterprise Value EBITDA Multiple (c) 1.7x - 17.5x 11.1x 1,415 Enterprise Value Asset Multiple (c) 1.0x - 1.4x 1.4x 2,945 Transaction Precedent Transaction Price (d) N/A - N/A N/A Total $ 2,825,898 __________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participants would take into account market yield when pricing the investment. (c) Used when market participants would use such multiples when pricing the investment. (d) Used when there is an observable transaction or pending event for the investment. (e) Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (f) Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique. The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of September 30, 2022: Asset Fair Value Valuation Technique Unobservable Input Range Weighted Senior Secured Debt $ 1,599,148 Market Yield Market Yield (b) 9.0% - 30.0% 13.7% 14,333 Enterprise Value EBITDA Multiple (c) 5.0x - 7.0x 6.0x 297,125 Broker Quotations Broker Quoted Price (e) N/A - N/A N/A Subordinated Debt 12,855 Market Yield Market Yield (b) 10.0% - 19.0% 13.8% Debt Investments in the JVs 146,533 Enterprise Value N/A (f) N/A - N/A N/A Preferred & Common Equity 61,693 Enterprise Value Revenue Multiple (c) 0.4x - 10.1x 4.3x 36,913 Enterprise Value EBITDA Multiple (c) 3.0x - 20.0x 11.4x 3 Enterprise Value Asset Multiple (c) 0.9x - 1.1x 1.0x 872 Transaction Precedent Transaction Price (d) N/A - N/A N/A Total $ 2,169,475 __________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participants would take into account market yield when pricing the investment. (c) Used when market participants would use such multiples when pricing the investment. (d) Used when there is an observable transaction or pending event for the investment. (e) Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (f) Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique. Under the market yield technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt securities is the market yield. Increases or decreases in the market yield may result in a lower or higher fair value measurement, respectively. Under the EV technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt or equity securities is the earnings before interest, taxes, depreciation and amortization ("EBITDA"), revenue or asset multiple, as applicable. Increases or decreases in the valuation multiples in isolation may result in a higher or lower fair value measurement, respectively. Financial Instruments Disclosed, But Not Carried, At Fair Value The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of June 30, 2023 and the level of each financial liability within the fair value hierarchy: Carrying Fair Value Level 1 Level 2 Level 3 Syndicated Facility payable $ 800,000 $ 800,000 $ — $ — $ 800,000 OSI2 Citibank Facility payable 335,000 335,000 — — 335,000 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount) 297,928 285,717 — 285,717 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 307,138 302,260 — 302,260 — Total $ 1,740,066 $ 1,722,977 $ — $ 587,977 $ 1,135,000 The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of September 30, 2022 and the level of each financial liability within the fair value hierarchy: Carrying Fair Value Level 1 Level 2 Level 3 Syndicated Facility payable $ 540,000 $ 540,000 $ — $ — $ 540,000 Citibank Facility payable 160,000 160,000 — — 160,000 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount) 296,991 283,077 — 283,077 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 304,052 294,028 — 294,028 — Total $ 1,301,043 $ 1,277,105 $ — $ 577,105 $ 700,000 The principal values of the credit facilities payable approximate fair value due to their variable interest rates and are included in Level 3 of the hierarchy. Oaktree used market quotes as of the valuation date to estimate the fair value of the Company's 3.500% notes due 2025 (the "2025 Notes") and 2.700% notes due 2027 (the "2027 Notes"), which are included in Level 2 of the hierarchy. Portfolio Composition Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables: June 30, 2023 September 30, 2022 Cost: % of Total Investments % of Total Investments Senior secured debt $ 2,886,772 87.59 % $ 2,227,245 85.08 % Debt investments in the JVs 162,653 4.93 % 146,444 5.59 % Preferred equity 99,597 3.02 % 85,300 3.26 % Subordinated debt 55,450 1.68 % 67,147 2.57 % LLC equity interests of the JVs 54,791 1.66 % 49,322 1.88 % Common equity and warrants 37,022 1.12 % 42,296 1.62 % Total $ 3,296,285 100.00 % $ 2,617,754 100.00 % June 30, 2023 September 30, 2022 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Senior secured debt $ 2,774,373 88.48 % 183.80 % $ 2,166,409 86.86 % 173.93 % Debt investments in the JVs 162,288 5.18 % 10.75 % 146,533 5.88 % 11.77 % Preferred equity 92,186 2.94 % 6.11 % 79,523 3.19 % 6.38 % Subordinated debt 51,996 1.66 % 3.44 % 56,920 2.28 % 4.57 % LLC equity interests of the JVs 27,973 0.89 % 1.85 % 20,715 0.83 % 1.66 % Common equity and warrants 26,803 0.85 % 1.78 % 24,011 0.96 % 1.93 % Total $ 3,135,619 100.00 % 207.73 % $ 2,494,111 100.00 % 200.24 % The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets: June 30, 2023 September 30, 2022 Cost: % of Total Investments % of Total Investments Northeast $ 994,695 30.17 % $ 747,420 28.55 % Midwest 448,981 13.62 % 373,236 14.26 % Southeast 446,546 13.55 % 356,041 13.60 % West 440,634 13.37 % 358,306 13.69 % International 434,844 13.19 % 301,242 11.51 % South 197,754 6.00 % 168,819 6.45 % Northwest 168,992 5.13 % 91,382 3.49 % Southwest 163,839 4.97 % 221,308 8.45 % Total $ 3,296,285 100.00 % $ 2,617,754 100.00 % June 30, 2023 September 30, 2022 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Northeast $ 936,888 29.87 % 62.07 % $ 696,368 27.93 % 55.90 % International 432,986 13.81 % 28.69 % 279,646 11.21 % 22.45 % Midwest 429,317 13.69 % 28.44 % 356,934 14.31 % 28.66 % West 428,232 13.66 % 28.37 % 345,251 13.84 % 27.72 % Southeast 406,523 12.96 % 26.93 % 344,567 13.82 % 27.66 % South 186,792 5.96 % 12.37 % 166,230 6.66 % 13.35 % Northwest 166,089 5.30 % 11.00 % 90,131 3.61 % 7.24 % Southwest 148,792 4.75 % 9.86 % 214,984 8.62 % 17.26 % Total $ 3,135,619 100.00 % 207.73 % $ 2,494,111 100.00 % 200.24 % The following tables show the composition of the Company's portfolio by industry at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets as of June 30, 2023 and September 30, 2022: June 30, 2023 September 30, 2022 Cost: % of Total Investments % of Total Investments Application Software $ 560,503 16.98 % $ 391,938 14.98 % Multi-Sector Holdings (1) 219,130 6.65 195,766 7.48 Data Processing & Outsourced Services 133,422 4.05 120,477 4.60 Health Care Technology 129,178 3.92 100,084 3.82 Biotechnology 127,394 3.86 109,960 4.20 Pharmaceuticals 121,497 3.69 126,508 4.83 Aerospace & Defense 110,680 3.36 61,963 2.37 Industrial Machinery & Supplies & Components 99,237 3.01 — — Broadline Retail 83,201 2.52 — — Health Care Services 77,364 2.35 58,674 2.24 Real Estate Operating Companies 76,462 2.32 47,585 1.82 Specialized Finance 69,188 2.10 80,864 3.09 Personal Care Products 68,671 2.08 — — Automotive Retail 64,825 1.97 59,254 2.26 Fertilizers & Agricultural Chemicals 64,750 1.96 49,301 1.88 Internet Services & Infrastructure 63,057 1.91 54,095 2.07 Health Care Distributors 62,079 1.88 57,112 2.18 Diversified Financial Services 61,693 1.87 — — Auto Parts & Equipment 61,091 1.85 12,474 0.48 Metal, Glass & Plastic Containers 57,949 1.76 — — Airport Services 55,919 1.70 43,322 1.65 Home Improvement Retail 54,939 1.67 45,802 1.75 Insurance Brokers 52,960 1.61 35,628 1.36 Diversified Metals & Mining 49,787 1.51 — — Leisure Facilities 49,501 1.50 39,768 1.52 Real Estate Services 44,783 1.36 40,243 1.54 Soft Drinks & Non-alcoholic Beverages 43,021 1.31 — — Diversified Support Services 42,706 1.30 37,992 1.45 Other Specialty Retail 41,790 1.27 — — Specialty Chemicals 38,248 1.16 37,319 1.43 Distributors 37,668 1.14 25,278 0.97 Integrated Telecommunication Services 33,663 1.02 34,628 1.32 Electrical Components & Equipment 32,380 0.98 33,814 1.29 Construction & Engineering 27,231 0.83 60,996 2.33 Environmental & Facilities Services 25,943 0.79 20,857 0.80 Advertising 25,597 0.78 28,245 1.08 Passenger Airlines 24,888 0.76 — — Oil & Gas Storage & Transportation 24,231 0.74 22,290 0.85 Home Furnishings 23,832 0.72 19,550 0.75 Gold 23,274 0.71 — — Systems Software 23,089 0.70 14,890 0.57 Health Care Equipment 22,374 0.68 24,353 0.93 Real Estate Development 19,567 0.59 — — Interactive Media & Services 18,963 0.58 — — Hotels, Resorts & Cruise Lines 17,221 0.52 13,960 0.53 Consumer Finance 16,411 0.50 14,492 0.55 Education Services 15,660 0.48 9,080 0.35 IT Consulting & Other Services 15,434 0.47 11,697 0.45 Restaurants 12,589 0.38 9,338 0.36 Movies & Entertainment 12,188 0.37 26,161 1.00 Health Care Supplies 11,675 0.35 36,471 1.39 Food Distributors 5,900 0.18 4,646 0.18 Apparel Retail 5,293 0.16 5,268 0.20 Air Freight & Logistics 4,925 0.15 7,295 0.28 Integrated Oil & Gas 4,887 0.15 4,866 0.19 Research & Consulting Services 4,879 0.15 9,187 0.35 Cable & Satellite 4,687 0.14 20,716 0.79 Other Specialized REITs 4,364 0.13 — — Paper & Plastic Packaging Products & Materials 3,262 0.10 — — Housewares & Specialties 2,908 0.09 2,293 0.09 Electronic Components 2,101 0.06 2,092 0.08 Leisure Products 2,039 0.06 — — Technology Distributors 1,084 0.03 3,163 0.12 Communications Equipment 1,053 0.03 — — Industrial Machinery — — 81,787 3.12 Internet & Direct Marketing Retail — — 67,926 2.59 Personal Products — — 53,214 2.03 Metal & Glass Containers — — 47,704 1.82 Soft Drinks — — 34,272 1.31 Other Diversified Financial Services — — 29,300 1.12 Oil & Gas Refining & Marketing — — 8,627 0.33 Trading Companies & Distributors — — 7,628 0.29 Apparel, Accessories & Luxury Goods — — 5,165 0.20 Specialized REITs — — 4,318 0.16 Diversified Banks — — 3,515 0.13 Construction Materials — — 2,331 0.09 Alternative Carriers — — 212 0.01 $ 3,296,285 100.00 % $ 2,617,754 100.00 % June 30, 2023 September 30, 2022 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Application Software $ 544,685 17.38 % 36.03 % $ 384,589 15.43 % 30.87 % Multi-Sector Holdings (1) 192,160 6.13 12.73 167,248 6.71 13.43 Biotechnology 128,343 4.09 8.50 108,465 4.35 8.71 Data Processing & Outsourced Services 124,548 3.97 8.25 111,335 4.46 8.94 Pharmaceuticals 116,199 3.71 7.70 119,511 4.79 9.59 Health Care Technology 115,659 3.69 7.66 97,315 3.90 7.81 Aerospace & Defense 111,464 3.55 7.38 61,881 2.48 4.97 Industrial Machinery & Supplies & Components 99,021 3.16 6.56 — — — Broadline Retail 80,882 2.58 5.36 — — — Real Estate Operating Companies 75,111 2.40 4.98 48,062 1.93 3.86 Specialized Finance 66,333 2.12 4.39 73,087 2.93 5.87 Fertilizers & Agricultural Chemicals 63,185 2.02 4.19 51,972 2.08 4.17 Internet Services & Infrastructure 62,726 2.00 4.16 53,797 2.16 4.32 Automotive Retail 62,356 1.99 4.13 57,629 2.31 4.63 Health Care Services 62,190 1.98 4.12 45,943 1.84 3.69 Diversified Financial Services 61,073 1.95 4.05 — — — Personal Care Products 60,962 1.94 4.04 — — — Auto Parts & Equipment 60,809 1.94 4.03 11,469 0.46 0.92 Health Care Distributors 60,340 1.92 4.00 54,662 2.19 4.39 Airport Services 55,221 1.76 3.66 42,883 1.72 3.44 Insurance Brokers 54,680 1.74 3.62 33,081 1.33 2.66 Home Improvement Retail 54,235 1.73 3.59 45,421 1.82 3.65 Diversified Metals & Mining 49,809 1.59 3.30 — — — Leisure Facilities 46,990 1.50 3.11 39,258 1.57 3.15 Real Estate Services 44,227 1.41 2.93 39,573 1.59 3.18 Metal, Glass & Plastic Containers 43,954 1.40 2.91 — — — Soft Drinks & Non-alcoholic Beverages 42,798 1.36 2.84 — — — Other Specialty Retail 41,790 1.33 2.77 — — — Diversified Support Services 41,302 1.32 2.74 36,712 1.47 2.95 Distributors 36,829 1.17 2.44 24,494 0.98 1.97 Electrical Components & Equipment 32,379 1.03 2.15 32,933 1.32 2.64 Specialty Chemicals 32,231 1.03 2.14 33,969 1.36 2.73 Integrated Telecommunication Services 30,922 0.99 2.05 32,201 1.29 2.59 Passenger Airlines 26,985 0.86 1.79 — — — Construction & Engineering 26,901 0.86 1.78 61,188 2.45 4.91 Environmental & Facilities Services 25,436 0.81 1.69 20,585 0.83 1.65 Gold 23,292 0.74 1.54 — — — Health Care Equipment 22,531 0.72 1.49 24,161 0.97 1.94 Systems Software 22,168 0.71 1.47 12,834 0.51 1.03 Oil & Gas Storage & Transportation 21,660 0.69 1.43 20,853 0.84 1.67 Home Furnishings 19,514 0.62 1.29 18,188 0.73 1.46 Real Estate Development 19,246 0.61 1.28 — — — Interactive Media & Services 19,000 0.61 1.26 — — — Advertising 18,969 0.60 1.26 26,948 1.08 2.16 Hotels, Resorts & Cruise Lines 17,261 0.55 1.14 13,985 0.56 1.12 Education Services 14,116 0.45 0.94 8,582 0.34 0.69 Consumer Finance 12,616 0.40 0.84 13,284 0.53 1.07 Restaurants 12,168 0.39 0.81 8,692 0.35 0.70 Movies & Entertainment 11,865 0.38 0.79 26,645 1.07 2.14 Health Care Supplies 11,408 0.36 0.76 36,577 1.47 2.94 IT Consulting & Other Services 11,176 0.36 0.74 8,596 0.34 0.69 Food Distributors 5,296 0.17 0.35 3,367 0.13 0.27 Apparel Retail 5,230 0.17 0.35 5,223 0.21 0.42 Integrated Oil & Gas 4,810 0.15 0.32 4,872 0.20 0.39 Cable & Satellite 4,672 0.15 0.31 19,576 0.78 1.57 Research & Consulting Services 4,632 0.15 0.31 8,573 0.34 0.69 Air Freight & Logistics 4,025 0.13 0.27 6,405 0.26 0.51 Other Specialized REITs 3,438 0.11 0.23 — — — Paper & Plastic Packaging Products & Materials 3,100 0.10 0.21 — — — Housewares & Specialties 2,858 0.09 0.19 2,456 0.10 0.20 Leisure Products 1,995 0.06 0.13 — — — Electronic Components 1,834 0.06 0.12 1,890 0.08 0.15 Technology Distributors 1,024 0.03 0.07 2,997 0.12 0.24 Communications Equipment 980 0.03 0.06 — — — Industrial Machinery — — — 81,008 3.25 6.50 Internet & Direct Marketing Retail — — — 70,419 2.82 5.65 Personal Products — — — 50,150 2.01 4.03 Metal & Glass Containers — — — 47,599 1.91 3.82 Soft Drinks — — — 33,670 1.35 2.70 Other Diversified Financial Services — — — 24,326 0.98 1.95 June 30, 2023 September 30, 2022 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Oil & Gas Refining & Marketing $ — — — $ 8,604 0.34 0.69 Trading Companies & Distributors — — — 5,567 0.22 0.45 Diversified Banks — — — 3,402 0.14 0.27 Specialized REITs — — — 3,264 0.13 0.26 Construction Materials — — — 1,934 0.08 0.16 Alternative Carriers — — — 201 0.01 0.02 Total $ 3,135,619 100.00 % 207.73 % $ 2,494,111 100.00 % 200.24 % ___________________ (1) This industry includes the Company's investments in the JVs. As of June 30, 2023 and September 30, 2022, the Company had no single investment that represented greater than 10% of the total investment portfolio at fair value. Income, consisting of interest, dividends, fees, other investment income and realization of gains or losses, may fluctuate and in any given period can be highly concentrated among several investments. Senior Loan Fund JV I, LLC In May 2014, the Company entered into an LLC agreement with Kemper to form SLF JV I. The Company co-invests in senior secured loans of middle-market companies and other corporate debt securities with Kemper through its investment in SLF JV I. SLF JV I is managed by a four person Board of Directors, two of whom are selected by the Company and two of whom are selected by Kemper. All portfolio decisions and investment decisions in respect of SLF JV I must be approved by the SLF JV I investment committee, which consists of one representative selected by the Company and one representative selected by Kemper (with approval from a representative of each required). Since the Company does not have a controlling financial interest in SLF JV I, the Company does not consolidate SLF JV I. SLF JV I is capitalized pro rata with LLC equity interes |
Fee Income
Fee Income | 9 Months Ended |
Jun. 30, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Fee Income | Fee IncomeFor the three and nine months ended June 30, 2023, the Company recorded total fee income of $1.6 million and $6.0 million, respectively, of which $0.2 million and $0.8 million, respectively, was recurring in nature. For the three and nine months ended June 30, 2022, the Company recorded total fee income of $2.3 million and $5.1 million, respectively, of which $0.2 million and $0.7 million, respectively, was recurring in nature. Recurring fee income primarily consisted of servicing fees and certain exit fees. |
Share Data and Net Assets
Share Data and Net Assets | 9 Months Ended |
Jun. 30, 2023 | |
Stockholders' Equity Note [Abstract] | |
Share Data and Net Assets | Share Data and Net Assets The share and per share information for periods prior to March 31, 2023 disclosed in Note 5 have been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. Earnings per Share The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share , for the three and nine months ended June 30, 2023 and 2022: (Share amounts in thousands) Three months ended Three months ended Nine months ended Nine months ended Earnings (loss) per common share — basic and diluted: Net increase (decrease) in net assets resulting from operations $ 36,685 $ (37,834) $ 71,379 $ 16,015 Weighted average common shares outstanding — basic and diluted 77,080 61,123 70,431 60,593 Earnings (loss) per common share — basic and diluted $ 0.48 $ (0.62) $ 1.01 $ 0.26 Changes in Net Assets The following table presents the changes in net assets for the three and nine months ended June 30, 2023: Common Stock (Share amounts in thousands) Shares Par Value Additional paid-in-capital Accumulated Overdistributed Earnings Total Net Assets Balance as of September 30, 2022 61,125 $ 611 $ 1,827,721 $ (582,769) $ 1,245,563 Net investment income — — — 38,808 38,808 Net unrealized appreciation (depreciation) — — — (22,982) (22,982) Net realized gains (losses) — — — (3,203) (3,203) (Provision) benefit for taxes on realized and unrealized gains (losses) — — — 549 549 Distributions to stockholders — — — (58,679) (58,679) Issuance of common stock under dividend reinvestment plan 95 1 1,932 — 1,933 Balance as of December 31, 2022 61,220 $ 612 $ 1,829,653 $ (628,276) $ 1,201,989 Net investment income — — — 45,978 45,978 Net unrealized appreciation (depreciation) — — — (18,279) (18,279) Net realized gains (losses) — — — (6,111) (6,111) (Provision) benefit for taxes on realized and unrealized gains (losses) — — — (66) (66) Distributions to stockholders — — — (42,395) (42,395) Issuance of common stock in connection with the OSI2 Merger 15,860 159 333,875 — 334,034 Issuance of common stock under dividend reinvestment plan 68 1 1,294 — 1,295 Repurchase of common stock under dividend reinvestment plan (68) (1) (1,294) — (1,295) Balance as of March 31, 2023 77,080 $ 771 $ 2,163,528 $ (649,149) $ 1,515,150 Net investment income — — — 48,413 48,413 Net unrealized appreciation (depreciation) — — — (1,039) (1,039) Net realized gains (losses) — — — (10,603) (10,603) (Provision) benefit for taxes on realized and unrealized gains (losses) — — — (86) (86) Distributions to stockholders — — — (42,394) (42,394) Issuance of common stock under dividend reinvestment plan 57 1 1,122 — 1,123 Repurchase of common stock under dividend reinvestment plan (57) (1) (1,122) — (1,123) Balance as of June 30, 2023 77,080 $ 771 $ 2,163,528 $ (654,858) $ 1,509,441 The following table presents the changes in net assets for the three and nine months ended June 30, 2022: Common Stock Shares Par Value Additional paid-in-capital Accumulated Overdistributed Earnings Total Net Assets Balance as of September 30, 2021 60,120 $ 601 $ 1,805,557 $ (493,335) $ 1,312,823 Net investment income — — — 32,295 32,295 Net unrealized appreciation (depreciation) — — — (4,586) (4,586) Net realized gains (losses) — — — 9,321 9,321 (Provision) benefit for taxes on realized and unrealized gains (losses) — — — 2,378 2,378 Distributions to stockholders — — — (27,956) (27,956) Issuance of common stock under dividend reinvestment plan 36 1 785 — 786 Balance as of December 31, 2021 60,156 $ 602 $ 1,806,342 $ (481,883) $ 1,325,061 Net investment income — — — 40,098 40,098 Net unrealized appreciation (depreciation) — — — (27,038) (27,038) Net realized gains (losses) — — — 1,402 1,402 (Provision) benefit for taxes on realized and unrealized gains (losses) — — — (21) (21) Distributions to stockholders — — — (29,271) (29,271) Issuance of common stock in connection with the "at the market" offering 877 9 19,370 — 19,379 Issuance of common stock under dividend reinvestment plan 35 — 766 — 766 Balance as of March 31, 2022 61,068 $ 611 $ 1,826,478 $ (496,713) $ 1,330,376 Net investment income — — — 40,370 40,370 Net unrealized appreciation (depreciation) — — — (86,755) (86,755) Net realized gains (losses) — — — 9,212 9,212 (Provision) benefit for taxes on realized and unrealized gains (losses) — — — (661) (661) Distributions to stockholders — — — (30,256) (30,256) Issuance of common stock in connection with the "at the market" offering 57 — 1,243 — 1,243 Issuance of common stock under dividend reinvestment plan 44 1 873 — 874 Repurchases of common stock under dividend reinvestment plan (44) (1) (873) — (874) Balance as of June 30, 2022 61,125 $ 611 $ 1,827,721 $ (564,803) $ 1,263,529 Distributions Distributions to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the Board of Directors and is based on management’s estimate of the Company’s annual taxable income. Net realized capital gains, if any, may be distributed to stockholders or retained for reinvestment. The Company has adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of any distributions the Company declares in cash on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, if the Company’s Board of Directors declares a cash distribution, then the Company’s stockholders who have not “opted out” of the Company’s DRIP will have their cash distribution automatically reinvested in additional shares of the Company’s common stock, rather than receiving the cash distribution. If the Company’s shares are trading at a premium to net asset value, the Company typically issues new shares to implement the DRIP with such shares issued at the greater of the most recently computed net asset value per share of common stock or 95% of the current market price per share of common stock on the payment date for such distribution. If the Company’s shares are trading at a discount to net asset value, the Company typically purchases shares in the open market in connection with the Company’s obligations under the DRIP. For income tax purposes, the Company has reported its distributions for the 2022 calendar year as ordinary income. The character of such distributions was appropriately reported to the Internal Revenue Service and stockholders for the 2022 calendar year. To the extent the Company’s taxable earnings for a fiscal and taxable year fall below the amount of distributions paid for the fiscal and taxable year, a portion of the total amount of the Company’s distributions for the fiscal and taxable year is deemed a return of capital for U.S. federal income tax purposes to the Company’s stockholders. The following table reflects the distributions per share that the Company has paid, including shares issued under the DRIP, on its common stock during the nine months ended June 30, 2023 and 2022: Distribution Date Declared Record Date Payment Date Amount Cash DRIP Shares DRIP Shares Quarterly November 10, 2022 December 15, 2022 December 30, 2022 $ 0.54 $ 32.0 million 53,369 (1) $ 1.1 million Special November 10, 2022 December 15, 2022 December 30, 2022 0.42 24.8 million 41,510 (1) 0.8 million Quarterly January 27, 2023 March 15, 2023 March 31, 2023 0.55 41.1 million 68,412 (2) 1.3 million Quarterly April 28, 2023 June 15, 2023 June 30, 2023 0.55 41.3 million 57,279 (2) 1.1 million Total for the nine months ended June 30, 2023 $ 2.06 $ 139.1 million 220,570 $ 4.4 million Distribution Date Declared Record Date Payment Date Amount Cash DRIP Shares DRIP Shares Quarterly October 13, 2021 December 15, 2021 December 31, 2021 $ 0.465 $ 27.2 million 35,990 (1) $ 0.8 million Quarterly January 28, 2022 March 15, 2022 March 31, 2022 0.48 28.5 million 34,804 (1) 0.8 million Quarterly April 29, 2022 June 15, 2022 June 30, 2022 0.495 29.4 million 43,676 (2) 0.9 million Total for the nine months ended June 30, 2022 $ 1.44 $ 85.1 million 114,470 $ 2.4 million __________ (1) New shares were issued and distributed. (2) Shares were purchased on the open market and distributed. (3) Totals may not sum due to rounding. Common Stock Issuances On January 23, 2023, in connection with the OSI2 Merger, the Company issued an aggregate of 15,860,200 shares of common stock to former OSI2 stockholders. During the three and nine months ended June 30, 2023, the Company issued zero and 94,879 shares of common stock, respectively, as part of the DRIP. During the three and nine months ended June 30, 2022, the Company issued an aggregate of zero and 70,794 shares of common stock, respectively, as part of the DRIP. On February 7, 2022, the Company entered into an equity distribution agreement by and among the Company, Oaktree, Oaktree Administrator and Keefe, Bruyette & Woods, Inc., JMP Securities LLC, Raymond James & Associates, Inc. and SMBC Nikko Securities America, Inc., as placement agents, in connection with the issuance and sale by the Company of shares of common stock, having an aggregate offering price of up to $125.0 million. The equity distribution agreement was amended on February 8, 2023 to allow for the sale of shares of the Company’s common stock having an aggregate offering price of up to $125 million under the Company’s current registration statement. Sales of the common stock may be made in negotiated transactions or transactions that are deemed to be “at the market,” as defined in Rule 415 under the Securities Act of 1933, as amended, including sales made directly on the Nasdaq Global Select Market or similar securities exchanges or sales made to or through a market maker other than on an exchange, at prices related to the prevailing market prices or at negotiated prices. In connection with the "at the market" offering, the Company did not issue or sell any shares of common stock during the nine months ended June 30, 2023. In connection with the "at the market" offering, the Company issued and sold 2,801,206 shares of common stock during the nine months ended June 30, 2022 for net proceeds of $20.6 million (net of offering costs). |
Borrowings
Borrowings | 9 Months Ended |
Jun. 30, 2023 | |
Debt Disclosure [Abstract] | |
Borrowings | Borrowings Syndicated Facility On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans, mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank. As of June 30, 2023, the size of the Syndicated Facility was $1.218 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances. As of June 30, 2023, (i) the period during which the Company may make drawings with respect to $1.035 billion of commitments will expire on June 23, 2027 and the maturity date is June 23, 2028, (ii) the period during which the Company may make drawings with respect to the remaining commitments will expire on May 4, 2025 and the maturity date is May 4, 2026 and (iii) the interest rate margin for (a) SOFR loans (which may be 1- or 3-month, at the Company’s option) was 2.00% plus a SOFR adjustment which ranges between 0.11448% and 0.26161% and (b) alternate base rate loans was 1.00%. The Syndicated Facility is secured by substantially all of the Company’s assets (excluding, among other things, investments held in and by certain subsidiaries of the Company (including OSI 2 Senior Lending SPV, LLC) or investments in certain portfolio companies of the Company) and guaranteed by certain subsidiaries of the Company. As of June 30, 2023, except for assets that were held by OSI 2 Senior Lending SPV, LLC and certain immaterial subsidiaries, substantially all of the Company's assets are pledged as collateral under the Syndicated Facility. The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of June 30, 2023, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions. As of June 30, 2023 and September 30, 2022, the Company had $800.0 million and $540.0 million of borrowings outstanding under the Syndicated Facility, respectively, which had a fair value of $800.0 million and $540.0 million, respectively. The Company's borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 6.584% and 2.406% for the nine months ended June 30, 2023 and 2022, respectively. For the three and nine months ended June 30, 2023, the Company recorded interest expense (inclusive of fees) of $14.3 million and $37.4 million, respectively, related to the Syndicated Facility. For the three and nine months ended June 30, 2022, the Company recorded interest expense (inclusive of fees) of $4.8 million and $12.6 million, respectively, related to the Syndicated Facility. Citibank Facility On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC (formerly OCSI Senior Funding II LLC), the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. On May 25, 2023, in connection with an amendment to the OSI2 Citibank Facility, the Citibank Facility was terminated. In connection with the termination of the Citibank Facility, the Company accelerated $0.6 million of deferred financing costs into interest expense during the three months ended June 30, 2023. As of September 30, 2022, the Company had $160.0 million outstanding under the Citibank Facility, which had a fair value of $160.0 million. The Company's borrowings under the Citibank Facility bore interest at a weighted average interest rate of 6.762% and 2.563% for the nine months ended June 30, 2023 and 2022, respectively. For the three and nine months ended June 30, 2023, the Company recorded interest expense (inclusive of fees) of $2.4 million and $8.0 million, respectively, related to the Citibank Facility. For the three and nine months ended June 30, 2022, the Company recorded interest expense (inclusive of fees) of $1.6 million and $3.5 million, respectively, related to the Citibank Facility. OSI2 Citibank Facility On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “OSI2 Citibank Facility”) with OSI 2 Senior Lending SPV, LLC (“OSI 2 SPV”), the Company’s wholly-owned and consolidated subsidiary, as the borrower, the Company, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent. As of June 30, 2023, the Company was able to borrow up to $400 million under the OSI2 Citibank Facility (subject to borrowing base and other limitations). As of June 30, 2023, the OSI2 Citibank Facility has a reinvestment period through May 25, 2025, during which advances may be made, and matures on January 26, 2027. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% on all other eligible loans and (b) for all other lenders, SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans, in all cases subject to a minimum overall rate of SOFR plus 2.50% per annum. After the reinvestment period, the applicable spread is 4.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility. As of June 30, 2023, the Company had $335.0 million outstanding under the OSI2 Citibank Facility, which had a fair value of $335.0 million. The Company’s borrowings under the OSI2 Citibank Facility bore interest at a weighted average interest rate of 7.275% for the period from January 23, 2023 to June 30, 2023. For the three months ended June 30, 2023 and the period from January 23, 2023 to June 30, 2023, the Company recorded interest expense (inclusive of fees) of $4.9 million and $8.0 million, respectively, related to the OSI2 Citibank Facility. 2025 Notes On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes. The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2025 Notes is paid semi-annually on February 25 and August 25 at a rate of 3.500% per annum. The 2025 Notes mature on February 25, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2025 Notes can require the Company to repurchase the 2025 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2025 Notes Indenture. The 2025 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the nine months ended June 30, 2023, the Company did not repurchase any of the 2025 Notes in the open market. The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture. 2027 Notes On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes. The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2027 Notes is paid semi-annually on January 15 and July 15, beginning on January 15, 2022, at a rate of 2.700% per annum. The 2027 Notes mature on January 15, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2027 Notes can require the Company to repurchase the 2027 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2027 Notes Indenture. The 2027 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the nine months ended June 30, 2023, the Company did not repurchase any of the 2027 Notes in the open market. The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture. In connection with the 2027 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 2.700% and pays a floating interest rate of the three-month LIBOR plus 1.658% on a notional amount of $350 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap. The below table presents the components of the carrying value of the 2025 Notes and the 2027 Notes as of June 30, 2023 and September 30, 2022: As of June 30, 2023 As of September 30, 2022 ($ in millions) 2025 Notes 2027 Notes 2025 Notes 2027 Notes Principal $ 300.0 $ 350.0 $ 300.0 $ 350.0 Unamortized financing costs (1.2) (2.7) (1.8) (3.2) Unaccreted discount (0.8) (0.6) (1.2) (0.7) Interest rate swap fair value adjustment — (39.6) — (42.0) Net carrying value $ 298.0 $ 307.1 $ 297.0 $ 304.1 Fair Value $ 285.7 $ 302.3 $ 283.1 $ 294.0 The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three and nine months ended June 30, 2023: ($ in millions) 2025 Notes 2027 Notes Three months ended June 30, 2023 Nine months ended June 30, 2023 Three months ended June 30, 2023 Nine months ended June 30, 2023 Coupon interest $ 2.6 $ 7.9 $ 2.4 $ 7.1 Amortization of financing costs and discount 0.3 0.9 0.2 0.7 Effect of interest rate swap — — 3.7 9.4 Total interest expense $ 2.9 $ 8.8 $ 6.3 $ 17.2 Coupon interest rate (net of effect of interest rate swap for 2027 Notes) 3.500 % 3.500 % 6.912 % 6.274 % The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three and nine months ended June 30, 2022: ($ in millions) 2025 Notes 2027 Notes Three months ended June 30, 2022 Nine months ended June 30, 2022 Three months ended June 30, 2022 Nine months ended June 30, 2022 Coupon interest $ 2.6 $ 7.9 $ 2.4 $ 7.1 Amortization of financing costs and discount 0.3 0.9 0.2 0.7 Effect of interest rate swap — — (0.1) (1.6) Total interest expense $ 2.9 $ 8.8 $ 2.5 $ 6.2 Coupon interest rate (net of effect of interest rate swap for 2027 Notes) 3.500 % 3.500 % 2.572 % 2.069 % |
Taxable_Distributable Income an
Taxable/Distributable Income and Dividend Distributions | 9 Months Ended |
Jun. 30, 2023 | |
Income Tax Disclosure [Abstract] | |
Taxable/Distributable Income and Dividend Distributions | Taxable/Distributable Income and Dividend Distributions Taxable income differs from net increase (decrease) in net assets resulting from operations primarily due to: (1) unrealized appreciation (depreciation) on investments and foreign currency, as gains and losses are not included in taxable income until they are realized; (2) origination and exit fees received in connection with investments in portfolio companies; (3) organizational costs; (4) income or loss recognition on exited investments; and (5) recognition of interest income on certain loans. As of September 30, 2022, the Company had net capital loss carryforwards of $523.7 million to offset net capital gains that will not expire, to the extent available and permitted by U.S. federal income tax law, of which $64.5 million are available to offset future short-term capital gains and $459.2 million are available to offset future long-term capital gains. A portion of such net capital loss carryfowards represented a realized loss under sections 382 and 383 of the Code, which is carried forward to future years to offset future gains subject to certain limitations. Listed below is a reconciliation of "net increase (decrease) in net assets resulting from operations" to taxable income for the three and nine months ended June 30, 2023 and 2022. Three months ended Three months ended Nine months ended Nine months ended Net increase (decrease) in net assets resulting from operations $ 36,685 $ (37,834) $ 71,379 $ 16,015 Net unrealized (appreciation) depreciation 1,039 86,755 42,300 118,379 Book/tax difference due to organizational costs — (21) — (65) Book/tax difference due to capital losses utilized 12,118 (3,736) 20,380 (19,183) Other book/tax differences (3,825) (8,819) (14,912) (18,597) Taxable/Distributable Income (1) $ 46,017 $ 36,345 $ 119,147 $ 96,549 __________ (1) The Company's taxable income for the three and nine months ended June 30, 2023 is an estimate and will not be finally determined until the Company files its tax return for the fiscal year ending September 30, 2023. Therefore, the final taxable income may be different than the estimate. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences. When assessing the realizability of deferred tax assets, the Company considers whether it is probable that some or all of the deferred tax assets will not be realized. In determining whether the deferred tax assets are realizable, the Company considers the period of expiration of the tax asset, historical and projected taxable income and tax liabilities for the tax jurisdiction in which the tax asset is located. The deferred tax asset recognized by the Company, as it relates to the higher tax basis in the carrying value of certain assets compared to the book basis of those assets, will be recognized in future years by these taxable entities. Deferred tax assets are based on the amount of the tax benefit that the Company’s management has determined is more likely than not to be realized in future periods. In determining the realizability of this tax benefit, management considered numerous factors that will give rise to pre-tax income in future periods. Among these are the historical and expected future book and tax basis pre-tax income of the Company and unrealized gains in the Company’s assets at the determination date. Based on these and other factors, the Company determined that, as of June 30, 2023, $6.1 million of the $8.8 million deferred tax assets would not more likely than not be realized in future periods. As of June 30, 2023, the Company recorded a net deferred tax asset of $2.7 million on the Consolidated Statements of Assets and Liabilities. For the three months ended June 30, 2023, the Company recognized a total expense for income tax related to realized and unrealized gains (losses) of $0.1 million, which was composed of (i) a current income tax expense of approximately $1.0 million and (ii) a deferred income tax benefit of approximately $0.9 million, which resulted from unrealized depreciation on investments held by the Company’s wholly-owned taxable subsidiaries. For the nine months ended June 30, 2023, the Company recognized a total benefit for income tax related to realized and unrealized gains (losses) of $0.4 million, which was composed of (i) a current income tax expense of approximately $0.6 million and (ii) a deferred income tax benefit of approximately $1.0 million, which resulted from unrealized depreciation on investments held by the Company’s wholly-owned taxable subsidiaries. As of September 30, 2022, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows: Undistributed ordinary income, net $ (43,624) Net realized capital losses 473,274 Unrealized losses, net 153,119 Accumulated overdistributed earnings $ 582,769 The aggregate cost of investments for U.S. federal income tax purposes was $2,654.3 million as of September 30, 2022. As of September 30, 2022, the aggregate gross unrealized appreciation for all investments in which there was an excess of value over cost for U.S. federal income tax purposes was $466.9 million. As of September 30, 2022, the aggregate gross unrealized depreciation for all investments in which there was an excess of cost for U.S. federal income tax purposes over value was |
Realized Gains or Losses and Ne
Realized Gains or Losses and Net Unrealized Appreciation or Depreciation | 9 Months Ended |
Jun. 30, 2023 | |
Investment Company [Abstract] | |
Realized Gains or Losses and Net Unrealized Appreciation or Depreciation | Realized Gains or Losses and Net Unrealized Appreciation or Depreciation Realized Gains or Losses Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption and the cost basis of the investment without regard to unrealized appreciation or depreciation previously recognized, and include investments written-off during the period, net of recoveries. Realized losses may also be recorded in connection with the Company's determination that certain investments are considered worthless securities and/or meet the conditions for loss recognition per the applicable tax rules. During the three months ended June 30, 2023, the Company recorded an aggregate net realized loss of $10.6 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Foreign currency forward contracts $ (6.3) Aden & Anais Merger Sub Inc. (5.2) Radiology Partners Inc. (3.8) WP CPP Holdings LLC (1.3) Tersera Therapeutics LLC 5.2 Other, net 0.8 Total, net $ (10.6) During the three months ended June 30, 2022, the Company recorded an aggregate net realized gain of $9.2 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Foreign currency forward contracts $ 8.8 Other, net 0.4 Total, net $ 9.2 During the nine months ended June 30, 2023, the Company recorded an aggregate net realized loss of $19.9 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Foreign currency forward contracts $ (5.5) Aden & Anais Merger Sub Inc. (5.2) Radiology Partners Inc. (4.2) Carvana Co. (2.8) ASP Unifrax Holdings Inc. (2.1) WP CPP Holdings LLC (1.3) Global Medical Response Inc. (1.0) Tersera Therapeutics LLC 5.2 Other, net (3.0) Total, net $ (19.9) During the nine months ended June 30, 2022, the Company recorded an aggregate net realized gain of $19.9 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Foreign currency forward contracts $ 12.2 OmniSYS Acquisition Corporation 2.2 First Star Speir Aviation Limited 1.9 TigerConnect Inc. 1.8 Other, net 1.8 Total, net $ 19.9 Net Unrealized Appreciation or Depreciation Net unrealized appreciation or depreciation reflects the net change in the valuation of the portfolio pursuant to the Company's valuation guidelines and the reclassification of any prior period unrealized appreciation or depreciation. During the three months ended June 30, 2023 and 2022, the Company recorded net unrealized depreciation of $1.0 million and $86.8 million, respectively. For the three months ended June 30, 2023, this consisted of $9.8 million of net unrealized depreciation on debt investments and $0.8 million of net unrealized depreciation on equity investments, partially offset by $5.0 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $4.6 million of net unrealized appreciation of foreign currency forward contracts. For the three months ended June 30, 2022, this consisted of $66.8 million of net unrealized depreciation on debt investments, $17.9 million of net unrealized depreciation on equity investments, $1.6 million of net unrealized depreciation of foreign currency forward contracts and $0.4 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains). During the nine months ended June 30, 2023 and 2022, the Company recorded net unrealized depreciation of $42.3 million and $118.4 million, respectively. For the nine months ended June 30, 2023, this consisted of $54.3 million of net unrealized depreciation on debt investments and $4.8 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $11.8 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $5.1 million of net unrealized appreciation on equity investments. For the nine months ended June 30, 2022, this consisted of $84.6 million of net unrealized depreciation on debt investments, $23.8 million of net unrealized depreciation on equity investments, $9.2 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains) and $0.8 million of net unrealized depreciation of foreign currency forward contracts. During the nine months ended June 30, 2023, unrealized depreciation included a one-time unrealized loss of $20.7 million that resulted solely from accounting adjustments related to the OSI2 Merger. |
Concentration of Credit Risk
Concentration of Credit Risk | 9 Months Ended |
Jun. 30, 2023 | |
Risks and Uncertainties [Abstract] | |
Concentration of Credit Risk | Concentration of Credit Risks The Company deposits its cash with financial institutions and at times such balances are in excess of the FDIC insurance limit. The Company limits its exposure to credit loss by depositing its cash with high credit quality financial institutions and monitoring their financial stability. |
Related Party Transactions
Related Party Transactions | 9 Months Ended |
Jun. 30, 2023 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Related Party Transactions As of June 30, 2023 and September 30, 2022, the Company had a liability on its Consolidated Statements of Assets and Liabilities in the amount of $20.1 million and $15.9 million, respectively, reflecting the unpaid portion of the base management fees and incentive fees payable to Oaktree. Investment Advisory Agreement The Company is party to the Investment Advisory Agreement. Under the Investment Advisory Agreement, the Company pays Oaktree a fee for its services under the Investment Advisory Agreement consisting of two components: a base management fee and an incentive fee. The cost of both the base management fee payable to Oaktree and any incentive fees earned by Oaktree is ultimately borne by common stockholders of the Company. From October 17, 2017 through May 3, 2020, the Company was externally managed by OCM pursuant to an investment advisory agreement. On May 4, 2020, OCM effected the novation of such investment advisory agreement to Oaktree. Immediately following such novation, the Company and Oaktree entered into a new investment advisory agreement with the same terms, including fee structure, as the investment advisory agreement with OCM. The investment advisory agreement with Oaktree was subsequently amended and restated on March 19, 2021 in connection with the closing of the OCSI Merger and on January 23, 2023 in connection with the closing of OSI2 Merger. The term “Investment Advisory Agreement” refers collectively to the agreements with Oaktree and, prior to its novation, with OCM. Unless earlier terminated as described below, the Investment Advisory Agreement will remain in effect from year-to-year if approved annually by the Board of Directors of the Company or by the affirmative vote of the holders of a majority of the Company’s outstanding voting securities, including, in either case, approval by a majority of the directors of the Company who are not interested persons. The Investment Advisory Agreement will automatically terminate in the event of its assignment. The Investment Advisory Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Investment Advisory Agreement may also be terminated, without penalty, upon the vote of a majority of the outstanding voting securities of the Company. Base Management Fee Under the Investment Advisory Agreement, the base management fee is calculated at an annual rate of 1.50% of total gross assets, including any investment made with borrowings, but excluding cash and cash equivalents. The base management fee is payable quarterly in arrears and the fee for any partial month or quarter is appropriately prorated. Effective May 3, 2019, the base management fee on the Company’s gross assets, including any investments made with borrowings, but excluding any cash and cash equivalents, that exceed the product of (A) 200% and (B) the Company’s net asset value will be 1.00%. For the avoidance of doubt, the 200% will be calculated in accordance with the Investment Company Act and will give effect to exemptive relief the Company received from the SEC with respect to debentures issued by a small business investment company subsidiary. In connection with the OCSI Merger, Oaktree waived an aggregate of $6 million of base management fees otherwise payable to Oaktree in the two years following the closing of the OCSI Merger on March 19, 2021 at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter). In connection with the OSI2 Merger, Oaktree waived an aggregate of $9.0 million of base management fees payable to Oaktree as follows: $6.0 million at a rate of $1.5 million per quarter (with such amount appropriately prorated for any partial quarter) in the first year following closing of the OSI2 Merger on January 23, 2023 and $3.0 million at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter) in the second year following closing of the OSI2 Merger. For the three and nine months ended June 30, 2023, the base management fee incurred under the Investment Advisory Agreement was $10.5 million (net of waiver) and $29.4 million (net of waiver), respectively. For the three and nine months ended June 30, 2022, the base management fee incurred under the Investment Advisory Agreement was $9.1 million (net of waiver) and $27.6 million (net of waiver), respectively. Incentive Fee The incentive fee consists of two parts. Under the Investment Advisory Agreement, the first part of the incentive fee (the “incentive fee on income” or "Part I incentive fee") is calculated and payable quarterly in arrears based upon the “pre-incentive fee net investment income” of the Company for the immediately preceding quarter. The payment of the incentive fee on income is subject to payment of a preferred return to investors each quarter (i.e., a “hurdle rate”), expressed as a rate of return on the value of the Company’s net assets at the end of the most recently completed quarter, of 1.50%, subject to a “catch up” feature. For this purpose, “pre-incentive fee net investment income” means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies, other than fees for providing managerial assistance) accrued during the fiscal quarter, minus the Company’s operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as OID debt, instruments with PIK interest and zero coupon securities), accrued income that the Company has not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. In addition, pre-incentive fee net investment income does not include any amortization or accretion of any purchase premium or purchase discount to interest income resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in pre-incentive fee net investment income. Under the Investment Advisory Agreement, the calculation of the incentive fee on income for each quarter is as follows: • No incentive fee is payable to Oaktree in any quarter in which the Company’s pre-incentive fee net investment income does not exceed the preferred return rate of 1.50% (the “preferred return”) on net assets; • 100% of the Company’s pre-incentive fee net investment income, if any, that exceeds the preferred return but is less than or equal to 1.8182% in any fiscal quarter is payable to Oaktree. This portion of the incentive fee on income is referred to as the “catch-up” provision, and it is intended to provide Oaktree with an incentive fee of 17.5% on all of the Company’s pre-incentive fee net investment income when the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets in any fiscal quarter; and • For any quarter in which the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets, the incentive fee on income is equal to 17.5% of the amount of the Company’s pre-incentive fee net investment income, as the preferred return and catch-up will have been achieved. There is no accumulation of amounts on the hurdle rate from quarter to quarter and accordingly there is no clawback of amounts previously paid if subsequent quarters are below the quarterly hurdle. For the three and nine months ended June 30, 2023, the first part of the incentive fee (incentive fee on income) incurred under the Investment Advisory Agreement was $9.6 million and $26.3 million, respectively. For the three and nine months ended June 30, 2022, the first part of the incentive fee (incentive fee on income) incurred under the Investment Advisory Agreement was $6.5 million and $19.7 million, respectively. Under the Investment Advisory Agreement, the second part of the incentive fee (the "capital gains incentive fee") is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Investment Advisory Agreement, as of the termination date) commencing with the fiscal year ended September 30, 2019 and equals 17.5% of the Company’s realized capital gains, if any, on a cumulative basis from the beginning of the fiscal year ended September 30, 2019 through the end of each subsequent fiscal year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees under the Investment Advisory Agreement. Any realized capital gains, realized capital losses, unrealized capital appreciation and unrealized capital depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the calculations of the second part of the incentive fee. In addition, the calculation of realized capital gains, realized capital losses and unrealized capital depreciation does (1) not include any such amounts resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in the capital gains incentive fee, (2) include any such amounts associated with the investments acquired in the OCSI Merger for the period from October 1, 2018 to the date of closing of the OCSI Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee and (3) include any such amounts associated with the investments acquired in the OSI2 Merger for the period from August 6, 2018 to the date of closing of the OSI2 Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee. As of June 30, 2023, the Company paid $9.6 million of capital gains incentive fees cumulatively under the Investment Advisory Agreement (net of waivers). Part II incentive fees are contractually calculated and paid at the end of the fiscal year in accordance with the Investment Advisory Agreement, which, as described above, differs from Part II incentive fees accrued under GAAP. Hypothetically, if Part II incentive fees were calculated as of June 30, 2023 under the Investment Advisory Agreement, no Part II incentive fees would be payable. GAAP requires that the capital gains incentive fee accrual consider the cumulative aggregate unrealized capital appreciation in the calculation, as a capital gains incentive fee would be payable if such unrealized capital appreciation were realized on a theoretical "liquidation basis." A fee so calculated and accrued would not be payable under applicable law and may never be paid based upon the computation of capital gains incentive fees in subsequent periods. Amounts ultimately paid under the Investment Advisory Agreement will be consistent with the formula reflected in the Investment Advisory Agreement. This GAAP accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital depreciation included in the calculation of the capital gains incentive fee plus the aggregate cumulative unrealized capital appreciation. Any realized capital gains and losses and cumulative unrealized capital appreciation and depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the GAAP accrual. If such amount is positive at the end of a period, then GAAP requires the Company to record a capital gains incentive fee equal to 17.5% of such cumulative amount, less the aggregate amount of actual capital gains incentive fees payable or capital gains incentive fees accrued under GAAP in all prior periods. The resulting accrual for any capital gains incentive fee under GAAP in a given period may result in an additional expense if such cumulative amount is greater than in the prior period or a reversal of previously recorded expense if such cumulative amount is less than in the prior period. If such cumulative amount is negative, then there is no accrual. There can be no assurance that such unrealized capital appreciation will be realized in the future or any accrued capital gains incentive fee will become payable under the Investment Advisory Agreement. For the three and nine months ended June 30, 2023, there were no accrued capital gains incentive fees. For the three and nine months ended June 30, 2022, $6.8 million and $8.8 million of accrued capital gains incentive fees were reversed, respectively. As of June 30, 2023, the total accrued capital gains incentive fee liability was zero. Indemnification The Investment Advisory Agreement provides that, absent willful misfeasance, bad faith or gross negligence in the performance of their respective duties or by reason of the reckless disregard of their respective duties and obligations, Oaktree and its officers, managers, partners, members (and their members, including the owners of their members), agents, employees, controlling persons and any other person or entity affiliated with it, are entitled to indemnification from the Company for any damages, liabilities, costs and expenses (including reasonable attorneys' fees and amounts reasonably paid in settlement) arising from the rendering of Oaktree's services under the Investment Advisory Agreement or otherwise as investment adviser. Administrative Services The Company is party to the Administration Agreement with Oaktree Administrator. Pursuant to the Administration Agreement, Oaktree Administrator provides administrative services to the Company necessary for the operations of the Company, which include providing office facilities, equipment, clerical, bookkeeping and record keeping services at such facilities and such other services as Oaktree Administrator, subject to review by the Company’s Board of Directors, shall from time to time deem to be necessary or useful to perform its obligations under the Administration Agreement. Oaktree Administrator may, on behalf of the Company, conduct relations and negotiate agreements with custodians, trustees, depositories, attorneys, underwriters, brokers and dealers, corporate fiduciaries, insurers, banks and such other persons in any such other capacity deemed to be necessary or desirable. Oaktree Administrator makes reports to the Company’s Board of Directors of its performance of obligations under the Administration Agreement and furnishes advice and recommendations with respect to such other aspects of the Company’s business and affairs, in each case, as it shall determine to be desirable or as reasonably required by the Company’s Board of Directors; provided that Oaktree Administrator shall not provide any investment advice or recommendation. Oaktree Administrator also provides portfolio collection functions for interest income, fees and warrants and is responsible for the financial and other records that the Company is required to maintain and prepares, prints and disseminates reports to the Company’s stockholders and all other materials filed with the SEC. In addition, Oaktree Administrator assists the Company in determining and publishing the Company’s net asset value, overseeing the preparation and filing of the Company’s tax returns, and generally overseeing the payment of the Company’s expenses and the performance of administrative and professional services rendered to the Company by others. Oaktree Administrator may also offer to provide, on the Company’s behalf, managerial assistance to the Company’s portfolio companies. For providing these services, facilities and personnel, the Company reimburses Oaktree Administrator the allocable portion of overhead and other expenses incurred by Oaktree Administrator in performing its obligations under the Administration Agreement, including the Company’s allocable portion of the rent of the Company’s principal executive offices (which are located in a building owned by a Brookfield affiliate) at market rates and the Company’s allocable portion of the costs of compensation and related expenses of its Chief Financial Officer, Chief Compliance Officer, their staffs and other non-investment professionals at Oaktree that perform duties for the Company. Such reimbursement is at cost, with no profit to, or markup by, Oaktree Administrator. The Administration Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Administration Agreement may also be terminated, without penalty, upon the vote of a majority of the Company’s outstanding voting securities. For the three months ended June 30, 2023 and 2022, the Company accrued administrative expenses of $0.4 million and $0.3 million, respectively, including $0.1 million and $0.1 million of general and administrative expenses, respectively. For the nine months ended June 30, 2023 and 2022, the Company accrued administrative expenses of $1.2 million and $1.2 million, respectively, including $0.2 million and $0.2 million of general and administrative expenses, respectively. |
Financial Highlights
Financial Highlights | 9 Months Ended |
Jun. 30, 2023 | |
Investment Company [Abstract] | |
Financial Highlights | Financial Highlights (Share amounts in thousands) Three months ended Three months ended Nine months ended Nine months ended Net asset value per share at beginning of period $19.66 $21.79 $20.38 $21.84 Net investment income (1) 0.63 0.66 1.89 1.86 Net unrealized appreciation (depreciation) (1)(8) (0.02) (1.42) (0.36) (1.95) Net realized gains (losses) (1) (0.14) 0.15 (0.28) 0.33 (Provision) benefit for taxes on realized and unrealized gains (losses) (1) — (0.01) 0.01 0.03 Distributions of net investment income to stockholders (0.55) (0.50) (2.06) (1.44) Net asset value per share at end of period $19.58 $20.67 $19.58 $20.67 Per share market value at beginning of period $18.77 $22.11 $18.00 $21.18 Per share market value at end of period $19.43 $19.65 $19.43 19.65 Total return (2) 6.42% (8.93)% 19.58% (0.79)% Common shares outstanding at beginning of period 77,080 61,068 61,125 60,120 Common shares outstanding at end of period 77,080 61,125 77,080 61,125 Net assets at beginning of period $1,515,150 $1,330,376 $1,245,563 $1,312,823 Net assets at end of period $1,509,441 $1,263,529 $1,509,441 $1,263,529 Average net assets (3) $1,526,644 $1,306,727 $1,407,814 $1,323,232 Ratio of net investment income to average net assets (4) 12.72% 12.39% 12.65% 11.39% Ratio of total expenses to average net assets (4) 14.45% 7.22% 14.07% 7.94% Ratio of net expenses to average net assets (4) 14.05% 6.99% 13.69% 7.71% Ratio of portfolio turnover to average investments at fair value 7.48% 4.73% 18.43% 21.44% Weighted average outstanding debt (5) $1,756,758 $1,369,615 $1,640,062 $1,358,150 Average debt per share (1) $22.79 $22.41 $23.29 $22.41 Asset coverage ratio at end of period (6) 182.05% 187.82% 182.05% 187.82% __________ (1) Calculated based upon weighted average shares outstanding for the period. (2) Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load. (3) Calculated based upon the weighted average net assets for the period. (4) Interim periods are annualized. (5) Calculated based upon the weighted average of principal debt outstanding for the period. (6) Based on outstanding senior securities of $1,785.0 million and $1,395.0 million as of June 30, 2023 and 2022, respectively. (7) The share and per share information disclosed in this table has been retrospectively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. (8) For the nine months ended June 30, 2023, the amount shown for net unrealized appreciation (depreciation) includes the effect of the timing of common stock issuances in connection with the OSI2 Merger. |
Derivative Instruments
Derivative Instruments | 9 Months Ended |
Jun. 30, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Instruments | Derivative Instruments The Company enters into foreign currency forward contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies. In order to better define its contractual rights and to secure rights that will help the Company mitigate its counterparty risk, the Company entered into an International Swaps and Derivatives Association, Inc. Master Agreement (the "ISDA Master Agreement") with its derivative counterparty, JPMorgan Chase Bank, N.A. The ISDA Master Agreement permits a single net payment in the event of a default or similar event. As of June 30, 2023, no cash collateral has been pledged to cover obligations and no cash collateral has been received from the counterparty with respect to the Company's forward currency contracts. In connection with the issuance of the 2027 Notes, the Company entered into an interest rate swap agreement with the Royal Bank of Canada pursuant to an ISDA Master Agreement. As of June 30, 2023, the Company paid $40.0 million to the Royal Bank of Canada to cover collateral obligations under the terms of the interest swap agreement, which is included in due from broker on the Consolidated Statement of Assets and Liabilities. Certain information related to the Company’s foreign currency forward contracts is presented below as of June 30, 2023. Description Notional Amount to be Purchased Notional Amount to be Sold Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Foreign currency forward contract $ 78,866 € 71,658 8/10/2023 $ 531 $ — Derivative asset Foreign currency forward contract $ 71,438 £ 56,556 8/10/2023 $ — $ 482 Derivative asset $ 531 $ 482 Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2022. Description Notional Amount to be Purchased Notional Amount to be Sold Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Foreign currency forward contract $ 43,179 € 41,444 11/10/2022 $ 2,466 $ — Derivative asset Foreign currency forward contract $ 45,692 £ 37,033 11/10/2022 $ 4,323 $ — Derivative asset $ 6,789 $ — Certain information related to the Company’s interest rate swap is presented below as of June 30, 2023. Description Notional Amount Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Interest rate swap $ 350,000 1/15/2027 $ — $ 39,567 Derivative liability $ — $ 39,567 Certain information related to the Company’s interest rate swap is presented below as of September 30, 2022. Description Notional Amount Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Interest rate swap $ 350,000 1/15/2027 $ — $ 41,969 Derivative liability $ — $ 41,969 |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Jun. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Off-Balance Sheet Arrangements The Company may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of its portfolio companies. As of June 30, 2023, the Company's only off-balance sheet arrangements consisted of $274.4 million of unfunded commitments, which was comprised of $247.3 million to provide debt and equity financing to certain of its portfolio companies and $27.1 million to provide financing to the JVs. As of September 30, 2022, the Company's only off-balance sheet arrangements consisted of $224.2 million of unfunded commitments, which was comprised of $175.2 million to provide debt and equity financing to certain of its portfolio companies and $49.0 million to provide financing to the JVs. Such commitments are subject to the portfolio companies' satisfaction of certain financial and nonfinancial covenants and may involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Consolidated Statements of Assets and Liabilities. A list of unfunded commitments by investment (consisting of revolvers, term loans with delayed draw components, subordinated notes and LLC equity interests in the JVs, preferred stock and limited partnership interests) as of June 30, 2023 and September 30, 2022 is shown in the table below: June 30, 2023 September 30, 2022 107-109 Beech OAK22 LLC $ 30,922 $ — Fairbridge Strategic Capital Funding LLC 20,382 22,150 Delta Leasing SPV II LLC 18,822 27,187 BioXcel Therapeutics, Inc. 14,543 11,785 OCSI Glick JV LLC 13,998 13,998 Senior Loan Fund JV I, LLC 13,125 35,000 SiO2 Medical Products, Inc. 10,765 — MND Holdings III Corp 8,470 — Seres Therapeutics, Inc. 8,090 — iCIMs, Inc. 7,704 6,930 Dominion Diagnostics, LLC 7,664 11,148 Marinus Pharmaceuticals, Inc. 7,139 5,734 Assembled Brands Capital LLC 7,062 2,008 Grove Hotel Parcel Owner, LLC 5,286 4,293 scPharmaceuticals Inc. 5,212 — Innocoll Pharmaceuticals Limited 5,200 4,195 Avalara, Inc. 5,047 — Mindbody, Inc. 4,762 4,000 Accupac, Inc. 4,500 4,605 Mesoblast, Inc. 4,405 3,553 107 Fair Street LLC 4,322 — Harrow Health, Inc. 4,011 — Inventus Power, Inc. 3,792 — Establishment Labs Holdings Inc. 3,384 5,075 MRI Software LLC 3,302 5,196 OTG Management, LLC 3,190 3,789 PRGX Global, Inc. 3,127 2,518 Salus Workers' Compensation, LLC 3,102 — ADC Therapeutics SA 3,020 3,020 Relativity ODA LLC 2,762 2,218 112-126 Van Houten Real22 LLC 2,703 — LSL Holdco, LLC 2,650 427 Supreme Fitness Group NY Holdings, LLC 2,540 1,527 Pluralsight, LLC 2,395 3,532 SCP Eye Care Services, LLC 2,356 — Spanx, LLC 2,185 2,226 Tahoe Bidco B.V. 2,162 1,741 Coupa Holdings, LLC 2,075 — Galileo Parent, Inc. 2,061 — Oranje Holdco, Inc. 1,904 — Apptio, Inc. 1,885 1,338 Kings Buyer, LLC 1,771 1,537 MHE Intermediate Holdings, LLC 1,536 1,429 PPW Aero Buyer, Inc. 1,466 — Liquid Environmental Solutions Corporation 1,383 1,115 Berner Food & Beverage, LLC 1,314 1,392 CorEvitas, LLC 1,251 915 Digital.AI Software Holdings, Inc. 1,156 826 Coyote Buyer, LLC 800 1,333 Telestream Holdings Corporation 678 528 Acquia Inc. 596 1,326 ASP-R-PAC Acquisition Co LLC 396 — BAART Programs, Inc. — 8,645 RumbleOn, Inc. — 4,822 Ardonagh Midco 3 PLC — 4,372 Dialyze Holdings, LLC — 3,431 Thrasio, LLC — 2,578 109 Montgomery Owner LLC — 477 GKD Index Partners, LLC — 320 Total $ 274,373 $ 224,239 |
Merger with OSI2
Merger with OSI2 | 9 Months Ended |
Jun. 30, 2023 | |
Business Combination and Asset Acquisition [Abstract] | |
Merger with OSI2 | Merger with OSI2 On January 23, 2023, the Company completed its previously announced acquisition of OSI2. The Company was the accounting survivor of the OSI2 Merger. In accordance with the terms of the OSI2 Merger Agreement, at the effective time of the OSI2 Merger, each outstanding share of OSI2 common stock was converted into the right to receive 0.9115 shares of the Company’s common stock (with OSI2’s stockholders receiving cash in lieu of fractional shares of the Company’s common stock). As a result of the Merger, the Company issued an aggregate of 15,860,200 shares of its common stock to former OSI2 stockholders. The OSI2 Merger was accounted for as an asset acquisition in accordance with the asset acquisition method of accounting as detailed in ASC 805-50, Business Combinations—Related Issues (“ASC 805”). The Company determined the fair value of the shares of the Company’s common stock that were issued to former OSI2 stockholders pursuant to the OSI2 Merger Agreement plus transaction costs to be the consideration paid in connection with the OSI2 Merger under ASC 805. The consideration paid to OSI2 stockholders, as determined in accordance with ASC 805, was more than the aggregate fair values of the assets acquired and liabilities assumed, which resulted in a purchase premium (the “purchase premium”). The consideration paid was allocated to the individual assets acquired and liabilities assumed based on the relative fair values of net identifiable assets acquired other than “non-qualifying” assets (for example, cash). As a result, the purchase premium was allocated to the cost basis of the OSI2 investments acquired by the Company on a pro-rata basis based on their relative fair values as of the effective time of the OSI2 Merger. Immediately following the OSI2 Merger, the investments were marked to their respective fair values in accordance with ASC 820 which resulted in $20.7 million of unrealized depreciation in the Consolidated Statement of Operations as a result of the OSI2 Merger. The purchase premium allocated to the debt investments acquired will amortize over the life of each respective debt investment through interest income, with a corresponding adjustment recorded to unrealized depreciation on such investment acquired through its ultimate disposition. The purchase premium allocated to equity investments acquired will not amortize over the life of such investments through interest income and, assuming no subsequent change to the fair value of the equity investments acquired and disposition of such equity investments at fair value, the Company will recognize a realized loss with a corresponding reversal of the unrealized depreciation on disposition of such equity investments acquired. The OSI2 Merger was considered a tax-free reorganization, and the Company has elected to carry forward the historical cost basis of the acquired OSI2 investments for tax purposes. The following table summarizes the allocation of the consideration paid to the assets acquired and liabilities assumed as a result of the OSI2 Merger: Common stock issued by the Company (1) $ 334,034 Transaction costs 1,932 Consideration paid $ 335,966 Investments $ 592,809 Cash and cash equivalents 22,317 Other assets 6,679 Total assets acquired 621,805 Debt 225,000 Other liabilities 60,839 Total liabilities acquired 285,839 Total net assets acquired $ 335,966 __________ (1) Common stock issued by the Company includes $19 of cash paid in lieu of issuing fractional shares. |
Schedule_12-14
Schedule 12-14 | 9 Months Ended |
Jun. 30, 2023 | |
Investments in and Advances to Affiliates [Abstract] | |
Schedule 12-14 | Schedule 12-14 Oaktree Specialty Lending Corporation Schedule of Investments in and Advances to Affiliates (in thousands, except share and per share amounts, percentages and as otherwise indicated) Nine months ended June 30, 2023 (unaudited) Portfolio Company Industry Investment Type Index Spread Cash PIK Rate Maturity Date Shares Principal Net Realized Gain (Loss) Amount of Interest, Fees or Dividends Credited in Income (2) Fair Value at October 1, 2022 Gross Additions (3) Gross Reductions (4) Fair Value at June 30, 2023 % of Total Net Assets Control Investments C5 Technology Holdings, LLC Data Processing & Outsourced Services Common Stock 829 $ — $ — $ — $ — $ — $ — $ — — % C5 Technology Holdings, LLC Data Processing & Outsourced Services Preferred Equity 34,984,460 — — — 27,638 — — 27,638 1.8 % Dominion Diagnostics, LLC Health Care Services First Lien Term Loan SOFR+ 5.00 % 10.39 % 8/28/2025 14,102 — 1,070 14,333 — (231) 14,102 0.9 % Dominion Diagnostics, LLC Health Care Services First Lien Term Loan SOFR+ 5.00 % 8/28/2025 — — — — — — — — % Dominion Diagnostics, LLC Health Care Services First Lien Revolver SOFR+ 5.00 % 10.24 % 8/28/2025 3,484 — 136 — 3,484 — 3,484 0.2 % Dominion Diagnostics, LLC Health Care Services Common Stock 30,031 — — — 4,946 — (2,235) 2,711 0.2 % OCSI Glick JV LLC (5) Multi-Sector Holdings Subordinated Debt L+ 4.50 % 9.36 % 10/20/2028 58,349 — 4,961 50,283 1,116 (1,767) 49,632 3.3 % OCSI Glick JV LLC (5) Multi-Sector Holdings Membership Interest 87.50 % — — — — — — — — % Senior Loan Fund JV I, LLC (6) Multi-Sector Holdings Subordinated Debt L+ 7.00 % 11.86 % 12/29/2028 112,656 — 9,197 96,250 16,406 — 112,656 7.5 % Senior Loan Fund JV I, LLC (6) Multi-Sector Holdings Membership Interest 87.50 % — — 3,150 20,715 7,258 — 27,973 1.9 % Total Control Investments $ 188,591 $ — $ 18,514 $ 214,165 $ 28,264 $ (4,233) $ 238,196 15.8 % Affiliate Investments Assembled Brands Capital LLC Specialized Finance First Lien Revolver L+ 6.75 % 12.29 % 10/17/2023 22,304 — 1,985 24,225 2,378 (4,417) 22,186 1.5 % Assembled Brands Capital LLC Specialized Finance Common Stock 1,783,332 — — — 370 40 (410) — — % Assembled Brands Capital LLC Specialized Finance Preferred Equity 1,129,453 — — — 1,223 189 — 1,412 0.1 % Assembled Brands Capital LLC Specialized Finance Warrants 78,045 — — — — — — — — % Caregiver Services, Inc. Health Care Services Preferred Equity 1,080,399 — — — 378 — (65) 313 — % Total Affiliate Investments $ 22,304 $ — $ 1,985 $ 26,196 $ 2,607 $ (4,892) $ 23,911 1.6 % Total Control & Affiliate Investments $ 210,895 $ — $ 20,499 $ 240,361 $ 30,871 $ (9,125) $ 262,107 17.4 % This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements. ______________________ (1) The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments. (2) Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories. (3) Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category. (4) Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category. (5) Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required). (6) Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required). Schedule 12-14 Oaktree Specialty Lending Corporation Schedule of Investments in and Advances to Affiliates (in thousands, except share and per share amounts, percentages and as otherwise indicated) Nine months ended June 30, 2022 (unaudited) Portfolio Company Industry Investment Type Index Spread Cash PIK Rate Maturity Date Shares Principal Net Realized Gain (Loss) Amount of Interest, Fees or Dividends Credited in Income (2) Fair Value at October 1, 2021 Gross Additions (3) Gross Reductions (4) Fair Value at June 30, 2022 % of Total Net Assets Control Investments C5 Technology Holdings, LLC Data Processing & Outsourced Services Common Stock 829 $ — $ — $ — $ — $ — $ — $ — — % C5 Technology Holdings, LLC Data Processing & Outsourced Services Preferred Equity 34,984,460 — — — 27,638 — — 27,638 2.2 % Dominion Diagnostics, LLC Health Care Services First Lien Term Loan L+ 5.00 % 7.26 % 2/28/2024 16,074 — 1,078 27,381 — (11,307) 16,074 1.3 % Dominion Diagnostics, LLC Health Care Services First Lien Revolver L+ 5.00 % 2/28/2024 — — 42 — — — — — % Dominion Diagnostics, LLC Health Care Services Common Stock 30,031 — — 3,308 18,065 — (8,798) 9,267 0.7 % First Star Speir Aviation Limited (5) Airlines First Lien Term Loan 9.00 % 12/15/2025 — 7,500 — 7,500 — (7,500) — — % First Star Speir Aviation Limited (5) Airlines Membership Interest 100.00 % — (5,632) 158 698 — (698) — — % OCSI Glick JV LLC (6) Multi-Sector Holdings Subordinated Debt L+ 4.50 % 4.94 % 10/20/2028 60,274 — 3,292 55,582 1,123 (6,099) 50,606 4.0 % OCSI Glick JV LLC (6) Multi-Sector Holdings Membership Interest 87.50 % — — — — — — — — % Senior Loan Fund JV I, LLC (7) Multi-Sector Holdings Subordinated Debt L+ 7.00 % 8.00 % 12/29/2028 96,250 — 5,839 96,250 — — 96,250 7.6 % Senior Loan Fund JV I, LLC (7) Multi-Sector Holdings Membership Interest 87.50 % — — 2,026 37,651 — (14,628) 23,023 1.8 % Total Control Investments $ 172,598 $ 1,868 $ 15,743 $ 270,765 $ 1,123 $ (49,030) $ 222,858 17.6 % Affiliate Investments Assembled Brands Capital LLC Specialized Finance First Lien Revolver L+ 6.75 % 9.00 % 10/17/2023 21,754 — 1,185 15,712 11,585 (6,037) 21,260 1.7 % Assembled Brands Capital LLC Specialized Finance Common Stock 1,609,201 — — — 587 — (24) 563 — % Assembled Brands Capital LLC Specialized Finance Preferred Equity 1,019,169 — — — 1,152 51 — 1,203 0.1 % Assembled Brands Capital LLC Specialized Finance Warrants 70,425 — — — — — — — — % Caregiver Services, Inc. Health Care Services Preferred Equity 1,080,399 — — — 838 — (437) 401 — % Total Affiliate Investments $ 21,754 $ — $ 1,185 $ 18,289 $ 11,636 $ (6,498) $ 23,427 1.9 % Total Control & Affiliate Investments $ 194,352 $ 1,868 $ 16,928 $ 289,054 $ 12,759 $ (55,528) $ 246,285 19.5 % This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements. ______________________ (1) The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments included in the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2022. (2) Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories. (3) Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category. (4) Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category. (5) First Star Speir Aviation Limited is a wholly-owned holding company formed by the Company in order to facilitate its investment strategy. In accordance with ASU 2013-08, the Company has deemed the holding company to be an investment company under GAAP and therefore deemed it appropriate to consolidate the financial results and financial position of the holding company and to recognize dividend income versus a combination of interest income and dividend income. Accordingly, the debt and equity investments in the wholly-owned holding company are disregarded for accounting purposes since the economic substance of these instruments are equity investments in the operating entities. (6) Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required). (7) Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required). |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Pay vs Performance Disclosure | ||||
Net increase (decrease) in net assets resulting from operations | $ 36,685 | $ (37,834) | $ 71,379 | $ 16,015 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Jun. 30, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
N-2
N-2 - USD ($) $ / shares in Units, $ in Millions | 9 Months Ended | |||||||
Jun. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Sep. 30, 2021 | |||
Cover [Abstract] | ||||||||
Entity Central Index Key | 0001414932 | |||||||
Amendment Flag | false | |||||||
Securities Act File Number | 1-33901 | |||||||
Document Type | 10-Q | |||||||
Entity Registrant Name | Oaktree Specialty Lending Corporation | |||||||
Entity Address, Address Line One | 333 South Grand Avenue | |||||||
Entity Address, Address Line Two | 28th Floor | |||||||
Entity Address, City or Town | Los Angeles | |||||||
Entity Address, State or Province | CA | |||||||
Entity Address, Postal Zip Code | 90071 | |||||||
City Area Code | 213 | |||||||
Local Phone Number | 830-6300 | |||||||
Entity Emerging Growth Company | false | |||||||
Financial Highlights [Abstract] | ||||||||
Senior Securities Amount | $ 1,785 | $ 1,395 | ||||||
General Description of Registrant [Abstract] | ||||||||
Investment Objectives and Practices [Text Block] | Our investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. We may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. Our portfolio may also include certain structured finance and other non-traditional structures. We invest in companies that typically possess resilient business models with strong underlying fundamentals. We intend to deploy capital across credit and economic cycles with a focus on long-term results, which we believe will enable us to build lasting partnerships with financial sponsors and management teams, and we may seek to opportunistically take advantage of dislocations in the financial markets and other situations that may benefit from Oaktree’s credit and structuring expertise. Sponsors may include financial sponsors, such as an institutional investor or a private equity firm, or a strategic entity seeking to invest in a portfolio company. Oaktree is generally focused on middle-market companies, which we define as companies with enterprise values of between $100 million and $750 million. We generally invest in securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Below investment grade securities, which are often referred to as “high yield” and “junk,” have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal. In the current market environment, Oaktree intends to focus on the following area, in which Oaktree believes there is less competition and thus potential for greater returns, for our new investment opportunities: (1) situational lending, which we define to include directly originated loans to non-sponsor companies that are hard to understand and value using traditional underwriting techniques, (2) select sponsor lending, which we define to include financing to support leveraged buyouts of companies with specialized sponsors that have expertise in certain industries, and (3) stressed sector and rescue lending, which we define to include opportunistic private loans in industries experiencing stress or limited access to capital. Oaktree intends to continue to rotate our portfolio into investments that are better aligned with Oaktree's overall approach to credit investing and that it believes have the potential to generate attractive returns across market cycles (which we call "core investments"). Oaktree has performed a comprehensive review of our portfolio and categorized our portfolio into core investments, non-core performing investments and underperforming investments. Certain additional information on such categorization and our portfolio composition is included in investor presentations that we file with the SEC. Since an Oaktree affiliate became our investment adviser in October 2017, Oaktree and its affiliates have reduced the investments identified as non-core by approximately $800 million at fair value. Over time, Oaktree intends to rotate us out of the remaining non-core investments, which were approximately $67 million at fair value as of June 30, 2023. Oaktree periodically reviews designations of investments as core and non-core and may change such designations over time. | |||||||
NAV Per Share | $ 19.58 | [1] | $ 19.66 | $ 20.38 | $ 20.67 | [1] | $ 21.79 | $ 21.84 |
Capital Stock, Long-Term Debt, and Other Securities [Abstract] | ||||||||
Long Term Debt [Table Text Block] | Syndicated Facility On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans, mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank. As of June 30, 2023, the size of the Syndicated Facility was $1.218 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances. As of June 30, 2023, (i) the period during which the Company may make drawings with respect to $1.035 billion of commitments will expire on June 23, 2027 and the maturity date is June 23, 2028, (ii) the period during which the Company may make drawings with respect to the remaining commitments will expire on May 4, 2025 and the maturity date is May 4, 2026 and (iii) the interest rate margin for (a) SOFR loans (which may be 1- or 3-month, at the Company’s option) was 2.00% plus a SOFR adjustment which ranges between 0.11448% and 0.26161% and (b) alternate base rate loans was 1.00%. The Syndicated Facility is secured by substantially all of the Company’s assets (excluding, among other things, investments held in and by certain subsidiaries of the Company (including OSI 2 Senior Lending SPV, LLC) or investments in certain portfolio companies of the Company) and guaranteed by certain subsidiaries of the Company. As of June 30, 2023, except for assets that were held by OSI 2 Senior Lending SPV, LLC and certain immaterial subsidiaries, substantially all of the Company's assets are pledged as collateral under the Syndicated Facility. The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of June 30, 2023, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions. As of June 30, 2023 and September 30, 2022, the Company had $800.0 million and $540.0 million of borrowings outstanding under the Syndicated Facility, respectively, which had a fair value of $800.0 million and $540.0 million, respectively. The Company's borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 6.584% and 2.406% for the nine months ended June 30, 2023 and 2022, respectively. For the three and nine months ended June 30, 2023, the Company recorded interest expense (inclusive of fees) of $14.3 million and $37.4 million, respectively, related to the Syndicated Facility. For the three and nine months ended June 30, 2022, the Company recorded interest expense (inclusive of fees) of $4.8 million and $12.6 million, respectively, related to the Syndicated Facility. Citibank Facility On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC (formerly OCSI Senior Funding II LLC), the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. On May 25, 2023, in connection with an amendment to the OSI2 Citibank Facility, the Citibank Facility was terminated. In connection with the termination of the Citibank Facility, the Company accelerated $0.6 million of deferred financing costs into interest expense during the three months ended June 30, 2023. As of September 30, 2022, the Company had $160.0 million outstanding under the Citibank Facility, which had a fair value of $160.0 million. The Company's borrowings under the Citibank Facility bore interest at a weighted average interest rate of 6.762% and 2.563% for the nine months ended June 30, 2023 and 2022, respectively. For the three and nine months ended June 30, 2023, the Company recorded interest expense (inclusive of fees) of $2.4 million and $8.0 million, respectively, related to the Citibank Facility. For the three and nine months ended June 30, 2022, the Company recorded interest expense (inclusive of fees) of $1.6 million and $3.5 million, respectively, related to the Citibank Facility. OSI2 Citibank Facility On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “OSI2 Citibank Facility”) with OSI 2 Senior Lending SPV, LLC (“OSI 2 SPV”), the Company’s wholly-owned and consolidated subsidiary, as the borrower, the Company, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent. As of June 30, 2023, the Company was able to borrow up to $400 million under the OSI2 Citibank Facility (subject to borrowing base and other limitations). As of June 30, 2023, the OSI2 Citibank Facility has a reinvestment period through May 25, 2025, during which advances may be made, and matures on January 26, 2027. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% on all other eligible loans and (b) for all other lenders, SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans, in all cases subject to a minimum overall rate of SOFR plus 2.50% per annum. After the reinvestment period, the applicable spread is 4.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility. As of June 30, 2023, the Company had $335.0 million outstanding under the OSI2 Citibank Facility, which had a fair value of $335.0 million. The Company’s borrowings under the OSI2 Citibank Facility bore interest at a weighted average interest rate of 7.275% for the period from January 23, 2023 to June 30, 2023. For the three months ended June 30, 2023 and the period from January 23, 2023 to June 30, 2023, the Company recorded interest expense (inclusive of fees) of $4.9 million and $8.0 million, respectively, related to the OSI2 Citibank Facility. 2025 Notes On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes. The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2025 Notes is paid semi-annually on February 25 and August 25 at a rate of 3.500% per annum. The 2025 Notes mature on February 25, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2025 Notes can require the Company to repurchase the 2025 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2025 Notes Indenture. The 2025 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the nine months ended June 30, 2023, the Company did not repurchase any of the 2025 Notes in the open market. The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture. 2027 Notes On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes. The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. Interest on the 2027 Notes is paid semi-annually on January 15 and July 15, beginning on January 15, 2022, at a rate of 2.700% per annum. The 2027 Notes mature on January 15, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2027 Notes can require the Company to repurchase the 2027 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2027 Notes Indenture. The 2027 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the nine months ended June 30, 2023, the Company did not repurchase any of the 2027 Notes in the open market. The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture. | |||||||
2025 Notes [Member] | ||||||||
Capital Stock, Long-Term Debt, and Other Securities [Abstract] | ||||||||
Long Term Debt, Title [Text Block] | 2025 Notes | |||||||
Long Term Debt, Structuring [Text Block] | On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes. The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. | |||||||
Long Term Debt, Dividends and Covenants [Text Block] | The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture. | |||||||
2027 Notes [Member] | ||||||||
Capital Stock, Long-Term Debt, and Other Securities [Abstract] | ||||||||
Long Term Debt, Title [Text Block] | 2027 Notes | |||||||
Long Term Debt, Structuring [Text Block] | On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes. The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities. | |||||||
Long Term Debt, Dividends and Covenants [Text Block] | The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture. | |||||||
Syndicated Facility [Member] | ||||||||
Capital Stock, Long-Term Debt, and Other Securities [Abstract] | ||||||||
Long Term Debt, Title [Text Block] | Syndicated Facility | |||||||
Long Term Debt, Structuring [Text Block] | On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans, mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank. As of June 30, 2023, the size of the Syndicated Facility was $1.218 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances. As of June 30, 2023, (i) the period during which the Company may make drawings with respect to $1.035 billion of commitments will expire on June 23, 2027 and the maturity date is June 23, 2028, (ii) the period during which the Company may make drawings with respect to the remaining commitments will expire on May 4, 2025 and the maturity date is May 4, 2026 and (iii) the interest rate margin for (a) SOFR loans (which may be 1- or 3-month, at the Company’s option) was 2.00% plus a SOFR adjustment which ranges between 0.11448% and 0.26161% and (b) alternate base rate loans was 1.00%. | |||||||
Long Term Debt, Dividends and Covenants [Text Block] | The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of June 30, 2023, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions. | |||||||
Citibank Facility [Member] | ||||||||
Capital Stock, Long-Term Debt, and Other Securities [Abstract] | ||||||||
Long Term Debt, Title [Text Block] | Citibank Facility | |||||||
Long Term Debt, Structuring [Text Block] | On March 19, 2021, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC (formerly OCSI Senior Funding II LLC), the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. On May 25, 2023, in connection with an amendment to the OSI2 Citibank Facility, the Citibank Facility was terminated. In connection with the termination of the Citibank Facility, the Company accelerated $0.6 million of deferred financing costs into interest expense during the three months ended June 30, 2023. | |||||||
OSI2 Citibank Facility [Member] | ||||||||
Capital Stock, Long-Term Debt, and Other Securities [Abstract] | ||||||||
Long Term Debt, Title [Text Block] | OSI2 Citibank Facility | |||||||
Long Term Debt, Structuring [Text Block] | On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “OSI2 Citibank Facility”) with OSI 2 Senior Lending SPV, LLC (“OSI 2 SPV”), the Company’s wholly-owned and consolidated subsidiary, as the borrower, the Company, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent.As of June 30, 2023, the Company was able to borrow up to $400 million under the OSI2 Citibank Facility (subject to borrowing base and other limitations). | |||||||
Long Term Debt, Dividends and Covenants [Text Block] | As of June 30, 2023, the OSI2 Citibank Facility has a reinvestment period through May 25, 2025, during which advances may be made, and matures on January 26, 2027. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% on all other eligible loans and (b) for all other lenders, SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans, in all cases subject to a minimum overall rate of SOFR plus 2.50% per annum. After the reinvestment period, the applicable spread is 4.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility. | |||||||
[1](1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis. |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 9 Months Ended |
Jun. 30, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation: The Consolidated Financial Statements of the Company have been prepared in accordance with GAAP and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the Consolidated Financial Statements have been made. All intercompany balances and transactions have been eliminated. The Company is an investment company following the accounting and reporting guidance in ASC Topic 946, Financial Services - Investment Companies ("ASC 946"). Certain prior period amounts have been reclassified to conform to the current period presentation. All per share amounts and common shares outstanding as of and for periods prior to March 31, 2023 reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. |
Use of Estimates | Use of Estimates: The preparation of the financial statements in conformity with accounting principles generally accepted in the United States ("GAAP") requires management to make certain estimates and assumptions affecting amounts reported in the financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition. |
Consolidation | Consolidation: The accompanying Consolidated Financial Statements include the accounts of Oaktree Specialty Lending Corporation and its consolidated subsidiaries. Each consolidated subsidiary is wholly-owned and, as such, consolidated into the Consolidated Financial Statements. Certain subsidiaries that hold investments are treated as pass through entities for U.S. federal income tax purposes. The assets of certain of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of Oaktree Specialty Lending Corporation or any of its other subsidiaries. |
Fair Value Measurements | Fair Value Measurements: The Company values its investments in accordance with ASC 820, which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity. Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows: • Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date. • Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities. • Level 3 — Unobservable inputs that reflect Oaktree's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. Oaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions. Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations. Oaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If Oaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within Oaktree's set threshold, Oaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, Oaktree does not adjust any of the prices received from these sources. If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, Oaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. Oaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and Oaktree considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, Oaktree depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable. Oaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates. Rule 2a-5 under the Investment Company Act permits boards of directors of registered investment companies and Business Development Companies to either (i) choose to determine fair value in good faith or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Directors has designated Oaktree to serve as its valuation designee effective September 8, 2022. Oaktree undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments: • The quarterly valuation process begins with each portfolio company or investment being initially valued by Oaktree's valuation team; • Preliminary valuations are then reviewed and discussed with management of Oaktree; • Separately, independent valuation firms prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to Oaktree; • Oaktree compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee; • The Audit Committee reviews the valuation report with Oaktree, and Oaktree responds and supplements the valuation report to reflect any discussions between Oaktree and the Audit Committee; and • Oaktree, as valuation designee, determines the fair value of each investment in the Company's portfolio. The fair value of the Company's investments as of June 30, 2023 and September 30, 2022 was determined by Oaktree, as the Company's valuation designee. The Company has and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of its portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material. |
Foreign Currency Translation | Foreign Currency Translation: The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company. |
Derivative Instruments | Derivative Instruments: Foreign Currency Forward Contracts The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded within derivative assets or derivative liabilities on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statements of Operations. Interest Rate Swaps The Company uses an interest rate swap to hedge some of the Company's fixed rate debt. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship, and therefore the periodic payments are recognized as components of interest expense in the Consolidated Statements of Operations. Depending on the nature of the balance at period end, the fair value of the interest rate swap is either included as a derivative asset or derivative liability on the Company's Consolidated Statements of Assets and Liabilities. The change in fair value of the interest rate swap is offset by a change in the carrying value of the fixed rate debt. Any amounts paid to the counterparty to cover collateral obligations under the terms of the interest rate swap agreement are included in due from broker on the Company's Consolidated Statements of Assets and Liabilities. |
Investment Income | Investment Income: Interest Income Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of June 30, 2023, there were five investments on non-accrual status that in aggregate represented 3.6% and 3.1% of total debt investments at cost and fair value, respectively. As of September 30, 2022, there were no investments on non-accrual status. In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan. PIK Interest Income The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost bases of these investments in the Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by the Company to Oaktree. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s stockholders, even though the Company has not yet collected the cash and may never do so. Fee Income Oaktree or its affiliates may provide financial advisory services to portfolio companies and, in return, the Company may receive fees for capital structuring services. These fees are generally non-recurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment, exit and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered. Dividend Income The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment. |
Cash and Cash Equivalents and Restricted Cash | Cash and Cash Equivalents and Restricted Cash: Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less when acquired. The Company places its cash and cash equivalents and restricted cash with financial institutions and, at times, cash held in bank accounts exceeds the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets. |
Due From Portfolio Companies | Due from Portfolio Companies: Due from portfolio companies consists of amounts payable to the Company from its portfolio companies, including proceeds from the sale of portfolio companies not yet received or being held in escrow and excluding those amounts attributable to interest, dividends or fees receivable. These amounts are recognized as they become payable to the Company ( e.g. , principal payments on the scheduled amortization payment date). |
Receivables/Payables from Unsettled Transactions | Receivables/Payables from Unsettled Transactions: Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date. |
Deferred Financing Costs | Deferred Financing Costs: Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities and debt offerings. Deferred financing costs in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Company's Consolidated Statements of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense. For extinguishments of the Company’s unsecured notes payable, any unamortized deferred financing costs are deducted from the carrying amount of the debt in determining the gain or loss from the extinguishment. |
Deferred Offering Costs | Deferred Offering Costs: Legal fees and other costs incurred in connection with the Company’s shelf registration statement are capitalized as deferred offering costs in the Consolidated Statements of Assets and Liabilities. To the extent any such costs relate to equity offerings, these costs are charged as a reduction of capital upon utilization. To the extent any such costs relate to debt offerings, these costs are treated as deferred financing costs and are amortized over the term of the respective debt arrangement. Any deferred offering costs that remain at the expiration of the shelf registration statement or when it becomes probable that an offering will not be completed are expensed. |
Income Taxes | Income Taxes: The Company has elected to be subject to tax as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to be subject to tax as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute dividends to its stockholders of an amount generally at least equal to 90% of investment company taxable income, as defined by the Code and determined without regard to any deduction for dividends paid, for each taxable year. As a RIC, the Company is not subject to U.S. federal income tax on the portion of its taxable income and gains distributed currently to stockholders as a dividend. Depending on the level of taxable income earned during a taxable year, the Company may choose to retain taxable income in excess of current year dividend distributions and would distribute such taxable income in the next taxable year. The Company would then incur a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income, determined on a calendar year basis, could exceed estimated current calendar year dividend distributions, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. The Company anticipates timely distribution of its taxable income within the tax rules under Subchapter M of the Code. The Company did not incur a U.S. federal excise tax for calendar year 2021. For the calendar year 2022, the Company incurred $0.1 million of excise tax. The Company does not expect to incur a U.S. federal excise tax for calendar year 2023. The Company holds certain portfolio investments through taxable subsidiaries. The purpose of the Company's taxable subsidiaries is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiaries are consolidated for financial reporting purposes, and portfolio investments held by them are included in the Company’s Consolidated Financial Statements as portfolio investments and recorded at fair value. The taxable subsidiaries are not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statements of Operations. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences. FASB ASC Topic 740, Accounting for Uncertainty in Income Taxes ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the Company's Consolidated Financial Statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Management's determinations regarding ASC 740 may be subject to review and adjustment at a later date based upon factors including an ongoing analysis of tax laws, regulations and interpretations thereof. The Company recognizes the tax benefits of uncertain tax positions only where the position is "more-likely-than-not" to be sustained assuming examination by tax authorities. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years 2020, 2021 and 2022. The Company identifies its major tax jurisdictions as U.S. Federal and California, and the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months. |
Portfolio Investments (Tables)
Portfolio Investments (Tables) | 9 Months Ended |
Jun. 30, 2023 | |
Schedule of Investments [Abstract] | |
Composition of Investments | Below is certain summarized financial information for SLF JV I as of June 30, 2023 and September 30, 2022 and for the three and nine months ended June 30, 2023 and 2022: June 30, 2023 September 30, 2022 Selected Balance Sheet Information: Investments at fair value (cost June 30, 2023:$348,782; cost September 30, 2022: $382,673) $ 329,809 $ 359,625 Cash and cash equivalents 21,906 14,274 Restricted cash 8,715 5,642 Other assets 9,798 5,686 Total assets $ 370,228 $ 385,227 Senior credit facility payable $ 200,000 $ 230,000 SLF JV I Notes payable at fair value (proceeds June 30, 2023: $128,750; proceeds September 30, 2022: $110,000) 128,750 110,000 Other liabilities 9,509 21,539 Total liabilities $ 338,259 $ 361,539 Members' equity 31,969 23,688 Total liabilities and members' equity $ 370,228 $ 385,227 Three months ended June 30, 2023 Three months ended June 30, 2022 Nine months ended June 30, 2023 Nine months ended June 30, 2022 Selected Statements of Operations Information: Interest income $ 10,312 $ 5,796 $ 29,106 $ 16,664 Other income — 32 62 105 Total investment income 10,312 5,828 29,168 16,769 Senior credit facility interest expense 4,190 1,929 12,004 4,995 SLF JV I Notes interest expense 3,859 2,224 10,511 6,673 Other expenses 73 77 249 198 Total expenses (1) 8,122 4,230 22,764 11,866 Net investment income 2,190 1,598 6,404 4,903 Net unrealized appreciation (depreciation) 2,652 (16,411) 4,075 (19,856) Net realized gains (losses) (2,137) 165 (4,850) 568 Net income (loss) $ 2,705 $ (14,648) $ 5,629 $ (14,385) __________ (1) There are no management fees or incentive fees charged at SLF JV I. Below is certain summarized financial information for the Glick JV as of June 30, 2023 and September 30, 2022 and for the three and nine months ended June 30, 2023 and June 30, 2022: June 30, 2023 September 30, 2022 Selected Balance Sheet Information: Investments at fair value (cost June 30, 2023: $120,172; September 30, 2022: $140,083) $ 113,833 $ 133,144 Cash and cash equivalents 8,895 7,021 Restricted cash 1,812 1,788 Other assets 2,284 4,855 Total assets $ 126,824 $ 146,808 Senior credit facility payable $ 66,082 $ 82,082 Glick JV Notes payable at fair value (proceeds June 30, 2023: $66,684; September 30, 2022: $68,185) 56,723 57,463 Other liabilities 4,019 7,263 Total liabilities $ 126,824 $ 146,808 Members' equity — — Total liabilities and members' equity $ 126,824 $ 146,808 For the three months ended June 30, 2023 For the three months ended June 30, 2022 For the nine months ended June 30, 2023 For the nine months ended June 30, 2022 Selected Statements of Operations Information: Interest income $ 3,576 $ 2,416 $ 10,488 $ 6,796 Fee income — 47 35 82 Total investment income 3,576 2,463 10,523 6,878 Senior credit facility interest expense 1,400 694 4,002 1,742 Glick JV Notes interest expense 1,577 860 4,394 2,479 Other expenses 70 59 148 127 Total expenses (1) 3,047 1,613 8,544 4,348 Net investment income 529 850 1,979 2,530 Net unrealized appreciation (depreciation) 431 (753) (159) (2,549) Realized gain (loss) (960) (97) (1,820) 19 Net income (loss) $ — $ — $ — $ — __________ (1) There are no management fees or incentive fees charged at the Glick JV. The Glick JV has elected to fair value the Glick JV Notes issued to the Company and GF Debt Funding under ASC 825. The Glick JV Notes are valued based on the total assets less the liabilities senior to the Glick JV Notes in an amount not exceeding par under the EV technique. |
Investment Holdings, Schedule of Investments | The composition of the Company's investments as of June 30, 2023 and September 30, 2022 at cost and fair value was as follows: June 30, 2023 September 30, 2022 Cost Fair Value Cost Fair Value Investments in debt securities $ 2,942,222 $ 2,826,369 $ 2,294,392 $ 2,223,329 Investments in equity securities 136,619 118,989 127,596 103,534 Debt investments in the JVs 162,653 162,288 146,444 146,533 Equity investments in the JVs 54,791 27,973 49,322 20,715 Total $ 3,296,285 $ 3,135,619 $ 2,617,754 $ 2,494,111 The following table presents the composition of the Company's debt investments as of June 30, 2023 and September 30, 2022 at fixed rates and floating rates: June 30, 2023 September 30, 2022 Fair Value % of Debt Fair Value % of Debt Floating rate debt securities, including the debt investments in the JVs $ 2,571,458 86.04 % $ 2,049,644 86.49 % Fixed rate debt securities 417,199 13.96 320,218 13.51 Total $ 2,988,657 100.00 % $ 2,369,862 100.00 % The following tables show the composition of the Company's portfolio by industry at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets as of June 30, 2023 and September 30, 2022: June 30, 2023 September 30, 2022 Cost: % of Total Investments % of Total Investments Application Software $ 560,503 16.98 % $ 391,938 14.98 % Multi-Sector Holdings (1) 219,130 6.65 195,766 7.48 Data Processing & Outsourced Services 133,422 4.05 120,477 4.60 Health Care Technology 129,178 3.92 100,084 3.82 Biotechnology 127,394 3.86 109,960 4.20 Pharmaceuticals 121,497 3.69 126,508 4.83 Aerospace & Defense 110,680 3.36 61,963 2.37 Industrial Machinery & Supplies & Components 99,237 3.01 — — Broadline Retail 83,201 2.52 — — Health Care Services 77,364 2.35 58,674 2.24 Real Estate Operating Companies 76,462 2.32 47,585 1.82 Specialized Finance 69,188 2.10 80,864 3.09 Personal Care Products 68,671 2.08 — — Automotive Retail 64,825 1.97 59,254 2.26 Fertilizers & Agricultural Chemicals 64,750 1.96 49,301 1.88 Internet Services & Infrastructure 63,057 1.91 54,095 2.07 Health Care Distributors 62,079 1.88 57,112 2.18 Diversified Financial Services 61,693 1.87 — — Auto Parts & Equipment 61,091 1.85 12,474 0.48 Metal, Glass & Plastic Containers 57,949 1.76 — — Airport Services 55,919 1.70 43,322 1.65 Home Improvement Retail 54,939 1.67 45,802 1.75 Insurance Brokers 52,960 1.61 35,628 1.36 Diversified Metals & Mining 49,787 1.51 — — Leisure Facilities 49,501 1.50 39,768 1.52 Real Estate Services 44,783 1.36 40,243 1.54 Soft Drinks & Non-alcoholic Beverages 43,021 1.31 — — Diversified Support Services 42,706 1.30 37,992 1.45 Other Specialty Retail 41,790 1.27 — — Specialty Chemicals 38,248 1.16 37,319 1.43 Distributors 37,668 1.14 25,278 0.97 Integrated Telecommunication Services 33,663 1.02 34,628 1.32 Electrical Components & Equipment 32,380 0.98 33,814 1.29 Construction & Engineering 27,231 0.83 60,996 2.33 Environmental & Facilities Services 25,943 0.79 20,857 0.80 Advertising 25,597 0.78 28,245 1.08 Passenger Airlines 24,888 0.76 — — Oil & Gas Storage & Transportation 24,231 0.74 22,290 0.85 Home Furnishings 23,832 0.72 19,550 0.75 Gold 23,274 0.71 — — Systems Software 23,089 0.70 14,890 0.57 Health Care Equipment 22,374 0.68 24,353 0.93 Real Estate Development 19,567 0.59 — — Interactive Media & Services 18,963 0.58 — — Hotels, Resorts & Cruise Lines 17,221 0.52 13,960 0.53 Consumer Finance 16,411 0.50 14,492 0.55 Education Services 15,660 0.48 9,080 0.35 IT Consulting & Other Services 15,434 0.47 11,697 0.45 Restaurants 12,589 0.38 9,338 0.36 Movies & Entertainment 12,188 0.37 26,161 1.00 Health Care Supplies 11,675 0.35 36,471 1.39 Food Distributors 5,900 0.18 4,646 0.18 Apparel Retail 5,293 0.16 5,268 0.20 Air Freight & Logistics 4,925 0.15 7,295 0.28 Integrated Oil & Gas 4,887 0.15 4,866 0.19 Research & Consulting Services 4,879 0.15 9,187 0.35 Cable & Satellite 4,687 0.14 20,716 0.79 Other Specialized REITs 4,364 0.13 — — Paper & Plastic Packaging Products & Materials 3,262 0.10 — — Housewares & Specialties 2,908 0.09 2,293 0.09 Electronic Components 2,101 0.06 2,092 0.08 Leisure Products 2,039 0.06 — — Technology Distributors 1,084 0.03 3,163 0.12 Communications Equipment 1,053 0.03 — — Industrial Machinery — — 81,787 3.12 Internet & Direct Marketing Retail — — 67,926 2.59 Personal Products — — 53,214 2.03 Metal & Glass Containers — — 47,704 1.82 Soft Drinks — — 34,272 1.31 Other Diversified Financial Services — — 29,300 1.12 Oil & Gas Refining & Marketing — — 8,627 0.33 Trading Companies & Distributors — — 7,628 0.29 Apparel, Accessories & Luxury Goods — — 5,165 0.20 Specialized REITs — — 4,318 0.16 Diversified Banks — — 3,515 0.13 Construction Materials — — 2,331 0.09 Alternative Carriers — — 212 0.01 $ 3,296,285 100.00 % $ 2,617,754 100.00 % June 30, 2023 September 30, 2022 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Application Software $ 544,685 17.38 % 36.03 % $ 384,589 15.43 % 30.87 % Multi-Sector Holdings (1) 192,160 6.13 12.73 167,248 6.71 13.43 Biotechnology 128,343 4.09 8.50 108,465 4.35 8.71 Data Processing & Outsourced Services 124,548 3.97 8.25 111,335 4.46 8.94 Pharmaceuticals 116,199 3.71 7.70 119,511 4.79 9.59 Health Care Technology 115,659 3.69 7.66 97,315 3.90 7.81 Aerospace & Defense 111,464 3.55 7.38 61,881 2.48 4.97 Industrial Machinery & Supplies & Components 99,021 3.16 6.56 — — — Broadline Retail 80,882 2.58 5.36 — — — Real Estate Operating Companies 75,111 2.40 4.98 48,062 1.93 3.86 Specialized Finance 66,333 2.12 4.39 73,087 2.93 5.87 Fertilizers & Agricultural Chemicals 63,185 2.02 4.19 51,972 2.08 4.17 Internet Services & Infrastructure 62,726 2.00 4.16 53,797 2.16 4.32 Automotive Retail 62,356 1.99 4.13 57,629 2.31 4.63 Health Care Services 62,190 1.98 4.12 45,943 1.84 3.69 Diversified Financial Services 61,073 1.95 4.05 — — — Personal Care Products 60,962 1.94 4.04 — — — Auto Parts & Equipment 60,809 1.94 4.03 11,469 0.46 0.92 Health Care Distributors 60,340 1.92 4.00 54,662 2.19 4.39 Airport Services 55,221 1.76 3.66 42,883 1.72 3.44 Insurance Brokers 54,680 1.74 3.62 33,081 1.33 2.66 Home Improvement Retail 54,235 1.73 3.59 45,421 1.82 3.65 Diversified Metals & Mining 49,809 1.59 3.30 — — — Leisure Facilities 46,990 1.50 3.11 39,258 1.57 3.15 Real Estate Services 44,227 1.41 2.93 39,573 1.59 3.18 Metal, Glass & Plastic Containers 43,954 1.40 2.91 — — — Soft Drinks & Non-alcoholic Beverages 42,798 1.36 2.84 — — — Other Specialty Retail 41,790 1.33 2.77 — — — Diversified Support Services 41,302 1.32 2.74 36,712 1.47 2.95 Distributors 36,829 1.17 2.44 24,494 0.98 1.97 Electrical Components & Equipment 32,379 1.03 2.15 32,933 1.32 2.64 Specialty Chemicals 32,231 1.03 2.14 33,969 1.36 2.73 Integrated Telecommunication Services 30,922 0.99 2.05 32,201 1.29 2.59 Passenger Airlines 26,985 0.86 1.79 — — — Construction & Engineering 26,901 0.86 1.78 61,188 2.45 4.91 Environmental & Facilities Services 25,436 0.81 1.69 20,585 0.83 1.65 Gold 23,292 0.74 1.54 — — — Health Care Equipment 22,531 0.72 1.49 24,161 0.97 1.94 Systems Software 22,168 0.71 1.47 12,834 0.51 1.03 Oil & Gas Storage & Transportation 21,660 0.69 1.43 20,853 0.84 1.67 Home Furnishings 19,514 0.62 1.29 18,188 0.73 1.46 Real Estate Development 19,246 0.61 1.28 — — — Interactive Media & Services 19,000 0.61 1.26 — — — Advertising 18,969 0.60 1.26 26,948 1.08 2.16 Hotels, Resorts & Cruise Lines 17,261 0.55 1.14 13,985 0.56 1.12 Education Services 14,116 0.45 0.94 8,582 0.34 0.69 Consumer Finance 12,616 0.40 0.84 13,284 0.53 1.07 Restaurants 12,168 0.39 0.81 8,692 0.35 0.70 Movies & Entertainment 11,865 0.38 0.79 26,645 1.07 2.14 Health Care Supplies 11,408 0.36 0.76 36,577 1.47 2.94 IT Consulting & Other Services 11,176 0.36 0.74 8,596 0.34 0.69 Food Distributors 5,296 0.17 0.35 3,367 0.13 0.27 Apparel Retail 5,230 0.17 0.35 5,223 0.21 0.42 Integrated Oil & Gas 4,810 0.15 0.32 4,872 0.20 0.39 Cable & Satellite 4,672 0.15 0.31 19,576 0.78 1.57 Research & Consulting Services 4,632 0.15 0.31 8,573 0.34 0.69 Air Freight & Logistics 4,025 0.13 0.27 6,405 0.26 0.51 Other Specialized REITs 3,438 0.11 0.23 — — — Paper & Plastic Packaging Products & Materials 3,100 0.10 0.21 — — — Housewares & Specialties 2,858 0.09 0.19 2,456 0.10 0.20 Leisure Products 1,995 0.06 0.13 — — — Electronic Components 1,834 0.06 0.12 1,890 0.08 0.15 Technology Distributors 1,024 0.03 0.07 2,997 0.12 0.24 Communications Equipment 980 0.03 0.06 — — — Industrial Machinery — — — 81,008 3.25 6.50 Internet & Direct Marketing Retail — — — 70,419 2.82 5.65 Personal Products — — — 50,150 2.01 4.03 Metal & Glass Containers — — — 47,599 1.91 3.82 Soft Drinks — — — 33,670 1.35 2.70 Other Diversified Financial Services — — — 24,326 0.98 1.95 June 30, 2023 September 30, 2022 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Oil & Gas Refining & Marketing $ — — — $ 8,604 0.34 0.69 Trading Companies & Distributors — — — 5,567 0.22 0.45 Diversified Banks — — — 3,402 0.14 0.27 Specialized REITs — — — 3,264 0.13 0.26 Construction Materials — — — 1,934 0.08 0.16 Alternative Carriers — — — 201 0.01 0.02 Total $ 3,135,619 100.00 % 207.73 % $ 2,494,111 100.00 % 200.24 % SLF JV I Portfolio as of June 30, 2023 Portfolio Company Industry Type of Investment Index Spread Cash Interest Rate (1)(2) PIK Maturity Date Shares Principal Cost Fair Value (3) Notes Access CIG, LLC Diversified Support Services First Lien Term Loan L+ 3.75% 8.94% 2/27/2025 $ 5,596 $ 5,559 $ 5,545 ADB Companies, LLC Construction & Engineering First Lien Term Loan SOFR+ 6.50% 12.00% 12/18/2025 6,911 6,832 6,784 (4) ADB Companies, LLC Construction & Engineering First Lien Term Loan SOFR+ 6.50% 12.00% 12/18/2025 1,173 1,158 1,152 (4) Altice France S.A. Integrated Telecommunication Services First Lien Term Loan L+ 4.00% 9.32% 8/14/2026 2,977 2,850 2,808 Alvogen Pharma US, Inc. Pharmaceuticals First Lien Term Loan SOFR+ 7.50% 12.89% 6/30/2025 8,916 8,845 8,514 (4) American Rock Salt Company LLC Diversified Metals & Mining First Lien Term Loan SOFR+ 4.00% 9.22% 6/9/2028 4,970 4,734 4,692 American Tire Distributors, Inc. Distributors First Lien Term Loan SOFR+ 6.25% 11.49% 10/20/2028 4,836 4,775 4,219 (4) Amplify Finco Pty Ltd. Movies & Entertainment First Lien Term Loan SOFR+ 4.00% 9.39% 11/26/2026 7,740 7,663 7,721 Anastasia Parent, LLC Personal Care Products First Lien Term Loan SOFR+ 3.75% 9.25% 8/11/2025 1,527 1,194 1,179 (4) Apptio, Inc. Application Software First Lien Term Loan L+ 5.00% 10.20% 1/10/2025 4,615 4,592 4,615 (4) Apptio, Inc. Application Software First Lien Revolver L+ 5.00% 10.20% 1/10/2025 115 113 115 (4)(5) ASP-R-PAC Acquisition Co LLC Paper & Plastic Packaging Products & Materials First Lien Term Loan SOFR+ 6.00% 11.31% 12/29/2027 4,145 4,083 3,938 (4) ASP-R-PAC Acquisition Co LLC Paper & Plastic Packaging Products & Materials First Lien Revolver SOFR+ 6.00% 12/29/2027 — (7) (25) (4)(5) Astra Acquisition Corp. Application Software First Lien Term Loan L+ 5.25% 10.44% 10/25/2028 5,052 4,880 3,560 (4) Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.00% 9.20% 8/19/2028 4,963 4,749 4,710 Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.25% 9.47% 8/19/2028 1,995 1,883 1,902 Asurion, LLC Property & Casualty Insurance Second Lien Term Loan SOFR+ 5.25% 10.47% 1/20/2029 4,346 4,022 3,657 athenahealth Group Inc. Health Care Technology First Lien Term Loan SOFR+ 3.50% 8.59% 2/15/2029 4,331 4,079 4,179 athenahealth Group Inc. Health Care Technology First Lien Term Loan SOFR+ 3.50% 2/15/2029 — (32) (19) (5) Aurora Lux Finco S.À.R.L. Airport Services First Lien Term Loan L+ 6.00% 11.27% 12/24/2026 6,289 6,211 6,031 (4) BAART Programs, Inc. Health Care Services First Lien Term Loan SOFR+ 5.00% 10.50% 6/11/2027 6,322 6,263 6,158 (4) BAART Programs, Inc. Health Care Services First Lien Term Loan SOFR+ 5.00% 10.50% 6/11/2027 1,759 1,748 1,713 (4) C5 Technology Holdings, LLC Data Processing & Outsourced Services Common Stock 171 — — (4) C5 Technology Holdings, LLC Data Processing & Outsourced Services Preferred Equity 7,193,540 7,194 5,683 (4) Centerline Communications, LLC Wireless Telecommunication Services First Lien Term Loan SOFR+ 6.00% 11.44% 8/10/2027 1,965 1,938 1,930 Centerline Communications, LLC Wireless Telecommunication Services First Lien Term Loan SOFR+ 6.00% 11.44% 8/10/2027 2,366 2,332 2,324 Centerline Communications, LLC Wireless Telecommunication Services First Lien Term Loan SOFR+ 6.00% 11.44% 8/10/2027 1,988 1,957 1,952 Centerline Communications, LLC Wireless Telecommunication Services First Lien Revolver SOFR+ 6.00% 11.38% 8/10/2027 200 192 189 (5) Convergeone Holdings, Inc. IT Consulting & Other Services First Lien Term Loan L+ 5.00% 10.37% 1/4/2026 7,315 7,188 4,670 (4) Covetrus, Inc. Health Care Distributors First Lien Term Loan SOFR+ 5.00% 10.24% 10/13/2029 6,359 5,983 5,937 (4) Curium Bidco S.à.r.l. Biotechnology First Lien Term Loan L+ 4.00% 9.54% 7/9/2026 7,760 7,689 7,730 Curium Bidco S.à.r.l. Biotechnology First Lien Term Loan L+ 4.25% 9.79% 12/2/2027 992 974 987 DirecTV Financing, LLC Cable & Satellite First Lien Term Loan SOFR+ 5.00% 10.22% 8/2/2027 5,958 5,869 5,838 (4) DTI Holdco, Inc. Research & Consulting Services First Lien Term Loan SOFR+ 4.75% 9.80% 4/26/2029 7,940 7,807 7,411 (4) Gibson Brands, Inc. Leisure Products First Lien Term Loan SOFR+ 5.00% 10.25% 8/11/2028 7,388 7,314 5,984 (4) Harbor Purchaser Inc. Education Services First Lien Term Loan SOFR+ 5.25% 10.45% 4/9/2029 7,940 7,742 6,818 (4) Portfolio Company Industry Type of Investment Index Spread Cash Interest Rate (1)(2) PIK Maturity Date Shares Principal Cost Fair Value (3) Notes Indivior Finance S.À.R.L. Pharmaceuticals First Lien Term Loan SOFR+ 5.25% 10.75% 6/30/2026 $ 7,350 $ 7,260 $ 7,359 INW Manufacturing, LLC Personal Care Products First Lien Term Loan L+ 5.75% 11.29% 3/25/2027 9,125 8,950 7,239 (4) Iris Holding, Inc. Metal, Glass & Plastic Containers First Lien Term Loan SOFR+ 4.75% 9.90% 6/28/2028 4,963 4,638 4,226 LABL, Inc. Office Services & Supplies First Lien Term Loan SOFR+ 5.00% 10.20% 10/29/2028 3,972 3,817 3,940 LaserAway Intermediate Holdings II, LLC Health Care Services First Lien Term Loan SOFR+ 5.75% 11.08% 10/14/2027 7,388 7,281 7,267 Lightbox Intermediate, L.P. Real Estate Services First Lien Term Loan SOFR+ 5.00% 10.50% 5/9/2026 11,279 11,121 10,997 (4) LogMeIn, Inc. Application Software First Lien Term Loan L+ 4.75% 9.94% 8/31/2027 7,800 7,705 4,918 LTI Holdings, Inc. Electronic Components First Lien Term Loan SOFR+ 3.50% 8.72% 9/6/2025 7,308 7,246 7,037 McAfee Corp. Systems Software First Lien Term Loan SOFR+ 3.75% 9.01% 3/1/2029 5,955 5,655 5,713 Mindbody, Inc. Internet Services & Infrastructure First Lien Term Loan L+ 7.00% 12.19% 2/14/2025 4,669 4,644 4,599 (4) Mindbody, Inc. Internet Services & Infrastructure First Lien Revolver L+ 8.00% 2/14/2025 — (3) (7) (4)(5) Mitchell International Inc Application Software First Lien Term Loan L+ 3.75% 8.94% 10/15/2028 2,991 2,845 2,931 MRI Software LLC Application Software First Lien Term Loan SOFR+ 5.50% 10.84% 2/10/2026 8,340 8,172 8,111 (4) MRI Software LLC Application Software First Lien Revolver SOFR+ 5.50% 2/10/2026 — (3) (9) (4)(5) MRI Software LLC Application Software First Lien Term Loan SOFR+ 5.50% 10.84% 2/10/2026 2,217 2,216 2,156 (4) Northern Star Industries Inc. Electrical Components & Equipment First Lien Term Loan SOFR+ 4.50% 10.00% 3/31/2025 6,633 6,624 6,583 OEConnection LLC Application Software First Lien Term Loan L+ 4.00% 9.25% 9/25/2026 11,015 10,845 10,852 Park Place Technologies, LLC Internet Services & Infrastructure First Lien Term Loan SOFR+ 5.00% 10.20% 11/10/2027 9,849 9,495 9,603 (4) Planview Parent, Inc. Application Software First Lien Term Loan SOFR+ 4.00% 9.50% 12/17/2027 2,422 2,297 2,305 Planview Parent, Inc. Application Software Second Lien Term Loan SOFR+ 7.25% 12.59% 12/18/2028 4,503 4,435 4,023 (4) Pluralsight, LLC Application Software First Lien Term Loan SOFR+ 8.00% 13.04% 4/6/2027 8,116 7,831 7,815 (4) Pluralsight, LLC Application Software First Lien Revolver SOFR+ 8.00% 13.04% 4/6/2027 254 236 235 (4)(5) Renaissance Holding Corp. Education Services First Lien Term Loan SOFR+ 4.75% 9.99% 4/5/2030 5,000 4,855 4,948 RevSpring, Inc. Commercial Printing First Lien Term Loan L+ 4.00% 9.50% 10/11/2025 9,550 9,536 9,208 SHO Holding I Corporation Footwear First Lien Term Loan L+ 5.25% 10.52% 4/27/2024 8,135 8,132 5,749 SHO Holding I Corporation Footwear First Lien Term Loan L+ 5.23% 10.50% 4/27/2024 138 138 100 SM Wellness Holdings, Inc. Health Care Services First Lien Term Loan SOFR+ 4.75% 9.97% 4/17/2028 2,985 2,564 2,768 (4) Sorenson Communications, LLC Communications Equipment First Lien Term Loan L+ 5.50% 10.69% 3/17/2026 2,328 2,305 2,166 (4) Spanx, LLC Apparel Retail First Lien Term Loan SOFR+ 5.50% 10.70% 11/20/2028 8,865 8,729 8,655 (4) SPX Flow, Inc. Industrial Machinery & Supplies & Components First Lien Term Loan SOFR+ 4.50% 9.70% 4/5/2029 8,801 8,426 8,710 TIBCO Software Inc. Application Software First Lien Term Loan SOFR+ 4.50% 9.84% 3/30/2029 8,235 7,548 7,722 (4) Touchstone Acquisition, Inc. Health Care Supplies First Lien Term Loan SOFR+ 6.00% 11.20% 12/29/2028 7,230 7,116 7,050 (4) Veritas US Inc. Application Software First Lien Term Loan L+ 5.00% 10.22% 9/1/2025 6,322 6,266 5,185 Windstream Services II, LLC Integrated Telecommunication Services First Lien Term Loan SOFR+ 6.25% 11.45% 9/21/2027 7,757 7,570 7,263 (4) WP CPP Holdings, LLC Aerospace & Defense First Lien Term Loan L+ 3.75% 9.03% 4/30/2025 1,970 1,917 1,791 (4) Total Portfolio Investments $ 350,214 $ 348,782 $ 329,809 _________ (1) Represents the interest rate as of June 30, 2023. All interest rates are payable in cash, unless otherwise noted. (2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All the LIBOR shown above is in U.S. dollars. As of June 30, 2023, the reference rates for SLF JV I's variable rate loans were the 30-day LIBOR at 5.19%, the 90-day LIBOR at 5.54 %, the 180-day LIBOR at 5.73%, the 30-day SOFR at 5.10%, and the 90-day SOFR at 5.24%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. (3) Represents the current determination of fair value as of June 30, 2023 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein. (4) This investment was held by both the Company and SLF JV I as of June 30, 2023. (5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. SLF JV I Portfolio as of September 30, 2022 Portfolio Company Industry Type of Investment Index Spread Cash Interest Rate (1)(2) PIK Maturity Date Shares Principal Cost Fair Value (3) Notes Access CIG, LLC Diversified Support Services First Lien Term Loan L+ 3.75% 6.82% 2/27/2025 $ 10,093 $ 10,028 $ 9,692 ADB Companies, LLC Construction & Engineering First Lien Term Loan SOFR+ 6.25% 9.80% 12/18/2025 8,518 8,389 8,371 (4) Altice France S.A. Integrated Telecommunication Services First Lien Term Loan L+ 4.00% 6.91% 8/14/2026 3,000 2,841 2,730 Alvogen Pharma US, Inc. Pharmaceuticals First Lien Term Loan SOFR+ 7.50% 11.20% 6/30/2025 9,267 9,166 9,221 (4) American Tire Distributors, Inc. Distributors First Lien Term Loan L+ 6.25% 9.03% 10/20/2028 4,873 4,812 4,576 (4) Amplify Finco Pty Ltd. Movies & Entertainment First Lien Term Loan L+ 4.25% 7.92% 11/26/2026 7,800 7,722 7,527 (4) Anastasia Parent, LLC Personal Products First Lien Term Loan L+ 3.75% 7.42% 8/11/2025 1,539 1,203 1,232 (4) Apptio, Inc. Application Software First Lien Term Loan L+ 6.00% 8.46% 1/10/2025 4,615 4,580 4,519 (4) Apptio, Inc. Application Software First Lien Revolver L+ 6.00% 8.46% 1/10/2025 154 151 146 (4)(5) ASP-R-PAC Acquisition Co LLC Paper Packaging First Lien Term Loan L+ 6.00% 9.67% 12/29/2027 4,176 4,103 4,080 ASP-R-PAC Acquisition Co LLC Paper Packaging First Lien Revolver L+ 6.00% 12/29/2027 (9) (11) (5) Astra Acquisition Corp. Application Software First Lien Term Loan L+ 5.25% 8.37% 10/25/2028 5,052 4,858 4,319 (4) Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.00% 7.70% 8/19/2028 5,000 4,753 4,276 Asurion, LLC Property & Casualty Insurance Second Lien Term Loan L+ 5.25% 8.37% 1/20/2029 4,346 3,981 3,347 Aurora Lux Finco S.À.R.L. Airport Services First Lien Term Loan L+ 6.00% 8.78% 12/24/2026 6,338 6,242 6,027 (4) BAART Programs, Inc. Health Care Services First Lien Term Loan L+ 5.00% 8.12% 6/11/2027 6,371 6,311 6,148 BAART Programs, Inc. Health Care Services First Lien Term Loan L+ 5.00% 8.12% 6/11/2027 1,771 1,751 1,664 (4)(5) Blackhawk Network Holdings, Inc. Data Processing & Outsourced Services First Lien Term Loan L+ 3.00% 6.03% 6/15/2025 9,575 9,566 8,977 BYJU's Alpha, Inc. Application Software First Lien Term Loan L+ 6.00% 8.98% 11/24/2026 7,444 7,347 5,455 C5 Technology Holdings, LLC Data Processing & Outsourced Services Common Stock 171 — — (4) C5 Technology Holdings, LLC Data Processing & Outsourced Services Preferred Equity 7,193,540 7,194 5,683 (4) Centerline Communications, LLC Wireless Telecommunication Services First Lien Term Loan SOFR+ 5.50% 9.12% 8/10/2027 4,358 4,286 4,280 Centerline Communications, LLC Wireless Telecommunication Services First Lien Term Loan SOFR+ 5.50% 9.12% 8/10/2027 449 432 413 Centerline Communications, LLC Wireless Telecommunication Services First Lien Revolver SOFR+ 5.50% 8/10/2027 — (10) (11) (5) CITGO Petroleum Corp. Oil & Gas Refining & Marketing First Lien Term Loan L+ 6.25% 9.37% 3/28/2024 7,038 6,967 7,057 (4) City Football Group Limited Movies & Entertainment First Lien Term Loan L+ 3.50% 6.48% 7/21/2028 6,451 6,419 6,166 Convergeone Holdings, Inc. IT Consulting & Other Services First Lien Term Loan L+ 5.00% 8.12% 1/4/2026 7,373 7,206 5,320 (4) Covetrus, Inc. Health Care Distributors First Lien Term Loan SOFR+ 5.00% 7.65% 9/20/2029 5,375 5,053 5,035 (4) Curium Bidco S.à.r.l. Biotechnology First Lien Term Loan L+ 4.00% 7.67% 7/9/2026 5,820 5,776 5,587 Dealer Tire, LLC Distributors First Lien Term Loan L+ 4.25% 7.37% 12/12/2025 2,992 2,935 2,924 Delivery Hero FinCo LLC Internet & Direct Marketing Retail First Lien Term Loan SOFR+ 5.75% 8.49% 8/12/2027 6,035 5,876 5,756 (4) DirecTV Financing, LLC Cable & Satellite First Lien Term Loan L+ 5.00% 8.12% 8/2/2027 6,436 6,332 6,012 (4) Domtar Corporation Paper Products First Lien Term Loan L+ 5.50% 8.26% 11/30/2028 4,100 4,065 3,921 DTI Holdco, Inc. Research & Consulting Services First Lien Term Loan SOFR+ 4.75% 7.33% 4/26/2029 8,000 7,849 7,616 (4) Eagle Parent Corp. Industrial Machinery First Lien Term Loan SOFR+ 4.25% 7.80% 4/2/2029 4,478 4,373 4,367 eResearch Technology, Inc. Application Software First Lien Term Loan L+ 4.50% 7.62% 2/4/2027 7,331 7,258 6,859 Portfolio Company Industry Type of Investment Index Spread Cash Interest Rate (1)(2) PIK Maturity Date Shares Principal Cost Fair Value (3) Notes Gibson Brands, Inc. Leisure Products First Lien Term Loan L+ 5.00% 7.94% 8/11/2028 $ 7,444 $ 7,369 $ 6,029 Global Medical Response, Inc. Health Care Services First Lien Term Loan L+ 4.25% 7.37% 3/14/2025 1,979 1,979 1,722 (4) Global Medical Response, Inc. Health Care Services First Lien Term Loan L+ 4.25% 6.81% 10/2/2025 2,192 2,165 1,912 Harbor Purchaser Inc. Education Services First Lien Term Loan SOFR+ 5.25% 8.38% 4/9/2029 8,000 7,774 7,310 (4) Indivior Finance S.À.R.L. Pharmaceuticals First Lien Term Loan L+ 5.25% 8.80% 6/30/2026 7,406 7,293 7,286 INW Manufacturing, LLC Personal Products First Lien Term Loan L+ 5.75% 9.42% 3/25/2027 9,500 9,282 8,408 (4) Iris Holding, Inc. Metal & Glass Containers First Lien Term Loan SOFR+ 4.75% 7.89% 6/28/2028 5,000 4,624 4,610 LaserAway Intermediate Holdings II, LLC Health Care Services First Lien Term Loan L+ 5.75% 8.23% 10/14/2027 7,444 7,318 7,323 Lightbox Intermediate, L.P. Real Estate Services First Lien Term Loan L+ 5.00% 8.67% 5/9/2026 7,367 7,315 7,109 (4) LogMeIn, Inc. Application Software First Lien Term Loan L+ 4.75% 7.80% 8/31/2027 7,860 7,751 5,494 LTI Holdings, Inc. Electronic Components First Lien Term Loan L+ 3.25% 6.37% 9/6/2025 7,366 7,282 6,835 Mindbody, Inc. Internet Services & Infrastructure First Lien Term Loan L+ 7.00% 10.64% 2/14/2025 4,687 4,651 4,570 (4) Mindbody, Inc. Internet Services & Infrastructure First Lien Revolver L+ 8.00% 2/14/2025 — (4) (12) (4)(5) MRI Software LLC Application Software First Lien Term Loan L+ 5.50% 9.17% 2/10/2026 6,139 6,104 5,966 (4) MRI Software LLC Application Software First Lien Revolver L+ 5.50% 2/10/2026 (3) (10) (4)(5) Northern Star Industries Inc. Electrical Components & Equipment First Lien Term Loan L+ 4.75% 7.87% 3/31/2025 6,685 6,673 6,484 OEConnection LLC Application Software First Lien Term Loan L+ 4.00% 7.12% 9/25/2026 7,777 7,741 7,505 (4) Park Place Technologies, LLC Internet Services & Infrastructure First Lien Term Loan SOFR+ 5.00% 8.13% 11/10/2027 4,925 4,781 4,687 (4) Peloton Interactive, Inc. Leisure Products First Lien Term Loan SOFR+ 6.50% 8.35% 5/25/2027 5,486 5,251 5,371 Planview Parent, Inc. Application Software Second Lien Term Loan L+ 7.25% 10.92% 12/18/2028 4,503 4,435 4,323 (4) Pluralsight, LLC Application Software First Lien Term Loan L+ 8.00% 10.68% 4/6/2027 6,796 6,694 6,582 (4) Pluralsight, LLC Application Software First Lien Revolver L+ 8.00% 4/6/2027 — (6) (13) (4)(5) RevSpring, Inc. Commercial Printing First Lien Term Loan L+ 4.00% 7.67% 10/11/2025 9,625 9,607 9,304 Sabert Corporation Metal & Glass Containers First Lien Term Loan L+ 4.50% 7.63% 12/10/2026 2,536 2,511 2,435 (4) SHO Holding I Corporation Footwear First Lien Term Loan L+ 5.25% 8.06% 4/27/2024 8,201 8,194 7,176 SHO Holding I Corporation Footwear First Lien Term Loan L+ 5.23% 8.04% 4/27/2024 138 138 121 Sorenson Communications, LLC Communications Equipment First Lien Term Loan L+ 5.50% 9.17% 3/17/2026 2,553 2,528 2,454 Spanx, LLC Apparel Retail First Lien Term Loan L+ 5.25% 8.30% 11/20/2028 8,933 8,776 8,721 (4) SPX Flow, Inc. Industrial Machinery First Lien Term Loan SOFR+ 4.50% 7.63% 4/5/2029 7,500 7,184 6,966 (4) Supermoose Borrower, LLC Application Software First Lien Term Loan L+ 3.75% 7.42% 8/29/2025 7,743 7,479 6,827 (4) Surgery Center Holdings, Inc. Health Care Facilities First Lien Term Loan L+ 3.75% 6.51% 8/31/2026 3,377 3,365 3,213 TIBCO Software Inc. Application Software First Lien Term Loan SOFR+ 4.50% 8.15% 3/30/2029 6,256 5,693 5,629 (4) Touchstone Acquisition, Inc. Health Care Supplies First Lien Term Loan L+ 6.00% 9.12% 12/29/2028 7,285 7,155 7,140 (4) Veritas US Inc. Application Software First Lien Term Loan L+ 5.00% 8.67% 9/1/2025 6,365 6,290 5,087 Windstream Services II, LLC Integrated Telecommunication Services First Lien Term Loan L+ 6.25% 9.37% 9/21/2027 7,818 7,596 7,115 (4) WP CPP Holdings, LLC Aerospace & Defense Second Lien Term Loan L+ 7.75% 10.56% 4/30/2026 6,000 5,972 5,070 (4) WP CPP Holdings, LLC Aerospace & Defense First Lien Term Loan L+ 3.75% 6.56% 4/30/2025 1,985 1,910 1,783 (4) Zayo Group Holdings, Inc. Alternative Carriers First Lien Term Loan L+ 3.00% 6.12% 3/9/2027 2,155 2,000 1,812 Total Portfolio Investments $ 383,194 $ 382,673 $ 359,625 _________ (1) Represents the interest rate as of September 30, 2022. All interest rates are payable in cash, unless otherwise noted. (2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to SOFR. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All the LIBOR shown above is in U.S. dollars. As of September 30, 2022, the reference rates for SLF JV I's variable rate loans were the 30-day LIBOR at 3.12%, the 90-day LIBOR at 3.67%, the 30-day SOFR at 3.03%, the 90-day SOFR at 3.55% and the 180-day SOFR at 3.98%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread. (3) Represents the current determination of fair value as of September 30, 2022 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein. (4) This investment was held by both the Company and SLF JV I as of September 30, 2022. (5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par. Glick JV Portfolio as of June 30, 2023 Portfolio Company Industry Investment Type Index Spread Cash Interest Rate (1)(2) PIK Maturity Date Principal Cost Fair Value (3) Notes ADB Companies, LLC Construction & Engineering First Lien Term Loan SOFR+ 6.50% 12.00% 12/18/2025 $ 587 $ 579 $ 576 (4) ADB Companies, LLC Construction & Engineering First Lien Term Loan SOFR+ 6.50% 12.00% 12/18/2025 3,824 3,782 3,753 (4) Alvogen Pharma US, Inc. Pharmaceuticals First Lien Term Loan SOFR+ 7.50% 12.89% 6/30/2025 6,313 6,261 6,029 (4) American Rock Salt Company LLC Diversified Metals & Mining First Lien Term Loan SOFR+ 4.00% 9.22% 6/9/2028 2,485 2,367 2,346 American Tire Distributors, Inc. Distributors First Lien Term Loan SOFR+ 6.25% 11.49% 10/20/2028 2,868 2,832 2,502 (4) Amplify Finco Pty Ltd. Movies & Entertainment First Lien Term Loan SOFR+ 4.00% 9.39% 11/26/2026 2,903 2,873 2,895 Amynta Agency Borrower Inc. Property & Casualty Insurance First Lien Term Loan SOFR+ 5.00% 10.20% 2/28/2028 3,000 2,915 2,925 Anastasia Parent, LLC Personal Care Products First Lien Term Loan SOFR+ 3.75% 9.25% 8/11/2025 910 707 702 (4) ASP-R-PAC Acquisition Co LLC Paper & Plastic Packaging Products & Materials First Lien Term Loan SOFR+ 6.00% 11.31% 12/29/2027 1,721 1,695 1,635 (4) ASP-R-PAC Acquisition Co LLC Paper & Plastic Packaging Products & Materials First Lien Revolver SOFR+ 6.00% 12/29/2027 — (3) (10) (4)(5) Astra Acquisition Corp. Application Software First Lien Term Loan L+ 5.25% 10.44% 10/25/2028 2,078 2,037 1,464 (4) Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.00% 9.20% 8/19/2028 1,985 1,900 1,884 Asurion, LLC Property & Casualty Insurance First Lien Term Loan SOFR+ 4.25% 9.47% 8/19/2028 998 941 951 Asurion, LLC Property & Casualty Insurance Second Lien Term Loan SOFR+ 5.25% 10.47% 1/20/2029 2,423 2,236 2,039 athenahealth Group Inc. Health Care Technology First Lien Term Loan SOFR+ 3.50% 8.59% 2/15/2029 1,777 1,674 1,715 athenahealth Group Inc. Health Care Technology First Lien Term Loan SOFR+ 3.50% 2/15/2029 — (13) (8) (5) Aurora Lux Finco S.À.R.L. Airport Services First Lien Term Loan L+ 6.00% 11.27% 12/24/2026 3,628 3,583 3,479 (4) BAART Programs, Inc. Health Care Services First Lien Term Loan SOFR+ 5.00% 10.50% 6/11/2027 3,372 3,340 3,284 (4) BAART Programs, Inc. Health Care Services First Lien Term Loan SOFR+ 5.00% 10.50% 6/11/2027 802 798 782 (4) Covetrus, Inc. Health Care Distributors First Lien Term Loan SOFR+ 5.00% 10.24% 10/13/2029 2,773 2,607 2,589 (4) Curium Bidco S.à.r.l. Biotechnology First Lien Term Loan L+ 4.00% 9.54% 7/9/2026 2,848 2,827 2,838 DirecTV Financing, LLC Cable & Satellite First Lien Term Loan SOFR+ 5.00% 10.22% 8/2/2027 2,528 2,502 2,477 (4) Portfolio Company Industry Investment Type Index Spread Cash Interest Rate (1)(2) PIK Maturity Date Principal Cost Fair Value (3) Notes DTI Holdco, Inc. Research & Consulting Services First |
Schedule of Financial Instruments Carried at Fair Value | The following table presents the financial instruments carried at fair value as of June 30, 2023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820: Level 1 Level 2 Level 3 Measured at Net Asset Value (a) Total Investments in debt securities (senior secured) $ — $ 245,925 $ 2,528,448 $ — $ 2,774,373 Investments in debt securities (subordinated, including the debt investments in the JVs) — 29,368 184,916 — 214,284 Investments in equity securities (preferred) — — 92,186 — 92,186 Investments in equity securities (common and warrants, including LLC equity interests of the JVs) 6,455 — 20,348 27,973 54,776 Total investments at fair value 6,455 275,293 2,825,898 27,973 3,135,619 Cash equivalents 5,193 — — — 5,193 Derivative asset — 49 — — 49 Total assets at fair value $ 11,648 $ 275,342 $ 2,825,898 $ 27,973 $ 3,140,861 Derivative liability $ — $ 39,567 $ — $ — $ 39,567 Total liabilities at fair value $ — $ 39,567 $ — $ — $ 39,567 __________ (a) In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The following table presents the financial instruments carried at fair value as of September 30, 2022 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820: Level 1 Level 2 Level 3 Measured at Net Asset Value (a) Total Investments in debt securities (senior secured) $ — $ 255,803 $ 1,910,606 $ — $ 2,166,409 Investments in debt securities (subordinated, including the debt investments in the JVs) — 44,065 159,388 — 203,453 Investments in equity securities (preferred) — — 79,523 — 79,523 Investments in equity securities (common and warrants, including LLC equity interests of the JVs) 4,053 — 19,958 20,715 44,726 Total investments at fair value 4,053 299,868 2,169,475 20,715 2,494,111 Cash equivalents 5,261 — — — 5,261 Derivative assets — 6,789 — — 6,789 Total assets at fair value $ 9,314 $ 306,657 $ 2,169,475 $ 20,715 $ 2,506,161 Derivative liability $ — $ 41,969 $ — $ — $ 41,969 Total liabilities at fair value $ — $ 41,969 $ — $ — $ 41,969 __________ |
Roll-Forward in the Changes in Fair Value | The following table provides a roll-forward in the changes in fair value from March 31, 2023 to June 30, 2023 for all investments for which the Company determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of March 31, 2023 $ 2,493,622 $ 183,756 $ 91,447 $ 25,509 $ 2,794,334 Purchases 228,375 4,183 — 182 232,740 Sales and repayments (191,409) (350) — (7,320) (199,079) Transfers out (a) — (2,708) — — (2,708) Capitalized PIK interest income 3,610 358 — — 3,968 Accretion of OID 4,086 381 — — 4,467 Net unrealized appreciation (depreciation) (8,027) (704) 739 1,893 (6,099) Net realized gains (losses) (1,809) — — 84 (1,725) Fair value as of June 30, 2023 $ 2,528,448 $ 184,916 $ 92,186 $ 20,348 $ 2,825,898 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2023 $ (10,360) $ (704) $ 739 $ 1,095 $ (9,230) __________ (a) There were transfers out of Level 3 to Level 2 for certain investments during the three months ended June 30, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity. The following table provides a roll-forward in the changes in fair value from March 31, 2022 to June 30, 2022 for all investments for which the Company determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of March 31, 2022 $ 1,955,858 $ 160,727 $ 84,372 $ 33,588 $ 2,234,545 Purchases 60,692 29 — 125 60,846 Sales and repayments (91,730) (733) — (3,890) (96,353) Transfers in (a) 28,475 — — — 28,475 Transfers out (b) — — — (5,838) (5,838) Capitalized PIK interest income 5,537 — — — 5,537 Accretion of OID 5,100 430 — — 5,530 Net unrealized appreciation (depreciation) (33,208) (4,873) (2,756) (873) (41,710) Net realized gains (losses) (10) — — 393 383 Fair value as of June 30, 2022 $ 1,930,714 $ 155,580 $ 81,616 $ 23,505 $ 2,191,415 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2022 $ (33,199) $ (4,873) $ (2,756) $ (917) $ (41,745) __________ (a) There was a transfer into Level 3 from Level 2 for an investment during the three months ended June 30, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity. (b) This transfer out was the result of a transaction in which Level 3 common equity was exchanged for Level 1 common equity The following table provides a roll-forward in the changes in fair value from September 30, 2022 to June 30, 2023 for all investments for which the Company determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of September 30, 2022 $ 1,910,606 $ 159,388 $ 79,523 $ 19,958 $ 2,169,475 Purchases (a) 980,595 26,508 14,296 5,610 1,027,009 Sales and repayments (357,903) (1,396) — (8,295) (367,594) Transfers in (b) 19,075 — — — 19,075 Capitalized PIK interest income 12,549 376 — — 12,925 Accretion of OID 11,684 1,109 — — 12,793 Net unrealized appreciation (depreciation) (45,019) (1,069) (1,633) 2,804 (44,917) Net realized gains (losses) (3,139) — — 271 (2,868) Fair value as of June 30, 2023 $ 2,528,448 $ 184,916 $ 92,186 $ 20,348 $ 2,825,898 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the nine months ended June 30, 2023 $ (46,680) $ (1,069) $ (1,633) $ (355) $ (49,737) __________ (a) Includes Level 3 investments acquired in connection with the OSI2 Merger during the nine months ended June 30, 2023. (b) There was a transfer into Level 3 from Level 2 for an investment during the nine months ended June 30, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity. The following table provides a roll-forward in the changes in fair value from September 30, 2021 to June 30, 2022 for all investments for which the Company determined fair value using unobservable (Level 3) factors: Investments Senior Secured Debt Subordinated Preferred Common Total Fair value as of September 30, 2021 $ 1,878,536 $ 176,317 $ 63,565 $ 43,163 $ 2,161,581 Purchases 437,922 3,777 19,243 2,180 463,122 Sales and repayments (391,959) (21,868) (163) (12,836) (426,826) Transfers in (a) 37,042 — — — 37,042 Transfers out (a)(b) (17,070) — — (5,838) (22,908) Capitalized PIK interest income 16,653 313 — — 16,966 Accretion of OID 19,048 1,628 — — 20,676 Net unrealized appreciation (depreciation) (57,909) (4,587) (517) (2,520) (65,533) Net realized gains (losses) 8,451 — (512) (644) 7,295 Fair value as of June 30, 2022 $ 1,930,714 $ 155,580 $ 81,616 $ 23,505 $ 2,191,415 Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the nine months ended June 30, 2022 $ (45,187) $ (4,734) $ (752) $ (7,629) $ (58,302) __________ (a) There were transfers into/out of Level 3 from/to Level 2 for certain investments during the nine months ended June 30, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity. (b) This transfer out was the result of a transaction in which Level 3 common equity was exchanged for Level 1 common equity. |
Schedule of Significant Unobservable Inputs for Level 3 Investments | The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of June 30, 2023: Asset Fair Value Valuation Technique Unobservable Input Range Weighted Senior Secured Debt $ 2,058,831 Market Yield Market Yield (b) 9.0% - 38.0% 14.1% 43,954 Enterprise Value Revenue Multiple (c) 5.0x - 7.0x 6.0x 34,466 Enterprise Value EBITDA Multiple (c) 3.4x - 5.4x 5.2x 32,379 Transaction Precedent Transaction Price (d) N/A - N/A N/A 358,818 Broker quotations Broker Quoted Price (e) N/A - N/A N/A Subordinated Debt 18,464 Market Yield Market Yield (b) 10.0% - 22.0% 11.4% 4,164 Broker Quotations Broker Quoted Price (e) N/A - N/A N/A Debt Investments in the JVs 162,288 Enterprise Value N/A (f) N/A - N/A N/A Preferred & Common Equity 70,852 Enterprise Value Revenue Multiple (c) 0.4x - 6.0x 1.4x 37,322 Enterprise Value EBITDA Multiple (c) 1.7x - 17.5x 11.1x 1,415 Enterprise Value Asset Multiple (c) 1.0x - 1.4x 1.4x 2,945 Transaction Precedent Transaction Price (d) N/A - N/A N/A Total $ 2,825,898 __________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participants would take into account market yield when pricing the investment. (c) Used when market participants would use such multiples when pricing the investment. (d) Used when there is an observable transaction or pending event for the investment. (e) Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (f) Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique. The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of September 30, 2022: Asset Fair Value Valuation Technique Unobservable Input Range Weighted Senior Secured Debt $ 1,599,148 Market Yield Market Yield (b) 9.0% - 30.0% 13.7% 14,333 Enterprise Value EBITDA Multiple (c) 5.0x - 7.0x 6.0x 297,125 Broker Quotations Broker Quoted Price (e) N/A - N/A N/A Subordinated Debt 12,855 Market Yield Market Yield (b) 10.0% - 19.0% 13.8% Debt Investments in the JVs 146,533 Enterprise Value N/A (f) N/A - N/A N/A Preferred & Common Equity 61,693 Enterprise Value Revenue Multiple (c) 0.4x - 10.1x 4.3x 36,913 Enterprise Value EBITDA Multiple (c) 3.0x - 20.0x 11.4x 3 Enterprise Value Asset Multiple (c) 0.9x - 1.1x 1.0x 872 Transaction Precedent Transaction Price (d) N/A - N/A N/A Total $ 2,169,475 __________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participants would take into account market yield when pricing the investment. (c) Used when market participants would use such multiples when pricing the investment. (d) Used when there is an observable transaction or pending event for the investment. (e) Oaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (f) Oaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique. |
Fair Value Disclosure of Asset and Liability Not Measured at Fair Value | The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of June 30, 2023 and the level of each financial liability within the fair value hierarchy: Carrying Fair Value Level 1 Level 2 Level 3 Syndicated Facility payable $ 800,000 $ 800,000 $ — $ — $ 800,000 OSI2 Citibank Facility payable 335,000 335,000 — — 335,000 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount) 297,928 285,717 — 285,717 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 307,138 302,260 — 302,260 — Total $ 1,740,066 $ 1,722,977 $ — $ 587,977 $ 1,135,000 The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of September 30, 2022 and the level of each financial liability within the fair value hierarchy: Carrying Fair Value Level 1 Level 2 Level 3 Syndicated Facility payable $ 540,000 $ 540,000 $ — $ — $ 540,000 Citibank Facility payable 160,000 160,000 — — 160,000 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount) 296,991 283,077 — 283,077 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment) 304,052 294,028 — 294,028 — Total $ 1,301,043 $ 1,277,105 $ — $ 577,105 $ 700,000 |
Portfolio Composition | Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables: June 30, 2023 September 30, 2022 Cost: % of Total Investments % of Total Investments Senior secured debt $ 2,886,772 87.59 % $ 2,227,245 85.08 % Debt investments in the JVs 162,653 4.93 % 146,444 5.59 % Preferred equity 99,597 3.02 % 85,300 3.26 % Subordinated debt 55,450 1.68 % 67,147 2.57 % LLC equity interests of the JVs 54,791 1.66 % 49,322 1.88 % Common equity and warrants 37,022 1.12 % 42,296 1.62 % Total $ 3,296,285 100.00 % $ 2,617,754 100.00 % June 30, 2023 September 30, 2022 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Senior secured debt $ 2,774,373 88.48 % 183.80 % $ 2,166,409 86.86 % 173.93 % Debt investments in the JVs 162,288 5.18 % 10.75 % 146,533 5.88 % 11.77 % Preferred equity 92,186 2.94 % 6.11 % 79,523 3.19 % 6.38 % Subordinated debt 51,996 1.66 % 3.44 % 56,920 2.28 % 4.57 % LLC equity interests of the JVs 27,973 0.89 % 1.85 % 20,715 0.83 % 1.66 % Common equity and warrants 26,803 0.85 % 1.78 % 24,011 0.96 % 1.93 % Total $ 3,135,619 100.00 % 207.73 % $ 2,494,111 100.00 % 200.24 % The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets: June 30, 2023 September 30, 2022 Cost: % of Total Investments % of Total Investments Northeast $ 994,695 30.17 % $ 747,420 28.55 % Midwest 448,981 13.62 % 373,236 14.26 % Southeast 446,546 13.55 % 356,041 13.60 % West 440,634 13.37 % 358,306 13.69 % International 434,844 13.19 % 301,242 11.51 % South 197,754 6.00 % 168,819 6.45 % Northwest 168,992 5.13 % 91,382 3.49 % Southwest 163,839 4.97 % 221,308 8.45 % Total $ 3,296,285 100.00 % $ 2,617,754 100.00 % June 30, 2023 September 30, 2022 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Northeast $ 936,888 29.87 % 62.07 % $ 696,368 27.93 % 55.90 % International 432,986 13.81 % 28.69 % 279,646 11.21 % 22.45 % Midwest 429,317 13.69 % 28.44 % 356,934 14.31 % 28.66 % West 428,232 13.66 % 28.37 % 345,251 13.84 % 27.72 % Southeast 406,523 12.96 % 26.93 % 344,567 13.82 % 27.66 % South 186,792 5.96 % 12.37 % 166,230 6.66 % 13.35 % Northwest 166,089 5.30 % 11.00 % 90,131 3.61 % 7.24 % Southwest 148,792 4.75 % 9.86 % 214,984 8.62 % 17.26 % Total $ 3,135,619 100.00 % 207.73 % $ 2,494,111 100.00 % 200.24 % (Share amounts in thousands) Three months ended Three months ended Nine months ended Nine months ended Net asset value per share at beginning of period $19.66 $21.79 $20.38 $21.84 Net investment income (1) 0.63 0.66 1.89 1.86 Net unrealized appreciation (depreciation) (1)(8) (0.02) (1.42) (0.36) (1.95) Net realized gains (losses) (1) (0.14) 0.15 (0.28) 0.33 (Provision) benefit for taxes on realized and unrealized gains (losses) (1) — (0.01) 0.01 0.03 Distributions of net investment income to stockholders (0.55) (0.50) (2.06) (1.44) Net asset value per share at end of period $19.58 $20.67 $19.58 $20.67 Per share market value at beginning of period $18.77 $22.11 $18.00 $21.18 Per share market value at end of period $19.43 $19.65 $19.43 19.65 Total return (2) 6.42% (8.93)% 19.58% (0.79)% Common shares outstanding at beginning of period 77,080 61,068 61,125 60,120 Common shares outstanding at end of period 77,080 61,125 77,080 61,125 Net assets at beginning of period $1,515,150 $1,330,376 $1,245,563 $1,312,823 Net assets at end of period $1,509,441 $1,263,529 $1,509,441 $1,263,529 Average net assets (3) $1,526,644 $1,306,727 $1,407,814 $1,323,232 Ratio of net investment income to average net assets (4) 12.72% 12.39% 12.65% 11.39% Ratio of total expenses to average net assets (4) 14.45% 7.22% 14.07% 7.94% Ratio of net expenses to average net assets (4) 14.05% 6.99% 13.69% 7.71% Ratio of portfolio turnover to average investments at fair value 7.48% 4.73% 18.43% 21.44% Weighted average outstanding debt (5) $1,756,758 $1,369,615 $1,640,062 $1,358,150 Average debt per share (1) $22.79 $22.41 $23.29 $22.41 Asset coverage ratio at end of period (6) 182.05% 187.82% 182.05% 187.82% __________ (1) Calculated based upon weighted average shares outstanding for the period. (2) Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load. (3) Calculated based upon the weighted average net assets for the period. (4) Interim periods are annualized. (5) Calculated based upon the weighted average of principal debt outstanding for the period. (6) Based on outstanding senior securities of $1,785.0 million and $1,395.0 million as of June 30, 2023 and 2022, respectively. (7) The share and per share information disclosed in this table has been retrospectively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. (8) For the nine months ended June 30, 2023, the amount shown for net unrealized appreciation (depreciation) includes the effect of the timing of common stock issuances in connection with the OSI2 Merger. |
Share Data and Net Assets (Tabl
Share Data and Net Assets (Tables) | 9 Months Ended |
Jun. 30, 2023 | |
Stockholders' Equity Note [Abstract] | |
Schedule of Basic and Diluted Earnings Per Share | The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share , for the three and nine months ended June 30, 2023 and 2022: (Share amounts in thousands) Three months ended Three months ended Nine months ended Nine months ended Earnings (loss) per common share — basic and diluted: Net increase (decrease) in net assets resulting from operations $ 36,685 $ (37,834) $ 71,379 $ 16,015 Weighted average common shares outstanding — basic and diluted 77,080 61,123 70,431 60,593 Earnings (loss) per common share — basic and diluted $ 0.48 $ (0.62) $ 1.01 $ 0.26 |
Schedule of Changes in Net Assets | The following table presents the changes in net assets for the three and nine months ended June 30, 2023: Common Stock (Share amounts in thousands) Shares Par Value Additional paid-in-capital Accumulated Overdistributed Earnings Total Net Assets Balance as of September 30, 2022 61,125 $ 611 $ 1,827,721 $ (582,769) $ 1,245,563 Net investment income — — — 38,808 38,808 Net unrealized appreciation (depreciation) — — — (22,982) (22,982) Net realized gains (losses) — — — (3,203) (3,203) (Provision) benefit for taxes on realized and unrealized gains (losses) — — — 549 549 Distributions to stockholders — — — (58,679) (58,679) Issuance of common stock under dividend reinvestment plan 95 1 1,932 — 1,933 Balance as of December 31, 2022 61,220 $ 612 $ 1,829,653 $ (628,276) $ 1,201,989 Net investment income — — — 45,978 45,978 Net unrealized appreciation (depreciation) — — — (18,279) (18,279) Net realized gains (losses) — — — (6,111) (6,111) (Provision) benefit for taxes on realized and unrealized gains (losses) — — — (66) (66) Distributions to stockholders — — — (42,395) (42,395) Issuance of common stock in connection with the OSI2 Merger 15,860 159 333,875 — 334,034 Issuance of common stock under dividend reinvestment plan 68 1 1,294 — 1,295 Repurchase of common stock under dividend reinvestment plan (68) (1) (1,294) — (1,295) Balance as of March 31, 2023 77,080 $ 771 $ 2,163,528 $ (649,149) $ 1,515,150 Net investment income — — — 48,413 48,413 Net unrealized appreciation (depreciation) — — — (1,039) (1,039) Net realized gains (losses) — — — (10,603) (10,603) (Provision) benefit for taxes on realized and unrealized gains (losses) — — — (86) (86) Distributions to stockholders — — — (42,394) (42,394) Issuance of common stock under dividend reinvestment plan 57 1 1,122 — 1,123 Repurchase of common stock under dividend reinvestment plan (57) (1) (1,122) — (1,123) Balance as of June 30, 2023 77,080 $ 771 $ 2,163,528 $ (654,858) $ 1,509,441 The following table presents the changes in net assets for the three and nine months ended June 30, 2022: Common Stock Shares Par Value Additional paid-in-capital Accumulated Overdistributed Earnings Total Net Assets Balance as of September 30, 2021 60,120 $ 601 $ 1,805,557 $ (493,335) $ 1,312,823 Net investment income — — — 32,295 32,295 Net unrealized appreciation (depreciation) — — — (4,586) (4,586) Net realized gains (losses) — — — 9,321 9,321 (Provision) benefit for taxes on realized and unrealized gains (losses) — — — 2,378 2,378 Distributions to stockholders — — — (27,956) (27,956) Issuance of common stock under dividend reinvestment plan 36 1 785 — 786 Balance as of December 31, 2021 60,156 $ 602 $ 1,806,342 $ (481,883) $ 1,325,061 Net investment income — — — 40,098 40,098 Net unrealized appreciation (depreciation) — — — (27,038) (27,038) Net realized gains (losses) — — — 1,402 1,402 (Provision) benefit for taxes on realized and unrealized gains (losses) — — — (21) (21) Distributions to stockholders — — — (29,271) (29,271) Issuance of common stock in connection with the "at the market" offering 877 9 19,370 — 19,379 Issuance of common stock under dividend reinvestment plan 35 — 766 — 766 Balance as of March 31, 2022 61,068 $ 611 $ 1,826,478 $ (496,713) $ 1,330,376 Net investment income — — — 40,370 40,370 Net unrealized appreciation (depreciation) — — — (86,755) (86,755) Net realized gains (losses) — — — 9,212 9,212 (Provision) benefit for taxes on realized and unrealized gains (losses) — — — (661) (661) Distributions to stockholders — — — (30,256) (30,256) Issuance of common stock in connection with the "at the market" offering 57 — 1,243 — 1,243 Issuance of common stock under dividend reinvestment plan 44 1 873 — 874 Repurchases of common stock under dividend reinvestment plan (44) (1) (873) — (874) Balance as of June 30, 2022 61,125 $ 611 $ 1,827,721 $ (564,803) $ 1,263,529 |
Schedule of Distributions | The following table reflects the distributions per share that the Company has paid, including shares issued under the DRIP, on its common stock during the nine months ended June 30, 2023 and 2022: Distribution Date Declared Record Date Payment Date Amount Cash DRIP Shares DRIP Shares Quarterly November 10, 2022 December 15, 2022 December 30, 2022 $ 0.54 $ 32.0 million 53,369 (1) $ 1.1 million Special November 10, 2022 December 15, 2022 December 30, 2022 0.42 24.8 million 41,510 (1) 0.8 million Quarterly January 27, 2023 March 15, 2023 March 31, 2023 0.55 41.1 million 68,412 (2) 1.3 million Quarterly April 28, 2023 June 15, 2023 June 30, 2023 0.55 41.3 million 57,279 (2) 1.1 million Total for the nine months ended June 30, 2023 $ 2.06 $ 139.1 million 220,570 $ 4.4 million Distribution Date Declared Record Date Payment Date Amount Cash DRIP Shares DRIP Shares Quarterly October 13, 2021 December 15, 2021 December 31, 2021 $ 0.465 $ 27.2 million 35,990 (1) $ 0.8 million Quarterly January 28, 2022 March 15, 2022 March 31, 2022 0.48 28.5 million 34,804 (1) 0.8 million Quarterly April 29, 2022 June 15, 2022 June 30, 2022 0.495 29.4 million 43,676 (2) 0.9 million Total for the nine months ended June 30, 2022 $ 1.44 $ 85.1 million 114,470 $ 2.4 million __________ (1) New shares were issued and distributed. (2) Shares were purchased on the open market and distributed. (3) Totals may not sum due to rounding. |
Borrowings (Tables)
Borrowings (Tables) | 9 Months Ended |
Jun. 30, 2023 | |
Debt Disclosure [Abstract] | |
Components of Debt | The below table presents the components of the carrying value of the 2025 Notes and the 2027 Notes as of June 30, 2023 and September 30, 2022: As of June 30, 2023 As of September 30, 2022 ($ in millions) 2025 Notes 2027 Notes 2025 Notes 2027 Notes Principal $ 300.0 $ 350.0 $ 300.0 $ 350.0 Unamortized financing costs (1.2) (2.7) (1.8) (3.2) Unaccreted discount (0.8) (0.6) (1.2) (0.7) Interest rate swap fair value adjustment — (39.6) — (42.0) Net carrying value $ 298.0 $ 307.1 $ 297.0 $ 304.1 Fair Value $ 285.7 $ 302.3 $ 283.1 $ 294.0 The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three and nine months ended June 30, 2023: ($ in millions) 2025 Notes 2027 Notes Three months ended June 30, 2023 Nine months ended June 30, 2023 Three months ended June 30, 2023 Nine months ended June 30, 2023 Coupon interest $ 2.6 $ 7.9 $ 2.4 $ 7.1 Amortization of financing costs and discount 0.3 0.9 0.2 0.7 Effect of interest rate swap — — 3.7 9.4 Total interest expense $ 2.9 $ 8.8 $ 6.3 $ 17.2 Coupon interest rate (net of effect of interest rate swap for 2027 Notes) 3.500 % 3.500 % 6.912 % 6.274 % The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three and nine months ended June 30, 2022: ($ in millions) 2025 Notes 2027 Notes Three months ended June 30, 2022 Nine months ended June 30, 2022 Three months ended June 30, 2022 Nine months ended June 30, 2022 Coupon interest $ 2.6 $ 7.9 $ 2.4 $ 7.1 Amortization of financing costs and discount 0.3 0.9 0.2 0.7 Effect of interest rate swap — — (0.1) (1.6) Total interest expense $ 2.9 $ 8.8 $ 2.5 $ 6.2 Coupon interest rate (net of effect of interest rate swap for 2027 Notes) 3.500 % 3.500 % 2.572 % 2.069 % |
Taxable_Distributable Income _2
Taxable/Distributable Income and Dividend Distributions (Tables) | 9 Months Ended |
Jun. 30, 2023 | |
Income Tax Disclosure [Abstract] | |
Reconciliation of Net Increase (Decrease) in Net Assets Resulting from Operations | Listed below is a reconciliation of "net increase (decrease) in net assets resulting from operations" to taxable income for the three and nine months ended June 30, 2023 and 2022. Three months ended Three months ended Nine months ended Nine months ended Net increase (decrease) in net assets resulting from operations $ 36,685 $ (37,834) $ 71,379 $ 16,015 Net unrealized (appreciation) depreciation 1,039 86,755 42,300 118,379 Book/tax difference due to organizational costs — (21) — (65) Book/tax difference due to capital losses utilized 12,118 (3,736) 20,380 (19,183) Other book/tax differences (3,825) (8,819) (14,912) (18,597) Taxable/Distributable Income (1) $ 46,017 $ 36,345 $ 119,147 $ 96,549 |
Components of Accumulated Overdistributed Earnings | As of September 30, 2022, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows: Undistributed ordinary income, net $ (43,624) Net realized capital losses 473,274 Unrealized losses, net 153,119 Accumulated overdistributed earnings $ 582,769 |
Realized Gains or Losses and _2
Realized Gains or Losses and Net Unrealized Appreciation or Depreciation (Tables) | 9 Months Ended |
Jun. 30, 2023 | |
Investment Company [Abstract] | |
Schedule of Aggregate Net Realized Gains | During the three months ended June 30, 2023, the Company recorded an aggregate net realized loss of $10.6 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Foreign currency forward contracts $ (6.3) Aden & Anais Merger Sub Inc. (5.2) Radiology Partners Inc. (3.8) WP CPP Holdings LLC (1.3) Tersera Therapeutics LLC 5.2 Other, net 0.8 Total, net $ (10.6) During the three months ended June 30, 2022, the Company recorded an aggregate net realized gain of $9.2 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Foreign currency forward contracts $ 8.8 Other, net 0.4 Total, net $ 9.2 During the nine months ended June 30, 2023, the Company recorded an aggregate net realized loss of $19.9 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Foreign currency forward contracts $ (5.5) Aden & Anais Merger Sub Inc. (5.2) Radiology Partners Inc. (4.2) Carvana Co. (2.8) ASP Unifrax Holdings Inc. (2.1) WP CPP Holdings LLC (1.3) Global Medical Response Inc. (1.0) Tersera Therapeutics LLC 5.2 Other, net (3.0) Total, net $ (19.9) During the nine months ended June 30, 2022, the Company recorded an aggregate net realized gain of $19.9 million, which consisted of the following: ($ in millions) Portfolio Company Net Realized Gain (Loss) Foreign currency forward contracts $ 12.2 OmniSYS Acquisition Corporation 2.2 First Star Speir Aviation Limited 1.9 TigerConnect Inc. 1.8 Other, net 1.8 Total, net $ 19.9 |
Financial Highlights (Tables)
Financial Highlights (Tables) | 9 Months Ended |
Jun. 30, 2023 | |
Investment Company [Abstract] | |
Portfolio Composition | Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables: June 30, 2023 September 30, 2022 Cost: % of Total Investments % of Total Investments Senior secured debt $ 2,886,772 87.59 % $ 2,227,245 85.08 % Debt investments in the JVs 162,653 4.93 % 146,444 5.59 % Preferred equity 99,597 3.02 % 85,300 3.26 % Subordinated debt 55,450 1.68 % 67,147 2.57 % LLC equity interests of the JVs 54,791 1.66 % 49,322 1.88 % Common equity and warrants 37,022 1.12 % 42,296 1.62 % Total $ 3,296,285 100.00 % $ 2,617,754 100.00 % June 30, 2023 September 30, 2022 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Senior secured debt $ 2,774,373 88.48 % 183.80 % $ 2,166,409 86.86 % 173.93 % Debt investments in the JVs 162,288 5.18 % 10.75 % 146,533 5.88 % 11.77 % Preferred equity 92,186 2.94 % 6.11 % 79,523 3.19 % 6.38 % Subordinated debt 51,996 1.66 % 3.44 % 56,920 2.28 % 4.57 % LLC equity interests of the JVs 27,973 0.89 % 1.85 % 20,715 0.83 % 1.66 % Common equity and warrants 26,803 0.85 % 1.78 % 24,011 0.96 % 1.93 % Total $ 3,135,619 100.00 % 207.73 % $ 2,494,111 100.00 % 200.24 % The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets: June 30, 2023 September 30, 2022 Cost: % of Total Investments % of Total Investments Northeast $ 994,695 30.17 % $ 747,420 28.55 % Midwest 448,981 13.62 % 373,236 14.26 % Southeast 446,546 13.55 % 356,041 13.60 % West 440,634 13.37 % 358,306 13.69 % International 434,844 13.19 % 301,242 11.51 % South 197,754 6.00 % 168,819 6.45 % Northwest 168,992 5.13 % 91,382 3.49 % Southwest 163,839 4.97 % 221,308 8.45 % Total $ 3,296,285 100.00 % $ 2,617,754 100.00 % June 30, 2023 September 30, 2022 Fair Value: % of Total Investments % of Net Assets % of Total Investments % of Net Assets Northeast $ 936,888 29.87 % 62.07 % $ 696,368 27.93 % 55.90 % International 432,986 13.81 % 28.69 % 279,646 11.21 % 22.45 % Midwest 429,317 13.69 % 28.44 % 356,934 14.31 % 28.66 % West 428,232 13.66 % 28.37 % 345,251 13.84 % 27.72 % Southeast 406,523 12.96 % 26.93 % 344,567 13.82 % 27.66 % South 186,792 5.96 % 12.37 % 166,230 6.66 % 13.35 % Northwest 166,089 5.30 % 11.00 % 90,131 3.61 % 7.24 % Southwest 148,792 4.75 % 9.86 % 214,984 8.62 % 17.26 % Total $ 3,135,619 100.00 % 207.73 % $ 2,494,111 100.00 % 200.24 % (Share amounts in thousands) Three months ended Three months ended Nine months ended Nine months ended Net asset value per share at beginning of period $19.66 $21.79 $20.38 $21.84 Net investment income (1) 0.63 0.66 1.89 1.86 Net unrealized appreciation (depreciation) (1)(8) (0.02) (1.42) (0.36) (1.95) Net realized gains (losses) (1) (0.14) 0.15 (0.28) 0.33 (Provision) benefit for taxes on realized and unrealized gains (losses) (1) — (0.01) 0.01 0.03 Distributions of net investment income to stockholders (0.55) (0.50) (2.06) (1.44) Net asset value per share at end of period $19.58 $20.67 $19.58 $20.67 Per share market value at beginning of period $18.77 $22.11 $18.00 $21.18 Per share market value at end of period $19.43 $19.65 $19.43 19.65 Total return (2) 6.42% (8.93)% 19.58% (0.79)% Common shares outstanding at beginning of period 77,080 61,068 61,125 60,120 Common shares outstanding at end of period 77,080 61,125 77,080 61,125 Net assets at beginning of period $1,515,150 $1,330,376 $1,245,563 $1,312,823 Net assets at end of period $1,509,441 $1,263,529 $1,509,441 $1,263,529 Average net assets (3) $1,526,644 $1,306,727 $1,407,814 $1,323,232 Ratio of net investment income to average net assets (4) 12.72% 12.39% 12.65% 11.39% Ratio of total expenses to average net assets (4) 14.45% 7.22% 14.07% 7.94% Ratio of net expenses to average net assets (4) 14.05% 6.99% 13.69% 7.71% Ratio of portfolio turnover to average investments at fair value 7.48% 4.73% 18.43% 21.44% Weighted average outstanding debt (5) $1,756,758 $1,369,615 $1,640,062 $1,358,150 Average debt per share (1) $22.79 $22.41 $23.29 $22.41 Asset coverage ratio at end of period (6) 182.05% 187.82% 182.05% 187.82% __________ (1) Calculated based upon weighted average shares outstanding for the period. (2) Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load. (3) Calculated based upon the weighted average net assets for the period. (4) Interim periods are annualized. (5) Calculated based upon the weighted average of principal debt outstanding for the period. (6) Based on outstanding senior securities of $1,785.0 million and $1,395.0 million as of June 30, 2023 and 2022, respectively. (7) The share and per share information disclosed in this table has been retrospectively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023. (8) For the nine months ended June 30, 2023, the amount shown for net unrealized appreciation (depreciation) includes the effect of the timing of common stock issuances in connection with the OSI2 Merger. |
Derivative Instruments (Tables)
Derivative Instruments (Tables) | 9 Months Ended |
Jun. 30, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Foreign Currency Forward Contracts and Interest Rate Swap | Certain information related to the Company’s foreign currency forward contracts is presented below as of June 30, 2023. Description Notional Amount to be Purchased Notional Amount to be Sold Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Foreign currency forward contract $ 78,866 € 71,658 8/10/2023 $ 531 $ — Derivative asset Foreign currency forward contract $ 71,438 £ 56,556 8/10/2023 $ — $ 482 Derivative asset $ 531 $ 482 Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2022. Description Notional Amount to be Purchased Notional Amount to be Sold Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Foreign currency forward contract $ 43,179 € 41,444 11/10/2022 $ 2,466 $ — Derivative asset Foreign currency forward contract $ 45,692 £ 37,033 11/10/2022 $ 4,323 $ — Derivative asset $ 6,789 $ — Certain information related to the Company’s interest rate swap is presented below as of June 30, 2023. Description Notional Amount Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Interest rate swap $ 350,000 1/15/2027 $ — $ 39,567 Derivative liability $ — $ 39,567 Certain information related to the Company’s interest rate swap is presented below as of September 30, 2022. Description Notional Amount Maturity Date Gross Amount of Recognized Assets Gross Amount of Recognized Liabilities Balance Sheet Location of Net Amounts Interest rate swap $ 350,000 1/15/2027 $ — $ 41,969 Derivative liability $ — $ 41,969 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 9 Months Ended |
Jun. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Unfunded Commitments | A list of unfunded commitments by investment (consisting of revolvers, term loans with delayed draw components, subordinated notes and LLC equity interests in the JVs, preferred stock and limited partnership interests) as of June 30, 2023 and September 30, 2022 is shown in the table below: June 30, 2023 September 30, 2022 107-109 Beech OAK22 LLC $ 30,922 $ — Fairbridge Strategic Capital Funding LLC 20,382 22,150 Delta Leasing SPV II LLC 18,822 27,187 BioXcel Therapeutics, Inc. 14,543 11,785 OCSI Glick JV LLC 13,998 13,998 Senior Loan Fund JV I, LLC 13,125 35,000 SiO2 Medical Products, Inc. 10,765 — MND Holdings III Corp 8,470 — Seres Therapeutics, Inc. 8,090 — iCIMs, Inc. 7,704 6,930 Dominion Diagnostics, LLC 7,664 11,148 Marinus Pharmaceuticals, Inc. 7,139 5,734 Assembled Brands Capital LLC 7,062 2,008 Grove Hotel Parcel Owner, LLC 5,286 4,293 scPharmaceuticals Inc. 5,212 — Innocoll Pharmaceuticals Limited 5,200 4,195 Avalara, Inc. 5,047 — Mindbody, Inc. 4,762 4,000 Accupac, Inc. 4,500 4,605 Mesoblast, Inc. 4,405 3,553 107 Fair Street LLC 4,322 — Harrow Health, Inc. 4,011 — Inventus Power, Inc. 3,792 — Establishment Labs Holdings Inc. 3,384 5,075 MRI Software LLC 3,302 5,196 OTG Management, LLC 3,190 3,789 PRGX Global, Inc. 3,127 2,518 Salus Workers' Compensation, LLC 3,102 — ADC Therapeutics SA 3,020 3,020 Relativity ODA LLC 2,762 2,218 112-126 Van Houten Real22 LLC 2,703 — LSL Holdco, LLC 2,650 427 Supreme Fitness Group NY Holdings, LLC 2,540 1,527 Pluralsight, LLC 2,395 3,532 SCP Eye Care Services, LLC 2,356 — Spanx, LLC 2,185 2,226 Tahoe Bidco B.V. 2,162 1,741 Coupa Holdings, LLC 2,075 — Galileo Parent, Inc. 2,061 — Oranje Holdco, Inc. 1,904 — Apptio, Inc. 1,885 1,338 Kings Buyer, LLC 1,771 1,537 MHE Intermediate Holdings, LLC 1,536 1,429 PPW Aero Buyer, Inc. 1,466 — Liquid Environmental Solutions Corporation 1,383 1,115 Berner Food & Beverage, LLC 1,314 1,392 CorEvitas, LLC 1,251 915 Digital.AI Software Holdings, Inc. 1,156 826 Coyote Buyer, LLC 800 1,333 Telestream Holdings Corporation 678 528 Acquia Inc. 596 1,326 ASP-R-PAC Acquisition Co LLC 396 — BAART Programs, Inc. — 8,645 RumbleOn, Inc. — 4,822 Ardonagh Midco 3 PLC — 4,372 Dialyze Holdings, LLC — 3,431 Thrasio, LLC — 2,578 109 Montgomery Owner LLC — 477 GKD Index Partners, LLC — 320 Total $ 274,373 $ 224,239 |
Merger with OSI2 (Tables)
Merger with OSI2 (Tables) | 9 Months Ended |
Jun. 30, 2023 | |
Business Combination and Asset Acquisition [Abstract] | |
Allocation of Consideration Paid to the Assets Acquired and Liabilities Assumed | The following table summarizes the allocation of the consideration paid to the assets acquired and liabilities assumed as a result of the OSI2 Merger: Common stock issued by the Company (1) $ 334,034 Transaction costs 1,932 Consideration paid $ 335,966 Investments $ 592,809 Cash and cash equivalents 22,317 Other assets 6,679 Total assets acquired 621,805 Debt 225,000 Other liabilities 60,839 Total liabilities acquired 285,839 Total net assets acquired $ 335,966 __________ (1) Common stock issued by the Company includes $19 of cash paid in lieu of issuing fractional shares. |
Significant Accounting Polici_3
Significant Accounting Policies (Details) $ in Thousands | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||
Jan. 20, 2023 | Jun. 30, 2023 USD ($) | Jun. 30, 2022 USD ($) | Jun. 30, 2023 USD ($) | Jun. 30, 2022 USD ($) | Sep. 30, 2022 USD ($) | |
Restricted Cash and Cash Equivalents Items [Line Items] | ||||||
Stock split, conversion ratio | 0.0033 | |||||
Restricted cash | $ 12,956 | $ 12,956 | $ 2,836 | |||
Excise tax | 0 | $ 0 | $ 78 | $ 0 | $ 100 | |
Investment Owned, Cost | Non-Accrual Status, Debt Securities | Investment Type Concentration Risk | ||||||
Restricted Cash and Cash Equivalents Items [Line Items] | ||||||
Stock split, conversion ratio | 0.036 | |||||
Concentration risk | 0% | |||||
Investment Owned, Fair Value | Non-Accrual Status, Debt Securities | Investment Type Concentration Risk | ||||||
Restricted Cash and Cash Equivalents Items [Line Items] | ||||||
Stock split, conversion ratio | 0.031 | |||||
Concentration risk | 0% | |||||
Wells Fargo Bank, N.A. | ||||||
Restricted Cash and Cash Equivalents Items [Line Items] | ||||||
Restricted cash | $ 2,800 | |||||
Deutsche Bank Trust Company Americas | ||||||
Restricted Cash and Cash Equivalents Items [Line Items] | ||||||
Restricted cash | $ 13,000 | $ 13,000 |
Portfolio Investments - Narrati
Portfolio Investments - Narrative (Details) | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||
Jun. 30, 2023 USD ($) borrower member | Mar. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | Jun. 30, 2022 USD ($) | Mar. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Jun. 30, 2023 USD ($) borrower member | Jun. 30, 2022 USD ($) | Sep. 30, 2022 USD ($) borrower | Sep. 30, 2021 USD ($) | May 18, 2021 | Feb. 25, 2020 | |
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Investment owned, percent of net assets | 207.73% | 207.73% | 200.24% | |||||||||
Investments at fair value | $ 3,135,619,000 | $ 3,135,619,000 | $ 2,494,111,000 | |||||||||
Number of borrowers | borrower | 156 | 156 | 149 | |||||||||
Money market funds, percent of net assets | 4.80% | 4.80% | 2.10% | |||||||||
Cash, cash equivalents and restricted cash | $ 72,660,000 | $ 36,315,000 | $ 72,660,000 | $ 36,315,000 | $ 26,364,000 | $ 31,635,000 | ||||||
Restricted cash | 12,956,000 | 12,956,000 | 2,836,000 | |||||||||
Net realized gains (losses) | (10,603,000) | $ (6,111,000) | $ (3,203,000) | 9,212,000 | $ 1,402,000 | $ 9,321,000 | (19,900,000) | 19,900,000 | ||||
Net unrealized appreciation (depreciation) | (1,039,000) | $ (18,279,000) | $ (22,982,000) | (86,755,000) | $ (27,038,000) | $ (4,586,000) | (42,300,000) | (118,400,000) | ||||
Credit facilities payable | 1,135,000,000 | 1,135,000,000 | 700,000,000 | |||||||||
Assets | 3,335,974,000 | 3,335,974,000 | 2,646,313,000 | |||||||||
Unfunded commitments | 274,373,000 | 274,373,000 | 224,239,000 | |||||||||
Investment owned, at cost | 3,296,285,000 | 3,296,285,000 | 2,617,754,000 | |||||||||
Senior Loan Fund JV I, LLC | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Investments at fair value | 140,600,000 | 140,600,000 | 117,000,000 | |||||||||
OCSI Glick JV LLC | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Investments at fair value | $ 49,600,000 | $ 49,600,000 | $ 50,300,000 | |||||||||
Investment Owned, At Fair Value | Investment Type Concentration Risk | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Concentration risk | 100% | 100% | ||||||||||
Debt Securities, Senior Secured | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Investment owned, percent of net assets | 183.80% | 183.80% | 173.93% | |||||||||
Investments at fair value | $ 2,774,373,000 | $ 2,774,373,000 | $ 2,166,409,000 | |||||||||
Investment owned, at cost | 2,886,772,000 | $ 2,886,772,000 | $ 2,227,245,000 | |||||||||
Debt Securities, Senior Secured | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Concentration risk | 88.48% | 86.86% | ||||||||||
Debt Securities, Subordinated, Including JV Debt Instruments | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Investments at fair value | 214,284,000 | $ 214,284,000 | $ 203,453,000 | |||||||||
Debt Securities, Subordinated, Including JV Debt Instruments | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Concentration risk | 6.80% | 8.10% | ||||||||||
SLF JV I | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Investments at fair value | 140,600,000 | $ 140,600,000 | $ 117,000,000 | |||||||||
OCSI Glick JV LLC | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Investments at fair value | 49,600,000 | 49,600,000 | 50,300,000 | |||||||||
Investment owned, at cost | $ 50,000,000 | $ 50,000,000 | 50,200,000 | |||||||||
2025 Notes | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Interest rate, percentage | 3.50% | 3.50% | 3.50% | |||||||||
2027 Notes | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Interest rate, percentage | 2.70% | 2.70% | 2.70% | |||||||||
The JVs | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Money market funds, percent of net assets | 4.80% | 4.80% | ||||||||||
Cash, cash equivalents and restricted cash | $ 72,700,000 | $ 72,700,000 | ||||||||||
Restricted cash | 13,000,000 | 13,000,000 | ||||||||||
SLF JV I | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Investments at fair value | $ 329,809,000 | $ 329,809,000 | $ 359,625,000 | |||||||||
Number of borrowers | borrower | 52,000 | 52,000 | 60 | |||||||||
Restricted cash | $ 8,715,000 | $ 8,715,000 | $ 5,642,000 | |||||||||
Number of board of directors | member | 4 | 4 | ||||||||||
Number of board of directors selected by company | member | 2 | 2 | ||||||||||
Number of board of directors selected by counterparty | member | 2 | 2 | ||||||||||
Number of investment committee members selected by company | member | 1 | 1 | ||||||||||
Number of investment committee members selected by counterparty | member | 1 | 1 | ||||||||||
Investment owned, ownership percentage | 87.50% | 87.50% | 87.50% | |||||||||
Credit facilities payable | $ 200,000,000 | $ 200,000,000 | $ 230,000,000 | |||||||||
Assets | 370,228,000 | 370,228,000 | 385,227,000 | |||||||||
Financial support funded by company and counterparty | 190,500,000 | 190,500,000 | 165,500,000 | |||||||||
Financial support funded by company for investee | 166,700,000 | 166,700,000 | 144,800,000 | |||||||||
Unfunded commitments | 13,100,000 | 13,100,000 | 35,000,000 | |||||||||
Investment owned, at cost | 348,782,000 | 348,782,000 | 382,673,000 | |||||||||
Interest income | 10,312,000 | 5,796,000 | 29,106,000 | 16,664,000 | ||||||||
Investments sold | 18,800,000 | 9,700,000 | ||||||||||
Proceeds from sale of investments | 18,000,000 | 9,700,000 | ||||||||||
Gain (loss) on sale of investments | (200,000) | 500,000 | ||||||||||
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Borrowing capacity | 260,000,000 | 260,000,000 | 260,000,000 | |||||||||
Credit facilities payable | $ 200,000,000 | $ 200,000,000 | $ 230,000,000 | |||||||||
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Secured Overnight Financing Rate, Floor | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Debt instrument, basis spread, variable rate | 0.125% | |||||||||||
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Until November 3, 2023 | Secured Overnight Financing Rate | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Debt instrument, basis spread, variable rate | 2.50% | |||||||||||
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Remainder of Reinvestment Period | Secured Overnight Financing Rate | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Debt instrument, basis spread, variable rate | 2.75% | |||||||||||
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | First Year After Reinvestment Period | Secured Overnight Financing Rate | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Debt instrument, basis spread, variable rate | 3.25% | |||||||||||
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Second Year After Reinvestment Period | Secured Overnight Financing Rate | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Debt instrument, basis spread, variable rate | 3.35% | |||||||||||
SLF JV I | SLF JV I Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Third Year After Reinvestment Period, And There After | Secured Overnight Financing Rate | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Debt instrument, basis spread, variable rate | 3.60% | |||||||||||
SLF JV I | Kemper | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Investment owned, ownership percentage | 12.50% | 12.50% | 12.50% | |||||||||
OCSI Glick JV LLC | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Investments at fair value | $ 113,833,000 | $ 113,833,000 | $ 133,144,000 | |||||||||
Number of borrowers | borrower | 37 | 37 | 43 | |||||||||
Restricted cash | $ 1,812,000 | $ 1,812,000 | $ 1,788,000 | |||||||||
Number of board of directors | member | 4 | 4 | ||||||||||
Number of board of directors selected by company | member | 2 | 2 | ||||||||||
Number of board of directors selected by counterparty | member | 2 | 2 | ||||||||||
Number of investment committee members selected by company | member | 1 | 1 | ||||||||||
Number of investment committee members selected by counterparty | member | 1 | 1 | ||||||||||
Credit facilities payable | $ 66,082,000 | $ 66,082,000 | 82,082,000 | |||||||||
Assets | 126,824,000 | 126,824,000 | 146,808,000 | |||||||||
Financial support funded by company and counterparty | 84,000,000 | 84,000,000 | 84,000,000 | |||||||||
Financial support funded by company for investee | 73,500,000 | 73,500,000 | 73,500,000 | |||||||||
Investment owned, at cost | 120,172,000 | 120,172,000 | 140,083,000 | |||||||||
Interest income | 3,576,000 | $ 2,416,000 | 10,488,000 | $ 6,796,000 | ||||||||
Financial commitment to investee by company and counterparty, aggregate amount | 100,000,000 | 100,000,000 | 100,000,000 | |||||||||
Financial commitment to investee, aggregate amount | 87,500,000 | 87,500,000 | 87,500,000 | |||||||||
Financial commitment to investee by counterparty, aggregate amount | 12,500,000 | 12,500,000 | 12,500,000 | |||||||||
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Borrowing capacity | 90,000,000 | 90,000,000 | ||||||||||
Credit facilities payable | $ 66,100,000 | $ 66,100,000 | $ 82,100,000 | |||||||||
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Secured Overnight Financing Rate, Floor | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Debt instrument, basis spread, variable rate | 0.125% | |||||||||||
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Until November 3, 2023 | Secured Overnight Financing Rate | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Debt instrument, basis spread, variable rate | 2.50% | |||||||||||
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Remainder of Reinvestment Period | Secured Overnight Financing Rate | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Debt instrument, basis spread, variable rate | 2.75% | |||||||||||
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | First Year After Reinvestment Period | Secured Overnight Financing Rate | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Debt instrument, basis spread, variable rate | 3.25% | |||||||||||
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Second Year After Reinvestment Period | Secured Overnight Financing Rate | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Debt instrument, basis spread, variable rate | 3.35% | |||||||||||
OCSI Glick JV LLC | Glick JV Deutsche Bank Facility | Revolving Credit Facility | Line of Credit | Third Year After Reinvestment Period, And There After | Secured Overnight Financing Rate | ||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||
Debt instrument, basis spread, variable rate | 3.60% |
Portfolio Investments - Composi
Portfolio Investments - Composition of Investments (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Sep. 30, 2022 |
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 3,296,285 | $ 2,617,754 |
Investments at fair value | 3,135,619 | 2,494,111 |
Debt investments, fair value | $ 2,988,657 | $ 2,369,862 |
% of Debt Portfolio | 100% | 100% |
Investments in debt securities | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 2,942,222 | $ 2,294,392 |
Investments at fair value | 2,826,369 | 2,223,329 |
Investments in equity securities | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | 136,619 | 127,596 |
Investments at fair value | 118,989 | 103,534 |
Debt investments in the JVs | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | 162,653 | 146,444 |
Investments at fair value | 162,288 | 146,533 |
Equity investments in the JVs | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | 54,791 | 49,322 |
Investments at fair value | 27,973 | 20,715 |
Floating rate debt securities, including the debt investments in the JVs | ||
Schedule of Investments [Line Items] | ||
Debt investments, fair value | $ 2,571,458 | $ 2,049,644 |
% of Debt Portfolio | 86.04% | 86.49% |
Fixed rate debt securities | ||
Schedule of Investments [Line Items] | ||
Debt investments, fair value | $ 417,199 | $ 320,218 |
% of Debt Portfolio | 13.96% | 13.51% |
Portfolio Investments - Schedul
Portfolio Investments - Schedule of Financial Instruments Carried at Fair Value (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Sep. 30, 2022 |
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 3,135,619 | $ 2,494,111 |
Cash equivalents | 5,193 | 5,261 |
Derivative assets at fair value | 49 | 6,789 |
Total assets at fair value | 3,140,861 | 2,506,161 |
Derivative liability at fair value | 39,567 | 41,969 |
Total liabilities at fair value | 39,567 | 41,969 |
Carrying Value | 1,740,066 | 1,301,043 |
Fair Value | 1,722,977 | 1,277,105 |
Debt Securities, Senior Secured | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 2,774,373 | 2,166,409 |
Debt Securities, Subordinated, Including JV Debt Instruments | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 214,284 | 203,453 |
Equity Securities, Preferred | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 92,186 | 79,523 |
Equity Securities, Common And Warrants, Including JV Investments | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 54,776 | 44,726 |
Syndicated Facility | ||
Schedule of Investments [Line Items] | ||
Carrying Value | 800,000 | 540,000 |
Fair Value | 800,000 | 540,000 |
Citibank Facility | ||
Schedule of Investments [Line Items] | ||
Carrying Value | 160,000 | |
Fair Value | 160,000 | |
2027 Notes | ||
Schedule of Investments [Line Items] | ||
Carrying Value | 307,138 | 304,052 |
Fair Value | 302,260 | 294,028 |
Level 1 | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 6,455 | 4,053 |
Cash equivalents | 5,193 | 5,261 |
Derivative assets at fair value | 0 | 0 |
Total assets at fair value | 11,648 | 9,314 |
Derivative liability at fair value | 0 | 0 |
Total liabilities at fair value | 0 | 0 |
Fair Value | 0 | 0 |
Level 1 | Debt Securities, Senior Secured | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 0 | 0 |
Level 1 | Debt Securities, Subordinated, Including JV Debt Instruments | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 0 | 0 |
Level 1 | Equity Securities, Preferred | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 0 | 0 |
Level 1 | Equity Securities, Common And Warrants, Including JV Investments | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 6,455 | 4,053 |
Level 1 | Syndicated Facility | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 1 | Citibank Facility | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | |
Level 1 | 2027 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 2 | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 275,293 | 299,868 |
Cash equivalents | 0 | 0 |
Derivative assets at fair value | 49 | 6,789 |
Total assets at fair value | 275,342 | 306,657 |
Derivative liability at fair value | 39,567 | 41,969 |
Total liabilities at fair value | 39,567 | 41,969 |
Fair Value | 587,977 | 577,105 |
Level 2 | Debt Securities, Senior Secured | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 245,925 | 255,803 |
Level 2 | Debt Securities, Subordinated, Including JV Debt Instruments | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 29,368 | 44,065 |
Level 2 | Equity Securities, Preferred | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 0 | 0 |
Level 2 | Equity Securities, Common And Warrants, Including JV Investments | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 0 | 0 |
Level 2 | Syndicated Facility | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 2 | Citibank Facility | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | |
Level 2 | 2027 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 302,260 | 294,028 |
Level 3 | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 2,825,898 | 2,169,475 |
Cash equivalents | 0 | 0 |
Derivative assets at fair value | 0 | 0 |
Total assets at fair value | 2,825,898 | 2,169,475 |
Derivative liability at fair value | 0 | 0 |
Total liabilities at fair value | 0 | 0 |
Fair Value | 1,135,000 | 700,000 |
Level 3 | Debt Securities, Senior Secured | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 2,528,448 | 1,910,606 |
Level 3 | Debt Securities, Subordinated, Including JV Debt Instruments | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 184,916 | 159,388 |
Level 3 | Equity Securities, Preferred | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 92,186 | 79,523 |
Level 3 | Equity Securities, Common And Warrants, Including JV Investments | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 20,348 | 19,958 |
Level 3 | Syndicated Facility | ||
Schedule of Investments [Line Items] | ||
Fair Value | 800,000 | 540,000 |
Level 3 | Citibank Facility | ||
Schedule of Investments [Line Items] | ||
Fair Value | 160,000 | |
Level 3 | 2027 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Fair Value Measured at Net Asset Value Per Share | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 27,973 | 20,715 |
Cash equivalents | 0 | 0 |
Derivative assets at fair value | 0 | 0 |
Total assets at fair value | 27,973 | 20,715 |
Derivative liability at fair value | 0 | 0 |
Total liabilities at fair value | 0 | |
Fair Value Measured at Net Asset Value Per Share | Debt Securities, Senior Secured | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 0 | 0 |
Total liabilities at fair value | 0 | |
Fair Value Measured at Net Asset Value Per Share | Debt Securities, Subordinated, Including JV Debt Instruments | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 0 | 0 |
Fair Value Measured at Net Asset Value Per Share | Equity Securities, Preferred | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | 0 | 0 |
Fair Value Measured at Net Asset Value Per Share | Equity Securities, Common And Warrants, Including JV Investments | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 27,973 | $ 20,715 |
Portfolio Investments - Roll-Fo
Portfolio Investments - Roll-Forward in the Changes in Fair Value (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||
Fair value, beginning balance | $ 2,794,334 | $ 2,234,545 | $ 2,169,475 | $ 2,161,581 |
Purchases | 232,740 | 60,846 | 1,027,009 | 463,122 |
Sales and repayments | (199,079) | (96,353) | (367,594) | (426,826) |
Transfers in | 28,475 | 19,075 | 37,042 | |
Transfers out | (2,708) | (5,838) | (22,908) | |
Capitalized PIK interest income | 3,968 | 5,537 | 12,925 | 16,966 |
Accretion of OID | 4,467 | 5,530 | 12,793 | 20,676 |
Fair value, ending balance | 2,825,898 | 2,191,415 | 2,825,898 | 2,191,415 |
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2023 | (9,230) | (41,745) | (49,737) | (58,302) |
Net unrealized appreciation (depreciation) | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||
Total gains or losses included in earnings | (6,099) | (41,710) | (44,917) | (65,533) |
Net realized gains (losses) | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||
Total gains or losses included in earnings | (1,725) | 383 | (2,868) | 7,295 |
Debt Securities, Senior Secured | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||
Fair value, beginning balance | 2,493,622 | 1,955,858 | 1,910,606 | 1,878,536 |
Purchases | 228,375 | 60,692 | 980,595 | 437,922 |
Sales and repayments | (191,409) | (91,730) | (357,903) | (391,959) |
Transfers in | 28,475 | 19,075 | 37,042 | |
Transfers out | 0 | 0 | (17,070) | |
Capitalized PIK interest income | 3,610 | 5,537 | 12,549 | 16,653 |
Accretion of OID | 4,086 | 5,100 | 11,684 | 19,048 |
Fair value, ending balance | 2,528,448 | 1,930,714 | 2,528,448 | 1,930,714 |
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2023 | (10,360) | (33,199) | (46,680) | (45,187) |
Debt Securities, Senior Secured | Net unrealized appreciation (depreciation) | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||
Total gains or losses included in earnings | (8,027) | (33,208) | (45,019) | (57,909) |
Debt Securities, Senior Secured | Net realized gains (losses) | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||
Total gains or losses included in earnings | (1,809) | (10) | (3,139) | 8,451 |
Debt Securities, Subordinated | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||
Fair value, beginning balance | 183,756 | 160,727 | 159,388 | 176,317 |
Purchases | 4,183 | 29 | 26,508 | 3,777 |
Sales and repayments | (350) | (733) | (1,396) | (21,868) |
Transfers in | 0 | 0 | 0 | |
Transfers out | (2,708) | 0 | 0 | |
Capitalized PIK interest income | 358 | 0 | 376 | 313 |
Accretion of OID | 381 | 430 | 1,109 | 1,628 |
Fair value, ending balance | 184,916 | 155,580 | 184,916 | 155,580 |
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2023 | (704) | (4,873) | (1,069) | (4,734) |
Debt Securities, Subordinated | Net unrealized appreciation (depreciation) | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||
Total gains or losses included in earnings | (704) | (4,873) | (1,069) | (4,587) |
Debt Securities, Subordinated | Net realized gains (losses) | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||
Total gains or losses included in earnings | 0 | 0 | 0 | 0 |
Equity Securities, Preferred | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||
Fair value, beginning balance | 91,447 | 84,372 | 79,523 | 63,565 |
Purchases | 0 | 0 | 14,296 | 19,243 |
Sales and repayments | 0 | 0 | 0 | (163) |
Transfers in | 0 | 0 | 0 | |
Transfers out | 0 | 0 | 0 | |
Capitalized PIK interest income | 0 | 0 | 0 | 0 |
Accretion of OID | 0 | 0 | 0 | 0 |
Fair value, ending balance | 92,186 | 81,616 | 92,186 | 81,616 |
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2023 | 739 | (2,756) | (1,633) | (752) |
Equity Securities, Preferred | Net unrealized appreciation (depreciation) | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||
Total gains or losses included in earnings | 739 | (2,756) | (1,633) | (517) |
Equity Securities, Preferred | Net realized gains (losses) | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||
Total gains or losses included in earnings | 0 | 0 | 0 | (512) |
Equity Securities, Common And Warrants | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||
Fair value, beginning balance | 25,509 | 33,588 | 19,958 | 43,163 |
Purchases | 182 | 125 | 5,610 | 2,180 |
Sales and repayments | (7,320) | (3,890) | (8,295) | (12,836) |
Transfers in | 0 | 0 | 0 | |
Transfers out | 0 | (5,838) | (5,838) | |
Capitalized PIK interest income | 0 | 0 | 0 | 0 |
Accretion of OID | 0 | 0 | 0 | 0 |
Fair value, ending balance | 20,348 | 23,505 | 20,348 | 23,505 |
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2023 | 1,095 | (917) | (355) | (7,629) |
Equity Securities, Common And Warrants | Net unrealized appreciation (depreciation) | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||
Total gains or losses included in earnings | 1,893 | (873) | 2,804 | (2,520) |
Equity Securities, Common And Warrants | Net realized gains (losses) | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||
Total gains or losses included in earnings | $ 84 | $ 393 | $ 271 | $ (644) |
Portfolio Investments - Signifi
Portfolio Investments - Significant Unobservable Inputs for Level 3 Investments (Details) $ in Thousands | Jun. 30, 2023 USD ($) | Sep. 30, 2022 USD ($) |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 3,135,619 | $ 2,494,111 |
Debt Securities, Senior Secured | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | 2,774,373 | 2,166,409 |
Debt investments in the JVs | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | 162,288 | 146,533 |
Level 3 | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | 2,825,898 | 2,169,475 |
Level 3 | Debt Securities, Senior Secured | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | 2,528,448 | 1,910,606 |
Level 3 | Debt Securities, Senior Secured | Valuation, Market Approach | Measurement Input, Market Yield | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 2,058,831 | $ 1,599,148 |
Level 3 | Debt Securities, Senior Secured | Valuation, Market Approach | Measurement Input, Market Yield | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 0.090 | 0.090 |
Level 3 | Debt Securities, Senior Secured | Valuation, Market Approach | Measurement Input, Market Yield | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 0.380 | 0.300 |
Level 3 | Debt Securities, Senior Secured | Valuation, Market Approach | Measurement Input, Market Yield | Weighted Average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 0.141 | 0.137 |
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 34,466 | $ 14,333 |
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 3.4 | 5 |
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 5.4 | 7 |
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Weighted Average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 5.2 | 6 |
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 43,954 | |
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 5 | |
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 7 | |
Level 3 | Debt Securities, Senior Secured | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Weighted Average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 6 | |
Level 3 | Debt Securities, Senior Secured | Valuation, Transaction Precedent | Measurement Input, Transaction Price | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 32,379 | |
Level 3 | Debt Securities, Senior Secured | Valuation, Broker Quotations | Measurement Input, Transaction Price | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 297,125 | |
Level 3 | Debt Securities, Senior Secured | Valuation, Broker Quotations | Measurement Input, Broker Quoted Price | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | 358,818 | |
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 18,464 | $ 12,855 |
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 0.100 | 0.100 |
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 0.220 | 0.190 |
Level 3 | Subordinated Debt | Valuation, Market Approach | Measurement Input, Market Yield | Weighted Average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 0.114 | 0.138 |
Level 3 | Subordinated Debt | Valuation, Broker Quotations | Measurement Input, Broker Quoted Price | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 4,164 | |
Level 3 | Debt investments in the JVs | Valuation, Enterprise Value | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | 162,288 | $ 146,533 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 37,322 | $ 36,913 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 1.7 | 3 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 17.5 | 20 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, EBITDA Multiple | Weighted Average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 11.1 | 11.4 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 70,852 | $ 61,693 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 0.4 | 0.4 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 6 | 10.1 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Revenue Multiple | Weighted Average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 1.4 | 4.3 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 1,415 | $ 3 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 1 | 0.9 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 1.4 | 1.1 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Enterprise Value | Measurement Input, Asset Multiple | Weighted Average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Measurement input | 1.4 | 1 |
Level 3 | Equity Securities, Preferred & Common | Valuation, Transaction Precedent | Measurement Input, Transaction Price | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Investments at fair value | $ 2,945 | $ 872 |
Portfolio Investments - Sched_2
Portfolio Investments - Schedule of Financial Instruments Disclosed, but Carried at Fair Value (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Sep. 30, 2022 |
Schedule of Investments [Line Items] | ||
Carrying Value | $ 1,740,066 | $ 1,301,043 |
Fair Value | 1,722,977 | 1,277,105 |
Syndicated Facility | ||
Schedule of Investments [Line Items] | ||
Carrying Value | 800,000 | 540,000 |
Fair Value | 800,000 | 540,000 |
Citibank Facility | ||
Schedule of Investments [Line Items] | ||
Carrying Value | 160,000 | |
Fair Value | 160,000 | |
OSI2 Citibank Facility | ||
Schedule of Investments [Line Items] | ||
Carrying Value | 335,000 | |
Fair Value | 335,000 | |
2025 Notes | ||
Schedule of Investments [Line Items] | ||
Carrying Value | 297,928 | 296,991 |
Fair Value | 285,717 | 283,077 |
2027 Notes | ||
Schedule of Investments [Line Items] | ||
Carrying Value | 307,138 | 304,052 |
Fair Value | 302,260 | 294,028 |
Level 1 | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 1 | Syndicated Facility | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 1 | Citibank Facility | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | |
Level 1 | OSI2 Citibank Facility | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | |
Level 1 | 2025 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 1 | 2027 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 2 | ||
Schedule of Investments [Line Items] | ||
Fair Value | 587,977 | 577,105 |
Level 2 | Syndicated Facility | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 2 | Citibank Facility | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | |
Level 2 | OSI2 Citibank Facility | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | |
Level 2 | 2025 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 285,717 | 283,077 |
Level 2 | 2027 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 302,260 | 294,028 |
Level 3 | ||
Schedule of Investments [Line Items] | ||
Fair Value | 1,135,000 | 700,000 |
Level 3 | Syndicated Facility | ||
Schedule of Investments [Line Items] | ||
Fair Value | 800,000 | 540,000 |
Level 3 | Citibank Facility | ||
Schedule of Investments [Line Items] | ||
Fair Value | 160,000 | |
Level 3 | OSI2 Citibank Facility | ||
Schedule of Investments [Line Items] | ||
Fair Value | 335,000 | |
Level 3 | 2025 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | 0 | 0 |
Level 3 | 2027 Notes | ||
Schedule of Investments [Line Items] | ||
Fair Value | $ 0 | $ 0 |
Portfolio Investments - Portfol
Portfolio Investments - Portfolio Composition (Details) - USD ($) $ in Thousands | 9 Months Ended | 12 Months Ended |
Jun. 30, 2023 | Sep. 30, 2022 | |
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 3,296,285 | $ 2,617,754 |
Investments at fair value | $ 3,135,619 | $ 2,494,111 |
Investment owned, percent of net assets | 207.73% | 200.24% |
Northeast | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 994,695 | $ 747,420 |
Investments at fair value | $ 936,888 | $ 696,368 |
Investment owned, percent of net assets | 62.07% | 55.90% |
Midwest | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 448,981 | $ 373,236 |
Investments at fair value | $ 429,317 | $ 356,934 |
Investment owned, percent of net assets | 28.44% | 28.66% |
Southeast | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 446,546 | $ 356,041 |
Investments at fair value | $ 406,523 | $ 344,567 |
Investment owned, percent of net assets | 26.93% | 27.66% |
West | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 440,634 | $ 358,306 |
Investments at fair value | $ 428,232 | $ 345,251 |
Investment owned, percent of net assets | 28.37% | 27.72% |
International | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 434,844 | $ 301,242 |
Investments at fair value | $ 432,986 | $ 279,646 |
Investment owned, percent of net assets | 28.69% | 22.45% |
South | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 197,754 | $ 168,819 |
Investments at fair value | $ 186,792 | $ 166,230 |
Investment owned, percent of net assets | 12.37% | 13.35% |
Northwest | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 168,992 | $ 91,382 |
Investments at fair value | $ 166,089 | $ 90,131 |
Investment owned, percent of net assets | 11% | 7.24% |
Southwest | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 163,839 | $ 221,308 |
Investments at fair value | $ 148,792 | $ 214,984 |
Investment owned, percent of net assets | 9.86% | 17.26% |
Investment Owned, At Cost | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 100% | 100% |
Investment Owned, At Cost | Geographic Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 100% | 100% |
Investment Owned, At Cost | Geographic Concentration Risk | Northeast | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 30.17% | 28.55% |
Investment Owned, At Cost | Geographic Concentration Risk | Midwest | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 13.62% | 14.26% |
Investment Owned, At Cost | Geographic Concentration Risk | Southeast | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 13.55% | 13.60% |
Investment Owned, At Cost | Geographic Concentration Risk | West | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 13.37% | 13.69% |
Investment Owned, At Cost | Geographic Concentration Risk | International | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 13.19% | 11.51% |
Investment Owned, At Cost | Geographic Concentration Risk | South | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 6% | 6.45% |
Investment Owned, At Cost | Geographic Concentration Risk | Northwest | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 5.13% | 3.49% |
Investment Owned, At Cost | Geographic Concentration Risk | Southwest | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 4.97% | 8.45% |
Investment Owned, At Fair Value | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 100% | 100% |
Investment Owned, At Fair Value | Geographic Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 100% | 100% |
Investment Owned, At Fair Value | Geographic Concentration Risk | Northeast | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 29.87% | 27.93% |
Investment Owned, At Fair Value | Geographic Concentration Risk | Midwest | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 13.69% | 14.31% |
Investment Owned, At Fair Value | Geographic Concentration Risk | Southeast | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 12.96% | 13.82% |
Investment Owned, At Fair Value | Geographic Concentration Risk | West | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 13.66% | 13.84% |
Investment Owned, At Fair Value | Geographic Concentration Risk | International | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 13.81% | 11.21% |
Investment Owned, At Fair Value | Geographic Concentration Risk | South | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 5.96% | 6.66% |
Investment Owned, At Fair Value | Geographic Concentration Risk | Northwest | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 5.30% | 3.61% |
Investment Owned, At Fair Value | Geographic Concentration Risk | Southwest | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 4.75% | 8.62% |
Debt Securities, Senior Secured | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 2,886,772 | $ 2,227,245 |
Investments at fair value | $ 2,774,373 | $ 2,166,409 |
Investment owned, percent of net assets | 183.80% | 173.93% |
Debt Securities, Senior Secured | Investment Owned, At Cost | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 87.59% | 85.08% |
Debt Securities, Senior Secured | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 88.48% | 86.86% |
Debt investments in the JVs | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 162,653 | $ 146,444 |
Investments at fair value | $ 162,288 | $ 146,533 |
Investment owned, percent of net assets | 10.75% | 11.77% |
Debt investments in the JVs | Investment Owned, At Cost | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 4.93% | 5.59% |
Debt investments in the JVs | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 5.18% | 5.88% |
Equity Securities, Preferred | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 99,597 | $ 85,300 |
Investments at fair value | $ 92,186 | $ 79,523 |
Investment owned, percent of net assets | 6.11% | 6.38% |
Equity Securities, Preferred | Investment Owned, At Cost | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 3.02% | 3.26% |
Equity Securities, Preferred | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.94% | 3.19% |
Debt Securities, Subordinated | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 55,450 | $ 67,147 |
Investments at fair value | $ 51,996 | $ 56,920 |
Investment owned, percent of net assets | 3.44% | 4.57% |
Debt Securities, Subordinated | Investment Owned, At Cost | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.68% | 2.57% |
Debt Securities, Subordinated | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.66% | 2.28% |
Equity Securities, JV LLC | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 54,791 | $ 49,322 |
Investments at fair value | $ 27,973 | $ 20,715 |
Investment owned, percent of net assets | 1.85% | 1.66% |
Equity Securities, JV LLC | Investment Owned, At Cost | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.66% | 1.88% |
Equity Securities, JV LLC | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.89% | 0.83% |
Equity Securities, Common And Warrants | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 37,022 | $ 42,296 |
Investments at fair value | $ 26,803 | $ 24,011 |
Investment owned, percent of net assets | 1.78% | 1.93% |
Equity Securities, Common And Warrants | Investment Owned, At Cost | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.12% | 1.62% |
Equity Securities, Common And Warrants | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.85% | 0.96% |
Portfolio Investments - Portf_2
Portfolio Investments - Portfolio of Investments by Industry (Details) - USD ($) $ in Thousands | 9 Months Ended | 12 Months Ended |
Jun. 30, 2023 | Sep. 30, 2022 | |
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 3,296,285 | $ 2,617,754 |
Investments at fair value | $ 3,135,619 | $ 2,494,111 |
Investment owned, percent of net assets | 207.73% | 200.24% |
Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 100% | 100% |
Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 100% | 100% |
Application Software | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 560,503 | $ 391,938 |
Application Software | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 544,685 | $ 384,589 |
Investment owned, percent of net assets | 36.03% | 30.87% |
Application Software | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 17.38% | 15.43% |
Application Software | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 16.98% | 14.98% |
Multi-Sector Holdings | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 219,130 | $ 195,766 |
Multi-Sector Holdings | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 192,160 | $ 167,248 |
Investment owned, percent of net assets | 12.73% | 13.43% |
Multi-Sector Holdings | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 6.13% | 6.71% |
Multi-Sector Holdings | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 6.65% | 7.48% |
Data Processing & Outsourced Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 133,422 | $ 120,477 |
Data Processing & Outsourced Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 124,548 | $ 111,335 |
Investment owned, percent of net assets | 8.25% | 8.94% |
Data Processing & Outsourced Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 3.97% | 4.46% |
Data Processing & Outsourced Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 4.05% | 4.60% |
Health Care Technology | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 129,178 | $ 100,084 |
Health Care Technology | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 115,659 | $ 97,315 |
Investment owned, percent of net assets | 7.66% | 7.81% |
Health Care Technology | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 3.69% | 3.90% |
Health Care Technology | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 3.92% | 3.82% |
Biotechnology | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 127,394 | $ 109,960 |
Biotechnology | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 128,343 | $ 108,465 |
Investment owned, percent of net assets | 8.50% | 8.71% |
Biotechnology | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 4.09% | 4.35% |
Biotechnology | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 3.86% | 4.20% |
Pharmaceuticals | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 121,497 | $ 126,508 |
Pharmaceuticals | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 116,199 | $ 119,511 |
Investment owned, percent of net assets | 7.70% | 9.59% |
Pharmaceuticals | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 3.71% | 4.79% |
Pharmaceuticals | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 3.69% | 4.83% |
Aerospace & Defense | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 110,680 | $ 61,963 |
Aerospace & Defense | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 111,464 | $ 61,881 |
Investment owned, percent of net assets | 7.38% | 4.97% |
Aerospace & Defense | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 3.55% | 2.48% |
Aerospace & Defense | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 3.36% | 2.37% |
Industrial Machinery & Supplies & Components | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 99,237 | $ 0 |
Industrial Machinery & Supplies & Components | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 99,021 | $ 0 |
Investment owned, percent of net assets | 6.56% | 0% |
Industrial Machinery & Supplies & Components | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 3.16% | 0% |
Industrial Machinery & Supplies & Components | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 3.01% | 0% |
Broadline Retail | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 83,201 | $ 0 |
Broadline Retail | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 80,882 | $ 0 |
Investment owned, percent of net assets | 5.36% | 0% |
Broadline Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.58% | 0% |
Broadline Retail | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.52% | 0% |
Health Care Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 77,364 | $ 58,674 |
Health Care Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 62,190 | $ 45,943 |
Investment owned, percent of net assets | 4.12% | 3.69% |
Health Care Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.98% | 1.84% |
Health Care Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.35% | 2.24% |
Real Estate Operating Companies | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 76,462 | $ 47,585 |
Real Estate Operating Companies | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 75,111 | $ 48,062 |
Investment owned, percent of net assets | 4.98% | 3.86% |
Real Estate Operating Companies | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.40% | 1.93% |
Real Estate Operating Companies | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.32% | 1.82% |
Specialized Finance | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 69,188 | $ 80,864 |
Specialized Finance | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 66,333 | $ 73,087 |
Investment owned, percent of net assets | 4.39% | 5.87% |
Specialized Finance | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.12% | 2.93% |
Specialized Finance | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.10% | 3.09% |
Personal Care Products | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 68,671 | $ 0 |
Personal Care Products | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 60,962 | $ 0 |
Investment owned, percent of net assets | 4.04% | 0% |
Personal Care Products | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.94% | 0% |
Personal Care Products | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.08% | 0% |
Automotive Retail | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 64,825 | $ 59,254 |
Automotive Retail | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 62,356 | $ 57,629 |
Investment owned, percent of net assets | 4.13% | 4.63% |
Automotive Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.99% | 2.31% |
Automotive Retail | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.97% | 2.26% |
Fertilizers & Agricultural Chemicals | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 64,750 | $ 49,301 |
Fertilizers & Agricultural Chemicals | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 63,185 | $ 51,972 |
Investment owned, percent of net assets | 4.19% | 4.17% |
Fertilizers & Agricultural Chemicals | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2.02% | 2.08% |
Fertilizers & Agricultural Chemicals | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.96% | 1.88% |
Internet Services & Infrastructure | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 63,057 | $ 54,095 |
Internet Services & Infrastructure | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 62,726 | $ 53,797 |
Investment owned, percent of net assets | 4.16% | 4.32% |
Internet Services & Infrastructure | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 2% | 2.16% |
Internet Services & Infrastructure | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.91% | 2.07% |
Health Care Distributors | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 62,079 | $ 57,112 |
Health Care Distributors | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 60,340 | $ 54,662 |
Investment owned, percent of net assets | 4% | 4.39% |
Health Care Distributors | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.92% | 2.19% |
Health Care Distributors | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.88% | 2.18% |
Diversified Financial Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 61,693 | $ 0 |
Diversified Financial Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 61,073 | $ 0 |
Investment owned, percent of net assets | 4.05% | 0% |
Diversified Financial Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.95% | 0% |
Diversified Financial Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.87% | 0% |
Auto Parts & Equipment | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 61,091 | $ 12,474 |
Auto Parts & Equipment | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 60,809 | $ 11,469 |
Investment owned, percent of net assets | 4.03% | 0.92% |
Auto Parts & Equipment | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.94% | 0.46% |
Auto Parts & Equipment | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.85% | 0.48% |
Metal, Glass & Plastic Containers | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 57,949 | $ 0 |
Metal, Glass & Plastic Containers | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 43,954 | $ 0 |
Investment owned, percent of net assets | 2.91% | 0% |
Metal, Glass & Plastic Containers | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.40% | 0% |
Metal, Glass & Plastic Containers | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.76% | 0% |
Airport Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 55,919 | $ 43,322 |
Airport Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 55,221 | $ 42,883 |
Investment owned, percent of net assets | 3.66% | 3.44% |
Airport Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.76% | 1.72% |
Airport Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.70% | 1.65% |
Home Improvement Retail | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 54,939 | $ 45,802 |
Home Improvement Retail | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 54,235 | $ 45,421 |
Investment owned, percent of net assets | 3.59% | 3.65% |
Home Improvement Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.73% | 1.82% |
Home Improvement Retail | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.67% | 1.75% |
Insurance Brokers | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 52,960 | $ 35,628 |
Insurance Brokers | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 54,680 | $ 33,081 |
Investment owned, percent of net assets | 3.62% | 2.66% |
Insurance Brokers | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.74% | 1.33% |
Insurance Brokers | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.61% | 1.36% |
Diversified Metals & Mining | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 49,787 | $ 0 |
Diversified Metals & Mining | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 49,809 | $ 0 |
Investment owned, percent of net assets | 3.30% | 0% |
Diversified Metals & Mining | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.59% | 0% |
Diversified Metals & Mining | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.51% | 0% |
Leisure Facilities | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 49,501 | $ 39,768 |
Leisure Facilities | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 46,990 | $ 39,258 |
Investment owned, percent of net assets | 3.11% | 3.15% |
Leisure Facilities | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.50% | 1.57% |
Leisure Facilities | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.50% | 1.52% |
Real Estate Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 44,783 | $ 40,243 |
Real Estate Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 44,227 | $ 39,573 |
Investment owned, percent of net assets | 2.93% | 3.18% |
Real Estate Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.41% | 1.59% |
Real Estate Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.36% | 1.54% |
Soft Drinks & Non-alcoholic Beverages | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 43,021 | $ 0 |
Soft Drinks & Non-alcoholic Beverages | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 42,798 | $ 0 |
Investment owned, percent of net assets | 2.84% | 0% |
Soft Drinks & Non-alcoholic Beverages | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.36% | 0% |
Soft Drinks & Non-alcoholic Beverages | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.31% | 0% |
Diversified Support Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 42,706 | $ 37,992 |
Diversified Support Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 41,302 | $ 36,712 |
Investment owned, percent of net assets | 2.74% | 2.95% |
Diversified Support Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.32% | 1.47% |
Diversified Support Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.30% | 1.45% |
Other Specialty Retail | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 41,790 | $ 0 |
Other Specialty Retail | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 41,790 | $ 0 |
Investment owned, percent of net assets | 2.77% | 0% |
Other Specialty Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.33% | 0% |
Other Specialty Retail | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.27% | 0% |
Specialty Chemicals | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 38,248 | $ 37,319 |
Specialty Chemicals | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 32,231 | $ 33,969 |
Investment owned, percent of net assets | 2.14% | 2.73% |
Specialty Chemicals | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.03% | 1.36% |
Specialty Chemicals | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.16% | 1.43% |
Distributors | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 37,668 | $ 25,278 |
Distributors | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 36,829 | $ 24,494 |
Investment owned, percent of net assets | 2.44% | 1.97% |
Distributors | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.17% | 0.98% |
Distributors | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.14% | 0.97% |
Integrated Telecommunication Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 33,663 | $ 34,628 |
Integrated Telecommunication Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 30,922 | $ 32,201 |
Investment owned, percent of net assets | 2.05% | 2.59% |
Integrated Telecommunication Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.99% | 1.29% |
Integrated Telecommunication Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.02% | 1.32% |
Electrical Components & Equipment | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 32,380 | $ 33,814 |
Electrical Components & Equipment | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 32,379 | $ 32,933 |
Investment owned, percent of net assets | 2.15% | 2.64% |
Electrical Components & Equipment | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 1.03% | 1.32% |
Electrical Components & Equipment | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.98% | 1.29% |
Construction & Engineering | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 27,231 | $ 60,996 |
Construction & Engineering | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 26,901 | $ 61,188 |
Investment owned, percent of net assets | 1.78% | 4.91% |
Construction & Engineering | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.86% | 2.45% |
Construction & Engineering | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.83% | 2.33% |
Environmental & Facilities Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 25,943 | $ 20,857 |
Environmental & Facilities Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 25,436 | $ 20,585 |
Investment owned, percent of net assets | 1.69% | 1.65% |
Environmental & Facilities Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.81% | 0.83% |
Environmental & Facilities Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.79% | 0.80% |
Advertising | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 25,597 | $ 28,245 |
Advertising | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 18,969 | $ 26,948 |
Investment owned, percent of net assets | 1.26% | 2.16% |
Advertising | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.60% | 1.08% |
Advertising | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.78% | 1.08% |
Passenger Airlines | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 24,888 | $ 0 |
Passenger Airlines | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 26,985 | $ 0 |
Investment owned, percent of net assets | 1.79% | 0% |
Passenger Airlines | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.86% | 0% |
Passenger Airlines | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.76% | 0% |
Oil & Gas Storage & Transportation | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 24,231 | $ 22,290 |
Oil & Gas Storage & Transportation | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 21,660 | $ 20,853 |
Investment owned, percent of net assets | 1.43% | 1.67% |
Oil & Gas Storage & Transportation | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.69% | 0.84% |
Oil & Gas Storage & Transportation | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.74% | 0.85% |
Home Furnishings | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 23,832 | $ 19,550 |
Home Furnishings | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 19,514 | $ 18,188 |
Investment owned, percent of net assets | 1.29% | 1.46% |
Home Furnishings | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.62% | 0.73% |
Home Furnishings | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.72% | 0.75% |
Gold | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 23,274 | $ 0 |
Gold | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 23,292 | $ 0 |
Investment owned, percent of net assets | 1.54% | 0% |
Gold | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.74% | 0% |
Gold | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.71% | 0% |
Systems Software | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 23,089 | $ 14,890 |
Systems Software | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 22,168 | $ 12,834 |
Investment owned, percent of net assets | 1.47% | 1.03% |
Systems Software | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.71% | 0.51% |
Systems Software | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.70% | 0.57% |
Health Care Equipment | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 22,374 | $ 24,353 |
Health Care Equipment | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 22,531 | $ 24,161 |
Investment owned, percent of net assets | 1.49% | 1.94% |
Health Care Equipment | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.72% | 0.97% |
Health Care Equipment | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.68% | 0.93% |
Real Estate Development | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 19,567 | $ 0 |
Real Estate Development | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 19,246 | $ 0 |
Investment owned, percent of net assets | 1.28% | 0% |
Real Estate Development | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.61% | 0% |
Real Estate Development | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.59% | 0% |
Interactive Media & Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 18,963 | $ 0 |
Interactive Media & Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 19,000 | $ 0 |
Investment owned, percent of net assets | 1.26% | 0% |
Interactive Media & Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.61% | 0% |
Interactive Media & Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.58% | 0% |
Hotels, Resorts & Cruise Lines | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 17,221 | $ 13,960 |
Hotels, Resorts & Cruise Lines | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 17,261 | $ 13,985 |
Investment owned, percent of net assets | 1.14% | 1.12% |
Hotels, Resorts & Cruise Lines | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.55% | 0.56% |
Hotels, Resorts & Cruise Lines | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.52% | 0.53% |
Consumer Finance | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 16,411 | $ 14,492 |
Consumer Finance | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 12,616 | $ 13,284 |
Investment owned, percent of net assets | 0.84% | 1.07% |
Consumer Finance | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.40% | 0.53% |
Consumer Finance | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.50% | 0.55% |
Education Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 15,660 | $ 9,080 |
Education Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 14,116 | $ 8,582 |
Investment owned, percent of net assets | 0.94% | 0.69% |
Education Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.45% | 0.34% |
Education Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.48% | 0.35% |
IT Consulting & Other Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 15,434 | $ 11,697 |
IT Consulting & Other Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 11,176 | $ 8,596 |
Investment owned, percent of net assets | 0.74% | 0.69% |
IT Consulting & Other Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.36% | 0.34% |
IT Consulting & Other Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.47% | 0.45% |
Restaurants | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 12,589 | $ 9,338 |
Restaurants | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 12,168 | $ 8,692 |
Investment owned, percent of net assets | 0.81% | 0.70% |
Restaurants | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.39% | 0.35% |
Restaurants | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.38% | 0.36% |
Movies & Entertainment | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 12,188 | $ 26,161 |
Movies & Entertainment | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 11,865 | $ 26,645 |
Investment owned, percent of net assets | 0.79% | 2.14% |
Movies & Entertainment | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.38% | 1.07% |
Movies & Entertainment | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.37% | 1% |
Health Care Supplies | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 11,675 | $ 36,471 |
Health Care Supplies | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 11,408 | $ 36,577 |
Investment owned, percent of net assets | 0.76% | 2.94% |
Health Care Supplies | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.36% | 1.47% |
Health Care Supplies | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.35% | 1.39% |
Food Distributors | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 5,900 | $ 4,646 |
Food Distributors | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 5,296 | $ 3,367 |
Investment owned, percent of net assets | 0.35% | 0.27% |
Food Distributors | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.17% | 0.13% |
Food Distributors | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.18% | 0.18% |
Apparel Retail | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 5,293 | $ 5,268 |
Apparel Retail | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 5,230 | $ 5,223 |
Investment owned, percent of net assets | 0.35% | 0.42% |
Apparel Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.17% | 0.21% |
Apparel Retail | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.16% | 0.20% |
Air Freight & Logistics | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 4,925 | $ 7,295 |
Air Freight & Logistics | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 4,025 | $ 6,405 |
Investment owned, percent of net assets | 0.27% | 0.51% |
Air Freight & Logistics | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.13% | 0.26% |
Air Freight & Logistics | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.15% | 0.28% |
Integrated Oil & Gas | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 4,887 | $ 4,866 |
Integrated Oil & Gas | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 4,810 | $ 4,872 |
Investment owned, percent of net assets | 0.32% | 0.39% |
Integrated Oil & Gas | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.15% | 0.20% |
Integrated Oil & Gas | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.15% | 0.19% |
Research & Consulting Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 4,879 | $ 9,187 |
Research & Consulting Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 4,632 | $ 8,573 |
Investment owned, percent of net assets | 0.31% | 0.69% |
Research & Consulting Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.15% | 0.34% |
Research & Consulting Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.15% | 0.35% |
Cable & Satellite | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 4,687 | $ 20,716 |
Cable & Satellite | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 4,672 | $ 19,576 |
Investment owned, percent of net assets | 0.31% | 1.57% |
Cable & Satellite | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.15% | 0.78% |
Cable & Satellite | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.14% | 0.79% |
Other Specialized REITs | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 4,364 | $ 0 |
Other Specialized REITs | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 3,438 | $ 0 |
Investment owned, percent of net assets | 0.23% | 0% |
Other Specialized REITs | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.11% | 0% |
Other Specialized REITs | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.13% | 0% |
Paper & Plastic Packaging Products & Materials | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 3,262 | $ 0 |
Paper & Plastic Packaging Products & Materials | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 3,100 | $ 0 |
Investment owned, percent of net assets | 0.21% | 0% |
Paper & Plastic Packaging Products & Materials | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.10% | 0% |
Paper & Plastic Packaging Products & Materials | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.10% | 0% |
Housewares & Specialties | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 2,908 | $ 2,293 |
Housewares & Specialties | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 2,858 | $ 2,456 |
Investment owned, percent of net assets | 0.19% | 0.20% |
Housewares & Specialties | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.09% | 0.10% |
Housewares & Specialties | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.09% | 0.09% |
Electronic Components | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 2,101 | $ 2,092 |
Electronic Components | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 1,834 | $ 1,890 |
Investment owned, percent of net assets | 0.12% | 0.15% |
Electronic Components | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.06% | 0.08% |
Electronic Components | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.06% | 0.08% |
Leisure Products | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 2,039 | $ 0 |
Leisure Products | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 1,995 | $ 0 |
Investment owned, percent of net assets | 0.13% | 0% |
Leisure Products | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.06% | 0% |
Leisure Products | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.06% | 0% |
Technology Distributors | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 1,084 | $ 3,163 |
Technology Distributors | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 1,024 | $ 2,997 |
Investment owned, percent of net assets | 0.07% | 0.24% |
Technology Distributors | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.03% | 0.12% |
Technology Distributors | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.03% | 0.12% |
Communications Equipment | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 1,053 | $ 0 |
Communications Equipment | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 980 | $ 0 |
Investment owned, percent of net assets | 0.06% | 0% |
Communications Equipment | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.03% | 0% |
Communications Equipment | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0.03% | 0% |
Industrial Machinery | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 0 | $ 81,787 |
Industrial Machinery | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 0 | $ 81,008 |
Investment owned, percent of net assets | 0% | 6.50% |
Industrial Machinery | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 3.25% |
Industrial Machinery | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 3.12% |
Internet & Direct Marketing Retail | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 0 | $ 67,926 |
Internet & Direct Marketing Retail | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 0 | $ 70,419 |
Investment owned, percent of net assets | 0% | 5.65% |
Internet & Direct Marketing Retail | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 2.82% |
Internet & Direct Marketing Retail | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 2.59% |
Personal Products | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 0 | $ 53,214 |
Personal Products | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 0 | $ 50,150 |
Investment owned, percent of net assets | 0% | 4.03% |
Personal Products | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 2.01% |
Personal Products | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 2.03% |
Metal & Glass Containers | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 0 | $ 47,704 |
Metal & Glass Containers | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 0 | $ 47,599 |
Investment owned, percent of net assets | 0% | 3.82% |
Metal & Glass Containers | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 1.91% |
Metal & Glass Containers | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 1.82% |
Soft Drinks | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 0 | $ 34,272 |
Soft Drinks | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 0 | $ 33,670 |
Investment owned, percent of net assets | 0% | 2.70% |
Soft Drinks | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 1.35% |
Soft Drinks | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 1.31% |
Other Diversified Financial Services | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 0 | $ 29,300 |
Other Diversified Financial Services | Investment Owned, At Fair Value | ||
Schedule of Investments [Line Items] | ||
Investments at fair value | $ 0 | $ 24,326 |
Investment owned, percent of net assets | 0% | 1.95% |
Other Diversified Financial Services | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.98% |
Other Diversified Financial Services | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 1.12% |
Oil & Gas Refining & Marketing | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 0 | $ 8,627 |
Investments at fair value | $ 0 | $ 8,604 |
Investment owned, percent of net assets | 0% | 0.69% |
Oil & Gas Refining & Marketing | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.34% |
Oil & Gas Refining & Marketing | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.33% |
Trading Companies & Distributors | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 0 | $ 7,628 |
Investments at fair value | $ 0 | $ 5,567 |
Investment owned, percent of net assets | 0% | 0.45% |
Trading Companies & Distributors | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.22% |
Trading Companies & Distributors | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.29% |
Apparel, Accessories & Luxury Goods | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 0 | $ 5,165 |
Apparel, Accessories & Luxury Goods | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.20% |
Specialized REITs | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 0 | $ 4,318 |
Investments at fair value | $ 0 | $ 3,264 |
Investment owned, percent of net assets | 0% | 0.26% |
Specialized REITs | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.13% |
Specialized REITs | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.16% |
Diversified Banks | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 0 | $ 3,515 |
Investments at fair value | $ 0 | $ 3,402 |
Investment owned, percent of net assets | 0% | 0.27% |
Diversified Banks | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.14% |
Diversified Banks | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.13% |
Construction Materials | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 0 | $ 2,331 |
Investments at fair value | $ 0 | $ 1,934 |
Investment owned, percent of net assets | 0% | 0.16% |
Construction Materials | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.08% |
Construction Materials | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.09% |
Alternative Carriers | ||
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 0 | $ 212 |
Investments at fair value | $ 0 | $ 201 |
Investment owned, percent of net assets | 0% | 0.02% |
Alternative Carriers | Investment Owned, At Fair Value | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.01% |
Alternative Carriers | Investment Owned, At Cost | Investment Sector Concentration Risk | ||
Schedule of Investments [Line Items] | ||
Concentration risk | 0% | 0.01% |
Portfolio Investments - Summary
Portfolio Investments - Summary of Portfolio (Details) € in Thousands, £ in Thousands, $ in Thousands | Jun. 30, 2023 USD ($) borrower | Jun. 30, 2023 EUR (€) borrower | Jun. 30, 2023 GBP (£) borrower | Sep. 30, 2022 USD ($) borrower | Sep. 30, 2022 EUR (€) borrower | Sep. 30, 2022 GBP (£) borrower | Jun. 30, 2022 USD ($) | |||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Number of borrowers in the Glick JV | borrower | 156 | 156 | 156 | 149 | 149 | 149 | ||||||||
Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[5] | $ 1,174 | ||||||||||||
Investment, interest rate | [1],[2],[3],[5],[6],[7] | 12.50% | 12.50% | 12.50% | ||||||||||
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4] | $ 14,916 | ||||||||||||
Investment, interest rate | [1],[2],[3],[6],[7] | 11% | 11% | 11% | ||||||||||
Investment, Identifier [Axis]: 109 Montgomery Owner LLC, Real Estate Operating Companies, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 389 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 9.80% | 9.80% | 9.80% | ||||||||||
Investment, Identifier [Axis]: 109 Montgomery Owner LLC, Real Estate Operating Companies, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11],[13] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[5] | $ 3,710 | ||||||||||||
Investment, interest rate | [1],[2],[3],[5],[6],[7] | 12% | 12% | 12% | ||||||||||
Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[14],[15] | $ 21,434 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[14],[15] | 14.25% | 14.25% | 14.25% | ||||||||||
Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,576 | [1],[3],[4],[14] | 33,997 | [8],[9],[10],[16] | ||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 14,685 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 9.80% | 9.80% | 9.80% | ||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 3,520 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12% | 12% | 12% | ||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 18,271 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12% | 12% | 12% | ||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 1,000 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 11.66% | 11.66% | 11.66% | ||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,589 | [1],[3],[4],[7],[14] | $ 6,589 | [8],[9],[10],[11],[16] | ||||||||||
Investment, interest rate | 12.89% | [1],[3],[6],[7],[14] | 12.89% | [1],[3],[6],[7],[14] | 12.89% | [1],[3],[6],[7],[14] | 11.20% | [8],[9],[11],[12],[16] | 11.20% | [8],[9],[11],[12],[16] | 11.20% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[3],[4],[7],[14] | $ 0 | [8],[9],[10],[11],[13],[16] | ||||||||||
Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | € | € 29,985 | [1],[3],[4],[7],[14] | € 24,838 | [8],[9],[10],[11],[16] | ||||||||||
Investment, interest rate | 10.67% | [1],[3],[6],[7],[14] | 10.67% | [1],[3],[6],[7],[14] | 10.67% | [1],[3],[6],[7],[14] | 7.94% | [8],[9],[11],[12],[16] | 7.94% | [8],[9],[11],[12],[16] | 7.94% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 17,873 | [1],[3],[4],[7] | $ 14,414 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 12.95% | [1],[3],[6],[7] | 12.95% | [1],[3],[6],[7] | 12.95% | [1],[3],[6],[7] | 10.88% | [8],[9],[11],[12] | 10.88% | [8],[9],[11],[12] | 10.88% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: APX Group Inc., Electrical Components & Equipment, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10],[16] | $ 2,075 | ||||||||||||
Investment, interest rate | [9],[11],[12],[16] | 5.75% | 5.75% | 5.75% | ||||||||||
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., Trading Companies & Distributors, Fixed Rate Bond 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10] | $ 5,500 | ||||||||||||
Investment, interest rate | [9],[11],[12] | 7.50% | 7.50% | 7.50% | ||||||||||
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., Trading Companies & Distributors, Fixed Rate Bond 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10] | $ 2,500 | ||||||||||||
Investment, interest rate | [9],[11],[12] | 5.25% | 5.25% | 5.25% | ||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7],[14] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7],[14] | $ 3,284 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[14] | 11.31% | 11.31% | 11.31% | ||||||||||
Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[14],[15] | $ 11,683 | ||||||||||||
Investment, Identifier [Axis]: Access CIG, LLC, Diversified Support Services, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 20,000 | [1],[3],[4],[7] | $ 20,000 | [9],[10],[11] | ||||||||||
Investment, interest rate | 12.94% | [1],[3],[6],[7] | 12.94% | [1],[3],[6],[7] | 12.94% | [1],[3],[6],[7] | 10.82% | [9],[11],[12] | 10.82% | [9],[11],[12] | 10.82% | [9],[11],[12] | ||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7] | $ 2,033 | ||||||||||||
Investment, interest rate | [1],[2],[3],[6],[7] | 10.86% | 10.86% | 10.86% | ||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 20,286 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 10.86% | 10.86% | 10.86% | ||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7] | $ 0 | ||||||||||||
Investment, interest rate | [1],[2],[3],[6],[7] | |||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11],[13] | $ 500 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12],[13] | 9.14% | 9.14% | 9.14% | ||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 15,976 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 9.12% | 9.12% | 9.12% | ||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11],[13] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,113 | [1],[2],[3],[4],[7] | $ 914 | [8],[9],[10],[11],[13] | ||||||||||
Investment, interest rate | 12.05% | [1],[2],[3],[6],[7] | 12.05% | [1],[2],[3],[6],[7] | 12.05% | [1],[2],[3],[6],[7] | 10.64% | [8],[9],[11],[12],[13] | 10.64% | [8],[9],[11],[12],[13] | 10.64% | [8],[9],[11],[12],[13] | ||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 27,349 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 9.63% | 9.63% | 9.63% | ||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 6,400 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12.34% | 12.34% | 12.34% | ||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 25,332 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12.34% | 12.34% | 12.34% | ||||||||||
Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 23,338 | ||||||||||||
Investment, Identifier [Axis]: All Web Leads, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7],[17] | $ 23,562 | ||||||||||||
Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,050 | [3],[4],[14] | $ 4,050 | [9],[10],[16] | ||||||||||
Investment, interest rate | 5.50% | [3],[6],[7],[14] | 5.50% | [3],[6],[7],[14] | 5.50% | [3],[6],[7],[14] | 5.50% | [9],[11],[12],[16] | 5.50% | [9],[11],[12],[16] | 5.50% | [9],[11],[12],[16] | ||
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 8,794 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 13.34% | 13.34% | 13.34% | ||||||||||
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 17,280 | [1],[3],[4],[7] | $ 13,134 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 12.89% | [1],[3],[6],[7] | 12.89% | [1],[3],[6],[7] | 12.89% | [1],[3],[6],[7] | 11.20% | [8],[9],[11],[12] | 11.20% | [8],[9],[11],[12] | 11.20% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[16] | $ 24,043 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12],[16] | 10% | 10% | 10% | ||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[14] | $ 28,464 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[14] | 8.50% | 8.50% | 8.50% | ||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[14] | $ 2,121 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[14] | 8.50% | 8.50% | 8.50% | ||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[14] | $ 27,692 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[14] | 8.50% | 8.50% | 8.50% | ||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 4 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[14] | $ 2,064 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[14] | 8.50% | 8.50% | 8.50% | ||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[16] | $ 23,522 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12],[16] | 10% | 10% | 10% | ||||||||||
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 17,048 | [1],[3],[4],[7] | $ 14,760 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 13.99% | [1],[3],[6],[7] | 13.99% | [1],[3],[6],[7] | 13.99% | [1],[3],[6],[7] | 12.30% | [8],[9],[11],[12] | 12.30% | [8],[9],[11],[12] | 12.30% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 19,163 | [3],[4],[7] | $ 9,895 | [9],[10],[11] | ||||||||||
Investment, interest rate | 11.49% | [3],[6],[7] | 11.49% | [3],[6],[7] | 11.49% | [3],[6],[7] | 9.03% | [9],[11],[12] | 9.03% | [9],[11],[12] | 9.03% | [9],[11],[12] | ||
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11],[16] | $ 15,220 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12],[16] | 7.92% | 7.92% | 7.92% | ||||||||||
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 12,500 | [1],[3],[4],[7],[14] | $ 12,500 | [8],[9],[10],[11],[16] | ||||||||||
Investment, interest rate | 13.39% | [1],[3],[6],[7],[14] | 13.39% | [1],[3],[6],[7],[14] | 13.39% | [1],[3],[6],[7],[14] | 11.67% | [8],[9],[11],[12],[16] | 11.67% | [8],[9],[11],[12],[16] | 11.67% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [3],[4],[7] | $ 3,710 | ||||||||||||
Investment, interest rate | [3],[6],[7] | 9.25% | 9.25% | 9.25% | ||||||||||
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Products, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10],[11] | $ 2,736 | ||||||||||||
Investment, interest rate | [9],[11],[12] | 7.42% | 7.42% | 7.42% | ||||||||||
Investment, Identifier [Axis]: Ankura Consulting Group LLC, Research & Consulting Services, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 4,346 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 10.78% | 10.78% | 10.78% | ||||||||||
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 808 | [1],[2],[3],[4],[7] | $ 892 | [8],[9],[10],[11],[13] | ||||||||||
Investment, interest rate | 10.20% | [1],[2],[3],[6],[7] | 10.20% | [1],[2],[3],[6],[7] | 10.20% | [1],[2],[3],[6],[7] | 8.46% | [8],[9],[11],[12],[13] | 8.46% | [8],[9],[11],[12],[13] | 8.46% | [8],[9],[11],[12],[13] | ||
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 34,458 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 8.46% | 8.46% | 8.46% | ||||||||||
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 9,280 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 10.20% | 10.20% | 10.20% | ||||||||||
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 32,308 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 10.20% | 10.20% | 10.20% | ||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | € | € 3,017 | [1],[3],[4],[7],[14] | € 1,964 | [8],[9],[10],[11],[16] | ||||||||||
Investment, interest rate | 10.07% | [1],[3],[6],[7],[14] | 10.07% | [1],[3],[6],[7],[14] | 10.07% | [1],[3],[6],[7],[14] | 8% | [8],[9],[11],[12],[16] | 8% | [8],[9],[11],[12],[16] | 8% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 10,519 | [1],[3],[4],[7],[14] | £ 18,636 | [8],[9],[10],[11],[16] | ||||||||||
Investment, interest rate | 11.25% | [1],[3],[6],[7],[14] | 11.25% | [1],[3],[6],[7],[14] | 11.25% | [1],[3],[6],[7],[14] | 9.19% | [8],[9],[11],[12],[16] | 9.19% | [8],[9],[11],[12],[16] | 9.19% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | £ 4,949 | [1],[3],[4],[7],[14] | $ 10,519 | [8],[9],[10],[11],[16] | ||||||||||
Investment, interest rate | 12.18% | [1],[3],[6],[7],[14] | 12.18% | [1],[3],[6],[7],[14] | 12.18% | [1],[3],[6],[7],[14] | 8.81% | [8],[9],[11],[12],[16] | 8.81% | [8],[9],[11],[12],[16] | 8.81% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | £ | £ 23,675 | [1],[3],[4],[7],[14] | £ 0 | [8],[9],[10],[11],[13],[16] | ||||||||||
Investment, interest rate | [1],[3],[6],[7],[14] | 12.45% | 12.45% | 12.45% | ||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | € | [1],[3],[4],[7],[14] | € 3,649 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[14] | 8.57% | 8.57% | 8.57% | ||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Common Stock | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 22,304 | $ 21,754 | ||||||||||||
Investment, interest rate | 12.29% | 12.29% | 12.29% | 9% | ||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Preferred Equity | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 22,304 | [1],[2],[4],[7],[18] | $ 24,490 | [8],[10],[11],[13],[19] | ||||||||||
Investment, interest rate | 12.29% | [1],[2],[6],[7],[18] | 12.29% | [1],[2],[6],[7],[18] | 12.29% | [1],[2],[6],[7],[18] | 10.42% | [8],[11],[12],[13],[19] | 10.42% | [8],[11],[12],[13],[19] | 10.42% | [8],[11],[12],[13],[19] | ||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Warrants | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | 0 | ||||||||||||
Investment, Identifier [Axis]: Associated Asphalt Partners, LLC, Construction Materials, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10],[11] | $ 2,501 | ||||||||||||
Investment, interest rate | [9],[11],[12] | 8.06% | 8.06% | 8.06% | ||||||||||
Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,490 | [3],[4],[7] | $ 5,640 | [9],[10],[11] | ||||||||||
Investment, interest rate | 10.44% | [3],[6],[7] | 10.44% | [3],[6],[7] | 10.44% | [3],[6],[7] | 8.37% | [9],[11],[12] | 8.37% | [9],[11],[12] | 8.37% | [9],[11],[12] | ||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,338 | [1],[3],[4],[14],[17] | $ 13,346 | [8],[9],[10],[16] | ||||||||||
Investment, interest rate | 11% | [1],[3],[6],[7],[14],[17] | 11% | [1],[3],[6],[7],[14],[17] | 11% | [1],[3],[6],[7],[14],[17] | 11% | [8],[9],[11],[12],[16] | 11% | [8],[9],[11],[12],[16] | 11% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,338 | [1],[3],[4],[14],[17] | $ 8,309 | [8],[9],[10],[16],[20] | ||||||||||
Investment, interest rate | [1],[3],[6],[7],[14],[17] | 11% | 11% | 11% | ||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[14],[17] | $ 5,350 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[14],[17] | 11% | 11% | 11% | ||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[14] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 29,509 | [1],[3],[4],[7],[14] | $ 22,425 | [8],[9],[10],[11],[16] | ||||||||||
Investment, interest rate | 11.27% | [1],[3],[6],[7],[14] | 11.27% | [1],[3],[6],[7],[14] | 11.27% | [1],[3],[6],[7],[14] | 8.78% | [8],[9],[11],[12],[16] | 8.78% | [8],[9],[11],[12],[16] | 8.78% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 50,470 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12.49% | 12.49% | 12.49% | ||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11],[13] | $ 2,546 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12],[13] | 8.12% | 8.12% | 8.12% | ||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 3,258 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 10.50% | 10.50% | 10.50% | ||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 1,264 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 10.50% | 10.50% | 10.50% | ||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,920 | [1],[3],[4],[7] | $ 7,166 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 14% | [1],[3],[6],[7] | 14% | [1],[3],[6],[7] | 14% | [1],[3],[6],[7] | 11.62% | [8],[9],[11],[12] | 11.62% | [8],[9],[11],[12] | 11.62% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,091 | [1],[3],[4],[7] | $ 4,227 | [8],[9],[10],[11],[13] | ||||||||||
Investment, interest rate | 14% | [1],[3],[6],[7] | 14% | [1],[3],[6],[7] | 14% | [1],[3],[6],[7] | 11.62% | [8],[9],[11],[12],[13] | 11.62% | [8],[9],[11],[12],[13] | 11.62% | [8],[9],[11],[12],[13] | ||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 4,361 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 14% | 14% | 14% | ||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7] | $ 2,528 | ||||||||||||
Investment, interest rate | [1],[2],[3],[6],[7] | 12.50% | 12.50% | 12.50% | ||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 40,764 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 10.70% | 10.70% | 10.70% | ||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11],[13] | $ 1,702 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12],[13] | 10.75% | 10.75% | 10.75% | ||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 33,078 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 8.31% | 8.31% | 8.31% | ||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[13],[16],[20] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,719 | [1],[3],[4],[14] | $ 5,322 | [8],[9],[10],[16] | ||||||||||
Investment, interest rate | 8% | [1],[3],[6],[7],[14] | 8% | [1],[3],[6],[7],[14] | 8% | [1],[3],[6],[7],[14] | 10.25% | [8],[9],[11],[12],[16] | 10.25% | [8],[9],[11],[12],[16] | 10.25% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,210 | [1],[3],[4],[14],[15] | $ 0 | [8],[9],[10],[13],[16] | ||||||||||
Investment, interest rate | [8],[9],[11],[12],[13],[16] | 10.25% | 10.25% | 10.25% | ||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[3],[4],[14] | $ 2,353 | [8],[9],[10],[16],[20] | ||||||||||
Investment, interest rate | [1],[3],[6],[7],[14] | 8% | 8% | 8% | ||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[14] | $ 0 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[14] | 8% | 8% | 8% | ||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[14],[15] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[14],[15] | 0 | ||||||||||||
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 30,625 | [3],[4],[7] | $ 30,625 | [9],[10],[11] | ||||||||||
Investment, interest rate | 12.25% | [3],[6],[7] | 12.25% | [3],[6],[7] | 12.25% | [3],[6],[7] | 9.50% | [9],[11],[12] | 9.50% | [9],[11],[12] | 9.50% | [9],[11],[12] | ||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,994 | [1],[3],[4] | $ 3,979 | [8],[9],[10] | ||||||||||
Investment, interest rate | 9% | [1],[3],[6],[7] | 9% | [1],[3],[6],[7] | 9% | [1],[3],[6],[7] | 9% | [8],[9],[11],[12] | 9% | [8],[9],[11],[12] | 9% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Common Stock | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | |||||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | |||||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | |||||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Preferred Equity | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | |||||||||||||
Investment, Identifier [Axis]: CCO Holdings LLC, Cable & Satellite, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10],[16] | $ 2,097 | ||||||||||||
Investment, interest rate | [9],[11],[12],[16] | 4.50% | 4.50% | 4.50% | ||||||||||
Investment, Identifier [Axis]: CITGO Holding, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10] | $ 7,857 | ||||||||||||
Investment, interest rate | [9],[11],[12] | 9.25% | 9.25% | 9.25% | ||||||||||
Investment, Identifier [Axis]: CITGO Petroleum Corp., Oil & Gas Refining & Marketing, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10],[11] | $ 795 | ||||||||||||
Investment, interest rate | [9],[11],[12] | 9.37% | 9.37% | 9.37% | ||||||||||
Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7],[17] | 727 | ||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 14,294 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 9.31% | 9.31% | 9.31% | ||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 13 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 11.91% | 11.91% | 11.91% | ||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 3,031 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 11.91% | 11.91% | 11.91% | ||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 1,557 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 11.91% | 11.91% | 11.91% | ||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 1,024 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 11.91% | 11.91% | 11.91% | ||||||||||
Investment, Identifier [Axis]: Caregiver Services, Inc., Preferred Equity | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | 0 | ||||||||||||
Investment, Identifier [Axis]: Carvana Co., Automotive Retail, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10],[16] | $ 6,700 | ||||||||||||
Investment, interest rate | [9],[11],[12],[16] | 5.63% | 5.63% | 5.63% | ||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 10,692 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 8.62% | 8.62% | 8.62% | ||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 130 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 10.70% | 10.70% | 10.70% | ||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 129 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 10.70% | 10.70% | 10.70% | ||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 1,084 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 10.70% | 10.70% | 10.70% | ||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 4 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 9,002 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 10.70% | 10.70% | 10.70% | ||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,632 | [3],[4],[14] | $ 4,311 | [9],[10],[16] | ||||||||||
Investment, interest rate | 7.50% | [3],[6],[7],[14] | 7.50% | [3],[6],[7],[14] | 7.50% | [3],[6],[7],[14] | 7.50% | [9],[11],[12],[16] | 7.50% | [9],[11],[12],[16] | 7.50% | [9],[11],[12],[16] | ||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 176 | [3],[4],[14] | $ 1,374 | [9],[10],[16] | ||||||||||
Investment, interest rate | 7.75% | [3],[6],[7],[14] | 7.75% | [3],[6],[7],[14] | 7.75% | [3],[6],[7],[14] | 5.13% | [9],[11],[12],[16] | 5.13% | [9],[11],[12],[16] | 5.13% | [9],[11],[12],[16] | ||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10],[16] | $ 676 | ||||||||||||
Investment, interest rate | [9],[11],[12],[16] | 7.75% | 7.75% | 7.75% | ||||||||||
Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,420 | [3],[4] | $ 8,420 | [9],[10] | ||||||||||
Investment, interest rate | 7.38% | [3],[6],[7] | 7.38% | [3],[6],[7] | 7.38% | [3],[6],[7] | 7.38% | [9],[11],[12] | 7.38% | [9],[11],[12] | 7.38% | [9],[11],[12] | ||
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 24,350 | [1],[3],[4],[7] | $ 22,537 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 13.69% | [1],[3],[6],[7] | 13.69% | [1],[3],[6],[7] | 13.69% | [1],[3],[6],[7] | 11.62% | [8],[9],[11],[12] | 11.62% | [8],[9],[11],[12] | 11.62% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Convergeone Holdings, Inc., IT Consulting & Other Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 17,506 | [3],[4],[7] | $ 11,913 | [9],[10],[11] | ||||||||||
Investment, interest rate | 10.37% | [3],[6],[7] | 10.37% | [3],[6],[7] | 10.37% | [3],[6],[7] | 8.12% | [9],[11],[12] | 8.12% | [9],[11],[12] | 8.12% | [9],[11],[12] | ||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,250 | [1],[2],[3],[4],[7] | $ 916 | [8],[9],[10],[11],[13] | ||||||||||
Investment, interest rate | 14% | [1],[2],[3],[6],[7] | 14% | [1],[2],[3],[6],[7] | 14% | [1],[2],[3],[6],[7] | 11% | [8],[9],[11],[12],[13] | 11% | [8],[9],[11],[12],[13] | 11% | [8],[9],[11],[12],[13] | ||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 13,712 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 8.88% | 8.88% | 8.88% | ||||||||||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 13,671 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 11.33% | 11.33% | 11.33% | ||||||||||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 4,903 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 11.33% | 11.33% | 11.33% | ||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 13,157 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12.60% | 12.60% | 12.60% | ||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 14,787 | [3],[4],[7] | $ 10,336 | [9],[10],[11] | ||||||||||
Investment, interest rate | 10.24% | [3],[6],[7] | 10.24% | [3],[6],[7] | 10.24% | [3],[6],[7] | 7.65% | [9],[11],[12] | 7.65% | [9],[11],[12] | 7.65% | [9],[11],[12] | ||
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 533 | [1],[2],[3],[4],[7] | $ 0 | [8],[9],[10],[11],[13] | ||||||||||
Investment, interest rate | [6],[7] | 11.20% | 11.20% | 11.20% | ||||||||||
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 18,060 | [1],[3],[4],[7] | $ 18,200 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 11.10% | [1],[3],[6],[7] | 11.10% | [1],[3],[6],[7] | 11.10% | [1],[3],[6],[7] | 8.81% | [8],[9],[11],[12] | 8.81% | [8],[9],[11],[12] | 8.81% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,963 | [3],[4],[7] | $ 5,000 | [9],[10],[11] | ||||||||||
Investment, interest rate | 9.80% | [3],[6],[7] | 9.80% | [3],[6],[7] | 9.80% | [3],[6],[7] | 7.33% | [9],[11],[12] | 7.33% | [9],[11],[12] | 7.33% | [9],[11],[12] | ||
Investment, Identifier [Axis]: Delivery Hero FinCo LLC, Internet & Direct Marketing Retail, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10],[11],[16] | $ 4,988 | ||||||||||||
Investment, interest rate | [9],[11],[12],[16] | 8.49% | 8.49% | 8.49% | ||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 13,043 | [1],[2],[3],[4],[14] | $ 4,183 | [8],[9],[10],[13],[16] | ||||||||||
Investment, interest rate | 3% | [1],[2],[3],[6],[7],[14] | 3% | [1],[2],[3],[6],[7],[14] | 3% | [1],[2],[3],[6],[7],[14] | 10% | [8],[9],[11],[12],[13],[16] | 10% | [8],[9],[11],[12],[13],[16] | 10% | [8],[9],[11],[12],[13],[16] | ||
Investment, Identifier [Axis]: Delta Topco, Inc., Systems Software, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10],[11] | $ 6,680 | ||||||||||||
Investment, interest rate | [9],[11],[12] | 9.34% | 9.34% | 9.34% | ||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 20,757 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 14.42% | 14.42% | 14.42% | ||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 24,396 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 12.67% | 12.67% | 12.67% | ||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11],[13] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4] | $ 641 | ||||||||||||
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 204 | [1],[2],[3],[4],[7] | $ 251 | [8],[9],[10],[11],[13] | ||||||||||
Investment, interest rate | 12.09% | [1],[2],[3],[6],[7] | 12.09% | [1],[2],[3],[6],[7] | 12.09% | [1],[2],[3],[6],[7] | 9.41% | [8],[9],[11],[12],[13] | 9.41% | [8],[9],[11],[12],[13] | 9.41% | [8],[9],[11],[12],[13] | ||
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 12,418 | [1],[3],[4],[7] | $ 9,902 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 12.34% | [1],[3],[6],[7] | 12.34% | [1],[3],[6],[7] | 12.34% | [1],[3],[6],[7] | 9.91% | [8],[9],[11],[12] | 9.91% | [8],[9],[11],[12] | 9.91% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,769 | [3],[4],[7] | $ 19,242 | [9],[10],[11] | ||||||||||
Investment, interest rate | 10.22% | [3],[6],[7] | 10.22% | [3],[6],[7] | 10.22% | [3],[6],[7] | 8.12% | [9],[11],[12] | 8.12% | [9],[11],[12] | 8.12% | [9],[11],[12] | ||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Common Stock | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 16,074 | |||||||||||||
Investment, interest rate | 7.26% | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,484 | [1],[2],[4],[7],[21],[22] | $ 0 | [8],[10],[11],[13],[23],[24] | ||||||||||
Investment, interest rate | [1],[2],[6],[7],[21],[22] | 10.24% | 10.24% | 10.24% | ||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[10],[11],[23],[24] | $ 14,333 | ||||||||||||
Investment, interest rate | [8],[11],[12],[23],[24] | 8.68% | 8.68% | 8.68% | ||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[4],[7],[21],[22] | $ 14,102 | ||||||||||||
Investment, interest rate | [1],[6],[7],[21],[22] | 10.39% | 10.39% | 10.39% | ||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[4],[7],[21],[22] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,974 | [1],[3],[4],[7] | $ 8,974 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 13.04% | [1],[3],[6],[7] | 13.04% | [1],[3],[6],[7] | 13.04% | [1],[3],[6],[7] | 11.17% | [8],[9],[11],[12] | 11.17% | [8],[9],[11],[12] | 11.17% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 10,899 | [1],[3],[4],[14] | $ 10,418 | [8],[9],[10],[16] | ||||||||||
Investment, interest rate | 3% | [1],[3],[6],[7],[14] | 3% | [1],[3],[6],[7],[14] | 3% | [1],[3],[6],[7],[14] | 3% | [8],[9],[11],[12],[16] | 3% | [8],[9],[11],[12],[16] | 3% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,746 | [1],[3],[4],[14] | $ 0 | [8],[9],[10],[13],[16] | ||||||||||
Investment, interest rate | 3% | [1],[3],[6],[7],[14] | 3% | [1],[3],[6],[7],[14] | 3% | [1],[3],[6],[7],[14] | 3% | [8],[9],[11],[12],[13],[16] | 3% | [8],[9],[11],[12],[13],[16] | 3% | [8],[9],[11],[12],[13],[16] | ||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[14] | $ 0 | ||||||||||||
Investment, interest rate | [1],[2],[3],[6],[7],[14] | 3% | 3% | 3% | ||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[14] | $ 0 | ||||||||||||
Investment, interest rate | [1],[2],[3],[6],[7],[14] | 3% | 3% | 3% | ||||||||||
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 31,074 | [3],[4],[7] | $ 25,061 | [9],[10],[11] | ||||||||||
Investment, interest rate | 11.94% | [3],[6],[7] | 11.94% | [3],[6],[7] | 11.94% | [3],[6],[7] | 9.87% | [9],[11],[12] | 9.87% | [9],[11],[12] | 9.87% | [9],[11],[12] | ||
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 52,658 | [1],[2],[3],[4] | $ 27,850 | [8],[9],[10],[25] | ||||||||||
Investment, interest rate | 9% | [1],[2],[3],[6],[7] | 9% | [1],[2],[3],[6],[7] | 9% | [1],[2],[3],[6],[7] | 9% | [8],[9],[11],[12],[25] | 9% | [8],[9],[11],[12],[25] | 9% | [8],[9],[11],[12],[25] | ||
Investment, Identifier [Axis]: First Star Speir Aviation Limited, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | |||||||||||||
Investment, interest rate | 9% | |||||||||||||
Investment, Identifier [Axis]: First Star Speir Aviation Limited, Membership Interest | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 11,918 | [1],[3],[4],[14] | $ 9,466 | [8],[9],[10],[16] | ||||||||||
Investment, interest rate | 11% | [1],[3],[6],[7],[14] | 11% | [1],[3],[6],[7],[14] | 11% | [1],[3],[6],[7],[14] | 11% | [8],[9],[11],[12],[16] | 11% | [8],[9],[11],[12],[16] | 11% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,881 | [3],[4],[14] | $ 4,881 | [9],[10],[16] | ||||||||||
Investment, interest rate | 6% | [3],[6],[7],[14] | 6% | [3],[6],[7],[14] | 6% | [3],[6],[7],[14] | 6% | [9],[11],[12],[16] | 6% | [9],[11],[12],[16] | 6% | [9],[11],[12],[16] | ||
Investment, Identifier [Axis]: GKD Index Partners, LLC, Specialized Finance, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11],[13] | $ 1,280 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12],[13] | 10.60% | 10.60% | 10.60% | ||||||||||
Investment, Identifier [Axis]: GKD Index Partners, LLC, Specialized Finance, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 25,128 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 10.67% | 10.67% | 10.67% | ||||||||||
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7] | $ 1,638 | ||||||||||||
Investment, interest rate | [1],[2],[3],[6],[7] | 12.34% | 12.34% | 12.34% | ||||||||||
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 23,774 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12.34% | 12.34% | 12.34% | ||||||||||
Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 2,463 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 10.25% | 10.25% | 10.25% | ||||||||||
Investment, Identifier [Axis]: Global Medical Response, Inc., Health Care Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10],[11] | $ 5,572 | ||||||||||||
Investment, interest rate | [9],[11],[12] | 7.37% | 7.37% | 7.37% | ||||||||||
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | € | [3],[4],[7],[14] | € 1,000 | ||||||||||||
Investment, interest rate | [3],[6],[7],[14] | 6.05% | 6.05% | 6.05% | ||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[3],[4],[7] | $ 0 | [8],[9],[10],[11],[13] | ||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 17,488 | [1],[3],[4],[7] | $ 14,311 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 13.39% | [1],[3],[6],[7] | 13.39% | [1],[3],[6],[7] | 13.39% | [1],[3],[6],[7] | 11.04% | [8],[9],[11],[12] | 11.04% | [8],[9],[11],[12] | 11.04% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[3],[4],[7] | $ 0 | [8],[9],[10],[11],[13] | ||||||||||
Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 14,383 | [3],[4],[7] | $ 9,392 | [9],[10],[11] | ||||||||||
Investment, interest rate | 10.45% | [3],[6],[7] | 10.45% | [3],[6],[7] | 10.45% | [3],[6],[7] | 8.38% | [9],[11],[12] | 8.38% | [9],[11],[12] | 8.38% | [9],[11],[12] | ||
Investment, Identifier [Axis]: Harrow Health, Inc., Pharmaceuticals, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7],[14] | $ 7,448 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[14] | 11.74% | 11.74% | 11.74% | ||||||||||
Investment, Identifier [Axis]: Harrow Health, Inc., Pharmaceuticals, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7],[14] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [3],[4],[14] | $ 6,932 | ||||||||||||
Investment, interest rate | [3],[6],[7],[14] | 4.46% | 4.46% | 4.46% | ||||||||||
Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7],[14] | $ 23,975 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[14] | 13.30% | 13.30% | 13.30% | ||||||||||
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 45,169 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 11.29% | 11.29% | 11.29% | ||||||||||
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Products, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 35,625 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 9.42% | 9.42% | 9.42% | ||||||||||
Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 40,484 | [1],[3],[4],[7] | $ 34,357 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 11.57% | [1],[3],[6],[7] | 11.57% | [1],[3],[6],[7] | 11.57% | [1],[3],[6],[7] | 9.44% | [8],[9],[11],[12] | 9.44% | [8],[9],[11],[12] | 9.44% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Immucor, Inc., Health Care Supplies, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 8,569 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 9.42% | 9.42% | 9.42% | ||||||||||
Investment, Identifier [Axis]: Immucor, Inc., Health Care Supplies, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 22,619 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 11.67% | 11.67% | 11.67% | ||||||||||
Investment, Identifier [Axis]: Impel Neuropharma, Inc., Health Care Technology, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 15,302 | [1],[3],[4],[15] | $ 13,083 | [8],[9],[10],[20] | ||||||||||
Investment, Identifier [Axis]: Impel Neuropharma, Inc., Health Care Technology, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 13,109 | [1],[3],[4],[7] | $ 12,161 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 14.14% | [1],[3],[6],[7] | 14.14% | [1],[3],[6],[7] | 14.14% | [1],[3],[6],[7] | 12.45% | [8],[9],[11],[12] | 12.45% | [8],[9],[11],[12] | 12.45% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,452 | [1],[3],[4],[14] | $ 6,817 | [8],[9],[10],[16] | ||||||||||
Investment, interest rate | 11% | [1],[3],[6],[7],[14] | 11% | [1],[3],[6],[7],[14] | 11% | [1],[3],[6],[7],[14] | 11% | [8],[9],[11],[12],[16] | 11% | [8],[9],[11],[12],[16] | 11% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[3],[4],[14] | $ 0 | [8],[9],[10],[13],[16] | ||||||||||
Investment, interest rate | 11% | [1],[2],[3],[6],[7],[14] | 11% | [1],[2],[3],[6],[7],[14] | 11% | [1],[2],[3],[6],[7],[14] | 11% | [8],[9],[11],[12],[13],[16] | 11% | [8],[9],[11],[12],[13],[16] | 11% | [8],[9],[11],[12],[13],[16] | ||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[14] | $ 0 | ||||||||||||
Investment, interest rate | [1],[2],[3],[6],[7],[14] | 11% | 11% | 11% | ||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 33,498 | [1],[3],[4],[7] | $ 18,660 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 12.72% | [1],[3],[6],[7] | 12.72% | [1],[3],[6],[7] | 12.72% | [1],[3],[6],[7] | 8.55% | [8],[9],[11],[12] | 8.55% | [8],[9],[11],[12] | 8.55% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 13,674 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 12.17% | 12.17% | 12.17% | ||||||||||
Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 13,939 | [3],[4],[7] | $ 10,247 | [9],[10],[11] | ||||||||||
Investment, interest rate | 12.42% | [3],[6],[7] | 12.42% | [3],[6],[7] | 12.42% | [3],[6],[7] | 10.33% | [9],[11],[12] | 10.33% | [9],[11],[12] | 10.33% | [9],[11],[12] | ||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 36,234 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 10.62% | 10.62% | 10.62% | ||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 17,069 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12.70% | 12.70% | 12.70% | ||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 27,360 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12.70% | 12.70% | 12.70% | ||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 15,150 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 10.60% | 10.60% | 10.60% | ||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 666 | [3],[4],[7] | $ 528 | [9],[10],[11] | ||||||||||
Investment, interest rate | 13.20% | [3],[6],[7] | 13.20% | [3],[6],[7] | 13.20% | [3],[6],[7] | 11.12% | [9],[11],[12] | 11.12% | [9],[11],[12] | 11.12% | [9],[11],[12] | ||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 545 | [1],[2],[3],[4],[7] | $ 329 | [8],[9],[10],[11],[13] | ||||||||||
Investment, interest rate | 11.84% | [1],[2],[3],[6],[7] | 11.84% | [1],[2],[3],[6],[7] | 11.84% | [1],[2],[3],[6],[7] | 10.17% | [8],[9],[11],[12],[13] | 10.17% | [8],[9],[11],[12],[13] | 10.17% | [8],[9],[11],[12],[13] | ||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 16,765 | [1],[3],[4],[7] | $ 13,623 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 11.84% | [1],[3],[6],[7] | 11.84% | [1],[3],[6],[7] | 11.84% | [1],[3],[6],[7] | 10.17% | [8],[9],[11],[12] | 10.17% | [8],[9],[11],[12] | 10.17% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[3],[4],[7] | $ 1,710 | [8],[9],[10],[11],[13] | ||||||||||
Investment, interest rate | [8],[9],[11],[12],[13] | 9.12% | 9.12% | 9.12% | ||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 19,236 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 9.12% | 9.12% | 9.12% | ||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 2,742 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 11.20% | 11.20% | 11.20% | ||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 23,554 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 11.20% | 11.20% | 11.20% | ||||||||||
Investment, Identifier [Axis]: LTI Holdings, Inc., Electronic Components, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,140 | [3],[4],[7] | $ 2,140 | [9],[10],[11] | ||||||||||
Investment, interest rate | 11.97% | [3],[6],[7] | 11.97% | [3],[6],[7] | 11.97% | [3],[6],[7] | 9.87% | [9],[11],[12] | 9.87% | [9],[11],[12] | 9.87% | [9],[11],[12] | ||
Investment, Identifier [Axis]: LaserShip, Inc., Air Freight & Logistics, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 2,394 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 10.38% | 10.38% | 10.38% | ||||||||||
Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [3],[4],[7],[14] | $ 26,489 | ||||||||||||
Investment, interest rate | [3],[6],[7],[14] | 14.61% | 14.61% | 14.61% | ||||||||||
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 45,361 | [1],[3],[4],[7] | $ 41,008 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 10.50% | [1],[3],[6],[7] | 10.50% | [1],[3],[6],[7] | 10.50% | [1],[3],[6],[7] | 8.67% | [8],[9],[11],[12] | 8.67% | [8],[9],[11],[12] | 8.67% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4] | |||||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,403 | [1],[3],[4],[7] | $ 4,357 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 13.84% | [1],[3],[6],[7] | 13.84% | [1],[3],[6],[7] | 13.84% | [1],[3],[6],[7] | 11.38% | [8],[9],[11],[12] | 11.38% | [8],[9],[11],[12] | 11.38% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,939 | [1],[2],[3],[4],[7] | $ 2,370 | [8],[9],[10],[11],[13] | ||||||||||
Investment, interest rate | 13.84% | [1],[2],[3],[6],[7] | 13.84% | [1],[2],[3],[6],[7] | 13.84% | [1],[2],[3],[6],[7] | 11.38% | [8],[9],[11],[12],[13] | 11.38% | [8],[9],[11],[12],[13] | 11.38% | [8],[9],[11],[12],[13] | ||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 250 | [1],[2],[3],[4],[7] | $ 0 | [8],[9],[10],[11],[13] | ||||||||||
Investment, interest rate | [1],[2],[3],[6],[7] | 11.25% | 11.25% | 11.25% | ||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 18,390 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 9.50% | 9.50% | 9.50% | ||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 20,176 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 11.20% | 11.20% | 11.20% | ||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 2,637 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 11.20% | 11.20% | 11.20% | ||||||||||
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7] | $ 2,118 | ||||||||||||
Investment, interest rate | [1],[2],[3],[6],[7] | 12.58% | 12.58% | 12.58% | ||||||||||
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 40,640 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12.74% | 12.74% | 12.74% | ||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[3],[4],[7] | $ 0 | [8],[9],[10],[11],[13] | ||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 12,397 | [1],[3],[4],[7] | $ 29,565 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 10.84% | [1],[3],[6],[7] | 10.84% | [1],[3],[6],[7] | 10.84% | [1],[3],[6],[7] | 9.17% | [8],[9],[11],[12] | 9.17% | [8],[9],[11],[12] | 9.17% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 21,383 | [1],[3],[4],[7] | $ 0 | [8],[9],[10],[11],[13] | ||||||||||
Investment, interest rate | [1],[3],[6],[7] | 10.84% | 10.84% | 10.84% | ||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7] | $ 570 | ||||||||||||
Investment, interest rate | [1],[2],[3],[6],[7] | 10.83% | 10.83% | 10.83% | ||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,568 | [1],[3],[4],[14] | $ 17,203 | [8],[9],[10],[16] | ||||||||||
Investment, interest rate | 11.50% | [1],[3],[6],[7],[14] | 11.50% | [1],[3],[6],[7],[14] | 11.50% | [1],[3],[6],[7],[14] | 11.50% | [8],[9],[11],[12],[16] | 11.50% | [8],[9],[11],[12],[16] | 11.50% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,284 | [1],[3],[4],[14] | $ 0 | [8],[9],[10],[13],[16] | ||||||||||
Investment, interest rate | 11.50% | [1],[3],[6],[7],[14] | 11.50% | [1],[3],[6],[7],[14] | 11.50% | [1],[3],[6],[7],[14] | 11.50% | [8],[9],[11],[12],[13],[16] | 11.50% | [8],[9],[11],[12],[13],[16] | 11.50% | [8],[9],[11],[12],[13],[16] | ||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[14] | $ 8,568 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[14] | 11.50% | 11.50% | 11.50% | ||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 4 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[14] | $ 0 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[14] | 11.50% | 11.50% | 11.50% | ||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 9,066 | [1],[3],[4],[14] | $ 7,215 | [8],[9],[10],[16] | ||||||||||
Investment, interest rate | 8% | [1],[3],[6],[7],[14] | 8% | [1],[3],[6],[7],[14] | 8% | [1],[3],[6],[7],[14] | 8% | [8],[9],[11],[12],[16] | 8% | [8],[9],[11],[12],[16] | 8% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[3],[4],[14] | $ 0 | [8],[9],[10],[13],[16] | ||||||||||
Investment, interest rate | 8% | [1],[3],[6],[7],[14] | 8% | [1],[3],[6],[7],[14] | 8% | [1],[3],[6],[7],[14] | 8% | [8],[9],[11],[12],[13],[16] | 8% | [8],[9],[11],[12],[13],[16] | 8% | [8],[9],[11],[12],[13],[16] | ||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[14] | $ 0 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[14] | 8% | 8% | 8% | ||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[14] | |||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[14] | |||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | [1],[2],[3],[4],[7] | $ 0 | [8],[9],[10],[11],[13] | ||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 45,665 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 10.64% | 10.64% | 10.64% | ||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 7,464 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12.19% | 12.19% | 12.19% | ||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 46,687 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12.19% | 12.19% | 12.19% | ||||||||||
Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 55,297 | [1],[3],[4],[7] | $ 46,499 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 11.97% | [1],[3],[6],[7] | 11.97% | [1],[3],[6],[7] | 11.97% | [1],[3],[6],[7] | 9.89% | [8],[9],[11],[12] | 9.89% | [8],[9],[11],[12] | 9.89% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [3],[4] | $ 10,191 | ||||||||||||
Investment, interest rate | [3],[6],[7] | 6.88% | 6.88% | 6.88% | ||||||||||
Investment, Identifier [Axis]: NFP Corp., Other Diversified Financial Services, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10] | $ 10,191 | ||||||||||||
Investment, interest rate | [9],[11],[12] | 6.88% | 6.88% | 6.88% | ||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7],[14] | $ 73,178 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[14] | 12.08% | 12.08% | 12.08% | ||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | € | [1],[3],[4],[7],[14] | € 0 | ||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | € | [3],[4],[7],[14] | € 0 | ||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11],[16] | $ 58,713 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12],[16] | 9.99% | 9.99% | 9.99% | ||||||||||
Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 30,339 | [1],[3],[4],[7] | $ 22,560 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 14.04% | [1],[3],[6],[7] | 14.04% | [1],[3],[6],[7] | 14.04% | [1],[3],[6],[7] | 12.17% | [8],[9],[11],[12] | 12.17% | [8],[9],[11],[12] | 12.17% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 64,606 | [1],[3],[4],[7] | $ 50,459 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 16.04% | [1],[3],[6],[7] | 16.04% | [1],[3],[6],[7] | 16.04% | [1],[3],[6],[7] | 14.17% | [8],[9],[11],[12] | 14.17% | [8],[9],[11],[12] | 14.17% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Membership Interest | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 0 | |||||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | |||||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 58,349 | [1],[2],[4],[7],[14],[21],[22],[26] | $ 59,662 | [8],[10],[11],[13],[16],[23],[24],[27] | ||||||||||
Investment, interest rate | 9.36% | [1],[2],[6],[7],[14],[21],[22],[26] | 9.36% | [1],[2],[6],[7],[14],[21],[22],[26] | 9.36% | [1],[2],[6],[7],[14],[21],[22],[26] | 6.30% | [8],[11],[12],[13],[16],[23],[24],[27] | 6.30% | [8],[11],[12],[13],[16],[23],[24],[27] | 6.30% | [8],[11],[12],[13],[16],[23],[24],[27] | ||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Subordinated Debt | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 60,274 | |||||||||||||
Investment, interest rate | 4.94% | |||||||||||||
Investment, Identifier [Axis]: OEConnection LLC, Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10],[11] | $ 3,323 | ||||||||||||
Investment, interest rate | [9],[11],[12] | 7.12% | 7.12% | 7.12% | ||||||||||
Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 9,323 | [1],[3],[4],[7] | $ 7,519 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 12.34% | [1],[3],[6],[7] | 12.34% | [1],[3],[6],[7] | 12.34% | [1],[3],[6],[7] | 10.05% | [8],[9],[11],[12] | 10.05% | [8],[9],[11],[12] | 10.05% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 25,712 | [1],[3],[4],[7] | $ 21,557 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 15.50% | [1],[3],[6],[7] | 15.50% | [1],[3],[6],[7] | 15.50% | [1],[3],[6],[7] | 5.08% | [8],[9],[11],[12] | 5.08% | [8],[9],[11],[12] | 5.08% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[3],[4],[7] | $ 0 | [8],[9],[10],[11],[13] | ||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7] | $ 1,210 | ||||||||||||
Investment, interest rate | [1],[2],[3],[6],[7] | 15.39% | 15.39% | 15.39% | ||||||||||
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 15,231 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12.79% | 12.79% | 12.79% | ||||||||||
Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,480 | [3],[4] | $ 7,776 | [9],[10] | ||||||||||
Investment, interest rate | 7.75% | [3],[6],[7] | 7.75% | [3],[6],[7] | 7.75% | [3],[6],[7] | 7.75% | [9],[11],[12] | 7.75% | [9],[11],[12] | 7.75% | [9],[11],[12] | ||
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11],[13] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 26,154 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 9.28% | 9.28% | 9.28% | ||||||||||
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11],[13] | $ 2,228 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12],[13] | 9.25% | 9.25% | 9.25% | ||||||||||
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 10,923 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12.10% | 12.10% | 12.10% | ||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[3],[4],[7] | $ 0 | [8],[9],[10],[11],[13] | ||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 38,521 | [1],[3],[4],[7] | $ 33,775 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 11.73% | [1],[3],[6],[7] | 11.73% | [1],[3],[6],[7] | 11.73% | [1],[3],[6],[7] | 10.42% | [8],[9],[11],[12] | 10.42% | [8],[9],[11],[12] | 10.42% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 9,701 | [3],[4],[7] | $ 9,850 | [9],[10],[11] | ||||||||||
Investment, interest rate | 10.20% | [3],[6],[7] | 10.20% | [3],[6],[7] | 10.20% | [3],[6],[7] | 8.13% | [9],[11],[12] | 8.13% | [9],[11],[12] | 8.13% | [9],[11],[12] | ||
Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 22,375 | [1],[3],[4],[7] | $ 17,976 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 10.96% | [1],[3],[6],[7] | 10.96% | [1],[3],[6],[7] | 10.96% | [1],[3],[6],[7] | 8.88% | [8],[9],[11],[12] | 8.88% | [8],[9],[11],[12] | 8.88% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 36,499 | [1],[3],[4],[7] | $ 28,627 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 12.59% | [1],[3],[6],[7] | 12.59% | [1],[3],[6],[7] | 12.59% | [1],[3],[6],[7] | 10.92% | [8],[9],[11],[12] | 10.92% | [8],[9],[11],[12] | 10.92% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,395 | [1],[2],[3],[4],[7] | $ 0 | [8],[9],[10],[11],[13] | ||||||||||
Investment, interest rate | [1],[2],[3],[6],[7] | 13.04% | 13.04% | 13.04% | ||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 67,244 | [1],[3],[4],[7] | $ 48,689 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 13.04% | [1],[3],[6],[7] | 13.04% | [1],[3],[6],[7] | 13.04% | [1],[3],[6],[7] | 10.68% | [8],[9],[11],[12] | 10.68% | [8],[9],[11],[12] | 10.68% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 24,537 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12.42% | 12.42% | 12.42% | ||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 2,823 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12.42% | 12.42% | 12.42% | ||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 23,275 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 10.01% | 10.01% | 10.01% | ||||||||||
Investment, Identifier [Axis]: Project Boost Purchaser, LLC, Application Software, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,750 | [1],[3],[4],[7] | $ 5,250 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 13.22% | [1],[3],[6],[7] | 13.22% | [1],[3],[6],[7] | 13.22% | [1],[3],[6],[7] | 11.12% | [8],[9],[11],[12] | 11.12% | [8],[9],[11],[12] | 11.12% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | £ | £ 4,626 | [1],[3],[4],[7],[14] | £ 3,501 | [8],[9],[10],[11],[16] | ||||||||||
Investment, interest rate | 10.88% | [1],[3],[6],[7],[14] | 10.88% | [1],[3],[6],[7],[14] | 10.88% | [1],[3],[6],[7],[14] | 8.39% | [8],[9],[11],[12],[16] | 8.39% | [8],[9],[11],[12],[16] | 8.39% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: RP Escrow Issuer LLC, Health Care Distributors, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10] | $ 1,325 | ||||||||||||
Investment, interest rate | [9],[11],[12] | 5.25% | 5.25% | 5.25% | ||||||||||
Investment, Identifier [Axis]: Radiology Partners, Inc., Health Care Distributors, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10],[11] | $ 3,400 | ||||||||||||
Investment, interest rate | [9],[11],[12] | 7.33% | 7.33% | 7.33% | ||||||||||
Investment, Identifier [Axis]: Radiology Partners, Inc., Health Care Distributors, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10] | $ 4,755 | ||||||||||||
Investment, interest rate | [9],[11],[12] | 9.25% | 9.25% | 9.25% | ||||||||||
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[3],[4],[7] | $ 0 | [8],[9],[10],[11],[13] | ||||||||||
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 32,329 | [1],[3],[4],[7] | 24,692 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | [1],[3],[6],[7] | 11.70% | 11.70% | 11.70% | ||||||||||
Investment, Identifier [Axis]: Renaissance Holding Corp., Diversified Banks, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10],[11] | $ 3,542 | ||||||||||||
Investment, interest rate | [9],[11],[12] | 10.12% | 10.12% | 10.12% | ||||||||||
Investment, Identifier [Axis]: Renaissance Holding Corp., Education Services, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [3],[4],[7] | $ 1,789 | ||||||||||||
Investment, interest rate | [3],[6],[7] | 12.19% | 12.19% | 12.19% | ||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 44,602 | [1],[3],[4],[7],[14] | $ 37,656 | [8],[9],[10],[11],[16] | ||||||||||
Investment, interest rate | 13.75% | [1],[3],[6],[7],[14] | 13.75% | [1],[3],[6],[7],[14] | 13.75% | [1],[3],[6],[7],[14] | 11.92% | [8],[9],[11],[12],[16] | 11.92% | [8],[9],[11],[12],[16] | 11.92% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 13,495 | [1],[3],[4],[7],[14] | $ 11,393 | [8],[9],[10],[11],[13],[16] | ||||||||||
Investment, interest rate | 13.75% | [1],[3],[6],[7],[14] | 13.75% | [1],[3],[6],[7],[14] | 13.75% | [1],[3],[6],[7],[14] | 11.92% | [8],[9],[11],[12],[13],[16] | 11.92% | [8],[9],[11],[12],[13],[16] | 11.92% | [8],[9],[11],[12],[13],[16] | ||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 8,010 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 14% | 14% | 14% | ||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 4,463 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 9.97% | 9.97% | 9.97% | ||||||||||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 12,034 | [1],[3],[4],[7] | $ 9,109 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 13.22% | [1],[3],[6],[7] | 13.22% | [1],[3],[6],[7] | 13.22% | [1],[3],[6],[7] | 10.74% | [8],[9],[11],[12] | 10.74% | [8],[9],[11],[12] | 10.74% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10],[11] | $ 1,500 | ||||||||||||
Investment, interest rate | [9],[11],[12] | 7.63% | 7.63% | 7.63% | ||||||||||
Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 25,592 | [1],[3],[4],[7] | $ 20,766 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 12.29% | [1],[3],[6],[7] | 12.29% | [1],[3],[6],[7] | 12.29% | [1],[3],[6],[7] | 10.42% | [8],[9],[11],[12] | 10.42% | [8],[9],[11],[12] | 10.42% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Sabert Corporation, Metal & Glass Containers, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10],[11] | $ 1,691 | ||||||||||||
Investment, interest rate | [9],[11],[12] | 7.63% | 7.63% | 7.63% | ||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 25,558 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 15.24% | 15.24% | 15.24% | ||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Membership Interest | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 112,656 | [1],[2],[4],[7],[14],[21],[22],[26] | $ 96,250 | [8],[10],[11],[13],[16],[23],[24],[27] | ||||||||||
Investment, interest rate | 11.86% | [1],[2],[6],[7],[14],[21],[22],[26] | 11.86% | [1],[2],[6],[7],[14],[21],[22],[26] | 11.86% | [1],[2],[6],[7],[14],[21],[22],[26] | 8.80% | [8],[11],[12],[13],[16],[23],[24],[27] | 8.80% | [8],[11],[12],[13],[16],[23],[24],[27] | 8.80% | [8],[11],[12],[13],[16],[23],[24],[27] | ||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Subordinated Debt | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 96,250 | |||||||||||||
Investment, interest rate | 8% | |||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7],[14] | $ 7,191 | ||||||||||||
Investment, interest rate | [1],[3],[7],[14] | 12.95% | 12.95% | 12.95% | ||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7],[14] | $ 2,697 | ||||||||||||
Investment, interest rate | [1],[3],[7],[14] | 12.88% | 12.88% | 12.88% | ||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7],[14] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7],[14] | 0 | ||||||||||||
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal & Glass Containers, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10] | $ 46,121 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[17] | $ 54,730 | ||||||||||||
Investment, interest rate | [1],[3],[17] | 14% | 14% | 14% | ||||||||||
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[17] | $ 14,993 | ||||||||||||
Investment, interest rate | [1],[3],[17] | 14% | 14% | 14% | ||||||||||
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[17] | $ 4,813 | ||||||||||||
Investment, interest rate | [1],[2],[3],[6],[7],[17] | 14% | 14% | 14% | ||||||||||
Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,095 | [1],[3],[4],[7] | $ 3,195 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 12.69% | [1],[3],[6],[7] | 12.69% | [1],[3],[6],[7] | 12.69% | [1],[3],[6],[7] | 10.48% | [8],[9],[11],[12] | 10.48% | [8],[9],[11],[12] | 10.48% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [3],[4],[7] | $ 1,054 | ||||||||||||
Investment, interest rate | [3],[6],[7] | 10.69% | 10.69% | 10.69% | ||||||||||
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 907 | [1],[2],[3],[4],[7] | $ 866 | [8],[9],[10],[11],[13] | ||||||||||
Investment, interest rate | 10.35% | [1],[2],[3],[6],[7] | 10.35% | [1],[2],[3],[6],[7] | 10.35% | [1],[2],[3],[6],[7] | 8.03% | [8],[9],[11],[12],[13] | 8.03% | [8],[9],[11],[12],[13] | 8.03% | [8],[9],[11],[12],[13] | ||
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,500 | [1],[3],[4],[7] | $ 4,534 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 10.70% | [1],[3],[6],[7] | 10.70% | [1],[3],[6],[7] | 10.70% | [1],[3],[6],[7] | 8.30% | [8],[9],[11],[12] | 8.30% | [8],[9],[11],[12] | 8.30% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | € | [1],[3],[4],[7],[14] | € 23,731 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[14] | 11.97% | 11.97% | 11.97% | ||||||||||
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Other Diversified Financial Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | £ | [8],[9],[10],[11],[16] | £ 16,911 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12],[16] | 10% | 10% | 10% | ||||||||||
Investment, Identifier [Axis]: Sunland Asphalt & Construction, LLC, Construction & Engineering, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 42,618 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 8.88% | 8.88% | 8.88% | ||||||||||
Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 49,645 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12.85% | 12.85% | 12.85% | ||||||||||
Investment, Identifier [Axis]: Supermoose Borrower, LLC, Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10],[11] | $ 3,466 | ||||||||||||
Investment, interest rate | [9],[11],[12] | 7.42% | 7.42% | 7.42% | ||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7],[28] | $ 1,552 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[28] | 12.18% | 12.18% | 12.18% | ||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7],[28] | $ 32,185 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[28] | 12.18% | 12.18% | 12.18% | ||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7],[28] | $ 2,756 | ||||||||||||
Investment, interest rate | [1],[2],[3],[6],[7],[28] | 12.18% | 12.18% | 12.18% | ||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7],[28] | $ 1,099 | ||||||||||||
Investment, interest rate | [1],[2],[3],[6],[7],[28] | 12.18% | 12.18% | 12.18% | ||||||||||
Investment, Identifier [Axis]: Swordfish Merger Sub LLC, Auto Parts & Equipment, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 12,500 | [1],[3],[4],[7] | $ 12,500 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 11.94% | [1],[3],[6],[7] | 11.94% | [1],[3],[6],[7] | 11.94% | [1],[3],[6],[7] | 9.81% | [8],[9],[11],[12] | 9.81% | [8],[9],[11],[12] | 9.81% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,984 | [3],[4],[5],[14] | $ 4,984 | [8],[9],[10],[16] | ||||||||||
Investment, interest rate | 11.50% | [3],[5],[6],[7],[14] | 11.50% | [3],[5],[6],[7],[14] | 11.50% | [3],[5],[6],[7],[14] | 11.50% | [8],[9],[11],[12],[16] | 11.50% | [8],[9],[11],[12],[16] | 11.50% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[14] | $ 50,419 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7],[14] | 13% | 13% | 13% | ||||||||||
Investment, Identifier [Axis]: TIBCO Software Inc., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 17,213 | [3],[4],[7] | $ 12,032 | [9],[10],[11] | ||||||||||
Investment, interest rate | 9.84% | [3],[6],[7] | 9.84% | [3],[6],[7] | 9.84% | [3],[6],[7] | 8.15% | [9],[11],[12] | 8.15% | [9],[11],[12] | 8.15% | [9],[11],[12] | ||
Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 12,843 | [3],[4],[7] | $ 9,448 | [9],[10],[11] | ||||||||||
Investment, interest rate | 12.69% | [3],[6],[7] | 12.69% | [3],[6],[7] | 12.69% | [3],[6],[7] | 10.62% | [9],[11],[12] | 10.62% | [9],[11],[12] | 10.62% | [9],[11],[12] | ||
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | [1],[2],[3],[4],[7],[14] | $ 0 | [8],[9],[10],[11],[13],[16] | ||||||||||
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 28,826 | [1],[3],[4],[7],[14] | $ 23,215 | [8],[9],[10],[11],[16] | ||||||||||
Investment, interest rate | 11.15% | [1],[3],[6],[7],[14] | 11.15% | [1],[3],[6],[7],[14] | 11.15% | [1],[3],[6],[7],[14] | 8.68% | [8],[9],[11],[12],[16] | 8.68% | [8],[9],[11],[12],[16] | 8.68% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: Tecta America Corp., Construction & Engineering, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,755 | [1],[3],[4],[7] | $ 5,203 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 13.72% | [1],[3],[6],[7] | 13.72% | [1],[3],[6],[7] | 13.72% | [1],[3],[6],[7] | 11.62% | [8],[9],[11],[12] | 11.62% | [8],[9],[11],[12] | 11.62% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,590 | [1],[2],[3],[4],[7] | $ 1,231 | [8],[9],[10],[11],[13] | ||||||||||
Investment, interest rate | 14.93% | [1],[2],[3],[6],[7] | 14.93% | [1],[2],[3],[6],[7] | 14.93% | [1],[2],[3],[6],[7] | 12.20% | [8],[9],[11],[12],[13] | 12.20% | [8],[9],[11],[12],[13] | 12.20% | [8],[9],[11],[12],[13] | ||
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 23,483 | [1],[3],[4],[7] | $ 18,323 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 14.99% | [1],[3],[6],[7] | 14.99% | [1],[3],[6],[7] | 14.99% | [1],[3],[6],[7] | 12.11% | [8],[9],[11],[12] | 12.11% | [8],[9],[11],[12] | 12.11% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 19,947 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 11.09% | 11.09% | 11.09% | ||||||||||
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Pharmaceuticals, Common Stock | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10] | |||||||||||||
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Pharmaceuticals, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 29,663 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 13.17% | 13.17% | 13.17% | ||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 19,163 | [1],[3],[4],[7],[17] | $ 15,674 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | [8],[9],[11],[12] | 10.44% | 10.44% | 10.44% | ||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | 4,641 | [1],[3],[4],[7],[17] | $ 3,789 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | [8],[9],[11],[12] | 16.17% | 16.17% | 16.17% | ||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 46,832 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12.50% | 12.50% | 12.50% | ||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 37,494 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 11.17% | 11.17% | 11.17% | ||||||||||
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 11,701 | [1],[3],[4],[7] | $ 6,016 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 11.20% | [1],[3],[6],[7] | 11.20% | [1],[3],[6],[7] | 11.20% | [1],[3],[6],[7] | 9.12% | [8],[9],[11],[12] | 9.12% | [8],[9],[11],[12] | 9.12% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [3],[4],[7],[14] | $ 1,000 | ||||||||||||
Investment, interest rate | [3],[6],[7],[14] | 12.72% | 12.72% | 12.72% | ||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [3],[4],[14] | $ 4,500 | ||||||||||||
Investment, interest rate | [3],[6],[7],[14] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [3],[4],[14] | $ 300 | ||||||||||||
Investment, interest rate | [3],[6],[7],[14] | 4.75% | 4.75% | 4.75% | ||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Specialized REITs, Fixed Rate Bond 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10],[16] | $ 4,500 | ||||||||||||
Investment, interest rate | [9],[11],[12],[16] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Specialized REITs, Fixed Rate Bond 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10],[16] | $ 300 | ||||||||||||
Investment, interest rate | [9],[11],[12],[16] | 4.75% | 4.75% | 4.75% | ||||||||||
Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 1,540 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12.47% | 12.47% | 12.47% | ||||||||||
Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[7] | $ 1,323 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 21.22% | 21.22% | 21.22% | ||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 11,822 | [3],[7] | $ 7,564 | [9],[10],[11] | ||||||||||
Investment, interest rate | 9.03% | [3],[6],[7] | 9.03% | [3],[6],[7] | 9.03% | [3],[6],[7] | 6.56% | [9],[11],[12] | 6.56% | [9],[11],[12] | 6.56% | [9],[11],[12] | ||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 6,000 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 10.56% | 10.56% | 10.56% | ||||||||||
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [8],[9],[10],[11] | $ 40,536 | ||||||||||||
Investment, interest rate | [8],[9],[11],[12] | 10.19% | 10.19% | 10.19% | ||||||||||
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[7] | $ 35,853 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 11.38% | 11.38% | 11.38% | ||||||||||
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[7] | $ 19,306 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12% | 12% | 12% | ||||||||||
Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,000 | [1],[3],[7] | $ 5,000 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 12.50% | [1],[3],[6],[7] | 12.50% | [1],[3],[6],[7] | 12.50% | [1],[3],[6],[7] | 10.67% | [8],[9],[11],[12] | 10.67% | [8],[9],[11],[12] | 10.67% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,565 | [1],[3],[7] | $ 2,316 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 21.22% | [1],[3],[6],[7] | 21.22% | [1],[3],[6],[7] | 21.22% | [1],[3],[6],[7] | 19.64% | [8],[9],[11],[12] | 19.64% | [8],[9],[11],[12] | 19.64% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 24,419 | [3],[7] | $ 25,499 | [9],[10],[11] | ||||||||||
Investment, interest rate | 11.45% | [3],[6],[7] | 11.45% | [3],[6],[7] | 11.45% | [3],[6],[7] | 9.37% | [9],[11],[12] | 9.37% | [9],[11],[12] | 9.37% | [9],[11],[12] | ||
Investment, Identifier [Axis]: Zayo Group Holdings, Inc., Alternative Carriers, Fixed Rate Bond | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [9],[10] | $ 250 | ||||||||||||
Investment, interest rate | [9],[11],[12] | 4% | 4% | 4% | ||||||||||
Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 19,578 | [1],[3],[7] | $ 19,578 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 13.79% | [1],[3],[6],[7] | 13.79% | [1],[3],[6],[7] | 13.79% | [1],[3],[6],[7] | 11.92% | [8],[9],[11],[12] | 11.92% | [8],[9],[11],[12] | 11.92% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | £ | £ 20,000 | [1],[3],[7],[14] | £ 18,000 | [8],[9],[10],[11],[16] | ||||||||||
Investment, interest rate | 12.46% | [1],[3],[6],[7],[14] | 12.46% | [1],[3],[6],[7],[14] | 12.46% | [1],[3],[6],[7],[14] | 9.72% | [8],[9],[11],[12],[16] | 9.72% | [8],[9],[11],[12],[16] | 9.72% | [8],[9],[11],[12],[16] | ||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 377 | [1],[2],[3],[4],[7] | $ 0 | [8],[9],[10],[11],[13] | ||||||||||
Investment, interest rate | [1],[2],[3],[6],[7] | 11.99% | 11.99% | 11.99% | ||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 24,188 | [1],[3],[4],[7] | $ 19,203 | [8],[9],[10],[11] | ||||||||||
Investment, interest rate | 8.50% | [1],[3],[6],[7] | 8.50% | [1],[3],[6],[7] | 8.50% | [1],[3],[6],[7] | 9.49% | [8],[9],[11],[12] | 9.49% | [8],[9],[11],[12] | 9.49% | [8],[9],[11],[12] | ||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,636 | [1],[3],[4],[7] | $ 0 | [8],[9],[10],[11],[13] | ||||||||||
Investment, interest rate | [1],[3],[6],[7] | 12.38% | 12.38% | 12.38% | ||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[3],[4],[7] | $ 5,212 | ||||||||||||
Investment, interest rate | [1],[3],[6],[7] | 11.75% | 11.75% | 11.75% | ||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | [1],[2],[3],[4],[7] | 0 | ||||||||||||
SLF JV I | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 350,214 | $ 383,194 | ||||||||||||
Number of borrowers in the Glick JV | borrower | 52,000 | 52,000 | 52,000 | 60 | 60 | 60 | ||||||||
SLF JV I | Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,911 | |||||||||||||
Investment, interest rate | 12% | 12% | 12% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,173 | |||||||||||||
Investment, interest rate | 12% | 12% | 12% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,518 | |||||||||||||
Investment, interest rate | 9.80% | 9.80% | 9.80% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,176 | |||||||||||||
Investment, interest rate | 9.67% | 9.67% | 9.67% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | |||||||||||||
SLF JV I | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,145 | |||||||||||||
Investment, interest rate | 11.31% | 11.31% | 11.31% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Access CIG, LLC, Diversified Support Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,596 | |||||||||||||
Investment, interest rate | 8.94% | 8.94% | 8.94% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 10,093 | |||||||||||||
Investment, interest rate | 6.82% | 6.82% | 6.82% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Altice France S.A., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,000 | |||||||||||||
Investment, interest rate | 6.91% | 6.91% | 6.91% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,977 | |||||||||||||
Investment, interest rate | 9.32% | 9.32% | 9.32% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 9,267 | |||||||||||||
Investment, interest rate | 11.20% | 11.20% | 11.20% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,916 | |||||||||||||
Investment, interest rate | 12.89% | 12.89% | 12.89% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: American Rock Salt Company LLC, Diversified Metals & Mining, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,970 | |||||||||||||
Investment, interest rate | 9.22% | 9.22% | 9.22% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,836 | |||||||||||||
Investment, interest rate | 11.49% | 11.49% | 11.49% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,873 | |||||||||||||
Investment, interest rate | 9.03% | 9.03% | 9.03% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,800 | |||||||||||||
Investment, interest rate | 7.92% | 7.92% | 7.92% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,740 | |||||||||||||
Investment, interest rate | 9.39% | 9.39% | 9.39% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,539 | |||||||||||||
Investment, interest rate | 7.42% | 7.42% | 7.42% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,527 | |||||||||||||
Investment, interest rate | 9.25% | 9.25% | 9.25% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 115 | |||||||||||||
Investment, interest rate | 10.20% | 10.20% | 10.20% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,615 | |||||||||||||
Investment, interest rate | 10.20% | 10.20% | 10.20% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Apptio, Inc., First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 154 | |||||||||||||
Investment, interest rate | 8.46% | 8.46% | 8.46% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Apptio, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,615 | |||||||||||||
Investment, interest rate | 8.46% | 8.46% | 8.46% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,052 | |||||||||||||
Investment, interest rate | 10.44% | 10.44% | 10.44% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,052 | |||||||||||||
Investment, interest rate | 8.37% | 8.37% | 8.37% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,000 | |||||||||||||
Investment, interest rate | 7.70% | 7.70% | 7.70% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,963 | |||||||||||||
Investment, interest rate | 9.20% | 9.20% | 9.20% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,995 | |||||||||||||
Investment, interest rate | 9.47% | 9.47% | 9.47% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,346 | |||||||||||||
Investment, interest rate | 10.47% | 10.47% | 10.47% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,346 | |||||||||||||
Investment, interest rate | 8.37% | 8.37% | 8.37% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,289 | |||||||||||||
Investment, interest rate | 11.27% | 11.27% | 11.27% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,338 | |||||||||||||
Investment, interest rate | 8.78% | 8.78% | 8.78% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,371 | |||||||||||||
Investment, interest rate | 8.12% | 8.12% | 8.12% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,771 | |||||||||||||
Investment, interest rate | 8.12% | 8.12% | 8.12% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,322 | |||||||||||||
Investment, interest rate | 10.50% | 10.50% | 10.50% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,759 | |||||||||||||
Investment, interest rate | 10.50% | 10.50% | 10.50% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: BYJU's Alpha, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,444 | |||||||||||||
Investment, interest rate | 8.98% | 8.98% | 8.98% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 9,575 | |||||||||||||
Investment, interest rate | 6.03% | 6.03% | 6.03% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: CITGO Petroleum Corp., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,038 | |||||||||||||
Investment, interest rate | 9.37% | 9.37% | 9.37% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | |||||||||||||
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,358 | |||||||||||||
Investment, interest rate | 9.12% | 9.12% | 9.12% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 449 | |||||||||||||
Investment, interest rate | 9.12% | 9.12% | 9.12% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, Wireless Telecommunication Services, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 200 | |||||||||||||
Investment, interest rate | 11.38% | 11.38% | 11.38% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, Wireless Telecommunication Services, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,965 | |||||||||||||
Investment, interest rate | 11.44% | 11.44% | 11.44% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, Wireless Telecommunication Services, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,366 | |||||||||||||
Investment, interest rate | 11.44% | 11.44% | 11.44% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Centerline Communications, LLC, Wireless Telecommunication Services, First Lien Term Loan 3 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,988 | |||||||||||||
Investment, interest rate | 11.44% | 11.44% | 11.44% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: City Football Group Limited, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,451 | |||||||||||||
Investment, interest rate | 6.48% | 6.48% | 6.48% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Convergeone Holdings, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,373 | |||||||||||||
Investment, interest rate | 8.12% | 8.12% | 8.12% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Convergeone Holdings, Inc., IT Consulting & Other Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,315 | |||||||||||||
Investment, interest rate | 10.37% | 10.37% | 10.37% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,375 | |||||||||||||
Investment, interest rate | 7.65% | 7.65% | 7.65% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,359 | |||||||||||||
Investment, interest rate | 10.24% | 10.24% | 10.24% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., Biotechnology, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,760 | |||||||||||||
Investment, interest rate | 9.54% | 9.54% | 9.54% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., Biotechnology, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 992 | |||||||||||||
Investment, interest rate | 9.79% | 9.79% | 9.79% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,820 | |||||||||||||
Investment, interest rate | 7.67% | 7.67% | 7.67% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,000 | |||||||||||||
Investment, interest rate | 7.33% | 7.33% | 7.33% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,940 | |||||||||||||
Investment, interest rate | 9.80% | 9.80% | 9.80% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Dealer Tire, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,992 | |||||||||||||
Investment, interest rate | 7.37% | 7.37% | 7.37% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Delivery Hero FinCo LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,035 | |||||||||||||
Investment, interest rate | 8.49% | 8.49% | 8.49% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,958 | |||||||||||||
Investment, interest rate | 10.22% | 10.22% | 10.22% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,436 | |||||||||||||
Investment, interest rate | 8.12% | 8.12% | 8.12% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Domtar Corporation, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,100 | |||||||||||||
Investment, interest rate | 8.26% | 8.26% | 8.26% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,478 | |||||||||||||
Investment, interest rate | 7.80% | 7.80% | 7.80% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 54,003,000 | $ 48,139 | ||||||||||||
SLF JV I | Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,444 | |||||||||||||
Investment, interest rate | 7.94% | 7.94% | 7.94% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,388 | |||||||||||||
Investment, interest rate | 10.25% | 10.25% | 10.25% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Global Medical Response, Inc., First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,979 | |||||||||||||
Investment, interest rate | 7.37% | 7.37% | 7.37% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Global Medical Response, Inc., First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,192 | |||||||||||||
Investment, interest rate | 6.81% | 6.81% | 6.81% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,940 | |||||||||||||
Investment, interest rate | 10.45% | 10.45% | 10.45% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,000 | |||||||||||||
Investment, interest rate | 8.38% | 8.38% | 8.38% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 9,500 | |||||||||||||
Investment, interest rate | 9.42% | 9.42% | 9.42% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 9,125 | |||||||||||||
Investment, interest rate | 11.29% | 11.29% | 11.29% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,406 | |||||||||||||
Investment, interest rate | 8.80% | 8.80% | 8.80% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Indivior Finance S.À.R.L., Pharmaceuticals, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,350 | |||||||||||||
Investment, interest rate | 10.75% | 10.75% | 10.75% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Iris Holding, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,000 | |||||||||||||
Investment, interest rate | 7.89% | 7.89% | 7.89% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Iris Holding, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,963 | |||||||||||||
Investment, interest rate | 9.90% | 9.90% | 9.90% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: LABL, Inc., Office Services & Supplies, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,972 | |||||||||||||
Investment, interest rate | 10.20% | 10.20% | 10.20% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: LTI Holdings, Inc., Electronic Components, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,308 | |||||||||||||
Investment, interest rate | 8.72% | 8.72% | 8.72% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: LTI Holdings, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,366 | |||||||||||||
Investment, interest rate | 6.37% | 6.37% | 6.37% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Largest Exposure To A Single Borrower | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 11,304,000 | $ 10,093 | ||||||||||||
SLF JV I | Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,444 | |||||||||||||
Investment, interest rate | 8.23% | 8.23% | 8.23% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, Health Care Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,388 | |||||||||||||
Investment, interest rate | 11.08% | 11.08% | 11.08% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Lightbox Intermediate, L.P., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,367 | |||||||||||||
Investment, interest rate | 8.67% | 8.67% | 8.67% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 11,279 | |||||||||||||
Investment, interest rate | 10.50% | 10.50% | 10.50% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: LogMeIn, Inc., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,800 | |||||||||||||
Investment, interest rate | 9.94% | 9.94% | 9.94% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: LogMeIn, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,860 | |||||||||||||
Investment, interest rate | 7.80% | 7.80% | 7.80% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | |||||||||||||
SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,340 | |||||||||||||
Investment, interest rate | 10.84% | 10.84% | 10.84% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,217 | |||||||||||||
Investment, interest rate | 10.84% | 10.84% | 10.84% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | ||||||||||||||
SLF JV I | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,139 | |||||||||||||
Investment, interest rate | 9.17% | 9.17% | 9.17% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: McAfee Corp., Systems Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,955 | |||||||||||||
Investment, interest rate | 9.01% | 9.01% | 9.01% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Mindbody, Inc., First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | |||||||||||||
SLF JV I | Investment, Identifier [Axis]: Mindbody, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,687 | |||||||||||||
Investment, interest rate | 10.64% | 10.64% | 10.64% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | |||||||||||||
SLF JV I | Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,669 | |||||||||||||
Investment, interest rate | 12.19% | 12.19% | 12.19% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Mitchell International Inc, Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,991 | |||||||||||||
Investment, interest rate | 8.94% | 8.94% | 8.94% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Northern Star Industries Inc., Electrical Components & Equipment, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,633 | |||||||||||||
Investment, interest rate | 10% | 10% | 10% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,685 | |||||||||||||
Investment, interest rate | 7.87% | 7.87% | 7.87% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: OEConnection LLC, Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 11,015 | |||||||||||||
Investment, interest rate | 9.25% | 9.25% | 9.25% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,777 | |||||||||||||
Investment, interest rate | 7.12% | 7.12% | 7.12% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Park Place Technologies, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,925 | |||||||||||||
Investment, interest rate | 8.13% | 8.13% | 8.13% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 9,849 | |||||||||||||
Investment, interest rate | 10.20% | 10.20% | 10.20% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Peloton Interactive, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,486 | |||||||||||||
Investment, interest rate | 8.35% | 8.35% | 8.35% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,422 | |||||||||||||
Investment, interest rate | 9.50% | 9.50% | 9.50% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,503 | |||||||||||||
Investment, interest rate | 12.59% | 12.59% | 12.59% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,503 | |||||||||||||
Investment, interest rate | 10.92% | 10.92% | 10.92% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 254 | |||||||||||||
Investment, interest rate | 13.04% | 13.04% | 13.04% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,116 | |||||||||||||
Investment, interest rate | 13.04% | 13.04% | 13.04% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | |||||||||||||
SLF JV I | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,796 | |||||||||||||
Investment, interest rate | 10.68% | 10.68% | 10.68% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Renaissance Holding Corp., Education Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,000 | |||||||||||||
Investment, interest rate | 9.99% | 9.99% | 9.99% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: RevSpring, Inc., Commercial Printing, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 9,550 | |||||||||||||
Investment, interest rate | 9.50% | 9.50% | 9.50% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: RevSpring, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 9,625 | |||||||||||||
Investment, interest rate | 7.67% | 7.67% | 7.67% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,201 | |||||||||||||
Investment, interest rate | 8.06% | 8.06% | 8.06% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 138 | |||||||||||||
Investment, interest rate | 8.04% | 8.04% | 8.04% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, Footwear, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,135 | |||||||||||||
Investment, interest rate | 10.52% | 10.52% | 10.52% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: SHO Holding I Corporation, Footwear, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 138 | |||||||||||||
Investment, interest rate | 10.50% | 10.50% | 10.50% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,985 | |||||||||||||
Investment, interest rate | 9.97% | 9.97% | 9.97% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,500 | |||||||||||||
Investment, interest rate | 7.63% | 7.63% | 7.63% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,801 | |||||||||||||
Investment, interest rate | 9.70% | 9.70% | 9.70% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Sabert Corporation, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,536 | |||||||||||||
Investment, interest rate | 7.63% | 7.63% | 7.63% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,328 | |||||||||||||
Investment, interest rate | 10.69% | 10.69% | 10.69% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Sorenson Communications, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,553 | |||||||||||||
Investment, interest rate | 9.17% | 9.17% | 9.17% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,865 | |||||||||||||
Investment, interest rate | 10.70% | 10.70% | 10.70% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,933 | |||||||||||||
Investment, interest rate | 8.30% | 8.30% | 8.30% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Supermoose Borrower, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,743 | |||||||||||||
Investment, interest rate | 7.42% | 7.42% | 7.42% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Surgery Center Holdings, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,377 | |||||||||||||
Investment, interest rate | 6.51% | 6.51% | 6.51% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: TIBCO Software Inc., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 8,235 | |||||||||||||
Investment, interest rate | 9.84% | 9.84% | 9.84% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,256 | |||||||||||||
Investment, interest rate | 8.15% | 8.15% | 8.15% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,285 | |||||||||||||
Investment, interest rate | 9.12% | 9.12% | 9.12% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,230 | |||||||||||||
Investment, interest rate | 11.20% | 11.20% | 11.20% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Veritas US Inc., Application Software, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,322 | |||||||||||||
Investment, interest rate | 10.22% | 10.22% | 10.22% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Veritas US Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,365 | |||||||||||||
Investment, interest rate | 8.67% | 8.67% | 8.67% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,970 | |||||||||||||
Investment, interest rate | 9.03% | 9.03% | 9.03% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,985 | |||||||||||||
Investment, interest rate | 6.56% | 6.56% | 6.56% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: WP CPP Holdings, LLC, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,000 | |||||||||||||
Investment, interest rate | 10.56% | 10.56% | 10.56% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,818 | |||||||||||||
Investment, interest rate | 9.37% | 9.37% | 9.37% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,757 | |||||||||||||
Investment, interest rate | 11.45% | 11.45% | 11.45% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: Zayo Group Holdings, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,155 | |||||||||||||
Investment, interest rate | 6.12% | 6.12% | 6.12% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,331 | |||||||||||||
Investment, interest rate | 8.59% | 8.59% | 8.59% | |||||||||||
SLF JV I | Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | |||||||||||||
SLF JV I | Investment, Identifier [Axis]: eResearch Technology, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 7,331 | |||||||||||||
Investment, interest rate | 7.62% | 7.62% | 7.62% | |||||||||||
SLF JV I | Senior secured loans | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 350,214 | $ 383,194 | ||||||||||||
SLF JV I | Weighted Average | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, interest rate | 10.40% | 10.40% | 10.40% | 8.33% | 8.33% | 8.33% | ||||||||
Glick JV LLC | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 123,126 | $ 143,225 | ||||||||||||
Number of borrowers in the Glick JV | borrower | 37 | 37 | 37 | 43 | 43 | 43 | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,647 | |||||||||||||
Investment, interest rate | 9.80% | 9.80% | 9.80% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 587 | |||||||||||||
Investment, interest rate | 12% | 12% | 12% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,824 | |||||||||||||
Investment, interest rate | 12% | 12% | 12% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | $ 0 | ||||||||||||
Glick JV LLC | Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,721 | $ 1,734 | ||||||||||||
Investment, interest rate | 11.31% | 11.31% | 11.31% | 9.67% | 9.67% | 9.67% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Alvogen Pharma Inc, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,313 | $ 6,562 | ||||||||||||
Investment, interest rate | 12.89% | 12.89% | 12.89% | 11.20% | 11.20% | 11.20% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,485 | |||||||||||||
Investment, interest rate | 9.22% | 9.22% | 9.22% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,868 | $ 2,889 | ||||||||||||
Investment, interest rate | 11.49% | 11.49% | 11.49% | 9.03% | 9.03% | 9.03% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,903 | $ 2,925 | ||||||||||||
Investment, interest rate | 9.39% | 9.39% | 9.39% | 7.92% | 7.92% | 7.92% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Amynta Agency Borrower Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,000 | |||||||||||||
Investment, interest rate | 10.20% | 10.20% | 10.20% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 910 | $ 917 | ||||||||||||
Investment, interest rate | 9.25% | 9.25% | 9.25% | 7.42% | 7.42% | 7.42% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,078 | $ 2,078 | ||||||||||||
Investment, interest rate | 10.44% | 10.44% | 10.44% | 8.37% | 8.37% | 8.37% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,000 | |||||||||||||
Investment, interest rate | 7.70% | 7.70% | 7.70% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,985 | |||||||||||||
Investment, interest rate | 9.20% | 9.20% | 9.20% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 998 | |||||||||||||
Investment, interest rate | 9.47% | 9.47% | 9.47% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,423 | |||||||||||||
Investment, interest rate | 10.47% | 10.47% | 10.47% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,423 | |||||||||||||
Investment, interest rate | 8.37% | 8.37% | 8.37% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,628 | |||||||||||||
Investment, interest rate | 11.27% | 11.27% | 11.27% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,656 | |||||||||||||
Investment, interest rate | 8.78% | 8.78% | 8.78% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Delayed Draw Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 808 | |||||||||||||
Investment, interest rate | 8.12% | 8.12% | 8.12% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,398 | |||||||||||||
Investment, interest rate | 8.12% | 8.12% | 8.12% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,372 | |||||||||||||
Investment, interest rate | 10.50% | 10.50% | 10.50% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 802 | |||||||||||||
Investment, interest rate | 10.50% | 10.50% | 10.50% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: BYJU's Alpha, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,970 | |||||||||||||
Investment, interest rate | 8.98% | 8.98% | 8.98% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: CITGO Petroleum Corp., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,519 | |||||||||||||
Investment, interest rate | 9.37% | 9.37% | 9.37% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: City Football Group Limited, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,481 | |||||||||||||
Investment, interest rate | 6.48% | 6.48% | 6.48% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,773 | $ 2,280 | ||||||||||||
Investment, interest rate | 10.24% | 10.24% | 10.24% | 7.65% | 7.65% | 7.65% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,848 | $ 2,870 | ||||||||||||
Investment, interest rate | 9.54% | 9.54% | 9.54% | 7.67% | 7.67% | 7.67% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: DTI Holdco, Inc First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,978 | |||||||||||||
Investment, interest rate | 9.80% | 9.80% | 9.80% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,000 | |||||||||||||
Investment, interest rate | 7.33% | 7.33% | 7.33% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,528 | $ 2,730 | ||||||||||||
Investment, interest rate | 10.22% | 10.22% | 10.22% | 8.12% | 8.12% | 8.12% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Domtar Corporation, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,503 | |||||||||||||
Investment, interest rate | 8.26% | 8.26% | 8.26% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,488 | |||||||||||||
Investment, interest rate | 7.80% | 7.80% | 7.80% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 28,457 | $ 28,973 | ||||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,940 | $ 3,970 | ||||||||||||
Investment, interest rate | 10.25% | 10.25% | 10.25% | 7.94% | 7.94% | 7.94% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,970 | $ 4,000 | ||||||||||||
Investment, interest rate | 10.45% | 10.45% | 10.45% | 8.38% | 8.38% | 8.38% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,281 | $ 2,375 | ||||||||||||
Investment, interest rate | 11.29% | 11.29% | 11.29% | 9.42% | 9.42% | 9.42% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,920 | $ 3,950 | ||||||||||||
Investment, interest rate | 10.75% | 10.75% | 10.75% | 8.80% | 8.80% | 8.80% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Iris Holding, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,985 | $ 2,000 | ||||||||||||
Investment, interest rate | 9.90% | 9.90% | 9.90% | 7.89% | 7.89% | 7.89% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: LTI Holdings, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,347 | $ 1,358 | ||||||||||||
Investment, interest rate | 8.72% | 8.72% | 8.72% | 6.37% | 6.37% | 6.37% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Largest Loan Exposure To A Single Borrower | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,313 | $ 6,562 | ||||||||||||
Glick JV LLC | Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,940 | $ 3,970 | ||||||||||||
Investment, interest rate | 11.08% | 11.08% | 11.08% | 8.23% | 8.23% | 8.23% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | $ 0 | ||||||||||||
Glick JV LLC | Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,634 | $ 1,647 | ||||||||||||
Investment, interest rate | 10.84% | 10.84% | 10.84% | 9.17% | 9.17% | 9.17% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,211 | $ 5,252 | ||||||||||||
Investment, interest rate | 10% | 10% | 10% | 7.87% | 7.87% | 7.87% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,858 | $ 3,888 | ||||||||||||
Investment, interest rate | 9.25% | 9.25% | 9.25% | 7.12% | 7.12% | 7.12% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 685 | |||||||||||||
Investment, interest rate | 9.50% | 9.50% | 9.50% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,842 | $ 2,842 | ||||||||||||
Investment, interest rate | 12.59% | 12.59% | 12.59% | 10.92% | 10.92% | 10.92% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 180 | $ 0 | ||||||||||||
Investment, interest rate | 13.04% | 13.04% | 13.04% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,182 | $ 4,465 | ||||||||||||
Investment, interest rate | 13.04% | 13.04% | 13.04% | 10.68% | 10.68% | 10.68% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 6,045 | $ 6,094 | ||||||||||||
Investment, interest rate | 10.52% | 10.52% | 10.52% | 8.06% | 8.06% | 8.06% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2 | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 102 | $ 102 | ||||||||||||
Investment, interest rate | 10.50% | 10.50% | 10.50% | 8.04% | 8.04% | 8.04% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 5,227 | $ 6,000 | ||||||||||||
Investment, interest rate | 9.70% | 9.70% | 9.70% | 7.63% | 7.63% | 7.63% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Sabert Corporation, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,691 | |||||||||||||
Investment, interest rate | 7.63% | 7.63% | 7.63% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,925 | $ 4,962 | ||||||||||||
Investment, interest rate | 10.70% | 10.70% | 10.70% | 8.30% | 8.30% | 8.30% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Supermoose Borrower, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,820 | |||||||||||||
Investment, interest rate | 7.42% | 7.42% | 7.42% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Surgery Center Holdings, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,377 | |||||||||||||
Investment, interest rate | 6.51% | 6.51% | 6.51% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,647 | $ 2,654 | ||||||||||||
Investment, interest rate | 9.84% | 9.84% | 9.84% | 8.15% | 8.15% | 8.15% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,001 | $ 3,024 | ||||||||||||
Investment, interest rate | 11.20% | 11.20% | 11.20% | 9.12% | 9.12% | 9.12% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: Tribe Buyer LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,570 | $ 1,583 | ||||||||||||
Investment, interest rate | 9.69% | 9.69% | 9.69% | 7.62% | 7.62% | 7.62% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 985 | $ 993 | ||||||||||||
Investment, interest rate | 9.03% | 9.03% | 9.03% | 6.56% | 6.56% | 6.56% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: WP CPP Holdings, LLC, Second Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 3,000 | |||||||||||||
Investment, interest rate | 10.56% | 10.56% | 10.56% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 4,848 | $ 4,886 | ||||||||||||
Investment, interest rate | 11.45% | 11.45% | 11.45% | 9.37% | 9.37% | 9.37% | ||||||||
Glick JV LLC | Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, First Lien Delayed Draw Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 0 | |||||||||||||
Glick JV LLC | Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 1,777 | |||||||||||||
Investment, interest rate | 8.59% | 8.59% | 8.59% | |||||||||||
Glick JV LLC | Investment, Identifier [Axis]: eResearch Technology, Inc., First Lien Term Loan | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 2,444 | |||||||||||||
Investment, interest rate | 7.62% | 7.62% | 7.62% | |||||||||||
Glick JV LLC | Senior secured loans | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, principal | $ 123,126 | $ 143,225 | ||||||||||||
Glick JV LLC | Weighted Average | ||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||||||||||||
Investment, interest rate | 10.66% | 10.66% | 10.66% | 8.52% | 8.52% | 8.52% | ||||||||
[1] As of June 30, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820"). |
Portfolio Investments - Portf_3
Portfolio Investments - Portfolio Listing (Details) € in Thousands, £ in Thousands, $ in Thousands | Jun. 30, 2023 USD ($) shares | Jun. 30, 2023 EUR (€) shares | Jun. 30, 2023 GBP (£) shares | Sep. 30, 2022 USD ($) shares | Sep. 30, 2022 EUR (€) shares | Sep. 30, 2022 GBP (£) shares | Jun. 30, 2022 USD ($) shares | Sep. 30, 2021 USD ($) | |||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, at cost | $ 3,296,285 | $ 2,617,754 | |||||||||||||
Investments at fair value | 3,135,619 | 2,494,111 | |||||||||||||
SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | 350,214 | 383,194 | |||||||||||||
Investment owned, at cost | 348,782 | 382,673 | |||||||||||||
Investments at fair value | 329,809 | 359,625 | |||||||||||||
OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | 123,126 | 143,225 | |||||||||||||
Investment owned, at cost | 120,172 | 140,083 | |||||||||||||
Investments at fair value | $ 113,833 | $ 133,144 | |||||||||||||
Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[3],[4],[5],[6] | 12.50% | 12.50% | 12.50% | |||||||||||
Investment, principal | [1],[3],[4],[6],[7] | $ 1,174 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[6] | 1,133 | |||||||||||||
Investments at fair value | [1],[3],[4],[6] | $ 1,112 | |||||||||||||
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[3],[4],[5] | 11% | 11% | 11% | |||||||||||
Investment, principal | [1],[3],[4],[7] | $ 14,916 | |||||||||||||
Investment owned, at cost | [1],[3],[4] | 14,770 | |||||||||||||
Investments at fair value | [1],[3],[4] | $ 14,489 | |||||||||||||
Investment, Identifier [Axis]: 109 Montgomery Owner LLC, Real Estate Operating Companies, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 9.80% | 9.80% | 9.80% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 389 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 387 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 727 | |||||||||||||
Investment, Identifier [Axis]: 109 Montgomery Owner LLC, Real Estate Operating Companies, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10],[13] | 7% | 7% | 7% | |||||||||||
Investment, principal | [8],[9],[10],[12],[13] | $ 0 | |||||||||||||
Investment owned, at cost | [8],[9],[10],[13] | (31) | |||||||||||||
Investments at fair value | [8],[9],[10],[13] | 0 | |||||||||||||
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[3],[4],[5],[6] | 12% | 12% | 12% | |||||||||||
Investment, principal | [1],[3],[4],[6],[7] | $ 3,710 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[6] | 3,664 | |||||||||||||
Investments at fair value | [1],[3],[4],[6] | $ 3,645 | |||||||||||||
Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[4],[5],[14],[15] | 14.25% | 14.25% | 14.25% | |||||||||||
Investment, principal | [1],[4],[7],[14],[15] | $ 21,434 | |||||||||||||
Investment owned, at cost | [1],[4],[14],[15] | 21,620 | |||||||||||||
Investments at fair value | [1],[4],[14],[15] | 21,434 | |||||||||||||
Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | 5,576 | [1],[4],[7],[14] | 33,997 | [8],[9],[12],[16] | |||||||||||
Investment owned, at cost | 5,561 | [1],[4],[14] | 33,960 | [8],[9],[16] | |||||||||||
Investments at fair value | $ 5,464 | [1],[4],[14] | $ 34,891 | [8],[9],[16] | |||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 6.25% | 6.25% | 6.25% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 9.80% | 9.80% | 9.80% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 14,685 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 14,217 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 14,431 | |||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12% | 12% | 12% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 3,520 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 3,480 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 3,455 | |||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | 6.50% | 6.50% | ||||||||||||
Investment, interest rate | 12% | 12% | 12% | ||||||||||||
Investment, principal | $ 6,911 | ||||||||||||||
Investment owned, at cost | 6,832 | ||||||||||||||
Investments at fair value | $ 6,784 | ||||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12% | 12% | 12% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 18,271 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 18,091 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 17,935 | |||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | 6.50% | 6.50% | ||||||||||||
Investment, interest rate | 12% | 12% | 12% | ||||||||||||
Investment, principal | $ 1,173 | ||||||||||||||
Investment owned, at cost | 1,158 | ||||||||||||||
Investments at fair value | $ 1,152 | ||||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 11.66% | 11.66% | 11.66% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 1,000 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 983 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 982 | |||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | 6.25% | 6.25% | ||||||||||||
Investment, interest rate | 9.80% | 9.80% | 9.80% | ||||||||||||
Investment, principal | $ 8,518 | ||||||||||||||
Investment owned, at cost | 8,389 | ||||||||||||||
Investments at fair value | $ 8,371 | ||||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | 6.25% | 6.25% | ||||||||||||
Investment, interest rate | 9.80% | 9.80% | 9.80% | ||||||||||||
Investment, principal | $ 4,647 | ||||||||||||||
Investment owned, at cost | 4,579 | ||||||||||||||
Investments at fair value | $ 4,567 | ||||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 1 | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | 6.50% | 6.50% | ||||||||||||
Investment, interest rate | 12% | 12% | 12% | ||||||||||||
Investment, principal | $ 587 | ||||||||||||||
Investment owned, at cost | 579 | ||||||||||||||
Investments at fair value | $ 576 | ||||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, First Lien Term Loan 2 | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | 6.50% | 6.50% | ||||||||||||
Investment, interest rate | 12% | 12% | 12% | ||||||||||||
Investment, principal | $ 3,824 | ||||||||||||||
Investment owned, at cost | 3,782 | ||||||||||||||
Investments at fair value | $ 3,753 | ||||||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[4],[14] | 7.50% | [1],[4],[14] | 7.50% | [1],[4],[14] | 7.50% | [8],[9],[10],[16] | 7.50% | [8],[9],[10],[16] | 7.50% | [8],[9],[10],[16] | |||
Investment, interest rate | 12.89% | [1],[2],[4],[5],[14] | 12.89% | [1],[2],[4],[5],[14] | 12.89% | [1],[2],[4],[5],[14] | 11.20% | [8],[9],[10],[11],[16] | 11.20% | [8],[9],[10],[11],[16] | 11.20% | [8],[9],[10],[11],[16] | |||
Investment, principal | $ 6,589 | [1],[4],[5],[7],[14] | $ 6,589 | [8],[9],[10],[12],[16] | |||||||||||
Investment owned, at cost | 6,292 | [1],[4],[5],[14] | 6,256 | [8],[9],[10],[16] | |||||||||||
Investments at fair value | $ 6,267 | [1],[4],[5],[14] | $ 6,262 | [8],[9],[10],[16] | |||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[3],[4],[14] | 7.50% | [1],[3],[4],[14] | 7.50% | [1],[3],[4],[14] | 7.50% | [8],[9],[10],[13],[16] | 7.50% | [8],[9],[10],[13],[16] | 7.50% | [8],[9],[10],[13],[16] | |||
Investment, principal | $ 0 | [1],[3],[4],[5],[7],[14] | $ 0 | [8],[9],[10],[12],[13],[16] | |||||||||||
Investment owned, at cost | (38) | [1],[3],[4],[5],[14] | (38) | [8],[9],[10],[13],[16] | |||||||||||
Investments at fair value | $ (38) | [1],[3],[4],[5],[14] | $ (37) | [8],[9],[10],[13],[16] | |||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 28,948 | [1],[4],[14] | 28,948 | [1],[4],[14] | 28,948 | [1],[4],[14] | 28,948 | [8],[9],[16] | 28,948 | [8],[9],[16] | 28,948 | [8],[9],[16] | |||
Investment owned, at cost | $ 174 | [1],[4],[14] | $ 174 | [8],[9],[16] | |||||||||||
Investments at fair value | $ 18 | [1],[4],[14] | $ 73 | [8],[9],[16] | |||||||||||
Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[4],[5],[14] | 7.25% | [1],[4],[5],[14] | 7.25% | [1],[4],[5],[14] | 7.25% | [8],[9],[10],[16] | 7.25% | [8],[9],[10],[16] | 7.25% | [8],[9],[10],[16] | |||
Investment, interest rate | 10.67% | [1],[2],[4],[5],[14] | 10.67% | [1],[2],[4],[5],[14] | 10.67% | [1],[2],[4],[5],[14] | 7.94% | [8],[9],[10],[11],[16] | 7.94% | [8],[9],[10],[11],[16] | 7.94% | [8],[9],[10],[11],[16] | |||
Investment, principal | € | € 29,985 | [1],[4],[5],[7],[14] | € 24,838 | [8],[9],[10],[12],[16] | |||||||||||
Investment owned, at cost | $ 33,119 | [1],[4],[5],[14] | $ 27,752 | [8],[9],[10],[16] | |||||||||||
Investments at fair value | $ 32,128 | [1],[4],[5],[14] | $ 22,143 | [8],[9],[10],[16] | |||||||||||
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 17,870 | [1],[4] | 17,870 | [1],[4] | 17,870 | [1],[4] | 14,410 | [8],[9] | 14,410 | [8],[9] | 14,410 | [8],[9] | |||
Investment owned, at cost | $ 1,733 | [1],[4] | $ 1,352 | [8],[9] | |||||||||||
Investments at fair value | $ 2,578 | [1],[4] | $ 1,291 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.75% | [1],[4],[5] | 7.75% | [1],[4],[5] | 7.75% | [1],[4],[5] | 7.75% | [8],[9],[10] | 7.75% | [8],[9],[10] | 7.75% | [8],[9],[10] | |||
Investment, interest rate | 12.95% | [1],[2],[4],[5] | 12.95% | [1],[2],[4],[5] | 12.95% | [1],[2],[4],[5] | 10.88% | [8],[9],[10],[11] | 10.88% | [8],[9],[10],[11] | 10.88% | [8],[9],[10],[11] | |||
Investment, principal | $ 17,873 | [1],[4],[5],[7] | $ 14,414 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 17,646 | [1],[4],[5] | 14,154 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 17,533 | [1],[4],[5] | $ 13,910 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: APX Group Inc., Electrical Components & Equipment, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [9],[10],[11],[16] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, principal | [9],[12],[16] | $ 2,075 | |||||||||||||
Investment owned, at cost | [9],[16] | 1,733 | |||||||||||||
Investments at fair value | [9],[16] | $ 1,645 | |||||||||||||
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., Trading Companies & Distributors, Fixed Rate Bond 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [9],[10],[11] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, principal | [9],[12] | $ 5,500 | |||||||||||||
Investment owned, at cost | [9] | 5,408 | |||||||||||||
Investments at fair value | [9] | $ 3,641 | |||||||||||||
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., Trading Companies & Distributors, Fixed Rate Bond 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [9],[10],[11] | 5.25% | 5.25% | 5.25% | |||||||||||
Investment, principal | [9],[12] | $ 2,500 | |||||||||||||
Investment owned, at cost | [9] | 2,220 | |||||||||||||
Investments at fair value | [9] | $ 1,926 | |||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | ||||||||||||
Investment owned, at cost | $ (9) | ||||||||||||||
Investments at fair value | $ (11) | ||||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | 6% | 6% | 6% | |||||||||
Investment, principal | $ 0 | $ 0 | |||||||||||||
Investment owned, at cost | (3) | (4) | |||||||||||||
Investments at fair value | $ (10) | $ (5) | |||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | ||||||||||||
Investment, interest rate | 9.67% | 9.67% | 9.67% | ||||||||||||
Investment, principal | $ 4,176 | ||||||||||||||
Investment owned, at cost | 4,103 | ||||||||||||||
Investments at fair value | $ 4,080 | ||||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | 6% | 6% | 6% | |||||||||
Investment, interest rate | 11.31% | 11.31% | 11.31% | 9.67% | 9.67% | 9.67% | |||||||||
Investment, principal | $ 1,721 | $ 1,734 | |||||||||||||
Investment owned, at cost | 1,695 | 1,704 | |||||||||||||
Investments at fair value | $ 1,635 | $ 1,694 | |||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5],[14] | 6% | 6% | 6% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7],[14] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5],[14] | (14) | |||||||||||||
Investments at fair value | [1],[3],[4],[5],[14] | $ (20) | |||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | ||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investment owned, at cost | (7) | ||||||||||||||
Investments at fair value | $ (25) | ||||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5],[14] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [1],[2],[4],[5],[14] | 11.31% | 11.31% | 11.31% | |||||||||||
Investment, principal | [1],[4],[5],[7],[14] | $ 3,284 | |||||||||||||
Investment owned, at cost | [1],[4],[5],[14] | 3,276 | |||||||||||||
Investments at fair value | [1],[4],[5],[14] | $ 3,120 | |||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | ||||||||||||
Investment, interest rate | 11.31% | 11.31% | 11.31% | ||||||||||||
Investment, principal | $ 4,145 | ||||||||||||||
Investment owned, at cost | 4,083 | ||||||||||||||
Investments at fair value | 3,938 | ||||||||||||||
Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | [1],[4],[7],[14],[15] | 11,683 | |||||||||||||
Investment owned, at cost | [1],[4],[14],[15] | 11,723 | |||||||||||||
Investments at fair value | [1],[4],[14],[15] | $ 11,274 | |||||||||||||
Investment, Identifier [Axis]: Access CIG, LLC, Diversified Support Services, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 8.94% | 8.94% | 8.94% | ||||||||||||
Investment, principal | $ 5,596 | ||||||||||||||
Investment owned, at cost | 5,559 | ||||||||||||||
Investments at fair value | $ 5,545 | ||||||||||||||
Investment, Identifier [Axis]: Access CIG, LLC, Diversified Support Services, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.75% | [1],[4] | 7.75% | [1],[4] | 7.75% | [1],[4] | 7.75% | [9],[10] | 7.75% | [9],[10] | 7.75% | [9],[10] | |||
Investment, interest rate | 12.94% | [1],[2],[4],[5] | 12.94% | [1],[2],[4],[5] | 12.94% | [1],[2],[4],[5] | 10.82% | [9],[10],[11] | 10.82% | [9],[10],[11] | 10.82% | [9],[10],[11] | |||
Investment, principal | $ 20,000 | [1],[4],[5],[7] | $ 20,000 | [9],[10],[12] | |||||||||||
Investment owned, at cost | 19,943 | [1],[4],[5] | 19,927 | [9],[10] | |||||||||||
Investments at fair value | $ 18,883 | [1],[4],[5] | $ 19,075 | [9],[10] | |||||||||||
Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 6.82% | 6.82% | 6.82% | ||||||||||||
Investment, principal | $ 10,093 | ||||||||||||||
Investment owned, at cost | 10,028 | ||||||||||||||
Investments at fair value | $ 9,692 | ||||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [1],[2],[3],[4],[5] | 10.86% | 10.86% | 10.86% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7] | $ 2,033 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5] | 2,011 | |||||||||||||
Investments at fair value | [1],[3],[4],[5] | $ 2,027 | |||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 10.86% | 10.86% | 10.86% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 20,286 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 20,193 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 20,246 | |||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [1],[2],[3],[4],[5] | ||||||||||||||
Investment, principal | [1],[3],[4],[5],[7] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5] | (2) | |||||||||||||
Investments at fair value | [1],[3],[4],[5] | $ (8) | |||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10],[13] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [8],[9],[10],[11],[13] | 9.14% | 9.14% | 9.14% | |||||||||||
Investment, principal | [8],[9],[10],[12],[13] | $ 500 | |||||||||||||
Investment owned, at cost | [8],[9],[10],[13] | 462 | |||||||||||||
Investments at fair value | [8],[9],[10],[13] | $ 495 | |||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 9.12% | 9.12% | 9.12% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 15,976 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 15,686 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 15,944 | |||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10],[13] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, principal | [8],[9],[10],[12],[13] | $ 0 | |||||||||||||
Investment owned, at cost | [8],[9],[10],[13] | 0 | |||||||||||||
Investments at fair value | [8],[9],[10],[13] | $ (6) | |||||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[3],[4] | 7% | [1],[3],[4] | 7% | [1],[3],[4] | 7% | [8],[9],[10],[13] | 7% | [8],[9],[10],[13] | 7% | [8],[9],[10],[13] | |||
Investment, interest rate | 12.05% | [1],[2],[3],[4],[5] | 12.05% | [1],[2],[3],[4],[5] | 12.05% | [1],[2],[3],[4],[5] | 10.64% | [8],[9],[10],[11],[13] | 10.64% | [8],[9],[10],[11],[13] | 10.64% | [8],[9],[10],[11],[13] | |||
Investment, principal | $ 2,113 | [1],[3],[4],[5],[7] | $ 914 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | 2,101 | [1],[3],[4],[5] | 890 | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ 2,102 | [1],[3],[4],[5] | $ 898 | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 9.63% | 9.63% | 9.63% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 27,349 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 27,038 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 27,158 | |||||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12.34% | 12.34% | 12.34% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 6,400 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 6,327 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 6,374 | |||||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12.34% | 12.34% | 12.34% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 25,332 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 25,283 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 25,230 | |||||||||||||
Investment, Identifier [Axis]: Aden & Anais Merger Sub, Inc., Apparel, Accessories & Luxury Goods, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[9] | 51,645 | 51,645 | 51,645 | |||||||||||
Investment owned, at cost | [8],[9] | $ 5,165 | |||||||||||||
Investments at fair value | [8],[9] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: AirStrip Technologies, Inc., Application Software, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 5,715 | [1],[4] | 5,715 | [1],[4] | 5,715 | [1],[4] | 5,715 | [8],[9] | 5,715 | [8],[9] | 5,715 | [8],[9] | |||
Investment owned, at cost | $ 90 | [1],[4] | $ 90 | [8],[9] | |||||||||||
Investments at fair value | $ 0 | [1],[4] | $ 0 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 23,338 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 22,057 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 22,141 | |||||||||||||
Investment, Identifier [Axis]: All Web Leads, Inc., First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5],[17] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, principal | [1],[4],[5],[7],[17] | $ 23,562 | |||||||||||||
Investment owned, at cost | [1],[4],[5],[17] | 22,795 | |||||||||||||
Investments at fair value | [1],[4],[5],[17] | $ 16,880 | |||||||||||||
Investment, Identifier [Axis]: Altice France S.A., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 6.91% | 6.91% | 6.91% | ||||||||||||
Investment, principal | $ 3,000 | ||||||||||||||
Investment owned, at cost | 2,841 | ||||||||||||||
Investments at fair value | $ 2,730 | ||||||||||||||
Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 9.32% | 9.32% | 9.32% | ||||||||||||
Investment, principal | $ 2,977 | ||||||||||||||
Investment owned, at cost | 2,850 | ||||||||||||||
Investments at fair value | $ 2,808 | ||||||||||||||
Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 5.50% | [2],[4],[5],[14] | 5.50% | [2],[4],[5],[14] | 5.50% | [2],[4],[5],[14] | 5.50% | [9],[10],[11],[16] | 5.50% | [9],[10],[11],[16] | 5.50% | [9],[10],[11],[16] | |||
Investment, principal | $ 4,050 | [4],[7],[14] | $ 4,050 | [9],[12],[16] | |||||||||||
Investment owned, at cost | 3,561 | [4],[14] | 3,518 | [9],[16] | |||||||||||
Investments at fair value | $ 2,900 | [4],[14] | $ 3,057 | [9],[16] | |||||||||||
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 8% | 8% | 8% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 13.34% | 13.34% | 13.34% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 8,794 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 8,132 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 8,011 | |||||||||||||
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [1],[4] | 166,414 | 166,414 | 166,414 | |||||||||||
Investment owned, at cost | [1],[4] | $ 642 | |||||||||||||
Investments at fair value | [1],[4] | $ 518 | |||||||||||||
Investment, Identifier [Axis]: Alvogen Pharma Inc, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | 7.50% | 7.50% | 7.50% | 7.50% | 7.50% | |||||||||
Investment, interest rate | 12.89% | 12.89% | 12.89% | 11.20% | 11.20% | 11.20% | |||||||||
Investment, principal | $ 6,313 | $ 6,562 | |||||||||||||
Investment owned, at cost | 6,261 | 6,489 | |||||||||||||
Investments at fair value | $ 6,029 | $ 6,529 | |||||||||||||
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | 7.50% | 7.50% | ||||||||||||
Investment, interest rate | 11.20% | 11.20% | 11.20% | ||||||||||||
Investment, principal | $ 9,267 | ||||||||||||||
Investment owned, at cost | 9,166 | ||||||||||||||
Investments at fair value | $ 9,221 | ||||||||||||||
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[4],[5] | 7.50% | [1],[4],[5] | 7.50% | [1],[4],[5] | 7.50% | [8],[9],[10] | 7.50% | [8],[9],[10] | 7.50% | [8],[9],[10] | |||
Investment, interest rate | 12.89% | [1],[2],[4],[5] | 12.89% | [1],[2],[4],[5] | 12.89% | [1],[2],[4],[5] | 11.20% | [8],[9],[10],[11] | 11.20% | [8],[9],[10],[11] | 11.20% | [8],[9],[10],[11] | |||
Investment, principal | $ 17,280 | [1],[4],[5],[7] | $ 13,134 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 17,197 | [1],[4],[5] | 12,847 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 16,503 | [1],[4],[5] | $ 13,068 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | 7.50% | 7.50% | ||||||||||||
Investment, interest rate | 12.89% | 12.89% | 12.89% | ||||||||||||
Investment, principal | $ 8,916 | ||||||||||||||
Investment owned, at cost | 8,845 | ||||||||||||||
Investments at fair value | $ 8,514 | ||||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [8],[9],[10],[11],[16] | 10% | 10% | 10% | |||||||||||
Investment, principal | [8],[9],[12],[16] | $ 24,043 | |||||||||||||
Investment owned, at cost | [8],[9],[16] | 23,747 | |||||||||||||
Investments at fair value | [8],[9],[16] | $ 23,923 | |||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 824,197 | [4],[14] | 824,197 | [4],[14] | 824,197 | [4],[14] | 587,930 | [9],[16] | 587,930 | [9],[16] | 587,930 | [9],[16] | |||
Investment owned, at cost | $ 2,426 | [4],[14] | $ 5,308 | [9],[16] | |||||||||||
Investments at fair value | $ 6,379 | [4],[14] | $ 3,974 | [9],[16] | |||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 141,640 | [1],[4],[14],[18] | 141,640 | [1],[4],[14],[18] | 141,640 | [1],[4],[14],[18] | 124,780 | [8],[9],[16],[19] | 124,780 | [8],[9],[16],[19] | 124,780 | [8],[9],[16],[19] | |||
Investment owned, at cost | $ 566 | [1],[4],[14],[18] | $ 485 | [8],[9],[16],[19] | |||||||||||
Investments at fair value | $ 339 | [1],[4],[14],[18] | $ 212 | [8],[9],[16],[19] | |||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[4],[5],[14] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, principal | [1],[4],[7],[14] | $ 28,464 | |||||||||||||
Investment owned, at cost | [1],[4],[14] | 28,363 | |||||||||||||
Investments at fair value | [1],[4],[14] | $ 27,682 | |||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[4],[5],[14] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, principal | [1],[4],[7],[14] | $ 2,121 | |||||||||||||
Investment owned, at cost | [1],[4],[14] | 1,945 | |||||||||||||
Investments at fair value | [1],[4],[14] | $ 2,063 | |||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[4],[5],[14] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, principal | [1],[4],[7],[14] | $ 27,692 | |||||||||||||
Investment owned, at cost | [1],[4],[14] | 27,612 | |||||||||||||
Investments at fair value | [1],[4],[14] | $ 26,930 | |||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 4 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[4],[5],[14] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, principal | [1],[4],[7],[14] | $ 2,064 | |||||||||||||
Investment owned, at cost | [1],[4],[14] | 1,891 | |||||||||||||
Investments at fair value | [1],[4],[14] | $ 2,007 | |||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [8],[9],[10],[11],[16] | 10% | 10% | 10% | |||||||||||
Investment, principal | [8],[9],[12],[16] | $ 23,522 | |||||||||||||
Investment owned, at cost | [8],[9],[16] | 23,264 | |||||||||||||
Investments at fair value | [8],[9],[16] | $ 23,404 | |||||||||||||
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.75% | [1],[4],[5] | 8.75% | [1],[4],[5] | 8.75% | [1],[4],[5] | 8.75% | [8],[9],[10] | 8.75% | [8],[9],[10] | 8.75% | [8],[9],[10] | |||
Investment, interest rate | 13.99% | [1],[2],[4],[5] | 13.99% | [1],[2],[4],[5] | 13.99% | [1],[2],[4],[5] | 12.30% | [8],[9],[10],[11] | 12.30% | [8],[9],[10],[11] | 12.30% | [8],[9],[10],[11] | |||
Investment, principal | $ 17,048 | [1],[4],[5],[7] | $ 14,760 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 16,411 | [1],[4],[5] | 14,492 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 12,616 | [1],[4],[5] | $ 13,284 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: American Rock Salt Company LLC, Diversified Metals & Mining, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 9.22% | 9.22% | 9.22% | ||||||||||||
Investment, principal | $ 4,970 | ||||||||||||||
Investment owned, at cost | 4,734 | ||||||||||||||
Investments at fair value | $ 4,692 | ||||||||||||||
Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 9.22% | 9.22% | 9.22% | ||||||||||||
Investment, principal | $ 2,485 | ||||||||||||||
Investment owned, at cost | 2,367 | ||||||||||||||
Investments at fair value | $ 2,346 | ||||||||||||||
Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | [4],[5] | 6.25% | [4],[5] | 6.25% | [4],[5] | 6.25% | [9],[10] | 6.25% | [9],[10] | 6.25% | [9],[10] | |||
Investment, interest rate | 11.49% | [2],[4],[5] | 11.49% | [2],[4],[5] | 11.49% | [2],[4],[5] | 9.03% | [9],[10],[11] | 9.03% | [9],[10],[11] | 9.03% | [9],[10],[11] | |||
Investment, principal | $ 19,163 | [4],[5],[7] | $ 9,895 | [9],[10],[12] | |||||||||||
Investment owned, at cost | 18,289 | [4],[5] | 9,772 | [9],[10] | |||||||||||
Investments at fair value | $ 16,718 | [4],[5] | $ 9,293 | [9],[10] | |||||||||||
Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | 6.25% | 6.25% | ||||||||||||
Investment, interest rate | 11.49% | 11.49% | 11.49% | ||||||||||||
Investment, principal | $ 4,836 | ||||||||||||||
Investment owned, at cost | 4,775 | ||||||||||||||
Investments at fair value | $ 4,219 | ||||||||||||||
Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | 6.25% | 6.25% | ||||||||||||
Investment, interest rate | 9.03% | 9.03% | 9.03% | ||||||||||||
Investment, principal | $ 4,873 | ||||||||||||||
Investment owned, at cost | 4,812 | ||||||||||||||
Investments at fair value | $ 4,576 | ||||||||||||||
Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | 6.25% | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||
Investment, interest rate | 11.49% | 11.49% | 11.49% | 9.03% | 9.03% | 9.03% | |||||||||
Investment, principal | $ 2,868 | $ 2,889 | |||||||||||||
Investment owned, at cost | 2,832 | 2,853 | |||||||||||||
Investments at fair value | $ 2,502 | $ 2,714 | |||||||||||||
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.25% | 4.25% | 4.25% | ||||||||||||
Investment, interest rate | 7.92% | 7.92% | 7.92% | ||||||||||||
Investment, principal | $ 7,800 | ||||||||||||||
Investment owned, at cost | 7,722 | ||||||||||||||
Investments at fair value | $ 7,527 | ||||||||||||||
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | 4.25% | 4.25% | 4.25% | |||||||||
Investment, interest rate | 9.39% | 9.39% | 9.39% | 7.92% | 7.92% | 7.92% | |||||||||
Investment, principal | $ 2,903 | $ 2,925 | |||||||||||||
Investment owned, at cost | 2,873 | 2,896 | |||||||||||||
Investments at fair value | $ 2,895 | $ 2,823 | |||||||||||||
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10],[16] | 4.25% | 4.25% | 4.25% | |||||||||||
Investment, interest rate | [8],[9],[10],[11],[16] | 7.92% | 7.92% | 7.92% | |||||||||||
Investment, principal | [8],[9],[10],[12],[16] | $ 15,220 | |||||||||||||
Investment owned, at cost | [8],[9],[10],[16] | 13,973 | |||||||||||||
Investments at fair value | [8],[9],[10],[16] | $ 14,687 | |||||||||||||
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 9.39% | 9.39% | 9.39% | ||||||||||||
Investment, principal | $ 7,740 | ||||||||||||||
Investment owned, at cost | 7,663 | ||||||||||||||
Investments at fair value | $ 7,721 | ||||||||||||||
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | [1],[4],[5],[14] | 8% | [1],[4],[5],[14] | 8% | [1],[4],[5],[14] | 8% | [8],[9],[10],[16] | 8% | [8],[9],[10],[16] | 8% | [8],[9],[10],[16] | |||
Investment, interest rate | 13.39% | [1],[2],[4],[5],[14] | 13.39% | [1],[2],[4],[5],[14] | 13.39% | [1],[2],[4],[5],[14] | 11.67% | [8],[9],[10],[11],[16] | 11.67% | [8],[9],[10],[11],[16] | 11.67% | [8],[9],[10],[11],[16] | |||
Investment, principal | $ 12,500 | [1],[4],[5],[7],[14] | $ 12,500 | [8],[9],[10],[12],[16] | |||||||||||
Investment owned, at cost | 12,188 | [1],[4],[5],[14] | 12,188 | [8],[9],[10],[16] | |||||||||||
Investments at fair value | $ 11,865 | [1],[4],[5],[14] | $ 11,958 | [8],[9],[10],[16] | |||||||||||
Investment, Identifier [Axis]: Amynta Agency Borrower Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 10.20% | 10.20% | 10.20% | ||||||||||||
Investment, principal | $ 3,000 | ||||||||||||||
Investment owned, at cost | 2,915 | ||||||||||||||
Investments at fair value | $ 2,925 | ||||||||||||||
Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 7.42% | 7.42% | 7.42% | ||||||||||||
Investment, principal | $ 1,539 | ||||||||||||||
Investment owned, at cost | 1,203 | ||||||||||||||
Investments at fair value | $ 1,232 | ||||||||||||||
Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | 3.75% | 3.75% | 3.75% | |||||||||
Investment, interest rate | 9.25% | 9.25% | 9.25% | 7.42% | 7.42% | 7.42% | |||||||||
Investment, principal | $ 910 | $ 917 | |||||||||||||
Investment owned, at cost | 707 | 712 | |||||||||||||
Investments at fair value | $ 702 | $ 734 | |||||||||||||
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [4],[5] | 3.75% | 3.75% | 3.75% | |||||||||||
Investment, interest rate | [2],[4],[5] | 9.25% | 9.25% | 9.25% | |||||||||||
Investment, principal | [4],[5],[7] | $ 3,710 | |||||||||||||
Investment owned, at cost | [4],[5] | 3,075 | |||||||||||||
Investments at fair value | [4],[5] | $ 2,863 | |||||||||||||
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 9.25% | 9.25% | 9.25% | ||||||||||||
Investment, principal | $ 1,527 | ||||||||||||||
Investment owned, at cost | 1,194 | ||||||||||||||
Investments at fair value | $ 1,179 | ||||||||||||||
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Products, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [9],[10] | 3.75% | 3.75% | 3.75% | |||||||||||
Investment, interest rate | [9],[10],[11] | 7.42% | 7.42% | 7.42% | |||||||||||
Investment, principal | [9],[10],[12] | $ 2,736 | |||||||||||||
Investment owned, at cost | [9],[10] | 2,260 | |||||||||||||
Investments at fair value | [9],[10] | $ 2,189 | |||||||||||||
Investment, Identifier [Axis]: Ankura Consulting Group LLC, Research & Consulting Services, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 8% | 8% | 8% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 10.78% | 10.78% | 10.78% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 4,346 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 4,281 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 3,813 | |||||||||||||
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | [1],[3],[4],[5] | 5% | [1],[3],[4],[5] | 5% | [1],[3],[4],[5] | 6% | [8],[9],[10],[13] | 6% | [8],[9],[10],[13] | 6% | [8],[9],[10],[13] | |||
Investment, interest rate | 10.20% | [1],[2],[3],[4],[5] | 10.20% | [1],[2],[3],[4],[5] | 10.20% | [1],[2],[3],[4],[5] | 8.46% | [8],[9],[10],[11],[13] | 8.46% | [8],[9],[10],[11],[13] | 8.46% | [8],[9],[10],[11],[13] | |||
Investment, principal | $ 808 | [1],[3],[4],[5],[7] | $ 892 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | 792 | [1],[3],[4],[5] | 863 | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ 808 | [1],[3],[4],[5] | $ 846 | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Revolver | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 10.20% | 10.20% | 10.20% | ||||||||||||
Investment, principal | $ 115 | ||||||||||||||
Investment owned, at cost | 113 | ||||||||||||||
Investments at fair value | $ 115 | ||||||||||||||
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 8.46% | 8.46% | 8.46% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 34,458 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 33,737 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 33,738 | |||||||||||||
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 10.20% | 10.20% | 10.20% | ||||||||||||
Investment, principal | $ 4,615 | ||||||||||||||
Investment owned, at cost | 4,592 | ||||||||||||||
Investments at fair value | $ 4,615 | ||||||||||||||
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 5% | 5% | 5% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 10.20% | 10.20% | 10.20% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 9,280 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 9,189 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 9,280 | |||||||||||||
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 5% | 5% | 5% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 10.20% | 10.20% | 10.20% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 32,308 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 31,999 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 32,308 | |||||||||||||
Investment, Identifier [Axis]: Apptio, Inc., First Lien Revolver | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | ||||||||||||
Investment, interest rate | 8.46% | 8.46% | 8.46% | ||||||||||||
Investment, principal | $ 154 | ||||||||||||||
Investment owned, at cost | 151 | ||||||||||||||
Investments at fair value | $ 146 | ||||||||||||||
Investment, Identifier [Axis]: Apptio, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | ||||||||||||
Investment, interest rate | 8.46% | 8.46% | 8.46% | ||||||||||||
Investment, principal | $ 4,615 | ||||||||||||||
Investment owned, at cost | 4,580 | ||||||||||||||
Investments at fair value | $ 4,519 | ||||||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[4],[5],[14] | 7.25% | [1],[4],[5],[14] | 7.25% | [1],[4],[5],[14] | 7% | [8],[9],[10],[16] | 7% | [8],[9],[10],[16] | 7% | [8],[9],[10],[16] | |||
Investment, interest rate | 10.07% | [1],[2],[4],[5],[14] | 10.07% | [1],[2],[4],[5],[14] | 10.07% | [1],[2],[4],[5],[14] | 8% | [8],[9],[10],[11],[16] | 8% | [8],[9],[10],[11],[16] | 8% | [8],[9],[10],[11],[16] | |||
Investment, principal | € | € 3,017 | [1],[4],[5],[7],[14] | € 1,964 | [8],[9],[10],[12],[16] | |||||||||||
Investment owned, at cost | $ 3,341 | [1],[4],[5],[14] | $ 2,176 | [8],[9],[10],[16] | |||||||||||
Investments at fair value | $ 3,321 | [1],[4],[5],[14] | $ 1,927 | [8],[9],[10],[16] | |||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[4],[5],[14] | 6% | [1],[4],[5],[14] | 6% | [1],[4],[5],[14] | 7% | [8],[9],[10],[16] | 7% | [8],[9],[10],[16] | 7% | [8],[9],[10],[16] | |||
Investment, interest rate | 11.25% | [1],[2],[4],[5],[14] | 11.25% | [1],[2],[4],[5],[14] | 11.25% | [1],[2],[4],[5],[14] | 9.19% | [8],[9],[10],[11],[16] | 9.19% | [8],[9],[10],[11],[16] | 9.19% | [8],[9],[10],[11],[16] | |||
Investment, principal | $ 10,519 | [1],[4],[5],[7],[14] | £ 18,636 | [8],[9],[10],[12],[16] | |||||||||||
Investment owned, at cost | 10,389 | [1],[4],[5],[14] | $ 23,139 | [8],[9],[10],[16] | |||||||||||
Investments at fair value | $ 10,614 | [1],[4],[5],[14] | $ 20,826 | [8],[9],[10],[16] | |||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[4],[5],[14] | 7.25% | [1],[4],[5],[14] | 7.25% | [1],[4],[5],[14] | 5.75% | [8],[9],[10],[16] | 5.75% | [8],[9],[10],[16] | 5.75% | [8],[9],[10],[16] | |||
Investment, interest rate | 12.18% | [1],[2],[4],[5],[14] | 12.18% | [1],[2],[4],[5],[14] | 12.18% | [1],[2],[4],[5],[14] | 8.81% | [8],[9],[10],[11],[16] | 8.81% | [8],[9],[10],[11],[16] | 8.81% | [8],[9],[10],[11],[16] | |||
Investment, principal | £ 4,949 | [1],[4],[5],[7],[14] | $ 10,519 | [8],[9],[10],[12],[16] | |||||||||||
Investment owned, at cost | $ 6,364 | [1],[4],[5],[14] | 10,357 | [8],[9],[10],[16] | |||||||||||
Investments at fair value | $ 6,348 | [1],[4],[5],[14] | $ 10,328 | [8],[9],[10],[16] | |||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[4],[5],[14] | 7.25% | [1],[4],[5],[14] | 7.25% | [1],[4],[5],[14] | 5.75% | [8],[9],[10],[13],[16] | 5.75% | [8],[9],[10],[13],[16] | 5.75% | [8],[9],[10],[13],[16] | |||
Investment, interest rate | [1],[2],[4],[5],[14] | 12.45% | 12.45% | 12.45% | |||||||||||
Investment, principal | £ | £ 23,675 | [1],[4],[5],[7],[14] | £ 0 | [8],[9],[10],[12],[13],[16] | |||||||||||
Investment owned, at cost | $ 28,939 | [1],[4],[5],[14] | $ (44) | [8],[9],[10],[13],[16] | |||||||||||
Investments at fair value | $ 30,370 | [1],[4],[5],[14] | 0 | [8],[9],[10],[13],[16] | |||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5],[14] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, interest rate | [1],[2],[4],[5],[14] | 8.57% | 8.57% | 8.57% | |||||||||||
Investment, principal | € | [1],[4],[5],[7],[14] | € 3,649 | |||||||||||||
Investment owned, at cost | [1],[4],[5],[14] | $ 3,927 | |||||||||||||
Investments at fair value | [1],[4],[5],[14] | $ 4,027 | |||||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,783,332 | 1,783,332 | 1,783,332 | 1,609,201 | |||||||||||
Investment, principal | $ 0 | $ 0 | |||||||||||||
Investments at fair value | $ 0 | 370 | $ 563 | $ 587 | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | 6.75% | 6.75% | 6.75% | |||||||||||
Investment, interest rate | 12.29% | 12.29% | 12.29% | 9% | |||||||||||
Investment, principal | $ 22,304 | $ 21,754 | |||||||||||||
Investments at fair value | $ 22,186 | 24,225 | $ 21,260 | 15,712 | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,129,453 | 1,129,453 | 1,129,453 | 1,019,169 | |||||||||||
Investment, principal | $ 0 | $ 0 | |||||||||||||
Investments at fair value | $ 1,412 | $ 1,223 | $ 1,203 | 1,152 | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,783,332 | [1],[20] | 1,783,332 | [1],[20] | 1,783,332 | [1],[20] | 1,609,201 | [8],[21] | 1,609,201 | [8],[21] | 1,609,201 | [8],[21] | |||
Investment owned, at cost | $ 804 | [1],[20] | $ 764 | [8],[21] | |||||||||||
Investments at fair value | $ 0 | [1],[20] | $ 370 | [8],[21] | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [1],[3],[5],[20] | 6.75% | [1],[3],[5],[20] | 6.75% | [1],[3],[5],[20] | 6.75% | [8],[10],[13],[21] | 6.75% | [8],[10],[13],[21] | 6.75% | [8],[10],[13],[21] | |||
Investment, interest rate | 12.29% | [1],[2],[3],[5],[20] | 12.29% | [1],[2],[3],[5],[20] | 12.29% | [1],[2],[3],[5],[20] | 10.42% | [8],[10],[11],[13],[21] | 10.42% | [8],[10],[11],[13],[21] | 10.42% | [8],[10],[11],[13],[21] | |||
Investment, principal | $ 22,304 | [1],[3],[5],[7],[20] | $ 24,490 | [8],[10],[12],[13],[21] | |||||||||||
Investment owned, at cost | 22,327 | [1],[3],[5],[20] | 24,490 | [8],[10],[13],[21] | |||||||||||
Investments at fair value | $ 22,186 | [1],[3],[5],[20] | $ 24,225 | [8],[10],[13],[21] | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,129,453 | [1],[20] | 1,129,453 | [1],[20] | 1,129,453 | [1],[20] | 1,019,169 | [8],[21] | 1,019,169 | [8],[21] | 1,019,169 | [8],[21] | |||
Investment owned, at cost | $ 1,159 | [1],[20] | $ 1,019 | [8],[21] | |||||||||||
Investments at fair value | $ 1,412 | [1],[20] | $ 1,223 | [8],[21] | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 78,045 | [1],[20] | 78,045 | [1],[20] | 78,045 | [1],[20] | 70,425 | [8],[21] | 70,425 | [8],[21] | 70,425 | [8],[21] | |||
Investment owned, at cost | $ 0 | [1],[20] | $ 0 | [8],[21] | |||||||||||
Investments at fair value | $ 0 | [1],[20] | 0 | [8],[21] | |||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 78,045 | 78,045 | 78,045 | 70,425 | |||||||||||
Investment, principal | $ 0 | $ 0 | |||||||||||||
Investments at fair value | $ 0 | $ 0 | $ 0 | 0 | |||||||||||
Investment, Identifier [Axis]: Associated Asphalt Partners, LLC, Construction Materials, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [9],[10] | 5.25% | 5.25% | 5.25% | |||||||||||
Investment, interest rate | [9],[10],[11] | 8.06% | 8.06% | 8.06% | |||||||||||
Investment, principal | [9],[10],[12] | $ 2,501 | |||||||||||||
Investment owned, at cost | [9],[10] | 2,331 | |||||||||||||
Investments at fair value | [9],[10] | $ 1,934 | |||||||||||||
Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | [4],[5] | 5.25% | [4],[5] | 5.25% | [4],[5] | 5.25% | [9],[10] | 5.25% | [9],[10] | 5.25% | [9],[10] | |||
Investment, interest rate | 10.44% | [2],[4],[5] | 10.44% | [2],[4],[5] | 10.44% | [2],[4],[5] | 8.37% | [9],[10],[11] | 8.37% | [9],[10],[11] | 8.37% | [9],[10],[11] | |||
Investment, principal | $ 8,490 | [4],[5],[7] | $ 5,640 | [9],[10],[12] | |||||||||||
Investment owned, at cost | 8,153 | [4],[5] | 5,482 | [9],[10] | |||||||||||
Investments at fair value | $ 5,983 | [4],[5] | $ 4,822 | [9],[10] | |||||||||||
Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | ||||||||||||
Investment, interest rate | 10.44% | 10.44% | 10.44% | ||||||||||||
Investment, principal | $ 5,052 | ||||||||||||||
Investment owned, at cost | 4,880 | ||||||||||||||
Investments at fair value | $ 3,560 | ||||||||||||||
Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | ||||||||||||
Investment, interest rate | 8.37% | 8.37% | 8.37% | ||||||||||||
Investment, principal | $ 5,052 | ||||||||||||||
Investment owned, at cost | 4,858 | ||||||||||||||
Investments at fair value | $ 4,319 | ||||||||||||||
Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||
Investment, interest rate | 10.44% | 10.44% | 10.44% | 8.37% | 8.37% | 8.37% | |||||||||
Investment, principal | $ 2,078 | $ 2,078 | |||||||||||||
Investment owned, at cost | 2,037 | 2,033 | |||||||||||||
Investments at fair value | $ 1,464 | $ 1,777 | |||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 7.70% | 7.70% | 7.70% | ||||||||||||
Investment, principal | $ 5,000 | ||||||||||||||
Investment owned, at cost | 4,753 | ||||||||||||||
Investments at fair value | $ 4,276 | ||||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 7.70% | 7.70% | 7.70% | ||||||||||||
Investment, principal | $ 2,000 | ||||||||||||||
Investment owned, at cost | 1,901 | ||||||||||||||
Investments at fair value | $ 1,711 | ||||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 9.20% | 9.20% | 9.20% | ||||||||||||
Investment, principal | $ 4,963 | ||||||||||||||
Investment owned, at cost | 4,749 | ||||||||||||||
Investments at fair value | $ 4,710 | ||||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, First Lien Term Loan 1 | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 9.20% | 9.20% | 9.20% | ||||||||||||
Investment, principal | $ 1,985 | ||||||||||||||
Investment owned, at cost | 1,900 | ||||||||||||||
Investments at fair value | $ 1,884 | ||||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.25% | 4.25% | 4.25% | ||||||||||||
Investment, interest rate | 9.47% | 9.47% | 9.47% | ||||||||||||
Investment, principal | $ 1,995 | ||||||||||||||
Investment owned, at cost | 1,883 | ||||||||||||||
Investments at fair value | $ 1,902 | ||||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, First Lien Term Loan 2 | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.25% | 4.25% | 4.25% | ||||||||||||
Investment, interest rate | 9.47% | 9.47% | 9.47% | ||||||||||||
Investment, principal | $ 998 | ||||||||||||||
Investment owned, at cost | 941 | ||||||||||||||
Investments at fair value | $ 951 | ||||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, Second Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | ||||||||||||
Investment, interest rate | 10.47% | 10.47% | 10.47% | ||||||||||||
Investment, principal | $ 4,346 | ||||||||||||||
Investment owned, at cost | 4,022 | ||||||||||||||
Investments at fair value | $ 3,657 | ||||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, Property & Casualty Insurance, Second Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | ||||||||||||
Investment, interest rate | 10.47% | 10.47% | 10.47% | ||||||||||||
Investment, principal | $ 2,423 | ||||||||||||||
Investment owned, at cost | 2,236 | ||||||||||||||
Investments at fair value | $ 2,039 | ||||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | ||||||||||||
Investment, interest rate | 8.37% | 8.37% | 8.37% | ||||||||||||
Investment, principal | $ 4,346 | ||||||||||||||
Investment owned, at cost | 3,981 | ||||||||||||||
Investments at fair value | $ 3,347 | ||||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | ||||||||||||
Investment, interest rate | 8.37% | 8.37% | 8.37% | ||||||||||||
Investment, principal | $ 2,423 | ||||||||||||||
Investment owned, at cost | 2,212 | ||||||||||||||
Investments at fair value | $ 1,866 | ||||||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 11% | [1],[2],[4],[5],[14],[17] | 11% | [1],[2],[4],[5],[14],[17] | 11% | [1],[2],[4],[5],[14],[17] | 11% | [8],[9],[10],[11],[16] | 11% | [8],[9],[10],[11],[16] | 11% | [8],[9],[10],[11],[16] | |||
Investment, principal | $ 1,338 | [1],[4],[7],[14],[17] | $ 13,346 | [8],[9],[12],[16] | |||||||||||
Investment owned, at cost | 1,257 | [1],[4],[14],[17] | 12,929 | [8],[9],[16] | |||||||||||
Investments at fair value | $ 1,257 | [1],[4],[14],[17] | 12,812 | [8],[9],[16] | |||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[4],[5],[14],[17] | 11% | 11% | 11% | |||||||||||
Investment, principal | $ 1,338 | [1],[4],[7],[14],[17] | 8,309 | [8],[9],[12],[16],[22] | |||||||||||
Investment owned, at cost | 1,241 | [1],[4],[14],[17] | 8,264 | [8],[9],[16],[22] | |||||||||||
Investments at fair value | $ 1,257 | [1],[4],[14],[17] | $ 8,309 | [8],[9],[16],[22] | |||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[4],[5],[14],[17] | 11% | 11% | 11% | |||||||||||
Investment, principal | [1],[4],[7],[14],[17] | $ 5,350 | |||||||||||||
Investment owned, at cost | [1],[4],[14],[17] | 4,951 | |||||||||||||
Investments at fair value | [1],[4],[14],[17] | $ 5,029 | |||||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[9],[16] | 328,149 | 328,149 | 328,149 | |||||||||||
Investment owned, at cost | [8],[9],[16] | $ 973 | |||||||||||||
Investments at fair value | [8],[9],[16] | $ 16 | |||||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 10,634 | 10,634 | 10,634 | ||||||||||||
Investment, principal | [1],[4],[7],[14] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[4],[14] | 488 | |||||||||||||
Investments at fair value | [1],[4],[14] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [1],[4],[14] | 10,634 | 10,634 | 10,634 | |||||||||||
Investment owned, at cost | [1],[4],[14] | $ 488 | |||||||||||||
Investments at fair value | [1],[4],[14] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[4],[5],[14] | 6% | [1],[4],[5],[14] | 6% | [1],[4],[5],[14] | 6% | [8],[9],[10],[16] | 6% | [8],[9],[10],[16] | 6% | [8],[9],[10],[16] | |||
Investment, interest rate | 11.27% | [1],[2],[4],[5],[14] | 11.27% | [1],[2],[4],[5],[14] | 11.27% | [1],[2],[4],[5],[14] | 8.78% | [8],[9],[10],[11],[16] | 8.78% | [8],[9],[10],[11],[16] | 8.78% | [8],[9],[10],[11],[16] | |||
Investment, principal | $ 29,509 | [1],[4],[5],[7],[14] | $ 22,425 | [8],[9],[10],[12],[16] | |||||||||||
Investment owned, at cost | 29,137 | [1],[4],[5],[14] | 22,086 | [8],[9],[10],[16] | |||||||||||
Investments at fair value | $ 28,299 | [1],[4],[5],[14] | $ 21,326 | [8],[9],[10],[16] | |||||||||||
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | ||||||||||||
Investment, interest rate | 11.27% | 11.27% | 11.27% | ||||||||||||
Investment, principal | $ 6,289 | ||||||||||||||
Investment owned, at cost | 6,211 | ||||||||||||||
Investments at fair value | $ 6,031 | ||||||||||||||
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | ||||||||||||
Investment, interest rate | 11.27% | 11.27% | 11.27% | ||||||||||||
Investment, principal | $ 3,628 | ||||||||||||||
Investment owned, at cost | 3,583 | ||||||||||||||
Investments at fair value | $ 3,479 | ||||||||||||||
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | ||||||||||||
Investment, interest rate | 8.78% | 8.78% | 8.78% | ||||||||||||
Investment, principal | $ 6,338 | ||||||||||||||
Investment owned, at cost | 6,242 | ||||||||||||||
Investments at fair value | $ 6,027 | ||||||||||||||
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | ||||||||||||
Investment, interest rate | 8.78% | 8.78% | 8.78% | ||||||||||||
Investment, principal | $ 3,656 | ||||||||||||||
Investment owned, at cost | 3,601 | ||||||||||||||
Investments at fair value | $ 3,476 | ||||||||||||||
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5] | (113) | |||||||||||||
Investments at fair value | [1],[3],[4],[5] | $ (101) | |||||||||||||
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12.49% | 12.49% | 12.49% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 50,470 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 49,639 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 49,461 | |||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Delayed Draw Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 8.12% | 8.12% | 8.12% | ||||||||||||
Investment, principal | $ 808 | ||||||||||||||
Investment owned, at cost | 800 | ||||||||||||||
Investments at fair value | $ 760 | ||||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 8.12% | 8.12% | 8.12% | ||||||||||||
Investment, principal | $ 3,398 | ||||||||||||||
Investment owned, at cost | 3,366 | ||||||||||||||
Investments at fair value | $ 3,279 | ||||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 8.12% | 8.12% | 8.12% | ||||||||||||
Investment, principal | $ 6,371 | ||||||||||||||
Investment owned, at cost | 6,311 | ||||||||||||||
Investments at fair value | $ 6,148 | ||||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 1 | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 10.50% | 10.50% | 10.50% | ||||||||||||
Investment, principal | $ 3,372 | ||||||||||||||
Investment owned, at cost | 3,340 | ||||||||||||||
Investments at fair value | $ 3,284 | ||||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 8.12% | 8.12% | 8.12% | ||||||||||||
Investment, principal | $ 1,771 | ||||||||||||||
Investment owned, at cost | 1,751 | ||||||||||||||
Investments at fair value | $ 1,664 | ||||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., First Lien Term Loan 2 | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 10.50% | 10.50% | 10.50% | ||||||||||||
Investment, principal | $ 802 | ||||||||||||||
Investment owned, at cost | 798 | ||||||||||||||
Investments at fair value | $ 782 | ||||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10],[13] | 5% | 5% | 5% | |||||||||||
Investment, interest rate | [8],[9],[10],[11],[13] | 8.12% | 8.12% | 8.12% | |||||||||||
Investment, principal | [8],[9],[10],[12],[13] | $ 2,546 | |||||||||||||
Investment owned, at cost | [8],[9],[10],[13] | 2,503 | |||||||||||||
Investments at fair value | [8],[9],[10],[13] | $ 2,395 | |||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 5% | 5% | 5% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 10.50% | 10.50% | 10.50% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 3,258 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 3,227 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 3,173 | |||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 10.50% | 10.50% | 10.50% | ||||||||||||
Investment, principal | $ 6,322 | ||||||||||||||
Investment owned, at cost | 6,263 | ||||||||||||||
Investments at fair value | $ 6,158 | ||||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 5% | 5% | 5% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 10.50% | 10.50% | 10.50% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 1,264 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 1,273 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 1,232 | |||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 10.50% | 10.50% | 10.50% | ||||||||||||
Investment, principal | $ 1,759 | ||||||||||||||
Investment owned, at cost | 1,748 | ||||||||||||||
Investments at fair value | $ 1,713 | ||||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [1],[4],[5] | 8.50% | [1],[4],[5] | 8.50% | [1],[4],[5] | 8.50% | [8],[9],[10] | 8.50% | [8],[9],[10] | 8.50% | [8],[9],[10] | |||
Investment, interest rate | 14% | [1],[2],[4],[5] | 14% | [1],[2],[4],[5] | 14% | [1],[2],[4],[5] | 11.62% | [8],[9],[10],[11] | 11.62% | [8],[9],[10],[11] | 11.62% | [8],[9],[10],[11] | |||
Investment, principal | $ 8,920 | [1],[4],[5],[7] | $ 7,166 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 8,819 | [1],[4],[5] | 7,059 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 8,661 | [1],[4],[5] | $ 6,915 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [1],[4],[5] | 8.50% | [1],[4],[5] | 8.50% | [1],[4],[5] | 8.50% | [8],[9],[10],[13] | 8.50% | [8],[9],[10],[13] | 8.50% | [8],[9],[10],[13] | |||
Investment, interest rate | 14% | [1],[2],[4],[5] | 14% | [1],[2],[4],[5] | 14% | [1],[2],[4],[5] | 11.62% | [8],[9],[10],[11],[13] | 11.62% | [8],[9],[10],[11],[13] | 11.62% | [8],[9],[10],[11],[13] | |||
Investment, principal | $ 2,091 | [1],[4],[5],[7] | $ 4,227 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | 2,067 | [1],[4],[5] | 4,070 | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ 2,030 | [1],[4],[5] | $ 3,839 | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 14% | 14% | 14% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 4,361 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 4,296 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 4,235 | |||||||||||||
Investment, Identifier [Axis]: BYJU's Alpha, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | ||||||||||||
Investment, interest rate | 8.98% | 8.98% | 8.98% | ||||||||||||
Investment, principal | $ 7,444 | ||||||||||||||
Investment owned, at cost | 7,347 | ||||||||||||||
Investments at fair value | $ 5,455 | ||||||||||||||
Investment, Identifier [Axis]: BYJU's Alpha, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | ||||||||||||
Investment, interest rate | 8.98% | 8.98% | 8.98% | ||||||||||||
Investment, principal | $ 3,970 | ||||||||||||||
Investment owned, at cost | 3,919 | ||||||||||||||
Investments at fair value | $ 2,909 | ||||||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5] | 4.50% | 4.50% | 4.50% | |||||||||||
Investment, interest rate | [1],[2],[3],[4],[5] | 12.50% | 12.50% | 12.50% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7] | $ 2,528 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5] | 2,492 | |||||||||||||
Investments at fair value | [1],[3],[4],[5] | $ 2,482 | |||||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 10.70% | 10.70% | 10.70% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 40,764 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 40,529 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 40,316 | |||||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10],[13] | 4.50% | 4.50% | 4.50% | |||||||||||
Investment, interest rate | [8],[9],[10],[11],[13] | 10.75% | 10.75% | 10.75% | |||||||||||
Investment, principal | [8],[9],[10],[12],[13] | $ 1,702 | |||||||||||||
Investment owned, at cost | [8],[9],[10],[13] | 1,660 | |||||||||||||
Investments at fair value | [8],[9],[10],[13] | $ 1,617 | |||||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 8.31% | 8.31% | 8.31% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 33,078 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 32,612 | |||||||||||||
Investments at fair value | [8],[9],[10] | 32,053 | |||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | [8],[9],[12],[13],[16],[22] | 0 | |||||||||||||
Investment owned, at cost | [8],[9],[13],[16],[22] | 0 | |||||||||||||
Investments at fair value | [8],[9],[13],[16],[22] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 8% | [1],[2],[4],[5],[14] | 8% | [1],[2],[4],[5],[14] | 8% | [1],[2],[4],[5],[14] | 10.25% | [8],[9],[10],[11],[16] | 10.25% | [8],[9],[10],[11],[16] | 10.25% | [8],[9],[10],[11],[16] | |||
Investment, principal | $ 6,719 | [1],[4],[7],[14] | $ 5,322 | [8],[9],[12],[16] | |||||||||||
Investment owned, at cost | 6,508 | [1],[4],[14] | 5,111 | [8],[9],[16] | |||||||||||
Investments at fair value | 6,282 | [1],[4],[14] | $ 5,114 | [8],[9],[16] | |||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [8],[9],[10],[11],[13],[16] | 10.25% | 10.25% | 10.25% | |||||||||||
Investment, principal | 3,210 | [1],[4],[7],[14],[15] | $ 0 | [8],[9],[12],[13],[16] | |||||||||||
Investment owned, at cost | 3,230 | [1],[4],[14],[15] | 0 | [8],[9],[13],[16] | |||||||||||
Investments at fair value | $ 3,130 | [1],[4],[14],[15] | 0 | [8],[9],[13],[16] | |||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[4],[5],[14] | 8% | 8% | 8% | |||||||||||
Investment, principal | $ 0 | [1],[3],[4],[7],[14] | 2,353 | [8],[9],[12],[16],[22] | |||||||||||
Investment owned, at cost | 0 | [1],[3],[4],[14] | 2,353 | [8],[9],[16],[22] | |||||||||||
Investments at fair value | $ 0 | [1],[3],[4],[14] | $ 2,353 | [8],[9],[16],[22] | |||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[4],[5],[14] | 8% | 8% | 8% | |||||||||||
Investment, principal | [1],[3],[4],[7],[14] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[14] | 0 | |||||||||||||
Investments at fair value | [1],[3],[4],[14] | 0 | |||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | [1],[3],[4],[7],[14],[15] | 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[14],[15] | 0 | |||||||||||||
Investments at fair value | [1],[3],[4],[14],[15] | 0 | |||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | [1],[3],[4],[7],[14],[15] | 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[14],[15] | 0 | |||||||||||||
Investments at fair value | [1],[3],[4],[14],[15] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 26,131 | [1],[4],[14] | 26,131 | [1],[4],[14] | 26,131 | [1],[4],[14] | 21,177 | [8],[9],[16] | 21,177 | [8],[9],[16] | 21,177 | [8],[9],[16] | |||
Investment owned, at cost | $ 225 | [1],[4],[14] | $ 125 | [8],[9],[16] | |||||||||||
Investments at fair value | $ 34 | [1],[4],[14] | $ 98 | [8],[9],[16] | |||||||||||
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [4],[5] | 7% | [4],[5] | 7% | [4],[5] | 7% | [9],[10] | 7% | [9],[10] | 7% | [9],[10] | |||
Investment, interest rate | 12.25% | [2],[4],[5] | 12.25% | [2],[4],[5] | 12.25% | [2],[4],[5] | 9.50% | [9],[10],[11] | 9.50% | [9],[10],[11] | 9.50% | [9],[10],[11] | |||
Investment, principal | $ 30,625 | [4],[5],[7] | $ 30,625 | [9],[10],[12] | |||||||||||
Investment owned, at cost | 30,346 | [4],[5] | 30,276 | [9],[10] | |||||||||||
Investments at fair value | $ 29,385 | [4],[5] | $ 29,017 | [9],[10] | |||||||||||
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3% | 3% | 3% | ||||||||||||
Investment, interest rate | 6.03% | 6.03% | 6.03% | ||||||||||||
Investment, principal | $ 9,575 | ||||||||||||||
Investment owned, at cost | 9,566 | ||||||||||||||
Investments at fair value | $ 8,977 | ||||||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 394,297 | [1],[4] | 394,297 | [1],[4] | 394,297 | [1],[4] | 298,460 | [8],[9] | 298,460 | [8],[9] | 298,460 | [8],[9] | |||
Investment owned, at cost | $ 424 | [1],[4] | $ 298 | [8],[9] | |||||||||||
Investments at fair value | $ 355 | [1],[4] | $ 349 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 9% | [1],[2],[4],[5] | 9% | [1],[2],[4],[5] | 9% | [1],[2],[4],[5] | 9% | [8],[9],[10],[11] | 9% | [8],[9],[10],[11] | 9% | [8],[9],[10],[11] | |||
Investment, principal | $ 4,994 | [1],[4],[7] | $ 3,979 | [8],[9],[12] | |||||||||||
Investment owned, at cost | 5,006 | [1],[4] | 3,980 | [8],[9] | |||||||||||
Investments at fair value | $ 4,969 | [1],[4] | $ 3,960 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,708,618 | [1],[4] | 1,708,618 | [1],[4] | 1,708,618 | [1],[4] | 1,293,324 | [8],[9] | 1,293,324 | [8],[9] | 1,293,324 | [8],[9] | |||
Investment owned, at cost | $ 1,711 | [1],[4] | $ 1,293 | [8],[9] | |||||||||||
Investments at fair value | $ 2,085 | [1],[4] | $ 1,280 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 394,297 | [1],[4] | 394,297 | [1],[4] | 394,297 | [1],[4] | 298,460 | [8],[9] | 298,460 | [8],[9] | 298,460 | [8],[9] | |||
Investment owned, at cost | $ 395 | [1],[4] | $ 298 | [8],[9] | |||||||||||
Investments at fair value | $ 481 | [1],[4] | $ 295 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 829 | ||||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investments at fair value | $ 0 | 0 | |||||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Common Stock | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 171,000 | 171,000 | 171,000 | ||||||||||||
Investment owned, at cost | $ 0 | ||||||||||||||
Investments at fair value | $ 0 | ||||||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 829 | [1],[23],[24] | 829 | [1],[23],[24] | 829 | [1],[23],[24] | 829 | [8],[25],[26] | 829 | [8],[25],[26] | 829 | [8],[25],[26] | |||
Investment, principal | $ 0 | ||||||||||||||
Investment owned, at cost | 0 | [1],[23],[24] | $ 0 | [8],[25],[26] | |||||||||||
Investments at fair value | $ 0 | [1],[23],[24] | $ 0 | [8],[25],[26] | |||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 171,000 | 171,000 | 171,000 | ||||||||||||
Investment owned, at cost | $ 0 | ||||||||||||||
Investments at fair value | $ 0 | ||||||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 34,984,460 | [1],[23],[24] | 34,984,460 | [1],[23],[24] | 34,984,460 | [1],[23],[24] | 34,984,460 | [8],[25],[26] | 34,984,460 | [8],[25],[26] | 34,984,460 | [8],[25],[26] | |||
Investment, principal | $ 0 | ||||||||||||||
Investment owned, at cost | 34,984 | [1],[23],[24] | $ 34,984 | [8],[25],[26] | |||||||||||
Investments at fair value | $ 27,638 | [1],[23],[24] | $ 27,638 | [8],[25],[26] | |||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 7,193,540,000 | 7,193,540,000 | 7,193,540,000 | ||||||||||||
Investment owned, at cost | $ 7,194 | ||||||||||||||
Investments at fair value | $ 5,683 | ||||||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 34,984,460 | ||||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investments at fair value | $ 27,638 | 27,638 | |||||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Preferred Equity | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 7,193,540 | 7,193,540 | 7,193,540 | ||||||||||||
Investment owned, at cost | $ 7,194 | ||||||||||||||
Investments at fair value | $ 5,683 | ||||||||||||||
Investment, Identifier [Axis]: CCO Holdings LLC, Cable & Satellite, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [9],[10],[11],[16] | 4.50% | 4.50% | 4.50% | |||||||||||
Investment, principal | [9],[12],[16] | $ 2,097 | |||||||||||||
Investment owned, at cost | [9],[16] | 1,746 | |||||||||||||
Investments at fair value | [9],[16] | $ 1,603 | |||||||||||||
Investment, Identifier [Axis]: CITGO Holding, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [9],[10],[11] | 9.25% | 9.25% | 9.25% | |||||||||||
Investment, principal | [9],[12] | $ 7,857 | |||||||||||||
Investment owned, at cost | [9] | 7,857 | |||||||||||||
Investments at fair value | [9] | $ 7,807 | |||||||||||||
Investment, Identifier [Axis]: CITGO Petroleum Corp., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | 6.25% | 6.25% | ||||||||||||
Investment, interest rate | 9.37% | 9.37% | 9.37% | ||||||||||||
Investment, principal | $ 7,038 | ||||||||||||||
Investment owned, at cost | 6,967 | ||||||||||||||
Investments at fair value | $ 7,057 | ||||||||||||||
Investment, Identifier [Axis]: CITGO Petroleum Corp., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | 6.25% | 6.25% | ||||||||||||
Investment, interest rate | 9.37% | 9.37% | 9.37% | ||||||||||||
Investment, principal | $ 3,519 | ||||||||||||||
Investment owned, at cost | 3,484 | ||||||||||||||
Investments at fair value | $ 3,529 | ||||||||||||||
Investment, Identifier [Axis]: CITGO Petroleum Corp., Oil & Gas Refining & Marketing, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [9],[10] | 6.25% | 6.25% | 6.25% | |||||||||||
Investment, interest rate | [9],[10],[11] | 9.37% | 9.37% | 9.37% | |||||||||||
Investment, principal | [9],[10],[12] | $ 795 | |||||||||||||
Investment owned, at cost | [9],[10] | 770 | |||||||||||||
Investments at fair value | [9],[10] | $ 797 | |||||||||||||
Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5],[17] | 7.75% | 7.75% | 7.75% | |||||||||||
Investment, principal | [1],[4],[5],[7],[17] | $ 727 | |||||||||||||
Investment owned, at cost | [1],[4],[5],[17] | 462 | |||||||||||||
Investments at fair value | [1],[4],[5],[17] | $ 325 | |||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 9.31% | 9.31% | 9.31% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 14,294 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 13,471 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 13,143 | |||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 11.91% | 11.91% | 11.91% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 13 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 13 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 13 | |||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 11.91% | 11.91% | 11.91% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 3,031 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 2,971 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 3,031 | |||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 11.91% | 11.91% | 11.91% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 1,557 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 1,526 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 1,557 | |||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 11.91% | 11.91% | 11.91% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 1,024 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 1,002 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 1,024 | |||||||||||||
Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,080,399 | [1],[20] | 1,080,399 | [1],[20] | 1,080,399 | [1],[20] | 1,080,399 | [8],[21] | 1,080,399 | [8],[21] | 1,080,399 | [8],[21] | |||
Investment owned, at cost | $ 1,080 | [1],[20] | $ 1,080 | [8],[21] | |||||||||||
Investments at fair value | $ 313 | [1],[20] | 378 | [8],[21] | |||||||||||
Investment, Identifier [Axis]: Caregiver Services, Inc., Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,080,399 | 1,080,399 | 1,080,399 | 1,080,399 | |||||||||||
Investment, principal | $ 0 | $ 0 | |||||||||||||
Investments at fair value | $ 313 | $ 378 | $ 401 | 838 | |||||||||||
Investment, Identifier [Axis]: Carvana Co., Automotive Retail, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [9],[10],[11],[16] | 5.63% | 5.63% | 5.63% | |||||||||||
Investment, principal | [9],[12],[16] | $ 6,700 | |||||||||||||
Investment owned, at cost | [9],[16] | 5,825 | |||||||||||||
Investments at fair value | [9],[16] | $ 4,724 | |||||||||||||
Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Revolver | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | ||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investment owned, at cost | (10) | ||||||||||||||
Investments at fair value | $ (11) | ||||||||||||||
Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | ||||||||||||
Investment, interest rate | 9.12% | 9.12% | 9.12% | ||||||||||||
Investment, principal | $ 4,358 | ||||||||||||||
Investment owned, at cost | 4,286 | ||||||||||||||
Investments at fair value | $ 4,280 | ||||||||||||||
Investment, Identifier [Axis]: Centerline Communications, LLC, First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | ||||||||||||
Investment, interest rate | 9.12% | 9.12% | 9.12% | ||||||||||||
Investment, principal | $ 449 | ||||||||||||||
Investment owned, at cost | 432 | ||||||||||||||
Investments at fair value | $ 413 | ||||||||||||||
Investment, Identifier [Axis]: Centerline Communications, LLC, Wireless Telecommunication Services, First Lien Revolver | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | ||||||||||||
Investment, interest rate | 11.38% | 11.38% | 11.38% | ||||||||||||
Investment, principal | $ 200 | ||||||||||||||
Investment owned, at cost | 192 | ||||||||||||||
Investments at fair value | $ 189 | ||||||||||||||
Investment, Identifier [Axis]: Centerline Communications, LLC, Wireless Telecommunication Services, First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | ||||||||||||
Investment, interest rate | 11.44% | 11.44% | 11.44% | ||||||||||||
Investment, principal | $ 1,965 | ||||||||||||||
Investment owned, at cost | 1,938 | ||||||||||||||
Investments at fair value | $ 1,930 | ||||||||||||||
Investment, Identifier [Axis]: Centerline Communications, LLC, Wireless Telecommunication Services, First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | ||||||||||||
Investment, interest rate | 11.44% | 11.44% | 11.44% | ||||||||||||
Investment, principal | $ 2,366 | ||||||||||||||
Investment owned, at cost | 2,332 | ||||||||||||||
Investments at fair value | $ 2,324 | ||||||||||||||
Investment, Identifier [Axis]: Centerline Communications, LLC, Wireless Telecommunication Services, First Lien Term Loan 3 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | ||||||||||||
Investment, interest rate | 11.44% | 11.44% | 11.44% | ||||||||||||
Investment, principal | $ 1,988 | ||||||||||||||
Investment owned, at cost | 1,957 | ||||||||||||||
Investments at fair value | $ 1,952 | ||||||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 8.62% | 8.62% | 8.62% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 10,692 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 10,004 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 10,209 | |||||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 10.70% | 10.70% | 10.70% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 130 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 130 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 130 | |||||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 10.70% | 10.70% | 10.70% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 129 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 129 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 129 | |||||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 10.70% | 10.70% | 10.70% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 1,084 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 1,103 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 1,084 | |||||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 4 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 10.70% | 10.70% | 10.70% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 9,002 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 9,003 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 9,002 | |||||||||||||
Investment, Identifier [Axis]: City Football Group Limited, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.50% | 3.50% | 3.50% | ||||||||||||
Investment, interest rate | 6.48% | 6.48% | 6.48% | ||||||||||||
Investment, principal | $ 6,451 | ||||||||||||||
Investment owned, at cost | 6,419 | ||||||||||||||
Investments at fair value | $ 6,166 | ||||||||||||||
Investment, Identifier [Axis]: City Football Group Limited, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.50% | 3.50% | 3.50% | ||||||||||||
Investment, interest rate | 6.48% | 6.48% | 6.48% | ||||||||||||
Investment, principal | $ 2,481 | ||||||||||||||
Investment owned, at cost | 2,469 | ||||||||||||||
Investments at fair value | $ 2,372 | ||||||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 7.50% | [2],[4],[5],[14] | 7.50% | [2],[4],[5],[14] | 7.50% | [2],[4],[5],[14] | 7.50% | [9],[10],[11],[16] | 7.50% | [9],[10],[11],[16] | 7.50% | [9],[10],[11],[16] | |||
Investment, principal | $ 2,632 | [4],[7],[14] | $ 4,311 | [9],[12],[16] | |||||||||||
Investment owned, at cost | 2,632 | [4],[14] | 4,311 | [9],[16] | |||||||||||
Investments at fair value | $ 1,951 | [4],[14] | $ 3,132 | [9],[16] | |||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 7.75% | [2],[4],[5],[14] | 7.75% | [2],[4],[5],[14] | 7.75% | [2],[4],[5],[14] | 5.13% | [9],[10],[11],[16] | 5.13% | [9],[10],[11],[16] | 5.13% | [9],[10],[11],[16] | |||
Investment, principal | $ 176 | [4],[7],[14] | $ 1,374 | [9],[12],[16] | |||||||||||
Investment owned, at cost | 170 | [4],[14] | 1,229 | [9],[16] | |||||||||||
Investments at fair value | $ 138 | [4],[14] | $ 1,163 | [9],[16] | |||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [9],[10],[11],[16] | 7.75% | 7.75% | 7.75% | |||||||||||
Investment, principal | [9],[12],[16] | $ 676 | |||||||||||||
Investment owned, at cost | [9],[16] | 648 | |||||||||||||
Investments at fair value | [9],[16] | $ 512 | |||||||||||||
Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 7.38% | [2],[4],[5] | 7.38% | [2],[4],[5] | 7.38% | [2],[4],[5] | 7.38% | [9],[10],[11] | 7.38% | [9],[10],[11] | 7.38% | [9],[10],[11] | |||
Investment, principal | $ 8,420 | [4],[7] | $ 8,420 | [9],[12] | |||||||||||
Investment owned, at cost | 8,257 | [4] | 8,243 | [9] | |||||||||||
Investments at fair value | $ 7,330 | [4] | $ 6,900 | [9] | |||||||||||
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [1],[4],[5] | 8.50% | [1],[4],[5] | 8.50% | [1],[4],[5] | 8.50% | [8],[9],[10] | 8.50% | [8],[9],[10] | 8.50% | [8],[9],[10] | |||
Investment, interest rate | 13.69% | [1],[2],[4],[5] | 13.69% | [1],[2],[4],[5] | 13.69% | [1],[2],[4],[5] | 11.62% | [8],[9],[10],[11] | 11.62% | [8],[9],[10],[11] | 11.62% | [8],[9],[10],[11] | |||
Investment, principal | $ 24,350 | [1],[4],[5],[7] | $ 22,537 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 23,525 | [1],[4],[5] | 21,642 | [8],[9],[10] | |||||||||||
Investments at fair value | 21,506 | [1],[4],[5] | 20,396 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, at cost | 706 | [1],[4] | 648 | [8],[9] | |||||||||||
Investments at fair value | $ 154 | [1],[4] | $ 457 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Convergeone Holdings, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 8.12% | 8.12% | 8.12% | ||||||||||||
Investment, principal | $ 7,373 | ||||||||||||||
Investment owned, at cost | 7,206 | ||||||||||||||
Investments at fair value | $ 5,320 | ||||||||||||||
Investment, Identifier [Axis]: Convergeone Holdings, Inc., IT Consulting & Other Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | [4],[5] | 5% | [4],[5] | 5% | [4],[5] | 5% | [9],[10] | 5% | [9],[10] | 5% | [9],[10] | |||
Investment, interest rate | 10.37% | [2],[4],[5] | 10.37% | [2],[4],[5] | 10.37% | [2],[4],[5] | 8.12% | [9],[10],[11] | 8.12% | [9],[10],[11] | 8.12% | [9],[10],[11] | |||
Investment, principal | $ 17,506 | [4],[5],[7] | $ 11,913 | [9],[10],[12] | |||||||||||
Investment owned, at cost | 15,434 | [4],[5] | 11,697 | [9],[10] | |||||||||||
Investments at fair value | $ 11,176 | [4],[5] | $ 8,596 | [9],[10] | |||||||||||
Investment, Identifier [Axis]: Convergeone Holdings, Inc., IT Consulting & Other Services, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 10.37% | 10.37% | 10.37% | ||||||||||||
Investment, principal | $ 7,315 | ||||||||||||||
Investment owned, at cost | 7,188 | ||||||||||||||
Investments at fair value | $ 4,670 | ||||||||||||||
Investment, Identifier [Axis]: Conviva Inc., Application Software, Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 417,851 | [1],[4] | 417,851 | [1],[4] | 417,851 | [1],[4] | 417,851 | [8],[9] | 417,851 | [8],[9] | 417,851 | [8],[9] | |||
Investment owned, at cost | $ 605 | [1],[4] | $ 605 | [8],[9] | |||||||||||
Investments at fair value | $ 894 | [1],[4] | $ 894 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 1,500 | [1],[4] | 1,500 | [1],[4] | 1,500 | [1],[4] | 1,099 | [8],[9] | 1,099 | [8],[9] | 1,099 | [8],[9] | |||
Investment owned, at cost | $ 1,574 | [1],[4] | $ 690 | [8],[9] | |||||||||||
Investments at fair value | $ 3,299 | [1],[4] | $ 2,340 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.75% | [1],[3],[4],[5] | 5.75% | [1],[3],[4],[5] | 5.75% | [1],[3],[4],[5] | 4.75% | [8],[9],[10],[13] | 4.75% | [8],[9],[10],[13] | 4.75% | [8],[9],[10],[13] | |||
Investment, interest rate | 14% | [1],[2],[3],[4],[5] | 14% | [1],[2],[3],[4],[5] | 14% | [1],[2],[3],[4],[5] | 11% | [8],[9],[10],[11],[13] | 11% | [8],[9],[10],[11],[13] | 11% | [8],[9],[10],[11],[13] | |||
Investment, principal | $ 1,250 | [1],[3],[4],[5],[7] | $ 916 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | 1,226 | [1],[3],[4],[5] | 898 | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ 1,202 | [1],[3],[4],[5] | $ 898 | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 8.88% | 8.88% | 8.88% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 13,712 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 13,554 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 13,583 | |||||||||||||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 6.13% | 6.13% | 6.13% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 11.33% | 11.33% | 11.33% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 13,671 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 13,633 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 13,408 | |||||||||||||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 6.13% | 6.13% | 6.13% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 11.33% | 11.33% | 11.33% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 4,903 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 4,853 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 4,809 | |||||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5] | (21) | |||||||||||||
Investments at fair value | [1],[3],[4],[5] | $ (21) | |||||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12.60% | 12.60% | 12.60% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 13,157 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 12,843 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 12,852 | |||||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5] | (15) | |||||||||||||
Investments at fair value | [1],[3],[4],[5] | $ (14) | |||||||||||||
Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 7.65% | 7.65% | 7.65% | ||||||||||||
Investment, principal | $ 5,375 | ||||||||||||||
Investment owned, at cost | 5,053 | ||||||||||||||
Investments at fair value | $ 5,035 | ||||||||||||||
Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.24% | 10.24% | 10.24% | 7.65% | 7.65% | 7.65% | |||||||||
Investment, principal | $ 2,773 | $ 2,280 | |||||||||||||
Investment owned, at cost | 2,607 | 2,143 | |||||||||||||
Investments at fair value | $ 2,589 | $ 2,136 | |||||||||||||
Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | [4],[5] | 5% | [4],[5] | 5% | [4],[5] | 5% | [9],[10] | 5% | [9],[10] | 5% | [9],[10] | |||
Investment, interest rate | 10.24% | [2],[4],[5] | 10.24% | [2],[4],[5] | 10.24% | [2],[4],[5] | 7.65% | [9],[10],[11] | 7.65% | [9],[10],[11] | 7.65% | [9],[10],[11] | |||
Investment, principal | $ 14,787 | [4],[5],[7] | $ 10,336 | [9],[10],[12] | |||||||||||
Investment owned, at cost | 14,186 | [4],[5] | 9,716 | [9],[10] | |||||||||||
Investments at fair value | $ 13,807 | [4],[5] | $ 9,681 | [9],[10] | |||||||||||
Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 10.24% | 10.24% | 10.24% | ||||||||||||
Investment, principal | $ 6,359 | ||||||||||||||
Investment owned, at cost | 5,983 | ||||||||||||||
Investments at fair value | $ 5,937 | ||||||||||||||
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[3],[4],[5] | 6% | [1],[3],[4],[5] | 6% | [1],[3],[4],[5] | 6% | [8],[9],[10],[13] | 6% | [8],[9],[10],[13] | 6% | [8],[9],[10],[13] | |||
Investment, interest rate | [2],[5] | 11.20% | 11.20% | 11.20% | |||||||||||
Investment, principal | $ 533 | [1],[3],[4],[5],[7] | $ 0 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | 520 | [1],[3],[4],[5] | (13) | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ 507 | [1],[3],[4],[5] | $ (26) | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[4],[5] | 6% | [1],[4],[5] | 6% | [1],[4],[5] | 6% | [8],[9],[10] | 6% | [8],[9],[10] | 6% | [8],[9],[10] | |||
Investment, interest rate | 11.10% | [1],[2],[4],[5] | 11.10% | [1],[2],[4],[5] | 11.10% | [1],[2],[4],[5] | 8.81% | [8],[9],[10],[11] | 8.81% | [8],[9],[10],[11] | 8.81% | [8],[9],[10],[11] | |||
Investment, principal | $ 18,060 | [1],[4],[5],[7] | $ 18,200 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 17,715 | [1],[4],[5] | 17,790 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 17,706 | [1],[4],[5] | $ 17,843 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Curium Bidco S.à.r.l., Biotechnology, First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 9.54% | 9.54% | 9.54% | ||||||||||||
Investment, principal | $ 7,760 | ||||||||||||||
Investment owned, at cost | 7,689 | ||||||||||||||
Investments at fair value | $ 7,730 | ||||||||||||||
Investment, Identifier [Axis]: Curium Bidco S.à.r.l., Biotechnology, First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.25% | 4.25% | 4.25% | ||||||||||||
Investment, interest rate | 9.79% | 9.79% | 9.79% | ||||||||||||
Investment, principal | $ 992 | ||||||||||||||
Investment owned, at cost | 974 | ||||||||||||||
Investments at fair value | $ 987 | ||||||||||||||
Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 7.67% | 7.67% | 7.67% | ||||||||||||
Investment, principal | $ 5,820 | ||||||||||||||
Investment owned, at cost | 5,776 | ||||||||||||||
Investments at fair value | $ 5,587 | ||||||||||||||
Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | 4% | 4% | 4% | |||||||||
Investment, interest rate | 9.54% | 9.54% | 9.54% | 7.67% | 7.67% | 7.67% | |||||||||
Investment, principal | $ 2,848 | $ 2,870 | |||||||||||||
Investment owned, at cost | 2,827 | 2,849 | |||||||||||||
Investments at fair value | $ 2,838 | $ 2,756 | |||||||||||||
Investment, Identifier [Axis]: DTI Holdco, Inc First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | 4.75% | 4.75% | ||||||||||||
Investment, interest rate | 9.80% | 9.80% | 9.80% | ||||||||||||
Investment, principal | $ 2,978 | ||||||||||||||
Investment owned, at cost | 2,928 | ||||||||||||||
Investments at fair value | $ 2,779 | ||||||||||||||
Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | 4.75% | 4.75% | ||||||||||||
Investment, interest rate | 7.33% | 7.33% | 7.33% | ||||||||||||
Investment, principal | $ 8,000 | ||||||||||||||
Investment owned, at cost | 7,849 | ||||||||||||||
Investments at fair value | $ 7,616 | ||||||||||||||
Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | 4.75% | 4.75% | ||||||||||||
Investment, interest rate | 7.33% | 7.33% | 7.33% | ||||||||||||
Investment, principal | $ 3,000 | ||||||||||||||
Investment owned, at cost | 2,943 | ||||||||||||||
Investments at fair value | $ 2,856 | ||||||||||||||
Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | [4],[5] | 4.75% | [4],[5] | 4.75% | [4],[5] | 4.75% | [9],[10] | 4.75% | [9],[10] | 4.75% | [9],[10] | |||
Investment, interest rate | 9.80% | [2],[4],[5] | 9.80% | [2],[4],[5] | 9.80% | [2],[4],[5] | 7.33% | [9],[10],[11] | 7.33% | [9],[10],[11] | 7.33% | [9],[10],[11] | |||
Investment, principal | $ 4,963 | [4],[5],[7] | $ 5,000 | [9],[10],[12] | |||||||||||
Investment owned, at cost | 4,879 | [4],[5] | 4,906 | [9],[10] | |||||||||||
Investments at fair value | $ 4,632 | [4],[5] | $ 4,760 | [9],[10] | |||||||||||
Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | 4.75% | 4.75% | ||||||||||||
Investment, interest rate | 9.80% | 9.80% | 9.80% | ||||||||||||
Investment, principal | $ 7,940 | ||||||||||||||
Investment owned, at cost | 7,807 | ||||||||||||||
Investments at fair value | $ 7,411 | ||||||||||||||
Investment, Identifier [Axis]: Dealer Tire, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.25% | 4.25% | 4.25% | ||||||||||||
Investment, interest rate | 7.37% | 7.37% | 7.37% | ||||||||||||
Investment, principal | $ 2,992 | ||||||||||||||
Investment owned, at cost | 2,935 | ||||||||||||||
Investments at fair value | $ 2,924 | ||||||||||||||
Investment, Identifier [Axis]: Delivery Hero FinCo LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.75% | 5.75% | 5.75% | ||||||||||||
Investment, interest rate | 8.49% | 8.49% | 8.49% | ||||||||||||
Investment, principal | $ 6,035 | ||||||||||||||
Investment owned, at cost | 5,876 | ||||||||||||||
Investments at fair value | $ 5,756 | ||||||||||||||
Investment, Identifier [Axis]: Delivery Hero FinCo LLC, Internet & Direct Marketing Retail, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [9],[10],[16] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, interest rate | [9],[10],[11],[16] | 8.49% | 8.49% | 8.49% | |||||||||||
Investment, principal | [9],[10],[12],[16] | $ 4,988 | |||||||||||||
Investment owned, at cost | [9],[10],[16] | 4,882 | |||||||||||||
Investments at fair value | [9],[10],[16] | $ 4,757 | |||||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 2 | [1],[4],[14] | 2 | [1],[4],[14] | 2 | [1],[4],[14] | 2 | [8],[9],[16] | 2 | [8],[9],[16] | 2 | [8],[9],[16] | |||
Investment owned, at cost | $ 2 | [1],[4],[14] | $ 2 | [8],[9],[16] | |||||||||||
Investments at fair value | $ 2 | [1],[4],[14] | $ 2 | [8],[9],[16] | |||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 419 | [1],[4],[14] | 419 | [1],[4],[14] | 419 | [1],[4],[14] | 419 | [8],[9],[16] | 419 | [8],[9],[16] | 419 | [8],[9],[16] | |||
Investment owned, at cost | $ 419 | [1],[4],[14] | $ 419 | [8],[9],[16] | |||||||||||
Investments at fair value | $ 419 | [1],[4],[14] | $ 419 | [8],[9],[16] | |||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 3% | [1],[2],[3],[4],[5],[14] | 3% | [1],[2],[3],[4],[5],[14] | 3% | [1],[2],[3],[4],[5],[14] | 10% | [8],[9],[10],[11],[13],[16] | 10% | [8],[9],[10],[11],[13],[16] | 10% | [8],[9],[10],[11],[13],[16] | |||
Investment, principal | $ 13,043 | [1],[3],[4],[7],[14] | $ 4,183 | [8],[9],[12],[13],[16] | |||||||||||
Investment owned, at cost | 13,043 | [1],[3],[4],[14] | 4,183 | [8],[9],[13],[16] | |||||||||||
Investments at fair value | $ 13,043 | [1],[3],[4],[14] | $ 4,183 | [8],[9],[13],[16] | |||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 31 | [1],[4],[14] | 31 | [1],[4],[14] | 31 | [1],[4],[14] | 31 | [8],[9],[16] | 31 | [8],[9],[16] | 31 | [8],[9],[16] | |||
Investment owned, at cost | $ 0 | [1],[4],[14] | $ 0 | [8],[9],[16] | |||||||||||
Investments at fair value | $ 0 | [1],[4],[14] | $ 0 | [8],[9],[16] | |||||||||||
Investment, Identifier [Axis]: Delta Topco, Inc., Systems Software, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [9],[10] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [9],[10],[11] | 9.34% | 9.34% | 9.34% | |||||||||||
Investment, principal | [9],[10],[12] | $ 6,680 | |||||||||||||
Investment owned, at cost | [9],[10] | 6,647 | |||||||||||||
Investments at fair value | [9],[10] | $ 5,934 | |||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 9% | 9% | 9% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 14.42% | 14.42% | 14.42% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 20,757 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 20,092 | |||||||||||||
Investments at fair value | [1],[4],[5] | 20,705 | |||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 9% | 9% | 9% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 12.67% | 12.67% | 12.67% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 24,396 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 23,083 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 22,993 | |||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10],[13] | 9% | 9% | 9% | |||||||||||
Investment, principal | [8],[9],[10],[12],[13] | $ 0 | |||||||||||||
Investment owned, at cost | [8],[9],[10],[13] | (135) | |||||||||||||
Investments at fair value | [8],[9],[10],[13] | $ (129) | |||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | [1],[4],[7] | 641 | |||||||||||||
Investment owned, at cost | [1],[4] | 640 | |||||||||||||
Investments at fair value | [1],[4] | $ 611 | |||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 6,397,254 | [1],[4] | 6,397,254 | [1],[4] | 6,397,254 | [1],[4] | 5,403,823 | [8],[9] | 5,403,823 | [8],[9] | 5,403,823 | [8],[9] | |||
Investment owned, at cost | $ 1,642 | [1],[4] | $ 1,405 | [8],[9] | |||||||||||
Investments at fair value | $ 1,215 | [1],[4] | $ 1,297 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [1],[3],[4],[5] | 6.75% | [1],[3],[4],[5] | 6.75% | [1],[3],[4],[5] | 6.50% | [8],[9],[10],[13] | 6.50% | [8],[9],[10],[13] | 6.50% | [8],[9],[10],[13] | |||
Investment, interest rate | 12.09% | [1],[2],[3],[4],[5] | 12.09% | [1],[2],[3],[4],[5] | 12.09% | [1],[2],[3],[4],[5] | 9.41% | [8],[9],[10],[11],[13] | 9.41% | [8],[9],[10],[11],[13] | 9.41% | [8],[9],[10],[11],[13] | |||
Investment, principal | $ 204 | [1],[3],[4],[5],[7] | $ 251 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | 184 | [1],[3],[4],[5] | 228 | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ 172 | [1],[3],[4],[5] | $ 239 | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[4],[5] | 7% | [1],[4],[5] | 7% | [1],[4],[5] | 7% | [8],[9],[10] | 7% | [8],[9],[10] | 7% | [8],[9],[10] | |||
Investment, interest rate | 12.34% | [1],[2],[4],[5] | 12.34% | [1],[2],[4],[5] | 12.34% | [1],[2],[4],[5] | 9.91% | [8],[9],[10],[11] | 9.91% | [8],[9],[10],[11] | 9.91% | [8],[9],[10],[11] | |||
Investment, principal | $ 12,418 | [1],[4],[5],[7] | $ 9,902 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 12,226 | [1],[4],[5] | 9,599 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 12,120 | [1],[4],[5] | $ 9,793 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | [4],[5] | 5% | [4],[5] | 5% | [4],[5] | 5% | [9],[10] | 5% | [9],[10] | 5% | [9],[10] | |||
Investment, interest rate | 10.22% | [2],[4],[5] | 10.22% | [2],[4],[5] | 10.22% | [2],[4],[5] | 8.12% | [9],[10],[11] | 8.12% | [9],[10],[11] | 8.12% | [9],[10],[11] | |||
Investment, principal | $ 4,769 | [4],[5],[7] | $ 19,242 | [9],[10],[12] | |||||||||||
Investment owned, at cost | 4,687 | [4],[5] | 18,970 | [9],[10] | |||||||||||
Investments at fair value | $ 4,672 | [4],[5] | $ 17,973 | [9],[10] | |||||||||||
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 10.22% | 10.22% | 10.22% | ||||||||||||
Investment, principal | $ 5,958 | ||||||||||||||
Investment owned, at cost | 5,869 | ||||||||||||||
Investments at fair value | $ 5,838 | ||||||||||||||
Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 8.12% | 8.12% | 8.12% | ||||||||||||
Investment, principal | $ 6,436 | ||||||||||||||
Investment owned, at cost | 6,332 | ||||||||||||||
Investments at fair value | $ 6,012 | ||||||||||||||
Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.22% | 10.22% | 10.22% | 8.12% | 8.12% | 8.12% | |||||||||
Investment, principal | $ 2,528 | $ 2,730 | |||||||||||||
Investment owned, at cost | 2,502 | 2,703 | |||||||||||||
Investments at fair value | $ 2,477 | $ 2,549 | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 30,031 | ||||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investments at fair value | $ 9,267 | 18,065 | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | ||||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investments at fair value | $ 0 | 0 | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | ||||||||||||||
Investment, interest rate | 7.26% | ||||||||||||||
Investment, principal | $ 16,074 | ||||||||||||||
Investments at fair value | $ 16,074 | 27,381 | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 30,031 | [1],[23],[24] | 30,031 | [1],[23],[24] | 30,031 | [1],[23],[24] | 30,031 | [8],[25],[26] | 30,031 | [8],[25],[26] | 30,031 | [8],[25],[26] | |||
Investment, principal | $ 0 | ||||||||||||||
Investment owned, at cost | 15,222 | [1],[23],[24] | $ 15,222 | [8],[25],[26] | |||||||||||
Investments at fair value | $ 2,711 | [1],[23],[24] | $ 4,946 | [8],[25],[26] | |||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | [1],[3],[5],[23],[24] | 5% | [1],[3],[5],[23],[24] | 5% | [1],[3],[5],[23],[24] | 5% | [8],[10],[13],[25],[26] | 5% | [8],[10],[13],[25],[26] | 5% | [8],[10],[13],[25],[26] | |||
Investment, interest rate | [1],[2],[3],[5],[23],[24] | 10.24% | 10.24% | 10.24% | |||||||||||
Investment, principal | $ 3,484 | [1],[3],[5],[7],[23],[24] | $ 0 | [8],[10],[12],[13],[25],[26] | |||||||||||
Investment owned, at cost | 3,484 | [1],[3],[5],[23],[24] | 0 | [8],[10],[13],[25],[26] | |||||||||||
Investments at fair value | $ 3,484 | [1],[3],[5],[23],[24] | $ 0 | [8],[10],[13],[25],[26] | |||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[10],[25],[26] | 5% | 5% | 5% | |||||||||||
Investment, interest rate | [8],[10],[11],[25],[26] | 8.68% | 8.68% | 8.68% | |||||||||||
Investment, principal | [8],[10],[12],[25],[26] | $ 14,333 | |||||||||||||
Investment owned, at cost | [8],[10],[25],[26] | 14,333 | |||||||||||||
Investments at fair value | [8],[10],[25],[26] | 14,333 | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[5],[23],[24] | 5% | 5% | 5% | |||||||||||
Investment, interest rate | [1],[2],[5],[23],[24] | 10.39% | 10.39% | 10.39% | |||||||||||
Investment, principal | [1],[5],[7],[23],[24] | $ 14,102 | |||||||||||||
Investment owned, at cost | [1],[5],[23],[24] | 14,102 | |||||||||||||
Investments at fair value | $ 14,102 | [1],[5],[23],[24] | 14,333 | ||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[5],[23],[24] | 5% | 5% | 5% | |||||||||||
Investment, principal | [1],[3],[5],[7],[23],[24] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[5],[23],[24] | 0 | |||||||||||||
Investments at fair value | $ 0 | [1],[3],[5],[23],[24] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Domtar Corporation, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | ||||||||||||
Investment, interest rate | 8.26% | 8.26% | 8.26% | ||||||||||||
Investment, principal | $ 4,100 | ||||||||||||||
Investment owned, at cost | 4,065 | ||||||||||||||
Investments at fair value | $ 3,921 | ||||||||||||||
Investment, Identifier [Axis]: Domtar Corporation, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | ||||||||||||
Investment, interest rate | 8.26% | 8.26% | 8.26% | ||||||||||||
Investment, principal | $ 2,503 | ||||||||||||||
Investment owned, at cost | 2,478 | ||||||||||||||
Investments at fair value | $ 2,394 | ||||||||||||||
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 12,500 | [1],[4] | 12,500 | [1],[4] | 12,500 | [1],[4] | 12,500 | [8],[9] | 12,500 | [8],[9] | 12,500 | [8],[9] | |||
Investment owned, at cost | $ 0 | [1],[4] | $ 0 | [8],[9] | |||||||||||
Investments at fair value | $ 0 | [1],[4] | $ 0 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 488 | [1],[4] | 488 | [1],[4] | 488 | [1],[4] | 488 | [8],[9] | 488 | [8],[9] | 488 | [8],[9] | |||
Investment owned, at cost | $ 488 | [1],[4] | $ 488 | [8],[9] | |||||||||||
Investments at fair value | $ 1,160 | [1],[4] | $ 966 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.25% | 4.25% | 4.25% | ||||||||||||
Investment, interest rate | 7.80% | 7.80% | 7.80% | ||||||||||||
Investment, principal | $ 4,478 | ||||||||||||||
Investment owned, at cost | 4,373 | ||||||||||||||
Investments at fair value | $ 4,367 | ||||||||||||||
Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.25% | 4.25% | 4.25% | ||||||||||||
Investment, interest rate | 7.80% | 7.80% | 7.80% | ||||||||||||
Investment, principal | $ 2,488 | ||||||||||||||
Investment owned, at cost | 2,429 | ||||||||||||||
Investments at fair value | $ 2,426 | ||||||||||||||
Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[4],[5] | 7.50% | [1],[4],[5] | 7.50% | [1],[4],[5] | 7.50% | [8],[9],[10] | 7.50% | [8],[9],[10] | 7.50% | [8],[9],[10] | |||
Investment, interest rate | 13.04% | [1],[2],[4],[5] | 13.04% | [1],[2],[4],[5] | 13.04% | [1],[2],[4],[5] | 11.17% | [8],[9],[10],[11] | 11.17% | [8],[9],[10],[11] | 11.17% | [8],[9],[10],[11] | |||
Investment, principal | $ 8,974 | [1],[4],[5],[7] | $ 8,974 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 8,884 | [1],[4],[5] | 8,884 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 7,359 | [1],[4],[5] | $ 8,503 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 3% | [1],[2],[4],[5],[14] | 3% | [1],[2],[4],[5],[14] | 3% | [1],[2],[4],[5],[14] | 3% | [8],[9],[10],[11],[16] | 3% | [8],[9],[10],[11],[16] | 3% | [8],[9],[10],[11],[16] | |||
Investment, principal | $ 10,899 | [1],[4],[7],[14] | $ 10,418 | [8],[9],[12],[16] | |||||||||||
Investment owned, at cost | 10,779 | [1],[4],[14] | 10,275 | [8],[9],[16] | |||||||||||
Investments at fair value | $ 10,463 | [1],[4],[14] | $ 10,231 | [8],[9],[16] | |||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 3% | [1],[2],[4],[5],[14] | 3% | [1],[2],[4],[5],[14] | 3% | [1],[2],[4],[5],[14] | 3% | [8],[9],[10],[11],[13],[16] | 3% | [8],[9],[10],[11],[13],[16] | 3% | [8],[9],[10],[11],[13],[16] | |||
Investment, principal | $ 1,746 | [1],[4],[7],[14] | $ 0 | [8],[9],[12],[13],[16] | |||||||||||
Investment owned, at cost | 1,720 | [1],[4],[14] | 3 | [8],[9],[13],[16] | |||||||||||
Investments at fair value | $ 1,676 | [1],[4],[14] | $ 0 | [8],[9],[13],[16] | |||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[3],[4],[5],[14] | 3% | 3% | 3% | |||||||||||
Investment, principal | [1],[3],[4],[7],[14] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[14] | 1 | |||||||||||||
Investments at fair value | [1],[3],[4],[14] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[3],[4],[5],[14] | 3% | 3% | 3% | |||||||||||
Investment, principal | [1],[3],[4],[7],[14] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[14] | 1 | |||||||||||||
Investments at fair value | [1],[3],[4],[14] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [4],[5] | 6.75% | [4],[5] | 6.75% | [4],[5] | 6.75% | [9],[10] | 6.75% | [9],[10] | 6.75% | [9],[10] | |||
Investment, interest rate | 11.94% | [2],[4],[5] | 11.94% | [2],[4],[5] | 11.94% | [2],[4],[5] | 9.87% | [9],[10],[11] | 9.87% | [9],[10],[11] | 9.87% | [9],[10],[11] | |||
Investment, principal | $ 31,074 | [4],[5],[7] | $ 25,061 | [9],[10],[12] | |||||||||||
Investment owned, at cost | 29,063 | [4],[5] | 24,685 | [9],[10] | |||||||||||
Investments at fair value | $ 18,664 | [4],[5] | $ 21,646 | [9],[10] | |||||||||||
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 9% | [1],[2],[3],[4],[5] | 9% | [1],[2],[3],[4],[5] | 9% | [1],[2],[3],[4],[5] | 9% | [8],[9],[10],[11],[27] | 9% | [8],[9],[10],[11],[27] | 9% | [8],[9],[10],[11],[27] | |||
Investment, principal | $ 52,658 | [1],[3],[4],[7] | $ 27,850 | [8],[9],[12],[27] | |||||||||||
Investment owned, at cost | 52,658 | [1],[3],[4] | 27,850 | [8],[9],[27] | |||||||||||
Investments at fair value | $ 52,658 | [1],[3],[4] | $ 27,850 | [8],[9],[27] | |||||||||||
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 2,500 | [1],[4],[14] | 2,500 | [1],[4],[14] | 2,500 | [1],[4],[14] | 2,500 | [8],[9],[16],[27] | 2,500 | [8],[9],[16],[27] | 2,500 | [8],[9],[16],[27] | |||
Investment owned, at cost | $ 0 | [1],[4],[14] | $ 0 | [8],[9],[16],[27] | |||||||||||
Investments at fair value | 3 | [1],[4],[14] | 3 | [8],[9],[16],[27] | |||||||||||
Investment, Identifier [Axis]: First Star Speir Aviation Limited, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 9% | ||||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investments at fair value | 0 | 7,500 | |||||||||||||
Investment, Identifier [Axis]: First Star Speir Aviation Limited, Membership Interest | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | 0 | ||||||||||||||
Investments at fair value | 0 | 698 | |||||||||||||
Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | 54,003,000 | 48,139 | |||||||||||||
Investment, Identifier [Axis]: Five Largest Loan Exposures To Borrowers | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | $ 28,457 | $ 28,973 | |||||||||||||
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 11% | [1],[2],[4],[5],[14] | 11% | [1],[2],[4],[5],[14] | 11% | [1],[2],[4],[5],[14] | 11% | [8],[9],[10],[11],[16] | 11% | [8],[9],[10],[11],[16] | 11% | [8],[9],[10],[11],[16] | |||
Investment, principal | $ 11,918 | [1],[4],[7],[14] | $ 9,466 | [8],[9],[12],[16] | |||||||||||
Investment owned, at cost | 11,572 | [1],[4],[14] | 9,071 | [8],[9],[16] | |||||||||||
Investments at fair value | $ 11,173 | [1],[4],[14] | $ 9,008 | [8],[9],[16] | |||||||||||
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 417,011 | [1],[4],[14] | 417,011 | [1],[4],[14] | 417,011 | [1],[4],[14] | 331,200 | [8],[9],[16] | 331,200 | [8],[9],[16] | 331,200 | [8],[9],[16] | |||
Investment owned, at cost | $ 427 | [1],[4],[14] | $ 405 | [8],[9],[16] | |||||||||||
Investments at fair value | $ 113 | [1],[4],[14] | $ 66 | [8],[9],[16] | |||||||||||
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 6% | [2],[4],[5],[14] | 6% | [2],[4],[5],[14] | 6% | [2],[4],[5],[14] | 6% | [9],[10],[11],[16] | 6% | [9],[10],[11],[16] | 6% | [9],[10],[11],[16] | |||
Investment, principal | $ 4,881 | [4],[7],[14] | $ 4,881 | [9],[12],[16] | |||||||||||
Investment owned, at cost | 4,456 | [4],[14] | 4,420 | [9],[16] | |||||||||||
Investments at fair value | $ 3,595 | [4],[14] | $ 3,845 | [9],[16] | |||||||||||
Investment, Identifier [Axis]: GKD Index Partners, LLC, Specialized Finance, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10],[13] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [8],[9],[10],[11],[13] | 10.60% | 10.60% | 10.60% | |||||||||||
Investment, principal | [8],[9],[10],[12],[13] | $ 1,280 | |||||||||||||
Investment owned, at cost | [8],[9],[10],[13] | 1,268 | |||||||||||||
Investments at fair value | [8],[9],[10],[13] | $ 1,262 | |||||||||||||
Investment, Identifier [Axis]: GKD Index Partners, LLC, Specialized Finance, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 10.67% | 10.67% | 10.67% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 25,128 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 24,915 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 24,851 | |||||||||||||
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [1],[2],[3],[4],[5] | 12.34% | 12.34% | 12.34% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7] | $ 1,638 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5] | 1,530 | |||||||||||||
Investments at fair value | [1],[3],[4],[5] | $ 1,532 | |||||||||||||
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12.34% | 12.34% | 12.34% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 23,774 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 23,080 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 23,094 | |||||||||||||
Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 7.94% | 7.94% | 7.94% | ||||||||||||
Investment, principal | $ 7,444 | ||||||||||||||
Investment owned, at cost | 7,369 | ||||||||||||||
Investments at fair value | $ 6,029 | ||||||||||||||
Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | 5% | 5% | 5% | |||||||||
Investment, interest rate | 10.25% | 10.25% | 10.25% | 7.94% | 7.94% | 7.94% | |||||||||
Investment, principal | $ 3,940 | $ 3,970 | |||||||||||||
Investment owned, at cost | 3,901 | 3,930 | |||||||||||||
Investments at fair value | $ 3,191 | $ 3,216 | |||||||||||||
Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 5% | 5% | 5% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 10.25% | 10.25% | 10.25% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 2,463 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 2,039 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 1,995 | |||||||||||||
Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 10.25% | 10.25% | 10.25% | ||||||||||||
Investment, principal | $ 7,388 | ||||||||||||||
Investment owned, at cost | 7,314 | ||||||||||||||
Investments at fair value | $ 5,984 | ||||||||||||||
Investment, Identifier [Axis]: Global Medical Response, Inc., First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.25% | 4.25% | 4.25% | ||||||||||||
Investment, interest rate | 7.37% | 7.37% | 7.37% | ||||||||||||
Investment, principal | $ 1,979 | ||||||||||||||
Investment owned, at cost | 1,979 | ||||||||||||||
Investments at fair value | $ 1,722 | ||||||||||||||
Investment, Identifier [Axis]: Global Medical Response, Inc., First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.25% | 4.25% | 4.25% | ||||||||||||
Investment, interest rate | 6.81% | 6.81% | 6.81% | ||||||||||||
Investment, principal | $ 2,192 | ||||||||||||||
Investment owned, at cost | 2,165 | ||||||||||||||
Investments at fair value | $ 1,912 | ||||||||||||||
Investment, Identifier [Axis]: Global Medical Response, Inc., Health Care Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [9],[10] | 4.25% | 4.25% | 4.25% | |||||||||||
Investment, interest rate | [9],[10],[11] | 7.37% | 7.37% | 7.37% | |||||||||||
Investment, principal | [9],[10],[12] | $ 5,572 | |||||||||||||
Investment owned, at cost | [9],[10] | 5,435 | |||||||||||||
Investments at fair value | [9],[10] | $ 4,848 | |||||||||||||
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [4],[5],[14] | 2.85% | 2.85% | 2.85% | |||||||||||
Investment, interest rate | [2],[4],[5],[14] | 6.05% | 6.05% | 6.05% | |||||||||||
Investment, principal | € | [4],[5],[7],[14] | € 1,000 | |||||||||||||
Investment owned, at cost | [4],[5],[14] | $ 872 | |||||||||||||
Investments at fair value | [4],[5],[14] | $ 970 | |||||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | [1],[3],[4],[5] | 8% | [1],[3],[4],[5] | 8% | [1],[3],[4],[5] | 8% | [8],[9],[10],[13] | 8% | [8],[9],[10],[13] | 8% | [8],[9],[10],[13] | |||
Investment, principal | $ 0 | [1],[3],[4],[5],[7] | $ 0 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | (29) | [1],[3],[4],[5] | (27) | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ (18) | [1],[3],[4],[5] | $ (25) | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | [1],[4],[5] | 8% | [1],[4],[5] | 8% | [1],[4],[5] | 8% | [8],[9],[10] | 8% | [8],[9],[10] | 8% | [8],[9],[10] | |||
Investment, interest rate | 13.39% | [1],[2],[4],[5] | 13.39% | [1],[2],[4],[5] | 13.39% | [1],[2],[4],[5] | 11.04% | [8],[9],[10],[11] | 11.04% | [8],[9],[10],[11] | 11.04% | [8],[9],[10],[11] | |||
Investment, principal | $ 17,488 | [1],[4],[5],[7] | $ 14,311 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 17,308 | [1],[4],[5] | 14,041 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 17,314 | [1],[4],[5] | $ 14,060 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | [1],[3],[4],[5] | 8% | [1],[3],[4],[5] | 8% | [1],[3],[4],[5] | 8% | [8],[9],[10],[13] | 8% | [8],[9],[10],[13] | 8% | [8],[9],[10],[13] | |||
Investment, principal | $ 0 | [1],[3],[4],[5],[7] | $ 0 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | (58) | [1],[3],[4],[5] | (54) | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ (35) | [1],[3],[4],[5] | $ (50) | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | [4],[5] | 5.25% | [4],[5] | 5.25% | [4],[5] | 5.25% | [9],[10] | 5.25% | [9],[10] | 5.25% | [9],[10] | |||
Investment, interest rate | 10.45% | [2],[4],[5] | 10.45% | [2],[4],[5] | 10.45% | [2],[4],[5] | 8.38% | [9],[10],[11] | 8.38% | [9],[10],[11] | 8.38% | [9],[10],[11] | |||
Investment, principal | $ 14,383 | [4],[5],[7] | $ 9,392 | [9],[10],[12] | |||||||||||
Investment owned, at cost | 13,885 | [4],[5] | 9,080 | [9],[10] | |||||||||||
Investments at fair value | $ 12,352 | [4],[5] | $ 8,582 | [9],[10] | |||||||||||
Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | ||||||||||||
Investment, interest rate | 10.45% | 10.45% | 10.45% | ||||||||||||
Investment, principal | $ 7,940 | ||||||||||||||
Investment owned, at cost | 7,742 | ||||||||||||||
Investments at fair value | $ 6,818 | ||||||||||||||
Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | ||||||||||||
Investment, interest rate | 8.38% | 8.38% | 8.38% | ||||||||||||
Investment, principal | $ 8,000 | ||||||||||||||
Investment owned, at cost | 7,774 | ||||||||||||||
Investments at fair value | $ 7,310 | ||||||||||||||
Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||
Investment, interest rate | 10.45% | 10.45% | 10.45% | 8.38% | 8.38% | 8.38% | |||||||||
Investment, principal | $ 3,970 | $ 4,000 | |||||||||||||
Investment owned, at cost | 3,871 | 3,887 | |||||||||||||
Investments at fair value | $ 3,409 | $ 3,655 | |||||||||||||
Investment, Identifier [Axis]: Harrow Health, Inc., Pharmaceuticals, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5],[14] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5],[14] | 11.74% | 11.74% | 11.74% | |||||||||||
Investment, principal | [1],[4],[5],[7],[14] | $ 7,448 | |||||||||||||
Investment owned, at cost | [1],[4],[5],[14] | 7,279 | |||||||||||||
Investments at fair value | [1],[4],[5],[14] | $ 7,295 | |||||||||||||
Investment, Identifier [Axis]: Harrow Health, Inc., Pharmaceuticals, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5],[14] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7],[14] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5],[14] | (91) | |||||||||||||
Investments at fair value | [1],[3],[4],[5],[14] | $ (83) | |||||||||||||
Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [2],[4],[5],[14] | 4.46% | 4.46% | 4.46% | |||||||||||
Investment, principal | [4],[7],[14] | $ 6,932 | |||||||||||||
Investment owned, at cost | [4],[14] | 5,577 | |||||||||||||
Investments at fair value | [4],[14] | $ 6,001 | |||||||||||||
Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5],[14] | 8.25% | 8.25% | 8.25% | |||||||||||
Investment, interest rate | [1],[2],[4],[5],[14] | 13.30% | 13.30% | 13.30% | |||||||||||
Investment, principal | [1],[4],[5],[7],[14] | $ 23,975 | |||||||||||||
Investment owned, at cost | [1],[4],[5],[14] | 23,274 | |||||||||||||
Investments at fair value | [1],[4],[5],[14] | $ 23,292 | |||||||||||||
Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.75% | 5.75% | 5.75% | ||||||||||||
Investment, interest rate | 9.42% | 9.42% | 9.42% | ||||||||||||
Investment, principal | $ 9,500 | ||||||||||||||
Investment owned, at cost | 9,282 | ||||||||||||||
Investments at fair value | $ 8,408 | ||||||||||||||
Investment, Identifier [Axis]: INW Manufacturing, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.75% | 5.75% | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||
Investment, interest rate | 11.29% | 11.29% | 11.29% | 9.42% | 9.42% | 9.42% | |||||||||
Investment, principal | $ 2,281 | $ 2,375 | |||||||||||||
Investment owned, at cost | 2,238 | 2,320 | |||||||||||||
Investments at fair value | $ 1,810 | $ 2,102 | |||||||||||||
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 11.29% | 11.29% | 11.29% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 45,169 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 43,394 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 35,834 | |||||||||||||
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.75% | 5.75% | 5.75% | ||||||||||||
Investment, interest rate | 11.29% | 11.29% | 11.29% | ||||||||||||
Investment, principal | $ 9,125 | ||||||||||||||
Investment owned, at cost | 8,950 | ||||||||||||||
Investments at fair value | $ 7,239 | ||||||||||||||
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Products, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 9.42% | 9.42% | 9.42% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 35,625 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 34,806 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 31,528 | |||||||||||||
Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[4],[5] | 6.50% | [1],[4],[5] | 6.50% | [1],[4],[5] | 6.50% | [8],[9],[10] | 6.50% | [8],[9],[10] | 6.50% | [8],[9],[10] | |||
Investment, interest rate | 11.57% | [1],[2],[4],[5] | 11.57% | [1],[2],[4],[5] | 11.57% | [1],[2],[4],[5] | 9.44% | [8],[9],[10],[11] | 9.44% | [8],[9],[10],[11] | 9.44% | [8],[9],[10],[11] | |||
Investment, principal | $ 40,484 | [1],[4],[5],[7] | $ 34,357 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 39,779 | [1],[4],[5] | 33,612 | [8],[9],[10] | |||||||||||
Investments at fair value | 38,662 | [1],[4],[5] | $ 32,639 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Immucor, Inc., Health Care Supplies, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 5.75% | 5.75% | 5.75% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 9.42% | 9.42% | 9.42% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 8,569 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 8,401 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 8,407 | |||||||||||||
Investment, Identifier [Axis]: Immucor, Inc., Health Care Supplies, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 8% | 8% | 8% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 11.67% | 11.67% | 11.67% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 22,619 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 22,162 | |||||||||||||
Investments at fair value | [8],[9],[10] | 22,275 | |||||||||||||
Investment, Identifier [Axis]: Impel Neuropharma, Inc., Health Care Technology, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | 15,302 | [1],[4],[7],[15] | 13,083 | [8],[9],[12],[22] | |||||||||||
Investment owned, at cost | 15,341 | [1],[4],[15] | 13,083 | [8],[9],[22] | |||||||||||
Investments at fair value | $ 14,269 | [1],[4],[15] | $ 13,083 | [8],[9],[22] | |||||||||||
Investment, Identifier [Axis]: Impel Neuropharma, Inc., Health Care Technology, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.75% | [1],[4],[5] | 8.75% | [1],[4],[5] | 8.75% | [1],[4],[5] | 8.75% | [8],[9],[10] | 8.75% | [8],[9],[10] | 8.75% | [8],[9],[10] | |||
Investment, interest rate | 14.14% | [1],[2],[4],[5] | 14.14% | [1],[2],[4],[5] | 14.14% | [1],[2],[4],[5] | 12.45% | [8],[9],[10],[11] | 12.45% | [8],[9],[10],[11] | 12.45% | [8],[9],[10],[11] | |||
Investment, principal | $ 13,109 | [1],[4],[5],[7] | $ 12,161 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 12,939 | [1],[4],[5] | 11,944 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 12,617 | [1],[4],[5] | $ 11,942 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | ||||||||||||
Investment, interest rate | 8.80% | 8.80% | 8.80% | ||||||||||||
Investment, principal | $ 7,406 | ||||||||||||||
Investment owned, at cost | 7,293 | ||||||||||||||
Investments at fair value | $ 7,286 | ||||||||||||||
Investment, Identifier [Axis]: Indivior Finance S.À.R.L., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||
Investment, interest rate | 10.75% | 10.75% | 10.75% | 8.80% | 8.80% | 8.80% | |||||||||
Investment, principal | $ 3,920 | $ 3,950 | |||||||||||||
Investment owned, at cost | 3,872 | 3,890 | |||||||||||||
Investments at fair value | $ 3,925 | $ 3,886 | |||||||||||||
Investment, Identifier [Axis]: Indivior Finance S.À.R.L., Pharmaceuticals, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | ||||||||||||
Investment, interest rate | 10.75% | 10.75% | 10.75% | ||||||||||||
Investment, principal | $ 7,350 | ||||||||||||||
Investment owned, at cost | 7,260 | ||||||||||||||
Investments at fair value | $ 7,359 | ||||||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 11% | [1],[2],[4],[5],[14] | 11% | [1],[2],[4],[5],[14] | 11% | [1],[2],[4],[5],[14] | 11% | [8],[9],[10],[11],[16] | 11% | [8],[9],[10],[11],[16] | 11% | [8],[9],[10],[11],[16] | |||
Investment, principal | $ 8,452 | [1],[4],[7],[14] | $ 6,817 | [8],[9],[12],[16] | |||||||||||
Investment owned, at cost | 8,185 | [1],[4],[14] | 6,553 | [8],[9],[16] | |||||||||||
Investments at fair value | $ 7,730 | [1],[4],[14] | $ 6,408 | [8],[9],[16] | |||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 11% | [1],[2],[3],[4],[5],[14] | 11% | [1],[2],[3],[4],[5],[14] | 11% | [1],[2],[3],[4],[5],[14] | 11% | [8],[9],[10],[11],[13],[16] | 11% | [8],[9],[10],[11],[13],[16] | 11% | [8],[9],[10],[11],[13],[16] | |||
Investment, principal | $ 0 | [1],[3],[4],[7],[14] | $ 0 | [8],[9],[12],[13],[16] | |||||||||||
Investment owned, at cost | 0 | [1],[3],[4],[14] | 0 | [8],[9],[13],[16] | |||||||||||
Investments at fair value | $ 0 | [1],[3],[4],[14] | $ 0 | [8],[9],[13],[16] | |||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[3],[4],[5],[14] | 11% | 11% | 11% | |||||||||||
Investment, principal | [1],[3],[4],[7],[14] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[14] | 0 | |||||||||||||
Investments at fair value | [1],[3],[4],[14] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 112,990 | [1],[4],[14] | 112,990 | [1],[4],[14] | 112,990 | [1],[4],[14] | 56,999 | [8],[9],[16] | 56,999 | [8],[9],[16] | 56,999 | [8],[9],[16] | |||
Investment owned, at cost | $ 300 | [1],[4],[14] | $ 135 | [8],[9],[16] | |||||||||||
Investments at fair value | $ 172 | [1],[4],[14] | $ 609 | [8],[9],[16] | |||||||||||
Investment, Identifier [Axis]: Integral Development Corporation, Diversified Financial Services, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [1],[4] | 1,078,284 | 1,078,284 | 1,078,284 | |||||||||||
Investment owned, at cost | [1],[4] | $ 113 | |||||||||||||
Investments at fair value | [1],[4] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Integral Development Corporation, Other Diversified Financial Services, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[9] | 1,078,284 | 1,078,284 | 1,078,284 | |||||||||||
Investment owned, at cost | [8],[9] | $ 113 | |||||||||||||
Investments at fair value | [8],[9] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5] | (114) | |||||||||||||
Investments at fair value | [1],[3],[4],[5] | $ (114) | |||||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[4],[5] | 7.50% | [1],[4],[5] | 7.50% | [1],[4],[5] | 5% | [8],[9],[10] | 5% | [8],[9],[10] | 5% | [8],[9],[10] | |||
Investment, interest rate | 12.72% | [1],[2],[4],[5] | 12.72% | [1],[2],[4],[5] | 12.72% | [1],[2],[4],[5] | 8.55% | [8],[9],[10],[11] | 8.55% | [8],[9],[10],[11] | 8.55% | [8],[9],[10],[11] | |||
Investment, principal | $ 33,498 | [1],[4],[5],[7] | $ 18,660 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 32,494 | [1],[4],[5] | 18,567 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 32,493 | [1],[4],[5] | $ 18,134 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 12.17% | 12.17% | 12.17% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 13,674 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 13,514 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 13,154 | |||||||||||||
Investment, Identifier [Axis]: Iris Holding, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | 4.75% | 4.75% | ||||||||||||
Investment, interest rate | 7.89% | 7.89% | 7.89% | ||||||||||||
Investment, principal | $ 5,000 | ||||||||||||||
Investment owned, at cost | 4,624 | ||||||||||||||
Investments at fair value | $ 4,610 | ||||||||||||||
Investment, Identifier [Axis]: Iris Holding, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | 4.75% | 4.75% | 4.75% | 4.75% | 4.75% | |||||||||
Investment, interest rate | 9.90% | 9.90% | 9.90% | 7.89% | 7.89% | 7.89% | |||||||||
Investment, principal | $ 1,985 | $ 2,000 | |||||||||||||
Investment owned, at cost | 1,852 | 1,846 | |||||||||||||
Investments at fair value | $ 1,690 | $ 1,844 | |||||||||||||
Investment, Identifier [Axis]: Iris Holding, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | 4.75% | 4.75% | ||||||||||||
Investment, interest rate | 9.90% | 9.90% | 9.90% | ||||||||||||
Investment, principal | $ 4,963 | ||||||||||||||
Investment owned, at cost | 4,638 | ||||||||||||||
Investments at fair value | $ 4,226 | ||||||||||||||
Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [4],[5] | 7.25% | [4],[5] | 7.25% | [4],[5] | 7.25% | [9],[10] | 7.25% | [9],[10] | 7.25% | [9],[10] | |||
Investment, interest rate | 12.42% | [2],[4],[5] | 12.42% | [2],[4],[5] | 12.42% | [2],[4],[5] | 10.33% | [9],[10],[11] | 10.33% | [9],[10],[11] | 10.33% | [9],[10],[11] | |||
Investment, principal | $ 13,939 | [4],[5],[7] | $ 10,247 | [9],[10],[12] | |||||||||||
Investment owned, at cost | 12,601 | [4],[5] | 10,196 | [9],[10] | |||||||||||
Investments at fair value | 9,252 | [4],[5] | $ 7,702 | [9],[10] | |||||||||||
Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund, Institutional Shares | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, at cost | 5,193 | ||||||||||||||
Investments at fair value | $ 5,193 | ||||||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 10.62% | 10.62% | 10.62% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 36,234 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 35,170 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 36,392 | |||||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12.70% | 12.70% | 12.70% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 17,069 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 17,053 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 16,966 | |||||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12.70% | 12.70% | 12.70% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 27,360 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 26,872 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 27,488 | |||||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 10.60% | 10.60% | 10.60% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 15,150 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 14,331 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 14,924 | |||||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | [4],[5] | 8% | [4],[5] | 8% | [4],[5] | 8% | [9],[10] | 8% | [9],[10] | 8% | [9],[10] | |||
Investment, interest rate | 13.20% | [2],[4],[5] | 13.20% | [2],[4],[5] | 13.20% | [2],[4],[5] | 11.12% | [9],[10],[11] | 11.12% | [9],[10],[11] | 11.12% | [9],[10],[11] | |||
Investment, principal | $ 666 | [4],[5],[7] | $ 528 | [9],[10],[12] | |||||||||||
Investment owned, at cost | 616 | [4],[5] | 478 | [9],[10] | |||||||||||
Investments at fair value | $ 652 | [4],[5] | $ 481 | [9],[10] | |||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[3],[4],[5] | 6.50% | [1],[3],[4],[5] | 6.50% | [1],[3],[4],[5] | 6.50% | [8],[9],[10],[13] | 6.50% | [8],[9],[10],[13] | 6.50% | [8],[9],[10],[13] | |||
Investment, interest rate | 11.84% | [1],[2],[3],[4],[5] | 11.84% | [1],[2],[3],[4],[5] | 11.84% | [1],[2],[3],[4],[5] | 10.17% | [8],[9],[10],[11],[13] | 10.17% | [8],[9],[10],[11],[13] | 10.17% | [8],[9],[10],[11],[13] | |||
Investment, principal | $ 545 | [1],[3],[4],[5],[7] | $ 329 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | 517 | [1],[3],[4],[5] | 311 | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ 510 | [1],[3],[4],[5] | $ 292 | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[4],[5] | 6.50% | [1],[4],[5] | 6.50% | [1],[4],[5] | 6.50% | [8],[9],[10] | 6.50% | [8],[9],[10] | 6.50% | [8],[9],[10] | |||
Investment, interest rate | 11.84% | [1],[2],[4],[5] | 11.84% | [1],[2],[4],[5] | 11.84% | [1],[2],[4],[5] | 10.17% | [8],[9],[10],[11] | 10.17% | [8],[9],[10],[11] | 10.17% | [8],[9],[10],[11] | |||
Investment, principal | $ 16,765 | [1],[4],[5],[7] | $ 13,623 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 16,636 | [1],[4],[5] | 13,487 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 16,511 | [1],[4],[5] | $ 13,351 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: LABL, Inc., Office Services & Supplies, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 10.20% | 10.20% | 10.20% | ||||||||||||
Investment, principal | $ 3,972 | ||||||||||||||
Investment owned, at cost | 3,817 | ||||||||||||||
Investments at fair value | $ 3,940 | ||||||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[3],[4],[5] | 6% | [1],[3],[4],[5] | 6% | [1],[3],[4],[5] | 6% | [8],[9],[10],[13] | 6% | [8],[9],[10],[13] | 6% | [8],[9],[10],[13] | |||
Investment, interest rate | [8],[9],[10],[11],[13] | 9.12% | 9.12% | 9.12% | |||||||||||
Investment, principal | $ 0 | [1],[3],[4],[5],[7] | $ 1,710 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | (44) | [1],[3],[4],[5] | 1,672 | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ (146) | [1],[3],[4],[5] | $ 1,651 | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 9.12% | 9.12% | 9.12% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 19,236 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 18,894 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 18,707 | |||||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 11.20% | 11.20% | 11.20% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 2,742 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 2,594 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 2,592 | |||||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 11.20% | 11.20% | 11.20% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 23,554 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 23,166 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 22,258 | |||||||||||||
Investment, Identifier [Axis]: LTI Holdings, Inc., Electronic Components, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.50% | 3.50% | 3.50% | ||||||||||||
Investment, interest rate | 8.72% | 8.72% | 8.72% | ||||||||||||
Investment, principal | $ 7,308 | ||||||||||||||
Investment owned, at cost | 7,246 | ||||||||||||||
Investments at fair value | $ 7,037 | ||||||||||||||
Investment, Identifier [Axis]: LTI Holdings, Inc., Electronic Components, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [4],[5] | 6.75% | [4],[5] | 6.75% | [4],[5] | 6.75% | [9],[10] | 6.75% | [9],[10] | 6.75% | [9],[10] | |||
Investment, interest rate | 11.97% | [2],[4],[5] | 11.97% | [2],[4],[5] | 11.97% | [2],[4],[5] | 9.87% | [9],[10],[11] | 9.87% | [9],[10],[11] | 9.87% | [9],[10],[11] | |||
Investment, principal | $ 2,140 | [4],[5],[7] | $ 2,140 | [9],[10],[12] | |||||||||||
Investment owned, at cost | 2,101 | [4],[5] | 2,092 | [9],[10] | |||||||||||
Investments at fair value | $ 1,834 | [4],[5] | $ 1,890 | [9],[10] | |||||||||||
Investment, Identifier [Axis]: LTI Holdings, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.25% | 3.25% | 3.25% | ||||||||||||
Investment, interest rate | 6.37% | 6.37% | 6.37% | ||||||||||||
Investment, principal | $ 7,366 | ||||||||||||||
Investment owned, at cost | 7,282 | ||||||||||||||
Investments at fair value | $ 6,835 | ||||||||||||||
Investment, Identifier [Axis]: LTI Holdings, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.50% | 3.50% | 3.50% | 3.25% | 3.25% | 3.25% | |||||||||
Investment, interest rate | 8.72% | 8.72% | 8.72% | 6.37% | 6.37% | 6.37% | |||||||||
Investment, principal | $ 1,347 | $ 1,358 | |||||||||||||
Investment owned, at cost | 1,224 | 1,192 | |||||||||||||
Investments at fair value | 1,297 | 1,260 | |||||||||||||
Investment, Identifier [Axis]: Largest Exposure To A Single Borrower | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | 11,304,000 | 10,093 | |||||||||||||
Investment, Identifier [Axis]: Largest Loan Exposure To A Single Borrower | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | $ 6,313 | $ 6,562 | |||||||||||||
Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.75% | 5.75% | 5.75% | ||||||||||||
Investment, interest rate | 8.23% | 8.23% | 8.23% | ||||||||||||
Investment, principal | $ 7,444 | ||||||||||||||
Investment owned, at cost | 7,318 | ||||||||||||||
Investments at fair value | $ 7,323 | ||||||||||||||
Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.75% | 5.75% | 5.75% | 5.75% | 5.75% | 5.75% | |||||||||
Investment, interest rate | 11.08% | 11.08% | 11.08% | 8.23% | 8.23% | 8.23% | |||||||||
Investment, principal | $ 3,940 | $ 3,970 | |||||||||||||
Investment owned, at cost | 3,883 | 3,903 | |||||||||||||
Investments at fair value | $ 3,876 | $ 3,905 | |||||||||||||
Investment, Identifier [Axis]: LaserAway Intermediate Holdings II, LLC, Health Care Services, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.75% | 5.75% | 5.75% | ||||||||||||
Investment, interest rate | 11.08% | 11.08% | 11.08% | ||||||||||||
Investment, principal | $ 7,388 | ||||||||||||||
Investment owned, at cost | 7,281 | ||||||||||||||
Investments at fair value | $ 7,267 | ||||||||||||||
Investment, Identifier [Axis]: LaserShip, Inc., Air Freight & Logistics, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 10.38% | 10.38% | 10.38% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 2,394 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 2,370 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 1,867 | |||||||||||||
Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [4],[5],[14] | 9.50% | 9.50% | 9.50% | |||||||||||
Investment, interest rate | [2],[4],[5],[14] | 14.61% | 14.61% | 14.61% | |||||||||||
Investment, principal | [4],[5],[7],[14] | $ 26,489 | |||||||||||||
Investment owned, at cost | [4],[5],[14] | 24,888 | |||||||||||||
Investments at fair value | [4],[5],[14] | $ 26,985 | |||||||||||||
Investment, Identifier [Axis]: Lift Brands Holdings, Inc., Leisure Facilities, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 2,000,000 | [1],[4] | 2,000,000 | [1],[4] | 2,000,000 | [1],[4] | 2,000,000 | [8],[9] | 2,000,000 | [8],[9] | 2,000,000 | [8],[9] | |||
Investment owned, at cost | $ 1,399 | [1],[4] | $ 1,399 | [8],[9] | |||||||||||
Investments at fair value | $ 0 | [1],[4] | $ 0 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 8.67% | 8.67% | 8.67% | ||||||||||||
Investment, principal | $ 7,367 | ||||||||||||||
Investment owned, at cost | 7,315 | ||||||||||||||
Investments at fair value | $ 7,109 | ||||||||||||||
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | [1],[4],[5] | 5% | [1],[4],[5] | 5% | [1],[4],[5] | 5% | [8],[9],[10] | 5% | [8],[9],[10] | 5% | [8],[9],[10] | |||
Investment, interest rate | 10.50% | [1],[2],[4],[5] | 10.50% | [1],[2],[4],[5] | 10.50% | [1],[2],[4],[5] | 8.67% | [8],[9],[10],[11] | 8.67% | [8],[9],[10],[11] | 8.67% | [8],[9],[10],[11] | |||
Investment, principal | $ 45,361 | [1],[4],[5],[7] | $ 41,008 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 44,783 | [1],[4],[5] | 40,243 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 44,227 | [1],[4],[5] | $ 39,573 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 10.50% | 10.50% | 10.50% | ||||||||||||
Investment, principal | $ 11,279 | ||||||||||||||
Investment owned, at cost | 11,121 | ||||||||||||||
Investments at fair value | $ 10,997 | ||||||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 559 | [1],[4] | 559 | [1],[4] | 559 | [1],[4] | 451 | [8],[9] | 451 | [8],[9] | 451 | [8],[9] | |||
Investment, principal | [1],[4],[7] | ||||||||||||||
Investment owned, at cost | 563 | [1],[4] | $ 451 | [8],[9] | |||||||||||
Investments at fair value | $ 487 | [1],[4] | $ 451 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [1],[4],[5] | 8.50% | [1],[4],[5] | 8.50% | [1],[4],[5] | 8.50% | [8],[9],[10] | 8.50% | [8],[9],[10] | 8.50% | [8],[9],[10] | |||
Investment, interest rate | 13.84% | [1],[2],[4],[5] | 13.84% | [1],[2],[4],[5] | 13.84% | [1],[2],[4],[5] | 11.38% | [8],[9],[10],[11] | 11.38% | [8],[9],[10],[11] | 11.38% | [8],[9],[10],[11] | |||
Investment, principal | $ 5,403 | [1],[4],[5],[7] | $ 4,357 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 5,344 | [1],[4],[5] | 4,285 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 5,173 | [1],[4],[5] | $ 4,226 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [1],[3],[4],[5] | 8.50% | [1],[3],[4],[5] | 8.50% | [1],[3],[4],[5] | 8.50% | [8],[9],[10],[13] | 8.50% | [8],[9],[10],[13] | 8.50% | [8],[9],[10],[13] | |||
Investment, interest rate | 13.84% | [1],[2],[3],[4],[5] | 13.84% | [1],[2],[3],[4],[5] | 13.84% | [1],[2],[3],[4],[5] | 11.38% | [8],[9],[10],[11],[13] | 11.38% | [8],[9],[10],[11],[13] | 11.38% | [8],[9],[10],[11],[13] | |||
Investment, principal | $ 2,939 | [1],[3],[4],[5],[7] | $ 2,370 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | 2,883 | [1],[3],[4],[5] | 2,323 | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ 2,755 | [1],[3],[4],[5] | $ 2,265 | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: LogMeIn, Inc., Application Software, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | 4.75% | 4.75% | ||||||||||||
Investment, interest rate | 9.94% | 9.94% | 9.94% | ||||||||||||
Investment, principal | $ 7,800 | ||||||||||||||
Investment owned, at cost | 7,705 | ||||||||||||||
Investments at fair value | $ 4,918 | ||||||||||||||
Investment, Identifier [Axis]: LogMeIn, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | 4.75% | 4.75% | ||||||||||||
Investment, interest rate | 7.80% | 7.80% | 7.80% | ||||||||||||
Investment, principal | $ 7,860 | ||||||||||||||
Investment owned, at cost | 7,751 | ||||||||||||||
Investments at fair value | $ 5,494 | ||||||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[3],[4],[5] | 6% | [1],[3],[4],[5] | 6% | [1],[3],[4],[5] | 6% | [8],[9],[10],[13] | 6% | [8],[9],[10],[13] | 6% | [8],[9],[10],[13] | |||
Investment, interest rate | [1],[2],[3],[4],[5] | 11.25% | 11.25% | 11.25% | |||||||||||
Investment, principal | $ 250 | [1],[3],[4],[5],[7] | $ 0 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | 220 | [1],[3],[4],[5] | (23) | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ 203 | [1],[3],[4],[5] | $ (54) | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 9.50% | 9.50% | 9.50% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 18,390 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 18,088 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 17,691 | |||||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 11.20% | 11.20% | 11.20% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 20,176 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 19,949 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 19,648 | |||||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 11.20% | 11.20% | 11.20% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 2,637 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 2,594 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 2,568 | |||||||||||||
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [1],[2],[3],[4],[5] | 12.58% | 12.58% | 12.58% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7] | $ 2,118 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5] | 1,853 | |||||||||||||
Investments at fair value | [1],[3],[4],[5] | $ 1,853 | |||||||||||||
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12.74% | 12.74% | 12.74% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 40,640 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 39,937 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 39,937 | |||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | [1],[3],[4],[5] | 5.50% | [1],[3],[4],[5] | 5.50% | [1],[3],[4],[5] | 5.50% | [8],[9],[10],[13] | 5.50% | [8],[9],[10],[13] | 5.50% | [8],[9],[10],[13] | |||
Investment, principal | $ 0 | [1],[3],[4],[5],[7] | $ 0 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | (29) | [1],[3],[4],[5] | (13) | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ (62) | [1],[3],[4],[5] | $ (51) | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | ||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investment owned, at cost | (3) | ||||||||||||||
Investments at fair value | $ (9) | ||||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | ||||||||||||
Investment, interest rate | 10.84% | 10.84% | 10.84% | ||||||||||||
Investment, principal | $ 8,340 | ||||||||||||||
Investment owned, at cost | 8,172 | ||||||||||||||
Investments at fair value | $ 8,111 | ||||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | [1],[4],[5] | 5.50% | [1],[4],[5] | 5.50% | [1],[4],[5] | 5.50% | [8],[9],[10] | 5.50% | [8],[9],[10] | 5.50% | [8],[9],[10] | |||
Investment, interest rate | 10.84% | [1],[2],[4],[5] | 10.84% | [1],[2],[4],[5] | 10.84% | [1],[2],[4],[5] | 9.17% | [8],[9],[10],[11] | 9.17% | [8],[9],[10],[11] | 9.17% | [8],[9],[10],[11] | |||
Investment, principal | $ 12,397 | [1],[4],[5],[7] | $ 29,565 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 12,357 | [1],[4],[5] | 29,128 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 12,056 | [1],[4],[5] | $ 28,734 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | [1],[4],[5] | 5.50% | [1],[4],[5] | 5.50% | [1],[4],[5] | 5.50% | [8],[9],[10],[13] | 5.50% | [8],[9],[10],[13] | 5.50% | [8],[9],[10],[13] | |||
Investment, interest rate | [1],[2],[4],[5] | 10.84% | 10.84% | 10.84% | |||||||||||
Investment, principal | $ 21,383 | [1],[4],[5],[7] | $ 0 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | 21,055 | [1],[4],[5] | (12) | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ 20,795 | [1],[4],[5] | $ (96) | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | ||||||||||||
Investment, interest rate | 10.84% | 10.84% | 10.84% | ||||||||||||
Investment, principal | $ 2,217 | ||||||||||||||
Investment owned, at cost | 2,216 | ||||||||||||||
Investments at fair value | $ 2,156 | ||||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [1],[2],[3],[4],[5] | 10.83% | 10.83% | 10.83% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7] | $ 570 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5] | 559 | |||||||||||||
Investments at fair value | [1],[3],[4],[5] | $ 526 | |||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | ||||||||||||
Investment, principal | |||||||||||||||
Investment owned, at cost | (3) | ||||||||||||||
Investments at fair value | $ (10) | ||||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, First Lien Revolver | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||
Investment, principal | $ 0 | $ 0 | |||||||||||||
Investment owned, at cost | (1) | (1) | |||||||||||||
Investments at fair value | $ (4) | $ (4) | |||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | ||||||||||||
Investment, interest rate | 9.17% | 9.17% | 9.17% | ||||||||||||
Investment, principal | $ 6,139 | ||||||||||||||
Investment owned, at cost | 6,104 | ||||||||||||||
Investments at fair value | $ 5,966 | ||||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | 5.50% | 5.50% | 5.50% | |||||||||
Investment, interest rate | 10.84% | 10.84% | 10.84% | 9.17% | 9.17% | 9.17% | |||||||||
Investment, principal | $ 1,634 | $ 1,647 | |||||||||||||
Investment owned, at cost | 1,621 | 1,632 | |||||||||||||
Investments at fair value | $ 1,589 | $ 1,600 | |||||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 11.50% | [1],[2],[4],[5],[14] | 11.50% | [1],[2],[4],[5],[14] | 11.50% | [1],[2],[4],[5],[14] | 11.50% | [8],[9],[10],[11],[16] | 11.50% | [8],[9],[10],[11],[16] | 11.50% | [8],[9],[10],[11],[16] | |||
Investment, principal | $ 8,568 | [1],[4],[7],[14] | $ 17,203 | [8],[9],[12],[16] | |||||||||||
Investment owned, at cost | 8,488 | [1],[4],[14] | 16,954 | [8],[9],[16] | |||||||||||
Investments at fair value | $ 8,225 | [1],[4],[14] | $ 16,644 | [8],[9],[16] | |||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 11.50% | [1],[2],[4],[5],[14] | 11.50% | [1],[2],[4],[5],[14] | 11.50% | [1],[2],[4],[5],[14] | 11.50% | [8],[9],[10],[11],[13],[16] | 11.50% | [8],[9],[10],[11],[13],[16] | 11.50% | [8],[9],[10],[11],[13],[16] | |||
Investment, principal | $ 4,284 | [1],[4],[7],[14] | $ 0 | [8],[9],[12],[13],[16] | |||||||||||
Investment owned, at cost | 4,244 | [1],[4],[14] | 0 | [8],[9],[13],[16] | |||||||||||
Investments at fair value | $ 4,112 | [1],[4],[14] | $ 0 | [8],[9],[13],[16] | |||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[4],[5],[14] | 11.50% | 11.50% | 11.50% | |||||||||||
Investment, principal | [1],[4],[7],[14] | $ 8,568 | |||||||||||||
Investment owned, at cost | [1],[4],[14] | 8,488 | |||||||||||||
Investments at fair value | [1],[4],[14] | $ 8,225 | |||||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 4 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[4],[5],[14] | 11.50% | 11.50% | 11.50% | |||||||||||
Investment, principal | [1],[3],[4],[7],[14] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[14] | 0 | |||||||||||||
Investments at fair value | [1],[3],[4],[14] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: McAfee Corp., Systems Software, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 9.01% | 9.01% | 9.01% | ||||||||||||
Investment, principal | $ 5,955 | ||||||||||||||
Investment owned, at cost | 5,655 | ||||||||||||||
Investments at fair value | $ 5,713 | ||||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 8% | [1],[2],[4],[5],[14] | 8% | [1],[2],[4],[5],[14] | 8% | [1],[2],[4],[5],[14] | 8% | [8],[9],[10],[11],[16] | 8% | [8],[9],[10],[11],[16] | 8% | [8],[9],[10],[11],[16] | |||
Investment, principal | $ 9,066 | [1],[4],[7],[14] | $ 7,215 | [8],[9],[12],[16] | |||||||||||
Investment owned, at cost | 8,496 | [1],[4],[14] | 6,650 | [8],[9],[16] | |||||||||||
Investments at fair value | $ 8,114 | [1],[4],[14] | $ 6,440 | [8],[9],[16] | |||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 8% | [1],[2],[4],[5],[14] | 8% | [1],[2],[4],[5],[14] | 8% | [1],[2],[4],[5],[14] | 8% | [8],[9],[10],[11],[13],[16] | 8% | [8],[9],[10],[11],[13],[16] | 8% | [8],[9],[10],[11],[13],[16] | |||
Investment, principal | $ 0 | [1],[3],[4],[7],[14] | $ 0 | [8],[9],[12],[13],[16] | |||||||||||
Investment owned, at cost | 1 | [1],[3],[4],[14] | 1 | [8],[9],[13],[16] | |||||||||||
Investments at fair value | $ 0 | [1],[3],[4],[14] | $ 0 | [8],[9],[13],[16] | |||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[4],[5],[14] | 8% | 8% | 8% | |||||||||||
Investment, principal | [1],[3],[4],[7],[14] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[14] | 0 | |||||||||||||
Investments at fair value | [1],[3],[4],[14] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[9],[16] | 209,588 | 209,588 | 209,588 | |||||||||||
Investment owned, at cost | [8],[9],[16] | $ 480 | |||||||||||||
Investments at fair value | [8],[9],[16] | $ 170 | |||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [1],[4],[14] | 259,877 | 259,877 | 259,877 | |||||||||||
Investment, principal | [1],[4],[7],[14] | ||||||||||||||
Investment owned, at cost | [1],[4],[14] | 545 | |||||||||||||
Investments at fair value | [1],[4],[14] | $ 437 | |||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [1],[4],[14] | 66,817 | 66,817 | 66,817 | |||||||||||
Investment, principal | [1],[4],[7],[14] | ||||||||||||||
Investment owned, at cost | [1],[4],[14] | 23 | |||||||||||||
Investments at fair value | [1],[4],[14] | $ 153 | |||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., First Lien Revolver | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | 8% | 8% | ||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investment owned, at cost | (4) | ||||||||||||||
Investments at fair value | $ (12) | ||||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | 7% | 7% | ||||||||||||
Investment, interest rate | 10.64% | 10.64% | 10.64% | ||||||||||||
Investment, principal | $ 4,687 | ||||||||||||||
Investment owned, at cost | 4,651 | ||||||||||||||
Investments at fair value | $ 4,570 | ||||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[3],[4],[5] | 7% | [1],[3],[4],[5] | 7% | [1],[3],[4],[5] | 8% | [8],[9],[10],[13] | 8% | [8],[9],[10],[13] | 8% | [8],[9],[10],[13] | |||
Investment, principal | $ 0 | [1],[3],[4],[5],[7] | $ 0 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | (51) | [1],[3],[4],[5] | (54) | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ (71) | [1],[3],[4],[5] | $ (100) | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | 8% | 8% | ||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investment owned, at cost | (3) | ||||||||||||||
Investments at fair value | $ (7) | ||||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 10.64% | 10.64% | 10.64% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 45,665 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 44,689 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 44,523 | |||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | 7% | 7% | ||||||||||||
Investment, interest rate | 12.19% | 12.19% | 12.19% | ||||||||||||
Investment, principal | $ 4,669 | ||||||||||||||
Investment owned, at cost | 4,644 | ||||||||||||||
Investments at fair value | $ 4,599 | ||||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12.19% | 12.19% | 12.19% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 7,464 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 7,416 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 7,352 | |||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12.19% | 12.19% | 12.19% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 46,687 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 46,157 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 45,987 | |||||||||||||
Investment, Identifier [Axis]: Mitchell International Inc, Application Software, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 8.94% | 8.94% | 8.94% | ||||||||||||
Investment, principal | $ 2,991 | ||||||||||||||
Investment owned, at cost | 2,845 | ||||||||||||||
Investments at fair value | $ 2,931 | ||||||||||||||
Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [1],[4],[5] | 6.75% | [1],[4],[5] | 6.75% | [1],[4],[5] | 6.75% | [8],[9],[10] | 6.75% | [8],[9],[10] | 6.75% | [8],[9],[10] | |||
Investment, interest rate | 11.97% | [1],[2],[4],[5] | 11.97% | [1],[2],[4],[5] | 11.97% | [1],[2],[4],[5] | 9.89% | [8],[9],[10],[11] | 9.89% | [8],[9],[10],[11] | 9.89% | [8],[9],[10],[11] | |||
Investment, principal | $ 55,297 | [1],[4],[5],[7] | $ 46,499 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 54,939 | [1],[4],[5] | 45,802 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 54,235 | [1],[4],[5] | $ 45,421 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [2],[4],[5] | 6.88% | 6.88% | 6.88% | |||||||||||
Investment, principal | [4],[7] | $ 10,191 | |||||||||||||
Investment owned, at cost | [4] | 9,816 | |||||||||||||
Investments at fair value | [4] | $ 8,860 | |||||||||||||
Investment, Identifier [Axis]: NFP Corp., Other Diversified Financial Services, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [9],[10],[11] | 6.88% | 6.88% | 6.88% | |||||||||||
Investment, principal | [9],[12] | $ 10,191 | |||||||||||||
Investment owned, at cost | [9] | 9,773 | |||||||||||||
Investments at fair value | [9] | $ 7,966 | |||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5],[14] | 6.88% | 6.88% | 6.88% | |||||||||||
Investment, interest rate | [1],[2],[4],[5],[14] | 12.08% | 12.08% | 12.08% | |||||||||||
Investment, principal | [1],[4],[5],[7],[14] | $ 73,178 | |||||||||||||
Investment owned, at cost | [1],[4],[5],[14] | 72,195 | |||||||||||||
Investments at fair value | [1],[4],[5],[14] | $ 69,885 | |||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 487,870 | 487,870 | 487,870 | ||||||||||||
Investment, principal | € | [1],[4],[5],[7],[14] | € 0 | |||||||||||||
Investment owned, at cost | [1],[4],[5],[14] | $ 0 | |||||||||||||
Investments at fair value | [1],[4],[5],[14] | $ 1,161 | |||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 487,870 | 487,870 | 487,870 | ||||||||||||
Investment, principal | € | [4],[5],[7],[14] | € 0 | |||||||||||||
Investment owned, at cost | [4],[5],[14] | $ 0 | |||||||||||||
Investments at fair value | [4],[5],[14] | $ 1,161 | |||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10],[16] | 6.88% | 6.88% | 6.88% | |||||||||||
Investment, interest rate | [8],[9],[10],[11],[16] | 9.99% | 9.99% | 9.99% | |||||||||||
Investment, principal | [8],[9],[10],[12],[16] | $ 58,713 | |||||||||||||
Investment owned, at cost | [8],[9],[10],[16] | 57,655 | |||||||||||||
Investments at fair value | [8],[9],[10],[16] | $ 56,805 | |||||||||||||
Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [1],[4],[5] | 8.50% | [1],[4],[5] | 8.50% | [1],[4],[5] | 8.50% | [8],[9],[10] | 8.50% | [8],[9],[10] | 8.50% | [8],[9],[10] | |||
Investment, interest rate | 14.04% | [1],[2],[4],[5] | 14.04% | [1],[2],[4],[5] | 14.04% | [1],[2],[4],[5] | 12.17% | [8],[9],[10],[11] | 12.17% | [8],[9],[10],[11] | 12.17% | [8],[9],[10],[11] | |||
Investment, principal | $ 30,339 | [1],[4],[5],[7] | $ 22,560 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 30,002 | [1],[4],[5] | 22,241 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 29,125 | [1],[4],[5] | $ 21,524 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 10.50% | [1],[4],[5] | 10.50% | [1],[4],[5] | 10.50% | [1],[4],[5] | 10.50% | [8],[9],[10] | 10.50% | [8],[9],[10] | 10.50% | [8],[9],[10] | |||
Investment, interest rate | 16.04% | [1],[2],[4],[5] | 16.04% | [1],[2],[4],[5] | 16.04% | [1],[2],[4],[5] | 14.17% | [8],[9],[10],[11] | 14.17% | [8],[9],[10],[11] | 14.17% | [8],[9],[10],[11] | |||
Investment, principal | $ 64,606 | [1],[4],[5],[7] | $ 50,459 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 64,750 | [1],[4],[5] | 49,301 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 63,185 | [1],[4],[5] | $ 51,972 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Northern Star Industries Inc., Electrical Components & Equipment, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | ||||||||||||
Investment, interest rate | 10% | 10% | 10% | ||||||||||||
Investment, principal | $ 6,633 | ||||||||||||||
Investment owned, at cost | 6,624 | ||||||||||||||
Investments at fair value | $ 6,583 | ||||||||||||||
Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | 4.75% | 4.75% | ||||||||||||
Investment, interest rate | 7.87% | 7.87% | 7.87% | ||||||||||||
Investment, principal | $ 6,685 | ||||||||||||||
Investment owned, at cost | 6,673 | ||||||||||||||
Investments at fair value | $ 6,484 | ||||||||||||||
Investment, Identifier [Axis]: Northern Star Industries Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | 4.75% | 4.75% | 4.75% | |||||||||
Investment, interest rate | 10% | 10% | 10% | 7.87% | 7.87% | 7.87% | |||||||||
Investment, principal | $ 5,211 | $ 5,252 | |||||||||||||
Investment owned, at cost | 5,205 | 5,243 | |||||||||||||
Investments at fair value | 5,172 | $ 5,095 | |||||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Membership Interest | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | 0 | ||||||||||||||
Investments at fair value | $ 0 | 0 | |||||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [13],[16],[25],[26],[28],[29] | 0.875 | 0.875 | 0.875 | |||||||||||
Investment, principal | 0 | ||||||||||||||
Investment owned, at cost | 0 | [3],[14],[23],[24],[30],[31] | $ 0 | [13],[16],[25],[26],[28],[29] | |||||||||||
Investments at fair value | $ 0 | [3],[14],[23],[24],[30],[31] | $ 0 | [13],[16],[25],[26],[28],[29] | |||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | [1],[3],[5],[14],[23],[24],[30] | 4.50% | [1],[3],[5],[14],[23],[24],[30] | 4.50% | [1],[3],[5],[14],[23],[24],[30] | 4.50% | [8],[10],[13],[16],[25],[26],[28] | 4.50% | [8],[10],[13],[16],[25],[26],[28] | 4.50% | [8],[10],[13],[16],[25],[26],[28] | |||
Investment, interest rate | 9.36% | [1],[2],[3],[5],[14],[23],[24],[30] | 9.36% | [1],[2],[3],[5],[14],[23],[24],[30] | 9.36% | [1],[2],[3],[5],[14],[23],[24],[30] | 6.30% | [8],[10],[11],[13],[16],[25],[26],[28] | 6.30% | [8],[10],[11],[13],[16],[25],[26],[28] | 6.30% | [8],[10],[11],[13],[16],[25],[26],[28] | |||
Investment, principal | $ 58,349 | [1],[3],[5],[7],[14],[23],[24],[30] | $ 59,662 | [8],[10],[12],[13],[16],[25],[26],[28] | |||||||||||
Investment owned, at cost | 49,997 | [1],[3],[5],[14],[23],[24],[30] | 50,194 | [8],[10],[13],[16],[25],[26],[28] | |||||||||||
Investments at fair value | $ 49,632 | [1],[3],[5],[14],[23],[24],[30] | $ 50,283 | [8],[10],[13],[16],[25],[26],[28] | |||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Subordinated Debt | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | ||||||||||||||
Investment, interest rate | 4.94% | ||||||||||||||
Investment, principal | $ 60,274 | ||||||||||||||
Investments at fair value | 50,606 | 55,582 | |||||||||||||
Investment, Identifier [Axis]: OEConnection LLC, Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [9],[10] | 4% | 4% | 4% | |||||||||||
Investment, interest rate | [9],[10],[11] | 7.12% | 7.12% | 7.12% | |||||||||||
Investment, principal | [9],[10],[12] | $ 3,323 | |||||||||||||
Investment owned, at cost | [9],[10] | 3,162 | |||||||||||||
Investments at fair value | [9],[10] | $ 3,207 | |||||||||||||
Investment, Identifier [Axis]: OEConnection LLC, Application Software, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 9.25% | 9.25% | 9.25% | ||||||||||||
Investment, principal | $ 11,015 | ||||||||||||||
Investment owned, at cost | 10,845 | ||||||||||||||
Investments at fair value | $ 10,852 | ||||||||||||||
Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[4],[5] | 7% | [1],[4],[5] | 7% | [1],[4],[5] | 7% | [8],[9],[10] | 7% | [8],[9],[10] | 7% | [8],[9],[10] | |||
Investment, interest rate | 12.34% | [1],[2],[4],[5] | 12.34% | [1],[2],[4],[5] | 12.34% | [1],[2],[4],[5] | 10.05% | [8],[9],[10],[11] | 10.05% | [8],[9],[10],[11] | 10.05% | [8],[9],[10],[11] | |||
Investment, principal | $ 9,323 | [1],[4],[5],[7] | $ 7,519 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 9,203 | [1],[4],[5] | 7,389 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 9,090 | [1],[4],[5] | $ 7,237 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 7.12% | 7.12% | 7.12% | ||||||||||||
Investment, principal | $ 7,777 | ||||||||||||||
Investment owned, at cost | 7,741 | ||||||||||||||
Investments at fair value | $ 7,505 | ||||||||||||||
Investment, Identifier [Axis]: OEConnection LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | 4% | 4% | 4% | |||||||||
Investment, interest rate | 9.25% | 9.25% | 9.25% | 7.12% | 7.12% | 7.12% | |||||||||
Investment, principal | $ 3,858 | $ 3,888 | |||||||||||||
Investment owned, at cost | 3,841 | 3,871 | |||||||||||||
Investments at fair value | $ 3,802 | $ 3,752 | |||||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 10% | [1],[4],[5] | 10% | [1],[4],[5] | 10% | [1],[4],[5] | 2% | [8],[9],[10] | 2% | [8],[9],[10] | 2% | [8],[9],[10] | |||
Investment, interest rate | 15.50% | [1],[2],[4],[5] | 15.50% | [1],[2],[4],[5] | 15.50% | [1],[2],[4],[5] | 5.08% | [8],[9],[10],[11] | 5.08% | [8],[9],[10],[11] | 5.08% | [8],[9],[10],[11] | |||
Investment, principal | $ 25,712 | [1],[4],[5],[7] | $ 21,557 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 25,603 | [1],[4],[5] | 21,267 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 25,712 | [1],[4],[5] | $ 21,557 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 10% | [1],[3],[4],[5] | 10% | [1],[3],[4],[5] | 10% | [1],[3],[4],[5] | 2% | [8],[9],[10],[13] | 2% | [8],[9],[10],[13] | 2% | [8],[9],[10],[13] | |||
Investment, principal | $ 0 | [1],[3],[4],[5],[7] | $ 0 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | (13) | [1],[3],[4],[5] | (31) | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ 0 | [1],[3],[4],[5] | $ 0 | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5] | 10% | 10% | 10% | |||||||||||
Investment, interest rate | [1],[2],[3],[4],[5] | 15.39% | 15.39% | 15.39% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7] | $ 1,210 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5] | 1,192 | |||||||||||||
Investments at fair value | [1],[3],[4],[5] | $ 1,210 | |||||||||||||
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5] | 7.75% | 7.75% | 7.75% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5] | (44) | |||||||||||||
Investments at fair value | [1],[3],[4],[5] | $ (44) | |||||||||||||
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 7.75% | 7.75% | 7.75% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12.79% | 12.79% | 12.79% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 15,231 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 14,876 | |||||||||||||
Investments at fair value | [1],[4],[5] | 14,882 | |||||||||||||
Investment, Identifier [Axis]: Other cash accounts | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, at cost | 67,467 | ||||||||||||||
Investments at fair value | $ 67,467 | ||||||||||||||
Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 7.75% | [2],[4],[5] | 7.75% | [2],[4],[5] | 7.75% | [2],[4],[5] | 7.75% | [9],[10],[11] | 7.75% | [9],[10],[11] | 7.75% | [9],[10],[11] | |||
Investment, principal | $ 7,480 | [4],[7] | $ 7,776 | [9],[12] | |||||||||||
Investment owned, at cost | 7,514 | [4] | 7,820 | [9] | |||||||||||
Investments at fair value | $ 6,090 | [4] | $ 5,846 | [9] | |||||||||||
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10],[13] | 7% | 7% | 7% | |||||||||||
Investment, principal | [8],[9],[10],[12],[13] | $ 0 | |||||||||||||
Investment owned, at cost | [8],[9],[10],[13] | (21) | |||||||||||||
Investments at fair value | [8],[9],[10],[13] | $ (13) | |||||||||||||
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 9.28% | 9.28% | 9.28% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 26,154 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 25,712 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 25,893 | |||||||||||||
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10],[13] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [8],[9],[10],[11],[13] | 9.25% | 9.25% | 9.25% | |||||||||||
Investment, principal | [8],[9],[10],[12],[13] | $ 2,228 | |||||||||||||
Investment owned, at cost | [8],[9],[10],[13] | 2,186 | |||||||||||||
Investments at fair value | [8],[9],[10],[13] | $ 2,203 | |||||||||||||
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5] | 7% | 7% | 7% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5] | (55) | |||||||||||||
Investments at fair value | [1],[3],[4],[5] | $ (57) | |||||||||||||
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12.10% | 12.10% | 12.10% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 10,923 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 10,513 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 10,497 | |||||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 100,000 | [1],[4] | 100,000 | [1],[4] | 100,000 | [1],[4] | 80,515 | [8],[9] | 80,515 | [8],[9] | 80,515 | [8],[9] | |||
Investment owned, at cost | $ 109 | [1],[4] | $ 79 | [8],[9] | |||||||||||
Investments at fair value | $ 221 | [1],[4] | $ 89 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[3],[4],[5] | 6.50% | [1],[3],[4],[5] | 6.50% | [1],[3],[4],[5] | 6.75% | [8],[9],[10],[13] | 6.75% | [8],[9],[10],[13] | 6.75% | [8],[9],[10],[13] | |||
Investment, principal | $ 0 | [1],[3],[4],[5],[7] | $ 0 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | (37) | [1],[3],[4],[5] | (34) | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ (26) | [1],[3],[4],[5] | $ (49) | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[4],[5] | 6.50% | [1],[4],[5] | 6.50% | [1],[4],[5] | 6.75% | [8],[9],[10] | 6.75% | [8],[9],[10] | 6.75% | [8],[9],[10] | |||
Investment, interest rate | 11.73% | [1],[2],[4],[5] | 11.73% | [1],[2],[4],[5] | 11.73% | [1],[2],[4],[5] | 10.42% | [8],[9],[10],[11] | 10.42% | [8],[9],[10],[11] | 10.42% | [8],[9],[10],[11] | |||
Investment, principal | $ 38,521 | [1],[4],[5],[7] | $ 33,775 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 38,018 | [1],[4],[5] | 32,931 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 38,205 | [1],[4],[5] | $ 33,116 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Park Place Technologies, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 8.13% | 8.13% | 8.13% | ||||||||||||
Investment, principal | $ 4,925 | ||||||||||||||
Investment owned, at cost | 4,781 | ||||||||||||||
Investments at fair value | $ 4,687 | ||||||||||||||
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | [4],[5] | 5% | [4],[5] | 5% | [4],[5] | 5% | [9],[10] | 5% | [9],[10] | 5% | [9],[10] | |||
Investment, interest rate | 10.20% | [2],[4],[5] | 10.20% | [2],[4],[5] | 10.20% | [2],[4],[5] | 8.13% | [9],[10],[11] | 8.13% | [9],[10],[11] | 8.13% | [9],[10],[11] | |||
Investment, principal | $ 9,701 | [4],[5],[7] | $ 9,850 | [9],[10],[12] | |||||||||||
Investment owned, at cost | 9,535 | [4],[5] | 9,460 | [9],[10] | |||||||||||
Investments at fair value | $ 9,458 | [4],[5] | $ 9,374 | [9],[10] | |||||||||||
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 10.20% | 10.20% | 10.20% | ||||||||||||
Investment, principal | $ 9,849 | ||||||||||||||
Investment owned, at cost | 9,495 | ||||||||||||||
Investments at fair value | $ 9,603 | ||||||||||||||
Investment, Identifier [Axis]: Peloton Interactive, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | 6.50% | 6.50% | ||||||||||||
Investment, interest rate | 8.35% | 8.35% | 8.35% | ||||||||||||
Investment, principal | $ 5,486 | ||||||||||||||
Investment owned, at cost | 5,251 | ||||||||||||||
Investments at fair value | $ 5,371 | ||||||||||||||
Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[4],[5] | 6% | [1],[4],[5] | 6% | [1],[4],[5] | 6% | [8],[9],[10] | 6% | [8],[9],[10] | 6% | [8],[9],[10] | |||
Investment, interest rate | 10.96% | [1],[2],[4],[5] | 10.96% | [1],[2],[4],[5] | 10.96% | [1],[2],[4],[5] | 8.88% | [8],[9],[10],[11] | 8.88% | [8],[9],[10],[11] | 8.88% | [8],[9],[10],[11] | |||
Investment, principal | $ 22,375 | [1],[4],[5],[7] | $ 17,976 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 22,177 | [1],[4],[5] | 17,690 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 21,829 | [1],[4],[5] | $ 17,537 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 9.50% | 9.50% | 9.50% | ||||||||||||
Investment, principal | $ 2,422 | ||||||||||||||
Investment owned, at cost | 2,297 | ||||||||||||||
Investments at fair value | $ 2,305 | ||||||||||||||
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[4],[5] | 7.25% | [1],[4],[5] | 7.25% | [1],[4],[5] | 7.25% | [8],[9],[10] | 7.25% | [8],[9],[10] | 7.25% | [8],[9],[10] | |||
Investment, interest rate | 12.59% | [1],[2],[4],[5] | 12.59% | [1],[2],[4],[5] | 12.59% | [1],[2],[4],[5] | 10.92% | [8],[9],[10],[11] | 10.92% | [8],[9],[10],[11] | 10.92% | [8],[9],[10],[11] | |||
Investment, principal | $ 36,499 | [1],[4],[5],[7] | $ 28,627 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 35,427 | [1],[4],[5] | 28,198 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 32,606 | [1],[4],[5] | $ 27,482 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | 7.25% | 7.25% | ||||||||||||
Investment, interest rate | 12.59% | 12.59% | 12.59% | ||||||||||||
Investment, principal | $ 4,503 | ||||||||||||||
Investment owned, at cost | 4,435 | ||||||||||||||
Investments at fair value | $ 4,023 | ||||||||||||||
Investment, Identifier [Axis]: Planview Parent, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 9.50% | 9.50% | 9.50% | ||||||||||||
Investment, principal | $ 685 | ||||||||||||||
Investment owned, at cost | 649 | ||||||||||||||
Investments at fair value | $ 652 | ||||||||||||||
Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | 7.25% | 7.25% | ||||||||||||
Investment, interest rate | 10.92% | 10.92% | 10.92% | ||||||||||||
Investment, principal | $ 4,503 | ||||||||||||||
Investment owned, at cost | 4,435 | ||||||||||||||
Investments at fair value | $ 4,323 | ||||||||||||||
Investment, Identifier [Axis]: Planview Parent, Inc., Second Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | 7.25% | 7.25% | 7.25% | 7.25% | 7.25% | |||||||||
Investment, interest rate | 12.59% | 12.59% | 12.59% | 10.92% | 10.92% | 10.92% | |||||||||
Investment, principal | $ 2,842 | $ 2,842 | |||||||||||||
Investment owned, at cost | 2,799 | 2,799 | |||||||||||||
Investments at fair value | $ 2,539 | $ 2,728 | |||||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | [1],[3],[4],[5] | 8% | [1],[3],[4],[5] | 8% | [1],[3],[4],[5] | 8% | [8],[9],[10],[13] | 8% | [8],[9],[10],[13] | 8% | [8],[9],[10],[13] | |||
Investment, interest rate | [1],[2],[3],[4],[5] | 13.04% | 13.04% | 13.04% | |||||||||||
Investment, principal | $ 2,395 | [1],[3],[4],[5],[7] | $ 0 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | 2,312 | [1],[3],[4],[5] | (53) | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ 2,218 | [1],[3],[4],[5] | $ (111) | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | 8% | 8% | ||||||||||||
Investment, interest rate | 13.04% | 13.04% | 13.04% | ||||||||||||
Investment, principal | $ 254 | ||||||||||||||
Investment owned, at cost | 236 | ||||||||||||||
Investments at fair value | $ 235 | ||||||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | [1],[4],[5] | 8% | [1],[4],[5] | 8% | [1],[4],[5] | 8% | [8],[9],[10] | 8% | [8],[9],[10] | 8% | [8],[9],[10] | |||
Investment, interest rate | 13.04% | [1],[2],[4],[5] | 13.04% | [1],[2],[4],[5] | 13.04% | [1],[2],[4],[5] | 10.68% | [8],[9],[10],[11] | 10.68% | [8],[9],[10],[11] | 10.68% | [8],[9],[10],[11] | |||
Investment, principal | $ 67,244 | [1],[4],[5],[7] | $ 48,689 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 66,290 | [1],[4],[5] | 47,951 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 64,756 | [1],[4],[5] | $ 47,155 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | 8% | 8% | ||||||||||||
Investment, interest rate | 13.04% | 13.04% | 13.04% | ||||||||||||
Investment, principal | $ 8,116 | ||||||||||||||
Investment owned, at cost | 7,831 | ||||||||||||||
Investments at fair value | $ 7,815 | ||||||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | 8% | 8% | ||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investment owned, at cost | (6) | ||||||||||||||
Investments at fair value | $ (13) | ||||||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Revolver | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | 8% | 8% | 8% | 8% | 8% | |||||||||
Investment, interest rate | 13.04% | 13.04% | 13.04% | ||||||||||||
Investment, principal | $ 180 | $ 0 | |||||||||||||
Investment owned, at cost | 169 | (5) | |||||||||||||
Investments at fair value | $ 167 | $ (10) | |||||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | 8% | 8% | ||||||||||||
Investment, interest rate | 10.68% | 10.68% | 10.68% | ||||||||||||
Investment, principal | $ 6,796 | ||||||||||||||
Investment owned, at cost | 6,694 | ||||||||||||||
Investments at fair value | $ 6,582 | ||||||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | 8% | 8% | 8% | 8% | 8% | |||||||||
Investment, interest rate | 13.04% | 13.04% | 13.04% | 10.68% | 10.68% | 10.68% | |||||||||
Investment, principal | $ 5,182 | $ 4,465 | |||||||||||||
Investment owned, at cost | 5,018 | 4,398 | |||||||||||||
Investments at fair value | $ 4,990 | $ 4,325 | |||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12.42% | 12.42% | 12.42% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 24,537 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 24,245 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 24,047 | |||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12.42% | 12.42% | 12.42% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 2,823 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 2,797 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 2,767 | |||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 10.01% | 10.01% | 10.01% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 23,275 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 22,722 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 22,810 | |||||||||||||
Investment, Identifier [Axis]: Project Boost Purchaser, LLC, Application Software, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | [1],[4],[5] | 8% | [1],[4],[5] | 8% | [1],[4],[5] | 8% | [8],[9],[10] | 8% | [8],[9],[10] | 8% | [8],[9],[10] | |||
Investment, interest rate | 13.22% | [1],[2],[4],[5] | 13.22% | [1],[2],[4],[5] | 13.22% | [1],[2],[4],[5] | 11.12% | [8],[9],[10],[11] | 11.12% | [8],[9],[10],[11] | 11.12% | [8],[9],[10],[11] | |||
Investment, principal | $ 6,750 | [1],[4],[5],[7] | $ 5,250 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 6,652 | [1],[4],[5] | 5,168 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 6,235 | [1],[4],[5] | $ 5,047 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.68% | [1],[4],[5],[14] | 5.68% | [1],[4],[5],[14] | 5.68% | [1],[4],[5],[14] | 6% | [8],[9],[10],[16] | 6% | [8],[9],[10],[16] | 6% | [8],[9],[10],[16] | |||
Investment, interest rate | 10.88% | [1],[2],[4],[5],[14] | 10.88% | [1],[2],[4],[5],[14] | 10.88% | [1],[2],[4],[5],[14] | 8.39% | [8],[9],[10],[11],[16] | 8.39% | [8],[9],[10],[11],[16] | 8.39% | [8],[9],[10],[11],[16] | |||
Investment, principal | £ | £ 4,626 | [1],[4],[5],[7],[14] | £ 3,501 | [8],[9],[10],[12],[16] | |||||||||||
Investment owned, at cost | $ 5,900 | [1],[4],[5],[14] | $ 4,646 | [8],[9],[10],[16] | |||||||||||
Investments at fair value | $ 5,296 | [1],[4],[5],[14] | $ 3,367 | [8],[9],[10],[16] | |||||||||||
Investment, Identifier [Axis]: QuorumLabs, Inc., Application Software, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 64,887,669 | [1],[4] | 64,887,669 | [1],[4] | 64,887,669 | [1],[4] | 64,887,669 | [8],[9] | 64,887,669 | [8],[9] | 64,887,669 | [8],[9] | |||
Investment owned, at cost | $ 375 | [1],[4] | $ 375 | [8],[9] | |||||||||||
Investments at fair value | $ 0 | [1],[4] | $ 0 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: RP Escrow Issuer LLC, Health Care Distributors, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [9],[10],[11] | 5.25% | 5.25% | 5.25% | |||||||||||
Investment, principal | [9],[12] | $ 1,325 | |||||||||||||
Investment owned, at cost | [9] | 1,218 | |||||||||||||
Investments at fair value | [9] | $ 1,097 | |||||||||||||
Investment, Identifier [Axis]: Radiology Partners, Inc., Health Care Distributors, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [9],[10] | 4.25% | 4.25% | 4.25% | |||||||||||
Investment, interest rate | [9],[10],[11] | 7.33% | 7.33% | 7.33% | |||||||||||
Investment, principal | [9],[10],[12] | $ 3,400 | |||||||||||||
Investment owned, at cost | [9],[10] | 3,202 | |||||||||||||
Investments at fair value | [9],[10] | $ 2,880 | |||||||||||||
Investment, Identifier [Axis]: Radiology Partners, Inc., Health Care Distributors, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [9],[10],[11] | 9.25% | 9.25% | 9.25% | |||||||||||
Investment, principal | [9],[12] | $ 4,755 | |||||||||||||
Investment owned, at cost | [9] | 4,720 | |||||||||||||
Investments at fair value | [9] | $ 3,109 | |||||||||||||
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.50% | [1],[3],[4],[5] | 6.50% | [1],[3],[4],[5] | 6.50% | [1],[3],[4],[5] | 6.50% | [8],[9],[10],[13] | 6.50% | [8],[9],[10],[13] | 6.50% | [8],[9],[10],[13] | |||
Investment, principal | $ 0 | [1],[3],[4],[5],[7] | $ 0 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | (46) | [1],[3],[4],[5] | (43) | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ (52) | [1],[3],[4],[5] | $ (64) | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[4],[5] | 7.50% | [1],[4],[5] | 7.50% | [1],[4],[5] | 7.50% | [8],[9],[10] | 7.50% | [8],[9],[10] | 7.50% | [8],[9],[10] | |||
Investment, interest rate | [1],[2],[4],[5] | 11.70% | 11.70% | 11.70% | |||||||||||
Investment, principal | $ 32,329 | [1],[4],[5],[7] | $ 24,692 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 32,052 | [1],[4],[5] | 24,265 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 31,715 | [1],[4],[5] | $ 24,101 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Renaissance Holding Corp., Diversified Banks, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [9],[10] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [9],[10],[11] | 10.12% | 10.12% | 10.12% | |||||||||||
Investment, principal | [9],[10],[12] | $ 3,542 | |||||||||||||
Investment owned, at cost | [9],[10] | 3,515 | |||||||||||||
Investments at fair value | [9],[10] | $ 3,402 | |||||||||||||
Investment, Identifier [Axis]: Renaissance Holding Corp., Education Services, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | 4.75% | 4.75% | ||||||||||||
Investment, interest rate | 9.99% | 9.99% | 9.99% | ||||||||||||
Investment, principal | $ 5,000 | ||||||||||||||
Investment owned, at cost | 4,855 | ||||||||||||||
Investments at fair value | $ 4,948 | ||||||||||||||
Investment, Identifier [Axis]: Renaissance Holding Corp., Education Services, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [4],[5] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [2],[4],[5] | 12.19% | 12.19% | 12.19% | |||||||||||
Investment, principal | [4],[5],[7] | $ 1,789 | |||||||||||||
Investment owned, at cost | [4],[5] | 1,775 | |||||||||||||
Investments at fair value | [4],[5] | $ 1,764 | |||||||||||||
Investment, Identifier [Axis]: RevSpring, Inc., Commercial Printing, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 9.50% | 9.50% | 9.50% | ||||||||||||
Investment, principal | $ 9,550 | ||||||||||||||
Investment owned, at cost | 9,536 | ||||||||||||||
Investments at fair value | $ 9,208 | ||||||||||||||
Investment, Identifier [Axis]: RevSpring, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4% | 4% | 4% | ||||||||||||
Investment, interest rate | 7.67% | 7.67% | 7.67% | ||||||||||||
Investment, principal | $ 9,625 | ||||||||||||||
Investment owned, at cost | 9,607 | ||||||||||||||
Investments at fair value | $ 9,304 | ||||||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.25% | [1],[4],[5],[14] | 8.25% | [1],[4],[5],[14] | 8.25% | [1],[4],[5],[14] | 8.25% | [8],[9],[10],[16] | 8.25% | [8],[9],[10],[16] | 8.25% | [8],[9],[10],[16] | |||
Investment, interest rate | 13.75% | [1],[2],[4],[5],[14] | 13.75% | [1],[2],[4],[5],[14] | 13.75% | [1],[2],[4],[5],[14] | 11.92% | [8],[9],[10],[11],[16] | 11.92% | [8],[9],[10],[11],[16] | 11.92% | [8],[9],[10],[11],[16] | |||
Investment, principal | $ 44,602 | [1],[4],[5],[7],[14] | $ 37,656 | [8],[9],[10],[12],[16] | |||||||||||
Investment owned, at cost | 43,077 | [1],[4],[5],[14] | 35,775 | [8],[9],[10],[16] | |||||||||||
Investments at fair value | $ 41,815 | [1],[4],[5],[14] | $ 36,187 | [8],[9],[10],[16] | |||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.25% | [1],[4],[5],[14] | 8.25% | [1],[4],[5],[14] | 8.25% | [1],[4],[5],[14] | 8.25% | [8],[9],[10],[13],[16] | 8.25% | [8],[9],[10],[13],[16] | 8.25% | [8],[9],[10],[13],[16] | |||
Investment, interest rate | 13.75% | [1],[2],[4],[5],[14] | 13.75% | [1],[2],[4],[5],[14] | 13.75% | [1],[2],[4],[5],[14] | 11.92% | [8],[9],[10],[11],[13],[16] | 11.92% | [8],[9],[10],[11],[13],[16] | 11.92% | [8],[9],[10],[11],[13],[16] | |||
Investment, principal | $ 13,495 | [1],[4],[5],[7],[14] | $ 11,393 | [8],[9],[10],[12],[13],[16] | |||||||||||
Investment owned, at cost | 13,010 | [1],[4],[5],[14] | 10,583 | [8],[9],[10],[13],[16] | |||||||||||
Investments at fair value | $ 12,651 | [1],[4],[5],[14] | $ 10,760 | [8],[9],[10],[13],[16] | |||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 204,454 | [1],[4],[14] | 204,454 | [1],[4],[14] | 204,454 | [1],[4],[14] | 164,660 | [8],[9],[16] | 164,660 | [8],[9],[16] | 164,660 | [8],[9],[16] | |||
Investment owned, at cost | $ 1,202 | [1],[4],[14] | $ 1,202 | [8],[9],[16] | |||||||||||
Investments at fair value | $ 0 | [1],[4],[14] | $ 74 | [8],[9],[16] | |||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [1],[4] | 1,037 | 1,037 | 1,037 | |||||||||||
Investment owned, at cost | [1],[4] | $ 1,037 | |||||||||||||
Investments at fair value | [1],[4] | $ 1,024 | |||||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 8.75% | 8.75% | 8.75% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 14% | 14% | 14% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 8,010 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 7,792 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 7,770 | |||||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5] | 8.75% | 8.75% | 8.75% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5] | (35) | |||||||||||||
Investments at fair value | [1],[3],[4],[5] | $ (71) | |||||||||||||
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | ||||||||||||
Investment, interest rate | 8.06% | 8.06% | 8.06% | ||||||||||||
Investment, principal | $ 8,201 | ||||||||||||||
Investment owned, at cost | 8,194 | ||||||||||||||
Investments at fair value | $ 7,176 | ||||||||||||||
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 1 | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | 5.25% | |||||||||
Investment, interest rate | 10.52% | 10.52% | 10.52% | 8.06% | 8.06% | 8.06% | |||||||||
Investment, principal | $ 6,045 | $ 6,094 | |||||||||||||
Investment owned, at cost | 6,039 | 6,082 | |||||||||||||
Investments at fair value | $ 4,272 | $ 5,332 | |||||||||||||
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.23% | 5.23% | 5.23% | ||||||||||||
Investment, interest rate | 8.04% | 8.04% | 8.04% | ||||||||||||
Investment, principal | $ 138 | ||||||||||||||
Investment owned, at cost | 138 | ||||||||||||||
Investments at fair value | $ 121 | ||||||||||||||
Investment, Identifier [Axis]: SHO Holding I Corporation, First Lien Term Loan 2 | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.23% | 5.23% | 5.23% | 5.23% | 5.23% | 5.23% | |||||||||
Investment, interest rate | 10.50% | 10.50% | 10.50% | 8.04% | 8.04% | 8.04% | |||||||||
Investment, principal | $ 102 | $ 102 | |||||||||||||
Investment owned, at cost | 102 | 102 | |||||||||||||
Investments at fair value | $ 74 | $ 90 | |||||||||||||
Investment, Identifier [Axis]: SHO Holding I Corporation, Footwear, First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | ||||||||||||
Investment, interest rate | 10.52% | 10.52% | 10.52% | ||||||||||||
Investment, principal | $ 8,135 | ||||||||||||||
Investment owned, at cost | 8,132 | ||||||||||||||
Investments at fair value | $ 5,749 | ||||||||||||||
Investment, Identifier [Axis]: SHO Holding I Corporation, Footwear, First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.23% | 5.23% | 5.23% | ||||||||||||
Investment, interest rate | 10.50% | 10.50% | 10.50% | ||||||||||||
Investment, principal | $ 138 | ||||||||||||||
Investment owned, at cost | 138 | ||||||||||||||
Investments at fair value | $ 100 | ||||||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal & Glass Containers, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[9] | 415 | 415 | 415 | |||||||||||
Investment owned, at cost | [8],[9] | $ 681 | |||||||||||||
Investments at fair value | [8],[9] | $ 681 | |||||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [1],[4] | 491 | 491 | 491 | |||||||||||
Investment owned, at cost | [1],[4] | $ 727 | |||||||||||||
Investments at fair value | [1],[4] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 4.75% | 4.75% | 4.75% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 9.97% | 9.97% | 9.97% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 4,463 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 3,780 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 4,139 | |||||||||||||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.75% | 4.75% | 4.75% | ||||||||||||
Investment, interest rate | 9.97% | 9.97% | 9.97% | ||||||||||||
Investment, principal | $ 2,985 | ||||||||||||||
Investment owned, at cost | 2,564 | ||||||||||||||
Investments at fair value | $ 2,768 | ||||||||||||||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8% | [1],[4],[5] | 8% | [1],[4],[5] | 8% | [1],[4],[5] | 8% | [8],[9],[10] | 8% | [8],[9],[10] | 8% | [8],[9],[10] | |||
Investment, interest rate | 13.22% | [1],[2],[4],[5] | 13.22% | [1],[2],[4],[5] | 13.22% | [1],[2],[4],[5] | 10.74% | [8],[9],[10],[11] | 10.74% | [8],[9],[10],[11] | 10.74% | [8],[9],[10],[11] | |||
Investment, principal | $ 12,034 | [1],[4],[5],[7] | $ 9,109 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 11,220 | [1],[4],[5] | 8,972 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 9,387 | [1],[4],[5] | $ 8,289 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | ||||||||||||
Investment, interest rate | 7.63% | 7.63% | 7.63% | ||||||||||||
Investment, principal | $ 7,500 | ||||||||||||||
Investment owned, at cost | 7,184 | ||||||||||||||
Investments at fair value | $ 6,966 | ||||||||||||||
Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | 4.50% | 4.50% | 4.50% | |||||||||
Investment, interest rate | 9.70% | 9.70% | 9.70% | 7.63% | 7.63% | 7.63% | |||||||||
Investment, principal | $ 5,227 | $ 6,000 | |||||||||||||
Investment owned, at cost | 5,023 | 5,734 | |||||||||||||
Investments at fair value | $ 5,174 | $ 5,572 | |||||||||||||
Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | ||||||||||||
Investment, interest rate | 9.70% | 9.70% | 9.70% | ||||||||||||
Investment, principal | $ 8,801 | ||||||||||||||
Investment owned, at cost | 8,426 | ||||||||||||||
Investments at fair value | $ 8,710 | ||||||||||||||
Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [9],[10] | 4.50% | 4.50% | 4.50% | |||||||||||
Investment, interest rate | [9],[10],[11] | 7.63% | 7.63% | 7.63% | |||||||||||
Investment, principal | [9],[10],[12] | $ 1,500 | |||||||||||||
Investment owned, at cost | [9],[10] | 1,410 | |||||||||||||
Investments at fair value | [9],[10] | $ 1,393 | |||||||||||||
Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [1],[4],[5] | 6.75% | [1],[4],[5] | 6.75% | [1],[4],[5] | 6.75% | [8],[9],[10] | 6.75% | [8],[9],[10] | 6.75% | [8],[9],[10] | |||
Investment, interest rate | 12.29% | [1],[2],[4],[5] | 12.29% | [1],[2],[4],[5] | 12.29% | [1],[2],[4],[5] | 10.42% | [8],[9],[10],[11] | 10.42% | [8],[9],[10],[11] | 10.42% | [8],[9],[10],[11] | |||
Investment, principal | $ 25,592 | [1],[4],[5],[7] | $ 20,766 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 23,832 | [1],[4],[5] | 19,550 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 19,514 | [1],[4],[5] | $ 18,188 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Sabert Corporation, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | ||||||||||||
Investment, interest rate | 7.63% | 7.63% | 7.63% | ||||||||||||
Investment, principal | $ 2,536 | ||||||||||||||
Investment owned, at cost | 2,511 | ||||||||||||||
Investments at fair value | $ 2,435 | ||||||||||||||
Investment, Identifier [Axis]: Sabert Corporation, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | ||||||||||||
Investment, interest rate | 7.63% | 7.63% | 7.63% | ||||||||||||
Investment, principal | $ 1,691 | ||||||||||||||
Investment owned, at cost | 1,674 | ||||||||||||||
Investments at fair value | $ 1,623 | ||||||||||||||
Investment, Identifier [Axis]: Sabert Corporation, Metal & Glass Containers, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [9],[10] | 4.50% | 4.50% | 4.50% | |||||||||||
Investment, interest rate | [9],[10],[11] | 7.63% | 7.63% | 7.63% | |||||||||||
Investment, principal | [9],[10],[12] | $ 1,691 | |||||||||||||
Investment owned, at cost | [9],[10] | 1,610 | |||||||||||||
Investments at fair value | [9],[10] | $ 1,623 | |||||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5] | 10% | 10% | 10% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5] | (103) | |||||||||||||
Investments at fair value | [1],[3],[4],[5] | $ (93) | |||||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 10% | 10% | 10% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 15.24% | 15.24% | 15.24% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 25,558 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 24,711 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 24,791 | |||||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [1],[4] | 991,019 | 991,019 | 991,019 | |||||||||||
Investment owned, at cost | [1],[4] | $ 327 | |||||||||||||
Investments at fair value | [1],[4] | $ 1,883 | |||||||||||||
Investment, Identifier [Axis]: Scilex Holding Co, Biotechnology, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [4],[14] | 9,307 | 9,307 | 9,307 | |||||||||||
Investment owned, at cost | [4],[14] | $ 78 | |||||||||||||
Investments at fair value | [4],[14] | 52 | |||||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Membership Interest | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, principal | 0 | ||||||||||||||
Investments at fair value | $ 23,023 | 37,651 | |||||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [13],[16],[25],[26],[28],[29],[32] | 0.875 | 0.875 | 0.875 | |||||||||||
Investment, principal | 0 | ||||||||||||||
Investment owned, at cost | 54,791 | [3],[14],[23],[24],[30],[31],[33] | $ 49,322 | [13],[16],[25],[26],[28],[29],[32] | |||||||||||
Investments at fair value | $ 27,973 | [3],[14],[23],[24],[30],[31],[33] | $ 20,715 | [13],[16],[25],[26],[28],[29],[32] | |||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[3],[5],[14],[23],[24],[30] | 7% | [1],[3],[5],[14],[23],[24],[30] | 7% | [1],[3],[5],[14],[23],[24],[30] | 7% | [8],[10],[13],[16],[25],[26],[28] | 7% | [8],[10],[13],[16],[25],[26],[28] | 7% | [8],[10],[13],[16],[25],[26],[28] | |||
Investment, interest rate | 11.86% | [1],[2],[3],[5],[14],[23],[24],[30] | 11.86% | [1],[2],[3],[5],[14],[23],[24],[30] | 11.86% | [1],[2],[3],[5],[14],[23],[24],[30] | 8.80% | [8],[10],[11],[13],[16],[25],[26],[28] | 8.80% | [8],[10],[11],[13],[16],[25],[26],[28] | 8.80% | [8],[10],[11],[13],[16],[25],[26],[28] | |||
Investment, principal | $ 112,656 | [1],[3],[5],[7],[14],[23],[24],[30] | $ 96,250 | [8],[10],[12],[13],[16],[25],[26],[28] | |||||||||||
Investment owned, at cost | 112,656 | [1],[3],[5],[14],[23],[24],[30] | 96,250 | [8],[10],[13],[16],[25],[26],[28] | |||||||||||
Investments at fair value | $ 112,656 | [1],[3],[5],[14],[23],[24],[30] | $ 96,250 | [8],[10],[13],[16],[25],[26],[28] | |||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Subordinated Debt | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | ||||||||||||||
Investment, interest rate | 8% | ||||||||||||||
Investment, principal | $ 96,250 | ||||||||||||||
Investments at fair value | $ 96,250 | $ 96,250 | |||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5],[14] | 7.88% | 7.88% | 7.88% | |||||||||||
Investment, interest rate | [1],[4],[5],[14] | 12.95% | 12.95% | 12.95% | |||||||||||
Investment, principal | [1],[4],[5],[7],[14] | $ 7,191 | |||||||||||||
Investment owned, at cost | [1],[4],[5],[14] | 6,923 | |||||||||||||
Investments at fair value | [1],[4],[5],[14] | $ 6,931 | |||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5],[14] | 7.88% | 7.88% | 7.88% | |||||||||||
Investment, interest rate | [1],[4],[5],[14] | 12.88% | 12.88% | 12.88% | |||||||||||
Investment, principal | [1],[4],[5],[7],[14] | $ 2,697 | |||||||||||||
Investment owned, at cost | [1],[4],[5],[14] | 2,596 | |||||||||||||
Investments at fair value | [1],[4],[5],[14] | $ 2,599 | |||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5],[14] | 7.88% | 7.88% | 7.88% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7],[14] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5],[14] | 0 | |||||||||||||
Investments at fair value | [1],[3],[4],[5],[14] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5],[14] | 7.88% | 7.88% | 7.88% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7],[14] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5],[14] | 0 | |||||||||||||
Investments at fair value | [1],[3],[4],[5],[14] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [1],[4],[14] | 58,210 | 58,210 | 58,210 | |||||||||||
Investment owned, at cost | [1],[4],[14] | $ 182 | |||||||||||||
Investments at fair value | [1],[4],[14] | $ 202 | |||||||||||||
Investment, Identifier [Axis]: ShareThis, Inc., Application Software, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 345,452 | [1],[4] | 345,452 | [1],[4] | 345,452 | [1],[4] | 345,452 | [8],[9] | 345,452 | [8],[9] | 345,452 | [8],[9] | |||
Investment owned, at cost | $ 367 | [1],[4] | $ 367 | [8],[9] | |||||||||||
Investments at fair value | $ 0 | [1],[4] | $ 0 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal & Glass Containers, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [8],[9],[10],[11] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, principal | [8],[9],[12] | $ 46,121 | |||||||||||||
Investment owned, at cost | [8],[9] | 45,413 | |||||||||||||
Investments at fair value | [8],[9] | $ 45,295 | |||||||||||||
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[4],[17] | 14% | 14% | 14% | |||||||||||
Investment, principal | [1],[4],[7],[17] | $ 54,730 | |||||||||||||
Investment owned, at cost | [1],[4],[17] | 41,705 | |||||||||||||
Investments at fair value | [1],[4],[17] | $ 25,997 | |||||||||||||
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[4],[17] | 14% | 14% | 14% | |||||||||||
Investment, principal | [1],[4],[7],[17] | $ 14,993 | |||||||||||||
Investment owned, at cost | [1],[4],[17] | 11,582 | |||||||||||||
Investments at fair value | [1],[4],[17] | $ 13,923 | |||||||||||||
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[3],[4],[5],[17] | 14% | 14% | 14% | |||||||||||
Investment, principal | [1],[3],[4],[7],[17] | $ 4,813 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[17] | 3,935 | |||||||||||||
Investments at fair value | [1],[3],[4],[17] | $ 4,034 | |||||||||||||
Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[4],[5] | 7.50% | [1],[4],[5] | 7.50% | [1],[4],[5] | 7.50% | [8],[9],[10] | 7.50% | [8],[9],[10] | 7.50% | [8],[9],[10] | |||
Investment, interest rate | 12.69% | [1],[2],[4],[5] | 12.69% | [1],[2],[4],[5] | 12.69% | [1],[2],[4],[5] | 10.48% | [8],[9],[10],[11] | 10.48% | [8],[9],[10],[11] | 10.48% | [8],[9],[10],[11] | |||
Investment, principal | $ 1,095 | [1],[4],[5],[7] | $ 3,195 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 1,084 | [1],[4],[5] | 3,163 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 1,024 | [1],[4],[5] | $ 2,997 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [4],[5] | 5.50% | 5.50% | 5.50% | |||||||||||
Investment, interest rate | [2],[4],[5] | 10.69% | 10.69% | 10.69% | |||||||||||
Investment, principal | [4],[5],[7] | $ 1,054 | |||||||||||||
Investment owned, at cost | [4],[5] | 1,053 | |||||||||||||
Investments at fair value | [4],[5] | $ 980 | |||||||||||||
Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | ||||||||||||
Investment, interest rate | 10.69% | 10.69% | 10.69% | ||||||||||||
Investment, principal | $ 2,328 | ||||||||||||||
Investment owned, at cost | 2,305 | ||||||||||||||
Investments at fair value | $ 2,166 | ||||||||||||||
Investment, Identifier [Axis]: Sorenson Communications, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | ||||||||||||
Investment, interest rate | 9.17% | 9.17% | 9.17% | ||||||||||||
Investment, principal | $ 2,553 | ||||||||||||||
Investment owned, at cost | 2,528 | ||||||||||||||
Investments at fair value | $ 2,454 | ||||||||||||||
Investment, Identifier [Axis]: Sorrento Therapeutics, Inc., Biotechnology, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 66,000 | [4],[14] | 66,000 | [4],[14] | 66,000 | [4],[14] | 50,000 | [9],[16] | 50,000 | [9],[16] | 50,000 | [9],[16] | |||
Investment owned, at cost | $ 139 | [4],[14] | $ 197 | [9],[16] | |||||||||||
Investments at fair value | $ 24 | [4],[14] | $ 79 | [9],[16] | |||||||||||
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | [1],[3],[4],[5] | 5.25% | [1],[3],[4],[5] | 5.25% | [1],[3],[4],[5] | 5.25% | [8],[9],[10],[13] | 5.25% | [8],[9],[10],[13] | 5.25% | [8],[9],[10],[13] | |||
Investment, interest rate | 10.35% | [1],[2],[3],[4],[5] | 10.35% | [1],[2],[3],[4],[5] | 10.35% | [1],[2],[3],[4],[5] | 8.03% | [8],[9],[10],[11],[13] | 8.03% | [8],[9],[10],[11],[13] | 8.03% | [8],[9],[10],[11],[13] | |||
Investment, principal | $ 907 | [1],[3],[4],[5],[7] | $ 866 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | 862 | [1],[3],[4],[5] | 813 | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ 837 | [1],[3],[4],[5] | $ 796 | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | [1],[4],[5] | 5.50% | [1],[4],[5] | 5.50% | [1],[4],[5] | 5.25% | [8],[9],[10] | 5.25% | [8],[9],[10] | 5.25% | [8],[9],[10] | |||
Investment, interest rate | 10.70% | [1],[2],[4],[5] | 10.70% | [1],[2],[4],[5] | 10.70% | [1],[2],[4],[5] | 8.30% | [8],[9],[10],[11] | 8.30% | [8],[9],[10],[11] | 8.30% | [8],[9],[10],[11] | |||
Investment, principal | $ 4,500 | [1],[4],[5],[7] | $ 4,534 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 4,431 | [1],[4],[5] | 4,455 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 4,393 | [1],[4],[5] | $ 4,427 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | ||||||||||||
Investment, interest rate | 10.70% | 10.70% | 10.70% | ||||||||||||
Investment, principal | $ 8,865 | ||||||||||||||
Investment owned, at cost | 8,729 | ||||||||||||||
Investments at fair value | $ 8,655 | ||||||||||||||
Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.25% | 5.25% | 5.25% | ||||||||||||
Investment, interest rate | 8.30% | 8.30% | 8.30% | ||||||||||||
Investment, principal | $ 8,933 | ||||||||||||||
Investment owned, at cost | 8,776 | ||||||||||||||
Investments at fair value | $ 8,721 | ||||||||||||||
Investment, Identifier [Axis]: Spanx, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5.50% | 5.50% | 5.50% | 5.25% | 5.25% | 5.25% | |||||||||
Investment, interest rate | 10.70% | 10.70% | 10.70% | 8.30% | 8.30% | 8.30% | |||||||||
Investment, principal | $ 4,925 | $ 4,962 | |||||||||||||
Investment owned, at cost | 4,849 | 4,876 | |||||||||||||
Investments at fair value | $ 4,808 | $ 4,845 | |||||||||||||
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5],[14] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5],[14] | 11.97% | 11.97% | 11.97% | |||||||||||
Investment, principal | € | [1],[4],[5],[7],[14] | € 23,731 | |||||||||||||
Investment owned, at cost | [1],[4],[5],[14] | $ 26,829 | |||||||||||||
Investments at fair value | [1],[4],[5],[14] | $ 25,632 | |||||||||||||
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Other Diversified Financial Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10],[16] | 8.50% | 8.50% | 8.50% | |||||||||||
Investment, interest rate | [8],[9],[10],[11],[16] | 10% | 10% | 10% | |||||||||||
Investment, principal | £ | [8],[9],[10],[12],[16] | £ 16,911 | |||||||||||||
Investment owned, at cost | [8],[9],[10],[16] | $ 19,414 | |||||||||||||
Investments at fair value | [8],[9],[10],[16] | $ 16,360 | |||||||||||||
Investment, Identifier [Axis]: Sunland Asphalt & Construction, LLC, Construction & Engineering, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 8.88% | 8.88% | 8.88% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 42,618 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 41,654 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 41,723 | |||||||||||||
Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 7.75% | 7.75% | 7.75% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12.85% | 12.85% | 12.85% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 49,645 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 48,611 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 49,128 | |||||||||||||
Investment, Identifier [Axis]: Supermoose Borrower, LLC, Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [9],[10] | 3.75% | 3.75% | 3.75% | |||||||||||
Investment, interest rate | [9],[10],[11] | 7.42% | 7.42% | 7.42% | |||||||||||
Investment, principal | [9],[10],[12] | $ 3,466 | |||||||||||||
Investment owned, at cost | [9],[10] | 3,141 | |||||||||||||
Investments at fair value | [9],[10] | $ 3,056 | |||||||||||||
Investment, Identifier [Axis]: Supermoose Borrower, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 7.42% | 7.42% | 7.42% | ||||||||||||
Investment, principal | $ 7,743 | ||||||||||||||
Investment owned, at cost | 7,479 | ||||||||||||||
Investments at fair value | $ 6,827 | ||||||||||||||
Investment, Identifier [Axis]: Supermoose Borrower, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 7.42% | 7.42% | 7.42% | ||||||||||||
Investment, principal | $ 2,820 | ||||||||||||||
Investment owned, at cost | 2,712 | ||||||||||||||
Investments at fair value | $ 2,487 | ||||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5],[34] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [1],[2],[4],[5],[34] | 12.18% | 12.18% | 12.18% | |||||||||||
Investment, principal | [1],[4],[5],[7],[34] | $ 1,552 | |||||||||||||
Investment owned, at cost | [1],[4],[5],[34] | 1,539 | |||||||||||||
Investments at fair value | [1],[4],[5],[34] | $ 1,471 | |||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5],[34] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [1],[2],[4],[5],[34] | 12.18% | 12.18% | 12.18% | |||||||||||
Investment, principal | [1],[4],[5],[7],[34] | $ 32,185 | |||||||||||||
Investment owned, at cost | [1],[4],[5],[34] | 31,923 | |||||||||||||
Investments at fair value | [1],[4],[5],[34] | $ 30,495 | |||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5],[34] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [1],[2],[3],[4],[5],[34] | 12.18% | 12.18% | 12.18% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7],[34] | $ 2,756 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5],[34] | 2,728 | |||||||||||||
Investments at fair value | [1],[3],[4],[5],[34] | $ 2,593 | |||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5],[34] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [1],[2],[3],[4],[5],[34] | 12.18% | 12.18% | 12.18% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7],[34] | $ 1,099 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5],[34] | 1,059 | |||||||||||||
Investments at fair value | [1],[3],[4],[5],[34] | $ 926 | |||||||||||||
Investment, Identifier [Axis]: Surgery Center Holdings, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 6.51% | 6.51% | 6.51% | ||||||||||||
Investment, principal | $ 3,377 | ||||||||||||||
Investment owned, at cost | 3,365 | ||||||||||||||
Investments at fair value | $ 3,213 | ||||||||||||||
Investment, Identifier [Axis]: Surgery Center Holdings, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 6.51% | 6.51% | 6.51% | ||||||||||||
Investment, principal | $ 3,377 | ||||||||||||||
Investment owned, at cost | 3,365 | ||||||||||||||
Investments at fair value | $ 3,213 | ||||||||||||||
Investment, Identifier [Axis]: Swordfish Merger Sub LLC, Auto Parts & Equipment, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [1],[4],[5] | 6.75% | [1],[4],[5] | 6.75% | [1],[4],[5] | 6.75% | [8],[9],[10] | 6.75% | [8],[9],[10] | 6.75% | [8],[9],[10] | |||
Investment, interest rate | 11.94% | [1],[2],[4],[5] | 11.94% | [1],[2],[4],[5] | 11.94% | [1],[2],[4],[5] | 9.81% | [8],[9],[10],[11] | 9.81% | [8],[9],[10],[11] | 9.81% | [8],[9],[10],[11] | |||
Investment, principal | $ 12,500 | [1],[4],[5],[7] | $ 12,500 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 12,480 | [1],[4],[5] | 12,474 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 11,681 | [1],[4],[5] | $ 11,469 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | 11.50% | [2],[4],[5],[6],[14] | 11.50% | [2],[4],[5],[6],[14] | 11.50% | [2],[4],[5],[6],[14] | 11.50% | [8],[9],[10],[11],[16] | 11.50% | [8],[9],[10],[11],[16] | 11.50% | [8],[9],[10],[11],[16] | |||
Investment, principal | $ 4,984 | [4],[6],[7],[14] | $ 4,984 | [8],[9],[12],[16] | |||||||||||
Investment owned, at cost | 4,887 | [4],[6],[14] | 4,866 | [8],[9],[16] | |||||||||||
Investments at fair value | $ 4,810 | [4],[6],[14] | $ 4,872 | [8],[9],[16] | |||||||||||
Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [1],[2],[4],[5],[14] | 13% | 13% | 13% | |||||||||||
Investment, principal | [1],[4],[7],[14] | $ 50,419 | |||||||||||||
Investment owned, at cost | [1],[4],[14] | 49,787 | |||||||||||||
Investments at fair value | [1],[4],[14] | $ 49,809 | |||||||||||||
Investment, Identifier [Axis]: TIBCO Software Inc., Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | [4],[5] | 4.50% | [4],[5] | 4.50% | [4],[5] | 4.50% | [9],[10] | 4.50% | [9],[10] | 4.50% | [9],[10] | |||
Investment, interest rate | 9.84% | [2],[4],[5] | 9.84% | [2],[4],[5] | 9.84% | [2],[4],[5] | 8.15% | [9],[10],[11] | 8.15% | [9],[10],[11] | 8.15% | [9],[10],[11] | |||
Investment, principal | $ 17,213 | [4],[5],[7] | $ 12,032 | [9],[10],[12] | |||||||||||
Investment owned, at cost | 15,952 | [4],[5] | 10,949 | [9],[10] | |||||||||||
Investments at fair value | $ 16,141 | [4],[5] | $ 10,827 | [9],[10] | |||||||||||
Investment, Identifier [Axis]: TIBCO Software Inc., Application Software, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | ||||||||||||
Investment, interest rate | 9.84% | 9.84% | 9.84% | ||||||||||||
Investment, principal | $ 8,235 | ||||||||||||||
Investment owned, at cost | 7,548 | ||||||||||||||
Investments at fair value | $ 7,722 | ||||||||||||||
Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | ||||||||||||
Investment, interest rate | 8.15% | 8.15% | 8.15% | ||||||||||||
Investment, principal | $ 6,256 | ||||||||||||||
Investment owned, at cost | 5,693 | ||||||||||||||
Investments at fair value | $ 5,629 | ||||||||||||||
Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | 4.50% | 4.50% | 4.50% | |||||||||
Investment, interest rate | 9.84% | 9.84% | 9.84% | 8.15% | 8.15% | 8.15% | |||||||||
Investment, principal | $ 2,647 | $ 2,654 | |||||||||||||
Investment owned, at cost | 2,435 | 2,415 | |||||||||||||
Investments at fair value | $ 2,483 | $ 2,388 | |||||||||||||
Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [4],[5] | 7.50% | [4],[5] | 7.50% | [4],[5] | 7.50% | [9],[10] | 7.50% | [9],[10] | 7.50% | [9],[10] | |||
Investment, interest rate | 12.69% | [2],[4],[5] | 12.69% | [2],[4],[5] | 12.69% | [2],[4],[5] | 10.62% | [9],[10],[11] | 10.62% | [9],[10],[11] | 10.62% | [9],[10],[11] | |||
Investment, principal | $ 12,843 | [4],[5],[7] | $ 9,448 | [9],[10],[12] | |||||||||||
Investment owned, at cost | 12,589 | [4],[5] | 9,338 | [9],[10] | |||||||||||
Investments at fair value | $ 12,168 | [4],[5] | $ 8,692 | [9],[10] | |||||||||||
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[3],[4],[5],[14] | 6% | [1],[3],[4],[5],[14] | 6% | [1],[3],[4],[5],[14] | 6% | [8],[9],[10],[13],[16] | 6% | [8],[9],[10],[13],[16] | 6% | [8],[9],[10],[13],[16] | |||
Investment, principal | $ 0 | [1],[3],[4],[5],[7],[14] | $ 0 | [8],[9],[10],[12],[13],[16] | |||||||||||
Investment owned, at cost | (31) | [1],[3],[4],[5],[14] | (29) | [8],[9],[10],[13],[16] | |||||||||||
Investments at fair value | $ (24) | [1],[3],[4],[5],[14] | $ (28) | [8],[9],[10],[13],[16] | |||||||||||
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[4],[5],[14] | 6% | [1],[4],[5],[14] | 6% | [1],[4],[5],[14] | 6% | [8],[9],[10],[16] | 6% | [8],[9],[10],[16] | 6% | [8],[9],[10],[16] | |||
Investment, interest rate | 11.15% | [1],[2],[4],[5],[14] | 11.15% | [1],[2],[4],[5],[14] | 11.15% | [1],[2],[4],[5],[14] | 8.68% | [8],[9],[10],[11],[16] | 8.68% | [8],[9],[10],[11],[16] | 8.68% | [8],[9],[10],[11],[16] | |||
Investment, principal | $ 28,826 | [1],[4],[5],[7],[14] | $ 23,215 | [8],[9],[10],[12],[16] | |||||||||||
Investment owned, at cost | 28,583 | [1],[4],[5],[14] | 22,815 | [8],[9],[10],[16] | |||||||||||
Investments at fair value | $ 28,537 | [1],[4],[5],[14] | $ 22,843 | [8],[9],[10],[16] | |||||||||||
Investment, Identifier [Axis]: Tecta America Corp., Construction & Engineering, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.50% | [1],[4],[5] | 8.50% | [1],[4],[5] | 8.50% | [1],[4],[5] | 8.50% | [8],[9],[10] | 8.50% | [8],[9],[10] | 8.50% | [8],[9],[10] | |||
Investment, interest rate | 13.72% | [1],[2],[4],[5] | 13.72% | [1],[2],[4],[5] | 13.72% | [1],[2],[4],[5] | 11.62% | [8],[9],[10],[11] | 11.62% | [8],[9],[10],[11] | 11.62% | [8],[9],[10],[11] | |||
Investment, principal | $ 4,755 | [1],[4],[5],[7] | $ 5,203 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 4,677 | [1],[4],[5] | 5,125 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 4,529 | [1],[4],[5] | $ 5,034 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 9.75% | [1],[3],[4],[5] | 9.75% | [1],[3],[4],[5] | 9.75% | [1],[3],[4],[5] | 9.25% | [8],[9],[10],[13] | 9.25% | [8],[9],[10],[13] | 9.25% | [8],[9],[10],[13] | |||
Investment, interest rate | 14.93% | [1],[2],[3],[4],[5] | 14.93% | [1],[2],[3],[4],[5] | 14.93% | [1],[2],[3],[4],[5] | 12.20% | [8],[9],[10],[11],[13] | 12.20% | [8],[9],[10],[11],[13] | 12.20% | [8],[9],[10],[11],[13] | |||
Investment, principal | $ 1,590 | [1],[3],[4],[5],[7] | $ 1,231 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | 1,572 | [1],[3],[4],[5] | 1,210 | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ 1,535 | [1],[3],[4],[5] | $ 1,187 | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 9.75% | [1],[4],[5] | 9.75% | [1],[4],[5] | 9.75% | [1],[4],[5] | 9.25% | [8],[9],[10] | 9.25% | [8],[9],[10] | 9.25% | [8],[9],[10] | |||
Investment, interest rate | 14.99% | [1],[2],[4],[5] | 14.99% | [1],[2],[4],[5] | 14.99% | [1],[2],[4],[5] | 12.11% | [8],[9],[10],[11] | 12.11% | [8],[9],[10],[11] | 12.11% | [8],[9],[10],[11] | |||
Investment, principal | $ 23,483 | [1],[4],[5],[7] | $ 18,323 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 23,239 | [1],[4],[5] | 17,956 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 22,919 | [1],[4],[5] | $ 17,865 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 11.09% | 11.09% | 11.09% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 19,947 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 18,963 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 19,000 | |||||||||||||
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Pharmaceuticals, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[9] | 668,879 | 668,879 | 668,879 | |||||||||||
Investment, principal | [8],[9],[12] | ||||||||||||||
Investment owned, at cost | [8],[9] | 2,028 | |||||||||||||
Investments at fair value | [8],[9] | $ 4,077 | |||||||||||||
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Pharmaceuticals, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 9.50% | 9.50% | 9.50% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 13.17% | 13.17% | 13.17% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 29,663 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 29,352 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 29,031 | |||||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.30% | [1],[4],[5],[17] | 7.30% | [1],[4],[5],[17] | 7.30% | [1],[4],[5],[17] | 7.30% | [8],[9],[10] | 7.30% | [8],[9],[10] | 7.30% | [8],[9],[10] | |||
Investment, interest rate | [8],[9],[10],[11] | 10.44% | 10.44% | 10.44% | |||||||||||
Investment, principal | $ 19,163 | [1],[4],[5],[7],[17] | $ 15,674 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 19,163 | [1],[4],[5],[17] | 15,605 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 18,286 | [1],[4],[5],[17] | $ 15,682 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 12.50% | [1],[4],[5],[17] | 12.50% | [1],[4],[5],[17] | 12.50% | [1],[4],[5],[17] | 12.50% | [8],[9],[10] | 12.50% | [8],[9],[10] | 12.50% | [8],[9],[10] | |||
Investment, interest rate | [8],[9],[10],[11] | 16.17% | 16.17% | 16.17% | |||||||||||
Investment, principal | $ 4,641 | [1],[4],[5],[7],[17] | $ 3,789 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 4,641 | [1],[4],[5],[17] | 3,774 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 4,164 | [1],[4],[5],[17] | $ 3,800 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12.50% | 12.50% | 12.50% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 46,832 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 45,609 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 41,919 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [1],[4] | 10,616 | 10,616 | 10,616 | |||||||||||
Investment owned, at cost | [1],[4] | $ 120 | |||||||||||||
Investments at fair value | [1],[4] | $ 55 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [1],[4] | 358,299 | 358,299 | 358,299 | |||||||||||
Investment owned, at cost | [1],[4] | $ 2,912 | |||||||||||||
Investments at fair value | [1],[4] | $ 1,526 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [1],[4] | 60,862 | 60,862 | 60,862 | |||||||||||
Investment owned, at cost | [1],[4] | $ 1,207 | |||||||||||||
Investments at fair value | [1],[4] | $ 795 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 4 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [1],[4] | 32,447 | 32,447 | 32,447 | |||||||||||
Investment owned, at cost | [1],[4] | $ 33,353 | |||||||||||||
Investments at fair value | [1],[4] | $ 36,587 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 7% | 7% | 7% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 11.17% | 11.17% | 11.17% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 37,494 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 36,569 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 35,807 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[9] | 8,434 | 8,434 | 8,434 | |||||||||||
Investment owned, at cost | [8],[9] | $ 101 | |||||||||||||
Investments at fair value | [8],[9] | $ 69 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[9] | 284,650 | 284,650 | 284,650 | |||||||||||
Investment owned, at cost | [8],[9] | $ 2,409 | |||||||||||||
Investments at fair value | [8],[9] | $ 2,320 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[9] | 48,352 | 48,352 | 48,352 | |||||||||||
Investment owned, at cost | [8],[9] | $ 979 | |||||||||||||
Investments at fair value | [8],[9] | $ 979 | |||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 4 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[9],[13] | 23,201 | 23,201 | 23,201 | |||||||||||
Investment owned, at cost | [8],[9],[13] | $ 22,986 | |||||||||||||
Investments at fair value | [8],[9],[13] | $ 26,487 | |||||||||||||
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | ||||||||||||
Investment, interest rate | 9.12% | 9.12% | 9.12% | ||||||||||||
Investment, principal | $ 7,285 | ||||||||||||||
Investment owned, at cost | 7,155 | ||||||||||||||
Investments at fair value | $ 7,140 | ||||||||||||||
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | 6% | 6% | 6% | |||||||||
Investment, interest rate | 11.20% | 11.20% | 11.20% | 9.12% | 9.12% | 9.12% | |||||||||
Investment, principal | $ 3,001 | $ 3,024 | |||||||||||||
Investment owned, at cost | 2,954 | 2,970 | |||||||||||||
Investments at fair value | $ 2,926 | $ 2,963 | |||||||||||||
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | [1],[4],[5] | 6% | [1],[4],[5] | 6% | [1],[4],[5] | 6% | [8],[9],[10] | 6% | [8],[9],[10] | 6% | [8],[9],[10] | |||
Investment, interest rate | 11.20% | [1],[2],[4],[5] | 11.20% | [1],[2],[4],[5] | 11.20% | [1],[2],[4],[5] | 9.12% | [8],[9],[10],[11] | 9.12% | [8],[9],[10],[11] | 9.12% | [8],[9],[10],[11] | |||
Investment, principal | $ 11,701 | [1],[4],[5],[7] | $ 6,016 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 11,675 | [1],[4],[5] | 5,908 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 11,408 | [1],[4],[5] | $ 5,895 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6% | 6% | 6% | ||||||||||||
Investment, interest rate | 11.20% | 11.20% | 11.20% | ||||||||||||
Investment, principal | $ 7,230 | ||||||||||||||
Investment owned, at cost | 7,116 | ||||||||||||||
Investments at fair value | $ 7,050 | ||||||||||||||
Investment, Identifier [Axis]: Tribe Buyer LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | 4.50% | 4.50% | 4.50% | |||||||||
Investment, interest rate | 9.69% | 9.69% | 9.69% | 7.62% | 7.62% | 7.62% | |||||||||
Investment, principal | $ 1,570 | $ 1,583 | |||||||||||||
Investment owned, at cost | 1,570 | 1,582 | |||||||||||||
Investments at fair value | $ 931 | $ 1,266 | |||||||||||||
Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [4],[5],[14] | 7.45% | 7.45% | 7.45% | |||||||||||
Investment, interest rate | [2],[4],[5],[14] | 12.72% | 12.72% | 12.72% | |||||||||||
Investment, principal | [4],[5],[7],[14] | $ 1,000 | |||||||||||||
Investment owned, at cost | [4],[5],[14] | 814 | |||||||||||||
Investments at fair value | [4],[5],[14] | $ 929 | |||||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [2],[4],[5],[14] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, principal | [4],[7],[14] | $ 4,500 | |||||||||||||
Investment owned, at cost | [4],[14] | 4,101 | |||||||||||||
Investments at fair value | [4],[14] | $ 3,189 | |||||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [2],[4],[5],[14] | 4.75% | 4.75% | 4.75% | |||||||||||
Investment, principal | [4],[7],[14] | $ 300 | |||||||||||||
Investment owned, at cost | [4],[14] | 263 | |||||||||||||
Investments at fair value | [4],[14] | $ 249 | |||||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Specialized REITs, Fixed Rate Bond 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [9],[10],[11],[16] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, principal | [9],[12],[16] | $ 4,500 | |||||||||||||
Investment owned, at cost | [9],[16] | 4,060 | |||||||||||||
Investments at fair value | [9],[16] | $ 3,026 | |||||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Specialized REITs, Fixed Rate Bond 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [9],[10],[11],[16] | 4.75% | 4.75% | 4.75% | |||||||||||
Investment, principal | [9],[12],[16] | $ 300 | |||||||||||||
Investment owned, at cost | [9],[16] | 258 | |||||||||||||
Investments at fair value | [9],[16] | $ 238 | |||||||||||||
Investment, Identifier [Axis]: Veritas US Inc., Application Software, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 10.22% | 10.22% | 10.22% | ||||||||||||
Investment, principal | $ 6,322 | ||||||||||||||
Investment owned, at cost | 6,266 | ||||||||||||||
Investments at fair value | $ 5,185 | ||||||||||||||
Investment, Identifier [Axis]: Veritas US Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 5% | 5% | 5% | ||||||||||||
Investment, interest rate | 8.67% | 8.67% | 8.67% | ||||||||||||
Investment, principal | $ 6,365 | ||||||||||||||
Investment owned, at cost | 6,290 | ||||||||||||||
Investments at fair value | $ 5,087 | ||||||||||||||
Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12.47% | 12.47% | 12.47% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 1,540 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 1,239 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 1,279 | |||||||||||||
Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 15% | 15% | 15% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 21.22% | 21.22% | 21.22% | |||||||||||
Investment, principal | [1],[4],[5] | $ 1,323 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 1,311 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 1,247 | |||||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | [4],[5] | 3.75% | [4],[5] | 3.75% | [4],[5] | 3.75% | [9],[10] | 3.75% | [9],[10] | 3.75% | [9],[10] | |||
Investment, interest rate | 9.03% | [2],[4],[5] | 9.03% | [2],[4],[5] | 9.03% | [2],[4],[5] | 6.56% | [9],[10],[11] | 6.56% | [9],[10],[11] | 6.56% | [9],[10],[11] | |||
Investment, principal | $ 11,822 | [4],[5] | $ 7,564 | [9],[10],[12] | |||||||||||
Investment owned, at cost | 11,228 | [4],[5] | 6,989 | [9],[10] | |||||||||||
Investments at fair value | $ 10,743 | [4],[5] | $ 6,795 | [9],[10] | |||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 9.03% | 9.03% | 9.03% | ||||||||||||
Investment, principal | $ 1,970 | ||||||||||||||
Investment owned, at cost | 1,917 | ||||||||||||||
Investments at fair value | $ 1,791 | ||||||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 7.75% | 7.75% | 7.75% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 10.56% | 10.56% | 10.56% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 6,000 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 5,855 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 5,070 | |||||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | ||||||||||||
Investment, interest rate | 6.56% | 6.56% | 6.56% | ||||||||||||
Investment, principal | $ 1,985 | ||||||||||||||
Investment owned, at cost | 1,910 | ||||||||||||||
Investments at fair value | $ 1,783 | ||||||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.75% | 3.75% | 3.75% | 3.75% | 3.75% | 3.75% | |||||||||
Investment, interest rate | 9.03% | 9.03% | 9.03% | 6.56% | 6.56% | 6.56% | |||||||||
Investment, principal | $ 985 | $ 993 | |||||||||||||
Investment owned, at cost | 959 | 955 | |||||||||||||
Investments at fair value | $ 895 | $ 892 | |||||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Second Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.75% | 7.75% | 7.75% | ||||||||||||
Investment, interest rate | 10.56% | 10.56% | 10.56% | ||||||||||||
Investment, principal | $ 6,000 | ||||||||||||||
Investment owned, at cost | 5,972 | ||||||||||||||
Investments at fair value | $ 5,070 | ||||||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Second Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.75% | 7.75% | 7.75% | ||||||||||||
Investment, interest rate | 10.56% | 10.56% | 10.56% | ||||||||||||
Investment, principal | $ 3,000 | ||||||||||||||
Investment owned, at cost | 2,986 | ||||||||||||||
Investments at fair value | $ 2,534 | ||||||||||||||
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [8],[9],[10] | 6% | 6% | 6% | |||||||||||
Investment, interest rate | [8],[9],[10],[11] | 10.19% | 10.19% | 10.19% | |||||||||||
Investment, principal | [8],[9],[10],[12] | $ 40,536 | |||||||||||||
Investment owned, at cost | [8],[9],[10] | 39,947 | |||||||||||||
Investments at fair value | [8],[9],[10] | $ 40,131 | |||||||||||||
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 11.38% | 11.38% | 11.38% | |||||||||||
Investment, principal | [1],[4],[5] | $ 35,853 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 35,764 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 35,495 | |||||||||||||
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 6.50% | 6.50% | 6.50% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 12% | 12% | 12% | |||||||||||
Investment, principal | [1],[4],[5] | $ 19,306 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 19,258 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 19,113 | |||||||||||||
Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7% | [1],[4],[5] | 7% | [1],[4],[5] | 7% | [1],[4],[5] | 7% | [8],[9],[10] | 7% | [8],[9],[10] | 7% | [8],[9],[10] | |||
Investment, interest rate | 12.50% | [1],[2],[4],[5] | 12.50% | [1],[2],[4],[5] | 12.50% | [1],[2],[4],[5] | 10.67% | [8],[9],[10],[11] | 10.67% | [8],[9],[10],[11] | 10.67% | [8],[9],[10],[11] | |||
Investment, principal | $ 5,000 | [1],[4],[5] | $ 5,000 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 4,925 | [1],[4],[5] | 4,925 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 4,025 | [1],[4],[5] | $ 4,538 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 15% | [1],[4],[5] | 15% | [1],[4],[5] | 15% | [1],[4],[5] | 15% | [8],[9],[10] | 15% | [8],[9],[10] | 15% | [8],[9],[10] | |||
Investment, interest rate | 21.22% | [1],[2],[4],[5] | 21.22% | [1],[2],[4],[5] | 21.22% | [1],[2],[4],[5] | 19.64% | [8],[9],[10],[11] | 19.64% | [8],[9],[10],[11] | 19.64% | [8],[9],[10],[11] | |||
Investment, principal | $ 1,565 | [1],[4],[5] | $ 2,316 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 1,551 | [1],[4],[5] | 2,293 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 1,475 | [1],[4],[5] | $ 2,264 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 4,871 | [1],[4] | 4,871 | [1],[4] | 4,871 | [1],[4] | 3,621 | [8],[9] | 3,621 | [8],[9] | 3,621 | [8],[9] | |||
Investment owned, at cost | $ 46 | [1],[4] | $ 0 | [8],[9] | |||||||||||
Investments at fair value | $ 136 | [1],[4] | $ 192 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | 6.25% | 6.25% | ||||||||||||
Investment, interest rate | 9.37% | 9.37% | 9.37% | ||||||||||||
Investment, principal | $ 7,818 | ||||||||||||||
Investment owned, at cost | 7,596 | ||||||||||||||
Investments at fair value | $ 7,115 | ||||||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | 6.25% | 6.25% | 6.25% | 6.25% | 6.25% | |||||||||
Investment, interest rate | 11.45% | 11.45% | 11.45% | 9.37% | 9.37% | 9.37% | |||||||||
Investment, principal | $ 4,848 | $ 4,886 | |||||||||||||
Investment owned, at cost | 4,731 | 4,747 | |||||||||||||
Investments at fair value | $ 4,539 | $ 4,447 | |||||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Common Stock | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 127,452 | [1],[4] | 127,452 | [1],[4] | 127,452 | [1],[4] | 18,032 | [8],[9] | 18,032 | [8],[9] | 18,032 | [8],[9] | |||
Investment owned, at cost | $ 2,057 | [1],[4] | $ 216 | [8],[9] | |||||||||||
Investments at fair value | $ 1,565 | [1],[4] | $ 296 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | [4],[5] | 6.25% | [4],[5] | 6.25% | [4],[5] | 6.25% | [9],[10] | 6.25% | [9],[10] | 6.25% | [9],[10] | |||
Investment, interest rate | 11.45% | [2],[4],[5] | 11.45% | [2],[4],[5] | 11.45% | [2],[4],[5] | 9.37% | [9],[10],[11] | 9.37% | [9],[10],[11] | 9.37% | [9],[10],[11] | |||
Investment, principal | $ 24,419 | [4],[5] | $ 25,499 | [9],[10],[12] | |||||||||||
Investment owned, at cost | 23,589 | [4],[5] | 24,632 | [9],[10] | |||||||||||
Investments at fair value | $ 22,862 | [4],[5] | $ 23,204 | [9],[10] | |||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.25% | 6.25% | 6.25% | ||||||||||||
Investment, interest rate | 11.45% | 11.45% | 11.45% | ||||||||||||
Investment, principal | $ 7,757 | ||||||||||||||
Investment owned, at cost | 7,570 | ||||||||||||||
Investments at fair value | $ 7,263 | ||||||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [8],[9] | 109,420 | 109,420 | 109,420 | |||||||||||
Investment owned, at cost | [8],[9] | $ 1,842 | |||||||||||||
Investments at fair value | [8],[9] | $ 1,799 | |||||||||||||
Investment, Identifier [Axis]: Zayo Group Holdings, Inc., Alternative Carriers, Fixed Rate Bond | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, interest rate | [9],[10],[11] | 4% | 4% | 4% | |||||||||||
Investment, principal | [9],[12] | $ 250 | |||||||||||||
Investment owned, at cost | [9] | 212 | |||||||||||||
Investments at fair value | [9] | $ 201 | |||||||||||||
Investment, Identifier [Axis]: Zayo Group Holdings, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3% | 3% | 3% | ||||||||||||
Investment, interest rate | 6.12% | 6.12% | 6.12% | ||||||||||||
Investment, principal | $ 2,155 | ||||||||||||||
Investment owned, at cost | 2,000 | ||||||||||||||
Investments at fair value | $ 1,812 | ||||||||||||||
Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 8.25% | [1],[4],[5] | 8.25% | [1],[4],[5] | 8.25% | [1],[4],[5] | 8.25% | [8],[9],[10] | 8.25% | [8],[9],[10] | 8.25% | [8],[9],[10] | |||
Investment, interest rate | 13.79% | [1],[2],[4],[5] | 13.79% | [1],[2],[4],[5] | 13.79% | [1],[2],[4],[5] | 11.92% | [8],[9],[10],[11] | 11.92% | [8],[9],[10],[11] | 11.92% | [8],[9],[10],[11] | |||
Investment, principal | $ 19,578 | [1],[4],[5] | $ 19,578 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 19,551 | [1],[4],[5] | 19,542 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 13,693 | [1],[4],[5] | $ 16,152 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.50% | [1],[4],[5],[14] | 7.50% | [1],[4],[5],[14] | 7.50% | [1],[4],[5],[14] | 7.50% | [8],[9],[10],[16] | 7.50% | [8],[9],[10],[16] | 7.50% | [8],[9],[10],[16] | |||
Investment, interest rate | 12.46% | [1],[2],[4],[5],[14] | 12.46% | [1],[2],[4],[5],[14] | 12.46% | [1],[2],[4],[5],[14] | 9.72% | [8],[9],[10],[11],[16] | 9.72% | [8],[9],[10],[11],[16] | 9.72% | [8],[9],[10],[11],[16] | |||
Investment, principal | £ | £ 20,000 | [1],[4],[5],[14] | £ 18,000 | [8],[9],[10],[12],[16] | |||||||||||
Investment owned, at cost | $ 25,857 | [1],[4],[5],[14] | $ 23,804 | [8],[9],[10],[16] | |||||||||||
Investments at fair value | $ 23,270 | [1],[4],[5],[14] | $ 16,552 | [8],[9],[10],[16] | |||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, First Lien Delayed Draw Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.50% | 3.50% | 3.50% | ||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investment owned, at cost | (13) | ||||||||||||||
Investments at fair value | $ (8) | ||||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.50% | 3.50% | 3.50% | ||||||||||||
Investment, interest rate | 8.59% | 8.59% | 8.59% | ||||||||||||
Investment, principal | $ 1,777 | ||||||||||||||
Investment owned, at cost | 1,674 | ||||||||||||||
Investments at fair value | $ 1,715 | ||||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, First Lien Term Loan 1 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.50% | 3.50% | 3.50% | ||||||||||||
Investment, interest rate | 8.59% | 8.59% | 8.59% | ||||||||||||
Investment, principal | $ 4,331 | ||||||||||||||
Investment owned, at cost | 4,079 | ||||||||||||||
Investments at fair value | $ 4,179 | ||||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, First Lien Term Loan 2 | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 3.50% | 3.50% | 3.50% | ||||||||||||
Investment, principal | $ 0 | ||||||||||||||
Investment owned, at cost | (32) | ||||||||||||||
Investments at fair value | $ (19) | ||||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Preferred Equity | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | 21,523 | [1],[4] | 21,523 | [1],[4] | 21,523 | [1],[4] | 18,635 | [8],[9] | 18,635 | [8],[9] | 18,635 | [8],[9] | |||
Investment owned, at cost | $ 20,789 | [1],[4] | $ 18,264 | [8],[9] | |||||||||||
Investments at fair value | $ 18,821 | [1],[4] | $ 16,575 | [8],[9] | |||||||||||
Investment, Identifier [Axis]: eResearch Technology, Inc., First Lien Term Loan | SLF JV I | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | ||||||||||||
Investment, interest rate | 7.62% | 7.62% | 7.62% | ||||||||||||
Investment, principal | $ 7,331 | ||||||||||||||
Investment owned, at cost | 7,258 | ||||||||||||||
Investments at fair value | $ 6,859 | ||||||||||||||
Investment, Identifier [Axis]: eResearch Technology, Inc., First Lien Term Loan | OCSI Glick JV LLC | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 4.50% | 4.50% | 4.50% | ||||||||||||
Investment, interest rate | 7.62% | 7.62% | 7.62% | ||||||||||||
Investment, principal | $ 2,444 | ||||||||||||||
Investment owned, at cost | 2,419 | ||||||||||||||
Investments at fair value | $ 2,286 | ||||||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 6.75% | [1],[3],[4],[5] | 6.75% | [1],[3],[4],[5] | 6.75% | [1],[3],[4],[5] | 6.75% | [8],[9],[10],[13] | 6.75% | [8],[9],[10],[13] | 6.75% | [8],[9],[10],[13] | |||
Investment, interest rate | [1],[2],[3],[4],[5] | 11.99% | 11.99% | 11.99% | |||||||||||
Investment, principal | $ 377 | [1],[3],[4],[5],[7] | $ 0 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | 331 | [1],[3],[4],[5] | (31) | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ 288 | [1],[3],[4],[5] | $ (32) | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[4],[5] | 7.25% | [1],[4],[5] | 7.25% | [1],[4],[5] | 6.75% | [8],[9],[10] | 6.75% | [8],[9],[10] | 6.75% | [8],[9],[10] | |||
Investment, interest rate | 8.50% | [1],[2],[4],[5] | 8.50% | [1],[2],[4],[5] | 8.50% | [1],[2],[4],[5] | 9.49% | [8],[9],[10],[11] | 9.49% | [8],[9],[10],[11] | 9.49% | [8],[9],[10],[11] | |||
Investment, principal | $ 24,188 | [1],[4],[5],[7] | $ 19,203 | [8],[9],[10],[12] | |||||||||||
Investment owned, at cost | 23,876 | [1],[4],[5] | 18,874 | [8],[9],[10] | |||||||||||
Investments at fair value | $ 23,235 | [1],[4],[5] | $ 18,867 | [8],[9],[10] | |||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | 7.25% | [1],[4],[5] | 7.25% | [1],[4],[5] | 7.25% | [1],[4],[5] | 6.75% | [8],[9],[10],[13] | 6.75% | [8],[9],[10],[13] | 6.75% | [8],[9],[10],[13] | |||
Investment, interest rate | [1],[2],[4],[5] | 12.38% | 12.38% | 12.38% | |||||||||||
Investment, principal | $ 3,636 | [1],[4],[5],[7] | $ 0 | [8],[9],[10],[12],[13] | |||||||||||
Investment owned, at cost | 3,600 | [1],[4],[5] | 0 | [8],[9],[10],[13] | |||||||||||
Investments at fair value | $ 3,563 | [1],[4],[5] | $ 0 | [8],[9],[10],[13] | |||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5] | 7.25% | 7.25% | 7.25% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5] | 0 | |||||||||||||
Investments at fair value | [1],[3],[4],[5] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[4],[5] | 8.75% | 8.75% | 8.75% | |||||||||||
Investment, interest rate | [1],[2],[4],[5] | 11.75% | 11.75% | 11.75% | |||||||||||
Investment, principal | [1],[4],[5],[7] | $ 5,212 | |||||||||||||
Investment owned, at cost | [1],[4],[5] | 4,973 | |||||||||||||
Investments at fair value | [1],[4],[5] | $ 5,034 | |||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5] | 8.75% | 8.75% | 8.75% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5] | 0 | |||||||||||||
Investments at fair value | [1],[3],[4],[5] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3 | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment, basis spread, variable rate | [1],[3],[4],[5] | 8.75% | 8.75% | 8.75% | |||||||||||
Investment, principal | [1],[3],[4],[5],[7] | $ 0 | |||||||||||||
Investment owned, at cost | [1],[3],[4],[5] | 0 | |||||||||||||
Investments at fair value | [1],[3],[4],[5] | $ 0 | |||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants | |||||||||||||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | |||||||||||||||
Investment owned, balance (in shares) | shares | [1],[4] | 53,700 | 53,700 | 53,700 | |||||||||||
Investment owned, at cost | [1],[4] | $ 175 | |||||||||||||
Investments at fair value | [1],[4] | $ 407 | |||||||||||||
[1] As of June 30, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820"). ten twenty ten twenty ten twenty ten twenty |
Portfolio Investments - Summari
Portfolio Investments - Summarized Balance Sheet Information (Details) - USD ($) $ in Thousands | 9 Months Ended | 12 Months Ended |
Jun. 30, 2023 | Sep. 30, 2022 | |
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||
Investments at fair value | $ 3,135,619 | $ 2,494,111 |
Cash and cash equivalents | 59,704 | 23,528 |
Restricted cash | 12,956 | 2,836 |
Other assets | 693 | 1,665 |
Total assets | 3,335,974 | 2,646,313 |
Credit facilities payable | 1,135,000 | 700,000 |
Due to affiliate | 7,724 | 3,180 |
Total liabilities | 1,826,533 | 1,400,750 |
Total liabilities and net assets | 3,335,974 | 2,646,313 |
Investment owned, at cost | 3,296,285 | 2,617,754 |
SLF JV I | ||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||
Investments at fair value | 329,809 | 359,625 |
Cash and cash equivalents | 21,906 | 14,274 |
Restricted cash | 8,715 | 5,642 |
Other assets | 9,798 | 5,686 |
Total assets | 370,228 | 385,227 |
Credit facilities payable | 200,000 | 230,000 |
Notes payable at fair value | 128,750 | 110,000 |
Due to affiliate | 9,509 | 21,539 |
Total liabilities | 338,259 | 361,539 |
Members' equity | 31,969 | 23,688 |
Total liabilities and net assets | 370,228 | 385,227 |
Investment owned, at cost | 348,782 | 382,673 |
Net proceeds | 128,750 | 110,000 |
OCSI Glick JV LLC | ||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||
Investments at fair value | 113,833 | 133,144 |
Cash and cash equivalents | 8,895 | 7,021 |
Restricted cash | 1,812 | 1,788 |
Other assets | 2,284 | 4,855 |
Total assets | 126,824 | 146,808 |
Credit facilities payable | 66,082 | 82,082 |
Notes payable at fair value | 56,723 | 57,463 |
Due to affiliate | 4,019 | 7,263 |
Total liabilities | 126,824 | 146,808 |
Members' equity | 0 | 0 |
Total liabilities and net assets | 126,824 | 146,808 |
Investment owned, at cost | 120,172 | 140,083 |
Net proceeds | $ 66,684 | $ 68,185 |
Portfolio Investments - Summa_2
Portfolio Investments - Summarized Statement of Operations Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||
Total investment income | $ 101,900 | $ 63,137 | $ 277,381 | $ 192,376 |
Interest expense | 30,793 | 11,870 | 79,316 | 31,178 |
Total expenses | 54,987 | 23,517 | 148,129 | 78,555 |
Net investment income before taxes | 48,413 | 40,370 | 133,277 | 116,071 |
Net increase (decrease) in net assets resulting from operations | 36,685 | (37,834) | 71,379 | 16,015 |
OCSI Glick JV LLC | ||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||
Interest income | 3,576 | 2,416 | 10,488 | 6,796 |
Fee income | 0 | 47 | 35 | 82 |
Total investment income | 3,576 | 2,463 | 10,523 | 6,878 |
Other expenses | 70 | 59 | 148 | 127 |
Total expenses | 3,047 | 1,613 | 8,544 | 4,348 |
Net investment income before taxes | 529 | 850 | 1,979 | 2,530 |
Net unrealized appreciation (depreciation) | 431 | (753) | (159) | (2,549) |
Realized gain (loss) | (960) | (97) | (1,820) | 19 |
Net increase (decrease) in net assets resulting from operations | 0 | 0 | 0 | 0 |
OCSI Glick JV LLC | Senior Credit Facility | ||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||
Interest expense | 1,400 | 694 | 4,002 | 1,742 |
OCSI Glick JV LLC | Glick JV Notes | ||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||
Interest expense | 1,577 | 860 | 4,394 | 2,479 |
SLF JV I | ||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||
Interest income | 10,312 | 5,796 | 29,106 | 16,664 |
Fee income | 0 | 32 | 62 | 105 |
Total investment income | 10,312 | 5,828 | 29,168 | 16,769 |
Other expenses | 73 | 77 | 249 | 198 |
Total expenses | 8,122 | 4,230 | 22,764 | 11,866 |
Net investment income before taxes | 2,190 | 1,598 | 6,404 | 4,903 |
Net unrealized appreciation (depreciation) | 2,652 | (16,411) | 4,075 | (19,856) |
Realized gain (loss) | (2,137) | 165 | (4,850) | 568 |
Net increase (decrease) in net assets resulting from operations | 2,705 | (14,648) | 5,629 | (14,385) |
SLF JV I | Senior Credit Facility | ||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||
Interest expense | 4,190 | 1,929 | 12,004 | 4,995 |
SLF JV I | SLF JV I Notes | ||||
Investment Company, Nonconsolidated Subsidiary [Line Items] | ||||
Interest expense | $ 3,859 | $ 2,224 | $ 10,511 | $ 6,673 |
Fee Income (Details)
Fee Income (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenue from Contract with Customer [Abstract] | ||||
Fee income | $ 1,573 | $ 2,275 | $ 5,974 | $ 5,092 |
Recurring fee income | $ 200 | $ 200 | $ 800 | $ 700 |
Share Data and Net Assets - Sch
Share Data and Net Assets - Schedule of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | ||
Earnings (loss) per common share — basic and diluted: | |||||
Net increase (decrease) in net assets resulting from operations | $ 36,685 | $ (37,834) | $ 71,379 | $ 16,015 | |
Weighted average common shares outstanding - basic (shares) | [1] | 77,080,000 | 61,123,000 | 70,431,000 | 60,593,000 |
Weighted average common shares outstanding - diluted (shares) | [1] | 77,080,000 | 61,123,000 | 70,431,000 | 60,593,000 |
Earnings (loss) per common share - basic (dollars per share) | [1] | $ 0.48 | $ (0.62) | $ 1.01 | $ 0.26 |
Earnings (loss) per common share - diluted (dollars per share) | [1] | $ 0.48 | $ (0.62) | $ 1.01 | $ 0.26 |
[1](1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis. |
Share Data and Net Assets - S_2
Share Data and Net Assets - Schedule of Changes in Net Assets (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||||||||||||
Jan. 23, 2023 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Jun. 30, 2023 | Mar. 31, 2023 | Dec. 31, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Jun. 30, 2023 | Jun. 30, 2022 | ||||
Investment Company, Net Assets [Roll Forward] | |||||||||||||||
Beginning of period (shares) | 61,125,000 | 61,125,000 | |||||||||||||
Net assets at beginning of period | $ 1,515,150 | $ 1,201,989 | $ 1,245,563 | [1] | $ 1,330,376 | $ 1,325,061 | $ 1,312,823 | $ 1,245,563 | [1] | $ 1,312,823 | |||||
Net investment income | 48,413 | 45,978 | 38,808 | 40,370 | 40,098 | 32,295 | 133,199 | 112,763 | |||||||
Net unrealized appreciation (depreciation) | (1,039) | (18,279) | (22,982) | (86,755) | (27,038) | (4,586) | (42,300) | (118,400) | |||||||
Net realized gains (losses) | (10,603) | (6,111) | (3,203) | 9,212 | 1,402 | 9,321 | (19,900) | 19,900 | |||||||
(Provision) benefit for taxes on realized and unrealized gains (losses) | (86) | (66) | 549 | (661) | (21) | 2,378 | 397 | 1,696 | |||||||
Net increase (decrease) in net assets from stockholder transactions | (42,394) | (42,395) | (58,679) | (30,256) | (29,271) | (27,956) | (143,468) | (87,483) | |||||||
Issuance of common stock in connection with the OSI2 Merger (shares) | 15,860,200 | ||||||||||||||
Issuance of common stock in connection with the OSI2 Merger | 0 | 334,034 | 0 | 334,034 | 0 | ||||||||||
Issuance of common stock in connection with the "at the market" offering | 0 | 1,243 | 19,379 | $ 0 | $ 20,622 | ||||||||||
Issuance of common stock under dividend reinvestment plan (shares) | 43,676,000 | 34,804,000 | 35,990,000 | 220,570,000 | 114,470,000 | ||||||||||
Issuance of common stock under dividend reinvestment plan | $ 900 | $ 800 | $ 800 | 1,123 | 1,295 | 1,933 | 874 | 766 | 786 | $ 4,351 | $ 2,426 | ||||
Repurchase of common stock under dividend reinvestment plan | $ (1,123) | (1,295) | (874) | $ (2,418) | (874) | ||||||||||
End of period (shares) | 77,080,000 | 77,080,000 | |||||||||||||
Net assets at end of period | $ 1,263,529 | $ 1,330,376 | $ 1,325,061 | $ 1,509,441 | [1] | $ 1,515,150 | $ 1,201,989 | $ 1,263,529 | $ 1,330,376 | $ 1,325,061 | $ 1,509,441 | [1] | $ 1,263,529 | ||
Common Stock | |||||||||||||||
Investment Company, Net Assets [Roll Forward] | |||||||||||||||
Beginning of period (shares) | 77,080,000 | 61,220,000 | 61,125,000 | 61,068,000 | 60,156,000 | 60,120,000 | 61,125,000 | 60,120,000 | |||||||
Net assets at beginning of period | $ 771 | $ 612 | $ 611 | $ 611 | $ 602 | $ 601 | $ 611 | $ 601 | |||||||
Issuance of common stock in connection with the OSI2 Merger (shares) | 15,860,000 | ||||||||||||||
Issuance of common stock in connection with the OSI2 Merger | $ 159 | ||||||||||||||
Issuance of common stock in connection with the "at the market" offering (shares) | 57,000 | 877,000 | |||||||||||||
Issuance of common stock in connection with the "at the market" offering | $ 0 | $ 9 | |||||||||||||
Issuance of common stock under dividend reinvestment plan (shares) | 57,000 | 68,000 | 95,000 | 44,000 | 35,000 | 36,000 | |||||||||
Issuance of common stock under dividend reinvestment plan | $ 1 | $ 1 | $ 1 | $ 1 | $ 0 | $ 1 | |||||||||
Repurchase of common stock under dividend reinvestment plan (shares) | (57,000) | (68,000) | (44,000) | ||||||||||||
Repurchase of common stock under dividend reinvestment plan | $ (1) | $ (1) | $ (1) | ||||||||||||
End of period (shares) | 61,125,000 | 61,068,000 | 60,156,000 | 77,080,000 | 77,080,000 | 61,220,000 | 61,125,000 | 61,068,000 | 60,156,000 | 77,080,000 | 61,125,000 | ||||
Net assets at end of period | $ 611 | $ 611 | $ 602 | $ 771 | $ 771 | $ 612 | $ 611 | $ 611 | $ 602 | $ 771 | $ 611 | ||||
Additional paid-in-capital | |||||||||||||||
Investment Company, Net Assets [Roll Forward] | |||||||||||||||
Net assets at beginning of period | 2,163,528 | 1,829,653 | 1,827,721 | 1,826,478 | 1,806,342 | 1,805,557 | 1,827,721 | 1,805,557 | |||||||
Issuance of common stock in connection with the OSI2 Merger | 333,875 | ||||||||||||||
Issuance of common stock in connection with the "at the market" offering | 1,243 | 19,370 | |||||||||||||
Issuance of common stock under dividend reinvestment plan | 1,122 | 1,294 | 1,932 | 873 | 766 | 785 | |||||||||
Repurchase of common stock under dividend reinvestment plan | (1,122) | (1,294) | (873) | ||||||||||||
Net assets at end of period | 1,827,721 | 1,826,478 | 1,806,342 | 2,163,528 | 2,163,528 | 1,829,653 | 1,827,721 | 1,826,478 | 1,806,342 | 2,163,528 | 1,827,721 | ||||
Accumulated Overdistributed Earnings | |||||||||||||||
Investment Company, Net Assets [Roll Forward] | |||||||||||||||
Net assets at beginning of period | (649,149) | (628,276) | (582,769) | (496,713) | (481,883) | (493,335) | (582,769) | (493,335) | |||||||
Net investment income | 48,413 | 45,978 | 38,808 | 40,370 | 40,098 | 32,295 | |||||||||
Net unrealized appreciation (depreciation) | (1,039) | (18,279) | (22,982) | (86,755) | (27,038) | (4,586) | |||||||||
Net realized gains (losses) | (10,603) | (6,111) | (3,203) | 9,212 | 1,402 | 9,321 | |||||||||
(Provision) benefit for taxes on realized and unrealized gains (losses) | (86) | (66) | 549 | (661) | (21) | 2,378 | |||||||||
Net increase (decrease) in net assets from stockholder transactions | (42,394) | (42,395) | (58,679) | (30,256) | (29,271) | (27,956) | |||||||||
Issuance of common stock under dividend reinvestment plan | 0 | ||||||||||||||
Net assets at end of period | $ (564,803) | $ (496,713) | $ (481,883) | $ (654,858) | $ (649,149) | $ (628,276) | $ (564,803) | $ (496,713) | $ (481,883) | $ (654,858) | $ (564,803) | ||||
[1](1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The issued and outstanding shares and net asset value per share reflect the reverse stock split on a retroactive basis. |
Share Data and Net Assets - S_3
Share Data and Net Assets - Schedule of Distributions (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||||||||
Jun. 30, 2023 | Mar. 31, 2023 | Dec. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Jun. 30, 2023 | Mar. 31, 2023 | Dec. 31, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Jun. 30, 2023 | Jun. 30, 2022 | |
Investment Company, Changes in Net Assets [Line Items] | ||||||||||||||
Amount per share (dollars per share) | $ 0.495 | $ 0.48 | $ 0.465 | $ 0.55 | $ 0.50 | $ 2.06 | $ 1.44 | |||||||
Distributions to stockholders | $ 29,400 | $ 28,500 | $ 27,200 | $ 139,100 | $ 85,100 | |||||||||
Issuance of common stock under dividend reinvestment plan (shares) | 43,676,000 | 34,804,000 | 35,990,000 | 220,570,000 | 114,470,000 | |||||||||
Issuance of common stock under dividend reinvestment plan | $ 900 | $ 800 | $ 800 | $ 1,123 | $ 1,295 | $ 1,933 | $ 874 | $ 766 | $ 786 | $ 4,351 | $ 2,426 | |||
Quarterly | ||||||||||||||
Investment Company, Changes in Net Assets [Line Items] | ||||||||||||||
Amount per share (dollars per share) | $ 0.55 | $ 0.55 | $ 0.54 | |||||||||||
Distributions to stockholders | $ 41,300 | $ 41,100 | $ 32,000 | |||||||||||
Issuance of common stock under dividend reinvestment plan (shares) | 57,279,000 | 68,412,000 | 53,369,000 | |||||||||||
Issuance of common stock under dividend reinvestment plan | $ 1,100 | $ 1,300 | $ 1,100 | |||||||||||
Special | ||||||||||||||
Investment Company, Changes in Net Assets [Line Items] | ||||||||||||||
Amount per share (dollars per share) | $ 0.42 | |||||||||||||
Distributions to stockholders | $ 24,800 | |||||||||||||
Issuance of common stock under dividend reinvestment plan (shares) | 41,510,000 | |||||||||||||
Issuance of common stock under dividend reinvestment plan | $ 800 |
Share Data and Net Assets - Nar
Share Data and Net Assets - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||||||||
Feb. 08, 2023 | Jan. 23, 2023 | Jun. 30, 2022 | Mar. 31, 2022 | Feb. 07, 2022 | Dec. 31, 2021 | Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Investment Company, Changes in Net Assets [Line Items] | ||||||||||
Issuance of common stock in connection with the OSI2 Merger (shares) | 15,860,200 | |||||||||
Issuance of common stock under dividend reinvestment plan (shares) | 43,676,000 | 34,804,000 | 35,990,000 | 220,570,000 | 114,470,000 | |||||
Aggregate offering price | $ 125 | $ 125 | ||||||||
Number of shares issued (in shares) | 0 | 0 | 2,801,206 | |||||||
Consideration received on transaction | $ 20.6 | |||||||||
Common Stock | ||||||||||
Investment Company, Changes in Net Assets [Line Items] | ||||||||||
Issuance of common stock under dividend reinvestment plan (shares) | 0 | 0 | 94,879,000 | 70,794 |
Borrowings (Details)
Borrowings (Details) - USD ($) $ in Thousands | 3 Months Ended | 5 Months Ended | 9 Months Ended | |||||||
May 26, 2023 | Jan. 23, 2023 | May 18, 2021 | Feb. 25, 2020 | Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2023 | Jun. 30, 2022 | Sep. 30, 2022 | |
Line of Credit Facility [Line Items] | ||||||||||
Borrowings outstanding | $ 1,135,000 | $ 1,135,000 | $ 1,135,000 | $ 700,000 | ||||||
Interest expense | 30,793 | $ 11,870 | 79,316 | $ 31,178 | ||||||
Fair Value | $ 1,722,977 | $ 1,722,977 | $ 1,722,977 | $ 1,277,105 | ||||||
Interest rate swap | ||||||||||
Line of Credit Facility [Line Items] | ||||||||||
Interest rate | 2.70% | 2.70% | 2.70% | 2.70% | ||||||
Floating interest rate | 1.658% | 1.658% | 1.658% | 1.658% | ||||||
Notional amount | $ 350,000 | $ 350,000 | $ 350,000 | $ 350,000 | ||||||
Interest rate swap | Designated as Hedging Instrument | ||||||||||
Line of Credit Facility [Line Items] | ||||||||||
Interest rate | 2.70% | |||||||||
Notional amount | $ 350,000 | |||||||||
Secured Overnight Financing Rate | ||||||||||
Line of Credit Facility [Line Items] | ||||||||||
Interest rate | 2% | |||||||||
Secured Overnight Financing Rate | Minimum | ||||||||||
Line of Credit Facility [Line Items] | ||||||||||
Debt instrument, basis spread, variable rate | 0.11448% | |||||||||
Secured Overnight Financing Rate | Maximum | ||||||||||
Line of Credit Facility [Line Items] | ||||||||||
Debt instrument, basis spread, variable rate | 0.26161% | |||||||||
London Interbank Offered Rate (LIBOR) | Interest rate swap | Designated as Hedging Instrument | ||||||||||
Line of Credit Facility [Line Items] | ||||||||||
Floating interest rate | 1.658% | |||||||||
Base Rate | ||||||||||
Line of Credit Facility [Line Items] | ||||||||||
Interest rate | 1% | |||||||||
Citibank Facility | ||||||||||
Line of Credit Facility [Line Items] | ||||||||||
Interest expense | 600 | |||||||||
2025 Notes | ||||||||||
Line of Credit Facility [Line Items] | ||||||||||
Principal amount | $ 300,000 | 300,000 | 300,000 | $ 300,000 | 300,000 | |||||
Net proceeds | 293,800 | |||||||||
Unaccreted discount | 2,500 | $ 800 | $ 800 | $ 800 | 1,200 | |||||
Underwriting commissions | 3,000 | |||||||||
Offering costs | $ 700 | |||||||||
Coupon interest rate (net of effect of interest rate swap for 2027 Notes) | 3.50% | 3.50% | 3.50% | 3.50% | ||||||
Redemption price | 100% | |||||||||
2027 Notes | ||||||||||
Line of Credit Facility [Line Items] | ||||||||||
Principal amount | $ 350,000 | $ 350,000 | $ 350,000 | $ 350,000 | 350,000 | |||||
Net proceeds | 344,800 | |||||||||
Unaccreted discount | 1,000 | $ 600 | $ 600 | $ 600 | 700 | |||||
Underwriting commissions | 3,500 | |||||||||
Offering costs | $ 700 | |||||||||
Coupon interest rate (net of effect of interest rate swap for 2027 Notes) | 2.70% | 2.70% | 2.70% | 2.70% | ||||||
Redemption price | 100% | |||||||||
Line of Credit | Revolving Credit Facility | Syndicated Facility | ||||||||||
Line of Credit Facility [Line Items] | ||||||||||
Borrowing capacity | $ 1,218,000 | $ 1,218,000 | $ 1,218,000 | |||||||
Accordion feature, increase limit | 1,250,000 | 1,250,000 | 1,250,000 | |||||||
Borrowing capacity subject to expiration | $ 1,035,000 | $ 1,035,000 | $ 1,035,000 | |||||||
Debt instrument, covenant, total assets to total indebtedness, ratio, minimum threshold | 1.50 | 1.50 | 1.50 | |||||||
Debt instrument, covenant, consolidated EBITDA to consolidated interest expense, ratio, minimum threshold | 2.25 | 2.25 | 2.25 | |||||||
Borrowings outstanding | $ 800,000 | $ 800,000 | $ 800,000 | 540,000 | ||||||
Fair value | $ 800,000 | $ 800,000 | $ 800,000 | 540,000 | ||||||
Weighted average interest rate | 6.584% | 2.406% | 6.584% | 6.584% | 2.406% | |||||
Interest expense inclusive of fees | $ 14,300 | $ 4,800 | $ 37,400 | $ 12,600 | ||||||
Line of Credit | Revolving Credit Facility | Citibank Facility | ||||||||||
Line of Credit Facility [Line Items] | ||||||||||
Borrowings outstanding | 160,000 | |||||||||
Fair value | $ 160,000 | |||||||||
Weighted average interest rate | 6.762% | 6.762% | 6.762% | 2.563% | ||||||
Interest expense inclusive of fees | $ 2,400 | $ 1,600 | $ 8,000 | $ 3,500 | ||||||
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility | ||||||||||
Line of Credit Facility [Line Items] | ||||||||||
Borrowing capacity | 400,000 | $ 400,000 | 400,000 | |||||||
Borrowings outstanding | $ 335,000 | $ 335,000 | $ 335,000 | |||||||
Weighted average interest rate | 7.275% | 7.275% | 7.275% | |||||||
Interest expense inclusive of fees | $ 4,900 | $ 8,000 | ||||||||
Unused capacity, commitment fee | 0.50% | |||||||||
Commitment fee, unused capacity threshold percentage | 30% | |||||||||
Fair Value | $ 335,000 | $ 335,000 | $ 335,000 | |||||||
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility | Secured Overnight Financing Rate | After Reinvestment Period | ||||||||||
Line of Credit Facility [Line Items] | ||||||||||
Debt instrument, basis spread, variable rate | 4% | |||||||||
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility | Secured Overnight Financing Rate | Minimum | ||||||||||
Line of Credit Facility [Line Items] | ||||||||||
Debt instrument, basis spread, variable rate | 2.50% | |||||||||
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility, Syndicated Loans | Secured Overnight Financing Rate | ||||||||||
Line of Credit Facility [Line Items] | ||||||||||
Debt instrument, basis spread, variable rate | 2% | |||||||||
Line of Credit | Revolving Credit Facility | OSI2 Citibank Facility, All Other Loans | Secured Overnight Financing Rate | ||||||||||
Line of Credit Facility [Line Items] | ||||||||||
Debt instrument, basis spread, variable rate | 2.75% |
Borrowings - Components of the
Borrowings - Components of the Carrying Value of Notes (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Sep. 30, 2022 | May 18, 2021 | Feb. 25, 2020 |
Debt Instrument [Line Items] | ||||
Unamortized financing costs | $ (3,909) | $ (5,020) | ||
Net carrying value | 1,740,066 | 1,301,043 | ||
2025 Notes | ||||
Debt Instrument [Line Items] | ||||
Principal amount | 300,000 | 300,000 | $ 300,000 | |
Unamortized financing costs | (1,200) | (1,800) | ||
Unaccreted discount | (800) | (1,200) | $ (2,500) | |
Interest rate swap fair value adjustment | 0 | 0 | ||
Net carrying value | 298,000 | 297,000 | ||
Fair Value | 285,700 | 283,100 | ||
2027 Notes | ||||
Debt Instrument [Line Items] | ||||
Principal amount | 350,000 | 350,000 | $ 350,000 | |
Unamortized financing costs | (2,700) | (3,200) | ||
Unaccreted discount | (600) | (700) | $ (1,000) | |
Interest rate swap fair value adjustment | (39,600) | (42,000) | ||
Net carrying value | 307,100 | 304,100 | ||
Fair Value | $ 302,300 | $ 294,000 |
Borrowings - Components of Inte
Borrowings - Components of Interest and Other Debt Expenses (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Debt Instrument [Line Items] | ||||
Effect of interest rate swap | $ 3.7 | $ (0.1) | $ 9.4 | $ (1.6) |
2025 Notes | ||||
Debt Instrument [Line Items] | ||||
Coupon interest | 2.6 | 2.6 | 7.9 | 7.9 |
Amortization of financing costs and discount | 0.3 | 0.3 | 0.9 | 0.9 |
Total interest expense | $ 2.9 | $ 2.9 | $ 8.8 | $ 8.8 |
Coupon interest rate | 3.50% | 3.50% | 3.50% | 3.50% |
2027 Notes | ||||
Debt Instrument [Line Items] | ||||
Coupon interest | $ 2.4 | $ 2.4 | $ 7.1 | $ 7.1 |
Amortization of financing costs and discount | 0.2 | 0.2 | 0.7 | 0.7 |
Total interest expense | $ 6.3 | $ 2.5 | $ 17.2 | $ 6.2 |
Coupon interest rate | 6.912% | 2.572% | 6.274% | 2.069% |
Taxable_Distributable Income _3
Taxable/Distributable Income and Dividend Distributions - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||||||
Jun. 30, 2023 | Mar. 31, 2023 | Dec. 31, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Jun. 30, 2023 | Jun. 30, 2022 | Sep. 30, 2022 | |
Investments, Owned, Federal Income Tax Note [Line Items] | |||||||||
Undistributed ordinary income, net | $ 523,700 | ||||||||
Valuation allowance | $ 6,100 | $ 6,100 | |||||||
Deferred tax assets | 8,800 | 8,800 | |||||||
Deferred tax asset, net | 2,695 | 2,695 | 1,687 | ||||||
(Provision) benefit for taxes on realized and unrealized gains (losses) | (86) | $ (66) | $ 549 | $ (661) | $ (21) | $ 2,378 | 397 | $ 1,696 | |
Income tax expense (benefit) | (1,000) | (600) | |||||||
Deferred taxes | $ (900) | $ (1,030) | $ (984) | ||||||
Cost of investments | 2,654,300 | ||||||||
Unrealized appreciation | 466,900 | ||||||||
Unrealized depreciation | 620,000 | ||||||||
Unrealized appreciation (depreciation) | 153,100 | ||||||||
Short-Term Capital Loss Carryforward | |||||||||
Investments, Owned, Federal Income Tax Note [Line Items] | |||||||||
Undistributed ordinary income, net | 64,500 | ||||||||
Long-Term Capital Loss Carryforward | |||||||||
Investments, Owned, Federal Income Tax Note [Line Items] | |||||||||
Undistributed ordinary income, net | $ 459,200 |
Taxable_Distributable Income _4
Taxable/Distributable Income and Dividend Distributions - Reconciliation of Net Increase (Decrease) in Net Assets Resulting from Operations (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Income Tax Disclosure [Abstract] | ||||
Net increase (decrease) in net assets resulting from operations | $ 36,685 | $ (37,834) | $ 71,379 | $ 16,015 |
Net unrealized (appreciation) depreciation | 1,039 | 86,755 | 42,300 | 118,379 |
Book/tax difference due to organizational costs | 0 | (21) | 0 | (65) |
Book/tax difference due to capital losses utilized | 12,118 | (3,736) | 20,380 | (19,183) |
Other book/tax differences | (3,825) | (8,819) | (14,912) | (18,597) |
Taxable/Distributable Income | $ 46,017 | $ 36,345 | $ 119,147 | $ 96,549 |
Taxable_Distributable Income _5
Taxable/Distributable Income and Dividend Distributions - Components of Accumulated Overdistributed Earnings (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Sep. 30, 2022 |
Income Tax Disclosure [Abstract] | ||
Undistributed ordinary income, net | $ (43,624) | |
Net realized capital losses | 473,274 | |
Unrealized losses, net | 153,119 | |
Accumulated overdistributed earnings | $ 654,858 | $ 582,769 |
Realized Gains or Losses and _3
Realized Gains or Losses and Net Unrealized Appreciation or Depreciation - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||
Jun. 30, 2023 | Mar. 31, 2023 | Dec. 31, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Jun. 30, 2023 | Jun. 30, 2022 | |
Schedule of Investments [Line Items] | ||||||||
Net realized gains (losses) | $ (10,603) | $ (6,111) | $ (3,203) | $ 9,212 | $ 1,402 | $ 9,321 | $ (19,900) | $ 19,900 |
Net unrealized appreciation (depreciation) | (1,039) | $ (18,279) | $ (22,982) | (86,755) | $ (27,038) | $ (4,586) | (42,300) | (118,400) |
OSI2 Merger | ||||||||
Schedule of Investments [Line Items] | ||||||||
Net unrealized appreciation (depreciation) | (20,700) | |||||||
Investments in debt securities | ||||||||
Schedule of Investments [Line Items] | ||||||||
Net unrealized appreciation (depreciation) | (9,800) | (66,800) | (54,300) | (84,600) | ||||
Investments in equity securities | ||||||||
Schedule of Investments [Line Items] | ||||||||
Net unrealized appreciation (depreciation) | (800) | (17,900) | 5,100 | (23,800) | ||||
Exited Investments | ||||||||
Schedule of Investments [Line Items] | ||||||||
Net unrealized appreciation (depreciation) | 5,000 | (400) | 11,800 | (9,200) | ||||
Foreign currency forward contract | ||||||||
Schedule of Investments [Line Items] | ||||||||
Net unrealized appreciation (depreciation) | $ 4,600 | $ (1,600) | $ (4,800) | $ (800) |
Realized Gains or Losses and _4
Realized Gains or Losses and Net Unrealized Appreciation or Depreciation - Aggregate Net Realized Gains (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||
Jun. 30, 2023 | Mar. 31, 2023 | Dec. 31, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Jun. 30, 2023 | Jun. 30, 2022 | |
Schedule of Investments [Line Items] | ||||||||
Net realized gains (losses) | $ (10,603) | $ (6,111) | $ (3,203) | $ 9,212 | $ 1,402 | $ 9,321 | $ (19,900) | $ 19,900 |
Foreign currency forward contract | ||||||||
Schedule of Investments [Line Items] | ||||||||
Net realized gains (losses) | (6,300) | 8,800 | (5,500) | 12,200 | ||||
Carvana Co | ||||||||
Schedule of Investments [Line Items] | ||||||||
Net realized gains (losses) | (2,800) | |||||||
ASP Unifrax Holdings Inc | ||||||||
Schedule of Investments [Line Items] | ||||||||
Net realized gains (losses) | (2,100) | |||||||
Global Medical Response Inc | ||||||||
Schedule of Investments [Line Items] | ||||||||
Net realized gains (losses) | (1,000) | |||||||
Other Investments, Net | ||||||||
Schedule of Investments [Line Items] | ||||||||
Net realized gains (losses) | 1,800 | |||||||
TigerConnect, Inc. | ||||||||
Schedule of Investments [Line Items] | ||||||||
Net realized gains (losses) | 1,800 | |||||||
OmniSYS Acquisition Corporation | ||||||||
Schedule of Investments [Line Items] | ||||||||
Net realized gains (losses) | 2,200 | |||||||
First Star Speir Aviation Limited | ||||||||
Schedule of Investments [Line Items] | ||||||||
Net realized gains (losses) | $ 1,900 | |||||||
Radiology Partners Inc | ||||||||
Schedule of Investments [Line Items] | ||||||||
Net realized gains (losses) | (3,800) | (4,200) | ||||||
WP CPP Holdings LLC | ||||||||
Schedule of Investments [Line Items] | ||||||||
Net realized gains (losses) | (1,300) | (1,300) | ||||||
Aden & Anais Merger Sub Inc | ||||||||
Schedule of Investments [Line Items] | ||||||||
Net realized gains (losses) | (5,200) | (5,200) | ||||||
Tersera Therapeutics LLC | ||||||||
Schedule of Investments [Line Items] | ||||||||
Net realized gains (losses) | 5,200 | 5,200 | ||||||
Other, net | ||||||||
Schedule of Investments [Line Items] | ||||||||
Net realized gains (losses) | $ 800 | $ 400 | $ (3,000) |
Related Party Transactions (Det
Related Party Transactions (Details) | 3 Months Ended | 9 Months Ended | |||||
Mar. 19, 2021 USD ($) | May 03, 2019 | Jun. 30, 2023 USD ($) component | Jun. 30, 2022 USD ($) | Jun. 30, 2023 USD ($) component | Jun. 30, 2022 USD ($) | Sep. 30, 2022 USD ($) | |
Related Party Transaction [Line Items] | |||||||
Base management fee and incentive fee payable | $ 20,072,000 | $ 20,072,000 | $ 15,940,000 | ||||
Base management fee rate | 1% | 1.50% | |||||
Base management fee, threshold | 200% | ||||||
Base management fee | 11,983,000 | $ 9,819,000 | $ 33,383,000 | $ 29,853,000 | |||
Part I incentive fee | 9,590,000 | 6,497,000 | 26,300,000 | 19,658,000 | |||
Due to affiliate | 7,724,000 | $ 7,724,000 | 3,180,000 | ||||
Affiliated Entity | |||||||
Related Party Transaction [Line Items] | |||||||
Related party transaction, termination, notice period | 60 days | ||||||
Administrator expense | 400,000 | 300,000 | $ 1,200,000 | 1,200,000 | |||
General and administrative expenses | 100,000 | 100,000 | 200,000 | 200,000 | |||
Due to affiliate | $ 7,700,000 | $ 7,700,000 | $ 3,200,000 | ||||
Oaktree Strategic Income Corporation Merger | |||||||
Related Party Transaction [Line Items] | |||||||
Investment company, contractual fee waived | $ 6,000,000 | ||||||
Contractual fee waived, period otherwise receivable | 2 years | ||||||
Contractual fee waived, per quarter | $ 750,000 | ||||||
Oaktree Strategic Income II, Inc. Merger | |||||||
Related Party Transaction [Line Items] | |||||||
Investment company, contractual fee waived | 9,000,000 | ||||||
Oaktree Strategic Income II, Inc Merger, Year One | |||||||
Related Party Transaction [Line Items] | |||||||
Investment company, contractual fee waived | 6,000,000 | ||||||
Contractual fee waived, per quarter | 1,500,000 | ||||||
Oaktree Strategic Income II, Inc Merger, Year Two | |||||||
Related Party Transaction [Line Items] | |||||||
Investment company, contractual fee waived | 3,000,000 | ||||||
Contractual fee waived, per quarter | $ 750,000 | ||||||
Investment Advisory Agreement | |||||||
Related Party Transaction [Line Items] | |||||||
Number of components | component | 2 | 2 | |||||
Related party transaction, termination, notice period | 60 days | ||||||
Base management fee | $ 10,500,000 | 9,100,000 | $ 29,400,000 | 27,600,000 | |||
Management incentive rate | 1.50% | ||||||
Investment Advisory Agreement | Affiliated Entity | |||||||
Related Party Transaction [Line Items] | |||||||
Part I incentive fee | $ 9,600,000 | 6,500,000 | $ 26,300,000 | 19,700,000 | |||
Incentive fee expense | $ 9,600,000 | ||||||
Accrued capital gains incentive fees reversed | $ 6,800,000 | $ 8,800,000 | |||||
Investment Advisory Agreement Incentive Rate Pre Incentive Fee Net Investment Income Below Catch Up | |||||||
Related Party Transaction [Line Items] | |||||||
Management incentive rate | 100% | ||||||
Investment Advisory Agreement Incentive Rate Quarterly Catch Up Threshold | |||||||
Related Party Transaction [Line Items] | |||||||
Management incentive rate | 1.8182% | ||||||
Investment Advisory Agreement Cumulative Pre Incentive Fee Net Investment Income | |||||||
Related Party Transaction [Line Items] | |||||||
Management incentive rate | 17.50% | ||||||
Investment Advisory Agreement - Incentive Rate, Realized Capital Gains | Affiliated Entity | |||||||
Related Party Transaction [Line Items] | |||||||
Management incentive rate | 17.50% |
Financial Highlights (Details)
Financial Highlights (Details) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||||||||
Jan. 20, 2023 | Jun. 30, 2022 USD ($) $ / shares shares | Mar. 31, 2022 USD ($) $ / shares shares | Dec. 31, 2021 $ / shares | Jun. 30, 2023 USD ($) $ / shares shares | Jun. 30, 2022 USD ($) $ / shares shares | Jun. 30, 2023 USD ($) $ / shares shares | Jun. 30, 2022 USD ($) $ / shares shares | |||||||
Investment Company, Financial Highlights [Roll Forward] | ||||||||||||||
Net asset value per share at beginning of period (dollars per share) | $ 19.66 | $ 21.79 | $ 20.38 | $ 21.84 | ||||||||||
Net investment income per common share - basic and diluted (dollars per share) | [1] | 0.63 | 0.66 | 1.89 | 1.86 | |||||||||
Net unrealized appreciation (depreciation) (dollars per share) | (0.02) | (1.42) | (0.36) | (1.95) | ||||||||||
Net realized gains (losses) (dollars per share) | (0.14) | 0.15 | (0.28) | 0.33 | ||||||||||
(Provision) benefit for taxes on realized and unrealized gains (losses) (dollars per share) | 0 | (0.01) | 0.01 | 0.03 | ||||||||||
Amount per share (dollars per share) | $ (0.495) | $ (0.48) | $ (0.465) | (0.55) | (0.50) | (2.06) | (1.44) | |||||||
Net asset value per share at end of period (dollars per share) | 20.67 | [2] | 21.79 | 19.58 | [2] | 20.67 | [2] | 19.58 | [2] | 20.67 | [2] | |||
Per share market value at beginning of period (dollars per share) | 18.77 | 22.11 | 18 | 21.18 | ||||||||||
Per share market value at end of period (dollars per share) | $ 19.65 | $ 22.11 | $ 19.43 | $ 19.65 | $ 19.43 | $ 19.65 | ||||||||
Total return | 6.42% | (8.93%) | 19.58% | (0.79%) | ||||||||||
Common shares outstanding at beginning of period (shares) | shares | 77,080,000 | 61,068,000 | 61,125,000 | 60,120,000 | ||||||||||
Common shares outstanding at end of period (shares) | shares | 61,125,000 | [2] | 61,068,000 | 77,080,000 | [2] | 61,125,000 | [2] | 77,080,000 | [2] | 61,125,000 | [2] | |||
Net assets at beginning of period | $ | $ 1,515,150 | $ 1,330,376 | $ 1,245,563 | $ 1,312,823 | ||||||||||
Net assets at end of period | $ | $ 1,263,529 | $ 1,330,376 | 1,509,441 | 1,263,529 | 1,509,441 | 1,263,529 | ||||||||
Average net assets | $ | $ 1,526,644 | $ 1,306,727 | $ 1,407,814 | $ 1,323,232 | ||||||||||
Ratio of net investment income to average net assets | 12.72% | 12.39% | 12.65% | 11.39% | ||||||||||
Ratio of total expenses to average net assets | 14.45% | 7.22% | 14.07% | 7.94% | ||||||||||
Ratio of net expenses to average net assets | 14.05% | 6.99% | 13.69% | 7.71% | ||||||||||
Ratio of portfolio turnover to average investments at fair value | 7.48% | 4.73% | 18.43% | 21.44% | ||||||||||
Weighted average outstanding debt | $ | $ 1,756,758 | $ 1,369,615 | $ 1,640,062 | $ 1,358,150 | ||||||||||
Average debt per share (dollars per share) | $ 22.79 | $ 22.41 | $ 23.29 | $ 22.41 | ||||||||||
Asset coverage ratio | 187.82% | 182.05% | 187.82% | 182.05% | 187.82% | |||||||||
Stock split, conversion ratio | 0.0033 | |||||||||||||
[1](1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.[2](1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis. |
Derivative Instruments (Details
Derivative Instruments (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Sep. 30, 2022 |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||
Due from broker | $ 39,990 | $ 45,530 |
Derivative Instruments - Schedu
Derivative Instruments - Schedule of Foreign Currency Forward Contracts and Interest Rate Swap (Details) € in Thousands, £ in Thousands, $ in Thousands | Jun. 30, 2023 USD ($) | Jun. 30, 2023 EUR (€) | Jun. 30, 2023 GBP (£) | Sep. 30, 2022 USD ($) | Sep. 30, 2022 EUR (€) | Sep. 30, 2022 GBP (£) |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Derivative assets at fair value | $ 49 | $ 6,789 | ||||
Derivative liability at fair value | 39,567 | 41,969 | ||||
Foreign currency forward contract | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Derivative assets at fair value | 49 | 6,789 | ||||
Interest rate swap | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Notional amount | 350,000 | 350,000 | ||||
Derivative liability at fair value | 39,567 | 41,969 | ||||
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 10, 2022, 1 | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Notional Amount to be Purchased | 43,179 | |||||
Notional Amount to be Sold | € | € 41,444 | |||||
Derivative assets at fair value | 2,466 | |||||
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing August 10, 2023 | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Derivative assets at fair value | 531 | |||||
Derivative liability at fair value | 482 | |||||
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing May 11, 2023 | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Notional Amount to be Purchased | 78,866 | |||||
Notional Amount to be Sold | € | € 71,658 | |||||
Derivative assets at fair value | 531 | |||||
Open Forward Foreign Currency Contract, Identifier [Axis]: EUR Foreign Currency Forward Contract, Maturing November 10, 2022 | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Notional Amount to be Purchased | 43,179 | |||||
Notional Amount to be Sold | € | € 41,444 | |||||
Derivative assets at fair value | 2,466 | |||||
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing May 11, 2023 | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Notional Amount to be Purchased | 71,438 | |||||
Notional Amount to be Sold | £ | £ 56,556 | |||||
Derivative liability at fair value | $ 482 | |||||
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 10, 2022 | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Notional Amount to be Purchased | 45,692 | |||||
Notional Amount to be Sold | £ | £ 37,033 | |||||
Derivative assets at fair value | 4,323 | |||||
Open Forward Foreign Currency Contract, Identifier [Axis]: GBP Foreign Currency Forward Contract, Maturing November 19, 2022, 2 | ||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||||
Notional Amount to be Purchased | 45,692 | |||||
Notional Amount to be Sold | £ | £ 37,033 | |||||
Derivative assets at fair value | $ 4,323 |
Commitments and Contingencies -
Commitments and Contingencies - Narrative (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Sep. 30, 2022 |
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | $ 274,373 | $ 224,239 |
Debt and Equity Financing | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 247,300 | 175,200 |
JV Financing | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | $ 27,100 | $ 49,000 |
Commitments and Contingencies_2
Commitments and Contingencies - Schedule of Unfunded Commitments by Investment (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Sep. 30, 2022 |
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | $ 274,373 | $ 224,239 |
Investment, Identifier [Axis]: 107 Fair Street LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 4,322 | 0 |
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 30,922 | 0 |
Investment, Identifier [Axis]: 109 Montgomery Owner LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 0 | 477 |
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 2,703 | 0 |
Investment, Identifier [Axis]: ADC Therapeutics SA | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 3,020 | 3,020 |
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 396 | 0 |
Investment, Identifier [Axis]: Accupac, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 4,500 | 4,605 |
Investment, Identifier [Axis]: Acquia Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 596 | 1,326 |
Investment, Identifier [Axis]: Apptio, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 1,885 | 1,338 |
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 0 | 4,372 |
Investment, Identifier [Axis]: Assembled Brands Capital LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 7,062 | 2,008 |
Investment, Identifier [Axis]: Avalara, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 5,047 | 0 |
Investment, Identifier [Axis]: BAART Programs, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 0 | 8,645 |
Investment, Identifier [Axis]: Berner Food & Beverage, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 1,314 | 1,392 |
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 14,543 | 11,785 |
Investment, Identifier [Axis]: CorEvitas, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 1,251 | 915 |
Investment, Identifier [Axis]: Coupa Holdings, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 2,075 | 0 |
Investment, Identifier [Axis]: Coyote Buyer, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 800 | 1,333 |
Investment, Identifier [Axis]: Delta Leasing SPV II LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 18,822 | 27,187 |
Investment, Identifier [Axis]: Dialyze Holdings, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 0 | 3,431 |
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 1,156 | 826 |
Investment, Identifier [Axis]: Dominion Diagnostics, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 7,664 | 11,148 |
Investment, Identifier [Axis]: Establishment Labs Holdings Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 3,384 | 5,075 |
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 20,382 | 22,150 |
Investment, Identifier [Axis]: GKD Index Partners, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 0 | 320 |
Investment, Identifier [Axis]: Galileo Parent, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 2,061 | 0 |
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 5,286 | 4,293 |
Investment, Identifier [Axis]: Harrow Health, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 4,011 | 0 |
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 5,200 | 4,195 |
Investment, Identifier [Axis]: Inventus Power, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 3,792 | 0 |
Investment, Identifier [Axis]: Kings Buyer, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 1,771 | 1,537 |
Investment, Identifier [Axis]: LSL Holdco, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 2,650 | 427 |
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 1,383 | 1,115 |
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 1,536 | 1,429 |
Investment, Identifier [Axis]: MND Holdings III Corp | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 8,470 | 0 |
Investment, Identifier [Axis]: MRI Software LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 3,302 | 5,196 |
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 7,139 | 5,734 |
Investment, Identifier [Axis]: Mesoblast, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 4,405 | 3,553 |
Investment, Identifier [Axis]: Mindbody, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 4,762 | 4,000 |
Investment, Identifier [Axis]: OCSI Glick JV LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 13,998 | 13,998 |
Investment, Identifier [Axis]: OTG Management, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 3,190 | 3,789 |
Investment, Identifier [Axis]: Oranje Holdco, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 1,904 | 0 |
Investment, Identifier [Axis]: PPW Aero Buyer, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 1,466 | 0 |
Investment, Identifier [Axis]: PRGX Global, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 3,127 | 2,518 |
Investment, Identifier [Axis]: Pluralsight, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 2,395 | 3,532 |
Investment, Identifier [Axis]: Relativity ODA LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 2,762 | 2,218 |
Investment, Identifier [Axis]: RumbleOn, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 0 | 4,822 |
Investment, Identifier [Axis]: SCP Eye Care Services, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 2,356 | 0 |
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 3,102 | 0 |
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 13,125 | 35,000 |
Investment, Identifier [Axis]: Seres Therapeutics, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 8,090 | 0 |
Investment, Identifier [Axis]: SiO2 Medical Products, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 10,765 | 0 |
Investment, Identifier [Axis]: Spanx, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 2,185 | 2,226 |
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 2,540 | 1,527 |
Investment, Identifier [Axis]: Tahoe Bidco B.V. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 2,162 | 1,741 |
Investment, Identifier [Axis]: Telestream Holdings Corporation | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 678 | 528 |
Investment, Identifier [Axis]: Thrasio, LLC | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 0 | 2,578 |
Investment, Identifier [Axis]: iCIMs, Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | 7,704 | 6,930 |
Investment, Identifier [Axis]: scPharmaceuticals Inc. | ||
Financial Support for Nonconsolidated Legal Entity [Line Items] | ||
Unfunded commitments | $ 5,212 | $ 0 |
Merger with OSI2 (Details)
Merger with OSI2 (Details) $ in Thousands | Jan. 23, 2023 USD ($) shares | Sep. 30, 2022 USD ($) |
Business Acquisition [Line Items] | ||
Unrealized appreciation (depreciation) | $ 153,100 | |
Cash paid in lieu of issuing fractional shares | $ 19 | |
OSI2 Merger | ||
Business Acquisition [Line Items] | ||
Conversion ratio (in shares) | 0.9115 | |
Number of shares issued (in shares) | shares | 15,860,200 | |
Unrealized appreciation (depreciation) | $ (20,700) | |
Common stock issued by the Company | 334,034 | |
Transaction costs | 1,932 | |
Consideration paid | 335,966 | |
Investments | 592,809 | |
Cash and cash equivalents | 22,317 | |
Other assets | 6,679 | |
Total assets acquired | 621,805 | |
Debt | 225,000 | |
Other liabilities | 60,839 | |
Total liabilities acquired | 285,839 | |
Total net assets acquired | $ 335,966 |
Subsequent Events (Details)
Subsequent Events (Details) | Jul. 28, 2023 $ / shares |
Subsequent Event | |
Subsequent Event [Line Items] | |
Common stock, dividends, per share, declared (in dollars per share) | $ 0.55 |
Schedule_12-14 - Schedule of In
Schedule 12-14 - Schedule of Investments in and Advances to Affiliates (Details) € in Thousands, £ in Thousands, $ in Thousands | 9 Months Ended | |||||||||||||
Jun. 30, 2023 USD ($) shares | Jun. 30, 2022 USD ($) shares | Jun. 30, 2023 EUR (€) shares | Jun. 30, 2023 GBP (£) shares | Sep. 30, 2022 USD ($) shares | Sep. 30, 2022 EUR (€) shares | Sep. 30, 2022 GBP (£) shares | ||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | $ 2,494,111 | |||||||||||||
Fair Value, Ending Balance | $ 3,135,619 | |||||||||||||
Investment owned, percent of net assets | 207.73% | 207.73% | 207.73% | 200.24% | 200.24% | 200.24% | ||||||||
Control & Affiliate Investments | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance, principal amount | $ 194,352 | |||||||||||||
Net Realized Gain (Loss) | 1,868 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 16,928 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | $ 26,196 | 289,054 | ||||||||||||
Gross Additions | 12,759 | |||||||||||||
Gross Reductions | (55,528) | |||||||||||||
Fair Value, Ending Balance | 23,911 | $ 246,285 | ||||||||||||
Investment owned, percent of net assets | 19.50% | |||||||||||||
Control Investments | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, ownership percentage | [1],[2] | 17.20% | 17.20% | 17.20% | ||||||||||
Investment owned, balance, principal amount | 188,591 | $ 172,598 | ||||||||||||
Net Realized Gain (Loss) | 0 | 1,868 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 18,514 | 15,743 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 214,165 | [1],[2] | 270,765 | |||||||||||
Gross Additions | 28,264 | 1,123 | ||||||||||||
Gross Reductions | (4,233) | (49,030) | ||||||||||||
Fair Value, Ending Balance | $ 238,196 | [3],[4] | $ 222,858 | |||||||||||
Investment owned, percent of net assets | 15.80% | [3],[4] | 17.60% | 15.80% | [3],[4] | 15.80% | [3],[4] | |||||||
Affiliate Investments | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [5] | 2.10% | 2.10% | 2.10% | ||||||||||
Investment owned, balance, principal amount | $ 22,304 | $ 21,754 | ||||||||||||
Net Realized Gain (Loss) | 0 | 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 1,985 | 1,185 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 26,196 | [5] | 18,289 | |||||||||||
Gross Additions | 2,607 | 11,636 | ||||||||||||
Gross Reductions | (4,892) | (6,498) | ||||||||||||
Fair Value, Ending Balance | $ 23,911 | [6] | $ 23,427 | |||||||||||
Investment owned, percent of net assets | 1.60% | [6] | 1.90% | 1.60% | [6] | 1.60% | [6] | |||||||
Investment, Affiliated Issuer, Control and Affiliate | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance, principal amount | $ 210,895 | |||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 20,499 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 240,361 | |||||||||||||
Gross Additions | 30,871 | |||||||||||||
Gross Reductions | (9,125) | |||||||||||||
Fair Value, Ending Balance | $ 262,107 | |||||||||||||
Investment owned, percent of net assets | 17.40% | 17.40% | 17.40% | |||||||||||
Investment, Identifier [Axis]: 107 Fair Street LLC, Real Estate Development, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[9],[10],[11],[12] | 12.50% | 12.50% | 12.50% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[12],[13] | $ 1,174 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[12] | $ 1,112 | ||||||||||||
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, Real Estate Development, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[9],[10],[11] | 11% | 11% | 11% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[13] | $ 14,916 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10] | 14,489 | ||||||||||||
Investment, Identifier [Axis]: 109 Montgomery Owner LLC, Real Estate Operating Companies, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 9.80% | 9.80% | 9.80% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 389 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 727 | ||||||||||||
Investment, Identifier [Axis]: 109 Montgomery Owner LLC, Real Estate Operating Companies, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16],[19] | 7% | 7% | 7% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18],[19] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, Real Estate Development, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[9],[10],[11],[12] | 12% | 12% | 12% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[12],[13] | $ 3,710 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[12] | $ 3,645 | ||||||||||||
Investment, Identifier [Axis]: A.T. Holdings II Ltd., Biotechnology, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[10],[11],[20],[21] | 14.25% | 14.25% | 14.25% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[13],[20],[21] | $ 21,434 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[20],[21] | 21,434 | ||||||||||||
Investment, Identifier [Axis]: A.T. Holdings II SÀRL, Biotechnology, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance, principal amount | 5,576 | [7],[10],[13],[20] | $ 33,997 | [14],[15],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | 34,891 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | 5,464 | ||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 6.25% | 6.25% | 6.25% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 9.80% | 9.80% | 9.80% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 14,685 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 14,431 | ||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12% | 12% | 12% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 3,520 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 3,455 | ||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12% | 12% | 12% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 18,271 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 17,935 | ||||||||||||
Investment, Identifier [Axis]: ADB Companies, LLC, Construction & Engineering, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 11.66% | 11.66% | 11.66% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 1,000 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 982 | ||||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[10],[20] | 7.50% | [7],[10],[20] | 7.50% | [7],[10],[20] | 7.50% | [14],[15],[16],[22] | 7.50% | [14],[15],[16],[22] | 7.50% | [14],[15],[16],[22] | ||
Investment, interest rate | 12.89% | [7],[8],[10],[11],[20] | 12.89% | [7],[8],[10],[11],[20] | 12.89% | [7],[8],[10],[11],[20] | 11.20% | [14],[15],[16],[17],[22] | 11.20% | [14],[15],[16],[17],[22] | 11.20% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | $ 6,589 | [7],[10],[11],[13],[20] | $ 6,589 | [14],[15],[16],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[22] | 6,262 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 6,267 | ||||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[9],[10],[20] | 7.50% | [7],[9],[10],[20] | 7.50% | [7],[9],[10],[20] | 7.50% | [14],[15],[16],[19],[22] | 7.50% | [14],[15],[16],[19],[22] | 7.50% | [14],[15],[16],[19],[22] | ||
Investment owned, balance, principal amount | $ 0 | [7],[9],[10],[11],[13],[20] | $ 0 | [14],[15],[16],[18],[19],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19],[22] | (37) | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11],[20] | $ (38) | ||||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Biotechnology, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 28,948 | [7],[10],[20] | 28,948 | [7],[10],[20] | 28,948 | [7],[10],[20] | 28,948 | [14],[15],[22] | 28,948 | [14],[15],[22] | 28,948 | [14],[15],[22] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | $ 73 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 18 | ||||||||||||
Investment, Identifier [Axis]: AI Sirona (Luxembourg) Acquisition S.a.r.l., Pharmaceuticals, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[10],[11],[20] | 7.25% | [7],[10],[11],[20] | 7.25% | [7],[10],[11],[20] | 7.25% | [14],[15],[16],[22] | 7.25% | [14],[15],[16],[22] | 7.25% | [14],[15],[16],[22] | ||
Investment, interest rate | 10.67% | [7],[8],[10],[11],[20] | 10.67% | [7],[8],[10],[11],[20] | 10.67% | [7],[8],[10],[11],[20] | 7.94% | [14],[15],[16],[17],[22] | 7.94% | [14],[15],[16],[17],[22] | 7.94% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | € | € 29,985 | [7],[10],[11],[13],[20] | € 24,838 | [14],[15],[16],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[22] | $ 22,143 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 32,128 | ||||||||||||
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 17,870 | [7],[10] | 17,870 | [7],[10] | 17,870 | [7],[10] | 14,410 | [14],[15] | 14,410 | [14],[15] | 14,410 | [14],[15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 1,291 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 2,578 | ||||||||||||
Investment, Identifier [Axis]: AIP RD Buyer Corp., Distributors, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.75% | [7],[10],[11] | 7.75% | [7],[10],[11] | 7.75% | [7],[10],[11] | 7.75% | [14],[15],[16] | 7.75% | [14],[15],[16] | 7.75% | [14],[15],[16] | ||
Investment, interest rate | 12.95% | [7],[8],[10],[11] | 12.95% | [7],[8],[10],[11] | 12.95% | [7],[8],[10],[11] | 10.88% | [14],[15],[16],[17] | 10.88% | [14],[15],[16],[17] | 10.88% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 17,873 | [7],[10],[11],[13] | $ 14,414 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 13,910 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | 17,533 | ||||||||||||
Investment, Identifier [Axis]: APX Group Inc., Electrical Components & Equipment, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [15],[16],[17],[22] | 5.75% | 5.75% | 5.75% | ||||||||||
Investment owned, balance, principal amount | [15],[18],[22] | $ 2,075 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[22] | 1,645 | ||||||||||||
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., Trading Companies & Distributors, Fixed Rate Bond 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [15],[16],[17] | 7.50% | 7.50% | 7.50% | ||||||||||
Investment owned, balance, principal amount | [15],[18] | $ 5,500 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | 3,641 | ||||||||||||
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., Trading Companies & Distributors, Fixed Rate Bond 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [15],[16],[17] | 5.25% | 5.25% | 5.25% | ||||||||||
Investment owned, balance, principal amount | [15],[18] | $ 2,500 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 1,926 | ||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11],[20] | 6% | 6% | 6% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13],[20] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11],[20] | $ (20) | ||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, Paper & Plastic Packaging Products & Materials, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11],[20] | 6% | 6% | 6% | ||||||||||
Investment, interest rate | [7],[8],[10],[11],[20] | 11.31% | 11.31% | 11.31% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13],[20] | $ 3,284 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | 3,120 | ||||||||||||
Investment, Identifier [Axis]: ATNX SPV, LLC, Pharmaceuticals, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance, principal amount | [7],[10],[13],[20],[21] | 11,683 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[20],[21] | $ 11,274 | ||||||||||||
Investment, Identifier [Axis]: Access CIG, LLC, Diversified Support Services, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.75% | [7],[10] | 7.75% | [7],[10] | 7.75% | [7],[10] | 7.75% | [15],[16] | 7.75% | [15],[16] | 7.75% | [15],[16] | ||
Investment, interest rate | 12.94% | [7],[8],[10],[11] | 12.94% | [7],[8],[10],[11] | 12.94% | [7],[8],[10],[11] | 10.82% | [15],[16],[17] | 10.82% | [15],[16],[17] | 10.82% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 20,000 | [7],[10],[11],[13] | $ 20,000 | [15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 19,075 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 18,883 | ||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment, interest rate | [7],[8],[9],[10],[11] | 10.86% | 10.86% | 10.86% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13] | $ 2,033 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ 2,027 | ||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 10.86% | 10.86% | 10.86% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 20,286 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 20,246 | ||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Care Products, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment, interest rate | [7],[8],[9],[10],[11] | |||||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | (8) | ||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16],[19] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment, interest rate | [14],[15],[16],[17],[19] | 9.14% | 9.14% | 9.14% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18],[19] | $ 500 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | 495 | ||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 9.12% | 9.12% | 9.12% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 15,976 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 15,944 | ||||||||||||
Investment, Identifier [Axis]: Accupac, Inc., Personal Products, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16],[19] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18],[19] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | $ (6) | ||||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[9],[10] | 7% | [7],[9],[10] | 7% | [7],[9],[10] | 7% | [14],[15],[16],[19] | 7% | [14],[15],[16],[19] | 7% | [14],[15],[16],[19] | ||
Investment, interest rate | 12.05% | [7],[8],[9],[10],[11] | 12.05% | [7],[8],[9],[10],[11] | 12.05% | [7],[8],[9],[10],[11] | 10.64% | [14],[15],[16],[17],[19] | 10.64% | [14],[15],[16],[17],[19] | 10.64% | [14],[15],[16],[17],[19] | ||
Investment owned, balance, principal amount | $ 2,113 | [7],[9],[10],[11],[13] | $ 914 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | 898 | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | 2,102 | ||||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 9.63% | 9.63% | 9.63% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 27,349 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 27,158 | ||||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12.34% | 12.34% | 12.34% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 6,400 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 6,374 | ||||||||||||
Investment, Identifier [Axis]: Acquia Inc., Application Software, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12.34% | 12.34% | 12.34% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 25,332 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | 25,230 | ||||||||||||
Investment, Identifier [Axis]: Aden & Anais Merger Sub, Inc., Apparel, Accessories & Luxury Goods, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [14],[15] | 51,645 | 51,645 | 51,645 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: AirStrip Technologies, Inc., Application Software, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 5,715 | [7],[10] | 5,715 | [7],[10] | 5,715 | [7],[10] | 5,715 | [14],[15] | 5,715 | [14],[15] | 5,715 | [14],[15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 0 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | 0 | ||||||||||||
Investment, Identifier [Axis]: All Web Leads, Inc., Advertising, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 8.50% | 8.50% | 8.50% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 23,338 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 22,141 | ||||||||||||
Investment, Identifier [Axis]: All Web Leads, Inc., First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11],[23] | 8.50% | 8.50% | 8.50% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13],[23] | $ 23,562 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[23] | $ 16,880 | ||||||||||||
Investment, Identifier [Axis]: Altice France S.A., Integrated Telecommunication Services, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 5.50% | [8],[10],[11],[20] | 5.50% | [8],[10],[11],[20] | 5.50% | [8],[10],[11],[20] | 5.50% | [15],[16],[17],[22] | 5.50% | [15],[16],[17],[22] | 5.50% | [15],[16],[17],[22] | ||
Investment owned, balance, principal amount | $ 4,050 | [10],[13],[20] | $ 4,050 | [15],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[22] | 3,057 | ||||||||||||
Fair Value, Ending Balance | [10],[20] | $ 2,900 | ||||||||||||
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 8% | 8% | 8% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 13.34% | 13.34% | 13.34% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 8,794 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 8,011 | ||||||||||||
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Health Care Technology, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [7],[10] | 166,414 | 166,414 | 166,414 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 518 | ||||||||||||
Investment, Identifier [Axis]: Alvogen Pharma US, Inc., Pharmaceuticals, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[10],[11] | 7.50% | [7],[10],[11] | 7.50% | [7],[10],[11] | 7.50% | [14],[15],[16] | 7.50% | [14],[15],[16] | 7.50% | [14],[15],[16] | ||
Investment, interest rate | 12.89% | [7],[8],[10],[11] | 12.89% | [7],[8],[10],[11] | 12.89% | [7],[8],[10],[11] | 11.20% | [14],[15],[16],[17] | 11.20% | [14],[15],[16],[17] | 11.20% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 17,280 | [7],[10],[11],[13] | $ 13,134 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 13,068 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | 16,503 | ||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [14],[15],[16],[17],[22] | 10% | 10% | 10% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18],[22] | $ 24,043 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | $ 23,923 | ||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 824,197 | [10],[20] | 824,197 | [10],[20] | 824,197 | [10],[20] | 587,930 | [15],[22] | 587,930 | [15],[22] | 587,930 | [15],[22] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[22] | $ 3,974 | ||||||||||||
Fair Value, Ending Balance | [10],[20] | $ 6,379 | ||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Common Stock 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 141,640 | [7],[10],[20],[24] | 141,640 | [7],[10],[20],[24] | 141,640 | [7],[10],[20],[24] | 124,780 | [14],[15],[22],[25] | 124,780 | [14],[15],[22],[25] | 124,780 | [14],[15],[22],[25] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22],[25] | $ 212 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20],[24] | $ 339 | ||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[10],[11],[20] | 8.50% | 8.50% | 8.50% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[13],[20] | $ 28,464 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 27,682 | ||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[10],[11],[20] | 8.50% | 8.50% | 8.50% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[13],[20] | $ 2,121 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 2,063 | ||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[10],[11],[20] | 8.50% | 8.50% | 8.50% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[13],[20] | $ 27,692 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 26,930 | ||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, First Lien Fixed Rate Bond 4 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[10],[11],[20] | 8.50% | 8.50% | 8.50% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[13],[20] | $ 2,064 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | 2,007 | ||||||||||||
Investment, Identifier [Axis]: Alvotech Holdings S.A., Biotechnology, Fixed Rate Bond 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [14],[15],[16],[17],[22] | 10% | 10% | 10% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18],[22] | $ 23,522 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | $ 23,404 | ||||||||||||
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Consumer Finance, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.75% | [7],[10],[11] | 8.75% | [7],[10],[11] | 8.75% | [7],[10],[11] | 8.75% | [14],[15],[16] | 8.75% | [14],[15],[16] | 8.75% | [14],[15],[16] | ||
Investment, interest rate | 13.99% | [7],[8],[10],[11] | 13.99% | [7],[8],[10],[11] | 13.99% | [7],[8],[10],[11] | 12.30% | [14],[15],[16],[17] | 12.30% | [14],[15],[16],[17] | 12.30% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 17,048 | [7],[10],[11],[13] | $ 14,760 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 13,284 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 12,616 | ||||||||||||
Investment, Identifier [Axis]: American Tire Distributors, Inc., Distributors, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.25% | [10],[11] | 6.25% | [10],[11] | 6.25% | [10],[11] | 6.25% | [15],[16] | 6.25% | [15],[16] | 6.25% | [15],[16] | ||
Investment, interest rate | 11.49% | [8],[10],[11] | 11.49% | [8],[10],[11] | 11.49% | [8],[10],[11] | 9.03% | [15],[16],[17] | 9.03% | [15],[16],[17] | 9.03% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 19,163 | [10],[11],[13] | $ 9,895 | [15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 9,293 | ||||||||||||
Fair Value, Ending Balance | [10],[11] | 16,718 | ||||||||||||
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16],[22] | 4.25% | 4.25% | 4.25% | ||||||||||
Investment, interest rate | [14],[15],[16],[17],[22] | 7.92% | 7.92% | 7.92% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18],[22] | $ 15,220 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[22] | $ 14,687 | ||||||||||||
Investment, Identifier [Axis]: Amplify Finco Pty Ltd., Movies & Entertainment, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[10],[11],[20] | 8% | [7],[10],[11],[20] | 8% | [7],[10],[11],[20] | 8% | [14],[15],[16],[22] | 8% | [14],[15],[16],[22] | 8% | [14],[15],[16],[22] | ||
Investment, interest rate | 13.39% | [7],[8],[10],[11],[20] | 13.39% | [7],[8],[10],[11],[20] | 13.39% | [7],[8],[10],[11],[20] | 11.67% | [14],[15],[16],[17],[22] | 11.67% | [14],[15],[16],[17],[22] | 11.67% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | $ 12,500 | [7],[10],[11],[13],[20] | $ 12,500 | [14],[15],[16],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[22] | 11,958 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 11,865 | ||||||||||||
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Care Products, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [10],[11] | 3.75% | 3.75% | 3.75% | ||||||||||
Investment, interest rate | [8],[10],[11] | 9.25% | 9.25% | 9.25% | ||||||||||
Investment owned, balance, principal amount | [10],[11],[13] | $ 3,710 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [10],[11] | 2,863 | ||||||||||||
Investment, Identifier [Axis]: Anastasia Parent, LLC, Personal Products, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [15],[16] | 3.75% | 3.75% | 3.75% | ||||||||||
Investment, interest rate | [15],[16],[17] | 7.42% | 7.42% | 7.42% | ||||||||||
Investment owned, balance, principal amount | [15],[16],[18] | $ 2,736 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 2,189 | ||||||||||||
Investment, Identifier [Axis]: Ankura Consulting Group LLC, Research & Consulting Services, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 8% | 8% | 8% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 10.78% | 10.78% | 10.78% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 4,346 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 3,813 | ||||||||||||
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | [7],[9],[10],[11] | 5% | [7],[9],[10],[11] | 5% | [7],[9],[10],[11] | 6% | [14],[15],[16],[19] | 6% | [14],[15],[16],[19] | 6% | [14],[15],[16],[19] | ||
Investment, interest rate | 10.20% | [7],[8],[9],[10],[11] | 10.20% | [7],[8],[9],[10],[11] | 10.20% | [7],[8],[9],[10],[11] | 8.46% | [14],[15],[16],[17],[19] | 8.46% | [14],[15],[16],[17],[19] | 8.46% | [14],[15],[16],[17],[19] | ||
Investment owned, balance, principal amount | $ 808 | [7],[9],[10],[11],[13] | $ 892 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | 846 | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | 808 | ||||||||||||
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 6% | 6% | 6% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 8.46% | 8.46% | 8.46% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 34,458 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 33,738 | ||||||||||||
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 5% | 5% | 5% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 10.20% | 10.20% | 10.20% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 9,280 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 9,280 | ||||||||||||
Investment, Identifier [Axis]: Apptio, Inc., Application Software, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 5% | 5% | 5% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 10.20% | 10.20% | 10.20% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 32,308 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 32,308 | ||||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[10],[11],[20] | 7.25% | [7],[10],[11],[20] | 7.25% | [7],[10],[11],[20] | 7% | [14],[15],[16],[22] | 7% | [14],[15],[16],[22] | 7% | [14],[15],[16],[22] | ||
Investment, interest rate | 10.07% | [7],[8],[10],[11],[20] | 10.07% | [7],[8],[10],[11],[20] | 10.07% | [7],[8],[10],[11],[20] | 8% | [14],[15],[16],[17],[22] | 8% | [14],[15],[16],[17],[22] | 8% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | € | € 3,017 | [7],[10],[11],[13],[20] | € 1,964 | [14],[15],[16],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[22] | $ 1,927 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 3,321 | ||||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[10],[11],[20] | 6% | [7],[10],[11],[20] | 6% | [7],[10],[11],[20] | 7% | [14],[15],[16],[22] | 7% | [14],[15],[16],[22] | 7% | [14],[15],[16],[22] | ||
Investment, interest rate | 11.25% | [7],[8],[10],[11],[20] | 11.25% | [7],[8],[10],[11],[20] | 11.25% | [7],[8],[10],[11],[20] | 9.19% | [14],[15],[16],[17],[22] | 9.19% | [14],[15],[16],[17],[22] | 9.19% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | $ 10,519 | [7],[10],[11],[13],[20] | £ 18,636 | [14],[15],[16],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[22] | 20,826 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 10,614 | ||||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[10],[11],[20] | 7.25% | [7],[10],[11],[20] | 7.25% | [7],[10],[11],[20] | 5.75% | [14],[15],[16],[22] | 5.75% | [14],[15],[16],[22] | 5.75% | [14],[15],[16],[22] | ||
Investment, interest rate | 12.18% | [7],[8],[10],[11],[20] | 12.18% | [7],[8],[10],[11],[20] | 12.18% | [7],[8],[10],[11],[20] | 8.81% | [14],[15],[16],[17],[22] | 8.81% | [14],[15],[16],[17],[22] | 8.81% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | £ 4,949 | [7],[10],[11],[13],[20] | $ 10,519 | [14],[15],[16],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[22] | $ 10,328 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 6,348 | ||||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 4 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[10],[11],[20] | 7.25% | [7],[10],[11],[20] | 7.25% | [7],[10],[11],[20] | 5.75% | [14],[15],[16],[19],[22] | 5.75% | [14],[15],[16],[19],[22] | 5.75% | [14],[15],[16],[19],[22] | ||
Investment, interest rate | [7],[8],[10],[11],[20] | 12.45% | 12.45% | 12.45% | ||||||||||
Investment owned, balance, principal amount | £ | £ 23,675 | [7],[10],[11],[13],[20] | £ 0 | [14],[15],[16],[18],[19],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19],[22] | $ 0 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 30,370 | ||||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, Insurance Brokers, First Lien Term Loan 5 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11],[20] | 5.75% | 5.75% | 5.75% | ||||||||||
Investment, interest rate | [7],[8],[10],[11],[20] | 8.57% | 8.57% | 8.57% | ||||||||||
Investment owned, balance, principal amount | € | [7],[10],[11],[13],[20] | € 3,649 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 4,027 | ||||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 1,783,332 | 1,609,201 | 1,783,332 | 1,783,332 | ||||||||||
Investment owned, balance, principal amount | $ 0 | $ 0 | ||||||||||||
Net Realized Gain (Loss) | 0 | 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 370 | 587 | ||||||||||||
Gross Additions | 40 | 0 | ||||||||||||
Gross Reductions | (410) | (24) | ||||||||||||
Fair Value, Ending Balance | $ 0 | $ 563 | ||||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | 0% | ||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.75% | 6.75% | 6.75% | 6.75% | ||||||||||
Investment, interest rate | 12.29% | 9% | 12.29% | 12.29% | ||||||||||
Investment owned, balance, principal amount | $ 22,304 | $ 21,754 | ||||||||||||
Net Realized Gain (Loss) | 0 | 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 1,985 | 1,185 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 24,225 | 15,712 | ||||||||||||
Gross Additions | 2,378 | 11,585 | ||||||||||||
Gross Reductions | (4,417) | (6,037) | ||||||||||||
Fair Value, Ending Balance | $ 22,186 | $ 21,260 | ||||||||||||
Investment owned, percent of net assets | 1.50% | 1.70% | 1.50% | 1.50% | ||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 1,129,453 | 1,019,169 | 1,129,453 | 1,129,453 | ||||||||||
Investment owned, balance, principal amount | $ 0 | $ 0 | ||||||||||||
Net Realized Gain (Loss) | 0 | 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 1,223 | 1,152 | ||||||||||||
Gross Additions | 189 | 51 | ||||||||||||
Gross Reductions | 0 | 0 | ||||||||||||
Fair Value, Ending Balance | $ 1,412 | $ 1,203 | ||||||||||||
Investment owned, percent of net assets | 0.10% | 0.10% | 0.10% | 0.10% | ||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 1,783,332 | [6],[7] | 1,783,332 | [6],[7] | 1,783,332 | [6],[7] | 1,609,201 | [5],[14] | 1,609,201 | [5],[14] | 1,609,201 | [5],[14] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [5],[14] | $ 370 | ||||||||||||
Fair Value, Ending Balance | [6],[7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.75% | [6],[7],[9],[11] | 6.75% | [6],[7],[9],[11] | 6.75% | [6],[7],[9],[11] | 6.75% | [5],[14],[16],[19] | 6.75% | [5],[14],[16],[19] | 6.75% | [5],[14],[16],[19] | ||
Investment, interest rate | 12.29% | [6],[7],[8],[9],[11] | 12.29% | [6],[7],[8],[9],[11] | 12.29% | [6],[7],[8],[9],[11] | 10.42% | [5],[14],[16],[17],[19] | 10.42% | [5],[14],[16],[17],[19] | 10.42% | [5],[14],[16],[17],[19] | ||
Investment owned, balance, principal amount | $ 22,304 | [6],[7],[9],[11],[13] | $ 24,490 | [5],[14],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [5],[14],[16],[19] | 24,225 | ||||||||||||
Fair Value, Ending Balance | [6],[7],[9],[11] | $ 22,186 | ||||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 1,129,453 | [6],[7] | 1,129,453 | [6],[7] | 1,129,453 | [6],[7] | 1,019,169 | [5],[14] | 1,019,169 | [5],[14] | 1,019,169 | [5],[14] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [5],[14] | $ 1,223 | ||||||||||||
Fair Value, Ending Balance | [6],[7] | $ 1,412 | ||||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Specialized Finance, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 78,045 | [6],[7] | 78,045 | [6],[7] | 78,045 | [6],[7] | 70,425 | [5],[14] | 70,425 | [5],[14] | 70,425 | [5],[14] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [5],[14] | $ 0 | ||||||||||||
Fair Value, Ending Balance | [6],[7] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Assembled Brands Capital LLC, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 78,045 | 70,425 | 78,045 | 78,045 | ||||||||||
Investment owned, balance, principal amount | $ 0 | $ 0 | ||||||||||||
Net Realized Gain (Loss) | 0 | 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 0 | 0 | ||||||||||||
Gross Additions | 0 | 0 | ||||||||||||
Gross Reductions | 0 | 0 | ||||||||||||
Fair Value, Ending Balance | $ 0 | $ 0 | ||||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | 0% | ||||||||||
Investment, Identifier [Axis]: Associated Asphalt Partners, LLC, Construction Materials, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [15],[16] | 5.25% | 5.25% | 5.25% | ||||||||||
Investment, interest rate | [15],[16],[17] | 8.06% | 8.06% | 8.06% | ||||||||||
Investment owned, balance, principal amount | [15],[16],[18] | $ 2,501 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | $ 1,934 | ||||||||||||
Investment, Identifier [Axis]: Astra Acquisition Corp., Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.25% | [10],[11] | 5.25% | [10],[11] | 5.25% | [10],[11] | 5.25% | [15],[16] | 5.25% | [15],[16] | 5.25% | [15],[16] | ||
Investment, interest rate | 10.44% | [8],[10],[11] | 10.44% | [8],[10],[11] | 10.44% | [8],[10],[11] | 8.37% | [15],[16],[17] | 8.37% | [15],[16],[17] | 8.37% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 8,490 | [10],[11],[13] | $ 5,640 | [15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 4,822 | ||||||||||||
Fair Value, Ending Balance | [10],[11] | $ 5,983 | ||||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 11% | [7],[8],[10],[11],[20],[23] | 11% | [7],[8],[10],[11],[20],[23] | 11% | [7],[8],[10],[11],[20],[23] | 11% | [14],[15],[16],[17],[22] | 11% | [14],[15],[16],[17],[22] | 11% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | $ 1,338 | [7],[10],[13],[20],[23] | $ 13,346 | [14],[15],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | 12,812 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20],[23] | $ 1,257 | ||||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[10],[11],[20],[23] | 11% | 11% | 11% | ||||||||||
Investment owned, balance, principal amount | $ 1,338 | [7],[10],[13],[20],[23] | $ 8,309 | [14],[15],[18],[22],[26] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22],[26] | 8,309 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20],[23] | $ 1,257 | ||||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[10],[11],[20],[23] | 11% | 11% | 11% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[13],[20],[23] | $ 5,350 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[20],[23] | 5,029 | ||||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [14],[15],[22] | 328,149 | 328,149 | 328,149 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | $ 16 | ||||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 10,634 | 10,634 | 10,634 | |||||||||||
Investment owned, balance, principal amount | [7],[10],[13],[20] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Athenex, Inc., Pharmaceuticals, Warrants 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [7],[10],[20] | 10,634 | 10,634 | 10,634 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Aurora Lux Finco S.À.R.L., Airport Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[10],[11],[20] | 6% | [7],[10],[11],[20] | 6% | [7],[10],[11],[20] | 6% | [14],[15],[16],[22] | 6% | [14],[15],[16],[22] | 6% | [14],[15],[16],[22] | ||
Investment, interest rate | 11.27% | [7],[8],[10],[11],[20] | 11.27% | [7],[8],[10],[11],[20] | 11.27% | [7],[8],[10],[11],[20] | 8.78% | [14],[15],[16],[17],[22] | 8.78% | [14],[15],[16],[17],[22] | 8.78% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | $ 29,509 | [7],[10],[11],[13],[20] | $ 22,425 | [14],[15],[16],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[22] | 21,326 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 28,299 | ||||||||||||
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11] | 7.25% | 7.25% | 7.25% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ (101) | ||||||||||||
Investment, Identifier [Axis]: Avalara, Inc., Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 7.25% | 7.25% | 7.25% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12.49% | 12.49% | 12.49% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 50,470 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | 49,461 | ||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16],[19] | 5% | 5% | 5% | ||||||||||
Investment, interest rate | [14],[15],[16],[17],[19] | 8.12% | 8.12% | 8.12% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18],[19] | $ 2,546 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | $ 2,395 | ||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 5% | 5% | 5% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 10.50% | 10.50% | 10.50% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 3,258 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 3,173 | ||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 5% | 5% | 5% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 10.50% | 10.50% | 10.50% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 1,264 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 1,232 | ||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[10],[11] | 8.50% | [7],[10],[11] | 8.50% | [7],[10],[11] | 8.50% | [14],[15],[16] | 8.50% | [14],[15],[16] | 8.50% | [14],[15],[16] | ||
Investment, interest rate | 14% | [7],[8],[10],[11] | 14% | [7],[8],[10],[11] | 14% | [7],[8],[10],[11] | 11.62% | [14],[15],[16],[17] | 11.62% | [14],[15],[16],[17] | 11.62% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 8,920 | [7],[10],[11],[13] | $ 7,166 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 6,915 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 8,661 | ||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[10],[11] | 8.50% | [7],[10],[11] | 8.50% | [7],[10],[11] | 8.50% | [14],[15],[16],[19] | 8.50% | [14],[15],[16],[19] | 8.50% | [14],[15],[16],[19] | ||
Investment, interest rate | 14% | [7],[8],[10],[11] | 14% | [7],[8],[10],[11] | 14% | [7],[8],[10],[11] | 11.62% | [14],[15],[16],[17],[19] | 11.62% | [14],[15],[16],[17],[19] | 11.62% | [14],[15],[16],[17],[19] | ||
Investment owned, balance, principal amount | $ 2,091 | [7],[10],[11],[13] | $ 4,227 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | 3,839 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 2,030 | ||||||||||||
Investment, Identifier [Axis]: BAART Programs, Inc., Health Care Services, Second Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 8.50% | 8.50% | 8.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 14% | 14% | 14% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 4,361 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 4,235 | ||||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11] | 4.50% | 4.50% | 4.50% | ||||||||||
Investment, interest rate | [7],[8],[9],[10],[11] | 12.50% | 12.50% | 12.50% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13] | $ 2,528 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ 2,482 | ||||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks & Non-alcoholic Beverages, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 10.70% | 10.70% | 10.70% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 40,764 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | 40,316 | ||||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16],[19] | 4.50% | 4.50% | 4.50% | ||||||||||
Investment, interest rate | [14],[15],[16],[17],[19] | 10.75% | 10.75% | 10.75% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18],[19] | $ 1,702 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | 1,617 | ||||||||||||
Investment, Identifier [Axis]: Berner Food & Beverage, LLC, Soft Drinks, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 8.31% | 8.31% | 8.31% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 33,078 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 32,053 | ||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance, principal amount | [14],[15],[18],[19],[22],[26] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[19],[22],[26] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 8% | [7],[8],[10],[11],[20] | 8% | [7],[8],[10],[11],[20] | 8% | [7],[8],[10],[11],[20] | 10.25% | [14],[15],[16],[17],[22] | 10.25% | [14],[15],[16],[17],[22] | 10.25% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | $ 6,719 | [7],[10],[13],[20] | $ 5,322 | [14],[15],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | 5,114 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | 6,282 | ||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [14],[15],[16],[17],[19],[22] | 10.25% | 10.25% | 10.25% | ||||||||||
Investment owned, balance, principal amount | 3,210 | [7],[10],[13],[20],[21] | $ 0 | [14],[15],[18],[19],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[19],[22] | 0 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20],[21] | $ 3,130 | ||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[10],[11],[20] | 8% | 8% | 8% | ||||||||||
Investment owned, balance, principal amount | $ 0 | [7],[9],[10],[13],[20] | $ 2,353 | [14],[15],[18],[22],[26] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22],[26] | 2,353 | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[20] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 4 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[10],[11],[20] | 8% | 8% | 8% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[13],[20] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[20] | 0 | ||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 5 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[13],[20],[21] | 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[20],[21] | 0 | ||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, First Lien Term Loan 6 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[13],[20],[21] | 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[20],[21] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Pharmaceuticals, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 26,131 | [7],[10],[20] | 26,131 | [7],[10],[20] | 26,131 | [7],[10],[20] | 21,177 | [14],[15],[22] | 21,177 | [14],[15],[22] | 21,177 | [14],[15],[22] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | $ 98 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 34 | ||||||||||||
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., Data Processing & Outsourced Services, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [10],[11] | 7% | [10],[11] | 7% | [10],[11] | 7% | [15],[16] | 7% | [15],[16] | 7% | [15],[16] | ||
Investment, interest rate | 12.25% | [8],[10],[11] | 12.25% | [8],[10],[11] | 12.25% | [8],[10],[11] | 9.50% | [15],[16],[17] | 9.50% | [15],[16],[17] | 9.50% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 30,625 | [10],[11],[13] | $ 30,625 | [15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 29,017 | ||||||||||||
Fair Value, Ending Balance | [10],[11] | $ 29,385 | ||||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 394,297 | [7],[10] | 394,297 | [7],[10] | 394,297 | [7],[10] | 298,460 | [14],[15] | 298,460 | [14],[15] | 298,460 | [14],[15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 349 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 355 | ||||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 9% | [7],[8],[10],[11] | 9% | [7],[8],[10],[11] | 9% | [7],[8],[10],[11] | 9% | [14],[15],[16],[17] | 9% | [14],[15],[16],[17] | 9% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 4,994 | [7],[10],[13] | $ 3,979 | [14],[15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 3,960 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 4,969 | ||||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 1,708,618 | [7],[10] | 1,708,618 | [7],[10] | 1,708,618 | [7],[10] | 1,293,324 | [14],[15] | 1,293,324 | [14],[15] | 1,293,324 | [14],[15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 1,280 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 2,085 | ||||||||||||
Investment, Identifier [Axis]: Blumenthal Temecula, LLC, Automotive Retail, Preferred Equity 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 394,297 | [7],[10] | 394,297 | [7],[10] | 394,297 | [7],[10] | 298,460 | [14],[15] | 298,460 | [14],[15] | 298,460 | [14],[15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 295 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 481 | ||||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 829 | |||||||||||||
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 0 | |||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | 0 | |||||||||||||
Fair Value, Ending Balance | $ 0 | |||||||||||||
Investment owned, percent of net assets | 0% | |||||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 829 | [3],[4],[7] | 829 | [3],[4],[7] | 829 | [3],[4],[7] | 829 | [1],[2],[14] | 829 | [1],[2],[14] | 829 | [1],[2],[14] | ||
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [1],[2],[14] | 0 | ||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | 0 | |||||||||||||
Fair Value, Ending Balance | [3],[4],[7] | $ 0 | ||||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | |||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Data Processing & Outsourced Services, Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 34,984,460 | [3],[4],[7] | 34,984,460 | [3],[4],[7] | 34,984,460 | [3],[4],[7] | 34,984,460 | [1],[2],[14] | 34,984,460 | [1],[2],[14] | 34,984,460 | [1],[2],[14] | ||
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [1],[2],[14] | 27,638 | ||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | 0 | |||||||||||||
Fair Value, Ending Balance | [3],[4],[7] | $ 27,638 | ||||||||||||
Investment owned, percent of net assets | 1.80% | 1.80% | 1.80% | |||||||||||
Investment, Identifier [Axis]: C5 Technology Holdings, LLC, Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 34,984,460 | |||||||||||||
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 27,638 | |||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | 0 | |||||||||||||
Fair Value, Ending Balance | $ 27,638 | |||||||||||||
Investment owned, percent of net assets | 2.20% | |||||||||||||
Investment, Identifier [Axis]: CCO Holdings LLC, Cable & Satellite, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [15],[16],[17],[22] | 4.50% | 4.50% | 4.50% | ||||||||||
Investment owned, balance, principal amount | [15],[18],[22] | $ 2,097 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[22] | $ 1,603 | ||||||||||||
Investment, Identifier [Axis]: CITGO Holding, Inc., Oil & Gas Refining & Marketing, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [15],[16],[17] | 9.25% | 9.25% | 9.25% | ||||||||||
Investment owned, balance, principal amount | [15],[18] | $ 7,857 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | 7,807 | ||||||||||||
Investment, Identifier [Axis]: CITGO Petroleum Corp., Oil & Gas Refining & Marketing, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [15],[16] | 6.25% | 6.25% | 6.25% | ||||||||||
Investment, interest rate | [15],[16],[17] | 9.37% | 9.37% | 9.37% | ||||||||||
Investment owned, balance, principal amount | [15],[16],[18] | $ 795 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | $ 797 | ||||||||||||
Investment, Identifier [Axis]: CPC Acquisition Corp., Specialty Chemicals, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11],[23] | 7.75% | 7.75% | 7.75% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13],[23] | $ 727 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[23] | 325 | ||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 9.31% | 9.31% | 9.31% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 14,294 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 13,143 | ||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 11.91% | 11.91% | 11.91% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 13 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 13 | ||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 11.91% | 11.91% | 11.91% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 3,031 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 3,031 | ||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 11.91% | 11.91% | 11.91% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 1,557 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 1,557 | ||||||||||||
Investment, Identifier [Axis]: Cadence Aerospace, LLC, Aerospace & Defense, First Lien Term Loan 4 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 11.91% | 11.91% | 11.91% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 1,024 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 1,024 | ||||||||||||
Investment, Identifier [Axis]: Caregiver Services, Inc., Health Care Services, Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 1,080,399 | [6],[7] | 1,080,399 | [6],[7] | 1,080,399 | [6],[7] | 1,080,399 | [5],[14] | 1,080,399 | [5],[14] | 1,080,399 | [5],[14] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [5],[14] | $ 378 | ||||||||||||
Fair Value, Ending Balance | [6],[7] | $ 313 | ||||||||||||
Investment, Identifier [Axis]: Caregiver Services, Inc., Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 1,080,399 | 1,080,399 | 1,080,399 | 1,080,399 | ||||||||||
Investment owned, balance, principal amount | $ 0 | $ 0 | ||||||||||||
Net Realized Gain (Loss) | 0 | 0 | ||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 378 | 838 | ||||||||||||
Gross Additions | 0 | 0 | ||||||||||||
Gross Reductions | (65) | (437) | ||||||||||||
Fair Value, Ending Balance | $ 313 | $ 401 | ||||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | 0% | ||||||||||
Investment, Identifier [Axis]: Carvana Co., Automotive Retail, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [15],[16],[17],[22] | 5.63% | 5.63% | 5.63% | ||||||||||
Investment owned, balance, principal amount | [15],[18],[22] | $ 6,700 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[22] | $ 4,724 | ||||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 8.62% | 8.62% | 8.62% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 10,692 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 10,209 | ||||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 10.70% | 10.70% | 10.70% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 130 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 130 | ||||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 10.70% | 10.70% | 10.70% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 129 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 129 | ||||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 10.70% | 10.70% | 10.70% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 1,084 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 1,084 | ||||||||||||
Investment, Identifier [Axis]: CircusTrix Holdings, LLC, Leisure Facilities, First Lien Term Loan 4 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 10.70% | 10.70% | 10.70% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 9,002 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 9,002 | ||||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 7.50% | [8],[10],[11],[20] | 7.50% | [8],[10],[11],[20] | 7.50% | [8],[10],[11],[20] | 7.50% | [15],[16],[17],[22] | 7.50% | [15],[16],[17],[22] | 7.50% | [15],[16],[17],[22] | ||
Investment owned, balance, principal amount | $ 2,632 | [10],[13],[20] | $ 4,311 | [15],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[22] | 3,132 | ||||||||||||
Fair Value, Ending Balance | [10],[20] | $ 1,951 | ||||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 7.75% | [8],[10],[11],[20] | 7.75% | [8],[10],[11],[20] | 7.75% | [8],[10],[11],[20] | 5.13% | [15],[16],[17],[22] | 5.13% | [15],[16],[17],[22] | 5.13% | [15],[16],[17],[22] | ||
Investment owned, balance, principal amount | $ 176 | [10],[13],[20] | $ 1,374 | [15],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[22] | 1,163 | ||||||||||||
Fair Value, Ending Balance | [10],[20] | 138 | ||||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Advertising, Fixed Rate Bond 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [15],[16],[17],[22] | 7.75% | 7.75% | 7.75% | ||||||||||
Investment owned, balance, principal amount | [15],[18],[22] | $ 676 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[22] | $ 512 | ||||||||||||
Investment, Identifier [Axis]: Condor Merger Sub Inc., Systems Software, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 7.38% | [8],[10],[11] | 7.38% | [8],[10],[11] | 7.38% | [8],[10],[11] | 7.38% | [15],[16],[17] | 7.38% | [15],[16],[17] | 7.38% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 8,420 | [10],[13] | $ 8,420 | [15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | 6,900 | ||||||||||||
Fair Value, Ending Balance | [10] | $ 7,330 | ||||||||||||
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[10],[11] | 8.50% | [7],[10],[11] | 8.50% | [7],[10],[11] | 8.50% | [14],[15],[16] | 8.50% | [14],[15],[16] | 8.50% | [14],[15],[16] | ||
Investment, interest rate | 13.69% | [7],[8],[10],[11] | 13.69% | [7],[8],[10],[11] | 13.69% | [7],[8],[10],[11] | 11.62% | [14],[15],[16],[17] | 11.62% | [14],[15],[16],[17] | 11.62% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 24,350 | [7],[10],[11],[13] | $ 22,537 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 20,396 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | 21,506 | ||||||||||||
Investment, Identifier [Axis]: Continental Intermodal Group LP, Oil & Gas Storage & Transportation, Warrants | ||||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 457 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 154 | ||||||||||||
Investment, Identifier [Axis]: Convergeone Holdings, Inc., IT Consulting & Other Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | [10],[11] | 5% | [10],[11] | 5% | [10],[11] | 5% | [15],[16] | 5% | [15],[16] | 5% | [15],[16] | ||
Investment, interest rate | 10.37% | [8],[10],[11] | 10.37% | [8],[10],[11] | 10.37% | [8],[10],[11] | 8.12% | [15],[16],[17] | 8.12% | [15],[16],[17] | 8.12% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 17,506 | [10],[11],[13] | $ 11,913 | [15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 8,596 | ||||||||||||
Fair Value, Ending Balance | [10],[11] | $ 11,176 | ||||||||||||
Investment, Identifier [Axis]: Conviva Inc., Application Software, Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 417,851 | [7],[10] | 417,851 | [7],[10] | 417,851 | [7],[10] | 417,851 | [14],[15] | 417,851 | [14],[15] | 417,851 | [14],[15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 894 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 894 | ||||||||||||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 1,500 | [7],[10] | 1,500 | [7],[10] | 1,500 | [7],[10] | 1,099 | [14],[15] | 1,099 | [14],[15] | 1,099 | [14],[15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 2,340 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 3,299 | ||||||||||||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.75% | [7],[9],[10],[11] | 5.75% | [7],[9],[10],[11] | 5.75% | [7],[9],[10],[11] | 4.75% | [14],[15],[16],[19] | 4.75% | [14],[15],[16],[19] | 4.75% | [14],[15],[16],[19] | ||
Investment, interest rate | 14% | [7],[8],[9],[10],[11] | 14% | [7],[8],[9],[10],[11] | 14% | [7],[8],[9],[10],[11] | 11% | [14],[15],[16],[17],[19] | 11% | [14],[15],[16],[17],[19] | 11% | [14],[15],[16],[17],[19] | ||
Investment owned, balance, principal amount | $ 1,250 | [7],[9],[10],[11],[13] | $ 916 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | 898 | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | 1,202 | ||||||||||||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 5.75% | 5.75% | 5.75% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 8.88% | 8.88% | 8.88% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 13,712 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 13,583 | ||||||||||||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 6.13% | 6.13% | 6.13% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 11.33% | 11.33% | 11.33% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 13,671 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 13,408 | ||||||||||||
Investment, Identifier [Axis]: CorEvitas, LLC, Health Care Technology, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 6.13% | 6.13% | 6.13% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 11.33% | 11.33% | 11.33% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 4,903 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 4,809 | ||||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11] | 7.50% | 7.50% | 7.50% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ (21) | ||||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 7.50% | 7.50% | 7.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12.60% | 12.60% | 12.60% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 13,157 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 12,852 | ||||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, Application Software, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11] | 7.50% | 7.50% | 7.50% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ (14) | ||||||||||||
Investment, Identifier [Axis]: Covetrus, Inc., Health Care Distributors, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | [10],[11] | 5% | [10],[11] | 5% | [10],[11] | 5% | [15],[16] | 5% | [15],[16] | 5% | [15],[16] | ||
Investment, interest rate | 10.24% | [8],[10],[11] | 10.24% | [8],[10],[11] | 10.24% | [8],[10],[11] | 7.65% | [15],[16],[17] | 7.65% | [15],[16],[17] | 7.65% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 14,787 | [10],[11],[13] | $ 10,336 | [15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 9,681 | ||||||||||||
Fair Value, Ending Balance | [10],[11] | $ 13,807 | ||||||||||||
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[9],[10],[11] | 6% | [7],[9],[10],[11] | 6% | [7],[9],[10],[11] | 6% | [14],[15],[16],[19] | 6% | [14],[15],[16],[19] | 6% | [14],[15],[16],[19] | ||
Investment, interest rate | [8],[11] | 11.20% | 11.20% | 11.20% | ||||||||||
Investment owned, balance, principal amount | $ 533 | [7],[9],[10],[11],[13] | $ 0 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | (26) | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ 507 | ||||||||||||
Investment, Identifier [Axis]: Coyote Buyer, LLC, Specialty Chemicals, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[10],[11] | 6% | [7],[10],[11] | 6% | [7],[10],[11] | 6% | [14],[15],[16] | 6% | [14],[15],[16] | 6% | [14],[15],[16] | ||
Investment, interest rate | 11.10% | [7],[8],[10],[11] | 11.10% | [7],[8],[10],[11] | 11.10% | [7],[8],[10],[11] | 8.81% | [14],[15],[16],[17] | 8.81% | [14],[15],[16],[17] | 8.81% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 18,060 | [7],[10],[11],[13] | $ 18,200 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 17,843 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 17,706 | ||||||||||||
Investment, Identifier [Axis]: DTI Holdco, Inc., Research & Consulting Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 4.75% | [10],[11] | 4.75% | [10],[11] | 4.75% | [10],[11] | 4.75% | [15],[16] | 4.75% | [15],[16] | 4.75% | [15],[16] | ||
Investment, interest rate | 9.80% | [8],[10],[11] | 9.80% | [8],[10],[11] | 9.80% | [8],[10],[11] | 7.33% | [15],[16],[17] | 7.33% | [15],[16],[17] | 7.33% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 4,963 | [10],[11],[13] | $ 5,000 | [15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 4,760 | ||||||||||||
Fair Value, Ending Balance | [10],[11] | 4,632 | ||||||||||||
Investment, Identifier [Axis]: Delivery Hero FinCo LLC, Internet & Direct Marketing Retail, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [15],[16],[22] | 5.75% | 5.75% | 5.75% | ||||||||||
Investment, interest rate | [15],[16],[17],[22] | 8.49% | 8.49% | 8.49% | ||||||||||
Investment owned, balance, principal amount | [15],[16],[18],[22] | $ 4,988 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16],[22] | $ 4,757 | ||||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 2 | [7],[10],[20] | 2 | [7],[10],[20] | 2 | [7],[10],[20] | 2 | [14],[15],[22] | 2 | [14],[15],[22] | 2 | [14],[15],[22] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | $ 2 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 2 | ||||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 419 | [7],[10],[20] | 419 | [7],[10],[20] | 419 | [7],[10],[20] | 419 | [14],[15],[22] | 419 | [14],[15],[22] | 419 | [14],[15],[22] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | $ 419 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 419 | ||||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Subordinated Debt Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 3% | [7],[8],[9],[10],[11],[20] | 3% | [7],[8],[9],[10],[11],[20] | 3% | [7],[8],[9],[10],[11],[20] | 10% | [14],[15],[16],[17],[19],[22] | 10% | [14],[15],[16],[17],[19],[22] | 10% | [14],[15],[16],[17],[19],[22] | ||
Investment owned, balance, principal amount | $ 13,043 | [7],[9],[10],[13],[20] | $ 4,183 | [14],[15],[18],[19],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[19],[22] | 4,183 | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[20] | $ 13,043 | ||||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Specialized Finance, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 31 | [7],[10],[20] | 31 | [7],[10],[20] | 31 | [7],[10],[20] | 31 | [14],[15],[22] | 31 | [14],[15],[22] | 31 | [14],[15],[22] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | $ 0 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | 0 | ||||||||||||
Investment, Identifier [Axis]: Delta Topco, Inc., Systems Software, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [15],[16] | 7.25% | 7.25% | 7.25% | ||||||||||
Investment, interest rate | [15],[16],[17] | 9.34% | 9.34% | 9.34% | ||||||||||
Investment owned, balance, principal amount | [15],[16],[18] | $ 6,680 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | $ 5,934 | ||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 9% | 9% | 9% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 14.42% | 14.42% | 14.42% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 20,757 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | 20,705 | ||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 9% | 9% | 9% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 12.67% | 12.67% | 12.67% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 24,396 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 22,993 | ||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16],[19] | 9% | 9% | 9% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18],[19] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | (129) | ||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Subordinated Debt Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance, principal amount | [7],[10],[13] | 641 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 611 | ||||||||||||
Investment, Identifier [Axis]: Dialyze Holdings, LLC, Health Care Equipment, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 6,397,254 | [7],[10] | 6,397,254 | [7],[10] | 6,397,254 | [7],[10] | 5,403,823 | [14],[15] | 5,403,823 | [14],[15] | 5,403,823 | [14],[15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 1,297 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 1,215 | ||||||||||||
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.75% | [7],[9],[10],[11] | 6.75% | [7],[9],[10],[11] | 6.75% | [7],[9],[10],[11] | 6.50% | [14],[15],[16],[19] | 6.50% | [14],[15],[16],[19] | 6.50% | [14],[15],[16],[19] | ||
Investment, interest rate | 12.09% | [7],[8],[9],[10],[11] | 12.09% | [7],[8],[9],[10],[11] | 12.09% | [7],[8],[9],[10],[11] | 9.41% | [14],[15],[16],[17],[19] | 9.41% | [14],[15],[16],[17],[19] | 9.41% | [14],[15],[16],[17],[19] | ||
Investment owned, balance, principal amount | $ 204 | [7],[9],[10],[11],[13] | $ 251 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | 239 | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ 172 | ||||||||||||
Investment, Identifier [Axis]: Digital.AI Software Holdings, Inc., Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[10],[11] | 7% | [7],[10],[11] | 7% | [7],[10],[11] | 7% | [14],[15],[16] | 7% | [14],[15],[16] | 7% | [14],[15],[16] | ||
Investment, interest rate | 12.34% | [7],[8],[10],[11] | 12.34% | [7],[8],[10],[11] | 12.34% | [7],[8],[10],[11] | 9.91% | [14],[15],[16],[17] | 9.91% | [14],[15],[16],[17] | 9.91% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 12,418 | [7],[10],[11],[13] | $ 9,902 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 9,793 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 12,120 | ||||||||||||
Investment, Identifier [Axis]: DirecTV Financing, LLC, Cable & Satellite, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | [10],[11] | 5% | [10],[11] | 5% | [10],[11] | 5% | [15],[16] | 5% | [15],[16] | 5% | [15],[16] | ||
Investment, interest rate | 10.22% | [8],[10],[11] | 10.22% | [8],[10],[11] | 10.22% | [8],[10],[11] | 8.12% | [15],[16],[17] | 8.12% | [15],[16],[17] | 8.12% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 4,769 | [10],[11],[13] | $ 19,242 | [15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 17,973 | ||||||||||||
Fair Value, Ending Balance | [10],[11] | $ 4,672 | ||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 30,031 | |||||||||||||
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 3,308 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 18,065 | |||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | (8,798) | |||||||||||||
Fair Value, Ending Balance | $ 9,267 | |||||||||||||
Investment owned, percent of net assets | 0.70% | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | |||||||||||||
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 42 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 0 | |||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | 0 | |||||||||||||
Fair Value, Ending Balance | $ 0 | |||||||||||||
Investment owned, percent of net assets | 0% | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | |||||||||||||
Investment, interest rate | 7.26% | |||||||||||||
Investment owned, balance, principal amount | $ 16,074 | |||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 1,078 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 27,381 | |||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | (11,307) | |||||||||||||
Fair Value, Ending Balance | $ 16,074 | |||||||||||||
Investment owned, percent of net assets | 1.30% | |||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 30,031 | [3],[4],[7] | 30,031 | [3],[4],[7] | 30,031 | [3],[4],[7] | 30,031 | [1],[2],[14] | 30,031 | [1],[2],[14] | 30,031 | [1],[2],[14] | ||
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [1],[2],[14] | 4,946 | ||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | (2,235) | |||||||||||||
Fair Value, Ending Balance | [3],[4],[7] | $ 2,711 | ||||||||||||
Investment owned, percent of net assets | 0.20% | 0.20% | 0.20% | |||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | [3],[4],[7],[9],[11] | 5% | [3],[4],[7],[9],[11] | 5% | [3],[4],[7],[9],[11] | 5% | [1],[2],[14],[16],[19] | 5% | [1],[2],[14],[16],[19] | 5% | [1],[2],[14],[16],[19] | ||
Investment, interest rate | [3],[4],[7],[8],[9],[11] | 10.24% | 10.24% | 10.24% | ||||||||||
Investment owned, balance, principal amount | $ 3,484 | [3],[4],[7],[9],[11],[13] | $ 0 | [1],[2],[14],[16],[18],[19] | ||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 136 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [1],[2],[14],[16],[19] | 0 | ||||||||||||
Gross Additions | 3,484 | |||||||||||||
Gross Reductions | 0 | |||||||||||||
Fair Value, Ending Balance | [3],[4],[7],[9],[11] | $ 3,484 | ||||||||||||
Investment owned, percent of net assets | 0.20% | 0.20% | 0.20% | |||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [1],[2],[14],[16] | 5% | 5% | 5% | ||||||||||
Investment, interest rate | [1],[2],[14],[16],[17] | 8.68% | 8.68% | 8.68% | ||||||||||
Investment owned, balance, principal amount | [1],[2],[14],[16],[18] | $ 14,333 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [1],[2],[14],[16] | $ 14,333 | ||||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [3],[4],[7],[11] | 5% | 5% | 5% | ||||||||||
Investment, interest rate | [3],[4],[7],[8],[11] | 10.39% | 10.39% | 10.39% | ||||||||||
Investment owned, balance, principal amount | [3],[4],[7],[11],[13] | $ 14,102 | ||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 1,070 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 14,333 | |||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | (231) | |||||||||||||
Fair Value, Ending Balance | [3],[4],[7],[11] | $ 14,102 | ||||||||||||
Investment owned, percent of net assets | 0.90% | 0.90% | 0.90% | |||||||||||
Investment, Identifier [Axis]: Dominion Diagnostics, LLC, Health Care Services, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [3],[4],[7],[11] | 5% | 5% | 5% | ||||||||||
Investment owned, balance, principal amount | [3],[4],[7],[9],[11],[13] | $ 0 | ||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 0 | |||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | 0 | |||||||||||||
Fair Value, Ending Balance | [3],[4],[7],[9],[11] | $ 0 | ||||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | |||||||||||
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 12,500 | [7],[10] | 12,500 | [7],[10] | 12,500 | [7],[10] | 12,500 | [14],[15] | 12,500 | [14],[15] | 12,500 | [14],[15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 0 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: EOS Fitness Opco Holdings, LLC, Leisure Facilities, Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 488 | [7],[10] | 488 | [7],[10] | 488 | [7],[10] | 488 | [14],[15] | 488 | [14],[15] | 488 | [14],[15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 966 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 1,160 | ||||||||||||
Investment, Identifier [Axis]: Eagleview Technology Corporation, Application Software, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[10],[11] | 7.50% | [7],[10],[11] | 7.50% | [7],[10],[11] | 7.50% | [14],[15],[16] | 7.50% | [14],[15],[16] | 7.50% | [14],[15],[16] | ||
Investment, interest rate | 13.04% | [7],[8],[10],[11] | 13.04% | [7],[8],[10],[11] | 13.04% | [7],[8],[10],[11] | 11.17% | [14],[15],[16],[17] | 11.17% | [14],[15],[16],[17] | 11.17% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 8,974 | [7],[10],[11],[13] | $ 8,974 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 8,503 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 7,359 | ||||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 3% | [7],[8],[10],[11],[20] | 3% | [7],[8],[10],[11],[20] | 3% | [7],[8],[10],[11],[20] | 3% | [14],[15],[16],[17],[22] | 3% | [14],[15],[16],[17],[22] | 3% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | $ 10,899 | [7],[10],[13],[20] | $ 10,418 | [14],[15],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | 10,231 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 10,463 | ||||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 3% | [7],[8],[10],[11],[20] | 3% | [7],[8],[10],[11],[20] | 3% | [7],[8],[10],[11],[20] | 3% | [14],[15],[16],[17],[19],[22] | 3% | [14],[15],[16],[17],[19],[22] | 3% | [14],[15],[16],[17],[19],[22] | ||
Investment owned, balance, principal amount | $ 1,746 | [7],[10],[13],[20] | $ 0 | [14],[15],[18],[19],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[19],[22] | 0 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 1,676 | ||||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[9],[10],[11],[20] | 3% | 3% | 3% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[13],[20] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[20] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., Health Care Technology, First Lien Term Loan 4 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[9],[10],[11],[20] | 3% | 3% | 3% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[13],[20] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[20] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: FINThrive Software Intermediate Holdings, Inc., Health Care Technology, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.75% | [10],[11] | 6.75% | [10],[11] | 6.75% | [10],[11] | 6.75% | [15],[16] | 6.75% | [15],[16] | 6.75% | [15],[16] | ||
Investment, interest rate | 11.94% | [8],[10],[11] | 11.94% | [8],[10],[11] | 11.94% | [8],[10],[11] | 9.87% | [15],[16],[17] | 9.87% | [15],[16],[17] | 9.87% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 31,074 | [10],[11],[13] | $ 25,061 | [15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 21,646 | ||||||||||||
Fair Value, Ending Balance | [10],[11] | $ 18,664 | ||||||||||||
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 9% | [7],[8],[9],[10],[11] | 9% | [7],[8],[9],[10],[11] | 9% | [7],[8],[9],[10],[11] | 9% | [14],[15],[16],[17],[27] | 9% | [14],[15],[16],[17],[27] | 9% | [14],[15],[16],[17],[27] | ||
Investment owned, balance, principal amount | $ 52,658 | [7],[9],[10],[13] | $ 27,850 | [14],[15],[18],[27] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[27] | 27,850 | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10] | $ 52,658 | ||||||||||||
Investment, Identifier [Axis]: Fairbridge Strategic Capital Funding LLC, Real Estate Operating Companies, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 2,500 | [7],[10],[20] | 2,500 | [7],[10],[20] | 2,500 | [7],[10],[20] | 2,500 | [14],[15],[22],[27] | 2,500 | [14],[15],[22],[27] | 2,500 | [14],[15],[22],[27] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22],[27] | $ 3 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 3 | ||||||||||||
Investment, Identifier [Axis]: First Star Speir Aviation Limited, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 9% | |||||||||||||
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | 7,500 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 7,500 | |||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | (7,500) | |||||||||||||
Fair Value, Ending Balance | $ 0 | |||||||||||||
Investment owned, percent of net assets | 0% | |||||||||||||
Investment, Identifier [Axis]: First Star Speir Aviation Limited, Membership Interest | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, ownership percentage | 100% | |||||||||||||
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | (5,632) | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 158 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 698 | |||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | (698) | |||||||||||||
Fair Value, Ending Balance | $ 0 | |||||||||||||
Investment owned, percent of net assets | 0% | |||||||||||||
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 11% | [7],[8],[10],[11],[20] | 11% | [7],[8],[10],[11],[20] | 11% | [7],[8],[10],[11],[20] | 11% | [14],[15],[16],[17],[22] | 11% | [14],[15],[16],[17],[22] | 11% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | $ 11,918 | [7],[10],[13],[20] | $ 9,466 | [14],[15],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | 9,008 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 11,173 | ||||||||||||
Investment, Identifier [Axis]: Fortress Biotech, Inc., Biotechnology, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 417,011 | [7],[10],[20] | 417,011 | [7],[10],[20] | 417,011 | [7],[10],[20] | 331,200 | [14],[15],[22] | 331,200 | [14],[15],[22] | 331,200 | [14],[15],[22] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | $ 66 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 113 | ||||||||||||
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Integrated Telecommunication Services, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 6% | [8],[10],[11],[20] | 6% | [8],[10],[11],[20] | 6% | [8],[10],[11],[20] | 6% | [15],[16],[17],[22] | 6% | [15],[16],[17],[22] | 6% | [15],[16],[17],[22] | ||
Investment owned, balance, principal amount | $ 4,881 | [10],[13],[20] | $ 4,881 | [15],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[22] | 3,845 | ||||||||||||
Fair Value, Ending Balance | [10],[20] | 3,595 | ||||||||||||
Investment, Identifier [Axis]: GKD Index Partners, LLC, Specialized Finance, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16],[19] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [14],[15],[16],[17],[19] | 10.60% | 10.60% | 10.60% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18],[19] | $ 1,280 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | 1,262 | ||||||||||||
Investment, Identifier [Axis]: GKD Index Partners, LLC, Specialized Finance, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 10.67% | 10.67% | 10.67% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 25,128 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 24,851 | ||||||||||||
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11] | 7.25% | 7.25% | 7.25% | ||||||||||
Investment, interest rate | [7],[8],[9],[10],[11] | 12.34% | 12.34% | 12.34% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13] | $ 1,638 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ 1,532 | ||||||||||||
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 7.25% | 7.25% | 7.25% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12.34% | 12.34% | 12.34% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 23,774 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 23,094 | ||||||||||||
Investment, Identifier [Axis]: Gibson Brands, Inc., Leisure Products, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 5% | 5% | 5% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 10.25% | 10.25% | 10.25% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 2,463 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | 1,995 | ||||||||||||
Investment, Identifier [Axis]: Global Medical Response, Inc., Health Care Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [15],[16] | 4.25% | 4.25% | 4.25% | ||||||||||
Investment, interest rate | [15],[16],[17] | 7.37% | 7.37% | 7.37% | ||||||||||
Investment owned, balance, principal amount | [15],[16],[18] | $ 5,572 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | $ 4,848 | ||||||||||||
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, Multi-Sector Holdings, CLO Notes | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [10],[11],[20] | 2.85% | 2.85% | 2.85% | ||||||||||
Investment, interest rate | [8],[10],[11],[20] | 6.05% | 6.05% | 6.05% | ||||||||||
Investment owned, balance, principal amount | € | [10],[11],[13],[20] | € 1,000 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [10],[11],[20] | $ 970 | ||||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[9],[10],[11] | 8% | [7],[9],[10],[11] | 8% | [7],[9],[10],[11] | 8% | [14],[15],[16],[19] | 8% | [14],[15],[16],[19] | 8% | [14],[15],[16],[19] | ||
Investment owned, balance, principal amount | $ 0 | [7],[9],[10],[11],[13] | $ 0 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | (25) | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ (18) | ||||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[10],[11] | 8% | [7],[10],[11] | 8% | [7],[10],[11] | 8% | [14],[15],[16] | 8% | [14],[15],[16] | 8% | [14],[15],[16] | ||
Investment, interest rate | 13.39% | [7],[8],[10],[11] | 13.39% | [7],[8],[10],[11] | 13.39% | [7],[8],[10],[11] | 11.04% | [14],[15],[16],[17] | 11.04% | [14],[15],[16],[17] | 11.04% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 17,488 | [7],[10],[11],[13] | $ 14,311 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 14,060 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 17,314 | ||||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, Hotels, Resorts & Cruise Lines, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[9],[10],[11] | 8% | [7],[9],[10],[11] | 8% | [7],[9],[10],[11] | 8% | [14],[15],[16],[19] | 8% | [14],[15],[16],[19] | 8% | [14],[15],[16],[19] | ||
Investment owned, balance, principal amount | $ 0 | [7],[9],[10],[11],[13] | $ 0 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | (50) | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ (35) | ||||||||||||
Investment, Identifier [Axis]: Harbor Purchaser Inc., Education Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.25% | [10],[11] | 5.25% | [10],[11] | 5.25% | [10],[11] | 5.25% | [15],[16] | 5.25% | [15],[16] | 5.25% | [15],[16] | ||
Investment, interest rate | 10.45% | [8],[10],[11] | 10.45% | [8],[10],[11] | 10.45% | [8],[10],[11] | 8.38% | [15],[16],[17] | 8.38% | [15],[16],[17] | 8.38% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 14,383 | [10],[11],[13] | $ 9,392 | [15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 8,582 | ||||||||||||
Fair Value, Ending Balance | [10],[11] | $ 12,352 | ||||||||||||
Investment, Identifier [Axis]: Harrow Health, Inc., Pharmaceuticals, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11],[20] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11],[20] | 11.74% | 11.74% | 11.74% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13],[20] | $ 7,448 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 7,295 | ||||||||||||
Investment, Identifier [Axis]: Harrow Health, Inc., Pharmaceuticals, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11],[20] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13],[20] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11],[20] | $ (83) | ||||||||||||
Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., Specialized Finance, CLO Notes | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [8],[10],[11],[20] | 4.46% | 4.46% | 4.46% | ||||||||||
Investment owned, balance, principal amount | [10],[13],[20] | $ 6,932 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [10],[20] | $ 6,001 | ||||||||||||
Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11],[20] | 8.25% | 8.25% | 8.25% | ||||||||||
Investment, interest rate | [7],[8],[10],[11],[20] | 13.30% | 13.30% | 13.30% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13],[20] | $ 23,975 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 23,292 | ||||||||||||
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Care Products, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 5.75% | 5.75% | 5.75% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 11.29% | 11.29% | 11.29% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 45,169 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | 35,834 | ||||||||||||
Investment, Identifier [Axis]: INW Manufacturing, LLC, Personal Products, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 5.75% | 5.75% | 5.75% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 9.42% | 9.42% | 9.42% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 35,625 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 31,528 | ||||||||||||
Investment, Identifier [Axis]: IPC Corp., Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[10],[11] | 6.50% | [7],[10],[11] | 6.50% | [7],[10],[11] | 6.50% | [14],[15],[16] | 6.50% | [14],[15],[16] | 6.50% | [14],[15],[16] | ||
Investment, interest rate | 11.57% | [7],[8],[10],[11] | 11.57% | [7],[8],[10],[11] | 11.57% | [7],[8],[10],[11] | 9.44% | [14],[15],[16],[17] | 9.44% | [14],[15],[16],[17] | 9.44% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 40,484 | [7],[10],[11],[13] | $ 34,357 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 32,639 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | 38,662 | ||||||||||||
Investment, Identifier [Axis]: Immucor, Inc., Health Care Supplies, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 5.75% | 5.75% | 5.75% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 9.42% | 9.42% | 9.42% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 8,569 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 8,407 | ||||||||||||
Investment, Identifier [Axis]: Immucor, Inc., Health Care Supplies, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 8% | 8% | 8% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 11.67% | 11.67% | 11.67% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 22,619 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 22,275 | ||||||||||||
Investment, Identifier [Axis]: Impel Neuropharma, Inc., Health Care Technology, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance, principal amount | 15,302 | [7],[10],[13],[21] | $ 13,083 | [14],[15],[18],[26] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[26] | 13,083 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[21] | $ 14,269 | ||||||||||||
Investment, Identifier [Axis]: Impel Neuropharma, Inc., Health Care Technology, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.75% | [7],[10],[11] | 8.75% | [7],[10],[11] | 8.75% | [7],[10],[11] | 8.75% | [14],[15],[16] | 8.75% | [14],[15],[16] | 8.75% | [14],[15],[16] | ||
Investment, interest rate | 14.14% | [7],[8],[10],[11] | 14.14% | [7],[8],[10],[11] | 14.14% | [7],[8],[10],[11] | 12.45% | [14],[15],[16],[17] | 12.45% | [14],[15],[16],[17] | 12.45% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 13,109 | [7],[10],[11],[13] | $ 12,161 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 11,942 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 12,617 | ||||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 11% | [7],[8],[10],[11],[20] | 11% | [7],[8],[10],[11],[20] | 11% | [7],[8],[10],[11],[20] | 11% | [14],[15],[16],[17],[22] | 11% | [14],[15],[16],[17],[22] | 11% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | $ 8,452 | [7],[10],[13],[20] | $ 6,817 | [14],[15],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | 6,408 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 7,730 | ||||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 11% | [7],[8],[9],[10],[11],[20] | 11% | [7],[8],[9],[10],[11],[20] | 11% | [7],[8],[9],[10],[11],[20] | 11% | [14],[15],[16],[17],[19],[22] | 11% | [14],[15],[16],[17],[19],[22] | 11% | [14],[15],[16],[17],[19],[22] | ||
Investment owned, balance, principal amount | $ 0 | [7],[9],[10],[13],[20] | $ 0 | [14],[15],[18],[19],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[19],[22] | 0 | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[20] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[9],[10],[11],[20] | 11% | 11% | 11% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[13],[20] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[20] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Health Care Technology, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 112,990 | [7],[10],[20] | 112,990 | [7],[10],[20] | 112,990 | [7],[10],[20] | 56,999 | [14],[15],[22] | 56,999 | [14],[15],[22] | 56,999 | [14],[15],[22] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | $ 609 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 172 | ||||||||||||
Investment, Identifier [Axis]: Integral Development Corporation, Diversified Financial Services, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [7],[10] | 1,078,284 | 1,078,284 | 1,078,284 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Integral Development Corporation, Other Diversified Financial Services, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [14],[15] | 1,078,284 | 1,078,284 | 1,078,284 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11] | 7.50% | 7.50% | 7.50% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ (114) | ||||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[10],[11] | 7.50% | [7],[10],[11] | 7.50% | [7],[10],[11] | 5% | [14],[15],[16] | 5% | [14],[15],[16] | 5% | [14],[15],[16] | ||
Investment, interest rate | 12.72% | [7],[8],[10],[11] | 12.72% | [7],[8],[10],[11] | 12.72% | [7],[8],[10],[11] | 8.55% | [14],[15],[16],[17] | 8.55% | [14],[15],[16],[17] | 8.55% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 33,498 | [7],[10],[11],[13] | $ 18,660 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 18,134 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | 32,493 | ||||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 8.50% | 8.50% | 8.50% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 12.17% | 12.17% | 12.17% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 13,674 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 13,154 | ||||||||||||
Investment, Identifier [Axis]: Ivanti Software, Inc., Application Software, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [10],[11] | 7.25% | [10],[11] | 7.25% | [10],[11] | 7.25% | [15],[16] | 7.25% | [15],[16] | 7.25% | [15],[16] | ||
Investment, interest rate | 12.42% | [8],[10],[11] | 12.42% | [8],[10],[11] | 12.42% | [8],[10],[11] | 10.33% | [15],[16],[17] | 10.33% | [15],[16],[17] | 10.33% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 13,939 | [10],[11],[13] | $ 10,247 | [15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 7,702 | ||||||||||||
Fair Value, Ending Balance | [10],[11] | 9,252 | ||||||||||||
Investment, Identifier [Axis]: JP Morgan Prime Money Market Fund, Institutional Shares | ||||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | 5,193 | |||||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 7.50% | 7.50% | 7.50% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 10.62% | 10.62% | 10.62% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 36,234 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 36,392 | ||||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 7.50% | 7.50% | 7.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12.70% | 12.70% | 12.70% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 17,069 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 16,966 | ||||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 7.50% | 7.50% | 7.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12.70% | 12.70% | 12.70% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 27,360 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 27,488 | ||||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 10.60% | 10.60% | 10.60% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 15,150 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 14,924 | ||||||||||||
Investment, Identifier [Axis]: Jazz Acquisition, Inc., Aerospace & Defense, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8% | [10],[11] | 8% | [10],[11] | 8% | [10],[11] | 8% | [15],[16] | 8% | [15],[16] | 8% | [15],[16] | ||
Investment, interest rate | 13.20% | [8],[10],[11] | 13.20% | [8],[10],[11] | 13.20% | [8],[10],[11] | 11.12% | [15],[16],[17] | 11.12% | [15],[16],[17] | 11.12% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 666 | [10],[11],[13] | $ 528 | [15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 481 | ||||||||||||
Fair Value, Ending Balance | [10],[11] | $ 652 | ||||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[9],[10],[11] | 6.50% | [7],[9],[10],[11] | 6.50% | [7],[9],[10],[11] | 6.50% | [14],[15],[16],[19] | 6.50% | [14],[15],[16],[19] | 6.50% | [14],[15],[16],[19] | ||
Investment, interest rate | 11.84% | [7],[8],[9],[10],[11] | 11.84% | [7],[8],[9],[10],[11] | 11.84% | [7],[8],[9],[10],[11] | 10.17% | [14],[15],[16],[17],[19] | 10.17% | [14],[15],[16],[17],[19] | 10.17% | [14],[15],[16],[17],[19] | ||
Investment owned, balance, principal amount | $ 545 | [7],[9],[10],[11],[13] | $ 329 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | 292 | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ 510 | ||||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, Environmental & Facilities Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[10],[11] | 6.50% | [7],[10],[11] | 6.50% | [7],[10],[11] | 6.50% | [14],[15],[16] | 6.50% | [14],[15],[16] | 6.50% | [14],[15],[16] | ||
Investment, interest rate | 11.84% | [7],[8],[10],[11] | 11.84% | [7],[8],[10],[11] | 11.84% | [7],[8],[10],[11] | 10.17% | [14],[15],[16],[17] | 10.17% | [14],[15],[16],[17] | 10.17% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 16,765 | [7],[10],[11],[13] | $ 13,623 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 13,351 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 16,511 | ||||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[9],[10],[11] | 6% | [7],[9],[10],[11] | 6% | [7],[9],[10],[11] | 6% | [14],[15],[16],[19] | 6% | [14],[15],[16],[19] | 6% | [14],[15],[16],[19] | ||
Investment, interest rate | [14],[15],[16],[17],[19] | 9.12% | 9.12% | 9.12% | ||||||||||
Investment owned, balance, principal amount | $ 0 | [7],[9],[10],[11],[13] | $ 1,710 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | 1,651 | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | (146) | ||||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 6% | 6% | 6% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 9.12% | 9.12% | 9.12% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 19,236 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 18,707 | ||||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 6% | 6% | 6% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 11.20% | 11.20% | 11.20% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 2,742 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 2,592 | ||||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, Health Care Distributors, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 6% | 6% | 6% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 11.20% | 11.20% | 11.20% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 23,554 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 22,258 | ||||||||||||
Investment, Identifier [Axis]: LTI Holdings, Inc., Electronic Components, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.75% | [10],[11] | 6.75% | [10],[11] | 6.75% | [10],[11] | 6.75% | [15],[16] | 6.75% | [15],[16] | 6.75% | [15],[16] | ||
Investment, interest rate | 11.97% | [8],[10],[11] | 11.97% | [8],[10],[11] | 11.97% | [8],[10],[11] | 9.87% | [15],[16],[17] | 9.87% | [15],[16],[17] | 9.87% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 2,140 | [10],[11],[13] | $ 2,140 | [15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 1,890 | ||||||||||||
Fair Value, Ending Balance | [10],[11] | 1,834 | ||||||||||||
Investment, Identifier [Axis]: LaserShip, Inc., Air Freight & Logistics, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 7.50% | 7.50% | 7.50% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 10.38% | 10.38% | 10.38% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 2,394 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 1,867 | ||||||||||||
Investment, Identifier [Axis]: Latam Airlines Group S.A., Passenger Airlines, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [10],[11],[20] | 9.50% | 9.50% | 9.50% | ||||||||||
Investment, interest rate | [8],[10],[11],[20] | 14.61% | 14.61% | 14.61% | ||||||||||
Investment owned, balance, principal amount | [10],[11],[13],[20] | $ 26,489 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [10],[11],[20] | $ 26,985 | ||||||||||||
Investment, Identifier [Axis]: Lift Brands Holdings, Inc., Leisure Facilities, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 2,000,000 | [7],[10] | 2,000,000 | [7],[10] | 2,000,000 | [7],[10] | 2,000,000 | [14],[15] | 2,000,000 | [14],[15] | 2,000,000 | [14],[15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 0 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Lightbox Intermediate, L.P., Real Estate Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | [7],[10],[11] | 5% | [7],[10],[11] | 5% | [7],[10],[11] | 5% | [14],[15],[16] | 5% | [14],[15],[16] | 5% | [14],[15],[16] | ||
Investment, interest rate | 10.50% | [7],[8],[10],[11] | 10.50% | [7],[8],[10],[11] | 10.50% | [7],[8],[10],[11] | 8.67% | [14],[15],[16],[17] | 8.67% | [14],[15],[16],[17] | 8.67% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 45,361 | [7],[10],[11],[13] | $ 41,008 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 39,573 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 44,227 | ||||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 559 | [7],[10] | 559 | [7],[10] | 559 | [7],[10] | 451 | [14],[15] | 451 | [14],[15] | 451 | [14],[15] | ||
Investment owned, balance, principal amount | [7],[10],[13] | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 451 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 487 | ||||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[10],[11] | 8.50% | [7],[10],[11] | 8.50% | [7],[10],[11] | 8.50% | [14],[15],[16] | 8.50% | [14],[15],[16] | 8.50% | [14],[15],[16] | ||
Investment, interest rate | 13.84% | [7],[8],[10],[11] | 13.84% | [7],[8],[10],[11] | 13.84% | [7],[8],[10],[11] | 11.38% | [14],[15],[16],[17] | 11.38% | [14],[15],[16],[17] | 11.38% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 5,403 | [7],[10],[11],[13] | $ 4,357 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 4,226 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 5,173 | ||||||||||||
Investment, Identifier [Axis]: Liquid Environmental Solutions Corporation, Environmental & Facilities Services, Second Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[9],[10],[11] | 8.50% | [7],[9],[10],[11] | 8.50% | [7],[9],[10],[11] | 8.50% | [14],[15],[16],[19] | 8.50% | [14],[15],[16],[19] | 8.50% | [14],[15],[16],[19] | ||
Investment, interest rate | 13.84% | [7],[8],[9],[10],[11] | 13.84% | [7],[8],[9],[10],[11] | 13.84% | [7],[8],[9],[10],[11] | 11.38% | [14],[15],[16],[17],[19] | 11.38% | [14],[15],[16],[17],[19] | 11.38% | [14],[15],[16],[17],[19] | ||
Investment owned, balance, principal amount | $ 2,939 | [7],[9],[10],[11],[13] | $ 2,370 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | 2,265 | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ 2,755 | ||||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[9],[10],[11] | 6% | [7],[9],[10],[11] | 6% | [7],[9],[10],[11] | 6% | [14],[15],[16],[19] | 6% | [14],[15],[16],[19] | 6% | [14],[15],[16],[19] | ||
Investment, interest rate | [7],[8],[9],[10],[11] | 11.25% | 11.25% | 11.25% | ||||||||||
Investment owned, balance, principal amount | $ 250 | [7],[9],[10],[11],[13] | $ 0 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | (54) | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | 203 | ||||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 6% | 6% | 6% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 9.50% | 9.50% | 9.50% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 18,390 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 17,691 | ||||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 6% | 6% | 6% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 11.20% | 11.20% | 11.20% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 20,176 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 19,648 | ||||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, Diversified Support Services, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 6% | 6% | 6% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 11.20% | 11.20% | 11.20% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 2,637 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 2,568 | ||||||||||||
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11] | 7.50% | 7.50% | 7.50% | ||||||||||
Investment, interest rate | [7],[8],[9],[10],[11] | 12.58% | 12.58% | 12.58% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13] | $ 2,118 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ 1,853 | ||||||||||||
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 7.50% | 7.50% | 7.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12.74% | 12.74% | 12.74% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 40,640 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 39,937 | ||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.50% | [7],[9],[10],[11] | 5.50% | [7],[9],[10],[11] | 5.50% | [7],[9],[10],[11] | 5.50% | [14],[15],[16],[19] | 5.50% | [14],[15],[16],[19] | 5.50% | [14],[15],[16],[19] | ||
Investment owned, balance, principal amount | $ 0 | [7],[9],[10],[11],[13] | $ 0 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | (51) | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ (62) | ||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.50% | [7],[10],[11] | 5.50% | [7],[10],[11] | 5.50% | [7],[10],[11] | 5.50% | [14],[15],[16] | 5.50% | [14],[15],[16] | 5.50% | [14],[15],[16] | ||
Investment, interest rate | 10.84% | [7],[8],[10],[11] | 10.84% | [7],[8],[10],[11] | 10.84% | [7],[8],[10],[11] | 9.17% | [14],[15],[16],[17] | 9.17% | [14],[15],[16],[17] | 9.17% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 12,397 | [7],[10],[11],[13] | $ 29,565 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 28,734 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 12,056 | ||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.50% | [7],[10],[11] | 5.50% | [7],[10],[11] | 5.50% | [7],[10],[11] | 5.50% | [14],[15],[16],[19] | 5.50% | [14],[15],[16],[19] | 5.50% | [14],[15],[16],[19] | ||
Investment, interest rate | [7],[8],[10],[11] | 10.84% | 10.84% | 10.84% | ||||||||||
Investment owned, balance, principal amount | $ 21,383 | [7],[10],[11],[13] | $ 0 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | (96) | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 20,795 | ||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment, interest rate | [7],[8],[9],[10],[11] | 10.83% | 10.83% | 10.83% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13] | $ 570 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ 526 | ||||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 11.50% | [7],[8],[10],[11],[20] | 11.50% | [7],[8],[10],[11],[20] | 11.50% | [7],[8],[10],[11],[20] | 11.50% | [14],[15],[16],[17],[22] | 11.50% | [14],[15],[16],[17],[22] | 11.50% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | $ 8,568 | [7],[10],[13],[20] | $ 17,203 | [14],[15],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | 16,644 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 8,225 | ||||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 11.50% | [7],[8],[10],[11],[20] | 11.50% | [7],[8],[10],[11],[20] | 11.50% | [7],[8],[10],[11],[20] | 11.50% | [14],[15],[16],[17],[19],[22] | 11.50% | [14],[15],[16],[17],[19],[22] | 11.50% | [14],[15],[16],[17],[19],[22] | ||
Investment owned, balance, principal amount | $ 4,284 | [7],[10],[13],[20] | $ 0 | [14],[15],[18],[19],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[19],[22] | 0 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 4,112 | ||||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[10],[11],[20] | 11.50% | 11.50% | 11.50% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[13],[20] | $ 8,568 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 8,225 | ||||||||||||
Investment, Identifier [Axis]: Marinus Pharmaceuticals, Inc., Pharmaceuticals, First Lien Term Loan 4 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[10],[11],[20] | 11.50% | 11.50% | 11.50% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[13],[20] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[20] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 8% | [7],[8],[10],[11],[20] | 8% | [7],[8],[10],[11],[20] | 8% | [7],[8],[10],[11],[20] | 8% | [14],[15],[16],[17],[22] | 8% | [14],[15],[16],[17],[22] | 8% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | $ 9,066 | [7],[10],[13],[20] | $ 7,215 | [14],[15],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | 6,440 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 8,114 | ||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 8% | [7],[8],[10],[11],[20] | 8% | [7],[8],[10],[11],[20] | 8% | [7],[8],[10],[11],[20] | 8% | [14],[15],[16],[17],[19],[22] | 8% | [14],[15],[16],[17],[19],[22] | 8% | [14],[15],[16],[17],[19],[22] | ||
Investment owned, balance, principal amount | $ 0 | [7],[9],[10],[13],[20] | $ 0 | [14],[15],[18],[19],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[19],[22] | 0 | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[20] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[10],[11],[20] | 8% | 8% | 8% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[13],[20] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[20] | 0 | ||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [14],[15],[22] | 209,588 | 209,588 | 209,588 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | $ 170 | ||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [7],[10],[20] | 259,877 | 259,877 | 259,877 | ||||||||||
Investment owned, balance, principal amount | [7],[10],[13],[20] | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 437 | ||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Biotechnology, Warrants 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [7],[10],[20] | 66,817 | 66,817 | 66,817 | ||||||||||
Investment owned, balance, principal amount | [7],[10],[13],[20] | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 153 | ||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[9],[10],[11] | 7% | [7],[9],[10],[11] | 7% | [7],[9],[10],[11] | 8% | [14],[15],[16],[19] | 8% | [14],[15],[16],[19] | 8% | [14],[15],[16],[19] | ||
Investment owned, balance, principal amount | $ 0 | [7],[9],[10],[11],[13] | $ 0 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | (100) | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | (71) | ||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 10.64% | 10.64% | 10.64% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 45,665 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 44,523 | ||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12.19% | 12.19% | 12.19% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 7,464 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 7,352 | ||||||||||||
Investment, Identifier [Axis]: Mindbody, Inc., Internet Services & Infrastructure, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12.19% | 12.19% | 12.19% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 46,687 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 45,987 | ||||||||||||
Investment, Identifier [Axis]: Mosaic Companies, LLC, Home Improvement Retail, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.75% | [7],[10],[11] | 6.75% | [7],[10],[11] | 6.75% | [7],[10],[11] | 6.75% | [14],[15],[16] | 6.75% | [14],[15],[16] | 6.75% | [14],[15],[16] | ||
Investment, interest rate | 11.97% | [7],[8],[10],[11] | 11.97% | [7],[8],[10],[11] | 11.97% | [7],[8],[10],[11] | 9.89% | [14],[15],[16],[17] | 9.89% | [14],[15],[16],[17] | 9.89% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 55,297 | [7],[10],[11],[13] | $ 46,499 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 45,421 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 54,235 | ||||||||||||
Investment, Identifier [Axis]: NFP Corp., Diversified Financial Services, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [8],[10],[11] | 6.88% | 6.88% | 6.88% | ||||||||||
Investment owned, balance, principal amount | [10],[13] | $ 10,191 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [10] | 8,860 | ||||||||||||
Investment, Identifier [Axis]: NFP Corp., Other Diversified Financial Services, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [15],[16],[17] | 6.88% | 6.88% | 6.88% | ||||||||||
Investment owned, balance, principal amount | [15],[18] | $ 10,191 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 7,966 | ||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11],[20] | 6.88% | 6.88% | 6.88% | ||||||||||
Investment, interest rate | [7],[8],[10],[11],[20] | 12.08% | 12.08% | 12.08% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13],[20] | $ 73,178 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 69,885 | ||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 487,870 | 487,870 | 487,870 | |||||||||||
Investment owned, balance, principal amount | € | [7],[10],[11],[13],[20] | € 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 1,161 | ||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery & Supplies & Components, Warrants 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 487,870 | 487,870 | 487,870 | |||||||||||
Investment owned, balance, principal amount | € | [10],[11],[13],[20] | € 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [10],[11],[20] | $ 1,161 | ||||||||||||
Investment, Identifier [Axis]: NN, Inc., Industrial Machinery, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16],[22] | 6.88% | 6.88% | 6.88% | ||||||||||
Investment, interest rate | [14],[15],[16],[17],[22] | 9.99% | 9.99% | 9.99% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18],[22] | $ 58,713 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[22] | $ 56,805 | ||||||||||||
Investment, Identifier [Axis]: Navisite, LLC, Data Processing & Outsourced Services, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[10],[11] | 8.50% | [7],[10],[11] | 8.50% | [7],[10],[11] | 8.50% | [14],[15],[16] | 8.50% | [14],[15],[16] | 8.50% | [14],[15],[16] | ||
Investment, interest rate | 14.04% | [7],[8],[10],[11] | 14.04% | [7],[8],[10],[11] | 14.04% | [7],[8],[10],[11] | 12.17% | [14],[15],[16],[17] | 12.17% | [14],[15],[16],[17] | 12.17% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 30,339 | [7],[10],[11],[13] | $ 22,560 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 21,524 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 29,125 | ||||||||||||
Investment, Identifier [Axis]: NeuAG, LLC, Fertilizers & Agricultural Chemicals, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 10.50% | [7],[10],[11] | 10.50% | [7],[10],[11] | 10.50% | [7],[10],[11] | 10.50% | [14],[15],[16] | 10.50% | [14],[15],[16] | 10.50% | [14],[15],[16] | ||
Investment, interest rate | 16.04% | [7],[8],[10],[11] | 16.04% | [7],[8],[10],[11] | 16.04% | [7],[8],[10],[11] | 14.17% | [14],[15],[16],[17] | 14.17% | [14],[15],[16],[17] | 14.17% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 64,606 | [7],[10],[11],[13] | $ 50,459 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 51,972 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 63,185 | ||||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Membership Interest | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, ownership percentage | 87.50% | |||||||||||||
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 0 | |||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | 0 | |||||||||||||
Fair Value, Ending Balance | $ 0 | |||||||||||||
Investment owned, percent of net assets | 0% | |||||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Membership Interest | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [1],[2],[19],[22],[28],[29] | 0.875 | 0.875 | 0.875 | ||||||||||
Investment owned, ownership percentage | [3],[4],[9],[20],[30],[31] | 87.50% | 87.50% | 87.50% | ||||||||||
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 0 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [1],[2],[19],[22],[28],[29] | 0 | ||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | 0 | |||||||||||||
Fair Value, Ending Balance | [3],[4],[9],[20],[30],[31] | $ 0 | ||||||||||||
Investment owned, percent of net assets | 0% | 0% | 0% | |||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Multi-Sector Holdings, Subordinated Debt | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 4.50% | [3],[4],[7],[9],[11],[20],[30] | 4.50% | [3],[4],[7],[9],[11],[20],[30] | 4.50% | [3],[4],[7],[9],[11],[20],[30] | 4.50% | [1],[2],[14],[16],[19],[22],[28] | 4.50% | [1],[2],[14],[16],[19],[22],[28] | 4.50% | [1],[2],[14],[16],[19],[22],[28] | ||
Investment, interest rate | 9.36% | [3],[4],[7],[8],[9],[11],[20],[30] | 9.36% | [3],[4],[7],[8],[9],[11],[20],[30] | 9.36% | [3],[4],[7],[8],[9],[11],[20],[30] | 6.30% | [1],[2],[14],[16],[17],[19],[22],[28] | 6.30% | [1],[2],[14],[16],[17],[19],[22],[28] | 6.30% | [1],[2],[14],[16],[17],[19],[22],[28] | ||
Investment owned, balance, principal amount | $ 58,349 | [3],[4],[7],[9],[11],[13],[20],[30] | $ 59,662 | [1],[2],[14],[16],[18],[19],[22],[28] | ||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 4,961 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [1],[2],[14],[16],[19],[22],[28] | 50,283 | ||||||||||||
Gross Additions | 1,116 | |||||||||||||
Gross Reductions | (1,767) | |||||||||||||
Fair Value, Ending Balance | [3],[4],[7],[9],[11],[20],[30] | $ 49,632 | ||||||||||||
Investment owned, percent of net assets | 3.30% | 3.30% | 3.30% | |||||||||||
Investment, Identifier [Axis]: OCSI Glick JV LLC, Subordinated Debt | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 4.50% | |||||||||||||
Investment, interest rate | 4.94% | |||||||||||||
Investment owned, balance, principal amount | $ 60,274 | |||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 3,292 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 55,582 | |||||||||||||
Gross Additions | 1,123 | |||||||||||||
Gross Reductions | (6,099) | |||||||||||||
Fair Value, Ending Balance | $ 50,606 | |||||||||||||
Investment owned, percent of net assets | 4% | |||||||||||||
Investment, Identifier [Axis]: OEConnection LLC, Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [15],[16] | 4% | 4% | 4% | ||||||||||
Investment, interest rate | [15],[16],[17] | 7.12% | 7.12% | 7.12% | ||||||||||
Investment owned, balance, principal amount | [15],[16],[18] | $ 3,323 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | $ 3,207 | ||||||||||||
Investment, Identifier [Axis]: OEConnection LLC, Application Software, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[10],[11] | 7% | [7],[10],[11] | 7% | [7],[10],[11] | 7% | [14],[15],[16] | 7% | [14],[15],[16] | 7% | [14],[15],[16] | ||
Investment, interest rate | 12.34% | [7],[8],[10],[11] | 12.34% | [7],[8],[10],[11] | 12.34% | [7],[8],[10],[11] | 10.05% | [14],[15],[16],[17] | 10.05% | [14],[15],[16],[17] | 10.05% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 9,323 | [7],[10],[11],[13] | $ 7,519 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 7,237 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 9,090 | ||||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 10% | [7],[10],[11] | 10% | [7],[10],[11] | 10% | [7],[10],[11] | 2% | [14],[15],[16] | 2% | [14],[15],[16] | 2% | [14],[15],[16] | ||
Investment, interest rate | 15.50% | [7],[8],[10],[11] | 15.50% | [7],[8],[10],[11] | 15.50% | [7],[8],[10],[11] | 5.08% | [14],[15],[16],[17] | 5.08% | [14],[15],[16],[17] | 5.08% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 25,712 | [7],[10],[11],[13] | $ 21,557 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 21,557 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 25,712 | ||||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 10% | [7],[9],[10],[11] | 10% | [7],[9],[10],[11] | 10% | [7],[9],[10],[11] | 2% | [14],[15],[16],[19] | 2% | [14],[15],[16],[19] | 2% | [14],[15],[16],[19] | ||
Investment owned, balance, principal amount | $ 0 | [7],[9],[10],[11],[13] | $ 0 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | 0 | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: OTG Management, LLC, Airport Services, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11] | 10% | 10% | 10% | ||||||||||
Investment, interest rate | [7],[8],[9],[10],[11] | 15.39% | 15.39% | 15.39% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13] | $ 1,210 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ 1,210 | ||||||||||||
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11] | 7.75% | 7.75% | 7.75% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ (44) | ||||||||||||
Investment, Identifier [Axis]: Oranje Holdco, Inc., Systems Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 7.75% | 7.75% | 7.75% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12.79% | 12.79% | 12.79% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 15,231 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | 14,882 | ||||||||||||
Investment, Identifier [Axis]: Other cash accounts | ||||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | $ 67,467 | |||||||||||||
Investment, Identifier [Axis]: P & L Development, LLC, Pharmaceuticals, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 7.75% | [8],[10],[11] | 7.75% | [8],[10],[11] | 7.75% | [8],[10],[11] | 7.75% | [15],[16],[17] | 7.75% | [15],[16],[17] | 7.75% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 7,480 | [10],[13] | $ 7,776 | [15],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | 5,846 | ||||||||||||
Fair Value, Ending Balance | [10] | 6,090 | ||||||||||||
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16],[19] | 7% | 7% | 7% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18],[19] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | (13) | ||||||||||||
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 9.28% | 9.28% | 9.28% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 26,154 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 25,893 | ||||||||||||
Investment, Identifier [Axis]: PFNY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16],[19] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [14],[15],[16],[17],[19] | 9.25% | 9.25% | 9.25% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18],[19] | $ 2,228 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | $ 2,203 | ||||||||||||
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11] | 7% | 7% | 7% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ (57) | ||||||||||||
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., Aerospace & Defense, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12.10% | 12.10% | 12.10% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 10,923 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 10,497 | ||||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 100,000 | [7],[10] | 100,000 | [7],[10] | 100,000 | [7],[10] | 80,515 | [14],[15] | 80,515 | [14],[15] | 80,515 | [14],[15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 89 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 221 | ||||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[9],[10],[11] | 6.50% | [7],[9],[10],[11] | 6.50% | [7],[9],[10],[11] | 6.75% | [14],[15],[16],[19] | 6.75% | [14],[15],[16],[19] | 6.75% | [14],[15],[16],[19] | ||
Investment owned, balance, principal amount | $ 0 | [7],[9],[10],[11],[13] | $ 0 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | (49) | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ (26) | ||||||||||||
Investment, Identifier [Axis]: PRGX Global, Inc., Data Processing & Outsourced Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[10],[11] | 6.50% | [7],[10],[11] | 6.50% | [7],[10],[11] | 6.75% | [14],[15],[16] | 6.75% | [14],[15],[16] | 6.75% | [14],[15],[16] | ||
Investment, interest rate | 11.73% | [7],[8],[10],[11] | 11.73% | [7],[8],[10],[11] | 11.73% | [7],[8],[10],[11] | 10.42% | [14],[15],[16],[17] | 10.42% | [14],[15],[16],[17] | 10.42% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 38,521 | [7],[10],[11],[13] | $ 33,775 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 33,116 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 38,205 | ||||||||||||
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5% | [10],[11] | 5% | [10],[11] | 5% | [10],[11] | 5% | [15],[16] | 5% | [15],[16] | 5% | [15],[16] | ||
Investment, interest rate | 10.20% | [8],[10],[11] | 10.20% | [8],[10],[11] | 10.20% | [8],[10],[11] | 8.13% | [15],[16],[17] | 8.13% | [15],[16],[17] | 8.13% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 9,701 | [10],[11],[13] | $ 9,850 | [15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 9,374 | ||||||||||||
Fair Value, Ending Balance | [10],[11] | $ 9,458 | ||||||||||||
Investment, Identifier [Axis]: Performance Health Holdings, Inc., Health Care Distributors, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[10],[11] | 6% | [7],[10],[11] | 6% | [7],[10],[11] | 6% | [14],[15],[16] | 6% | [14],[15],[16] | 6% | [14],[15],[16] | ||
Investment, interest rate | 10.96% | [7],[8],[10],[11] | 10.96% | [7],[8],[10],[11] | 10.96% | [7],[8],[10],[11] | 8.88% | [14],[15],[16],[17] | 8.88% | [14],[15],[16],[17] | 8.88% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 22,375 | [7],[10],[11],[13] | $ 17,976 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 17,537 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 21,829 | ||||||||||||
Investment, Identifier [Axis]: Planview Parent, Inc., Application Software, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[10],[11] | 7.25% | [7],[10],[11] | 7.25% | [7],[10],[11] | 7.25% | [14],[15],[16] | 7.25% | [14],[15],[16] | 7.25% | [14],[15],[16] | ||
Investment, interest rate | 12.59% | [7],[8],[10],[11] | 12.59% | [7],[8],[10],[11] | 12.59% | [7],[8],[10],[11] | 10.92% | [14],[15],[16],[17] | 10.92% | [14],[15],[16],[17] | 10.92% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 36,499 | [7],[10],[11],[13] | $ 28,627 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 27,482 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 32,606 | ||||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[9],[10],[11] | 8% | [7],[9],[10],[11] | 8% | [7],[9],[10],[11] | 8% | [14],[15],[16],[19] | 8% | [14],[15],[16],[19] | 8% | [14],[15],[16],[19] | ||
Investment, interest rate | [7],[8],[9],[10],[11] | 13.04% | 13.04% | 13.04% | ||||||||||
Investment owned, balance, principal amount | $ 2,395 | [7],[9],[10],[11],[13] | $ 0 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | (111) | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ 2,218 | ||||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[10],[11] | 8% | [7],[10],[11] | 8% | [7],[10],[11] | 8% | [14],[15],[16] | 8% | [14],[15],[16] | 8% | [14],[15],[16] | ||
Investment, interest rate | 13.04% | [7],[8],[10],[11] | 13.04% | [7],[8],[10],[11] | 13.04% | [7],[8],[10],[11] | 10.68% | [14],[15],[16],[17] | 10.68% | [14],[15],[16],[17] | 10.68% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 67,244 | [7],[10],[11],[13] | $ 48,689 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 47,155 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 64,756 | ||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 7.25% | 7.25% | 7.25% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12.42% | 12.42% | 12.42% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 24,537 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 24,047 | ||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery & Supplies & Components, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 7.25% | 7.25% | 7.25% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12.42% | 12.42% | 12.42% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 2,823 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | 2,767 | ||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, Industrial Machinery, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 8.50% | 8.50% | 8.50% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 10.01% | 10.01% | 10.01% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 23,275 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 22,810 | ||||||||||||
Investment, Identifier [Axis]: Project Boost Purchaser, LLC, Application Software, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[10],[11] | 8% | [7],[10],[11] | 8% | [7],[10],[11] | 8% | [14],[15],[16] | 8% | [14],[15],[16] | 8% | [14],[15],[16] | ||
Investment, interest rate | 13.22% | [7],[8],[10],[11] | 13.22% | [7],[8],[10],[11] | 13.22% | [7],[8],[10],[11] | 11.12% | [14],[15],[16],[17] | 11.12% | [14],[15],[16],[17] | 11.12% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 6,750 | [7],[10],[11],[13] | $ 5,250 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 5,047 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 6,235 | ||||||||||||
Investment, Identifier [Axis]: Quantum Bidco Limited, Food Distributors, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.68% | [7],[10],[11],[20] | 5.68% | [7],[10],[11],[20] | 5.68% | [7],[10],[11],[20] | 6% | [14],[15],[16],[22] | 6% | [14],[15],[16],[22] | 6% | [14],[15],[16],[22] | ||
Investment, interest rate | 10.88% | [7],[8],[10],[11],[20] | 10.88% | [7],[8],[10],[11],[20] | 10.88% | [7],[8],[10],[11],[20] | 8.39% | [14],[15],[16],[17],[22] | 8.39% | [14],[15],[16],[17],[22] | 8.39% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | £ | £ 4,626 | [7],[10],[11],[13],[20] | £ 3,501 | [14],[15],[16],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[22] | $ 3,367 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 5,296 | ||||||||||||
Investment, Identifier [Axis]: QuorumLabs, Inc., Application Software, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 64,887,669 | [7],[10] | 64,887,669 | [7],[10] | 64,887,669 | [7],[10] | 64,887,669 | [14],[15] | 64,887,669 | [14],[15] | 64,887,669 | [14],[15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 0 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | 0 | ||||||||||||
Investment, Identifier [Axis]: RP Escrow Issuer LLC, Health Care Distributors, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [15],[16],[17] | 5.25% | 5.25% | 5.25% | ||||||||||
Investment owned, balance, principal amount | [15],[18] | $ 1,325 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | 1,097 | ||||||||||||
Investment, Identifier [Axis]: Radiology Partners, Inc., Health Care Distributors, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [15],[16] | 4.25% | 4.25% | 4.25% | ||||||||||
Investment, interest rate | [15],[16],[17] | 7.33% | 7.33% | 7.33% | ||||||||||
Investment owned, balance, principal amount | [15],[16],[18] | $ 3,400 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 2,880 | ||||||||||||
Investment, Identifier [Axis]: Radiology Partners, Inc., Health Care Distributors, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [15],[16],[17] | 9.25% | 9.25% | 9.25% | ||||||||||
Investment owned, balance, principal amount | [15],[18] | $ 4,755 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 3,109 | ||||||||||||
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.50% | [7],[9],[10],[11] | 6.50% | [7],[9],[10],[11] | 6.50% | [7],[9],[10],[11] | 6.50% | [14],[15],[16],[19] | 6.50% | [14],[15],[16],[19] | 6.50% | [14],[15],[16],[19] | ||
Investment owned, balance, principal amount | $ 0 | [7],[9],[10],[11],[13] | $ 0 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | (64) | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ (52) | ||||||||||||
Investment, Identifier [Axis]: Relativity ODA LLC, Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[10],[11] | 7.50% | [7],[10],[11] | 7.50% | [7],[10],[11] | 7.50% | [14],[15],[16] | 7.50% | [14],[15],[16] | 7.50% | [14],[15],[16] | ||
Investment, interest rate | [7],[8],[10],[11] | 11.70% | 11.70% | 11.70% | ||||||||||
Investment owned, balance, principal amount | $ 32,329 | [7],[10],[11],[13] | $ 24,692 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 24,101 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | 31,715 | ||||||||||||
Investment, Identifier [Axis]: Renaissance Holding Corp., Diversified Banks, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [15],[16] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [15],[16],[17] | 10.12% | 10.12% | 10.12% | ||||||||||
Investment owned, balance, principal amount | [15],[16],[18] | $ 3,542 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | $ 3,402 | ||||||||||||
Investment, Identifier [Axis]: Renaissance Holding Corp., Education Services, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [10],[11] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [8],[10],[11] | 12.19% | 12.19% | 12.19% | ||||||||||
Investment owned, balance, principal amount | [10],[11],[13] | $ 1,789 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [10],[11] | $ 1,764 | ||||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.25% | [7],[10],[11],[20] | 8.25% | [7],[10],[11],[20] | 8.25% | [7],[10],[11],[20] | 8.25% | [14],[15],[16],[22] | 8.25% | [14],[15],[16],[22] | 8.25% | [14],[15],[16],[22] | ||
Investment, interest rate | 13.75% | [7],[8],[10],[11],[20] | 13.75% | [7],[8],[10],[11],[20] | 13.75% | [7],[8],[10],[11],[20] | 11.92% | [14],[15],[16],[17],[22] | 11.92% | [14],[15],[16],[17],[22] | 11.92% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | $ 44,602 | [7],[10],[11],[13],[20] | $ 37,656 | [14],[15],[16],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[22] | 36,187 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 41,815 | ||||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.25% | [7],[10],[11],[20] | 8.25% | [7],[10],[11],[20] | 8.25% | [7],[10],[11],[20] | 8.25% | [14],[15],[16],[19],[22] | 8.25% | [14],[15],[16],[19],[22] | 8.25% | [14],[15],[16],[19],[22] | ||
Investment, interest rate | 13.75% | [7],[8],[10],[11],[20] | 13.75% | [7],[8],[10],[11],[20] | 13.75% | [7],[8],[10],[11],[20] | 11.92% | [14],[15],[16],[17],[19],[22] | 11.92% | [14],[15],[16],[17],[19],[22] | 11.92% | [14],[15],[16],[17],[19],[22] | ||
Investment owned, balance, principal amount | $ 13,495 | [7],[10],[11],[13],[20] | $ 11,393 | [14],[15],[16],[18],[19],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19],[22] | 10,760 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 12,651 | ||||||||||||
Investment, Identifier [Axis]: RumbleOn, Inc., Automotive Retail, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 204,454 | [7],[10],[20] | 204,454 | [7],[10],[20] | 204,454 | [7],[10],[20] | 164,660 | [14],[15],[22] | 164,660 | [14],[15],[22] | 164,660 | [14],[15],[22] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | $ 74 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [7],[10] | 1,037 | 1,037 | 1,037 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 1,024 | ||||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 8.75% | 8.75% | 8.75% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 14% | 14% | 14% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 8,010 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 7,770 | ||||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Health Care Services, Second Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11] | 8.75% | 8.75% | 8.75% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | (71) | ||||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal & Glass Containers, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [14],[15] | 415 | 415 | 415 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 681 | ||||||||||||
Investment, Identifier [Axis]: SIO2 Medical Products, Inc., Metal, Glass & Plastic Containers, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [7],[10] | 491 | 491 | 491 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 4.75% | 4.75% | 4.75% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 9.97% | 9.97% | 9.97% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 4,463 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 4,139 | ||||||||||||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., Health Care Services, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8% | [7],[10],[11] | 8% | [7],[10],[11] | 8% | [7],[10],[11] | 8% | [14],[15],[16] | 8% | [14],[15],[16] | 8% | [14],[15],[16] | ||
Investment, interest rate | 13.22% | [7],[8],[10],[11] | 13.22% | [7],[8],[10],[11] | 13.22% | [7],[8],[10],[11] | 10.74% | [14],[15],[16],[17] | 10.74% | [14],[15],[16],[17] | 10.74% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 12,034 | [7],[10],[11],[13] | $ 9,109 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 8,289 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | 9,387 | ||||||||||||
Investment, Identifier [Axis]: SPX Flow, Inc., Industrial Machinery, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [15],[16] | 4.50% | 4.50% | 4.50% | ||||||||||
Investment, interest rate | [15],[16],[17] | 7.63% | 7.63% | 7.63% | ||||||||||
Investment owned, balance, principal amount | [15],[16],[18] | $ 1,500 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | $ 1,393 | ||||||||||||
Investment, Identifier [Axis]: SVP-Singer Holdings Inc., Home Furnishings, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.75% | [7],[10],[11] | 6.75% | [7],[10],[11] | 6.75% | [7],[10],[11] | 6.75% | [14],[15],[16] | 6.75% | [14],[15],[16] | 6.75% | [14],[15],[16] | ||
Investment, interest rate | 12.29% | [7],[8],[10],[11] | 12.29% | [7],[8],[10],[11] | 12.29% | [7],[8],[10],[11] | 10.42% | [14],[15],[16],[17] | 10.42% | [14],[15],[16],[17] | 10.42% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 25,592 | [7],[10],[11],[13] | $ 20,766 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 18,188 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | 19,514 | ||||||||||||
Investment, Identifier [Axis]: Sabert Corporation, Metal & Glass Containers, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [15],[16] | 4.50% | 4.50% | 4.50% | ||||||||||
Investment, interest rate | [15],[16],[17] | 7.63% | 7.63% | 7.63% | ||||||||||
Investment owned, balance, principal amount | [15],[16],[18] | $ 1,691 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | $ 1,623 | ||||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11] | 10% | 10% | 10% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ (93) | ||||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 10% | 10% | 10% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 15.24% | 15.24% | 15.24% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 25,558 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 24,791 | ||||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Diversified Financial Services, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [7],[10] | 991,019 | 991,019 | 991,019 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 1,883 | ||||||||||||
Investment, Identifier [Axis]: Scilex Holding Co, Biotechnology, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [10],[20] | 9,307 | 9,307 | 9,307 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [10],[20] | $ 52 | ||||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Membership Interest | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, ownership percentage | 87.50% | |||||||||||||
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 2,026 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 37,651 | |||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | (14,628) | |||||||||||||
Fair Value, Ending Balance | $ 23,023 | |||||||||||||
Investment owned, percent of net assets | 1.80% | |||||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Membership Interest | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [1],[2],[19],[22],[28],[29],[32] | 0.875 | 0.875 | 0.875 | ||||||||||
Investment owned, ownership percentage | [3],[4],[9],[20],[30],[31],[33] | 87.50% | 87.50% | 87.50% | ||||||||||
Investment owned, balance, principal amount | $ 0 | |||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 3,150 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [1],[2],[19],[22],[28],[29],[32] | 20,715 | ||||||||||||
Gross Additions | 7,258 | |||||||||||||
Gross Reductions | 0 | |||||||||||||
Fair Value, Ending Balance | [3],[4],[9],[20],[30],[31],[33] | $ 27,973 | ||||||||||||
Investment owned, percent of net assets | 1.90% | 1.90% | 1.90% | |||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Multi-Sector Holdings, Subordinated Debt | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [3],[4],[7],[9],[11],[20],[30] | 7% | [3],[4],[7],[9],[11],[20],[30] | 7% | [3],[4],[7],[9],[11],[20],[30] | 7% | [1],[2],[14],[16],[19],[22],[28] | 7% | [1],[2],[14],[16],[19],[22],[28] | 7% | [1],[2],[14],[16],[19],[22],[28] | ||
Investment, interest rate | 11.86% | [3],[4],[7],[8],[9],[11],[20],[30] | 11.86% | [3],[4],[7],[8],[9],[11],[20],[30] | 11.86% | [3],[4],[7],[8],[9],[11],[20],[30] | 8.80% | [1],[2],[14],[16],[17],[19],[22],[28] | 8.80% | [1],[2],[14],[16],[17],[19],[22],[28] | 8.80% | [1],[2],[14],[16],[17],[19],[22],[28] | ||
Investment owned, balance, principal amount | $ 112,656 | [3],[4],[7],[9],[11],[13],[20],[30] | $ 96,250 | [1],[2],[14],[16],[18],[19],[22],[28] | ||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 9,197 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [1],[2],[14],[16],[19],[22],[28] | 96,250 | ||||||||||||
Gross Additions | 16,406 | |||||||||||||
Gross Reductions | 0 | |||||||||||||
Fair Value, Ending Balance | [3],[4],[7],[9],[11],[20],[30] | $ 112,656 | ||||||||||||
Investment owned, percent of net assets | 7.50% | 7.50% | 7.50% | |||||||||||
Investment, Identifier [Axis]: Senior Loan Fund JV I, LLC, Subordinated Debt | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | |||||||||||||
Investment, interest rate | 8% | |||||||||||||
Investment owned, balance, principal amount | $ 96,250 | |||||||||||||
Net Realized Gain (Loss) | 0 | |||||||||||||
Amount of Interest, Fees or Dividends Credited in Income | 5,839 | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | 96,250 | |||||||||||||
Gross Additions | 0 | |||||||||||||
Gross Reductions | 0 | |||||||||||||
Fair Value, Ending Balance | $ 96,250 | |||||||||||||
Investment owned, percent of net assets | 7.60% | |||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11],[20] | 7.88% | 7.88% | 7.88% | ||||||||||
Investment, interest rate | [7],[10],[11],[20] | 12.95% | 12.95% | 12.95% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13],[20] | $ 7,191 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 6,931 | ||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11],[20] | 7.88% | 7.88% | 7.88% | ||||||||||
Investment, interest rate | [7],[10],[11],[20] | 12.88% | 12.88% | 12.88% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13],[20] | $ 2,697 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 2,599 | ||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11],[20] | 7.88% | 7.88% | 7.88% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13],[20] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11],[20] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11],[20] | 7.88% | 7.88% | 7.88% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13],[20] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11],[20] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [7],[10],[20] | 58,210 | 58,210 | 58,210 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 202 | ||||||||||||
Investment, Identifier [Axis]: ShareThis, Inc., Application Software, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 345,452 | [7],[10] | 345,452 | [7],[10] | 345,452 | [7],[10] | 345,452 | [14],[15] | 345,452 | [14],[15] | 345,452 | [14],[15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 0 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | 0 | ||||||||||||
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal & Glass Containers, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [14],[15],[16],[17] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18] | $ 46,121 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 45,295 | ||||||||||||
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[10],[23] | 14% | 14% | 14% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[13],[23] | $ 54,730 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[23] | $ 25,997 | ||||||||||||
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[10],[23] | 14% | 14% | 14% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[13],[23] | $ 14,993 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[23] | $ 13,923 | ||||||||||||
Investment, Identifier [Axis]: SiO2 Medical Products, Inc., Metal, Glass & Plastic Containers, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[9],[10],[11],[23] | 14% | 14% | 14% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[13],[23] | $ 4,813 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[23] | $ 4,034 | ||||||||||||
Investment, Identifier [Axis]: SonicWall US Holdings Inc., Technology Distributors, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[10],[11] | 7.50% | [7],[10],[11] | 7.50% | [7],[10],[11] | 7.50% | [14],[15],[16] | 7.50% | [14],[15],[16] | 7.50% | [14],[15],[16] | ||
Investment, interest rate | 12.69% | [7],[8],[10],[11] | 12.69% | [7],[8],[10],[11] | 12.69% | [7],[8],[10],[11] | 10.48% | [14],[15],[16],[17] | 10.48% | [14],[15],[16],[17] | 10.48% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 1,095 | [7],[10],[11],[13] | $ 3,195 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 2,997 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 1,024 | ||||||||||||
Investment, Identifier [Axis]: Sorenson Communications, LLC, Communications Equipment, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [10],[11] | 5.50% | 5.50% | 5.50% | ||||||||||
Investment, interest rate | [8],[10],[11] | 10.69% | 10.69% | 10.69% | ||||||||||
Investment owned, balance, principal amount | [10],[11],[13] | $ 1,054 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [10],[11] | $ 980 | ||||||||||||
Investment, Identifier [Axis]: Sorrento Therapeutics, Inc., Biotechnology, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 66,000 | [10],[20] | 66,000 | [10],[20] | 66,000 | [10],[20] | 50,000 | [15],[22] | 50,000 | [15],[22] | 50,000 | [15],[22] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[22] | $ 79 | ||||||||||||
Fair Value, Ending Balance | [10],[20] | $ 24 | ||||||||||||
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.25% | [7],[9],[10],[11] | 5.25% | [7],[9],[10],[11] | 5.25% | [7],[9],[10],[11] | 5.25% | [14],[15],[16],[19] | 5.25% | [14],[15],[16],[19] | 5.25% | [14],[15],[16],[19] | ||
Investment, interest rate | 10.35% | [7],[8],[9],[10],[11] | 10.35% | [7],[8],[9],[10],[11] | 10.35% | [7],[8],[9],[10],[11] | 8.03% | [14],[15],[16],[17],[19] | 8.03% | [14],[15],[16],[17],[19] | 8.03% | [14],[15],[16],[17],[19] | ||
Investment owned, balance, principal amount | $ 907 | [7],[9],[10],[11],[13] | $ 866 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | 796 | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ 837 | ||||||||||||
Investment, Identifier [Axis]: Spanx, LLC, Apparel Retail, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 5.50% | [7],[10],[11] | 5.50% | [7],[10],[11] | 5.50% | [7],[10],[11] | 5.25% | [14],[15],[16] | 5.25% | [14],[15],[16] | 5.25% | [14],[15],[16] | ||
Investment, interest rate | 10.70% | [7],[8],[10],[11] | 10.70% | [7],[8],[10],[11] | 10.70% | [7],[8],[10],[11] | 8.30% | [14],[15],[16],[17] | 8.30% | [14],[15],[16],[17] | 8.30% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 4,500 | [7],[10],[11],[13] | $ 4,534 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 4,427 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 4,393 | ||||||||||||
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Diversified Financial Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11],[20] | 8.50% | 8.50% | 8.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11],[20] | 11.97% | 11.97% | 11.97% | ||||||||||
Investment owned, balance, principal amount | € | [7],[10],[11],[13],[20] | € 23,731 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 25,632 | ||||||||||||
Investment, Identifier [Axis]: SumUp Holdings Luxembourg S.À.R.L., Other Diversified Financial Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16],[22] | 8.50% | 8.50% | 8.50% | ||||||||||
Investment, interest rate | [14],[15],[16],[17],[22] | 10% | 10% | 10% | ||||||||||
Investment owned, balance, principal amount | £ | [14],[15],[16],[18],[22] | £ 16,911 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[22] | 16,360 | ||||||||||||
Investment, Identifier [Axis]: Sunland Asphalt & Construction, LLC, Construction & Engineering, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 6% | 6% | 6% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 8.88% | 8.88% | 8.88% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 42,618 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 41,723 | ||||||||||||
Investment, Identifier [Axis]: Superior Industries International, Inc., Auto Parts & Equipment, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 7.75% | 7.75% | 7.75% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12.85% | 12.85% | 12.85% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 49,645 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | 49,128 | ||||||||||||
Investment, Identifier [Axis]: Supermoose Borrower, LLC, Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [15],[16] | 3.75% | 3.75% | 3.75% | ||||||||||
Investment, interest rate | [15],[16],[17] | 7.42% | 7.42% | 7.42% | ||||||||||
Investment owned, balance, principal amount | [15],[16],[18] | $ 3,466 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | $ 3,056 | ||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11],[34] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [7],[8],[10],[11],[34] | 12.18% | 12.18% | 12.18% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13],[34] | $ 1,552 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[34] | $ 1,471 | ||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11],[34] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [7],[8],[10],[11],[34] | 12.18% | 12.18% | 12.18% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13],[34] | $ 32,185 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[34] | $ 30,495 | ||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11],[34] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [7],[8],[9],[10],[11],[34] | 12.18% | 12.18% | 12.18% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13],[34] | $ 2,756 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11],[34] | $ 2,593 | ||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11],[34] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [7],[8],[9],[10],[11],[34] | 12.18% | 12.18% | 12.18% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13],[34] | $ 1,099 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11],[34] | $ 926 | ||||||||||||
Investment, Identifier [Axis]: Swordfish Merger Sub LLC, Auto Parts & Equipment, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.75% | [7],[10],[11] | 6.75% | [7],[10],[11] | 6.75% | [7],[10],[11] | 6.75% | [14],[15],[16] | 6.75% | [14],[15],[16] | 6.75% | [14],[15],[16] | ||
Investment, interest rate | 11.94% | [7],[8],[10],[11] | 11.94% | [7],[8],[10],[11] | 11.94% | [7],[8],[10],[11] | 9.81% | [14],[15],[16],[17] | 9.81% | [14],[15],[16],[17] | 9.81% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 12,500 | [7],[10],[11],[13] | $ 12,500 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 11,469 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 11,681 | ||||||||||||
Investment, Identifier [Axis]: TGNR HoldCo LLC, Integrated Oil & Gas, Subordinated Debt | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | 11.50% | [8],[10],[11],[12],[20] | 11.50% | [8],[10],[11],[12],[20] | 11.50% | [8],[10],[11],[12],[20] | 11.50% | [14],[15],[16],[17],[22] | 11.50% | [14],[15],[16],[17],[22] | 11.50% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | $ 4,984 | [10],[12],[13],[20] | $ 4,984 | [14],[15],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[22] | 4,872 | ||||||||||||
Fair Value, Ending Balance | [10],[12],[20] | $ 4,810 | ||||||||||||
Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [7],[8],[10],[11],[20] | 13% | 13% | 13% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[13],[20] | $ 50,419 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[20] | $ 49,809 | ||||||||||||
Investment, Identifier [Axis]: TIBCO Software Inc., Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 4.50% | [10],[11] | 4.50% | [10],[11] | 4.50% | [10],[11] | 4.50% | [15],[16] | 4.50% | [15],[16] | 4.50% | [15],[16] | ||
Investment, interest rate | 9.84% | [8],[10],[11] | 9.84% | [8],[10],[11] | 9.84% | [8],[10],[11] | 8.15% | [15],[16],[17] | 8.15% | [15],[16],[17] | 8.15% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 17,213 | [10],[11],[13] | $ 12,032 | [15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 10,827 | ||||||||||||
Fair Value, Ending Balance | [10],[11] | $ 16,141 | ||||||||||||
Investment, Identifier [Axis]: Tacala, LLC, Restaurants, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [10],[11] | 7.50% | [10],[11] | 7.50% | [10],[11] | 7.50% | [15],[16] | 7.50% | [15],[16] | 7.50% | [15],[16] | ||
Investment, interest rate | 12.69% | [8],[10],[11] | 12.69% | [8],[10],[11] | 12.69% | [8],[10],[11] | 10.62% | [15],[16],[17] | 10.62% | [15],[16],[17] | 10.62% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 12,843 | [10],[11],[13] | $ 9,448 | [15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 8,692 | ||||||||||||
Fair Value, Ending Balance | [10],[11] | $ 12,168 | ||||||||||||
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[9],[10],[11],[20] | 6% | [7],[9],[10],[11],[20] | 6% | [7],[9],[10],[11],[20] | 6% | [14],[15],[16],[19],[22] | 6% | [14],[15],[16],[19],[22] | 6% | [14],[15],[16],[19],[22] | ||
Investment owned, balance, principal amount | $ 0 | [7],[9],[10],[11],[13],[20] | $ 0 | [14],[15],[16],[18],[19],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19],[22] | (28) | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11],[20] | $ (24) | ||||||||||||
Investment, Identifier [Axis]: Tahoe Bidco B.V., Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[10],[11],[20] | 6% | [7],[10],[11],[20] | 6% | [7],[10],[11],[20] | 6% | [14],[15],[16],[22] | 6% | [14],[15],[16],[22] | 6% | [14],[15],[16],[22] | ||
Investment, interest rate | 11.15% | [7],[8],[10],[11],[20] | 11.15% | [7],[8],[10],[11],[20] | 11.15% | [7],[8],[10],[11],[20] | 8.68% | [14],[15],[16],[17],[22] | 8.68% | [14],[15],[16],[17],[22] | 8.68% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | $ 28,826 | [7],[10],[11],[13],[20] | $ 23,215 | [14],[15],[16],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[22] | 22,843 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 28,537 | ||||||||||||
Investment, Identifier [Axis]: Tecta America Corp., Construction & Engineering, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.50% | [7],[10],[11] | 8.50% | [7],[10],[11] | 8.50% | [7],[10],[11] | 8.50% | [14],[15],[16] | 8.50% | [14],[15],[16] | 8.50% | [14],[15],[16] | ||
Investment, interest rate | 13.72% | [7],[8],[10],[11] | 13.72% | [7],[8],[10],[11] | 13.72% | [7],[8],[10],[11] | 11.62% | [14],[15],[16],[17] | 11.62% | [14],[15],[16],[17] | 11.62% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 4,755 | [7],[10],[11],[13] | $ 5,203 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 5,034 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 4,529 | ||||||||||||
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 9.75% | [7],[9],[10],[11] | 9.75% | [7],[9],[10],[11] | 9.75% | [7],[9],[10],[11] | 9.25% | [14],[15],[16],[19] | 9.25% | [14],[15],[16],[19] | 9.25% | [14],[15],[16],[19] | ||
Investment, interest rate | 14.93% | [7],[8],[9],[10],[11] | 14.93% | [7],[8],[9],[10],[11] | 14.93% | [7],[8],[9],[10],[11] | 12.20% | [14],[15],[16],[17],[19] | 12.20% | [14],[15],[16],[17],[19] | 12.20% | [14],[15],[16],[17],[19] | ||
Investment owned, balance, principal amount | $ 1,590 | [7],[9],[10],[11],[13] | $ 1,231 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | 1,187 | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ 1,535 | ||||||||||||
Investment, Identifier [Axis]: Telestream Holdings Corporation, Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 9.75% | [7],[10],[11] | 9.75% | [7],[10],[11] | 9.75% | [7],[10],[11] | 9.25% | [14],[15],[16] | 9.25% | [14],[15],[16] | 9.25% | [14],[15],[16] | ||
Investment, interest rate | 14.99% | [7],[8],[10],[11] | 14.99% | [7],[8],[10],[11] | 14.99% | [7],[8],[10],[11] | 12.11% | [14],[15],[16],[17] | 12.11% | [14],[15],[16],[17] | 12.11% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 23,483 | [7],[10],[11],[13] | $ 18,323 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 17,865 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 22,919 | ||||||||||||
Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 6% | 6% | 6% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 11.09% | 11.09% | 11.09% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 19,947 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | 19,000 | ||||||||||||
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Pharmaceuticals, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [14],[15] | 668,879 | 668,879 | 668,879 | ||||||||||
Investment owned, balance, principal amount | [14],[15],[18] | |||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 4,077 | ||||||||||||
Investment, Identifier [Axis]: TerSera Therapeutics LLC, Pharmaceuticals, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 9.50% | 9.50% | 9.50% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 13.17% | 13.17% | 13.17% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 29,663 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 29,031 | ||||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.30% | [7],[10],[11],[23] | 7.30% | [7],[10],[11],[23] | 7.30% | [7],[10],[11],[23] | 7.30% | [14],[15],[16] | 7.30% | [14],[15],[16] | 7.30% | [14],[15],[16] | ||
Investment, interest rate | [14],[15],[16],[17] | 10.44% | 10.44% | 10.44% | ||||||||||
Investment owned, balance, principal amount | $ 19,163 | [7],[10],[11],[13],[23] | $ 15,674 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 15,682 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[23] | $ 18,286 | ||||||||||||
Investment, Identifier [Axis]: The Avery, Real Estate Operating Companies, Subordinated Debt Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 12.50% | [7],[10],[11],[23] | 12.50% | [7],[10],[11],[23] | 12.50% | [7],[10],[11],[23] | 12.50% | [14],[15],[16] | 12.50% | [14],[15],[16] | 12.50% | [14],[15],[16] | ||
Investment, interest rate | [14],[15],[16],[17] | 16.17% | 16.17% | 16.17% | ||||||||||
Investment owned, balance, principal amount | $ 4,641 | [7],[10],[11],[13],[23] | $ 3,789 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 3,800 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[23] | $ 4,164 | ||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12.50% | 12.50% | 12.50% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 46,832 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 41,919 | ||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [7],[10] | 10,616 | 10,616 | 10,616 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 55 | ||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [7],[10] | 358,299 | 358,299 | 358,299 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 1,526 | ||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [7],[10] | 60,862 | 60,862 | 60,862 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 795 | ||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Broadline Retail, Preferred Equity 4 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [7],[10] | 32,447 | 32,447 | 32,447 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 36,587 | ||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 7% | 7% | 7% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 11.17% | 11.17% | 11.17% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 37,494 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 35,807 | ||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [14],[15] | 8,434 | 8,434 | 8,434 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 69 | ||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [14],[15] | 284,650 | 284,650 | 284,650 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 2,320 | ||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [14],[15] | 48,352 | 48,352 | 48,352 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 979 | ||||||||||||
Investment, Identifier [Axis]: Thrasio, LLC, Internet & Direct Marketing Retail, Preferred Equity 4 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [14],[15],[19] | 23,201 | 23,201 | 23,201 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[19] | $ 26,487 | ||||||||||||
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., Health Care Supplies, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6% | [7],[10],[11] | 6% | [7],[10],[11] | 6% | [7],[10],[11] | 6% | [14],[15],[16] | 6% | [14],[15],[16] | 6% | [14],[15],[16] | ||
Investment, interest rate | 11.20% | [7],[8],[10],[11] | 11.20% | [7],[8],[10],[11] | 11.20% | [7],[8],[10],[11] | 9.12% | [14],[15],[16],[17] | 9.12% | [14],[15],[16],[17] | 9.12% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 11,701 | [7],[10],[11],[13] | $ 6,016 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 5,895 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 11,408 | ||||||||||||
Investment, Identifier [Axis]: Trinitas CLO XV DAC, Multi-Sector Holdings, CLO Notes | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [10],[11],[20] | 7.45% | 7.45% | 7.45% | ||||||||||
Investment, interest rate | [8],[10],[11],[20] | 12.72% | 12.72% | 12.72% | ||||||||||
Investment owned, balance, principal amount | [10],[11],[13],[20] | $ 1,000 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [10],[11],[20] | $ 929 | ||||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [8],[10],[11],[20] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment owned, balance, principal amount | [10],[13],[20] | $ 4,500 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [10],[20] | $ 3,189 | ||||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Other Specialized REITs, Fixed Rate Bond 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [8],[10],[11],[20] | 4.75% | 4.75% | 4.75% | ||||||||||
Investment owned, balance, principal amount | [10],[13],[20] | $ 300 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [10],[20] | 249 | ||||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Specialized REITs, Fixed Rate Bond 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [15],[16],[17],[22] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment owned, balance, principal amount | [15],[18],[22] | $ 4,500 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[22] | 3,026 | ||||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Specialized REITs, Fixed Rate Bond 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [15],[16],[17],[22] | 4.75% | 4.75% | 4.75% | ||||||||||
Investment owned, balance, principal amount | [15],[18],[22] | $ 300 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[22] | $ 238 | ||||||||||||
Investment, Identifier [Axis]: Virgin Pulse, Inc., Application Software, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 7.25% | 7.25% | 7.25% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12.47% | 12.47% | 12.47% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 1,540 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 1,279 | ||||||||||||
Investment, Identifier [Axis]: WIN Brands Group LLC, Housewares & Specialties, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 15% | 15% | 15% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 21.22% | 21.22% | 21.22% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11] | $ 1,323 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 1,247 | ||||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 3.75% | [10],[11] | 3.75% | [10],[11] | 3.75% | [10],[11] | 3.75% | [15],[16] | 3.75% | [15],[16] | 3.75% | [15],[16] | ||
Investment, interest rate | 9.03% | [8],[10],[11] | 9.03% | [8],[10],[11] | 9.03% | [8],[10],[11] | 6.56% | [15],[16],[17] | 6.56% | [15],[16],[17] | 6.56% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 11,822 | [10],[11] | $ 7,564 | [15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 6,795 | ||||||||||||
Fair Value, Ending Balance | [10],[11] | 10,743 | ||||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, Aerospace & Defense, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 7.75% | 7.75% | 7.75% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 10.56% | 10.56% | 10.56% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 6,000 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 5,070 | ||||||||||||
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [14],[15],[16] | 6% | 6% | 6% | ||||||||||
Investment, interest rate | [14],[15],[16],[17] | 10.19% | 10.19% | 10.19% | ||||||||||
Investment owned, balance, principal amount | [14],[15],[16],[18] | $ 40,536 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | $ 40,131 | ||||||||||||
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 11.38% | 11.38% | 11.38% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11] | $ 35,853 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 35,495 | ||||||||||||
Investment, Identifier [Axis]: WPEngine, Inc., Application Software, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 6.50% | 6.50% | 6.50% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 12% | 12% | 12% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11] | $ 19,306 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 19,113 | ||||||||||||
Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, Air Freight & Logistics, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7% | [7],[10],[11] | 7% | [7],[10],[11] | 7% | [7],[10],[11] | 7% | [14],[15],[16] | 7% | [14],[15],[16] | 7% | [14],[15],[16] | ||
Investment, interest rate | 12.50% | [7],[8],[10],[11] | 12.50% | [7],[8],[10],[11] | 12.50% | [7],[8],[10],[11] | 10.67% | [14],[15],[16],[17] | 10.67% | [14],[15],[16],[17] | 10.67% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 5,000 | [7],[10],[11] | $ 5,000 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 4,538 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 4,025 | ||||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 15% | [7],[10],[11] | 15% | [7],[10],[11] | 15% | [7],[10],[11] | 15% | [14],[15],[16] | 15% | [14],[15],[16] | 15% | [14],[15],[16] | ||
Investment, interest rate | 21.22% | [7],[8],[10],[11] | 21.22% | [7],[8],[10],[11] | 21.22% | [7],[8],[10],[11] | 19.64% | [14],[15],[16],[17] | 19.64% | [14],[15],[16],[17] | 19.64% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 1,565 | [7],[10],[11] | $ 2,316 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 2,264 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 1,475 | ||||||||||||
Investment, Identifier [Axis]: Win Brands Group LLC, Housewares & Specialties, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 4,871 | [7],[10] | 4,871 | [7],[10] | 4,871 | [7],[10] | 3,621 | [14],[15] | 3,621 | [14],[15] | 3,621 | [14],[15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 192 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 136 | ||||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Common Stock | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 127,452 | [7],[10] | 127,452 | [7],[10] | 127,452 | [7],[10] | 18,032 | [14],[15] | 18,032 | [14],[15] | 18,032 | [14],[15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 296 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 1,565 | ||||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, First Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.25% | [10],[11] | 6.25% | [10],[11] | 6.25% | [10],[11] | 6.25% | [15],[16] | 6.25% | [15],[16] | 6.25% | [15],[16] | ||
Investment, interest rate | 11.45% | [8],[10],[11] | 11.45% | [8],[10],[11] | 11.45% | [8],[10],[11] | 9.37% | [15],[16],[17] | 9.37% | [15],[16],[17] | 9.37% | [15],[16],[17] | ||
Investment owned, balance, principal amount | $ 24,419 | [10],[11] | $ 25,499 | [15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15],[16] | 23,204 | ||||||||||||
Fair Value, Ending Balance | [10],[11] | 22,862 | ||||||||||||
Investment, Identifier [Axis]: Windstream Services II, LLC, Integrated Telecommunication Services, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [14],[15] | 109,420 | 109,420 | 109,420 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | 1,799 | ||||||||||||
Investment, Identifier [Axis]: Zayo Group Holdings, Inc., Alternative Carriers, Fixed Rate Bond | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, interest rate | [15],[16],[17] | 4% | 4% | 4% | ||||||||||
Investment owned, balance, principal amount | [15],[18] | $ 250 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [15] | $ 201 | ||||||||||||
Investment, Identifier [Axis]: Zep Inc., Specialty Chemicals, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 8.25% | [7],[10],[11] | 8.25% | [7],[10],[11] | 8.25% | [7],[10],[11] | 8.25% | [14],[15],[16] | 8.25% | [14],[15],[16] | 8.25% | [14],[15],[16] | ||
Investment, interest rate | 13.79% | [7],[8],[10],[11] | 13.79% | [7],[8],[10],[11] | 13.79% | [7],[8],[10],[11] | 11.92% | [14],[15],[16],[17] | 11.92% | [14],[15],[16],[17] | 11.92% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 19,578 | [7],[10],[11] | $ 19,578 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 16,152 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 13,693 | ||||||||||||
Investment, Identifier [Axis]: Zephyr Bidco Limited, Specialized Finance, Second Lien Term Loan | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.50% | [7],[10],[11],[20] | 7.50% | [7],[10],[11],[20] | 7.50% | [7],[10],[11],[20] | 7.50% | [14],[15],[16],[22] | 7.50% | [14],[15],[16],[22] | 7.50% | [14],[15],[16],[22] | ||
Investment, interest rate | 12.46% | [7],[8],[10],[11],[20] | 12.46% | [7],[8],[10],[11],[20] | 12.46% | [7],[8],[10],[11],[20] | 9.72% | [14],[15],[16],[17],[22] | 9.72% | [14],[15],[16],[17],[22] | 9.72% | [14],[15],[16],[17],[22] | ||
Investment owned, balance, principal amount | £ | £ 20,000 | [7],[10],[11],[20] | £ 18,000 | [14],[15],[16],[18],[22] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[22] | $ 16,552 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11],[20] | $ 23,270 | ||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., Health Care Technology, Preferred Equity | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | 21,523 | [7],[10] | 21,523 | [7],[10] | 21,523 | [7],[10] | 18,635 | [14],[15] | 18,635 | [14],[15] | 18,635 | [14],[15] | ||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15] | $ 16,575 | ||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 18,821 | ||||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 6.75% | [7],[9],[10],[11] | 6.75% | [7],[9],[10],[11] | 6.75% | [7],[9],[10],[11] | 6.75% | [14],[15],[16],[19] | 6.75% | [14],[15],[16],[19] | 6.75% | [14],[15],[16],[19] | ||
Investment, interest rate | [7],[8],[9],[10],[11] | 11.99% | 11.99% | 11.99% | ||||||||||
Investment owned, balance, principal amount | $ 377 | [7],[9],[10],[11],[13] | $ 0 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | (32) | ||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ 288 | ||||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[10],[11] | 7.25% | [7],[10],[11] | 7.25% | [7],[10],[11] | 6.75% | [14],[15],[16] | 6.75% | [14],[15],[16] | 6.75% | [14],[15],[16] | ||
Investment, interest rate | 8.50% | [7],[8],[10],[11] | 8.50% | [7],[8],[10],[11] | 8.50% | [7],[8],[10],[11] | 9.49% | [14],[15],[16],[17] | 9.49% | [14],[15],[16],[17] | 9.49% | [14],[15],[16],[17] | ||
Investment owned, balance, principal amount | $ 24,188 | [7],[10],[11],[13] | $ 19,203 | [14],[15],[16],[18] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16] | 18,867 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 23,235 | ||||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | 7.25% | [7],[10],[11] | 7.25% | [7],[10],[11] | 7.25% | [7],[10],[11] | 6.75% | [14],[15],[16],[19] | 6.75% | [14],[15],[16],[19] | 6.75% | [14],[15],[16],[19] | ||
Investment, interest rate | [7],[8],[10],[11] | 12.38% | 12.38% | 12.38% | ||||||||||
Investment owned, balance, principal amount | $ 3,636 | [7],[10],[11],[13] | $ 0 | [14],[15],[16],[18],[19] | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Beginning Balance | [14],[15],[16],[19] | 0 | ||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 3,563 | ||||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11] | 7.25% | 7.25% | 7.25% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 1 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[10],[11] | 8.75% | 8.75% | 8.75% | ||||||||||
Investment, interest rate | [7],[8],[10],[11] | 11.75% | 11.75% | 11.75% | ||||||||||
Investment owned, balance, principal amount | [7],[10],[11],[13] | $ 5,212 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10],[11] | $ 5,034 | ||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 2 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11] | 8.75% | 8.75% | 8.75% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, First Lien Term Loan 3 | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment, basis spread, variable rate | [7],[9],[10],[11] | 8.75% | 8.75% | 8.75% | ||||||||||
Investment owned, balance, principal amount | [7],[9],[10],[11],[13] | $ 0 | ||||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[9],[10],[11] | $ 0 | ||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Pharmaceuticals, Warrants | ||||||||||||||
Schedule of Investments [Line Items] | ||||||||||||||
Investment owned, balance (in shares) | shares | [7],[10] | 53,700 | 53,700 | 53,700 | ||||||||||
Investments in and Advances to Affiliates, at Fair Value [Roll Forward] | ||||||||||||||
Fair Value, Ending Balance | [7],[10] | $ 407 | ||||||||||||
[1]As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the year ended September 30, 2022 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.[2]Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.[3]As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the nine months ended June 30, 2023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.[4]Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.[5]Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.[6]Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.[7] As of June 30, 2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820"). ten twenty ten twenty ten twenty ten twenty |
Uncategorized Items - ocsl-2023
Label | Element | Value |
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | $ 26,364,000 |
SLF JV I, LLC [Member] | ||
Investment Owned, Cost | us-gaap_InvestmentOwnedAtCost | 54,800,000 |
Investment Owned, Cost | us-gaap_InvestmentOwnedAtCost | 49,300,000 |
Investment Owned, Fair Value | us-gaap_InvestmentOwnedAtFairValue | 28,000,000 |
Investment Owned, Fair Value | us-gaap_InvestmentOwnedAtFairValue | 20,700,000 |
Dividend Income, Operating | us-gaap_DividendIncomeOperating | 1,100,000 |
Dividend Income, Operating | us-gaap_DividendIncomeOperating | 3,200,000 |
Dividend Income, Operating | us-gaap_DividendIncomeOperating | 900,000 |
Dividend Income, Operating | us-gaap_DividendIncomeOperating | $ 2,000,000 |
SLF JV I Notes [Member] | ||
Investment, Interest Rate, Floor | us-gaap_InvestmentInterestRateFloor | 1% |
Investment, Basis Spread, Variable Rate | us-gaap_InvestmentBasisSpreadVariableRate | 7% |
Investment Owned, Cost | us-gaap_InvestmentOwnedAtCost | $ 96,300,000 |
Investment Owned, Cost | us-gaap_InvestmentOwnedAtCost | 112,700,000 |
Investment Owned, Fair Value | us-gaap_InvestmentOwnedAtFairValue | 112,700,000 |
Investment Owned, Fair Value | us-gaap_InvestmentOwnedAtFairValue | 96,300,000 |
Interest Income, Operating | us-gaap_InterestIncomeOperating | 3,400,000 |
Interest Income, Operating | us-gaap_InterestIncomeOperating | 9,200,000 |
Interest Income, Operating | us-gaap_InterestIncomeOperating | 1,900,000 |
Interest Income, Operating | us-gaap_InterestIncomeOperating | $ 5,800,000 |
Glick JV Notes [Member] | ||
Investment, Basis Spread, Variable Rate | us-gaap_InvestmentBasisSpreadVariableRate | 4.50% |
Interest Income, Operating | us-gaap_InterestIncomeOperating | $ 1,800,000 |
Interest Income, Operating | us-gaap_InterestIncomeOperating | 5,000,000 |
Interest Income, Operating | us-gaap_InterestIncomeOperating | 1,200,000 |
Interest Income, Operating | us-gaap_InterestIncomeOperating | 3,300,000 |
SLF JV I [Member] | SLF JV I, LLC [Member] | ||
Investment Company, Financial Support to Investee Contractually Required, Not Provided, Amount | us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount | 3,300,000 |
Investment Company, Financial Support to Investee Contractually Required, Not Provided, Amount | us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount | 8,800,000 |
Investment Company, Financial Support To Investee During Period | ocsl_InvestmentCompanyFinancialSupportToInvesteeDuringPeriod | 5,500,000 |
SLF JV I [Member] | SLF JV I Notes [Member] | ||
Investment Company, Financial Support to Investee Contractually Required, Not Provided, Amount | us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount | 9,800,000 |
Investment Company, Financial Support to Investee Contractually Required, Not Provided, Amount | us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount | 26,200,000 |
Investment Company, Financial Support To Investee During Period | ocsl_InvestmentCompanyFinancialSupportToInvesteeDuringPeriod | 16,400,000 |
OCSI Glick JV LLC [Member] | Glick JV Notes [Member] | ||
Investment Owned, Cost | us-gaap_InvestmentOwnedAtCost | 50,300,000 |
Investment Owned, Fair Value | us-gaap_InvestmentOwnedAtFairValue | 50,300,000 |
Investment Company, Financial Commitment To Investee, Aggregate Amount | ocsl_InvestmentCompanyFinancialCommitmentToInvesteeAggregateAmount | 78,800,000 |
Investment Company, Financial Commitment To Investee, Aggregate Amount | ocsl_InvestmentCompanyFinancialCommitmentToInvesteeAggregateAmount | 78,800,000 |
Investment Company, Financial Support to Investee Contractually Required, Not Provided, Amount | us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount | 12,400,000 |
Investment Company, Financial Support to Investee Contractually Required, Not Provided, Amount | us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount | $ 12,400,000 |
Investment Owned, Ownership Percentage | ocsl_InvestmentOwnedOwnershipPercentage | 87.50% |
Investment Owned, Ownership Percentage | ocsl_InvestmentOwnedOwnershipPercentage | 12.50% |
OCSI Glick JV LLC [Member] | Glick JV LLC [Member] | ||
Investment Owned, Cost | us-gaap_InvestmentOwnedAtCost | $ 49,600,000 |
Investment Owned, Fair Value | us-gaap_InvestmentOwnedAtFairValue | 49,600,000 |
Investment Company, Financial Commitment To Investee, Aggregate Amount | ocsl_InvestmentCompanyFinancialCommitmentToInvesteeAggregateAmount | 8,700,000 |
Investment Company, Financial Commitment To Investee, Aggregate Amount | ocsl_InvestmentCompanyFinancialCommitmentToInvesteeAggregateAmount | 8,700,000 |
Investment Company, Financial Support to Investee Contractually Required, Not Provided, Amount | us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount | 1,600,000 |
Investment Company, Financial Support to Investee Contractually Required, Not Provided, Amount | us-gaap_InvestmentCompanyFinancialCommitmentToInvesteeFutureAmount | $ 1,600,000 |
Investment Owned, Ownership Percentage | ocsl_InvestmentOwnedOwnershipPercentage | 87.50% |
Investment Owned, Ownership Percentage | ocsl_InvestmentOwnedOwnershipPercentage | 12.50% |